data_5obn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5obn _Structure_validation_residue.Date_analyzed 2018-01-19 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 19.5 p -129.79 167.37 18.2 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.58 1.952 . . . . 0.0 109.951 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.3 tt -68.92 144.38 14.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 O-C-N 121.511 -0.743 . . . . 0.0 111.106 -160.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 62.0 m -84.11 150.63 25.42 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.159 -0.338 . . . . 0.0 111.471 172.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 42.5 ttp85 -59.37 -41.24 88.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.54 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -61.67 -29.83 70.33 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -80.29 -44.39 19.67 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.449 1.1 . . . . 0.0 113.121 171.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 22.3 tp -59.18 -46.07 89.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.725 0.81 . . . . 0.0 112.145 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -60.3 -21.9 62.53 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -63.26 -33.87 76.43 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.889 0.768 . . . . 0.0 112.328 171.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -107.41 84.19 0.37 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.999 1.285 . . . . 0.0 110.958 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -161.34 152.51 18.59 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.259 0.624 . . . . 0.0 110.555 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.6 pt -127.76 151.07 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.131 0.972 . . . . 0.0 112.868 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 92.1 p -76.75 166.13 23.79 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.203 1.401 . . . . 0.0 112.057 162.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -57.03 -24.51 54.26 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 168.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -71.89 -37.28 70.17 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.493 1.517 . . . . 0.0 111.815 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -80.08 -37.04 34.61 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.487 0.715 . . . . 0.0 110.548 167.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 27.6 ttm -59.74 -46.86 87.84 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.614 -1.304 . . . . 0.0 112.161 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -78.8 15.0 1.15 Allowed 'General case' 0 CA--C 1.552 1.032 0 O-C-N 120.627 -1.296 . . . . 0.0 112.74 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.69 -31.92 5.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.28 2.632 . . . . 0.0 114.474 171.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 34.1 mt -75.54 133.69 40.93 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.857 1.663 . . . . 0.0 111.755 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 91.5 p -63.31 -32.32 73.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.277 1.031 . . . . 0.0 112.17 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.71 -15.34 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.328 78.0 m-85 -106.66 8.38 31.07 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -54.06 -16.27 1.88 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 118.105 2.632 . . . . 0.0 118.105 -165.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.4 m -147.6 14.19 1.07 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.589 1.155 . . . . 0.0 113.98 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -130.49 130.72 44.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.221 1.008 . . . . 0.0 109.465 -162.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -143.87 133.01 11.41 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.153 1.381 . . . . 0.0 113.183 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.02 -178.77 4.0 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 125.207 3.938 . . . . 0.0 114.982 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 96.52 -9.7 66.8 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 164.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -68.92 150.74 97.53 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 119.031 1.416 . . . . 0.0 113.204 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.11 114.35 4.01 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.767 2.978 . . . . 0.0 111.923 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.51 142.65 12.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.25 1.42 . . . . 0.0 107.579 168.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.5 p -77.51 -14.02 59.78 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.406 1.082 . . . . 0.0 112.691 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -107.33 141.09 39.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.531 1.132 . . . . 0.0 109.029 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 4.8 pt -126.94 159.21 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 125.504 1.522 . . . . 0.0 109.429 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -140.63 160.17 40.59 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.9 t -134.25 137.19 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.191 1.396 . . . . 0.0 111.261 -172.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -112.11 165.83 11.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.136 0.974 . . . . 0.0 109.961 166.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.3 t30 65.81 36.07 6.36 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.721 1.209 . . . . 0.0 113.491 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.95 153.78 42.81 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.422 -0.798 . . . . 0.0 110.294 163.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.76 148.45 49.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.857 0.863 . . . . 0.0 113.029 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -62.06 -34.04 75.52 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.767 -1.208 . . . . 0.0 111.141 158.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -60.86 -10.2 5.27 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.545 1.938 . . . . 0.0 115.418 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.1 p -121.13 155.99 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -170.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -119.53 161.65 20.23 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.619 1.567 . . . . 0.0 111.122 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -55.08 -35.38 64.51 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.955 -1.091 . . . . 0.0 113.059 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -63.63 -16.68 61.6 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.108 1.363 . . . . 0.0 114.585 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -91.64 -31.68 15.76 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.15 -21.36 66.52 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.319 -0.863 . . . . 0.0 112.315 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -48.57 -35.14 12.8 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.068 1.347 . . . . 0.0 112.813 169.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -58.6 -35.34 72.29 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.0 mt -98.6 -57.88 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.284 0.634 . . . . 0.0 110.298 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.291 59.6 m-85 -60.7 -30.38 69.92 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.44 -6.91 86.96 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.104 0.859 . . . . 0.0 114.669 173.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -56.36 -34.02 66.24 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.341 1.57 . . . . 0.0 111.412 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.96 9.8 26.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.106 1.762 . . . . 0.0 113.855 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.36 113.49 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.554 1.541 . . . . 0.0 109.535 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.77 80.17 0.19 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -54.7 -18.2 4.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 119.013 2.968 . . . . 0.0 119.013 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.4 m -71.75 -12.64 61.41 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.563 1.074 . . . . 0.0 112.857 170.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.7 m -115.15 116.49 28.47 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.191 1.796 . . . . 0.0 111.867 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -59.06 -43.41 91.74 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.216 -0.928 . . . . 0.0 112.704 -173.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.3 t -55.96 -14.56 2.59 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -88.09 -60.99 1.82 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.697 0.761 . . . . 0.0 110.018 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -69.69 -25.82 64.06 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.127 1.371 . . . . 0.0 113.876 -173.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.8 tt -55.25 -35.91 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.057 1.343 . . . . 0.0 112.098 170.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 10.5 mtm -90.03 -3.93 57.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.343 1.057 . . . . 0.0 112.614 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -101.12 134.21 44.48 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.244 2.217 . . . . 0.0 115.994 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -166.16 156.71 12.73 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.212 1.405 . . . . 0.0 108.183 174.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.2 mt -130.82 134.94 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.741 1.216 . . . . 0.0 110.283 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -120.81 132.8 55.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.891 0.876 . . . . 0.0 109.873 159.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 4.1 tt -103.2 133.29 48.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.155 1.382 . . . . 0.0 110.006 168.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.61 91.68 3.43 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 125.767 1.627 . . . . 0.0 110.846 171.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -67.95 -23.82 65.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 -174.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.407 ' HA ' ' HE3' ' A' ' 466' ' ' LYS . 26.0 pt-20 -154.76 175.03 14.23 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -175.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 87.79 -169.05 38.34 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.669 1.604 . . . . 0.0 114.15 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 4.02 1.99 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 74.1 mtp -129.98 20.21 5.44 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.965 2.506 . . . . 0.0 112.437 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.407 ' HE3' ' HA ' ' A' ' 462' ' ' GLU . 35.9 ttmt -52.08 138.85 24.47 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.994 1.318 . . . . 0.0 111.803 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.78 32.56 61.16 Favored Glycine 0 CA--C 1.524 0.619 0 O-C-N 121.809 -0.557 . . . . 0.0 111.81 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.71 155.49 20.13 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.683 1.193 . . . . 0.0 110.79 165.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -148.27 148.19 30.19 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.143 -0.973 . . . . 0.0 112.733 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -113.05 138.24 50.2 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.761 1.624 . . . . 0.0 114.768 167.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.7 112.72 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.164 1.786 . . . . 0.0 109.482 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -78.79 134.55 14.14 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 159.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 20.2 mt -109.39 161.96 21.99 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.226 1.41 . . . . 0.0 109.913 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.53 -12.3 29.17 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.031 2.487 . . . . 0.0 113.654 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -153.5 142.66 21.4 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.703 0.683 . . . . 0.0 112.013 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -60.12 -29.88 68.91 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -67.94 -36.42 80.1 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 170.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -66.48 -39.32 88.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.79 0.436 . . . . 0.0 110.663 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.39 -43.16 86.63 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.512 -0.743 . . . . 0.0 112.638 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -55.78 -43.52 76.85 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.35 0.977 . . . . 0.0 111.78 176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -65.69 -52.86 48.14 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.081 1.352 . . . . 0.0 111.773 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.27 71.44 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 51.3 mt -68.95 -39.05 79.76 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.929 -1.107 . . . . 0.0 110.712 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -68.07 -22.77 64.91 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.794 1.238 . . . . 0.0 112.44 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -110.14 -39.73 4.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -84.45 -17.75 38.17 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -75.45 117.33 17.12 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.097 -1.002 . . . . 0.0 112.308 -168.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 101.47 3.24 53.44 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.231 -1.316 . . . . 0.0 115.043 -169.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -69.08 125.49 26.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.482 1.641 . . . . 0.0 113.48 -169.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.266 1.9 t -86.01 46.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.632 1.573 . . . . 0.0 114.836 -162.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 57.3 tp -58.85 120.26 8.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.47 1.508 . . . . 0.0 111.71 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.334 72.1 m-85 55.22 21.25 3.89 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -173.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 98.31 -6.41 61.42 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.689 1.614 . . . . 0.0 115.015 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -106.15 122.11 43.33 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.182 1.491 . . . . 0.0 111.864 -170.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.75 105.92 2.17 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.416 2.744 . . . . 0.0 112.548 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 44.1 mtp -67.41 131.82 46.44 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.999 1.32 . . . . 0.0 113.403 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.52 84.7 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.901 2.081 . . . . 0.0 110.945 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.28 125.79 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 126.578 1.951 . . . . 0.0 112.321 -170.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -141.63 158.73 43.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.654 1.181 . . . . 0.0 113.046 -170.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -61.24 146.41 47.92 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 166.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 122.586 1.184 . . . . 0.0 112.233 -175.901 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 122.418 1.104 . . . . 0.0 111.99 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -143.28 167.66 21.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.132 1.373 . . . . 0.0 112.151 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.8 tt -78.68 154.29 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.855 1.262 . . . . 0.0 111.989 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 30.6 t -91.01 154.07 19.69 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.235 0.614 . . . . 0.0 111.101 167.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -44.26 -43.09 7.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.034 1.333 . . . . 0.0 112.502 164.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -71.55 -18.19 62.27 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -89.44 -39.34 13.44 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.177 -0.952 . . . . 0.0 113.445 165.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.38 -48.65 69.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.201 1.0 . . . . 0.0 112.788 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -56.8 -25.89 56.72 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.76 1.624 . . . . 0.0 113.941 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.86 -44.87 84.12 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.91 1.284 . . . . 0.0 110.832 175.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.55 78.08 0.73 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.308 1.432 . . . . 0.0 113.196 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -157.48 149.47 22.39 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.642 1.577 . . . . 0.0 109.642 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.7 pt -127.83 149.97 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.9 0.88 . . . . 0.0 111.567 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 8.8 m -80.41 167.78 19.78 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.89 0.876 . . . . 0.0 112.228 169.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -55.92 -29.22 59.73 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.271 -0.893 . . . . 0.0 112.765 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.63 -31.79 69.83 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.56 1.944 . . . . 0.0 113.309 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.57 -34.29 14.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.502 1.121 . . . . 0.0 110.947 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 9.7 ttm -61.26 -39.29 89.81 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.952 -1.092 . . . . 0.0 111.279 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.15 26.41 0.88 Allowed 'General case' 0 CA--C 1.552 1.056 0 O-C-N 120.846 -1.159 . . . . 0.0 112.455 172.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.51 -34.81 1.17 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.109 2.563 . . . . 0.0 113.858 174.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.37 134.0 42.48 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.803 1.641 . . . . 0.0 112.613 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 27.1 t -59.43 -37.86 79.18 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.707 0.803 . . . . 0.0 113.092 172.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . 0.27 3.1 m -60.44 -11.05 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 171.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -122.49 11.2 9.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 119.237 3.051 . . . . 0.0 119.237 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -14.28 16.27 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -173.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.53 -27.48 1.18 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.556 1.542 . . . . 0.0 114.423 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -69.83 136.56 50.92 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -144.86 124.98 7.25 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.53 171.97 16.66 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.128 3.219 . . . . 0.0 111.629 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.48 -4.79 33.02 Favored Glycine 0 N--CA 1.48 1.594 0 N-CA-C 117.33 1.692 . . . . 0.0 117.33 170.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -74.58 131.75 79.41 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 119.079 1.439 . . . . 0.0 111.817 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.12 112.92 2.43 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.105 2.537 . . . . 0.0 111.032 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -159.9 145.7 15.61 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.605 1.162 . . . . 0.0 109.498 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 21.3 p -86.1 -8.35 57.94 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -117.95 148.54 42.09 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.667 1.187 . . . . 0.0 110.07 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 17.8 pt -135.01 166.35 28.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.474 1.91 . . . . 0.0 110.046 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -137.93 163.64 31.0 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.88 143.85 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.652 1.581 . . . . 0.0 111.573 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -126.65 168.81 13.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.658 1.983 . . . . 0.0 109.905 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 12.9 t30 68.5 31.25 4.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.817 1.247 . . . . 0.0 112.808 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -74.54 144.51 44.01 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.018 -1.051 . . . . 0.0 111.856 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.34 156.98 17.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.928 1.691 . . . . 0.0 114.778 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -59.55 -45.74 90.93 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.238 -0.914 . . . . 0.0 112.964 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -70.87 -26.94 63.47 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -175.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.15 152.65 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -172.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -129.41 162.1 28.83 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.732 2.013 . . . . 0.0 111.038 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -53.22 -30.84 40.12 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.096 1.358 . . . . 0.0 113.401 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -58.06 -25.85 61.77 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.166 1.787 . . . . 0.0 115.282 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -90.02 -28.55 19.0 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.5 mp -66.47 -19.99 65.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.32 1.448 . . . . 0.0 112.206 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.44 -25.24 59.34 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 174.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -61.47 -36.33 80.12 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.941 0.791 . . . . 0.0 111.477 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.4 mp -96.78 -56.58 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.202 0.601 . . . . 0.0 110.679 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.258 70.1 m-85 -60.11 -32.99 71.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.82 -7.24 87.41 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.062 0.839 . . . . 0.0 114.522 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -61.2 -39.71 91.2 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.842 1.321 . . . . 0.0 111.46 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -81.06 -0.79 41.41 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.585 1.954 . . . . 0.0 113.815 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 36.0 t -115.09 116.53 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.718 1.207 . . . . 0.0 109.996 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.262 4.2 m-20 -68.72 90.97 0.42 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 176.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -61.74 -16.53 50.12 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 119.006 2.965 . . . . 0.0 119.006 -173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 71.0 m -79.09 1.5 24.0 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.01 0.924 . . . . 0.0 113.361 168.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 11.1 t -126.89 112.68 15.6 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.65 1.18 . . . . 0.0 110.947 -173.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -59.86 -47.14 86.95 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.243 -0.911 . . . . 0.0 112.274 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 3.9 t -55.92 -15.24 3.13 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -89.21 -58.39 2.55 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.221 1.008 . . . . 0.0 110.685 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -71.59 -25.58 62.24 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.716 1.206 . . . . 0.0 113.432 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.3 tt -56.65 -33.12 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.263 1.425 . . . . 0.0 112.151 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -87.51 -5.81 58.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.308 1.443 . . . . 0.0 112.964 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -115.81 120.11 38.19 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -162.41 155.34 19.87 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.327 1.451 . . . . 0.0 107.61 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.1 mt -125.05 137.6 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.767 1.627 . . . . 0.0 110.499 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 -127.51 128.78 46.24 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.395 1.478 . . . . 0.0 109.485 165.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 14.1 tp -111.18 134.91 52.41 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.439 1.896 . . . . 0.0 109.308 170.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 50.7 mtm -89.38 133.18 34.62 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 126.518 1.927 . . . . 0.0 111.151 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -129.45 11.53 5.83 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -167.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -136.98 153.16 50.76 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.555 1.142 . . . . 0.0 112.476 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 70.66 -160.75 53.8 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.659 1.123 . . . . 0.0 115.379 171.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -6.11 27.37 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.732 1.613 . . . . 0.0 115.269 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 95.8 mmm -102.39 1.23 35.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.563 1.545 . . . . 0.0 114.611 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -62.31 132.99 54.48 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.639 1.563 . . . . 0.0 110.651 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.56 29.36 36.21 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.98 0.8 . . . . 0.0 113.597 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -121.09 148.05 44.7 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.444 1.098 . . . . 0.0 112.265 165.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -140.35 155.24 46.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.427 1.491 . . . . 0.0 114.02 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -113.46 140.35 48.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.415 1.886 . . . . 0.0 115.711 167.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -138.06 128.28 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.764 1.626 . . . . 0.0 111.223 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.76 143.94 17.44 Favored Glycine 0 CA--C 1.534 1.246 0 O-C-N 121.434 -0.792 . . . . 0.0 111.955 164.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 31.7 mt -126.67 155.17 75.37 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.579 1.152 . . . . 0.0 110.799 172.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.47 -6.17 17.93 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.835 2.357 . . . . 0.0 114.94 -168.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -154.25 143.15 21.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.92 0.888 . . . . 0.0 110.606 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -56.29 -30.9 63.09 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.044 -1.035 . . . . 0.0 112.859 169.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -66.26 -41.17 90.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.274 0.943 . . . . 0.0 113.394 171.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.62 96.89 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 119.423 -0.322 . . . . 0.0 110.797 174.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.84 -46.62 77.84 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.763 0.711 . . . . 0.0 112.338 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.9 -41.97 83.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.277 0.944 . . . . 0.0 112.101 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -69.96 -45.8 66.63 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.527 1.131 . . . . 0.0 112.159 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -63.12 -31.56 72.73 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 26.6 mt -69.32 -45.98 68.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.634 1.106 . . . . 0.0 110.549 172.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -59.92 -34.38 73.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.97 1.308 . . . . 0.0 111.86 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -88.11 -49.52 6.97 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.22 -23.87 37.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -167.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -73.08 104.62 4.22 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.816 -0.553 . . . . 0.0 109.602 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 117.82 -6.8 15.59 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 117.829 -1.539 . . . . 0.0 116.134 -167.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -65.67 132.64 49.29 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.064 1.932 . . . . 0.0 113.874 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.281 0.2 OUTLIER -94.06 47.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -157.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 31.5 tp -54.9 122.02 9.91 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.016 1.326 . . . . 0.0 111.342 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.385 50.5 m-85 59.42 12.97 2.95 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 -173.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 89.15 1.42 79.15 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.046 -1.034 . . . . 0.0 114.306 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -107.06 125.13 33.28 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 126.235 1.814 . . . . 0.0 111.012 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.05 121.06 7.5 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.034 2.49 . . . . 0.0 112.644 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 71.5 mtp -73.01 127.58 32.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.163 1.385 . . . . 0.0 111.347 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 92.7 t -92.55 95.89 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.352 1.861 . . . . 0.0 109.041 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 15.2 t -100.07 114.54 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.399 2.28 . . . . 0.0 112.296 -172.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.09 162.5 32.75 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -56.91 144.98 31.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.418 1.087 . . . . 0.0 110.27 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -176.007 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 . . . . . 0 C--O 1.236 0.361 0 CA-C-O 121.396 0.617 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.3 p -148.0 161.9 40.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.328 1.451 . . . . 0.0 114.761 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.3 tt -69.87 158.64 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 126.177 1.791 . . . . 0.0 111.8 -172.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 73.8 m -92.33 152.38 19.8 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.953 -0.467 . . . . 0.0 111.399 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -56.56 -41.31 76.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.2 0.6 . . . . 0.0 111.365 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.09 -35.86 79.96 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -77.71 -30.87 52.0 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.2 tt -65.17 -48.96 71.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.378 1.071 . . . . 0.0 111.274 171.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -54.42 -24.69 20.95 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.376 1.871 . . . . 0.0 115.711 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -67.53 -36.01 80.19 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.568 1.147 . . . . 0.0 111.959 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.61 76.37 0.73 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 125.992 1.758 . . . . 0.0 111.372 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -163.65 145.98 9.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.24 1.016 . . . . 0.0 110.155 -172.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.7 pt -124.8 148.97 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.116 0.966 . . . . 0.0 112.509 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 33.7 t -81.28 166.97 20.05 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.643 1.177 . . . . 0.0 110.695 165.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -53.29 -31.96 46.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.41 1.084 . . . . 0.0 112.905 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -59.15 -19.68 47.0 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.927 1.691 . . . . 0.0 113.075 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -111.83 -28.56 8.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.342 1.857 . . . . 0.0 111.934 171.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 15.7 ttm -67.01 -38.38 85.87 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.195 -1.566 . . . . 0.0 111.936 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -83.89 31.51 0.48 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.815 0.846 . . . . 0.0 111.062 169.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.98 -42.18 0.53 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.313 1.845 . . . . 0.0 115.404 171.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.39 128.43 35.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.648 0.779 . . . . 0.0 109.308 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 50.9 m -59.97 -33.53 72.07 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.329 0.651 . . . . 0.0 112.34 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 5.3 m -63.41 -25.58 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.288 82.6 m-85 -94.07 -9.71 35.77 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -21.5 0.85 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 -163.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 15.6 m -143.9 24.82 1.65 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.476 1.91 . . . . 0.0 112.081 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -122.0 132.3 54.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.428 2.291 . . . . 0.0 112.371 -173.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -142.28 131.98 12.3 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -164.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.1 176.73 8.57 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.566 2.844 . . . . 0.0 111.685 161.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.01 69.16 1.41 Allowed Glycine 0 CA--C 1.532 1.098 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 172.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -145.7 155.16 52.62 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 126.463 1.905 . . . . 0.0 110.833 165.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -82.24 84.74 1.78 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.978 3.119 . . . . 0.0 112.371 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -139.4 143.46 37.68 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.232 -0.917 . . . . 0.0 111.792 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 29.8 p -84.33 7.21 20.16 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -135.11 145.49 47.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.682 1.593 . . . . 0.0 110.082 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 24.1 pt -139.53 162.21 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.507 1.923 . . . . 0.0 109.706 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -133.4 161.77 33.64 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 123.193 1.473 . . . . 0.0 107.722 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.5 t -130.27 139.35 51.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.769 1.628 . . . . 0.0 110.834 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -119.68 168.23 11.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.184 1.794 . . . . 0.0 109.916 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 9.8 t30 68.31 32.38 4.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.657 1.183 . . . . 0.0 111.602 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.96 134.51 41.5 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.522 -0.736 . . . . 0.0 109.972 167.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.9 170.82 1.91 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -173.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -65.52 -50.04 66.74 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.772 1.229 . . . . 0.0 112.92 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -68.06 -42.17 80.88 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.46 152.45 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 127.258 2.223 . . . . 0.0 116.231 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -139.69 170.39 15.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.975 1.31 . . . . 0.0 112.488 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -54.51 -33.77 60.49 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.435 -1.415 . . . . 0.0 113.565 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 34.6 pttt -58.75 -39.46 80.99 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 171.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.28 -32.75 72.11 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.737 1.215 . . . . 0.0 113.538 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.6 mp -69.57 -27.61 65.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.677 1.191 . . . . 0.0 112.805 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -30.67 63.55 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.023 0.829 . . . . 0.0 112.293 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.08 -34.18 74.51 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.46 1.104 . . . . 0.0 111.845 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.12 -58.34 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.127 -0.983 . . . . 0.0 110.827 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -57.68 -29.57 64.75 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.51 -14.78 82.11 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.077 -0.846 . . . . 0.0 114.581 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -56.97 -37.05 71.05 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.263 1.531 . . . . 0.0 111.959 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.63 -7.48 53.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.353 1.461 . . . . 0.0 113.686 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 18.1 t -118.54 123.11 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.72 2.008 . . . . 0.0 110.929 -171.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -75.69 111.6 11.19 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -65.42 -15.13 62.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 70.5 m -89.23 -12.47 40.69 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.197 0.999 . . . . 0.0 113.402 172.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 24.1 t -111.72 109.44 19.3 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.252 1.021 . . . . 0.0 110.845 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -57.92 -45.33 86.68 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.563 -0.711 . . . . 0.0 111.739 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.74 -17.2 5.48 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -87.34 -61.21 1.77 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.31 1.044 . . . . 0.0 110.28 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -70.5 -19.31 62.93 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.084 1.353 . . . . 0.0 113.986 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.1 tt -63.66 -32.62 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.468 1.507 . . . . 0.0 112.531 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.1 mmm -86.88 -14.52 41.77 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.639 1.176 . . . . 0.0 112.42 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -96.13 124.59 40.19 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -171.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -160.51 146.3 15.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.31 143.94 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.305 1.042 . . . . 0.0 110.57 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 73.0 mtp85 -126.66 138.76 53.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.573 1.549 . . . . 0.0 109.858 164.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 2.1 tt -118.96 125.0 48.41 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.057 1.343 . . . . 0.0 110.153 167.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -82.01 125.93 31.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.053 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -115.48 4.92 14.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.065 1.346 . . . . 0.0 112.998 -165.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.6 157.16 34.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.105 2.162 . . . . 0.0 110.457 -170.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 72.22 -164.62 54.41 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.507 1.051 . . . . 0.0 115.445 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -21.57 55.67 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 82.8 mtp -101.32 12.0 38.24 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -55.27 122.57 11.4 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.552 1.523 . . . . 0.0 111.154 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.23 28.05 56.7 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.599 1.095 . . . . 0.0 112.835 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -112.84 155.75 24.11 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.704 1.202 . . . . 0.0 110.909 163.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -149.08 155.62 41.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.508 1.123 . . . . 0.0 112.764 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.46 137.78 54.41 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.58 124.96 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.814 1.645 . . . . 0.0 110.623 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.65 141.19 15.42 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 160.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.6 mt -119.45 157.42 51.62 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.878 1.271 . . . . 0.0 110.187 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.59 -5.99 17.64 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.515 2.143 . . . . 0.0 114.242 -173.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -148.93 138.82 22.06 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.979 1.312 . . . . 0.0 110.102 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.07 -37.39 71.79 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.7 -0.625 . . . . 0.0 111.753 168.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -60.61 -37.66 82.14 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -69.23 -38.02 78.31 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.674 0.79 . . . . 0.0 111.701 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.82 -45.77 81.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.55 1.068 . . . . 0.0 111.86 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.05 76.12 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.766 0.712 . . . . 0.0 112.284 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -69.2 -47.78 63.89 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.998 0.919 . . . . 0.0 112.336 173.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.52 -31.52 71.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.484 0.714 . . . . 0.0 112.65 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 66.7 mt -73.28 -31.94 64.36 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.514 1.126 . . . . 0.0 112.468 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -71.03 -34.29 71.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.304 0.642 . . . . 0.0 111.34 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -89.85 -54.86 3.87 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -73.52 -17.05 61.26 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -69.22 101.92 1.59 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.281 1.032 . . . . 0.0 110.225 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 114.66 -2.1 23.27 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 117.919 -1.49 . . . . 0.0 116.103 -172.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -68.71 120.53 14.84 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.316 2.058 . . . . 0.0 109.367 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.32 69.83 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 124.067 1.889 . . . . 0.0 110.225 -167.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 22.7 tp -76.03 130.22 38.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.181 175.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.341 55.6 m-85 58.01 31.93 21.3 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 76.81 0.21 68.0 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.097 1.332 . . . . 0.0 115.594 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 27.4 tptt -112.78 108.61 53.6 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.653 1.581 . . . . 0.0 110.628 -169.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.39 113.44 3.32 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.756 2.304 . . . . 0.0 110.705 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 48.6 mtp -72.7 128.55 35.87 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.059 1.743 . . . . 0.0 111.891 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.5 t -93.59 99.0 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.078 1.751 . . . . 0.0 109.314 -176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.69 124.24 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.444 1.898 . . . . 0.0 112.266 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -147.82 155.17 41.37 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.098 1.359 . . . . 0.0 111.707 -170.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -54.23 148.19 11.84 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.835 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 177.373 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 122.054 0.931 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.3 p -155.02 160.27 40.93 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.595 1.158 . . . . 0.0 111.715 169.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.8 tt -68.39 145.99 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.328 1.451 . . . . 0.0 110.492 -174.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 37.1 t -82.63 157.08 23.55 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 122.107 0.956 . . . . 0.0 109.021 163.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -56.73 -30.14 63.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.699 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -63.82 -37.17 86.39 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 175.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -81.33 -27.84 34.78 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.44 -46.94 62.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.096 1.358 . . . . 0.0 113.042 174.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -55.88 -22.04 23.43 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.594 1.958 . . . . 0.0 114.411 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -62.9 -30.78 71.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.064 1.346 . . . . 0.0 112.704 173.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.22 80.66 0.31 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.55 1.548 . . . . 0.0 111.108 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -162.01 145.52 12.08 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.958 1.703 . . . . 0.0 109.908 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.8 pt -120.61 152.13 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 63.6 m -74.67 159.56 31.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.35 1.46 . . . . 0.0 111.823 161.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 33.3 mtm105 -58.84 -27.11 64.81 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.879 -1.138 . . . . 0.0 112.728 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -61.87 -31.56 71.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.949 1.3 . . . . 0.0 112.019 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.78 -32.18 21.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.672 1.189 . . . . 0.0 111.254 170.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 37.4 ttm -62.23 -43.52 98.64 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.653 -1.279 . . . . 0.0 111.483 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -78.99 29.47 0.21 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.568 0.747 . . . . 0.0 112.162 171.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.05 -39.7 0.44 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.049 1.74 . . . . 0.0 115.388 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 5.3 mp -68.19 134.96 51.3 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.052 1.341 . . . . 0.0 110.586 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 82.4 p -62.94 -27.64 69.53 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.401 HG21 ' CD2' ' A' ' 410' ' ' PHE . 11.4 m -65.79 -22.77 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 172.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.401 ' CD2' HG21 ' A' ' 409' ' ' VAL 0.401 66.4 m-85 -101.25 14.23 32.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 118.482 2.771 . . . . 0.0 118.482 -177.108 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -23.01 62.5 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 4.3 m -140.06 -33.72 0.57 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.847 1.659 . . . . 0.0 113.735 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.58 144.99 56.09 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -147.96 143.24 17.44 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -83.18 -171.67 1.18 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.757 3.638 . . . . 0.0 111.226 157.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.46 -0.48 32.71 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 117.494 1.758 . . . . 0.0 117.494 163.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -102.77 143.51 26.74 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 119.236 1.518 . . . . 0.0 113.91 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.31 82.74 2.42 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.849 3.7 . . . . 0.0 112.435 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . 0.483 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 18.1 t30 -128.29 146.59 50.71 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.552 -1.343 . . . . 0.0 111.026 174.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 32.0 p -77.34 -9.89 59.11 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . 0.483 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 36.3 mtm180 -119.59 146.4 45.55 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.715 1.206 . . . . 0.0 111.586 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 10.3 pt -134.82 151.11 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.997 1.719 . . . . 0.0 110.125 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -114.24 154.67 27.52 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.309 1.052 . . . . 0.0 108.486 166.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.82 147.45 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.531 1.532 . . . . 0.0 112.693 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -134.99 165.99 24.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.092 1.757 . . . . 0.0 111.011 -174.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.291 12.6 m-20 71.55 24.4 3.59 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -174.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.29 131.55 42.83 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.289 -1.507 . . . . 0.0 112.12 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -56.17 152.6 10.51 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.57 1.948 . . . . 0.0 115.513 -172.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -58.36 -40.23 81.67 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -84.52 -21.77 30.43 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.08 150.26 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -117.35 167.26 11.4 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.547 1.139 . . . . 0.0 112.125 171.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -53.94 -34.36 59.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.606 1.162 . . . . 0.0 112.613 170.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -66.58 -32.85 74.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.799 1.24 . . . . 0.0 114.115 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -68.02 -29.66 68.72 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.24 -18.25 60.76 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.01 1.324 . . . . 0.0 113.681 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -58.19 -29.29 65.54 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.361 0.982 . . . . 0.0 112.873 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.66 -32.21 72.36 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.398 0.545 . . . . 0.0 110.733 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.2 mt -99.16 -60.13 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.526 0.73 . . . . 0.0 110.844 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.294 81.5 m-85 -62.92 -23.98 67.63 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 117.349 2.352 . . . . 0.0 117.349 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -82.51 -5.51 89.45 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.737 1.16 . . . . 0.0 114.22 171.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -58.0 -31.8 67.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.656 1.728 . . . . 0.0 111.378 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -93.81 6.77 47.29 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.908 1.683 . . . . 0.0 111.572 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 19.0 t -118.37 120.29 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 120.209 1.368 . . . . 0.0 110.828 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -75.59 103.36 5.67 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.45 1.1 . . . . 0.0 110.422 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -56.42 -29.28 61.4 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 4.2 m -77.81 -2.6 37.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.293 1.837 . . . . 0.0 113.898 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.8 m -130.44 98.0 4.56 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.358 1.463 . . . . 0.0 110.468 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -51.93 -41.05 61.73 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.2 t -48.63 -16.67 0.12 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 118.688 2.847 . . . . 0.0 118.688 173.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -93.07 -58.65 2.26 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.463 -0.773 . . . . 0.0 111.575 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -71.14 -17.07 62.57 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.077 1.351 . . . . 0.0 113.78 -175.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.7 tt -63.3 -35.15 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.557 1.543 . . . . 0.0 111.803 168.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.5 mtm -85.04 -27.64 26.22 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.52 0.328 . . . . 0.0 110.891 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . 0.28 32.4 t80 -83.75 128.64 34.68 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 -173.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -162.28 155.85 20.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.778 1.631 . . . . 0.0 107.716 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 11.3 mt -130.78 135.88 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.617 1.167 . . . . 0.0 109.77 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -122.3 125.16 45.4 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.487 1.515 . . . . 0.0 108.044 163.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 7.1 tp -99.73 113.37 25.8 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.278 1.431 . . . . 0.0 108.203 165.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -77.7 107.04 9.9 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 126.355 1.862 . . . . 0.0 110.034 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -98.28 2.15 47.88 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.354 1.062 . . . . 0.0 113.763 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -118.68 157.16 27.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.4 1.88 . . . . 0.0 112.89 -171.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 74.07 174.55 30.91 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.997 1.284 . . . . 0.0 113.174 -171.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -28.77 68.46 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.445 -1.032 . . . . 0.0 113.068 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -91.89 34.64 0.99 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.55 1.14 . . . . 0.0 112.927 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -70.59 166.25 21.05 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.283 1.033 . . . . 0.0 113.139 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 68.7 38.16 85.41 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 124.891 1.234 . . . . 0.0 110.605 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -125.74 156.92 38.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.079 0.952 . . . . 0.0 110.525 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -143.77 136.99 27.75 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -93.85 127.06 39.4 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 165.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.17 135.83 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.327 1.451 . . . . 0.0 109.378 171.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.89 133.4 11.58 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 160.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 17.9 mt -106.58 160.27 26.87 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.349 1.46 . . . . 0.0 109.868 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.26 -10.46 20.8 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.579 2.186 . . . . 0.0 113.842 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -153.42 145.51 23.74 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.159 0.984 . . . . 0.0 110.249 -174.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -55.67 -36.37 67.02 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.977 -0.452 . . . . 0.0 111.756 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -62.68 -33.99 76.21 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -69.6 -39.87 77.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.203 0.601 . . . . 0.0 111.084 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -69.73 -42.87 73.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.05 0.841 . . . . 0.0 111.618 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.24 -31.11 67.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.984 0.914 . . . . 0.0 112.778 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -78.72 -49.08 13.69 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.328 -0.858 . . . . 0.0 112.617 168.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.87 -27.74 69.55 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 54.1 mt -76.49 -28.3 56.4 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.192 -0.943 . . . . 0.0 112.736 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -71.12 -40.36 71.5 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.108 0.563 . . . . 0.0 110.681 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.44 -55.01 5.18 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.36 -16.26 52.83 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -68.49 108.79 3.42 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.931 -1.106 . . . . 0.0 110.835 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 115.52 -6.09 20.87 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 117.987 -1.452 . . . . 0.0 115.42 -171.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.78 120.41 12.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.292 2.046 . . . . 0.0 114.99 -160.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.287 1.9 t -85.63 46.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.102 1.761 . . . . 0.0 115.507 -163.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 32.5 tp -52.9 130.06 32.18 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.353 1.061 . . . . 0.0 110.335 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . . 81.2 t80 60.31 16.04 5.89 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 86.77 10.3 72.95 Favored Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.464 -1.398 . . . . 0.0 114.656 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -127.66 125.55 23.77 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 126.031 1.732 . . . . 0.0 111.934 -172.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.54 127.51 12.56 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.09 1.86 . . . . 0.0 112.651 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 61.4 mtp -78.42 131.76 37.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.538 1.535 . . . . 0.0 112.524 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.28 97.05 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.356 1.862 . . . . 0.0 109.554 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.9 t -98.51 119.87 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 127.481 2.312 . . . . 0.0 112.774 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -139.41 158.76 43.58 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.825 1.25 . . . . 0.0 113.525 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -58.5 145.89 37.38 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.615 -0.678 . . . . 0.0 112.817 166.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 123.829 0.851 . . . . 0.0 112.606 179.304 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 121.52 0.676 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.1 p -141.9 175.69 9.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.657 1.183 . . . . 0.0 112.828 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.5 tt -82.62 150.42 4.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 126.063 1.745 . . . . 0.0 111.964 -172.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 6.5 m -81.77 161.02 23.44 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.511 0.725 . . . . 0.0 109.709 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -65.04 -39.63 93.61 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.113 -0.992 . . . . 0.0 110.769 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -54.89 -43.72 73.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.351 1.46 . . . . 0.0 112.785 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.87 -37.73 70.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.098 1.359 . . . . 0.0 114.551 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 19.8 tp -69.05 -39.6 79.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.251 1.021 . . . . 0.0 112.528 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -59.97 -18.03 42.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -65.66 -21.41 66.55 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.057 0.943 . . . . 0.0 112.253 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -134.96 86.49 0.25 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.656 1.598 . . . . 0.0 111.495 173.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -155.7 151.08 26.93 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.751 1.221 . . . . 0.0 109.658 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.3 pt -136.41 148.64 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 13.0 m -86.97 164.17 16.67 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.98 1.712 . . . . 0.0 110.178 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -50.24 -38.76 42.15 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.38 -27.35 66.16 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.54 -31.42 42.06 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.142 -0.974 . . . . 0.0 111.821 167.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 4.5 ttm -58.93 -38.7 79.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.784 0.834 . . . . 0.0 110.076 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -74.65 11.2 1.09 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.764 1.626 . . . . 0.0 114.059 171.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.47 -22.05 3.4 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.209 1.803 . . . . 0.0 115.227 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.0 mp -91.17 130.82 37.02 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.253 1.821 . . . . 0.0 111.202 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 14.5 p -62.41 -24.25 67.29 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 6.1 m -66.18 -23.22 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 119.501 1.046 . . . . 0.0 113.595 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.27 42.2 m-85 -100.44 -10.35 21.22 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 121.276 3.806 . . . . 0.0 121.276 -171.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.79 -19.59 29.42 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 -169.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 4.4 m -142.54 28.28 1.64 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.451 1.9 . . . . 0.0 111.799 -176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -134.12 137.72 44.73 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.192 2.197 . . . . 0.0 115.924 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 415' ' ' PRO . 78.7 mt-10 -142.11 121.01 7.76 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -171.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 414' ' ' GLU . 79.3 Cg_endo -74.84 176.79 9.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.178 3.252 . . . . 0.0 113.282 160.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.55 31.61 10.19 Favored Glycine 0 N--CA 1.468 0.787 0 C-N-CA 124.532 1.063 . . . . 0.0 114.853 167.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -125.82 149.87 67.06 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.693 1.197 . . . . 0.0 113.255 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.53 109.93 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.027 3.151 . . . . 0.0 114.056 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . 0.515 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 42.1 t30 -158.17 159.96 36.71 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.807 1.643 . . . . 0.0 109.669 160.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 25.4 p -80.59 -7.52 59.28 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . 0.515 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 20.3 mtp180 -130.92 152.39 50.3 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.086 1.754 . . . . 0.0 110.084 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 6.6 pt -137.88 165.13 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 126.725 2.01 . . . . 0.0 109.404 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -135.56 164.18 28.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.606 1.193 . . . . 0.0 107.818 167.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.4 143.34 34.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.608 1.163 . . . . 0.0 110.522 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -126.43 168.78 13.73 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.227 1.811 . . . . 0.0 110.868 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 38.8 t30 67.32 32.8 5.72 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.663 1.585 . . . . 0.0 113.085 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.56 139.79 53.77 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.449 1.1 . . . . 0.0 110.919 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -59.47 161.86 5.43 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.871 1.669 . . . . 0.0 115.098 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -63.09 -37.26 86.51 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -80.15 -32.7 38.88 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.713 1.605 . . . . 0.0 114.022 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.35 144.19 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -166.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -120.25 163.87 17.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.602 1.561 . . . . 0.0 112.308 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -56.15 -32.55 64.39 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.583 -1.323 . . . . 0.0 113.033 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -62.37 -33.37 74.61 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -66.98 -36.21 81.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.494 1.118 . . . . 0.0 113.028 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.56 -22.6 63.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.192 1.397 . . . . 0.0 112.969 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.88 -26.78 62.57 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.48 1.036 . . . . 0.0 112.471 176.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -62.5 -31.77 72.58 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.237 0.471 . . . . 0.0 110.494 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.11 -56.27 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 120.591 -1.318 . . . . 0.0 110.841 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -59.27 -30.32 68.21 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.28 -3.49 88.55 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.906 1.241 . . . . 0.0 114.641 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -59.25 -31.06 68.74 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.384 1.592 . . . . 0.0 112.23 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -97.94 13.85 29.3 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.205 2.202 . . . . 0.0 111.678 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 15.4 t -131.03 139.73 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.919 1.688 . . . . 0.0 110.389 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.61 117.05 14.91 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.717 -0.615 . . . . 0.0 109.872 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.31 -13.81 32.65 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 118.716 2.858 . . . . 0.0 118.716 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.2 t -123.04 -33.48 3.32 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.4 m -67.66 110.83 3.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.951 0.796 . . . . 0.0 110.814 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -57.07 -46.4 82.53 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -13.55 2.57 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -92.91 -60.34 1.83 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.819 1.248 . . . . 0.0 110.374 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -70.81 -12.55 61.62 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.986 1.714 . . . . 0.0 114.114 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.02 -39.91 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 126.869 2.068 . . . . 0.0 112.968 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 11.8 mtm -83.96 -29.96 26.64 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.573 0.749 . . . . 0.0 109.669 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -66.43 131.15 45.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.04 1.336 . . . . 0.0 113.825 164.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -165.43 149.04 8.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.358 1.463 . . . . 0.0 108.809 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.2 mt -125.95 137.03 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.48 1.112 . . . . 0.0 111.424 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -126.53 129.37 48.49 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.945 1.298 . . . . 0.0 108.892 162.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 5.7 tt -109.1 115.97 31.06 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.225 1.41 . . . . 0.0 109.533 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 59.7 mtm -72.8 134.26 44.84 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.065 1.346 . . . . 0.0 111.575 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -123.93 14.94 9.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.492 1.517 . . . . 0.0 113.168 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -139.89 153.31 46.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.898 1.679 . . . . 0.0 112.241 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 59.33 -146.88 43.04 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.046 1.308 . . . . 0.0 116.318 168.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -7.59 47.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.819 2.048 . . . . 0.0 115.465 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . 0.256 13.1 mtm -120.25 19.25 12.19 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 173.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -55.58 120.22 6.89 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.273 -1.517 . . . . 0.0 111.513 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.01 30.17 29.42 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.16 1.362 . . . . 0.0 113.77 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -123.85 149.33 45.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.472 1.109 . . . . 0.0 109.288 168.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -137.94 141.52 40.57 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.437 -0.79 . . . . 0.0 112.656 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -101.64 135.06 43.8 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 172.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.82 122.83 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.29 1.436 . . . . 0.0 110.533 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -85.73 149.99 23.86 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 162.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 21.9 mt -125.21 158.34 64.06 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.401 1.08 . . . . 0.0 110.233 170.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.3 -8.27 21.67 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.545 2.163 . . . . 0.0 113.991 -175.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -155.78 144.24 20.19 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.033 1.333 . . . . 0.0 110.487 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -58.36 -31.95 68.1 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.613 1.165 . . . . 0.0 113.154 168.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -56.3 -45.69 80.13 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.394 -0.816 . . . . 0.0 111.978 171.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.73 -35.87 81.98 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.993 0.808 . . . . 0.0 112.914 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.38 -44.37 75.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.439 1.472 . . . . 0.0 112.586 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.83 -38.22 75.23 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.42 -0.8 . . . . 0.0 112.022 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -67.2 -53.7 27.88 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.721 1.208 . . . . 0.0 112.192 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.79 -32.95 69.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.979 0.911 . . . . 0.0 112.608 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 50.8 mt -69.81 -43.58 71.77 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.068 0.947 . . . . 0.0 111.742 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -65.97 -26.1 67.41 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.81 0.844 . . . . 0.0 111.688 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -100.65 -44.69 5.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -175.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -76.1 -24.45 55.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.519 1.128 . . . . 0.0 113.865 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -72.5 120.5 18.2 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.645 -0.659 . . . . 0.0 112.343 -169.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 108.96 -8.19 33.51 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 117.984 -1.454 . . . . 0.0 115.032 -170.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . 0.262 61.7 t80 -64.82 133.12 51.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.524 1.662 . . . . 0.0 115.164 -164.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.252 2.5 t -99.8 46.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.181 1.392 . . . . 0.0 113.768 -158.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 19.4 tp -50.49 126.28 14.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.123 1.369 . . . . 0.0 110.572 172.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.361 32.9 m-85 58.64 12.58 2.22 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 89.84 3.03 74.36 Favored Glycine 0 CA--C 1.536 1.355 0 O-C-N 120.683 -1.26 . . . . 0.0 114.519 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -119.35 118.1 32.68 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 119.477 1.639 . . . . 0.0 112.829 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.18 126.76 14.1 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.886 2.39 . . . . 0.0 113.216 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 71.7 mtp -81.72 134.47 35.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.652 1.581 . . . . 0.0 112.137 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.76 93.47 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 126.655 1.982 . . . . 0.0 110.528 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.8 t -94.67 118.25 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 126.814 2.045 . . . . 0.0 113.086 -173.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -134.41 160.8 36.86 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.65 1.18 . . . . 0.0 114.119 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -60.01 144.58 48.96 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.165 -0.96 . . . . 0.0 113.174 167.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.713 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 30.1 p -144.82 164.78 30.01 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.3 tt -72.64 171.14 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.647 2.379 . . . . 0.0 111.701 -175.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 34.5 m -110.67 166.85 10.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.425 1.09 . . . . 0.0 111.834 167.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 14.1 ttm-85 -59.15 -48.33 81.99 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.037 -1.039 . . . . 0.0 112.48 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -61.78 -37.16 83.3 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.591 1.157 . . . . 0.0 113.398 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -70.31 -38.66 75.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.696 1.198 . . . . 0.0 113.226 173.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.06 -41.08 82.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.889 1.276 . . . . 0.0 112.982 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.33 -17.84 32.89 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.172 1.789 . . . . 0.0 115.101 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -70.29 -16.23 62.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.961 0.905 . . . . 0.0 113.357 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -127.29 87.6 0.33 Allowed Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.84 1.686 . . . . 0.0 113.166 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -167.7 147.25 4.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.629 1.172 . . . . 0.0 111.372 -170.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 10.8 pt -125.28 152.71 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 69.3 m -100.82 164.44 11.84 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.963 2.505 . . . . 0.0 111.111 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -55.46 -33.81 63.97 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -169.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -76.86 -10.56 59.45 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.588 1.086 . . . . 0.0 112.877 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -96.61 -33.19 11.87 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.001 -1.062 . . . . 0.0 111.208 163.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 17.5 ttp -63.29 -40.47 97.47 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.881 -1.137 . . . . 0.0 111.352 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -79.68 30.62 0.24 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.148 0.979 . . . . 0.0 112.723 171.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.12 -29.02 0.41 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 176.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.8 mp -72.27 134.31 45.51 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.17 0.988 . . . . 0.0 109.842 167.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 9.2 t -66.94 -29.48 69.36 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.444 -0.785 . . . . 0.0 111.923 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.7 m -66.63 -7.77 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 170.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.261 83.5 m-85 -119.74 3.68 11.1 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 118.553 2.797 . . . . 0.0 118.553 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -14.08 62.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -169.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.7 t -130.76 -25.9 2.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.218 1.007 . . . . 0.0 111.681 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -70.36 137.76 50.82 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.284 1.586 . . . . 0.0 115.284 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -142.81 125.79 9.14 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.22 179.71 5.68 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 125.045 3.83 . . . . 0.0 113.513 167.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 121.25 -19.68 8.62 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 156.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -82.03 150.2 64.5 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.13 96.98 1.09 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 124.109 3.206 . . . . 0.0 112.725 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.83 137.47 45.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.069 1.747 . . . . 0.0 106.903 161.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.9 p -72.99 -0.67 14.43 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -124.43 149.88 46.28 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.331 1.453 . . . . 0.0 110.849 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.6 pt -140.15 161.22 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.61 1.964 . . . . 0.0 109.654 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -131.35 156.97 44.6 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.5 t -127.2 143.76 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 125.349 1.46 . . . . 0.0 111.575 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -127.34 166.95 16.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.364 1.865 . . . . 0.0 109.569 173.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 34.6 t30 66.24 32.45 7.9 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.8 1.24 . . . . 0.0 113.109 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -71.33 157.23 38.46 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.318 -0.864 . . . . 0.0 111.49 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -71.46 166.52 21.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.255 1.422 . . . . 0.0 114.804 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -76.36 -42.1 45.87 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.204 -0.935 . . . . 0.0 113.034 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -70.98 -35.79 72.26 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.38 156.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -130.24 158.32 40.08 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.994 1.718 . . . . 0.0 110.55 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -56.15 -29.82 61.3 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.155 -1.59 . . . . 0.0 113.454 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -57.18 -37.71 72.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.066 1.747 . . . . 0.0 114.26 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -68.13 -33.98 75.5 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.65 -21.41 66.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.136 0.974 . . . . 0.0 112.547 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -24.12 62.27 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.841 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -59.39 -29.46 67.73 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.708 0.803 . . . . 0.0 110.96 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.41 -55.0 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 120.866 -1.147 . . . . 0.0 111.207 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -59.53 -29.64 68.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.73 -4.71 89.47 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.409 1.004 . . . . 0.0 114.43 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -65.36 -36.22 83.34 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 119.974 1.887 . . . . 0.0 111.527 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -79.26 6.29 10.24 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.623 1.969 . . . . 0.0 113.08 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 16.1 t -131.57 135.06 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.469 1.908 . . . . 0.0 110.862 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -91.13 113.32 25.55 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -63.77 -18.51 64.15 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 69.5 m -90.88 -0.58 57.77 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.3 t -118.5 107.22 13.52 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.29 1.036 . . . . 0.0 110.629 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -61.24 -43.16 99.33 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.186 -0.946 . . . . 0.0 111.998 -176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.91 -14.11 5.65 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 117.189 2.292 . . . . 0.0 117.189 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -88.27 -62.21 1.54 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.016 0.926 . . . . 0.0 110.095 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -69.92 -24.74 63.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.754 1.222 . . . . 0.0 114.227 -173.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 16.4 tt -54.19 -36.71 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.694 1.197 . . . . 0.0 112.28 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.2 mtm -84.71 -12.83 53.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.267 1.027 . . . . 0.0 112.483 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -94.36 134.13 37.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.859 1.664 . . . . 0.0 114.777 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -167.86 141.26 3.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.872 1.669 . . . . 0.0 107.303 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.8 mt -116.24 138.1 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.958 1.703 . . . . 0.0 110.149 174.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -132.13 133.98 44.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.023 1.329 . . . . 0.0 110.163 166.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 1.4 tt -112.2 124.8 53.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.098 1.359 . . . . 0.0 110.943 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 35.2 mtm -72.27 135.02 45.88 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.648 1.579 . . . . 0.0 111.172 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -134.51 -26.06 1.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.657 1.583 . . . . 0.0 115.136 -163.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -101.15 139.39 36.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.596 1.558 . . . . 0.0 111.512 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 72.5 -158.32 53.16 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.38 1.312 . . . . 0.0 116.38 163.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -13.97 62.32 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -169.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 75.9 mtm -110.63 12.42 22.68 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -61.17 148.82 39.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.844 -1.16 . . . . 0.0 111.949 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.77 24.61 76.45 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.737 0.684 . . . . 0.0 112.156 -175.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -104.23 160.04 15.21 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.758 1.223 . . . . 0.0 109.697 158.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -152.51 157.11 40.64 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.829 -1.17 . . . . 0.0 112.77 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -116.86 143.39 45.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.98 127.05 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.617 1.567 . . . . 0.0 109.071 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -97.18 145.6 17.92 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 162.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 27.1 mt -126.29 156.66 72.14 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.592 1.557 . . . . 0.0 110.412 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -73.06 -7.7 21.03 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.747 2.298 . . . . 0.0 114.579 -171.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -151.22 143.43 24.07 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.469 1.108 . . . . 0.0 111.397 -172.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.19 -41.93 69.15 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.559 -0.713 . . . . 0.0 111.394 166.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -67.16 -28.01 67.76 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.493 1.117 . . . . 0.0 113.381 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -71.24 -43.35 67.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.664 0.386 . . . . 0.0 110.777 174.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.81 -44.06 74.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.36 0.527 . . . . 0.0 112.056 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.79 -37.73 71.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.38 0.672 . . . . 0.0 111.923 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -73.15 -48.4 35.75 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.783 0.833 . . . . 0.0 112.744 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.96 -29.57 70.33 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.15 -34.13 70.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.106 -0.996 . . . . 0.0 112.461 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -63.92 -39.45 94.18 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.312 0.505 . . . . 0.0 111.429 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.06 -47.49 8.87 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -171.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -79.02 -20.89 47.86 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -69.1 109.48 4.04 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.277 -0.89 . . . . 0.0 110.699 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 108.96 -3.31 31.74 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 117.684 -1.62 . . . . 0.0 116.435 -174.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -65.89 131.23 45.77 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.779 1.789 . . . . 0.0 112.356 -172.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.299 1.2 t -93.31 44.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 -161.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 16.8 tp -50.01 122.26 6.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.016 1.726 . . . . 0.0 111.489 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.309 76.1 m-85 49.57 30.34 3.48 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 117.361 2.356 . . . . 0.0 117.361 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 77.37 24.36 65.9 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.125 -0.984 . . . . 0.0 114.171 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -132.43 116.62 15.24 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 119.028 1.414 . . . . 0.0 110.33 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.96 114.88 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.313 2.009 . . . . 0.0 112.003 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 61.9 mtp -71.25 127.81 33.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.723 1.609 . . . . 0.0 112.347 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 30.8 t -93.52 94.16 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.992 2.117 . . . . 0.0 109.63 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 3.7 t -100.4 120.49 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 127.142 2.177 . . . . 0.0 113.08 -171.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -137.95 158.95 43.29 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.399 1.479 . . . . 0.0 113.644 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -57.71 142.19 46.06 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 167.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.178 0 CA-C-N 118.507 0.594 . . . . 0.0 112.462 177.133 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.4 p -161.54 159.82 28.28 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.7 1.2 . . . . 0.0 113.403 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.8 tt -75.67 166.15 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.203 1.401 . . . . 0.0 112.441 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 19.9 m -115.39 161.49 18.46 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.199 1.4 . . . . 0.0 111.711 169.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -63.99 -39.36 93.95 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.616 -0.678 . . . . 0.0 112.132 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -58.8 -34.72 71.81 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -79.56 -38.77 33.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.759 1.624 . . . . 0.0 113.864 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.14 -41.62 97.11 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.768 1.227 . . . . 0.0 113.137 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -58.47 -23.32 57.47 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.637 1.575 . . . . 0.0 114.486 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.52 -18.43 64.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.611 1.164 . . . . 0.0 112.1 173.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -123.96 82.05 0.35 Allowed Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.986 2.232 . . . . 0.0 111.482 167.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -157.28 139.61 14.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.936 1.694 . . . . 0.0 109.346 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.8 pt -122.58 150.6 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 123.391 1.567 . . . . 0.0 115.002 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.6 m -78.58 160.86 27.38 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.796 2.039 . . . . 0.0 112.045 167.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -55.3 -30.05 59.41 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.371 -0.831 . . . . 0.0 112.092 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -65.1 -22.73 66.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.619 1.168 . . . . 0.0 113.826 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -93.06 -33.46 14.08 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.236 1.014 . . . . 0.0 111.24 168.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 37.8 ttm -59.59 -42.25 92.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 122.454 1.121 . . . . 0.0 111.574 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -85.96 33.79 0.6 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.587 1.555 . . . . 0.0 110.827 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.98 -41.24 0.35 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 128.099 2.56 . . . . 0.0 114.852 173.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.6 mp -66.88 136.83 55.98 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.354 1.062 . . . . 0.0 110.02 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 21.0 m -65.24 -34.33 78.1 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 169.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 17.5 m -59.0 -29.94 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 119.906 1.23 . . . . 0.0 112.704 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -101.68 11.16 39.31 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -19.17 49.48 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 47.3 t -142.57 -28.81 0.58 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.301 1.04 . . . . 0.0 113.015 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -71.72 146.52 48.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.2 1.4 . . . . 0.0 114.768 169.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.65 130.5 3.74 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 121.298 -0.876 . . . . 0.0 113.031 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -69.89 165.06 32.37 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 125.278 3.986 . . . . 0.0 114.66 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 143.86 -27.87 2.03 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.184 1.233 . . . . 0.0 116.184 152.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -72.42 139.67 81.54 Favored Pre-proline 0 CA--C 1.552 1.053 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -165.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.06 105.41 1.79 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.591 2.861 . . . . 0.0 112.988 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -134.17 150.52 51.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.689 1.995 . . . . 0.0 108.215 163.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 29.8 p -72.27 -2.18 18.05 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 38.7 mtm-85 -134.15 148.83 51.01 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.891 2.076 . . . . 0.0 110.082 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 4.4 pt -131.22 159.4 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.139 2.176 . . . . 0.0 110.456 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -128.86 158.48 38.62 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.32 139.58 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.512 1.525 . . . . 0.0 111.515 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -121.71 167.52 12.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.166 1.387 . . . . 0.0 110.116 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 31.4 t30 68.08 31.7 5.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.052 1.341 . . . . 0.0 112.859 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -66.64 145.95 55.02 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.41 -0.806 . . . . 0.0 110.617 173.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.24 163.61 12.51 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.49 1.516 . . . . 0.0 114.413 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -64.64 -47.98 76.5 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -71.42 -29.5 64.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.4 p -65.28 145.53 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -166.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -119.48 163.95 16.5 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.312 1.845 . . . . 0.0 111.906 170.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.36 -26.27 64.94 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.749 -1.219 . . . . 0.0 113.459 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -60.36 -37.03 79.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.656 1.182 . . . . 0.0 114.038 171.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -72.36 -26.93 62.1 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.87 1.268 . . . . 0.0 114.308 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -73.41 -21.47 60.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.229 1.812 . . . . 0.0 112.744 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -27.57 58.79 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.436 1.016 . . . . 0.0 112.585 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -60.99 -30.95 70.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.439 1.096 . . . . 0.0 111.56 -173.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.2 mp -104.48 -54.78 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.018 -1.051 . . . . 0.0 111.218 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -58.03 -27.68 63.78 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.24 -11.73 84.71 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 118.83 -0.983 . . . . 0.0 114.598 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -62.58 -30.99 71.73 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 120.792 2.296 . . . . 0.0 112.1 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -79.29 2.06 22.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.114 1.766 . . . . 0.0 112.858 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.58 136.22 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.35 1.86 . . . . 0.0 110.818 -172.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -79.73 119.64 22.92 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.898 -1.126 . . . . 0.0 108.056 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.329 49.5 m-85 -67.91 -16.91 64.29 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 167.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.0 t -94.03 -38.04 11.34 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.252 0.933 . . . . 0.0 113.469 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.1 m -83.27 118.62 23.77 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.394 -0.816 . . . . 0.0 111.588 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -57.89 -45.07 86.97 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.482 -0.761 . . . . 0.0 112.328 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.36 -16.02 1.98 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -89.75 -62.5 1.46 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.151 0.98 . . . . 0.0 110.562 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -68.39 -21.47 64.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.931 1.292 . . . . 0.0 113.295 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.74 -33.86 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.753 1.621 . . . . 0.0 112.261 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -93.85 3.13 55.86 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.938 1.295 . . . . 0.0 112.886 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -110.44 136.01 50.25 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.869 2.068 . . . . 0.0 115.81 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -166.53 152.31 8.4 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.411 1.885 . . . . 0.0 106.596 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.9 mt -126.11 137.32 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.238 1.015 . . . . 0.0 110.226 171.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 52.7 ttm-85 -125.3 133.8 52.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.115 0.966 . . . . 0.0 110.446 163.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.5 tp -118.15 124.1 47.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.582 1.553 . . . . 0.0 108.846 168.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 39.7 mtm -74.68 116.97 15.98 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.161 0.585 . . . . 0.0 110.083 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -103.0 5.28 38.15 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.014 1.726 . . . . 0.0 112.56 174.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -126.96 149.12 50.0 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.654 1.582 . . . . 0.0 112.952 -174.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.06 -156.51 52.01 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.241 1.4 . . . . 0.0 115.604 164.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -51.91 -34.47 41.64 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.305 1.442 . . . . 0.0 114.094 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 72.3 mtp -97.3 12.27 33.6 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -51.21 123.75 10.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.214 1.006 . . . . 0.0 111.448 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.03 31.47 31.82 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.586 1.565 . . . . 0.0 113.979 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -125.18 145.2 50.07 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.355 1.062 . . . . 0.0 112.224 169.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -135.15 156.05 49.66 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.938 1.295 . . . . 0.0 114.147 -169.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.8 132.8 52.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.585 1.954 . . . . 0.0 115.451 171.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.6 mp -132.34 122.07 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.891 1.676 . . . . 0.0 110.042 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.92 145.48 18.25 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 33.6 mt -126.3 158.96 65.09 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.012 1.325 . . . . 0.0 110.42 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -75.34 -9.08 20.17 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.418 2.745 . . . . 0.0 114.556 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -150.82 143.01 24.15 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.588 0.755 . . . . 0.0 111.388 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -59.01 -37.25 76.47 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.004 0.922 . . . . 0.0 111.803 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 18.6 mtmm -62.89 -35.88 81.48 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.85 92.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.411 0.55 . . . . 0.0 110.915 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -69.44 -44.44 71.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.247 0.93 . . . . 0.0 112.746 172.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.33 69.12 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.806 0.73 . . . . 0.0 112.122 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -75.48 -48.44 22.6 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.874 1.67 . . . . 0.0 113.069 170.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.78 70.33 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.845 0.748 . . . . 0.0 112.765 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 50.1 mt -68.67 -37.5 79.66 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.94 0.896 . . . . 0.0 112.178 174.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -65.3 -41.32 94.2 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.637 0.775 . . . . 0.0 111.463 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.9 -48.57 11.36 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -174.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.14 -16.74 59.03 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -63.75 107.4 1.18 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.025 0.93 . . . . 0.0 112.114 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 106.94 3.54 36.39 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.578 -1.123 . . . . 0.0 115.254 -174.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -71.57 112.99 8.13 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.184 1.492 . . . . 0.0 108.892 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.97 79.43 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.923 1.689 . . . . 0.0 108.029 -169.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 51.6 tp -79.05 132.83 36.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.058 1.743 . . . . 0.0 110.464 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.258 65.7 m-85 55.74 19.43 3.41 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -174.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 81.84 18.56 67.51 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.187 -1.341 . . . . 0.0 115.464 -171.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -128.42 120.64 21.03 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 119.833 1.816 . . . . 0.0 112.508 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.5 121.85 8.36 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 123.547 2.831 . . . . 0.0 112.305 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 38.6 mtp -79.14 132.0 36.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.828 1.251 . . . . 0.0 111.829 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.8 t -94.23 101.18 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.112 1.365 . . . . 0.0 109.816 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.15 127.3 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 126.716 2.006 . . . . 0.0 112.908 -173.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -146.3 161.35 40.5 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -64.26 143.56 57.8 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 121.038 -1.039 . . . . 0.0 108.962 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.395 0 C-N-CA 124.084 0.953 . . . . 0.0 112.696 -177.058 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 28.2 p -158.03 160.21 37.19 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -164.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.7 tt -76.6 161.05 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.268 1.427 . . . . 0.0 112.44 -170.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 18.5 m -114.33 162.33 16.76 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.821 1.649 . . . . 0.0 113.11 168.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -55.25 -43.26 74.45 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.809 0.844 . . . . 0.0 112.469 -172.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -61.76 -33.54 74.26 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -82.83 -37.21 24.73 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.779 0.832 . . . . 0.0 112.715 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.22 -42.16 96.71 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.404 1.082 . . . . 0.0 113.659 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.89 -24.0 48.79 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.635 1.574 . . . . 0.0 114.247 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -70.81 -13.0 61.88 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.979 1.712 . . . . 0.0 112.825 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -123.34 77.66 0.36 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 126.303 1.906 . . . . 0.0 112.63 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -161.39 142.69 11.44 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.386 1.075 . . . . 0.0 111.529 -174.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 20.7 pt -127.91 161.28 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.556 1.542 . . . . 0.0 112.2 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.9 m -110.7 179.36 4.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.144 1.378 . . . . 0.0 111.975 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 32.3 mtm105 -54.25 -27.3 33.92 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.267 -0.895 . . . . 0.0 113.292 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -58.67 -32.56 69.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.537 1.535 . . . . 0.0 112.672 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -98.93 -40.06 8.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.892 0.877 . . . . 0.0 111.209 168.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.88 -40.63 98.1 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.704 -1.248 . . . . 0.0 112.244 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -80.46 11.03 3.94 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 121.319 -0.863 . . . . 0.0 112.672 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.89 -27.08 5.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.584 2.353 . . . . 0.0 113.454 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 43.9 mt -77.51 135.87 38.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.305 1.442 . . . . 0.0 112.654 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 55.3 p -60.14 -34.26 73.28 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.048 0.939 . . . . 0.0 112.325 167.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . 0.255 1.8 m -67.32 -15.28 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 173.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.356 83.2 m-85 -112.52 9.16 19.5 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 118.852 2.908 . . . . 0.0 118.852 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -57.78 0.11 0.06 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 118.51 2.781 . . . . 0.0 118.51 -172.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.4 m -157.25 8.98 0.18 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -132.59 132.13 42.2 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.36 -0.838 . . . . 0.0 109.353 -155.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -138.5 131.04 16.02 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -164.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -90.09 176.09 2.78 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 125.168 3.912 . . . . 0.0 115.006 175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.77 -10.02 72.81 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.657 1.599 . . . . 0.0 116.572 161.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.34 142.39 74.88 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 118.749 1.275 . . . . 0.0 113.45 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -85.71 60.86 5.19 Favored 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 124.86 3.707 . . . . 0.0 114.757 -166.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . 0.456 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 34.0 t30 -96.5 151.29 19.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.08 0.952 . . . . 0.0 110.722 164.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.1 p -77.51 -4.05 43.62 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . 0.456 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 77.5 mtt180 -130.64 149.31 52.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.454 1.502 . . . . 0.0 111.883 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 12.9 pt -134.92 161.73 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.755 2.022 . . . . 0.0 110.141 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -131.52 159.93 36.72 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.81 138.21 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.565 1.546 . . . . 0.0 112.425 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -122.25 168.94 11.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.37 1.468 . . . . 0.0 110.545 170.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 33.0 t30 68.05 40.37 2.25 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.914 1.685 . . . . 0.0 112.533 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.85 153.16 40.01 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.45 -0.782 . . . . 0.0 110.92 171.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.7 154.36 41.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.928 1.291 . . . . 0.0 113.296 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -64.82 -36.31 83.93 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -77.3 -17.24 58.5 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 120.581 1.537 . . . . 0.0 115.097 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.4 p -75.08 151.39 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -165.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -126.02 160.86 28.95 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.869 1.668 . . . . 0.0 111.216 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -53.98 -34.09 58.8 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.408 -1.433 . . . . 0.0 113.46 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -63.8 -20.38 65.74 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -77.51 -43.31 32.52 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.949 0.899 . . . . 0.0 111.72 166.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.1 mp -61.65 -31.29 71.39 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.389 1.075 . . . . 0.0 111.836 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -47.58 -36.89 11.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.267 1.427 . . . . 0.0 113.06 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -62.25 -35.02 77.67 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.027 0.931 . . . . 0.0 112.383 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 4.2 mt -96.26 -58.46 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 121.254 -0.904 . . . . 0.0 110.679 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -57.16 -29.93 64.05 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.16 -14.51 82.52 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 118.43 -1.206 . . . . 0.0 114.619 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -25.1 67.17 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.976 2.388 . . . . 0.0 112.022 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -81.21 5.38 17.17 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.238 1.815 . . . . 0.0 113.19 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 12.7 t -130.52 122.29 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.256 1.823 . . . . 0.0 110.668 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -76.32 103.66 6.44 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -58.44 -16.24 14.18 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 t -82.89 -15.95 49.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.151 0.98 . . . . 0.0 113.021 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 36.1 t -111.24 120.04 40.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.558 1.143 . . . . 0.0 111.617 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -58.02 -48.76 79.09 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.587 -0.696 . . . . 0.0 112.032 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.63 -14.87 2.4 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -92.82 -63.91 1.16 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.851 1.261 . . . . 0.0 110.075 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -25.49 67.92 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.561 1.544 . . . . 0.0 113.361 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.8 tt -57.89 -37.96 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.24 1.416 . . . . 0.0 111.995 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.4 mmm -89.2 0.29 56.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.991 1.716 . . . . 0.0 113.259 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -109.57 132.39 54.19 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -164.43 144.67 7.81 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.527 1.531 . . . . 0.0 111.074 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 5.1 mt -123.81 140.01 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 119.419 1.009 . . . . 0.0 111.373 169.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -121.03 134.54 55.29 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.596 1.558 . . . . 0.0 107.945 154.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 32.1 tp -107.65 91.13 3.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.719 1.247 . . . . 0.0 108.097 166.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -59.43 123.7 17.64 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.66 1.584 . . . . 0.0 110.782 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . 0.304 51.5 mtmt -129.71 35.47 4.18 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -174.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -133.07 148.18 52.19 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.092 0.957 . . . . 0.0 113.565 174.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 69.62 -177.41 30.3 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.58 1.562 . . . . 0.0 114.266 -173.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -15.92 49.26 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.811 -1.406 . . . . 0.0 113.597 177.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 73.4 mtm -87.07 11.2 14.36 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.785 1.634 . . . . 0.0 113.698 171.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -64.83 152.31 43.18 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 119.555 -1.966 . . . . 0.0 111.819 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.35 26.13 52.59 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.152 0.882 . . . . 0.0 112.726 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -121.48 147.37 45.85 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.301 1.041 . . . . 0.0 110.265 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -133.39 148.98 51.84 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -172.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -107.13 139.56 41.37 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 162.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.4 mp -136.88 124.11 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.721 1.208 . . . . 0.0 109.865 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -92.68 146.63 18.24 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 162.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 24.2 mt -126.16 159.61 61.45 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.211 1.404 . . . . 0.0 111.347 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.55 -7.89 19.01 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.991 2.46 . . . . 0.0 115.317 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -150.55 147.59 27.65 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.643 1.177 . . . . 0.0 110.322 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -56.98 -38.98 73.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.564 1.146 . . . . 0.0 111.626 170.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.48 -42.04 95.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.113 0.965 . . . . 0.0 112.878 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.39 -40.39 96.32 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.19 -0.433 . . . . 0.0 111.592 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.98 -44.6 72.57 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.172 0.896 . . . . 0.0 112.832 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.22 83.84 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.869 0.758 . . . . 0.0 111.141 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -64.45 -48.95 73.37 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.154 1.382 . . . . 0.0 112.23 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.11 -32.34 70.9 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 177.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 58.1 mt -68.7 -45.6 71.19 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.105 -0.997 . . . . 0.0 111.341 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -63.22 -33.78 76.23 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.556 0.617 . . . . 0.0 111.837 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.3 -48.0 11.71 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.73 -18.24 45.01 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.21 105.59 1.13 Allowed 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.843 -1.16 . . . . 0.0 110.194 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 111.44 6.05 25.73 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 117.541 -1.7 . . . . 0.0 116.061 -172.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -73.34 126.85 31.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.07 1.935 . . . . 0.0 110.749 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 1.7 t -101.19 48.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 127.002 2.121 . . . . 0.0 114.298 -163.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.8 tp -48.84 123.68 7.36 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.186 1.395 . . . . 0.0 110.308 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.352 62.4 t80 63.92 -2.7 0.52 Allowed 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 107.24 -5.31 35.81 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 125.773 1.654 . . . . 0.0 114.134 -166.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -104.41 119.4 54.0 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 127.686 2.394 . . . . 0.0 111.14 -174.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -79.77 114.88 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.235 2.623 . . . . 0.0 113.137 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 66.5 mtp -73.21 131.32 41.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.112 1.365 . . . . 0.0 112.572 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 56.5 t -91.08 91.0 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.004 1.722 . . . . 0.0 109.38 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.4 t -91.3 125.81 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.93 1.692 . . . . 0.0 111.9 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -142.12 155.94 45.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.671 1.188 . . . . 0.0 113.816 -169.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -63.28 147.35 51.3 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.299 -0.876 . . . . 0.0 112.423 166.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.014 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -175.381 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 7.8 p -152.52 155.29 37.16 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.669 1.588 . . . . 0.0 113.333 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.3 tt -75.85 153.16 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.923 0.889 . . . . 0.0 111.994 -163.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 60.4 m -89.05 153.25 21.15 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.405 0.682 . . . . 0.0 110.349 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -61.71 -35.05 76.92 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 118.175 -0.917 . . . . 0.0 112.629 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -41.5 79.63 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 170.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -74.13 -34.31 63.85 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.976 1.311 . . . . 0.0 112.714 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.5 tt -66.76 -50.97 60.99 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.164 1.386 . . . . 0.0 111.661 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -57.62 -26.57 61.74 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.854 1.662 . . . . 0.0 114.792 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -46.61 80.43 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.273 1.029 . . . . 0.0 109.908 171.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -92.63 59.59 2.52 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 127.636 2.541 . . . . 0.0 112.511 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -150.14 157.06 42.72 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.876 1.27 . . . . 0.0 109.837 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.7 pt -136.98 162.57 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.95 1.7 . . . . 0.0 110.791 176.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.7 m -110.09 170.41 8.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.481 1.912 . . . . 0.0 111.154 172.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -43.67 -45.77 7.09 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -170.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.45 -26.0 68.53 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.01 -30.78 20.97 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.306 -0.871 . . . . 0.0 111.55 169.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 13.9 ttm -66.18 -27.53 68.07 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.424 -1.422 . . . . 0.0 113.248 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -85.58 0.88 51.27 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.2 -35.27 6.88 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.25 2.22 . . . . 0.0 116.857 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 3.5 mp -72.83 133.96 44.68 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.261 1.025 . . . . 0.0 111.908 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 78.3 p -62.41 -18.61 62.05 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 173.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.2 m -88.17 -10.84 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -122.83 -10.49 8.25 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -34.73 56.58 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.754 -1.216 . . . . 0.0 113.875 173.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 23.7 p -113.42 -3.58 13.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.286 2.235 . . . . 0.0 114.641 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -134.87 114.44 12.57 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.02 1.728 . . . . 0.0 113.681 -167.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -130.52 120.12 18.68 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -159.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.13 164.76 30.8 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 124.313 3.342 . . . . 0.0 113.114 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 116.28 -1.53 20.72 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 117.075 1.59 . . . . 0.0 117.075 163.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -78.2 145.56 69.13 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.948 1.374 . . . . 0.0 113.992 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.94 103.92 1.78 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.092 3.195 . . . . 0.0 112.015 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -143.13 147.28 34.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.752 1.221 . . . . 0.0 108.515 166.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 19.7 p -81.02 5.76 15.5 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.889 -1.132 . . . . 0.0 113.389 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -137.26 148.71 46.62 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.482 1.913 . . . . 0.0 110.604 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.0 164.65 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 126.678 1.991 . . . . 0.0 109.524 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -136.98 164.44 28.35 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.3 p -143.66 142.33 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.06 1.344 . . . . 0.0 111.543 -176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -118.77 171.03 8.49 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.745 2.018 . . . . 0.0 110.519 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 72.51 25.62 2.67 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.01 157.13 37.4 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.831 -1.168 . . . . 0.0 111.115 172.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -62.46 158.84 16.82 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.425 1.09 . . . . 0.0 113.548 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -68.28 -33.61 74.66 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.507 -0.746 . . . . 0.0 112.445 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -81.47 -40.56 23.09 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.14 155.78 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.884 1.673 . . . . 0.0 115.034 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -128.68 162.09 28.16 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.001 1.32 . . . . 0.0 112.837 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -33.8 57.69 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.81 -1.181 . . . . 0.0 113.237 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -58.05 -34.29 69.93 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.841 1.256 . . . . 0.0 114.213 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -77.46 -29.97 53.0 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -174.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.59 -20.73 66.43 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.923 1.689 . . . . 0.0 112.955 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.75 -17.23 21.29 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.351 0.978 . . . . 0.0 113.233 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -62.64 -36.72 83.73 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.557 1.143 . . . . 0.0 111.613 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 7.2 mt -105.97 -58.09 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.442 0.697 . . . . 0.0 110.089 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -54.67 -36.95 65.17 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.92 -10.58 85.06 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.939 0.781 . . . . 0.0 114.54 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -62.31 -29.11 70.2 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.584 1.692 . . . . 0.0 111.009 172.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -82.76 1.16 40.24 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.047 1.739 . . . . 0.0 115.533 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 32.1 t -132.12 132.14 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.03 1.732 . . . . 0.0 110.12 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -90.14 106.2 18.33 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.68 -0.637 . . . . 0.0 111.964 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -58.39 -18.17 25.96 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 92.3 p -77.52 -21.65 52.35 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 22.7 t -109.09 118.23 36.22 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.578 0.704 . . . . 0.0 110.974 -165.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -58.83 -51.07 71.56 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.307 0.643 . . . . 0.0 112.268 -170.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.37 -16.19 13.65 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.944 2.201 . . . . 0.0 116.944 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -85.65 -58.83 2.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.538 0.685 . . . . 0.0 109.966 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 15.0 ptt85 -75.62 -23.95 56.43 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.624 1.169 . . . . 0.0 113.662 -171.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.7 tt -54.01 -35.17 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.042 1.337 . . . . 0.0 112.442 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.3 mmm -86.07 -10.64 54.6 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.569 1.148 . . . . 0.0 112.83 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.86 109.04 20.85 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -169.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -154.08 149.49 27.21 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.161 1.384 . . . . 0.0 109.946 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 11.4 mt -128.98 134.64 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.372 1.469 . . . . 0.0 110.882 -173.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -116.6 145.33 43.45 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.764 1.226 . . . . 0.0 109.836 158.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.3 tp -125.21 120.22 30.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.943 2.097 . . . . 0.0 109.313 168.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 47.1 mtm -73.19 135.3 44.59 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 125.029 1.332 . . . . 0.0 110.851 166.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -134.12 -4.42 2.74 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -170.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.89 144.64 47.3 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.566 1.546 . . . . 0.0 111.36 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 60.47 -165.17 14.0 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.94 1.257 . . . . 0.0 114.412 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -19.29 48.53 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 96.0 mmm -85.87 1.68 48.89 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -58.98 149.66 26.71 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.651 1.114 . . . . 0.0 112.097 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 76.36 17.74 79.73 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.934 1.254 . . . . 0.0 112.952 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -114.33 134.21 55.12 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 123.803 0.841 . . . . 0.0 113.112 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -135.53 150.89 49.88 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -109.05 141.88 40.56 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.326 1.85 . . . . 0.0 114.013 167.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.4 mp -138.88 127.02 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.358 1.463 . . . . 0.0 109.872 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -91.93 146.87 18.47 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.522 -0.736 . . . . 0.0 112.167 165.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 39.7 mt -127.32 158.24 70.08 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.052 1.341 . . . . 0.0 110.927 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -74.22 -6.31 18.23 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.883 2.389 . . . . 0.0 114.737 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -153.28 146.01 24.31 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.249 -0.907 . . . . 0.0 111.153 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -65.39 -30.16 70.95 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.213 1.005 . . . . 0.0 111.523 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -63.94 -44.71 92.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.746 0.818 . . . . 0.0 113.014 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -60.74 -39.07 87.31 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.11 -0.472 . . . . 0.0 111.374 174.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.35 -47.51 76.18 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.089 0.859 . . . . 0.0 112.595 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.39 80.95 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.782 1.174 . . . . 0.0 112.174 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -67.71 -51.91 43.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.396 1.078 . . . . 0.0 112.164 175.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.48 70.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.953 0.501 . . . . 0.0 112.224 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.9 mt -69.0 -51.08 43.11 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.286 -0.884 . . . . 0.0 111.427 172.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -68.0 -14.91 63.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.865 0.866 . . . . 0.0 112.412 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -94.74 -50.79 5.0 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.705 1.602 . . . . 0.0 115.114 168.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.19 -19.72 42.71 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -173.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.32 100.82 0.86 Allowed 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.978 -1.076 . . . . 0.0 109.35 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 127.15 -5.97 7.26 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.313 -1.27 . . . . 0.0 114.912 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -72.31 129.63 38.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.257 1.529 . . . . 0.0 112.766 -170.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 3.3 t -96.03 110.25 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.444 1.097 . . . . 0.0 112.164 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 44.6 tp -121.22 141.82 50.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.536 1.934 . . . . 0.0 108.105 169.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.421 28.5 t80 61.77 17.83 9.13 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 73.54 15.59 79.16 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.332 1.444 . . . . 0.0 114.272 -168.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -127.4 133.39 25.03 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.165 1.386 . . . . 0.0 112.328 -170.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.36 120.27 6.85 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.182 2.588 . . . . 0.0 112.266 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 66.2 mtp -75.65 129.91 37.91 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.737 1.615 . . . . 0.0 112.089 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.09 73.5 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -171.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 1.4 t -76.56 120.51 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.294 1.038 . . . . 0.0 112.765 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -142.3 161.39 38.15 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.433 1.493 . . . . 0.0 112.92 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -61.53 144.3 54.52 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -172.257 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.3 p -146.56 159.04 43.95 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -170.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.5 tt -76.64 148.29 7.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.974 1.71 . . . . 0.0 110.122 -172.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 39.9 t -80.0 151.1 30.19 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.345 0.593 . . . . 0.0 110.197 164.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -47.23 -43.86 22.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.729 161.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -64.94 -30.05 71.02 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -75.27 -46.09 35.87 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.916 0.886 . . . . 0.0 112.865 167.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 27.5 tp -63.74 -38.19 90.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.749 1.62 . . . . 0.0 112.606 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -57.01 -24.26 52.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.084 1.354 . . . . 0.0 114.261 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -68.46 -20.66 64.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.374 1.07 . . . . 0.0 113.073 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.87 68.7 0.32 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.198 1.856 . . . . 0.0 111.814 174.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -159.23 136.56 9.84 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.048 1.339 . . . . 0.0 109.976 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.9 pt -112.6 150.75 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.682 0.793 . . . . 0.0 111.099 174.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 30.8 m -74.78 160.85 30.19 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.707 1.203 . . . . 0.0 111.666 163.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.38 -25.79 60.06 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.133 -0.979 . . . . 0.0 112.751 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.25 -28.79 69.0 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.113 1.365 . . . . 0.0 113.215 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.35 -30.64 23.51 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.692 -1.255 . . . . 0.0 110.72 167.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 27.3 ttp -62.8 -37.53 87.1 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 120.984 -1.072 . . . . 0.0 111.207 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -84.05 34.57 0.51 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.356 1.462 . . . . 0.0 111.889 170.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.78 -31.42 0.43 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.434 2.294 . . . . 0.0 114.142 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 11.3 mt -74.0 131.92 41.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.002 1.321 . . . . 0.0 111.596 174.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 98.2 p -65.96 -27.67 68.33 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.215 1.406 . . . . 0.0 112.383 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.16 -19.99 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.195 -0.94 . . . . 0.0 112.782 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.261 51.7 m-85 -113.91 12.29 18.07 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 119.133 3.012 . . . . 0.0 119.133 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -14.24 62.62 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 46.7 t -136.73 -39.46 0.63 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.172 1.389 . . . . 0.0 113.227 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -73.29 144.67 46.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -132.95 126.9 19.95 Favored Pre-proline 0 N--CA 1.478 0.948 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -163.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -84.79 -176.69 2.56 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.503 3.468 . . . . 0.0 113.132 164.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 83.41 -26.74 4.39 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.787 1.661 . . . . 0.0 116.712 164.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -60.41 140.83 91.81 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 117.828 0.814 . . . . 0.0 112.999 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.26 104.41 1.9 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.25 3.3 . . . . 0.0 112.826 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -150.25 144.52 25.64 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.373 1.069 . . . . 0.0 110.129 161.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 27.9 p -77.55 8.55 4.19 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.719 -1.238 . . . . 0.0 114.118 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -139.08 142.57 38.13 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.525 1.93 . . . . 0.0 109.463 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 10.7 pt -131.67 165.25 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 126.539 1.936 . . . . 0.0 109.125 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -132.08 162.05 31.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 123.285 1.517 . . . . 0.0 107.994 164.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 9.7 t -124.18 136.9 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 126.035 1.734 . . . . 0.0 109.952 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -115.9 165.84 12.64 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.335 1.454 . . . . 0.0 109.06 169.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 5.6 t30 66.0 35.09 6.59 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.08 0.552 . . . . 0.0 111.731 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -69.62 154.18 42.37 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.286 -0.884 . . . . 0.0 109.938 162.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -56.12 154.7 7.4 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.047 0.939 . . . . 0.0 111.873 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -74.84 -37.75 62.17 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.385 -0.822 . . . . 0.0 111.638 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -70.33 -41.79 72.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.027 1.731 . . . . 0.0 114.124 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.8 p -55.39 148.05 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -112.16 161.65 16.32 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.643 1.177 . . . . 0.0 113.057 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -56.51 -29.62 62.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.475 1.11 . . . . 0.0 113.277 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -64.48 -36.18 83.35 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 174.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.27 -30.79 68.98 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.319 1.448 . . . . 0.0 113.762 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.83 -19.93 62.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.996 1.718 . . . . 0.0 112.633 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.4 -26.49 63.3 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.383 0.992 . . . . 0.0 112.579 176.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -57.98 -37.55 74.42 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.429 0.558 . . . . 0.0 110.917 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.4 mt -95.16 -59.43 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.184 -0.948 . . . . 0.0 111.711 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -58.62 -29.56 66.59 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.04 -16.05 81.09 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.271 0.939 . . . . 0.0 114.469 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -14.32 62.02 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 119.879 1.84 . . . . 0.0 112.817 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -86.66 -4.77 59.22 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.873 2.069 . . . . 0.0 115.633 172.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.18 125.24 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.908 1.683 . . . . 0.0 110.83 -166.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -78.6 105.12 9.67 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.753 -0.592 . . . . 0.0 110.439 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -60.18 -10.83 4.94 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 70.2 m -93.9 -6.67 45.1 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.294 1.038 . . . . 0.0 113.709 172.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 40.0 t -115.22 115.61 26.98 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.345 1.058 . . . . 0.0 110.536 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -58.92 -48.49 81.28 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.721 0.808 . . . . 0.0 112.385 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.1 t -56.79 -16.63 6.92 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -87.9 -60.7 1.9 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.576 0.75 . . . . 0.0 110.03 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.6 ptt85 -72.17 -22.96 61.22 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.139 0.976 . . . . 0.0 112.971 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 18.7 tt -54.83 -41.68 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.824 1.25 . . . . 0.0 112.093 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.8 mtm -83.43 -6.85 59.59 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.761 0.71 . . . . 0.0 112.33 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -100.79 126.4 47.36 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -164.16 151.5 12.02 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.941 2.096 . . . . 0.0 108.28 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 10.5 mt -125.41 134.7 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.757 1.223 . . . . 0.0 110.538 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -133.72 90.3 2.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.899 0.88 . . . . 0.0 112.842 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.02 125.57 31.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.178 1.791 . . . . 0.0 111.273 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 34.9 mtm -79.31 127.01 31.54 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.835 2.454 . . . . 0.0 111.39 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -118.36 -3.41 10.98 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.725 1.61 . . . . 0.0 115.225 -173.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -130.37 148.57 52.21 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.653 1.181 . . . . 0.0 112.768 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 70.34 -159.21 53.57 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.771 1.177 . . . . 0.0 115.046 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -33.13 73.01 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.588 1.155 . . . . 0.0 113.521 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 73.3 mtm -85.96 12.41 9.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -54.81 106.34 0.21 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.157 0.889 . . . . 0.0 110.53 168.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.47 27.23 7.73 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.362 1.458 . . . . 0.0 115.401 -172.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -113.62 154.64 26.86 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.608 1.204 . . . . 0.0 110.131 163.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.57 139.69 21.12 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.462 -1.399 . . . . 0.0 113.973 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -90.68 144.24 25.94 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 166.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.72 122.58 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.118 1.767 . . . . 0.0 110.136 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.0 145.51 17.63 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 164.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 26.1 mt -126.93 156.3 74.29 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.794 1.238 . . . . 0.0 110.867 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.16 -4.32 15.19 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.578 2.852 . . . . 0.0 114.838 -173.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -153.88 130.87 10.99 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.461 1.104 . . . . 0.0 110.564 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -52.9 -38.49 61.8 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.1 1.36 . . . . 0.0 112.507 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -32.64 74.18 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.33 -37.49 74.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.117 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.54 72.31 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.41 1.004 . . . . 0.0 112.151 171.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.7 71.14 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 118.738 0.699 . . . . 0.0 111.914 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -69.9 -48.51 58.34 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.509 1.124 . . . . 0.0 112.96 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.2 -31.34 71.1 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.7 -0.625 . . . . 0.0 112.359 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 76.8 mt -67.31 -36.96 82.57 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.35 -0.844 . . . . 0.0 112.33 173.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -67.21 -33.1 74.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.601 0.76 . . . . 0.0 111.686 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -93.85 -34.05 13.3 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -170.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -91.01 -13.85 32.52 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.091 1.356 . . . . 0.0 113.931 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -65.3 105.94 1.24 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.212 1.005 . . . . 0.0 110.36 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 111.64 0.7 27.58 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.495 -1.17 . . . . 0.0 115.876 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -73.04 129.33 37.85 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 4.9 p -128.38 67.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 124.171 1.938 . . . . 0.0 109.521 -163.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.32 127.67 33.16 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 113.235 -1.802 . . . . 0.0 110.594 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.43 11.2 m-85 58.8 24.44 12.35 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 74.82 3.92 69.51 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.691 1.139 . . . . 0.0 114.422 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -95.37 104.4 15.43 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.025 1.73 . . . . 0.0 108.816 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.75 110.99 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.376 2.051 . . . . 0.0 110.025 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 28.0 mtp -74.13 124.06 25.62 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.748 1.619 . . . . 0.0 111.841 -169.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 97.1 t -90.26 91.92 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.736 1.614 . . . . 0.0 109.492 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.75 123.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 126.12 1.768 . . . . 0.0 112.323 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -153.67 152.19 30.54 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -164.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -61.4 150.14 36.27 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.737 -1.227 . . . . 0.0 111.153 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.029 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -175.975 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 11.1 p -149.15 163.14 38.45 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -171.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.5 tt -74.33 149.63 7.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 125.692 1.597 . . . . 0.0 111.313 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 17.7 m -86.55 152.11 22.91 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -63.36 -29.63 70.9 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.322 -0.861 . . . . 0.0 110.75 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -34.85 75.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.719 1.607 . . . . 0.0 114.64 174.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -78.58 -48.28 15.5 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.397 0.679 . . . . 0.0 111.636 170.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 16.5 tp -57.53 -37.66 73.4 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -57.41 -25.65 59.9 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.124 1.37 . . . . 0.0 113.941 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -73.99 -20.07 60.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.859 1.264 . . . . 0.0 112.506 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -120.36 63.94 0.47 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.532 2.015 . . . . 0.0 112.327 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -151.14 143.59 24.24 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.738 1.615 . . . . 0.0 110.006 -176.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 18.2 pt -125.04 163.08 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 44.6 t -110.54 172.43 6.87 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.691 1.596 . . . . 0.0 110.36 165.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 32.5 mtt-85 -49.96 -30.42 10.38 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.852 1.261 . . . . 0.0 113.899 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.25 -13.79 21.23 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 125.989 1.715 . . . . 0.0 113.187 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -123.1 -37.3 2.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.051 1.74 . . . . 0.0 112.289 167.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 53.7 ttp -61.18 -40.17 92.9 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.707 -1.246 . . . . 0.0 111.551 -176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.24 2.36 28.26 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.461 -0.774 . . . . 0.0 112.177 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.59 -34.28 10.29 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.415 2.286 . . . . 0.0 113.771 169.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 29.8 mt -77.88 129.07 34.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.363 1.865 . . . . 0.0 113.06 -174.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 88.4 p -58.17 -33.31 69.1 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.168 -0.958 . . . . 0.0 113.58 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.4 m -64.07 -12.64 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 175.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -125.64 14.89 8.14 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -61.28 -23.42 65.67 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.9 t -135.85 -16.15 1.75 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.096 0.958 . . . . 0.0 113.292 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -71.88 144.31 49.07 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -141.45 124.59 9.75 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -169.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.32 -176.49 3.29 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.785 2.99 . . . . 0.0 112.841 171.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 76.15 -4.83 45.68 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.779 1.872 . . . . 0.0 117.779 165.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -72.38 148.13 90.58 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 118.98 1.39 . . . . 0.0 113.384 174.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.39 110.58 3.13 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.775 2.983 . . . . 0.0 113.872 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . 0.424 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 40.6 t30 -157.01 154.77 30.13 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.254 1.822 . . . . 0.0 109.478 161.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 27.4 p -80.43 -3.52 50.15 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . 0.424 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 69.9 mtt180 -130.64 150.85 51.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.931 1.692 . . . . 0.0 110.408 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.4 pt -131.06 160.99 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.387 1.875 . . . . 0.0 109.965 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -135.11 162.09 33.48 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 173.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.9 t -136.35 135.36 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 125.673 1.589 . . . . 0.0 112.056 -174.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -117.61 169.03 9.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.44 1.896 . . . . 0.0 108.395 168.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.26 13.1 m-20 68.13 29.73 6.1 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -171.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.66 143.43 40.11 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 119.868 -1.77 . . . . 0.0 110.535 166.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.52 25.82 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 118.418 2.747 . . . . 0.0 118.418 -165.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp 59.58 -65.6 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 128.703 2.801 . . . . 0.0 113.863 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -58.16 -41.38 83.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.325 1.85 . . . . 0.0 113.89 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 9.1 p -51.12 140.76 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.291 1.037 . . . . 0.0 113.526 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -104.12 157.76 16.9 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.061 0.945 . . . . 0.0 113.102 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -61.02 -26.78 67.85 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.797 -1.814 . . . . 0.0 112.77 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -70.7 -22.05 62.5 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -74.41 -33.82 63.1 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.524 1.129 . . . . 0.0 112.97 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.6 mp -73.64 -23.79 59.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.193 1.797 . . . . 0.0 113.733 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -56.59 -28.78 61.11 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 118.842 0.747 . . . . 0.0 110.876 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -57.68 -33.22 68.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.758 1.623 . . . . 0.0 111.854 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.7 mt -98.33 -58.24 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.361 -0.837 . . . . 0.0 110.795 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -59.59 -25.91 64.99 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -80.74 -7.61 88.38 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.766 1.174 . . . . 0.0 114.379 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 36.7 ttp85 -61.03 -23.8 65.69 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.946 1.873 . . . . 0.0 112.049 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -95.72 2.16 53.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.026 2.131 . . . . 0.0 112.594 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.8 110.39 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.035 1.734 . . . . 0.0 110.701 -172.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -71.41 90.17 0.95 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.281 53.7 m-85 -58.32 -24.05 58.46 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 119.307 3.077 . . . . 0.0 119.307 -171.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.5 m -64.96 -22.48 67.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 17.4 m -101.08 122.66 43.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.122 1.369 . . . . 0.0 112.816 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -55.65 -48.46 74.97 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.453 -0.78 . . . . 0.0 112.181 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 2.8 t -54.05 -18.01 3.21 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -88.21 -63.64 1.27 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.592 0.757 . . . . 0.0 110.778 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -65.08 -29.57 70.46 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.696 1.198 . . . . 0.0 112.2 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.0 tt -58.02 -32.92 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.246 1.419 . . . . 0.0 112.679 173.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 9.1 mmm -84.93 -10.25 57.27 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.097 0.959 . . . . 0.0 112.499 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -105.85 135.03 48.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.136 1.774 . . . . 0.0 115.092 -172.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -168.0 145.16 4.2 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.984 1.314 . . . . 0.0 108.464 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.3 mt -117.13 132.52 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.738 1.215 . . . . 0.0 110.087 174.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -121.23 122.8 40.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.695 1.198 . . . . 0.0 109.976 166.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 3.3 tt -107.58 123.52 48.57 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.145 1.378 . . . . 0.0 110.352 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 45.7 mtm -79.88 130.51 35.36 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.117 1.367 . . . . 0.0 111.973 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -118.04 -7.03 10.9 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.851 1.66 . . . . 0.0 114.472 -168.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -117.25 154.67 30.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.533 1.133 . . . . 0.0 112.061 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 57.89 -142.12 44.28 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 161.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 29.0 tpt85 -57.67 -31.56 66.44 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.01 2.124 . . . . 0.0 115.11 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 20.8 mtm -111.44 18.79 18.83 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.065 1.346 . . . . 0.0 113.791 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -57.5 112.53 1.45 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.089 -1.007 . . . . 0.0 110.813 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 91.05 24.0 28.36 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 124.384 0.992 . . . . 0.0 114.805 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -112.32 155.65 23.75 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.668 1.187 . . . . 0.0 110.619 165.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -148.35 153.51 38.71 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -116.29 141.33 48.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.064 1.745 . . . . 0.0 115.346 170.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.3 124.02 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.275 1.43 . . . . 0.0 110.704 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -90.87 147.55 18.99 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.33 0.49 . . . . 0.0 112.028 163.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 19.3 mt -128.01 160.69 60.2 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.866 1.266 . . . . 0.0 111.105 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.58 -5.23 16.29 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.318 2.679 . . . . 0.0 115.05 -173.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -157.9 146.25 18.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.515 1.526 . . . . 0.0 109.993 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -56.38 -32.78 65.11 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.416 -0.802 . . . . 0.0 112.81 166.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -56.98 -44.69 82.92 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.417 -0.802 . . . . 0.0 113.163 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -64.16 -38.3 90.56 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.435 0.694 . . . . 0.0 111.097 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.83 -43.91 82.49 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.319 0.963 . . . . 0.0 112.25 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.67 85.32 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.197 0.908 . . . . 0.0 112.312 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -70.96 -46.73 61.86 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.316 1.047 . . . . 0.0 112.306 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.57 72.13 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 45.7 mt -66.25 -47.58 73.27 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.246 -0.909 . . . . 0.0 110.229 173.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -30.64 71.69 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.586 0.63 . . . . 0.0 112.242 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -84.77 -40.23 17.5 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -91.89 -22.47 20.05 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -67.12 106.58 2.03 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.871 -1.143 . . . . 0.0 109.498 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 120.88 -8.46 10.69 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.89 1.233 . . . . 0.0 115.579 -171.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -73.22 129.28 37.7 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.44 1.62 . . . . 0.0 109.169 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.305 7.3 p -115.44 55.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 124.183 1.944 . . . . 0.0 110.871 -163.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 26.2 tp -48.01 123.84 6.75 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.442 2.697 . . . . 0.0 111.475 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.307 68.7 m-85 55.08 8.39 0.24 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -174.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 101.67 0.52 52.75 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.994 1.283 . . . . 0.0 115.251 -173.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -107.35 113.6 61.81 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.202 1.501 . . . . 0.0 110.471 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.0 115.45 4.36 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 122.397 2.064 . . . . 0.0 110.23 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 32.4 mtp -75.19 129.15 37.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.812 1.645 . . . . 0.0 111.957 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.5 t -87.95 94.47 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.384 1.073 . . . . 0.0 109.035 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.57 123.35 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.05 1.74 . . . . 0.0 111.856 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -149.95 156.15 41.23 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.724 0.81 . . . . 0.0 112.291 -167.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -56.89 144.78 32.15 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.396 -0.815 . . . . 0.0 109.787 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -173.019 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 123.128 1.442 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.8 p -154.51 155.16 34.35 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.543 1.137 . . . . 0.0 112.527 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.4 tt -70.94 155.37 7.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 125.139 1.376 . . . . 0.0 110.53 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 30.2 t -86.66 150.67 24.03 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 121.442 -0.787 . . . . 0.0 110.756 161.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -43.96 -39.54 4.11 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.531 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -46.25 86.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -79.6 -33.7 41.36 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.031 0.933 . . . . 0.0 112.91 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.17 -48.61 80.99 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.252 1.421 . . . . 0.0 111.192 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -57.6 -23.29 50.09 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.866 1.266 . . . . 0.0 114.363 -176.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -65.42 -25.91 67.74 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.983 1.313 . . . . 0.0 113.042 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.51 89.28 0.46 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.66 1.6 . . . . 0.0 109.946 173.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -167.01 131.75 2.02 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.799 1.239 . . . . 0.0 109.334 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.2 pt -109.42 155.93 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.11 165.6 13.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.08 1.752 . . . . 0.0 110.575 161.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -57.3 -33.59 67.84 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.127 1.371 . . . . 0.0 111.442 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -59.92 -35.28 74.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.853 1.261 . . . . 0.0 113.272 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -79.74 -40.23 29.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.419 0.688 . . . . 0.0 110.602 167.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 31.3 ttm -55.28 -42.41 73.57 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.151 -0.968 . . . . 0.0 112.486 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -79.81 -14.24 58.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.034 0.934 . . . . 0.0 112.974 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.31 -37.27 45.09 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.95 1.7 . . . . 0.0 111.14 168.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 65.3 mt -77.31 121.16 23.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.658 1.583 . . . . 0.0 112.579 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 55.9 p -56.12 -29.64 60.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.233 1.013 . . . . 0.0 113.296 168.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.2 m -63.48 -31.92 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 175.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.311 58.6 m-85 -85.29 -5.66 59.3 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 -175.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -57.75 -16.01 9.84 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 -160.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.9 t -127.37 6.42 6.35 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.626 1.17 . . . . 0.0 113.096 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -129.16 133.73 47.73 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.831 -1.168 . . . . 0.0 107.85 -160.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -147.39 123.31 5.41 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -168.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.99 -173.45 1.88 Allowed 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.946 3.098 . . . . 0.0 112.934 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 99.37 -18.43 56.41 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 116.376 1.311 . . . . 0.0 116.376 170.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -76.59 155.8 83.32 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 118.682 1.241 . . . . 0.0 113.142 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -90.56 113.78 0.46 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.586 3.524 . . . . 0.0 113.768 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -154.29 147.54 24.84 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.636 1.175 . . . . 0.0 109.7 168.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 19.9 p -78.64 11.83 2.36 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.158 -1.589 . . . . 0.0 114.074 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -142.94 146.67 34.2 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.984 2.114 . . . . 0.0 109.063 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 19.0 pt -129.23 167.86 23.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 125.426 1.49 . . . . 0.0 109.606 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -145.57 162.61 37.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.94 139.83 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.782 1.233 . . . . 0.0 111.982 -170.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -119.11 165.81 13.71 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.934 1.693 . . . . 0.0 109.837 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 8.4 t30 64.18 45.78 3.88 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.71 1.204 . . . . 0.0 111.915 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.54 153.31 29.61 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.313 -0.867 . . . . 0.0 111.445 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.32 169.8 8.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.334 1.454 . . . . 0.0 114.502 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -70.23 -48.12 58.38 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.139 -0.976 . . . . 0.0 112.924 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -72.91 -25.23 60.98 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.4 1.48 . . . . 0.0 114.209 -176.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.7 p -69.4 146.49 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -123.36 162.08 23.43 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.419 1.888 . . . . 0.0 110.538 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.38 -29.89 59.32 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.61 -1.306 . . . . 0.0 112.72 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -60.19 -35.44 75.4 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.03 -33.39 70.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.111 0.964 . . . . 0.0 112.918 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.3 mp -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.481 1.512 . . . . 0.0 112.533 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -55.51 -31.34 61.96 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.075 0.852 . . . . 0.0 112.848 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -61.78 -29.98 70.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.741 0.816 . . . . 0.0 110.792 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.92 -55.27 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 121.227 -0.92 . . . . 0.0 110.783 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.253 50.2 m-85 -62.66 -23.84 67.31 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.25 -15.69 81.29 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.015 0.817 . . . . 0.0 114.069 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 38.0 ttp85 -59.52 -25.93 64.9 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.331 1.452 . . . . 0.0 112.849 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -90.2 -0.22 57.51 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.229 1.812 . . . . 0.0 111.676 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 15.2 t -120.92 116.14 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.326 1.85 . . . . 0.0 110.654 -173.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -79.85 97.43 6.67 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.845 0.858 . . . . 0.0 110.761 -175.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.286 58.5 m-85 -62.44 -11.68 17.37 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 119.064 2.987 . . . . 0.0 119.064 -173.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 72.6 m -75.95 -6.73 52.31 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 168.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 47.3 t -116.68 113.42 22.62 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.053 1.741 . . . . 0.0 110.715 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -59.77 -47.22 86.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.845 -0.535 . . . . 0.0 110.975 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -17.02 6.96 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -86.11 -64.9 1.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.801 0.81 . . . . 0.0 109.472 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -68.01 -23.22 64.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.909 1.284 . . . . 0.0 113.889 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.3 tt -56.2 -40.03 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.081 1.352 . . . . 0.0 111.911 172.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -8.85 59.62 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.287 1.035 . . . . 0.0 112.244 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -100.5 125.14 46.8 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -173.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -162.58 155.12 19.23 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.843 1.657 . . . . 0.0 107.767 172.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 4.5 mt -115.95 146.7 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.558 1.143 . . . . 0.0 109.85 174.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -128.05 137.5 52.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.569 1.148 . . . . 0.0 109.72 161.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.1 tp -120.4 136.6 54.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.457 1.503 . . . . 0.0 109.644 168.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 41.8 mtm -91.05 127.97 36.68 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.853 1.661 . . . . 0.0 110.664 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -113.57 -1.79 13.99 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.003 1.721 . . . . 0.0 114.229 -170.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -151.85 -169.86 3.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.787 1.635 . . . . 0.0 111.572 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.36 -163.22 46.21 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.143 0.878 . . . . 0.0 114.484 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -68.95 -11.93 61.16 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.569 1.948 . . . . 0.0 115.344 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 18.0 ptm -137.2 43.23 2.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.759 1.224 . . . . 0.0 112.841 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -52.7 127.69 23.95 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.68 1.192 . . . . 0.0 110.645 168.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 77.61 34.76 38.5 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.423 1.011 . . . . 0.0 112.286 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -120.91 150.69 40.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.132 0.973 . . . . 0.0 112.466 164.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -138.7 157.17 46.61 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.672 1.589 . . . . 0.0 113.49 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -120.33 144.09 48.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.549 1.939 . . . . 0.0 115.079 166.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.91 119.75 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.388 1.475 . . . . 0.0 110.93 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -82.23 137.98 17.84 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.365 -0.834 . . . . 0.0 111.285 162.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 24.2 mt -118.2 160.95 37.3 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.756 1.222 . . . . 0.0 110.112 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 -6.57 15.73 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.092 1.862 . . . . 0.0 114.983 -172.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -156.37 143.99 19.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.506 1.523 . . . . 0.0 110.351 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -51.64 -36.96 48.2 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.789 1.636 . . . . 0.0 112.341 165.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -61.42 -40.38 94.21 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.276 1.03 . . . . 0.0 112.853 174.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.56 -39.32 91.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.118 0.567 . . . . 0.0 110.723 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.68 87.38 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.922 -0.486 . . . . 0.0 112.107 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.26 -43.53 78.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.981 0.81 . . . . 0.0 112.16 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -75.76 -45.08 38.37 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.82 1.248 . . . . 0.0 112.855 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.39 -33.83 73.04 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.626 0.648 . . . . 0.0 112.729 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 38.3 mt -67.8 -46.55 71.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.85 0.75 . . . . 0.0 110.915 172.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -64.49 -32.76 74.53 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 119.114 -0.47 . . . . 0.0 111.322 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -82.8 -54.67 4.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.17 -17.86 61.91 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.38 102.59 0.14 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.167 1.387 . . . . 0.0 111.965 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 105.18 -0.77 40.76 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 118.149 -1.361 . . . . 0.0 115.754 -175.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.63 128.75 37.15 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.556 1.678 . . . . 0.0 112.84 -173.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.314 1.4 t -93.55 49.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -163.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 58.9 tp -57.91 122.42 12.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.663 1.585 . . . . 0.0 111.677 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.403 56.4 m-85 59.16 20.3 8.3 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -175.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 83.16 13.47 76.95 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.335 0.969 . . . . 0.0 114.198 -172.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -119.78 119.86 30.92 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.042 1.337 . . . . 0.0 110.616 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.9 114.59 4.08 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.064 2.509 . . . . 0.0 111.003 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 63.1 mtp -74.72 134.78 41.85 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.529 1.132 . . . . 0.0 111.952 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.47 100.15 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.473 1.509 . . . . 0.0 108.458 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.93 132.38 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.019 1.728 . . . . 0.0 112.993 -170.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -150.43 156.77 42.1 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -170.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -56.16 144.71 28.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.793 0.837 . . . . 0.0 109.346 170.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.479 0 O-C-N 121.23 -0.919 . . . . 0.0 113.145 -176.561 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 8.8 m -155.14 161.28 41.28 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.41 1.884 . . . . 0.0 112.568 171.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.5 tt -67.94 140.88 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 124.222 1.009 . . . . 0.0 110.892 -170.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 70.5 m -82.68 160.44 22.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.998 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -63.64 -33.2 75.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 118.889 -0.576 . . . . 0.0 111.809 -174.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -62.47 -55.72 24.91 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.67 0.788 . . . . 0.0 112.964 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -62.06 -38.37 88.51 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.25 -44.64 83.1 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -60.67 -21.16 62.52 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -61.29 -46.29 90.94 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.178 1.391 . . . . 0.0 111.892 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.9 75.55 0.39 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.477 1.037 . . . . 0.0 111.999 -170.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 6.1 ttp85 -155.5 152.97 29.54 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.212 1.005 . . . . 0.0 110.97 -173.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.6 pt -130.94 155.06 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.9 0.88 . . . . 0.0 112.031 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 74.5 p -86.65 172.12 10.47 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.321 1.048 . . . . 0.0 111.456 169.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -55.18 -32.92 62.55 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.567 -0.708 . . . . 0.0 111.43 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.12 -25.72 67.89 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.88 -32.05 14.74 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.767 0.712 . . . . 0.0 110.803 166.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 16.0 ttm -66.55 -42.26 87.41 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.444 -1.41 . . . . 0.0 112.598 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -78.43 12.48 1.96 Allowed 'General case' 0 CA--C 1.552 1.042 0 O-C-N 120.973 -1.079 . . . . 0.0 111.573 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -125.03 -30.31 3.24 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.116 2.166 . . . . 0.0 116.006 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 1.7 mp -75.7 130.67 39.08 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.916 -1.115 . . . . 0.0 109.753 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 38.1 m -66.07 -20.65 66.24 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 1.3 m -57.19 -25.91 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 167.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.15 21.22 17.02 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -63.87 -22.52 66.96 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.238 -1.539 . . . . 0.0 114.78 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 78.0 p -139.97 -19.49 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.741 1.616 . . . . 0.0 113.365 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.18 135.89 41.06 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -141.95 132.05 12.65 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -85.26 175.77 6.2 Favored 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.283 3.322 . . . . 0.0 113.683 168.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.26 -3.39 72.54 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 117.894 1.918 . . . . 0.0 117.894 165.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -81.7 144.37 52.26 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 119.096 1.448 . . . . 0.0 113.996 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.17 86.21 1.7 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.148 3.232 . . . . 0.0 112.686 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . 0.495 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 30.9 t30 -133.55 151.44 51.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.28 1.432 . . . . 0.0 110.257 165.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 24.2 p -82.07 -9.2 59.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . 0.495 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 82.7 mtt-85 -121.61 150.52 41.58 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.944 1.298 . . . . 0.0 110.629 177.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 19.7 pt -135.02 158.84 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.638 1.975 . . . . 0.0 110.37 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -133.79 158.11 44.18 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.24 131.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.246 1.418 . . . . 0.0 113.614 -171.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -108.63 172.66 6.71 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.262 1.425 . . . . 0.0 110.63 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.283 88.6 m-20 71.67 32.91 1.89 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.645 1.978 . . . . 0.0 116.029 -176.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.49 147.2 25.48 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.175 -0.953 . . . . 0.0 111.73 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.67 161.72 22.74 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.149 1.779 . . . . 0.0 115.109 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -67.14 -39.85 86.63 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.664 -1.272 . . . . 0.0 112.681 166.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -73.1 -27.83 61.93 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.752 1.621 . . . . 0.0 114.798 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.01 146.43 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -128.23 164.05 23.39 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.889 1.276 . . . . 0.0 112.584 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -33.99 68.21 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.63 -1.294 . . . . 0.0 113.021 -174.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -54.22 -30.82 51.43 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.191 1.797 . . . . 0.0 115.297 170.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -83.43 -34.18 25.52 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.877 1.671 . . . . 0.0 113.6 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.06 -22.32 66.88 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.323 1.049 . . . . 0.0 111.973 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -20.18 44.63 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -67.29 -30.52 70.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.83 0.741 . . . . 0.0 111.843 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.83 -55.47 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.27 -0.894 . . . . 0.0 110.46 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -57.61 -30.07 65.03 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.36 -12.07 82.14 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 123.997 0.808 . . . . 0.0 114.602 174.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 5.4 ttt85 -58.83 -27.89 65.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.334 1.567 . . . . 0.0 110.85 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -95.66 18.26 13.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.241 1.816 . . . . 0.0 113.558 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 27.3 t -140.54 124.56 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.099 1.76 . . . . 0.0 111.223 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -77.23 110.07 11.63 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -61.71 -12.42 16.51 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 118.178 2.658 . . . . 0.0 118.178 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 16.5 m -88.83 -18.95 26.6 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.455 0.702 . . . . 0.0 112.676 174.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 28.9 t -108.63 112.54 24.93 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.758 1.223 . . . . 0.0 111.754 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -54.11 -50.64 66.41 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.228 0.611 . . . . 0.0 111.016 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.45 -12.77 1.85 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -93.17 -61.76 1.51 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.978 1.311 . . . . 0.0 110.692 172.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -69.3 -20.41 63.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.796 1.239 . . . . 0.0 113.784 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.08 -28.97 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.773 1.629 . . . . 0.0 112.69 169.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 37.5 mtp -85.86 -13.1 48.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.958 1.303 . . . . 0.0 111.761 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -108.32 117.32 33.84 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -163.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -159.2 154.54 25.55 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.891 1.676 . . . . 0.0 110.065 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 8.4 mt -130.63 142.21 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.189 1.396 . . . . 0.0 110.797 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -123.37 142.64 50.76 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.028 1.331 . . . . 0.0 110.283 160.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 11.2 tp -133.47 115.68 15.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.842 2.057 . . . . 0.0 109.134 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 45.8 mtm -71.27 144.62 49.96 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 124.602 1.161 . . . . 0.0 111.751 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -128.64 -6.93 5.14 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -172.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.96 145.1 35.57 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.824 1.193 . . . . 0.0 114.122 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 75.37 -177.16 49.29 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.096 1.331 . . . . 0.0 113.216 -172.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -18.72 61.68 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -170.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 70.4 mtp -89.12 3.17 52.72 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -58.52 145.63 38.39 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.533 -1.354 . . . . 0.0 111.131 175.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.54 27.66 70.84 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.749 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -126.83 146.04 50.42 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.727 1.211 . . . . 0.0 111.339 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -137.07 155.26 49.87 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -167.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -125.71 134.0 51.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.678 1.991 . . . . 0.0 115.307 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.94 125.05 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.974 1.709 . . . . 0.0 109.952 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.07 137.62 14.27 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 162.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 25.2 mt -118.18 160.45 39.25 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.515 1.526 . . . . 0.0 109.26 173.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.03 -8.96 20.5 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.139 1.226 . . . . 0.0 114.642 -170.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -153.47 142.38 21.16 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.72 1.208 . . . . 0.0 111.059 -172.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -60.24 -37.19 79.63 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.389 -0.819 . . . . 0.0 111.147 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -65.25 -32.35 73.97 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.311 0.644 . . . . 0.0 112.591 176.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -73.58 -35.5 65.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.084 0.554 . . . . 0.0 111.777 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.97 -45.14 86.92 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.359 0.981 . . . . 0.0 111.696 168.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.56 77.83 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.767 1.167 . . . . 0.0 112.263 176.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.33 -50.97 61.78 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.207 1.403 . . . . 0.0 112.545 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.54 -33.53 72.8 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.862 0.865 . . . . 0.0 112.118 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 45.6 mt -71.19 -36.87 72.11 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.927 1.291 . . . . 0.0 111.521 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -67.28 -22.99 65.63 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.513 1.125 . . . . 0.0 112.698 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -112.15 -33.04 6.36 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -171.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -84.83 -17.54 37.73 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -66.56 109.29 2.73 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.263 1.025 . . . . 0.0 111.672 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 104.57 4.41 43.13 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 118.061 -1.41 . . . . 0.0 115.976 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -70.4 123.66 22.3 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.704 1.752 . . . . 0.0 110.956 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.27 2.0 t -92.31 52.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.196 1.398 . . . . 0.0 114.416 -163.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.08 126.01 25.82 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.739 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . . 4.9 t80 53.79 35.91 22.67 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.579 1.952 . . . . 0.0 110.14 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 76.89 11.53 85.4 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.664 -1.272 . . . . 0.0 115.068 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -127.11 123.35 23.43 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 119.253 1.526 . . . . 0.0 111.11 -176.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.2 118.15 5.41 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.566 2.177 . . . . 0.0 111.648 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 72.1 mtp -69.14 126.06 28.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.693 1.197 . . . . 0.0 112.304 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -86.23 83.11 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.674 1.589 . . . . 0.0 113.422 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 1.6 t -85.86 122.61 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.398 1.479 . . . . 0.0 112.895 -175.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -145.95 155.6 42.95 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.954 1.301 . . . . 0.0 111.693 -174.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -60.35 144.28 51.08 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.937 -1.102 . . . . 0.0 110.796 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.458 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 . . . . . 0 CA--C 1.544 0.722 0 CA-C-O 122.229 1.014 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 14.7 p -150.22 149.61 30.43 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.92 1.288 . . . . 0.0 114.332 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.5 tt -76.08 153.04 6.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 125.795 1.638 . . . . 0.0 111.516 -167.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 33.9 t -83.54 156.6 22.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.386 0.612 . . . . 0.0 110.745 165.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -53.92 -36.01 62.3 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.491 0.717 . . . . 0.0 111.029 163.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -45.4 86.78 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -71.1 -35.17 71.72 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.546 0.738 . . . . 0.0 112.85 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.431 HD13 ' CD2' ' A' ' 489' ' ' TYR . 31.4 tp -67.76 -44.68 76.9 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -54.91 -24.19 22.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.816 1.246 . . . . 0.0 114.03 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.68 -29.29 69.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.126 1.371 . . . . 0.0 112.855 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.22 97.94 0.76 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.436 1.017 . . . . 0.0 111.521 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -159.8 152.22 21.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.448 1.099 . . . . 0.0 110.635 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.44 150.21 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.428 0.632 . . . . 0.0 112.68 168.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 39.9 m -98.22 169.45 9.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.66 1.584 . . . . 0.0 111.694 168.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -54.57 -23.71 17.93 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -171.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -72.16 -28.43 63.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.798 0.839 . . . . 0.0 112.81 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.79 -32.9 14.49 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.527 1.131 . . . . 0.0 111.094 171.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 35.8 ttm -58.08 -46.3 85.69 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.08 -1.013 . . . . 0.0 111.239 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -85.04 37.16 0.65 Allowed 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.385 -0.822 . . . . 0.0 111.363 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.44 -37.52 0.31 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.948 2.099 . . . . 0.0 114.332 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.48 131.37 42.46 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.993 1.317 . . . . 0.0 110.008 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 53.1 p -69.01 -22.48 64.07 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.012 -1.055 . . . . 0.0 112.065 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.3 m -71.38 -7.53 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 168.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.286 89.4 m-85 -117.79 3.93 12.25 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 173.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -66.01 -15.07 62.71 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -174.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 79.9 p -141.1 -16.12 0.86 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.907 1.283 . . . . 0.0 114.187 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -80.75 141.27 34.96 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 170.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -140.59 129.8 13.09 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -169.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -84.91 -174.86 1.86 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 124.263 3.309 . . . . 0.0 114.242 171.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.83 -44.99 2.34 Favored Glycine 0 N--CA 1.466 0.659 0 C-N-CA 126.488 1.994 . . . . 0.0 115.774 164.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -65.85 142.37 98.08 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -164.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.2 106.5 2.29 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.53 2.82 . . . . 0.0 112.199 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -144.37 151.21 38.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.222 2.209 . . . . 0.0 107.752 159.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 28.9 p -75.06 2.55 10.35 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.476 -1.39 . . . . 0.0 114.361 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -137.53 147.69 45.36 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.124 1.77 . . . . 0.0 110.333 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 43.9 pt -134.43 159.97 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.203 2.201 . . . . 0.0 110.123 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -139.86 159.86 41.22 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.19 140.24 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.694 1.597 . . . . 0.0 113.412 -164.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -119.5 175.59 5.76 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.331 1.452 . . . . 0.0 111.168 167.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.279 13.6 m-20 69.07 25.42 5.85 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.322 1.849 . . . . 0.0 115.824 -172.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -74.68 146.53 42.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.262 -1.524 . . . . 0.0 111.043 173.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.18 173.65 3.69 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -173.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -77.98 -50.58 11.87 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.518 1.127 . . . . 0.0 111.78 -176.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -81.97 -23.68 35.94 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.24 1.816 . . . . 0.0 113.251 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.58 152.07 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -122.53 168.27 12.34 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.697 1.599 . . . . 0.0 113.346 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -57.2 -35.21 69.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.542 1.137 . . . . 0.0 112.616 174.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -62.35 -36.42 82.19 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -71.92 -25.18 61.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.641 1.176 . . . . 0.0 113.636 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.23 -15.4 59.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.099 2.16 . . . . 0.0 114.024 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.67 -22.75 57.75 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.324 0.966 . . . . 0.0 112.857 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -55.31 -37.23 67.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.076 1.351 . . . . 0.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.79 -57.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 121.253 -0.904 . . . . 0.0 111.659 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.274 58.9 m-85 -59.68 -31.83 69.92 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -175.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.76 -19.84 79.74 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 123.668 0.652 . . . . 0.0 114.072 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -55.0 -35.82 64.77 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.713 1.605 . . . . 0.0 112.506 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -77.71 0.79 22.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.431 1.892 . . . . 0.0 114.873 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 11.7 t -124.59 121.99 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.742 2.017 . . . . 0.0 109.946 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.254 3.2 m-20 -66.78 90.56 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 175.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -52.64 -21.42 3.93 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 173.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 15.8 m -65.2 -22.29 66.88 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.346 1.058 . . . . 0.0 113.176 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 31.2 m -124.45 117.84 25.31 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.697 1.599 . . . . 0.0 112.733 -170.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -63.09 -40.67 98.33 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.234 -0.916 . . . . 0.0 113.278 -174.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 2.9 t -54.48 -15.23 1.58 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -88.75 -62.65 1.44 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.213 1.405 . . . . 0.0 110.714 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -67.02 -24.55 66.03 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.14 1.376 . . . . 0.0 113.169 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.3 tt -58.53 -36.58 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.3 1.04 . . . . 0.0 112.366 171.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 16.6 mtm -87.52 -2.59 58.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.089 1.355 . . . . 0.0 112.439 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.56 143.81 31.77 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.938 2.495 . . . . 0.0 115.212 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -168.7 154.85 6.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.08 1.752 . . . . 0.0 107.006 168.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.08 126.75 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.599 1.16 . . . . 0.0 109.544 172.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -104.3 137.65 41.89 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.845 1.258 . . . . 0.0 108.899 165.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.2 tp -128.1 127.75 43.63 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.886 1.274 . . . . 0.0 109.191 164.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 48.0 mtm -93.17 125.04 37.57 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.808 1.643 . . . . 0.0 109.948 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -122.14 -0.46 9.43 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.963 2.105 . . . . 0.0 112.925 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.9 148.79 23.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.832 1.653 . . . . 0.0 112.512 173.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 90.57 -168.77 33.56 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 163.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -20.55 64.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.344 1.858 . . . . 0.0 113.772 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 62.7 mtp -115.92 24.28 11.59 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.282 2.233 . . . . 0.0 112.202 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -65.46 151.95 45.11 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.792 -1.193 . . . . 0.0 113.204 -172.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.66 36.83 18.5 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 126.194 1.854 . . . . 0.0 112.798 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -120.19 142.01 49.37 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.189 0.996 . . . . 0.0 112.128 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -129.93 153.37 48.41 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -168.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -126.83 129.63 48.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.0 2.12 . . . . 0.0 114.733 171.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.5 mp -126.42 120.56 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.674 1.59 . . . . 0.0 109.856 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -83.14 141.03 20.45 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 162.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 21.4 mt -124.51 158.82 60.41 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.726 1.61 . . . . 0.0 109.686 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.88 -15.62 26.39 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.948 2.432 . . . . 0.0 114.085 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -150.07 143.74 25.31 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.035 0.934 . . . . 0.0 110.623 -175.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -57.6 -37.67 73.61 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.41 1.084 . . . . 0.0 111.61 170.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -69.78 -23.23 63.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.346 1.058 . . . . 0.0 113.575 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -77.56 -38.22 48.98 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.774 171.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.06 79.27 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.254 0.933 . . . . 0.0 112.259 170.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -54.64 -43.19 72.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.4 1.0 . . . . 0.0 111.614 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -64.77 -50.05 68.35 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.962 1.305 . . . . 0.0 113.009 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.38 -31.54 72.22 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.359 0.664 . . . . 0.0 111.816 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 89.7 mt -77.87 -31.58 51.45 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.099 -1.001 . . . . 0.0 112.346 173.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -60.62 -33.29 72.55 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.617 1.167 . . . . 0.0 110.606 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -101.9 -54.45 2.72 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -174.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -75.52 -14.45 60.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -168.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -65.46 104.43 0.98 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.207 1.003 . . . . 0.0 110.323 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 107.31 1.5 35.46 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 117.583 -1.676 . . . . 0.0 116.18 -172.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.431 ' CD2' HD13 ' A' ' 394' ' ' LEU 0.314 92.2 t80 -64.65 128.86 37.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.672 2.236 . . . . 0.0 115.925 -168.285 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.325 2.0 t -91.68 45.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -160.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 23.2 tp -52.8 138.87 28.35 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.156 1.382 . . . . 0.0 110.183 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.356 7.0 t80 62.91 -4.08 0.28 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 94.7 9.57 58.57 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 124.958 1.266 . . . . 0.0 114.358 -166.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -127.21 128.48 24.09 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 126.686 1.995 . . . . 0.0 111.581 -173.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.86 119.04 5.51 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.544 2.162 . . . . 0.0 112.511 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 56.9 mtp -75.58 130.81 39.4 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.729 1.612 . . . . 0.0 112.419 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.95 76.79 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.857 1.663 . . . . 0.0 115.131 -175.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 1.7 t -79.83 122.72 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.355 1.062 . . . . 0.0 113.789 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -141.63 155.7 45.7 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.175 1.79 . . . . 0.0 112.514 -173.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -59.7 143.28 51.18 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.346 -1.471 . . . . 0.0 113.193 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -169.99 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 121.892 0.853 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 28.0 p -139.05 159.81 41.26 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.9 tt -70.06 152.37 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.863 1.665 . . . . 0.0 110.94 -174.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 1.6 m -86.65 152.6 22.44 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 7.2 ttm-85 -59.06 -35.79 73.95 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.1 -1.0 . . . . 0.0 111.124 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -41.51 98.26 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.838 1.655 . . . . 0.0 113.733 174.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.85 -38.91 92.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.095 0.958 . . . . 0.0 112.692 174.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.4 tt -70.2 -39.99 74.86 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.412 1.485 . . . . 0.0 111.943 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.36 -17.17 18.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.488 1.915 . . . . 0.0 115.153 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -63.95 -64.61 0.84 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.74 -0.6 . . . . 0.0 110.88 164.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -78.99 72.09 2.51 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.497 1.999 . . . . 0.0 114.072 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -159.66 143.33 14.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.763 1.225 . . . . 0.0 110.973 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.4 pt -123.3 153.74 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.356 1.063 . . . . 0.0 113.866 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 77.3 p -85.02 169.87 13.55 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.54 1.536 . . . . 0.0 111.828 168.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 -58.37 -28.92 65.6 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.326 -0.859 . . . . 0.0 113.288 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.83 -30.94 71.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.543 0.737 . . . . 0.0 112.265 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.44 -36.59 26.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.641 1.176 . . . . 0.0 111.775 168.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 20.3 ttp -63.06 -40.6 98.18 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.919 -1.113 . . . . 0.0 111.829 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -83.29 25.12 0.75 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.441 0.696 . . . . 0.0 112.609 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.69 -38.23 1.51 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.892 2.077 . . . . 0.0 115.933 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.58 127.58 33.44 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.509 1.524 . . . . 0.0 110.131 172.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 27.9 t -59.48 -32.12 69.96 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.543 -0.723 . . . . 0.0 112.314 168.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 18.5 m -60.21 -21.64 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 120.753 -1.217 . . . . 0.0 114.08 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.263 79.7 m-85 -109.52 6.8 24.39 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -69.67 -22.33 63.45 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 46.6 t -123.43 -42.16 2.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.426 1.09 . . . . 0.0 112.381 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -72.56 150.79 42.84 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.898 1.279 . . . . 0.0 114.319 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -140.24 125.49 11.36 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -163.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -92.74 177.01 1.55 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 124.958 3.772 . . . . 0.0 114.887 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 98.58 -8.86 62.2 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.302 1.906 . . . . 0.0 116.843 163.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -85.69 139.79 35.52 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 119.294 1.547 . . . . 0.0 114.556 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -83.55 65.43 7.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 1 C-N-CA 125.392 4.061 . . . . 0.0 113.038 -174.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 46.6 t30 -89.79 153.98 20.26 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.551 -0.718 . . . . 0.0 110.485 162.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 28.4 p -76.05 -3.63 36.94 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.088 -1.633 . . . . 0.0 115.068 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . 0.431 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 87.7 mtt-85 -136.44 152.52 50.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.352 1.861 . . . . 0.0 111.833 176.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.6 pt -135.4 164.14 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.671 1.989 . . . . 0.0 109.588 176.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -138.47 161.21 37.59 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.62 150.52 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.241 1.816 . . . . 0.0 112.018 -171.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -138.01 -178.25 5.18 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.292 0.496 . . . . 0.0 112.158 162.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 69.61 21.73 6.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.215 1.806 . . . . 0.0 114.516 -165.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.87 154.64 41.65 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.991 -1.068 . . . . 0.0 110.912 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -68.26 173.7 4.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.172 0.989 . . . . 0.0 113.03 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.02 -30.43 13.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.225 1.41 . . . . 0.0 112.285 170.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -73.69 -14.81 61.21 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.107 1.363 . . . . 0.0 113.92 172.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.8 p -86.16 147.16 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.807 1.643 . . . . 0.0 113.898 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -117.49 164.81 14.34 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.333 1.053 . . . . 0.0 111.953 173.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -58.67 -30.51 67.41 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.6 -1.313 . . . . 0.0 111.966 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -20.93 63.8 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.842 1.657 . . . . 0.0 114.84 174.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -76.78 -37.86 55.09 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.269 1.028 . . . . 0.0 113.533 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.18 -18.31 63.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.595 1.558 . . . . 0.0 112.541 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -49.14 -33.13 11.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.176 1.391 . . . . 0.0 112.869 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -66.14 -31.2 71.91 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -169.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.9 mt -98.75 -56.15 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.821 -1.174 . . . . 0.0 111.151 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.265 75.6 m-85 -60.79 -22.52 64.2 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.73 -6.88 88.89 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.399 0.999 . . . . 0.0 114.519 170.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -63.05 -26.39 68.82 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 120.794 2.297 . . . . 0.0 112.09 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -94.51 3.83 54.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.081 2.152 . . . . 0.0 111.424 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.8 107.8 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.355 1.462 . . . . 0.0 109.432 -174.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -72.15 104.96 3.79 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -170.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -50.3 -40.31 48.19 Favored 'General case' 0 C--N 1.338 0.109 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 -170.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.0 p -68.16 -4.08 12.66 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 14.9 t -118.02 116.05 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.747 1.158 . . . . 0.0 111.782 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -60.3 -43.78 96.0 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.209 -0.932 . . . . 0.0 112.25 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.2 t -54.83 -16.08 2.38 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -90.09 -60.28 1.97 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.186 0.994 . . . . 0.0 110.032 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -68.13 -23.86 64.94 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.785 1.234 . . . . 0.0 113.286 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.0 tt -61.36 -31.84 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.938 1.695 . . . . 0.0 112.96 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.7 mtm -97.85 2.39 49.25 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.23 1.412 . . . . 0.0 112.698 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -111.6 112.23 23.79 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.372 1.869 . . . . 0.0 115.85 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -154.62 131.85 11.07 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.573 -0.704 . . . . 0.0 109.419 -168.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 5.1 mt -113.47 142.96 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.654 1.182 . . . . 0.0 110.407 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -134.37 129.64 35.71 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.992 1.717 . . . . 0.0 109.322 165.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 4.2 tt -115.53 139.73 49.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.345 1.858 . . . . 0.0 111.005 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -101.67 131.78 47.73 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 125.234 1.414 . . . . 0.0 112.463 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -113.9 1.76 14.84 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -171.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -145.9 154.82 42.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.211 1.004 . . . . 0.0 113.042 -174.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 77.23 -162.08 51.03 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.207 1.384 . . . . 0.0 113.809 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -22.27 66.07 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 121.483 -1.01 . . . . 0.0 112.743 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 23.2 ptp -87.18 8.84 22.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.112 1.365 . . . . 0.0 114.395 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -56.77 115.85 2.81 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.825 1.193 . . . . 0.0 110.838 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.16 22.79 58.48 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.732 1.634 . . . . 0.0 113.859 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -93.79 155.98 16.92 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.353 0.661 . . . . 0.0 110.697 158.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -149.74 152.8 35.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.224 1.009 . . . . 0.0 113.179 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -105.63 144.53 32.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.145 1.778 . . . . 0.0 114.123 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.9 mp -139.62 115.01 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.198 1.399 . . . . 0.0 109.244 169.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -81.69 144.15 23.97 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 158.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.1 mt -123.5 159.83 53.44 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.712 1.205 . . . . 0.0 110.332 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.01 -8.78 24.44 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.658 2.906 . . . . 0.0 114.321 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -156.71 144.11 19.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.582 0.706 . . . . 0.0 112.125 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -49.77 -44.79 49.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.406 1.882 . . . . 0.0 112.579 166.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -68.01 -28.75 67.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.706 1.202 . . . . 0.0 113.779 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.52 73.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.563 174.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.0 88.03 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.939 0.79 . . . . 0.0 112.776 174.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.68 71.11 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.722 0.692 . . . . 0.0 112.371 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.16 -52.0 15.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.134 1.374 . . . . 0.0 112.885 172.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.08 -30.54 69.3 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.094 0.958 . . . . 0.0 113.293 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 28.8 mt -64.17 -49.32 72.56 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.379 0.671 . . . . 0.0 111.028 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -21.6 48.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.614 0.766 . . . . 0.0 112.729 -176.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -72.01 -54.57 9.48 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.397 0.999 . . . . 0.0 112.62 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.67 -14.67 59.56 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -172.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -61.8 99.07 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.013 1.325 . . . . 0.0 111.657 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 119.34 -1.5 14.29 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 117.778 -1.568 . . . . 0.0 115.405 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -71.23 131.0 42.85 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.354 1.577 . . . . 0.0 111.254 -172.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.18 67.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.971 1.708 . . . . 0.0 113.437 -168.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 23.6 tp -66.28 142.8 57.54 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.363 162.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.4 27.3 t80 63.8 7.81 3.44 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 118.228 2.677 . . . . 0.0 118.228 167.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 78.93 14.97 81.42 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.1 1.333 . . . . 0.0 114.277 -169.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -133.87 125.65 18.37 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.66 1.584 . . . . 0.0 110.689 -171.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.4 125.18 11.54 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.121 1.881 . . . . 0.0 112.167 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 63.7 mtp -73.15 127.3 32.2 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.817 1.247 . . . . 0.0 111.696 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.24 98.86 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.901 0.88 . . . . 0.0 109.712 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.0 t -94.18 124.27 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.641 1.577 . . . . 0.0 112.337 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -148.28 152.81 37.77 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.61 0.764 . . . . 0.0 112.765 -168.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . 0.31 17.6 p90 -57.85 144.66 37.98 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 173.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -171.312 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 . . . . . 0 CA--C 1.542 0.639 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 23.2 p -135.85 162.5 32.64 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 12.5 tt -76.66 144.03 12.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 125.694 1.597 . . . . 0.0 111.971 -162.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 69.3 m -90.05 155.96 18.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.506 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -53.48 -38.77 63.97 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.929 0.892 . . . . 0.0 111.655 -174.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -62.53 -47.97 81.58 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -69.67 -34.11 73.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -42.52 94.41 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.8 0.84 . . . . 0.0 112.408 169.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -57.91 -27.14 63.06 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.659 -1.276 . . . . 0.0 114.443 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -68.93 -21.84 64.18 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 118.996 0.816 . . . . 0.0 112.412 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -116.52 62.95 0.37 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.088 1.804 . . . . 0.0 112.888 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -148.21 166.25 28.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.832 1.653 . . . . 0.0 109.371 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.2 pt -144.83 148.88 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.125 0.97 . . . . 0.0 112.143 167.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.6 m -74.17 160.38 31.27 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.4 1.88 . . . . 0.0 112.815 165.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -53.76 -35.62 61.47 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.804 1.242 . . . . 0.0 112.323 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -60.3 -30.08 69.25 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.299 1.04 . . . . 0.0 113.258 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.33 -26.24 18.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.568 1.147 . . . . 0.0 112.123 172.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 8.2 ttm -61.77 -38.98 90.05 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 120.785 -1.197 . . . . 0.0 111.366 174.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -80.15 22.18 0.54 Allowed 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 171.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.38 -31.46 1.09 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 5.5 mp -74.5 137.85 42.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.64 1.176 . . . . 0.0 111.402 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 81.1 p -63.64 -31.89 73.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 1.5 m -63.54 -19.54 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.38 1.472 . . . . 0.0 114.677 173.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.308 65.7 m-85 -109.41 3.08 21.06 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 119.152 3.019 . . . . 0.0 119.152 -176.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -29.12 67.05 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 37.5 t -126.43 -34.94 2.42 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.064 1.346 . . . . 0.0 112.829 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -72.02 139.61 48.63 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -142.41 130.32 11.47 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.709 1.204 . . . . 0.0 112.15 -170.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -76.48 -166.28 0.36 Allowed 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 124.3 3.334 . . . . 0.0 113.156 164.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.16 13.8 58.35 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 117.688 1.835 . . . . 0.0 117.688 156.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -102.38 149.87 37.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 119.613 1.706 . . . . 0.0 113.088 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.54 109.53 2.92 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.583 2.856 . . . . 0.0 112.355 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -148.38 145.0 27.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.347 1.059 . . . . 0.0 109.098 164.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 24.2 p -76.0 -2.66 31.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 33.8 mtp85 -130.09 147.08 51.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.888 2.075 . . . . 0.0 108.901 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 3.3 pt -131.81 161.18 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 126.386 1.875 . . . . 0.0 109.431 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -136.8 161.44 35.98 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.7 t -131.65 140.68 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.453 1.501 . . . . 0.0 111.655 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -120.56 166.23 13.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.544 1.537 . . . . 0.0 109.36 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 69.49 36.88 2.1 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -171.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.8 160.2 26.23 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 120.148 -1.595 . . . . 0.0 112.221 168.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -79.02 176.15 9.92 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.002 1.721 . . . . 0.0 115.282 -171.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -77.93 -48.04 17.24 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 171.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -72.8 -36.04 67.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.656 1.182 . . . . 0.0 113.179 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.64 153.95 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -130.93 163.55 27.24 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.467 1.507 . . . . 0.0 111.566 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -52.62 -31.06 34.71 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.548 1.139 . . . . 0.0 113.408 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -60.08 -33.04 71.53 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 171.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -76.88 -26.82 54.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.427 1.491 . . . . 0.0 114.494 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.44 -19.98 60.83 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.044 1.738 . . . . 0.0 113.549 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.76 -25.88 61.08 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.587 1.085 . . . . 0.0 112.358 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -59.29 -38.87 81.25 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.552 0.741 . . . . 0.0 111.5 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mt -94.47 -56.97 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 121.26 -0.9 . . . . 0.0 110.632 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -60.25 -28.33 67.95 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.57 -12.75 84.21 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.437 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -55.12 -40.4 70.46 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.135 1.467 . . . . 0.0 112.064 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -80.89 -5.96 58.04 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.403 1.881 . . . . 0.0 112.022 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.61 117.54 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.154 1.782 . . . . 0.0 110.726 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -69.07 90.87 0.47 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.299 30.7 m-85 -59.14 -16.05 17.73 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 118.198 2.666 . . . . 0.0 118.198 177.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.9 t -66.73 -26.26 66.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.854 1.207 . . . . 0.0 112.295 171.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.1 m -110.23 120.76 43.46 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.636 1.574 . . . . 0.0 112.303 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -58.23 -44.11 88.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.005 -1.059 . . . . 0.0 112.826 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.11 -7.14 0.46 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -100.0 -55.6 2.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.842 1.257 . . . . 0.0 109.768 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -70.58 -24.13 62.71 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.485 1.114 . . . . 0.0 112.691 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.5 tt -59.24 -31.91 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.8 1.64 . . . . 0.0 112.694 171.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 36.1 mtp -86.71 -9.24 56.37 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.23 1.412 . . . . 0.0 112.485 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.22 122.23 46.51 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -170.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -159.62 119.33 2.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.215 1.006 . . . . 0.0 110.981 -170.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 8.1 mt -102.59 133.03 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.986 0.914 . . . . 0.0 111.323 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -133.19 120.46 21.2 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.004 0.921 . . . . 0.0 110.388 170.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 7.8 tt -108.76 129.63 55.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.132 1.773 . . . . 0.0 110.101 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -77.96 109.53 12.09 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.421 1.489 . . . . 0.0 110.982 176.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -85.0 -8.95 58.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pm0 -130.92 159.62 36.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -167.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 65.02 -160.25 42.62 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.965 1.269 . . . . 0.0 114.98 164.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -18.64 60.52 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 40.9 mtp -99.71 11.65 38.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.054 1.341 . . . . 0.0 113.029 174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -54.03 113.01 1.07 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.512 1.125 . . . . 0.0 110.306 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.81 31.39 23.97 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.282 0.944 . . . . 0.0 113.875 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -106.4 155.35 19.63 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.517 1.127 . . . . 0.0 110.412 157.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.2 154.48 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.962 -1.086 . . . . 0.0 113.604 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -116.23 144.41 44.23 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.653 1.981 . . . . 0.0 115.58 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.25 118.27 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.554 1.941 . . . . 0.0 110.026 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -81.95 142.02 22.12 Favored Glycine 0 CA--C 1.534 1.249 0 O-C-N 121.447 -0.783 . . . . 0.0 111.383 159.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.6 mt -120.87 160.8 43.25 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.059 1.344 . . . . 0.0 109.986 174.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.78 -6.19 17.84 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.527 2.152 . . . . 0.0 114.447 -175.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -155.59 143.56 19.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.563 0.745 . . . . 0.0 111.466 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.31 -43.31 32.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.407 1.483 . . . . 0.0 112.469 162.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -62.54 -34.96 77.96 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.466 -0.771 . . . . 0.0 113.017 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.03 -37.43 75.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.413 0.685 . . . . 0.0 111.816 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.74 80.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.394 0.997 . . . . 0.0 111.783 170.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.03 -34.07 67.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.583 0.753 . . . . 0.0 112.398 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -75.11 -49.39 19.76 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.849 1.26 . . . . 0.0 112.848 170.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.7 -29.73 68.3 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.575 -0.703 . . . . 0.0 112.602 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.9 mt -71.71 -28.84 63.97 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.299 1.04 . . . . 0.0 113.412 173.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -67.57 -37.72 83.04 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.575 0.75 . . . . 0.0 111.033 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -91.71 -56.49 3.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -169.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -74.35 -18.22 60.72 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -75.65 111.6 11.15 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.221 -0.924 . . . . 0.0 111.002 -174.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 107.12 8.49 31.36 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.022 -168.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -75.79 126.73 31.56 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.444 1.622 . . . . 0.0 110.082 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.316 1.2 t -97.76 45.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.473 1.509 . . . . 0.0 114.704 -162.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 36.0 tp -52.8 123.72 12.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.027 1.731 . . . . 0.0 111.218 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.37 65.7 m-85 57.84 11.58 1.42 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 118.345 2.72 . . . . 0.0 118.345 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 87.06 18.87 57.07 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 120.871 -1.143 . . . . 0.0 114.234 -171.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -121.69 118.95 29.34 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.536 1.535 . . . . 0.0 109.384 175.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -72.92 117.11 4.98 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.831 1.687 . . . . 0.0 111.893 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 32.2 mtp -71.65 130.97 42.49 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.974 1.71 . . . . 0.0 111.272 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.32 106.42 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.055 1.342 . . . . 0.0 108.088 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 11.6 t -98.95 123.72 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.302 1.441 . . . . 0.0 110.331 -176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -138.94 160.47 39.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.057 0.932 . . . . 0.0 112.972 -175.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -55.2 140.92 37.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.507 0.723 . . . . 0.0 111.611 167.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.609 0 O-C-N 121.721 -0.612 . . . . 0.0 112.245 -179.699 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 . . . . . 0 C--O 1.241 0.606 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 8.1 p -148.03 167.69 24.27 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -173.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.03 146.23 8.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 123.654 0.782 . . . . 0.0 111.133 -169.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 31.6 m -87.67 149.8 24.03 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -66.31 -27.81 68.2 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.976 -1.077 . . . . 0.0 112.704 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -67.34 -23.41 65.61 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 171.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -74.39 -52.43 12.16 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.307 0.958 . . . . 0.0 110.917 163.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.8 -45.12 78.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.914 1.286 . . . . 0.0 112.895 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -56.04 -17.98 8.32 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.597 1.959 . . . . 0.0 115.481 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -72.26 -30.63 65.04 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.936 -1.102 . . . . 0.0 112.811 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.62 90.63 0.5 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.612 1.101 . . . . 0.0 113.468 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 -164.71 147.73 8.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.504 1.122 . . . . 0.0 111.343 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.7 pt -126.76 158.7 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.671 1.188 . . . . 0.0 112.88 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.59 179.23 4.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.975 1.31 . . . . 0.0 111.074 163.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -61.84 -20.9 64.17 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 120.558 -1.339 . . . . 0.0 114.259 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -78.03 -29.09 49.24 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.063 0.945 . . . . 0.0 112.002 -173.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.87 -33.17 24.87 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.712 -1.243 . . . . 0.0 110.982 161.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 29.4 ttm -63.02 -38.45 91.22 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.438 -1.414 . . . . 0.0 113.371 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -83.22 12.83 4.74 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.285 -0.884 . . . . 0.0 112.196 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.62 -29.69 5.0 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.233 2.213 . . . . 0.0 115.119 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.82 128.1 34.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.908 1.283 . . . . 0.0 109.898 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 75.6 p -63.43 -27.01 69.0 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.299 -0.875 . . . . 0.0 111.38 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . 0.273 2.2 m -68.97 -16.02 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 171.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -119.6 -17.07 8.75 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 119.189 3.033 . . . . 0.0 119.189 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.24 -8.84 0.35 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 54.1 p -137.47 12.77 3.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.949 1.3 . . . . 0.0 113.456 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -131.55 137.91 48.67 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.39 1.876 . . . . 0.0 114.41 -173.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -142.66 129.02 10.68 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -157.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -86.47 -174.28 1.42 Allowed 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 124.736 3.624 . . . . 0.0 113.413 171.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.69 71.77 1.04 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 125.144 1.354 . . . . 0.0 116.13 164.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -145.59 151.96 48.02 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.377 1.471 . . . . 0.0 111.862 172.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.81 95.6 1.07 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.964 3.109 . . . . 0.0 113.0 -172.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . 0.548 HD22 ' HB2' ' A' ' 500' ' ' PHE . 0.3 OUTLIER -163.06 147.83 11.44 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.7 2.0 . . . . 0.0 111.431 166.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.2 p -82.11 18.72 1.3 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -135.16 150.24 50.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.985 1.314 . . . . 0.0 109.99 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.77 157.84 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 126.375 1.87 . . . . 0.0 109.929 -177.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -131.79 162.1 31.33 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.08 140.18 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 125.582 1.553 . . . . 0.0 111.631 -174.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -122.03 170.65 9.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.116 1.367 . . . . 0.0 109.951 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 22.8 t30 66.62 38.73 3.93 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.839 1.256 . . . . 0.0 111.717 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -77.12 139.56 40.0 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.963 -1.086 . . . . 0.0 110.318 167.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.41 142.09 58.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.485 1.514 . . . . 0.0 112.83 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.27 -29.15 60.76 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.649 -1.282 . . . . 0.0 113.932 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -73.35 -31.09 63.76 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -79.69 160.0 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -169.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -134.29 166.94 21.64 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.906 1.283 . . . . 0.0 111.326 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -59.89 -33.09 71.38 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.526 -1.359 . . . . 0.0 113.018 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -57.42 -22.04 40.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.871 1.668 . . . . 0.0 115.018 170.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.64 -33.08 18.95 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.749 1.619 . . . . 0.0 115.094 169.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.81 -25.27 67.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.89 0.876 . . . . 0.0 112.272 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -53.56 -30.97 44.66 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.341 1.056 . . . . 0.0 111.472 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.36 -41.59 97.32 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.945 1.298 . . . . 0.0 111.781 -173.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mt -91.81 -57.49 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 120.64 -1.287 . . . . 0.0 110.826 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -55.98 -36.04 67.42 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.69 -9.19 82.54 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.145 -0.808 . . . . 0.0 114.454 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -60.08 -29.03 68.29 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.36 1.58 . . . . 0.0 111.543 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -93.91 16.26 14.74 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.117 1.767 . . . . 0.0 114.341 -174.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 96.7 t -128.47 119.23 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.228 1.811 . . . . 0.0 107.52 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.257 57.3 m-20 -68.89 73.6 0.27 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 173.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -49.78 -22.49 1.44 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 120.044 3.35 . . . . 0.0 120.044 -169.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 17.2 m -71.99 -13.55 61.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.742 1.61 . . . . 0.0 112.935 172.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 4.8 t -104.39 123.38 47.32 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.19 1.396 . . . . 0.0 110.887 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -56.79 -45.39 82.22 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.394 -0.816 . . . . 0.0 112.068 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.3 t -55.18 -15.1 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -88.86 -61.75 1.64 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.905 0.882 . . . . 0.0 109.854 173.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -69.13 -24.52 64.11 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.854 1.262 . . . . 0.0 113.518 -172.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 11.3 tt -64.22 -33.45 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.505 1.522 . . . . 0.0 112.413 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 62.8 mmm -80.6 -13.71 58.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.104 1.362 . . . . 0.0 111.453 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -107.66 127.35 53.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.774 2.03 . . . . 0.0 113.804 -171.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -162.56 138.5 7.34 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.2 mt -119.85 136.79 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.69 1.196 . . . . 0.0 110.543 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -130.19 138.58 50.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.646 1.178 . . . . 0.0 111.071 164.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 2.1 tt -109.74 131.95 54.59 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.63 1.572 . . . . 0.0 109.127 172.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -90.57 134.81 34.12 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.667 1.587 . . . . 0.0 111.547 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -130.71 9.19 4.97 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -158.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -148.47 156.31 42.3 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.558 1.143 . . . . 0.0 111.975 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 61.34 -161.13 26.55 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.626 1.107 . . . . 0.0 114.911 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.71 -27.13 62.66 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.249 -1.148 . . . . 0.0 113.425 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 28.0 ttm -85.25 -2.8 58.45 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.423 1.089 . . . . 0.0 113.359 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -54.04 128.03 28.92 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.48 1.112 . . . . 0.0 111.868 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.3 27.22 66.36 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.403 1.001 . . . . 0.0 112.913 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -109.7 161.93 14.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.302 1.441 . . . . 0.0 110.71 160.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.12 157.19 42.86 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.94 1.296 . . . . 0.0 112.876 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -118.35 147.04 43.91 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 168.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.17 126.09 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.724 1.609 . . . . 0.0 110.339 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.62 150.09 19.72 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.482 -0.761 . . . . 0.0 112.001 161.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.7 mt -128.64 163.2 46.55 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.098 1.759 . . . . 0.0 110.758 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.53 -3.36 13.26 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.484 2.789 . . . . 0.0 115.552 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -155.72 150.82 26.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.881 1.272 . . . . 0.0 111.602 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -53.77 -43.52 69.28 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.513 -0.742 . . . . 0.0 112.859 163.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -60.38 -40.33 90.44 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.581 1.152 . . . . 0.0 113.003 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.59 99.1 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.588 0.555 . . . . 0.0 111.412 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.62 -42.64 77.81 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.212 0.915 . . . . 0.0 112.164 174.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.24 -43.69 83.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.48 0.712 . . . . 0.0 111.746 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -68.3 -51.96 39.03 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.084 0.954 . . . . 0.0 111.339 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.53 -29.8 66.59 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 29.4 mt -70.69 -47.67 58.64 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.56 1.073 . . . . 0.0 111.144 172.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -57.89 -34.55 69.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.945 0.898 . . . . 0.0 112.149 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.49 -49.13 7.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.208 1.003 . . . . 0.0 112.925 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -82.14 -20.06 38.72 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -66.37 105.14 1.37 Allowed 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.171 -0.956 . . . . 0.0 110.588 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 110.27 -0.92 29.63 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.004 -1.442 . . . . 0.0 116.148 -173.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -68.23 122.48 18.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.921 1.86 . . . . 0.0 113.836 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.299 1.7 t -86.43 57.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -166.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 15.2 tp -55.11 114.16 1.65 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.832 2.053 . . . . 0.0 111.436 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.332 61.3 m-85 58.42 23.17 10.33 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 -178.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 85.31 15.31 66.84 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 121.393 -0.817 . . . . 0.0 114.53 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.32 115.59 18.54 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.397 1.479 . . . . 0.0 110.672 -176.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.35 114.92 4.1 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.889 2.392 . . . . 0.0 112.149 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 72.3 mtp -68.98 128.07 35.38 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.834 1.254 . . . . 0.0 112.393 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 34.9 t -90.92 79.44 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.66 1.584 . . . . 0.0 110.799 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.6 t -83.24 126.93 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.627 1.971 . . . . 0.0 112.534 -174.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -145.19 157.64 44.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.996 1.318 . . . . 0.0 113.652 -170.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . 0.548 ' HB2' HD22 ' A' ' 419' ' ' ASN . 44.1 p90 -63.05 146.39 53.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.679 0.792 . . . . 0.0 110.936 173.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.696 0 O-C-N 121.562 -0.711 . . . . 0.0 111.004 173.56 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 . . . . . 0 C--O 1.237 0.4 0 CA-C-O 122.264 1.031 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.4 p -147.97 160.41 42.86 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.008 1.323 . . . . 0.0 111.697 172.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.9 tt -70.95 145.89 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 125.707 1.603 . . . . 0.0 111.071 -166.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 10.6 m -78.54 146.3 34.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -56.57 -41.63 77.22 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.624 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -62.59 -32.48 73.48 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -73.5 -41.73 62.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.835 0.854 . . . . 0.0 113.179 170.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.22 -46.9 88.54 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.866 0.866 . . . . 0.0 110.661 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -58.49 -24.72 61.16 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.425 1.89 . . . . 0.0 115.16 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 48.0 mmtt -62.56 -49.9 73.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.995 0.816 . . . . 0.0 111.333 168.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.87 65.27 3.28 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.175 1.845 . . . . 0.0 112.351 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -153.41 137.57 16.48 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.916 1.286 . . . . 0.0 110.873 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.3 pt -121.57 157.43 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.597 1.159 . . . . 0.0 113.284 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.0 m -95.8 169.01 10.3 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.267 1.427 . . . . 0.0 112.199 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -54.3 -31.07 53.12 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.902 -1.124 . . . . 0.0 113.433 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -60.68 -25.64 66.53 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.561 1.145 . . . . 0.0 113.167 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.0 -41.5 10.51 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.671 1.188 . . . . 0.0 110.988 169.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 15.9 ttm -65.87 -30.93 71.61 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.817 -1.177 . . . . 0.0 113.098 -172.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -82.97 6.35 19.0 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.318 -0.864 . . . . 0.0 112.823 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.93 -30.53 4.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.989 2.116 . . . . 0.0 114.051 -176.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 40.3 mt -74.12 129.5 37.96 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.581 1.552 . . . . 0.0 111.343 174.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 88.3 p -59.29 -34.2 72.0 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.628 -0.67 . . . . 0.0 111.989 171.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 33.7 m -60.38 -22.98 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 117.559 -1.21 . . . . 0.0 113.523 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.339 69.7 m-85 -94.55 2.0 55.66 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 119.113 3.005 . . . . 0.0 119.113 174.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -50.27 -23.58 2.37 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 -164.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 19.0 m -143.23 20.95 1.91 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.484 1.114 . . . . 0.0 112.926 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -135.71 133.87 38.51 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.343 1.457 . . . . 0.0 109.244 -161.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 415' ' ' PRO . 45.0 mt-10 -136.33 92.92 15.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -165.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 414' ' ' GLU . 54.3 Cg_endo -64.76 159.65 44.48 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.201 3.267 . . . . 0.0 113.608 165.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 84.32 0.67 89.49 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.021 1.296 . . . . 0.0 113.305 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -77.3 136.11 65.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.409 1.484 . . . . 0.0 112.447 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.51 126.6 9.11 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.33 2.687 . . . . 0.0 112.48 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -160.41 152.39 20.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.537 1.535 . . . . 0.0 109.156 158.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.9 p -77.87 3.15 15.15 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.101 -1.624 . . . . 0.0 114.59 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -135.91 145.58 46.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.669 2.387 . . . . 0.0 108.961 171.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 12.7 pt -124.46 165.82 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.496 1.918 . . . . 0.0 110.071 174.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.86 159.09 42.9 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 174.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 8.6 t -132.07 132.93 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.409 1.483 . . . . 0.0 110.897 -174.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -106.56 164.53 11.99 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.693 1.197 . . . . 0.0 109.936 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 16.5 t30 68.2 39.36 2.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.839 1.256 . . . . 0.0 113.394 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.67 150.02 41.55 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.421 -0.799 . . . . 0.0 111.459 171.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.51 160.56 8.74 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.168 1.387 . . . . 0.0 114.471 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -62.26 -43.36 99.01 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.99 -1.069 . . . . 0.0 112.491 169.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -70.61 -35.33 72.92 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.1 p -71.51 149.3 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -170.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -123.2 166.84 14.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.423 1.489 . . . . 0.0 112.556 170.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -55.39 -33.58 63.61 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.826 -1.171 . . . . 0.0 112.719 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 9.1 pttm -62.87 -28.99 70.41 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.77 -37.44 48.98 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.189 0.996 . . . . 0.0 113.469 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.01 -20.54 54.0 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.404 1.882 . . . . 0.0 113.39 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.99 -18.97 5.77 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 171.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -61.81 -38.97 90.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.829 0.852 . . . . 0.0 112.009 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.29 -51.86 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.297 -0.877 . . . . 0.0 110.032 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -63.37 -33.1 74.81 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.2 -12.8 83.27 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 123.478 0.561 . . . . 0.0 114.121 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -58.8 -34.61 71.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.926 1.291 . . . . 0.0 112.565 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -79.93 -6.41 57.43 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.897 1.679 . . . . 0.0 113.548 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.27 111.24 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.984 1.714 . . . . 0.0 111.085 -172.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -69.84 86.78 0.51 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -54.04 -23.94 15.39 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 118.482 2.771 . . . . 0.0 118.482 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 61.2 m -65.75 -21.72 66.54 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.1 m -109.87 121.99 46.51 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.327 1.851 . . . . 0.0 111.88 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.75 -45.91 88.63 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.275 -0.891 . . . . 0.0 113.037 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -17.15 5.48 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -89.87 -57.01 3.01 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.64 0.776 . . . . 0.0 108.984 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -72.58 -21.06 61.2 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.265 1.426 . . . . 0.0 113.539 -173.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 17.0 tt -62.89 -36.26 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.295 1.838 . . . . 0.0 112.265 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.4 mtm -87.36 -8.0 57.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.829 0.851 . . . . 0.0 112.208 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -102.91 124.67 48.86 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -173.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.42 158.98 21.74 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.978 1.311 . . . . 0.0 108.626 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.0 mt -123.24 147.99 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.002 1.321 . . . . 0.0 111.224 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -134.93 132.37 38.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.31 2.244 . . . . 0.0 109.457 169.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.4 tp -124.93 113.13 17.44 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.877 2.071 . . . . 0.0 110.776 172.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 57.3 mtm -70.68 108.34 4.36 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.649 1.18 . . . . 0.0 111.454 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -96.48 10.8 37.19 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -147.23 154.16 40.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.158 1.783 . . . . 0.0 110.821 -174.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 85.18 -166.8 40.82 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.286 1.422 . . . . 0.0 116.273 168.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -11.17 2.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.622 1.969 . . . . 0.0 116.007 -172.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 24.7 ptp -140.7 41.53 1.86 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.948 1.699 . . . . 0.0 112.468 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -52.81 133.39 37.3 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.465 1.106 . . . . 0.0 111.709 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.07 31.71 34.16 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 124.476 1.036 . . . . 0.0 113.34 -177.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -125.99 147.76 49.45 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.539 0.736 . . . . 0.0 111.389 172.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -139.48 155.42 47.57 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.93 1.292 . . . . 0.0 114.038 -165.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -119.87 142.48 48.62 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.757 2.023 . . . . 0.0 114.96 171.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.2 mp -141.44 120.4 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.812 1.645 . . . . 0.0 110.893 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -83.01 140.02 19.69 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.433 -0.792 . . . . 0.0 111.397 163.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 20.8 mt -120.33 158.0 52.1 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.428 1.091 . . . . 0.0 110.766 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.53 -11.75 28.56 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.01 2.473 . . . . 0.0 114.405 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -151.27 142.45 23.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.821 0.849 . . . . 0.0 110.804 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -53.7 -35.46 61.15 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.204 1.402 . . . . 0.0 112.391 167.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -65.91 -38.5 88.87 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.99 85.86 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.309 0.504 . . . . 0.0 110.695 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.38 78.76 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 170.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.64 -36.46 69.53 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.243 0.929 . . . . 0.0 112.553 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -73.52 -53.62 10.17 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.096 1.359 . . . . 0.0 112.694 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.17 -31.75 69.27 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 49.1 mt -69.22 -42.6 75.49 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.573 -0.705 . . . . 0.0 112.387 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.1 -34.47 78.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.446 0.698 . . . . 0.0 111.991 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -82.1 -51.28 8.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.116 1.366 . . . . 0.0 114.37 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.61 -16.31 61.73 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.19 106.08 0.48 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.003 1.721 . . . . 0.0 112.361 174.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 112.23 -6.73 26.89 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 118.49 -1.172 . . . . 0.0 114.949 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -71.7 128.39 35.65 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.154 1.477 . . . . 0.0 107.324 -174.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.253 5.8 p -122.72 63.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 124.185 1.945 . . . . 0.0 110.427 -162.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.16 131.22 50.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.485 1.914 . . . . 0.0 110.913 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.371 52.1 m-85 56.05 21.72 5.31 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -175.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 77.93 8.03 87.39 Favored Glycine 0 CA--C 1.537 1.466 0 O-C-N 121.027 -1.046 . . . . 0.0 114.351 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -112.78 112.59 50.61 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.861 1.664 . . . . 0.0 110.196 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.9 121.28 7.2 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.713 2.275 . . . . 0.0 110.965 -174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 41.7 mtp -79.77 124.44 28.61 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.614 1.566 . . . . 0.0 110.747 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 36.0 t -93.83 84.16 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.99 1.316 . . . . 0.0 110.719 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.78 131.84 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.012 1.725 . . . . 0.0 112.605 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -145.01 158.44 43.81 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.021 1.328 . . . . 0.0 113.469 -172.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -61.88 147.32 47.05 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.18 -0.95 . . . . 0.0 108.441 164.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.481 0 O-C-N 121.452 -0.78 . . . . 0.0 112.975 -177.274 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 121.882 0.848 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 25.7 p -151.43 163.26 39.38 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.052 1.741 . . . . 0.0 113.3 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 3.1 tt -72.44 158.35 6.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.199 1.399 . . . . 0.0 111.196 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 66.2 m -96.41 150.87 20.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.052 0.941 . . . . 0.0 110.797 168.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -56.75 -39.45 74.03 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 111.281 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -68.58 -26.4 65.37 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -78.68 -38.62 38.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.973 1.26 . . . . 0.0 112.811 166.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.08 -45.83 91.62 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.857 0.863 . . . . 0.0 112.385 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -56.1 -25.55 46.2 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.938 1.295 . . . . 0.0 114.091 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -69.8 -25.36 63.75 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.053 0.941 . . . . 0.0 112.98 176.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -105.17 72.95 0.23 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.088 1.328 . . . . 0.0 110.969 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -156.11 141.52 17.63 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.568 1.147 . . . . 0.0 109.316 -174.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.7 pt -115.3 155.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 83.4 p -67.4 160.14 28.0 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.393 1.477 . . . . 0.0 111.749 161.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 52.2 mmt-85 -61.87 -30.64 70.99 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.606 -0.684 . . . . 0.0 111.139 168.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.49 -42.34 95.92 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.451 0.7 . . . . 0.0 112.103 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -36.01 77.51 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.671 0.669 . . . . 0.0 109.621 172.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 11.3 ttp -65.01 -39.88 94.09 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 120.556 -1.34 . . . . 0.0 112.078 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -81.03 15.86 1.7 Allowed 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.73 -35.95 2.98 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.798 2.039 . . . . 0.0 116.485 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.31 125.21 25.71 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.694 1.197 . . . . 0.0 108.994 172.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.2 m -65.12 -17.76 64.73 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.89 -25.49 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 170.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.31 75.8 m-85 -98.35 10.49 40.63 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 118.565 2.802 . . . . 0.0 118.565 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -60.31 -19.0 53.42 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 9.6 t -139.13 -35.58 0.55 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.816 1.646 . . . . 0.0 112.68 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -76.12 145.8 39.73 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -138.46 129.82 15.57 Favored Pre-proline 0 N--CA 1.478 0.951 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -168.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.6 172.33 13.54 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.586 2.857 . . . . 0.0 113.983 170.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 95.8 -21.33 45.43 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 116.954 1.541 . . . . 0.0 116.954 164.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.09 138.54 96.2 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 119.019 1.41 . . . . 0.0 112.588 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.27 116.85 4.77 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.283 2.655 . . . . 0.0 113.23 -174.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -153.66 146.93 24.75 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.201 1.4 . . . . 0.0 108.595 164.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.1 p -73.8 6.21 3.43 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -144.47 145.46 31.89 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.306 1.842 . . . . 0.0 108.921 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 27.7 pt -133.99 164.13 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.554 1.942 . . . . 0.0 109.865 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -136.01 162.23 33.45 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 172.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.4 p -140.03 146.95 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.934 1.294 . . . . 0.0 110.696 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -131.13 -175.38 3.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.283 0.633 . . . . 0.0 111.062 165.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.0 t30 66.44 38.33 4.33 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.072 1.349 . . . . 0.0 111.305 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.17 148.14 34.21 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.819 0.848 . . . . 0.0 110.447 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.68 173.83 9.94 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.636 1.975 . . . . 0.0 115.062 -173.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -60.88 -53.98 50.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.747 1.219 . . . . 0.0 113.507 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -78.39 -19.18 53.87 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.436 1.494 . . . . 0.0 114.731 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.55 148.72 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -173.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -129.32 162.88 26.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.186 1.794 . . . . 0.0 110.399 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -59.16 -28.67 66.81 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 119.47 -2.019 . . . . 0.0 112.403 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -58.13 -30.97 66.75 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -72.7 -36.28 67.81 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 173.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.25 -27.35 66.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.626 0.77 . . . . 0.0 111.692 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.34 -31.33 61.63 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.823 0.849 . . . . 0.0 112.748 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -61.35 -30.03 70.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.013 1.325 . . . . 0.0 111.697 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.7 mt -106.6 -57.66 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.682 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -58.85 -30.77 67.95 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -76.53 -8.74 86.1 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.87 -0.961 . . . . 0.0 114.661 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -64.82 -21.74 66.85 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.376 1.588 . . . . 0.0 112.63 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -92.64 4.46 53.63 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.874 1.67 . . . . 0.0 113.566 -177.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.7 108.73 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.289 1.836 . . . . 0.0 110.622 -171.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -64.53 99.86 0.33 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.311 17.8 m-85 -62.62 -16.18 55.4 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 64.7 m -64.83 -16.12 62.7 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 169.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 16.4 m -130.49 117.82 20.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.443 1.097 . . . . 0.0 112.713 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -60.44 -39.94 89.29 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.007 -1.058 . . . . 0.0 112.39 -174.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.6 t -56.44 -13.95 2.66 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -86.91 -63.84 1.25 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.983 0.913 . . . . 0.0 109.546 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.9 ptt85 -69.81 -22.78 63.28 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.517 1.527 . . . . 0.0 114.16 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.8 tt -57.87 -35.39 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.257 1.023 . . . . 0.0 111.899 171.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 21.6 mtm -90.37 -2.95 58.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.948 1.299 . . . . 0.0 112.228 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -105.89 129.56 54.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.77 2.028 . . . . 0.0 116.086 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -166.14 149.03 7.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.963 1.305 . . . . 0.0 109.399 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.9 mt -120.65 136.53 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.494 1.518 . . . . 0.0 111.807 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -114.74 141.33 47.99 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.974 1.31 . . . . 0.0 110.571 158.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 13.7 tp -120.61 114.54 21.87 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.562 1.545 . . . . 0.0 109.212 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -71.28 120.33 16.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.98 1.312 . . . . 0.0 109.274 169.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . 0.423 ' O ' ' HE2' ' A' ' 466' ' ' LYS . 10.1 mtpt -113.51 12.86 18.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.753 1.621 . . . . 0.0 113.035 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -142.23 152.65 43.29 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.306 1.843 . . . . 0.0 112.126 -167.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 59.58 -144.08 46.14 Favored Glycine 0 CA--C 1.534 1.269 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 161.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.75 -12.71 2.02 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.065 2.146 . . . . 0.0 116.335 -172.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 24.9 ptp -145.44 41.13 1.23 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.507 1.123 . . . . 0.0 112.539 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 461' ' ' LYS . 23.6 ttmt -60.38 122.44 14.56 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.409 1.084 . . . . 0.0 112.256 175.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.65 37.91 18.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.411 1.958 . . . . 0.0 112.858 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -125.83 148.33 49.18 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.211 1.004 . . . . 0.0 110.892 173.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -138.94 151.59 47.02 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -109.08 137.98 46.14 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.829 2.051 . . . . 0.0 114.394 169.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.5 119.77 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.197 1.399 . . . . 0.0 109.968 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -85.2 142.04 19.5 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 162.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 19.3 mt -122.64 160.87 46.78 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.35 1.46 . . . . 0.0 110.343 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.01 -13.07 21.49 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.045 2.497 . . . . 0.0 114.55 -174.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -153.07 146.13 24.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.513 1.125 . . . . 0.0 110.254 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -52.31 -38.82 59.51 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.933 0.893 . . . . 0.0 111.95 165.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -61.42 -37.16 82.48 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.288 1.035 . . . . 0.0 113.122 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.36 90.84 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.262 -0.274 . . . . 0.0 110.947 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.3 -48.43 67.64 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.605 -0.684 . . . . 0.0 112.741 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.66 -28.05 68.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.306 1.042 . . . . 0.0 112.689 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -85.22 -44.27 13.06 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.048 0.939 . . . . 0.0 113.348 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.51 -33.21 71.08 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.881 1.219 . . . . 0.0 112.709 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.2 mt -65.47 -40.04 92.69 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.424 1.09 . . . . 0.0 112.989 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -63.34 -42.18 98.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.077 0.551 . . . . 0.0 111.454 174.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -78.87 -43.83 24.17 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -175.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.39 57.54 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -64.12 99.23 0.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.701 1.2 . . . . 0.0 112.245 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 115.45 1.6 21.65 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.469 -1.184 . . . . 0.0 115.044 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -74.44 110.4 8.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.944 1.372 . . . . 0.0 108.929 -169.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.275 6.4 p -93.71 65.77 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.054 1.742 . . . . 0.0 110.372 -170.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.79 129.42 39.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.199 1.8 . . . . 0.0 110.66 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.272 64.0 m-85 54.18 21.81 3.25 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -176.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 86.35 10.22 74.5 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 117.983 -1.454 . . . . 0.0 115.566 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -121.78 115.65 30.66 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 120.217 2.008 . . . . 0.0 111.751 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.44 112.41 3.54 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 123.868 3.045 . . . . 0.0 111.696 -174.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 80.1 mtp -73.64 131.44 41.67 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.855 1.262 . . . . 0.0 113.566 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 24.8 t -90.15 90.07 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.599 1.56 . . . . 0.0 111.502 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.17 129.47 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.889 1.276 . . . . 0.0 114.308 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -149.47 155.57 40.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.847 0.859 . . . . 0.0 112.953 -170.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -53.96 142.05 25.96 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 169.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.613 0 O-C-N 121.729 -0.607 . . . . 0.0 112.236 177.178 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 120.484 0.183 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 14.0 p -142.56 165.07 28.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.65 1.18 . . . . 0.0 113.474 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.3 tt -69.02 152.31 9.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 125.65 1.58 . . . . 0.0 111.678 -168.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 59.4 m -84.67 147.87 26.71 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.435 0.694 . . . . 0.0 110.429 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -58.06 -43.01 86.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.414 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -61.43 -29.87 70.21 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.324 1.45 . . . . 0.0 114.52 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -78.14 -49.69 13.4 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.39 1.076 . . . . 0.0 112.696 171.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 26.1 tp -57.89 -42.29 84.35 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.56 0.744 . . . . 0.0 112.096 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -58.67 -21.22 53.72 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.592 1.557 . . . . 0.0 114.977 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -75.76 -34.01 60.23 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.184 0.994 . . . . 0.0 112.753 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -93.66 75.26 1.13 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.026 1.298 . . . . 0.0 112.183 170.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -158.04 146.82 19.19 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.246 1.018 . . . . 0.0 111.008 -171.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 9.1 pt -128.66 157.84 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.45 1.5 . . . . 0.0 111.819 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 21.6 t -105.03 174.74 5.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.538 1.535 . . . . 0.0 111.047 166.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 21.6 mtp85 -57.93 -23.53 53.86 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.007 1.323 . . . . 0.0 113.402 175.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -54.61 -35.88 63.86 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.076 1.751 . . . . 0.0 111.856 171.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -99.18 -35.4 10.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.419 1.088 . . . . 0.0 112.526 169.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 26.3 ttp -65.18 -38.42 90.47 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.49 -1.381 . . . . 0.0 112.36 -172.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -80.23 17.26 1.06 Allowed 'General case' 0 CA--C 1.55 0.962 0 O-C-N 121.349 -0.845 . . . . 0.0 112.123 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.98 -30.37 2.72 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.405 2.282 . . . . 0.0 115.005 176.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 35.6 mt -74.22 137.92 43.36 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.59 1.956 . . . . 0.0 112.48 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 47.0 t -67.98 -36.61 80.34 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.036 0.934 . . . . 0.0 111.834 172.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.5 m -59.16 -14.41 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.261 94.0 m-85 -116.58 16.74 15.48 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 170.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -8.47 12.53 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 16.7 p -148.52 -46.05 0.15 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.828 2.051 . . . . 0.0 112.527 -159.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -81.79 140.52 34.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.222 1.809 . . . . 0.0 113.783 -175.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -134.57 123.0 16.04 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.792 0.837 . . . . 0.0 112.921 -169.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.3 174.49 9.87 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.354 3.37 . . . . 0.0 113.357 170.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.1 -16.71 20.94 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.671 1.605 . . . . 0.0 116.798 170.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -57.53 139.21 81.22 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 118.801 1.3 . . . . 0.0 112.661 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.48 108.73 2.09 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.773 2.315 . . . . 0.0 112.083 -172.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 7.5 t30 -156.64 149.41 23.75 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.693 1.597 . . . . 0.0 109.269 167.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.4 p -86.1 -10.71 54.39 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 173.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . 0.448 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 33.6 mtm180 -106.26 142.32 36.13 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.957 0.903 . . . . 0.0 110.022 172.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.16 162.59 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.373 1.469 . . . . 0.0 110.44 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -144.47 161.07 39.98 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.0 t -139.22 131.92 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.196 1.399 . . . . 0.0 113.422 -165.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -98.81 163.77 12.48 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.582 1.153 . . . . 0.0 111.904 167.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.287 98.0 m-20 75.78 34.9 0.54 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.925 2.09 . . . . 0.0 116.592 172.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.95 160.59 29.05 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.182 -0.949 . . . . 0.0 111.143 167.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.33 177.7 5.7 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.074 1.75 . . . . 0.0 114.172 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -82.41 -48.44 11.12 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.983 -1.073 . . . . 0.0 110.544 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -69.49 -18.98 63.74 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.2 p -77.08 139.84 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 121.008 -1.057 . . . . 0.0 113.08 171.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -120.65 167.22 12.67 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.189 1.396 . . . . 0.0 111.703 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.97 -34.1 58.81 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.94 -1.1 . . . . 0.0 112.657 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -59.97 -23.44 63.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.163 1.385 . . . . 0.0 114.675 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -87.57 -33.43 18.9 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.05 -19.69 64.63 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.699 1.6 . . . . 0.0 112.645 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -25.16 49.19 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.381 1.073 . . . . 0.0 112.869 174.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -60.01 -34.78 73.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.573 0.749 . . . . 0.0 112.4 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 4.4 mt -103.3 -57.0 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.635 -0.666 . . . . 0.0 110.739 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -59.55 -29.49 67.96 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.95 -11.41 84.73 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.806 -0.997 . . . . 0.0 114.847 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -62.49 -36.2 81.77 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.015 1.407 . . . . 0.0 111.435 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -77.47 3.37 13.59 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.926 1.69 . . . . 0.0 114.989 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 14.9 t -123.94 126.08 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.942 1.697 . . . . 0.0 110.593 -173.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -59.63 133.3 55.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -73.43 -23.14 60.09 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 99.0 p -92.14 -51.72 5.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.695 1.198 . . . . 0.0 113.262 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.2 m -76.45 118.78 19.48 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.412 0.685 . . . . 0.0 111.718 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -54.65 -49.59 70.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.115 1.366 . . . . 0.0 112.098 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.7 t -54.97 -15.2 1.85 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -88.75 -62.97 1.37 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.239 1.015 . . . . 0.0 110.228 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.17 -26.27 63.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.048 0.939 . . . . 0.0 113.253 -175.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.9 tt -58.18 -40.34 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.816 0.847 . . . . 0.0 111.857 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 9.2 mtm -86.93 -9.12 56.42 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.944 0.898 . . . . 0.0 112.334 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -87.6 125.83 34.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.853 1.661 . . . . 0.0 115.281 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -163.11 136.15 5.63 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.322 1.449 . . . . 0.0 110.195 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 10.7 mt -113.06 143.14 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.769 1.228 . . . . 0.0 111.55 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -129.57 143.21 50.73 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.822 1.649 . . . . 0.0 110.623 160.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 19.1 tp -123.59 119.65 30.52 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.871 2.069 . . . . 0.0 110.098 174.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -81.84 143.38 31.77 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.487 1.515 . . . . 0.0 112.25 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -130.9 8.99 4.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.107 1.763 . . . . 0.0 114.816 -167.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -145.49 143.38 29.96 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.615 1.166 . . . . 0.0 113.292 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 78.92 -160.58 46.8 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 126.514 2.007 . . . . 0.0 114.521 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.02 -18.05 59.28 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.833 -1.393 . . . . 0.0 113.269 172.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 98.2 mmm -83.86 -1.49 54.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.153 1.781 . . . . 0.0 114.546 171.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.6 127.0 29.34 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.701 -1.249 . . . . 0.0 111.834 176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.71 17.93 80.04 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.779 -175.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -108.33 139.77 42.56 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.799 0.8 . . . . 0.0 112.188 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -123.06 147.42 46.73 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.876 1.27 . . . . 0.0 112.736 -174.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -107.14 140.59 39.75 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.323 1.449 . . . . 0.0 114.629 161.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.61 113.81 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.239 1.816 . . . . 0.0 109.032 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -76.38 125.24 7.58 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 160.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 37.4 mt -101.15 159.77 28.54 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.126 0.963 . . . . 0.0 109.484 165.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.3 -10.46 17.61 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.895 1.73 . . . . 0.0 114.222 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -151.16 138.67 19.55 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.467 1.107 . . . . 0.0 110.583 -171.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -56.18 -35.23 66.99 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 171.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -62.07 -42.29 99.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.844 0.747 . . . . 0.0 112.608 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.9 92.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.127 0.571 . . . . 0.0 111.24 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.56 -50.43 63.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.437 0.562 . . . . 0.0 112.418 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.24 72.63 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.75 1.159 . . . . 0.0 112.047 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -70.9 -46.58 62.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.085 1.354 . . . . 0.0 112.834 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.15 -37.4 77.2 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.771 0.714 . . . . 0.0 112.415 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 79.8 mt -70.41 -25.84 63.41 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.667 1.187 . . . . 0.0 112.548 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.61 -24.29 36.51 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.711 1.204 . . . . 0.0 112.647 175.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -104.87 -48.08 3.85 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.74 -15.88 58.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.621 1.168 . . . . 0.0 113.468 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -73.65 112.66 9.96 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.442 -0.787 . . . . 0.0 109.666 -174.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 110.32 -4.82 29.9 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 118.858 -0.968 . . . . 0.0 115.298 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -69.48 129.43 39.69 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.492 1.146 . . . . 0.0 108.54 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.252 3.5 p -120.81 68.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 124.394 2.045 . . . . 0.0 108.87 -162.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 39.2 tp -61.25 139.15 58.2 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 112.763 -2.017 . . . . 0.0 109.588 168.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.324 75.5 t80 61.05 13.97 5.04 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 173.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 80.1 11.02 84.87 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.476 1.512 . . . . 0.0 114.896 -171.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -121.86 120.57 28.48 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 126.472 1.909 . . . . 0.0 110.832 -173.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.71 121.84 7.71 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 C-N-CA 122.774 2.316 . . . . 0.0 110.79 -175.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 59.9 mtp -76.89 129.79 36.68 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.919 1.688 . . . . 0.0 112.293 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 4.4 t -92.46 90.42 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.681 1.592 . . . . 0.0 112.306 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.6 t -85.67 120.52 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.989 1.315 . . . . 0.0 112.102 -172.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -135.99 157.38 46.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.22 1.008 . . . . 0.0 113.63 -168.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -59.74 145.41 45.23 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 163.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.822 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -152.41 29.67 0.55 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.874 1.27 . . . . 0.0 110.043 -174.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -134.09 142.53 47.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.9 1.68 . . . . 0.0 110.209 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 50.2 mtp 61.63 156.38 0.11 Allowed Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.478 1.511 . . . . 0.0 114.917 -161.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.63 147.72 28.4 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.591 2.194 . . . . 0.0 112.417 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 37.0 m -73.08 39.7 0.09 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.645 1.978 . . . . 0.0 115.0 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -149.72 127.05 11.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.51 1.524 . . . . 0.0 109.578 164.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 19.5 p -129.79 167.37 18.2 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.58 1.952 . . . . 0.0 109.951 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.3 tt -68.92 144.38 14.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 O-C-N 121.511 -0.743 . . . . 0.0 111.106 -160.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 62.0 m -84.11 150.63 25.42 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.159 -0.338 . . . . 0.0 111.471 172.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 42.5 ttp85 -59.37 -41.24 88.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.54 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -61.67 -29.83 70.33 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -80.29 -44.39 19.67 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.449 1.1 . . . . 0.0 113.121 171.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 22.3 tp -59.18 -46.07 89.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.725 0.81 . . . . 0.0 112.145 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -60.3 -21.9 62.53 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -63.26 -33.87 76.43 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.889 0.768 . . . . 0.0 112.328 171.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -107.41 84.19 0.37 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.999 1.285 . . . . 0.0 110.958 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -161.34 152.51 18.59 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.259 0.624 . . . . 0.0 110.555 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.6 pt -127.76 151.07 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.131 0.972 . . . . 0.0 112.868 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 92.1 p -76.75 166.13 23.79 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.203 1.401 . . . . 0.0 112.057 162.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -57.03 -24.51 54.26 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 168.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -71.89 -37.28 70.17 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.493 1.517 . . . . 0.0 111.815 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -80.08 -37.04 34.61 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.487 0.715 . . . . 0.0 110.548 167.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 27.6 ttm -59.74 -46.86 87.84 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.614 -1.304 . . . . 0.0 112.161 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -78.8 15.0 1.15 Allowed 'General case' 0 CA--C 1.552 1.032 0 O-C-N 120.627 -1.296 . . . . 0.0 112.74 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.69 -31.92 5.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.28 2.632 . . . . 0.0 114.474 171.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 34.1 mt -75.54 133.69 40.93 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.857 1.663 . . . . 0.0 111.755 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 91.5 p -63.31 -32.32 73.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.277 1.031 . . . . 0.0 112.17 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.71 -15.34 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.328 78.0 m-85 -106.66 8.38 31.07 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -54.06 -16.27 1.88 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 118.105 2.632 . . . . 0.0 118.105 -165.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.4 m -147.6 14.19 1.07 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.589 1.155 . . . . 0.0 113.98 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -130.49 130.72 44.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.221 1.008 . . . . 0.0 109.465 -162.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -143.87 133.01 11.41 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.153 1.381 . . . . 0.0 113.183 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.02 -178.77 4.0 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 125.207 3.938 . . . . 0.0 114.982 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 96.52 -9.7 66.8 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 164.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -68.92 150.74 97.53 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 119.031 1.416 . . . . 0.0 113.204 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.11 114.35 4.01 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.767 2.978 . . . . 0.0 111.923 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.51 142.65 12.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.25 1.42 . . . . 0.0 107.579 168.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.5 p -77.51 -14.02 59.78 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.406 1.082 . . . . 0.0 112.691 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -107.33 141.09 39.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.531 1.132 . . . . 0.0 109.029 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 4.8 pt -126.94 159.21 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 125.504 1.522 . . . . 0.0 109.429 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -140.63 160.17 40.59 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.9 t -134.25 137.19 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.191 1.396 . . . . 0.0 111.261 -172.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -112.11 165.83 11.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.136 0.974 . . . . 0.0 109.961 166.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.3 t30 65.81 36.07 6.36 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.721 1.209 . . . . 0.0 113.491 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.95 153.78 42.81 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.422 -0.798 . . . . 0.0 110.294 163.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.76 148.45 49.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.857 0.863 . . . . 0.0 113.029 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -62.06 -34.04 75.52 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.767 -1.208 . . . . 0.0 111.141 158.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -60.86 -10.2 5.27 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.545 1.938 . . . . 0.0 115.418 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.1 p -121.13 155.99 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -170.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -119.53 161.65 20.23 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.619 1.567 . . . . 0.0 111.122 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -55.08 -35.38 64.51 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.955 -1.091 . . . . 0.0 113.059 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -63.63 -16.68 61.6 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.108 1.363 . . . . 0.0 114.585 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -91.64 -31.68 15.76 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.15 -21.36 66.52 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.319 -0.863 . . . . 0.0 112.315 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -48.57 -35.14 12.8 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.068 1.347 . . . . 0.0 112.813 169.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -58.6 -35.34 72.29 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.0 mt -98.6 -57.88 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.284 0.634 . . . . 0.0 110.298 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.291 59.6 m-85 -60.7 -30.38 69.92 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.44 -6.91 86.96 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.104 0.859 . . . . 0.0 114.669 173.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -56.36 -34.02 66.24 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.341 1.57 . . . . 0.0 111.412 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.96 9.8 26.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.106 1.762 . . . . 0.0 113.855 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.36 113.49 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.554 1.541 . . . . 0.0 109.535 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.77 80.17 0.19 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -54.7 -18.2 4.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 119.013 2.968 . . . . 0.0 119.013 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.4 m -71.75 -12.64 61.41 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.563 1.074 . . . . 0.0 112.857 170.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.7 m -115.15 116.49 28.47 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.191 1.796 . . . . 0.0 111.867 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -59.06 -43.41 91.74 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.216 -0.928 . . . . 0.0 112.704 -173.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.3 t -55.96 -14.56 2.59 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -88.09 -60.99 1.82 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.697 0.761 . . . . 0.0 110.018 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -69.69 -25.82 64.06 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.127 1.371 . . . . 0.0 113.876 -173.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.8 tt -55.25 -35.91 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.057 1.343 . . . . 0.0 112.098 170.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 10.5 mtm -90.03 -3.93 57.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.343 1.057 . . . . 0.0 112.614 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -101.12 134.21 44.48 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.244 2.217 . . . . 0.0 115.994 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -166.16 156.71 12.73 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.212 1.405 . . . . 0.0 108.183 174.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.2 mt -130.82 134.94 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.741 1.216 . . . . 0.0 110.283 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -120.81 132.8 55.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.891 0.876 . . . . 0.0 109.873 159.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 4.1 tt -103.2 133.29 48.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.155 1.382 . . . . 0.0 110.006 168.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.61 91.68 3.43 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 125.767 1.627 . . . . 0.0 110.846 171.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -67.95 -23.82 65.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 -174.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.407 ' HA ' ' HE3' ' A' ' 466' ' ' LYS . 26.0 pt-20 -154.76 175.03 14.23 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -175.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 87.79 -169.05 38.34 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.669 1.604 . . . . 0.0 114.15 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 4.02 1.99 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 74.1 mtp -129.98 20.21 5.44 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.965 2.506 . . . . 0.0 112.437 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.407 ' HE3' ' HA ' ' A' ' 462' ' ' GLU . 35.9 ttmt -52.08 138.85 24.47 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.994 1.318 . . . . 0.0 111.803 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.78 32.56 61.16 Favored Glycine 0 CA--C 1.524 0.619 0 O-C-N 121.809 -0.557 . . . . 0.0 111.81 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.71 155.49 20.13 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.683 1.193 . . . . 0.0 110.79 165.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -148.27 148.19 30.19 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.143 -0.973 . . . . 0.0 112.733 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -113.05 138.24 50.2 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.761 1.624 . . . . 0.0 114.768 167.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.7 112.72 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.164 1.786 . . . . 0.0 109.482 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -78.79 134.55 14.14 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 159.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 20.2 mt -109.39 161.96 21.99 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.226 1.41 . . . . 0.0 109.913 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.53 -12.3 29.17 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.031 2.487 . . . . 0.0 113.654 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -153.5 142.66 21.4 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.703 0.683 . . . . 0.0 112.013 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -60.12 -29.88 68.91 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -67.94 -36.42 80.1 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 170.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -66.48 -39.32 88.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.79 0.436 . . . . 0.0 110.663 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.39 -43.16 86.63 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.512 -0.743 . . . . 0.0 112.638 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -55.78 -43.52 76.85 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.35 0.977 . . . . 0.0 111.78 176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -65.69 -52.86 48.14 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.081 1.352 . . . . 0.0 111.773 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.27 71.44 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 51.3 mt -68.95 -39.05 79.76 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.929 -1.107 . . . . 0.0 110.712 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -68.07 -22.77 64.91 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.794 1.238 . . . . 0.0 112.44 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -110.14 -39.73 4.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -84.45 -17.75 38.17 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -75.45 117.33 17.12 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.097 -1.002 . . . . 0.0 112.308 -168.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 101.47 3.24 53.44 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.231 -1.316 . . . . 0.0 115.043 -169.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -69.08 125.49 26.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.482 1.641 . . . . 0.0 113.48 -169.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.266 1.9 t -86.01 46.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.632 1.573 . . . . 0.0 114.836 -162.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 57.3 tp -58.85 120.26 8.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.47 1.508 . . . . 0.0 111.71 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.334 72.1 m-85 55.22 21.25 3.89 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -173.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 98.31 -6.41 61.42 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.689 1.614 . . . . 0.0 115.015 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -106.15 122.11 43.33 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.182 1.491 . . . . 0.0 111.864 -170.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.75 105.92 2.17 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.416 2.744 . . . . 0.0 112.548 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 44.1 mtp -67.41 131.82 46.44 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.999 1.32 . . . . 0.0 113.403 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.52 84.7 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.901 2.081 . . . . 0.0 110.945 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.28 125.79 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 126.578 1.951 . . . . 0.0 112.321 -170.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -141.63 158.73 43.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.654 1.181 . . . . 0.0 113.046 -170.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -61.24 146.41 47.92 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 166.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -59.12 132.6 54.5 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 122.586 1.184 . . . . 0.0 112.233 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 8.1 tpp85 -74.03 -46.67 41.89 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.551 -166.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 43.9 t -160.95 143.92 12.88 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.616 1.166 . . . . 0.0 111.302 165.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -154.14 155.84 36.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.1 1.76 . . . . 0.0 109.022 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 51.4 mmm-85 -117.9 53.14 1.53 Allowed Pre-proline 0 N--CA 1.476 0.867 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -170.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -69.05 170.54 15.5 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.638 2.225 . . . . 0.0 111.535 166.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -84.47 -32.3 24.08 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.639 1.575 . . . . 0.0 112.972 173.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -152.08 142.82 22.88 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.723 1.209 . . . . 0.0 112.666 -169.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -60.04 152.05 62.83 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 164.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -81.3 -176.17 2.98 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.504 2.802 . . . . 0.0 112.941 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 175.96 9.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.68 1.992 . . . . 0.0 111.896 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -70.29 133.2 46.75 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.667 1.187 . . . . 0.0 112.005 172.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -72.98 -36.29 57.29 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.037 -0.868 . . . . 0.0 114.973 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -85.77 108.85 18.27 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.287 1.044 . . . . 0.0 111.514 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 47.05 62.68 2.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 128.44 2.696 . . . . 0.0 114.31 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.319 0 CA-C-O 116.841 -1.552 . . . . 0.0 110.174 171.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . 0.269 4.2 p30 -139.32 -0.47 1.8 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -134.46 27.19 3.75 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.373 1.469 . . . . 0.0 113.632 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 86.6 mmm -68.62 136.88 90.5 Favored Pre-proline 0 CA--C 1.547 0.838 0 O-C-N 121.063 -1.023 . . . . 0.0 112.845 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -64.05 170.89 8.32 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.433 3.422 . . . . 0.0 113.353 167.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 31.4 t -120.16 124.2 45.17 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.697 1.199 . . . . 0.0 112.703 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -159.32 85.43 0.79 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.123 1.369 . . . . 0.0 111.99 170.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -143.28 167.66 21.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.132 1.373 . . . . 0.0 112.151 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.8 tt -78.68 154.29 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.855 1.262 . . . . 0.0 111.989 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 30.6 t -91.01 154.07 19.69 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.235 0.614 . . . . 0.0 111.101 167.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -44.26 -43.09 7.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.034 1.333 . . . . 0.0 112.502 164.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -71.55 -18.19 62.27 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -89.44 -39.34 13.44 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.177 -0.952 . . . . 0.0 113.445 165.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.38 -48.65 69.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.201 1.0 . . . . 0.0 112.788 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -56.8 -25.89 56.72 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.76 1.624 . . . . 0.0 113.941 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.86 -44.87 84.12 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.91 1.284 . . . . 0.0 110.832 175.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.55 78.08 0.73 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.308 1.432 . . . . 0.0 113.196 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -157.48 149.47 22.39 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.642 1.577 . . . . 0.0 109.642 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.7 pt -127.83 149.97 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.9 0.88 . . . . 0.0 111.567 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 8.8 m -80.41 167.78 19.78 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.89 0.876 . . . . 0.0 112.228 169.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -55.92 -29.22 59.73 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.271 -0.893 . . . . 0.0 112.765 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.63 -31.79 69.83 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.56 1.944 . . . . 0.0 113.309 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.57 -34.29 14.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.502 1.121 . . . . 0.0 110.947 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 9.7 ttm -61.26 -39.29 89.81 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.952 -1.092 . . . . 0.0 111.279 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.15 26.41 0.88 Allowed 'General case' 0 CA--C 1.552 1.056 0 O-C-N 120.846 -1.159 . . . . 0.0 112.455 172.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.51 -34.81 1.17 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.109 2.563 . . . . 0.0 113.858 174.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.37 134.0 42.48 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.803 1.641 . . . . 0.0 112.613 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 27.1 t -59.43 -37.86 79.18 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.707 0.803 . . . . 0.0 113.092 172.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . 0.27 3.1 m -60.44 -11.05 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 171.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -122.49 11.2 9.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 119.237 3.051 . . . . 0.0 119.237 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -14.28 16.27 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -173.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.53 -27.48 1.18 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.556 1.542 . . . . 0.0 114.423 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -69.83 136.56 50.92 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -144.86 124.98 7.25 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.53 171.97 16.66 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.128 3.219 . . . . 0.0 111.629 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.48 -4.79 33.02 Favored Glycine 0 N--CA 1.48 1.594 0 N-CA-C 117.33 1.692 . . . . 0.0 117.33 170.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -74.58 131.75 79.41 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 119.079 1.439 . . . . 0.0 111.817 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.12 112.92 2.43 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.105 2.537 . . . . 0.0 111.032 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -159.9 145.7 15.61 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.605 1.162 . . . . 0.0 109.498 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 21.3 p -86.1 -8.35 57.94 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -117.95 148.54 42.09 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.667 1.187 . . . . 0.0 110.07 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 17.8 pt -135.01 166.35 28.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.474 1.91 . . . . 0.0 110.046 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -137.93 163.64 31.0 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.88 143.85 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.652 1.581 . . . . 0.0 111.573 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -126.65 168.81 13.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.658 1.983 . . . . 0.0 109.905 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 12.9 t30 68.5 31.25 4.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.817 1.247 . . . . 0.0 112.808 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -74.54 144.51 44.01 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.018 -1.051 . . . . 0.0 111.856 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.34 156.98 17.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.928 1.691 . . . . 0.0 114.778 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -59.55 -45.74 90.93 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.238 -0.914 . . . . 0.0 112.964 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -70.87 -26.94 63.47 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -175.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.15 152.65 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -172.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -129.41 162.1 28.83 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.732 2.013 . . . . 0.0 111.038 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -53.22 -30.84 40.12 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.096 1.358 . . . . 0.0 113.401 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -58.06 -25.85 61.77 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.166 1.787 . . . . 0.0 115.282 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -90.02 -28.55 19.0 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.5 mp -66.47 -19.99 65.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.32 1.448 . . . . 0.0 112.206 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.44 -25.24 59.34 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 174.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -61.47 -36.33 80.12 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.941 0.791 . . . . 0.0 111.477 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.4 mp -96.78 -56.58 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.202 0.601 . . . . 0.0 110.679 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.258 70.1 m-85 -60.11 -32.99 71.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.82 -7.24 87.41 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.062 0.839 . . . . 0.0 114.522 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -61.2 -39.71 91.2 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.842 1.321 . . . . 0.0 111.46 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -81.06 -0.79 41.41 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.585 1.954 . . . . 0.0 113.815 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 36.0 t -115.09 116.53 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.718 1.207 . . . . 0.0 109.996 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.262 4.2 m-20 -68.72 90.97 0.42 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 176.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -61.74 -16.53 50.12 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 119.006 2.965 . . . . 0.0 119.006 -173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 71.0 m -79.09 1.5 24.0 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.01 0.924 . . . . 0.0 113.361 168.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 11.1 t -126.89 112.68 15.6 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.65 1.18 . . . . 0.0 110.947 -173.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -59.86 -47.14 86.95 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.243 -0.911 . . . . 0.0 112.274 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 3.9 t -55.92 -15.24 3.13 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -89.21 -58.39 2.55 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.221 1.008 . . . . 0.0 110.685 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -71.59 -25.58 62.24 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.716 1.206 . . . . 0.0 113.432 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.3 tt -56.65 -33.12 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.263 1.425 . . . . 0.0 112.151 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -87.51 -5.81 58.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.308 1.443 . . . . 0.0 112.964 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -115.81 120.11 38.19 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -162.41 155.34 19.87 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.327 1.451 . . . . 0.0 107.61 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.1 mt -125.05 137.6 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.767 1.627 . . . . 0.0 110.499 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 -127.51 128.78 46.24 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.395 1.478 . . . . 0.0 109.485 165.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 14.1 tp -111.18 134.91 52.41 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.439 1.896 . . . . 0.0 109.308 170.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 50.7 mtm -89.38 133.18 34.62 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 126.518 1.927 . . . . 0.0 111.151 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -129.45 11.53 5.83 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -167.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -136.98 153.16 50.76 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.555 1.142 . . . . 0.0 112.476 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 70.66 -160.75 53.8 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.659 1.123 . . . . 0.0 115.379 171.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -6.11 27.37 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.732 1.613 . . . . 0.0 115.269 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 95.8 mmm -102.39 1.23 35.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.563 1.545 . . . . 0.0 114.611 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -62.31 132.99 54.48 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.639 1.563 . . . . 0.0 110.651 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.56 29.36 36.21 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.98 0.8 . . . . 0.0 113.597 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -121.09 148.05 44.7 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.444 1.098 . . . . 0.0 112.265 165.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -140.35 155.24 46.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.427 1.491 . . . . 0.0 114.02 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -113.46 140.35 48.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.415 1.886 . . . . 0.0 115.711 167.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -138.06 128.28 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.764 1.626 . . . . 0.0 111.223 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.76 143.94 17.44 Favored Glycine 0 CA--C 1.534 1.246 0 O-C-N 121.434 -0.792 . . . . 0.0 111.955 164.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 31.7 mt -126.67 155.17 75.37 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.579 1.152 . . . . 0.0 110.799 172.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.47 -6.17 17.93 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.835 2.357 . . . . 0.0 114.94 -168.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -154.25 143.15 21.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.92 0.888 . . . . 0.0 110.606 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -56.29 -30.9 63.09 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.044 -1.035 . . . . 0.0 112.859 169.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -66.26 -41.17 90.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.274 0.943 . . . . 0.0 113.394 171.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.62 96.89 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 119.423 -0.322 . . . . 0.0 110.797 174.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.84 -46.62 77.84 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.763 0.711 . . . . 0.0 112.338 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.9 -41.97 83.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.277 0.944 . . . . 0.0 112.101 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -69.96 -45.8 66.63 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.527 1.131 . . . . 0.0 112.159 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -63.12 -31.56 72.73 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 26.6 mt -69.32 -45.98 68.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.634 1.106 . . . . 0.0 110.549 172.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -59.92 -34.38 73.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.97 1.308 . . . . 0.0 111.86 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -88.11 -49.52 6.97 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.22 -23.87 37.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -167.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -73.08 104.62 4.22 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.816 -0.553 . . . . 0.0 109.602 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 117.82 -6.8 15.59 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 117.829 -1.539 . . . . 0.0 116.134 -167.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -65.67 132.64 49.29 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.064 1.932 . . . . 0.0 113.874 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.281 0.2 OUTLIER -94.06 47.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -157.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 31.5 tp -54.9 122.02 9.91 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.016 1.326 . . . . 0.0 111.342 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.385 50.5 m-85 59.42 12.97 2.95 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 -173.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 89.15 1.42 79.15 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.046 -1.034 . . . . 0.0 114.306 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -107.06 125.13 33.28 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 126.235 1.814 . . . . 0.0 111.012 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.05 121.06 7.5 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.034 2.49 . . . . 0.0 112.644 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 71.5 mtp -73.01 127.58 32.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.163 1.385 . . . . 0.0 111.347 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 92.7 t -92.55 95.89 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.352 1.861 . . . . 0.0 109.041 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 15.2 t -100.07 114.54 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.399 2.28 . . . . 0.0 112.296 -172.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.09 162.5 32.75 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -56.91 144.98 31.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.418 1.087 . . . . 0.0 110.27 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -59.37 154.18 17.35 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -73.06 -1.47 17.41 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 1.7 t -149.19 171.93 15.65 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.859 1.208 . . . . 0.0 111.732 160.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -87.48 132.88 33.87 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -161.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -149.15 103.09 3.34 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.774 1.63 . . . . 0.0 111.341 167.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -67.52 143.52 63.28 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 124.129 3.219 . . . . 0.0 111.375 165.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 37.4 tptt -169.24 122.44 0.78 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.806 1.242 . . . . 0.0 109.717 171.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -158.9 138.82 11.99 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -79.63 158.78 72.98 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 167.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.29 148.47 61.67 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.816 2.344 . . . . 0.0 112.358 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 155.45 21.19 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.053 0.93 . . . . 0.0 112.46 173.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 15.4 pm0 -65.11 124.35 21.9 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.916 1.686 . . . . 0.0 113.65 -167.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -81.42 -16.17 74.45 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.49 1.043 . . . . 0.0 114.475 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -82.96 128.88 34.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.986 1.315 . . . . 0.0 111.659 173.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.48 154.62 42.43 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.898 1.679 . . . . 0.0 111.191 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 82.3 tttt . . . . . 0 C--O 1.253 1.244 0 C-N-CA 123.809 0.844 . . . . 0.0 113.046 -170.507 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -73.02 -48.9 32.17 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -153.17 157.93 41.04 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.237 2.215 . . . . 0.0 111.228 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 17.1 ptm -150.22 166.2 15.71 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.734 1.614 . . . . 0.0 110.33 173.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -53.79 149.67 32.26 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.386 2.724 . . . . 0.0 114.649 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 67.5 m -106.93 -2.62 21.07 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 -164.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -157.89 156.88 32.14 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.868 1.267 . . . . 0.0 111.323 -166.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.3 p -148.0 161.9 40.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.328 1.451 . . . . 0.0 114.761 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.3 tt -69.87 158.64 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 126.177 1.791 . . . . 0.0 111.8 -172.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 73.8 m -92.33 152.38 19.8 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.953 -0.467 . . . . 0.0 111.399 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -56.56 -41.31 76.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.2 0.6 . . . . 0.0 111.365 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.09 -35.86 79.96 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -77.71 -30.87 52.0 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.2 tt -65.17 -48.96 71.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.378 1.071 . . . . 0.0 111.274 171.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -54.42 -24.69 20.95 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.376 1.871 . . . . 0.0 115.711 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -67.53 -36.01 80.19 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.568 1.147 . . . . 0.0 111.959 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.61 76.37 0.73 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 125.992 1.758 . . . . 0.0 111.372 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -163.65 145.98 9.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.24 1.016 . . . . 0.0 110.155 -172.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.7 pt -124.8 148.97 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.116 0.966 . . . . 0.0 112.509 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 33.7 t -81.28 166.97 20.05 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.643 1.177 . . . . 0.0 110.695 165.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -53.29 -31.96 46.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.41 1.084 . . . . 0.0 112.905 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -59.15 -19.68 47.0 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.927 1.691 . . . . 0.0 113.075 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -111.83 -28.56 8.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.342 1.857 . . . . 0.0 111.934 171.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 15.7 ttm -67.01 -38.38 85.87 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.195 -1.566 . . . . 0.0 111.936 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -83.89 31.51 0.48 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.815 0.846 . . . . 0.0 111.062 169.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.98 -42.18 0.53 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.313 1.845 . . . . 0.0 115.404 171.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.39 128.43 35.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.648 0.779 . . . . 0.0 109.308 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 50.9 m -59.97 -33.53 72.07 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.329 0.651 . . . . 0.0 112.34 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 5.3 m -63.41 -25.58 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.288 82.6 m-85 -94.07 -9.71 35.77 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -21.5 0.85 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 -163.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 15.6 m -143.9 24.82 1.65 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.476 1.91 . . . . 0.0 112.081 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -122.0 132.3 54.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.428 2.291 . . . . 0.0 112.371 -173.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -142.28 131.98 12.3 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -164.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.1 176.73 8.57 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.566 2.844 . . . . 0.0 111.685 161.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.01 69.16 1.41 Allowed Glycine 0 CA--C 1.532 1.098 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 172.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -145.7 155.16 52.62 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 126.463 1.905 . . . . 0.0 110.833 165.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -82.24 84.74 1.78 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.978 3.119 . . . . 0.0 112.371 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -139.4 143.46 37.68 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.232 -0.917 . . . . 0.0 111.792 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 29.8 p -84.33 7.21 20.16 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -135.11 145.49 47.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.682 1.593 . . . . 0.0 110.082 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 24.1 pt -139.53 162.21 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.507 1.923 . . . . 0.0 109.706 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -133.4 161.77 33.64 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 123.193 1.473 . . . . 0.0 107.722 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.5 t -130.27 139.35 51.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.769 1.628 . . . . 0.0 110.834 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -119.68 168.23 11.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.184 1.794 . . . . 0.0 109.916 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 9.8 t30 68.31 32.38 4.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.657 1.183 . . . . 0.0 111.602 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.96 134.51 41.5 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.522 -0.736 . . . . 0.0 109.972 167.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.9 170.82 1.91 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -173.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -65.52 -50.04 66.74 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.772 1.229 . . . . 0.0 112.92 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -68.06 -42.17 80.88 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.46 152.45 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 127.258 2.223 . . . . 0.0 116.231 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -139.69 170.39 15.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.975 1.31 . . . . 0.0 112.488 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -54.51 -33.77 60.49 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.435 -1.415 . . . . 0.0 113.565 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 34.6 pttt -58.75 -39.46 80.99 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 171.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.28 -32.75 72.11 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.737 1.215 . . . . 0.0 113.538 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.6 mp -69.57 -27.61 65.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.677 1.191 . . . . 0.0 112.805 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -30.67 63.55 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.023 0.829 . . . . 0.0 112.293 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.08 -34.18 74.51 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.46 1.104 . . . . 0.0 111.845 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.12 -58.34 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.127 -0.983 . . . . 0.0 110.827 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -57.68 -29.57 64.75 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.51 -14.78 82.11 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.077 -0.846 . . . . 0.0 114.581 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -56.97 -37.05 71.05 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.263 1.531 . . . . 0.0 111.959 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.63 -7.48 53.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.353 1.461 . . . . 0.0 113.686 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 18.1 t -118.54 123.11 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.72 2.008 . . . . 0.0 110.929 -171.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -75.69 111.6 11.19 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -65.42 -15.13 62.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 70.5 m -89.23 -12.47 40.69 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.197 0.999 . . . . 0.0 113.402 172.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 24.1 t -111.72 109.44 19.3 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.252 1.021 . . . . 0.0 110.845 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -57.92 -45.33 86.68 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.563 -0.711 . . . . 0.0 111.739 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.74 -17.2 5.48 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -87.34 -61.21 1.77 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.31 1.044 . . . . 0.0 110.28 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -70.5 -19.31 62.93 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.084 1.353 . . . . 0.0 113.986 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.1 tt -63.66 -32.62 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.468 1.507 . . . . 0.0 112.531 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.1 mmm -86.88 -14.52 41.77 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.639 1.176 . . . . 0.0 112.42 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -96.13 124.59 40.19 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -171.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -160.51 146.3 15.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.31 143.94 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.305 1.042 . . . . 0.0 110.57 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 73.0 mtp85 -126.66 138.76 53.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.573 1.549 . . . . 0.0 109.858 164.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 2.1 tt -118.96 125.0 48.41 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.057 1.343 . . . . 0.0 110.153 167.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -82.01 125.93 31.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.053 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -115.48 4.92 14.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.065 1.346 . . . . 0.0 112.998 -165.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.6 157.16 34.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.105 2.162 . . . . 0.0 110.457 -170.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 72.22 -164.62 54.41 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.507 1.051 . . . . 0.0 115.445 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -21.57 55.67 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 82.8 mtp -101.32 12.0 38.24 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -55.27 122.57 11.4 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.552 1.523 . . . . 0.0 111.154 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.23 28.05 56.7 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.599 1.095 . . . . 0.0 112.835 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -112.84 155.75 24.11 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.704 1.202 . . . . 0.0 110.909 163.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -149.08 155.62 41.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.508 1.123 . . . . 0.0 112.764 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.46 137.78 54.41 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.58 124.96 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.814 1.645 . . . . 0.0 110.623 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.65 141.19 15.42 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 160.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.6 mt -119.45 157.42 51.62 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.878 1.271 . . . . 0.0 110.187 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.59 -5.99 17.64 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.515 2.143 . . . . 0.0 114.242 -173.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -148.93 138.82 22.06 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.979 1.312 . . . . 0.0 110.102 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.07 -37.39 71.79 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.7 -0.625 . . . . 0.0 111.753 168.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -60.61 -37.66 82.14 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -69.23 -38.02 78.31 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.674 0.79 . . . . 0.0 111.701 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.82 -45.77 81.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.55 1.068 . . . . 0.0 111.86 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.05 76.12 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.766 0.712 . . . . 0.0 112.284 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -69.2 -47.78 63.89 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.998 0.919 . . . . 0.0 112.336 173.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.52 -31.52 71.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.484 0.714 . . . . 0.0 112.65 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 66.7 mt -73.28 -31.94 64.36 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.514 1.126 . . . . 0.0 112.468 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -71.03 -34.29 71.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.304 0.642 . . . . 0.0 111.34 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -89.85 -54.86 3.87 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -73.52 -17.05 61.26 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -69.22 101.92 1.59 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.281 1.032 . . . . 0.0 110.225 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 114.66 -2.1 23.27 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 117.919 -1.49 . . . . 0.0 116.103 -172.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -68.71 120.53 14.84 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.316 2.058 . . . . 0.0 109.367 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.32 69.83 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 124.067 1.889 . . . . 0.0 110.225 -167.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 22.7 tp -76.03 130.22 38.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.181 175.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.341 55.6 m-85 58.01 31.93 21.3 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 76.81 0.21 68.0 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.097 1.332 . . . . 0.0 115.594 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 27.4 tptt -112.78 108.61 53.6 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.653 1.581 . . . . 0.0 110.628 -169.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.39 113.44 3.32 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.756 2.304 . . . . 0.0 110.705 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 48.6 mtp -72.7 128.55 35.87 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.059 1.743 . . . . 0.0 111.891 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.5 t -93.59 99.0 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.078 1.751 . . . . 0.0 109.314 -176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.69 124.24 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.444 1.898 . . . . 0.0 112.266 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -147.82 155.17 41.37 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.098 1.359 . . . . 0.0 111.707 -170.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -54.23 148.19 11.84 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -61.58 158.01 16.1 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 16.2 mmm-85 -121.01 -21.64 6.43 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -160.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 30.2 t -104.09 88.51 3.02 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.121 1.768 . . . . 0.0 107.431 162.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -155.5 160.19 40.37 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -165.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.38 86.76 34.27 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.545 1.538 . . . . 0.0 107.664 161.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -57.34 138.43 86.18 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 123.456 2.771 . . . . 0.0 112.694 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -157.23 133.37 9.61 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.489 1.916 . . . . 0.0 109.305 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -73.66 139.83 45.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.938 1.295 . . . . 0.0 112.933 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -79.13 147.68 69.94 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 170.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.87 159.64 53.0 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.742 2.961 . . . . 0.0 114.422 -171.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 166.67 11.83 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.343 1.457 . . . . 0.0 114.272 175.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -67.27 -28.98 68.48 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.773 1.629 . . . . 0.0 114.564 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 91.26 22.19 32.98 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.094 1.33 . . . . 0.0 113.647 -172.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -151.93 130.84 12.52 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.896 2.478 . . . . 0.0 109.889 -172.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.35 130.1 40.5 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.655 0.782 . . . . 0.0 111.98 -172.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt . . . . . 0 C--O 1.252 1.199 0 C-N-CA 127.675 2.39 . . . . 0.0 112.706 -177.482 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 N--CA 1.475 0.788 0 CA-C-O 119.534 -0.27 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -74.22 175.81 7.22 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -174.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -75.52 -54.04 7.65 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.181 1.392 . . . . 0.0 113.505 -165.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 68.8 mtp 59.64 157.76 0.1 Allowed Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 129.772 3.229 . . . . 0.0 118.188 171.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -93.16 165.64 2.48 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 124.089 3.193 . . . . 0.0 113.258 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 59.1 p -78.43 46.55 0.64 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.615 1.566 . . . . 0.0 114.028 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -88.81 71.39 8.67 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.038 -1.663 . . . . 0.0 111.57 -173.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.3 p -155.02 160.27 40.93 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.595 1.158 . . . . 0.0 111.715 169.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.8 tt -68.39 145.99 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.328 1.451 . . . . 0.0 110.492 -174.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 37.1 t -82.63 157.08 23.55 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 122.107 0.956 . . . . 0.0 109.021 163.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -56.73 -30.14 63.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.699 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -63.82 -37.17 86.39 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 175.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -81.33 -27.84 34.78 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.44 -46.94 62.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.096 1.358 . . . . 0.0 113.042 174.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -55.88 -22.04 23.43 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.594 1.958 . . . . 0.0 114.411 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -62.9 -30.78 71.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.064 1.346 . . . . 0.0 112.704 173.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.22 80.66 0.31 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.55 1.548 . . . . 0.0 111.108 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -162.01 145.52 12.08 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.958 1.703 . . . . 0.0 109.908 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.8 pt -120.61 152.13 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 63.6 m -74.67 159.56 31.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.35 1.46 . . . . 0.0 111.823 161.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 33.3 mtm105 -58.84 -27.11 64.81 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.879 -1.138 . . . . 0.0 112.728 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -61.87 -31.56 71.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.949 1.3 . . . . 0.0 112.019 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.78 -32.18 21.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.672 1.189 . . . . 0.0 111.254 170.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 37.4 ttm -62.23 -43.52 98.64 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.653 -1.279 . . . . 0.0 111.483 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -78.99 29.47 0.21 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.568 0.747 . . . . 0.0 112.162 171.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.05 -39.7 0.44 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.049 1.74 . . . . 0.0 115.388 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 5.3 mp -68.19 134.96 51.3 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.052 1.341 . . . . 0.0 110.586 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 82.4 p -62.94 -27.64 69.53 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.401 HG21 ' CD2' ' A' ' 410' ' ' PHE . 11.4 m -65.79 -22.77 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 172.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.401 ' CD2' HG21 ' A' ' 409' ' ' VAL 0.401 66.4 m-85 -101.25 14.23 32.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 118.482 2.771 . . . . 0.0 118.482 -177.108 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -23.01 62.5 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 4.3 m -140.06 -33.72 0.57 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.847 1.659 . . . . 0.0 113.735 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.58 144.99 56.09 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -147.96 143.24 17.44 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -83.18 -171.67 1.18 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.757 3.638 . . . . 0.0 111.226 157.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.46 -0.48 32.71 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 117.494 1.758 . . . . 0.0 117.494 163.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -102.77 143.51 26.74 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 119.236 1.518 . . . . 0.0 113.91 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.31 82.74 2.42 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.849 3.7 . . . . 0.0 112.435 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . 0.483 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 18.1 t30 -128.29 146.59 50.71 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.552 -1.343 . . . . 0.0 111.026 174.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 32.0 p -77.34 -9.89 59.11 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . 0.483 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 36.3 mtm180 -119.59 146.4 45.55 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.715 1.206 . . . . 0.0 111.586 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 10.3 pt -134.82 151.11 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.997 1.719 . . . . 0.0 110.125 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -114.24 154.67 27.52 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.309 1.052 . . . . 0.0 108.486 166.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.82 147.45 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.531 1.532 . . . . 0.0 112.693 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -134.99 165.99 24.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.092 1.757 . . . . 0.0 111.011 -174.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.291 12.6 m-20 71.55 24.4 3.59 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -174.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.29 131.55 42.83 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.289 -1.507 . . . . 0.0 112.12 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -56.17 152.6 10.51 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.57 1.948 . . . . 0.0 115.513 -172.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -58.36 -40.23 81.67 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -84.52 -21.77 30.43 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.08 150.26 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -117.35 167.26 11.4 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.547 1.139 . . . . 0.0 112.125 171.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -53.94 -34.36 59.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.606 1.162 . . . . 0.0 112.613 170.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -66.58 -32.85 74.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.799 1.24 . . . . 0.0 114.115 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -68.02 -29.66 68.72 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.24 -18.25 60.76 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.01 1.324 . . . . 0.0 113.681 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -58.19 -29.29 65.54 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.361 0.982 . . . . 0.0 112.873 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.66 -32.21 72.36 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.398 0.545 . . . . 0.0 110.733 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.2 mt -99.16 -60.13 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.526 0.73 . . . . 0.0 110.844 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.294 81.5 m-85 -62.92 -23.98 67.63 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 117.349 2.352 . . . . 0.0 117.349 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -82.51 -5.51 89.45 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.737 1.16 . . . . 0.0 114.22 171.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -58.0 -31.8 67.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.656 1.728 . . . . 0.0 111.378 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -93.81 6.77 47.29 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.908 1.683 . . . . 0.0 111.572 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 19.0 t -118.37 120.29 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 120.209 1.368 . . . . 0.0 110.828 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -75.59 103.36 5.67 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.45 1.1 . . . . 0.0 110.422 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -56.42 -29.28 61.4 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 4.2 m -77.81 -2.6 37.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.293 1.837 . . . . 0.0 113.898 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.8 m -130.44 98.0 4.56 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.358 1.463 . . . . 0.0 110.468 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -51.93 -41.05 61.73 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.2 t -48.63 -16.67 0.12 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 118.688 2.847 . . . . 0.0 118.688 173.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -93.07 -58.65 2.26 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.463 -0.773 . . . . 0.0 111.575 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -71.14 -17.07 62.57 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.077 1.351 . . . . 0.0 113.78 -175.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.7 tt -63.3 -35.15 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.557 1.543 . . . . 0.0 111.803 168.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.5 mtm -85.04 -27.64 26.22 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.52 0.328 . . . . 0.0 110.891 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . 0.28 32.4 t80 -83.75 128.64 34.68 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 -173.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -162.28 155.85 20.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.778 1.631 . . . . 0.0 107.716 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 11.3 mt -130.78 135.88 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.617 1.167 . . . . 0.0 109.77 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -122.3 125.16 45.4 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.487 1.515 . . . . 0.0 108.044 163.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 7.1 tp -99.73 113.37 25.8 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.278 1.431 . . . . 0.0 108.203 165.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -77.7 107.04 9.9 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 126.355 1.862 . . . . 0.0 110.034 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -98.28 2.15 47.88 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.354 1.062 . . . . 0.0 113.763 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -118.68 157.16 27.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.4 1.88 . . . . 0.0 112.89 -171.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 74.07 174.55 30.91 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.997 1.284 . . . . 0.0 113.174 -171.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -28.77 68.46 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.445 -1.032 . . . . 0.0 113.068 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -91.89 34.64 0.99 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.55 1.14 . . . . 0.0 112.927 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -70.59 166.25 21.05 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.283 1.033 . . . . 0.0 113.139 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 68.7 38.16 85.41 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 124.891 1.234 . . . . 0.0 110.605 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -125.74 156.92 38.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.079 0.952 . . . . 0.0 110.525 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -143.77 136.99 27.75 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -93.85 127.06 39.4 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 165.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.17 135.83 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.327 1.451 . . . . 0.0 109.378 171.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.89 133.4 11.58 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 160.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 17.9 mt -106.58 160.27 26.87 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.349 1.46 . . . . 0.0 109.868 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.26 -10.46 20.8 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.579 2.186 . . . . 0.0 113.842 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -153.42 145.51 23.74 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.159 0.984 . . . . 0.0 110.249 -174.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -55.67 -36.37 67.02 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.977 -0.452 . . . . 0.0 111.756 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -62.68 -33.99 76.21 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -69.6 -39.87 77.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.203 0.601 . . . . 0.0 111.084 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -69.73 -42.87 73.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.05 0.841 . . . . 0.0 111.618 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.24 -31.11 67.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.984 0.914 . . . . 0.0 112.778 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -78.72 -49.08 13.69 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.328 -0.858 . . . . 0.0 112.617 168.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.87 -27.74 69.55 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 54.1 mt -76.49 -28.3 56.4 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.192 -0.943 . . . . 0.0 112.736 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -71.12 -40.36 71.5 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.108 0.563 . . . . 0.0 110.681 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.44 -55.01 5.18 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.36 -16.26 52.83 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -68.49 108.79 3.42 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.931 -1.106 . . . . 0.0 110.835 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 115.52 -6.09 20.87 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 117.987 -1.452 . . . . 0.0 115.42 -171.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.78 120.41 12.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.292 2.046 . . . . 0.0 114.99 -160.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.287 1.9 t -85.63 46.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.102 1.761 . . . . 0.0 115.507 -163.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 32.5 tp -52.9 130.06 32.18 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.353 1.061 . . . . 0.0 110.335 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . . 81.2 t80 60.31 16.04 5.89 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 86.77 10.3 72.95 Favored Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.464 -1.398 . . . . 0.0 114.656 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -127.66 125.55 23.77 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 126.031 1.732 . . . . 0.0 111.934 -172.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.54 127.51 12.56 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.09 1.86 . . . . 0.0 112.651 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 61.4 mtp -78.42 131.76 37.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.538 1.535 . . . . 0.0 112.524 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.28 97.05 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.356 1.862 . . . . 0.0 109.554 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.9 t -98.51 119.87 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 127.481 2.312 . . . . 0.0 112.774 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -139.41 158.76 43.58 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.825 1.25 . . . . 0.0 113.525 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -58.5 145.89 37.38 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.615 -0.678 . . . . 0.0 112.817 166.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -52.69 142.72 17.83 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.829 0.851 . . . . 0.0 112.606 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -80.56 -12.73 59.48 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -166.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 21.7 m -72.23 142.92 48.97 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.585 1.954 . . . . 0.0 110.702 170.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -60.22 151.99 25.85 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -174.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 31.0 tpt85 -124.78 82.35 60.38 Favored Pre-proline 0 N--CA 1.48 1.053 0 C-N-CA 126.936 2.094 . . . . 0.0 110.915 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.44 -176.94 2.45 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.634 2.889 . . . . 0.0 112.617 177.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -53.1 126.15 19.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.329 1.051 . . . . 0.0 109.18 161.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -160.24 179.97 8.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.391 1.076 . . . . 0.0 110.169 -162.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -63.68 144.31 97.87 Favored Pre-proline 0 CA--C 1.545 0.782 0 O-C-N 120.474 -1.391 . . . . 0.0 112.006 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.83 166.54 28.61 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.988 2.458 . . . . 0.0 113.103 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 168.67 6.19 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.548 1.139 . . . . 0.0 112.599 168.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -125.09 173.15 8.91 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -172.86 -165.95 30.63 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.404 1.002 . . . . 0.0 112.843 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -160.41 167.44 27.33 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.958 1.303 . . . . 0.0 112.258 160.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.76 -44.7 8.83 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.84 1.656 . . . . 0.0 111.001 171.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 15.7 pttp . . . . . 0 C--O 1.252 1.197 0 C-N-CA 128.325 2.65 . . . . 0.0 112.841 170.131 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 26.4 p . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 117.958 -1.02 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -129.81 -70.55 0.64 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.52 -22.76 54.0 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 69.3 mmm -136.63 162.68 54.71 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.872 1.669 . . . . 0.0 112.834 -172.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.71 164.36 11.69 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.801 3.001 . . . . 0.0 113.393 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 5.6 m -117.36 149.36 40.62 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.199 1.4 . . . . 0.0 114.311 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -159.83 156.78 28.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.14 2.176 . . . . 0.0 109.804 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.1 p -141.9 175.69 9.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.657 1.183 . . . . 0.0 112.828 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.5 tt -82.62 150.42 4.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 126.063 1.745 . . . . 0.0 111.964 -172.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 6.5 m -81.77 161.02 23.44 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.511 0.725 . . . . 0.0 109.709 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -65.04 -39.63 93.61 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.113 -0.992 . . . . 0.0 110.769 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -54.89 -43.72 73.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.351 1.46 . . . . 0.0 112.785 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.87 -37.73 70.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.098 1.359 . . . . 0.0 114.551 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 19.8 tp -69.05 -39.6 79.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.251 1.021 . . . . 0.0 112.528 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -59.97 -18.03 42.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -65.66 -21.41 66.55 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.057 0.943 . . . . 0.0 112.253 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -134.96 86.49 0.25 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.656 1.598 . . . . 0.0 111.495 173.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -155.7 151.08 26.93 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.751 1.221 . . . . 0.0 109.658 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.3 pt -136.41 148.64 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 13.0 m -86.97 164.17 16.67 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.98 1.712 . . . . 0.0 110.178 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -50.24 -38.76 42.15 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.38 -27.35 66.16 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.54 -31.42 42.06 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.142 -0.974 . . . . 0.0 111.821 167.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 4.5 ttm -58.93 -38.7 79.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.784 0.834 . . . . 0.0 110.076 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -74.65 11.2 1.09 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.764 1.626 . . . . 0.0 114.059 171.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.47 -22.05 3.4 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.209 1.803 . . . . 0.0 115.227 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.0 mp -91.17 130.82 37.02 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.253 1.821 . . . . 0.0 111.202 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 14.5 p -62.41 -24.25 67.29 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 6.1 m -66.18 -23.22 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 119.501 1.046 . . . . 0.0 113.595 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.27 42.2 m-85 -100.44 -10.35 21.22 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 121.276 3.806 . . . . 0.0 121.276 -171.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.79 -19.59 29.42 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 -169.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 4.4 m -142.54 28.28 1.64 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.451 1.9 . . . . 0.0 111.799 -176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -134.12 137.72 44.73 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.192 2.197 . . . . 0.0 115.924 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 415' ' ' PRO . 78.7 mt-10 -142.11 121.01 7.76 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -171.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 414' ' ' GLU . 79.3 Cg_endo -74.84 176.79 9.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.178 3.252 . . . . 0.0 113.282 160.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.55 31.61 10.19 Favored Glycine 0 N--CA 1.468 0.787 0 C-N-CA 124.532 1.063 . . . . 0.0 114.853 167.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -125.82 149.87 67.06 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.693 1.197 . . . . 0.0 113.255 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.53 109.93 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.027 3.151 . . . . 0.0 114.056 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . 0.515 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 42.1 t30 -158.17 159.96 36.71 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.807 1.643 . . . . 0.0 109.669 160.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 25.4 p -80.59 -7.52 59.28 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . 0.515 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 20.3 mtp180 -130.92 152.39 50.3 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.086 1.754 . . . . 0.0 110.084 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 6.6 pt -137.88 165.13 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 126.725 2.01 . . . . 0.0 109.404 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -135.56 164.18 28.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.606 1.193 . . . . 0.0 107.818 167.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.4 143.34 34.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.608 1.163 . . . . 0.0 110.522 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -126.43 168.78 13.73 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.227 1.811 . . . . 0.0 110.868 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 38.8 t30 67.32 32.8 5.72 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.663 1.585 . . . . 0.0 113.085 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.56 139.79 53.77 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.449 1.1 . . . . 0.0 110.919 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -59.47 161.86 5.43 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.871 1.669 . . . . 0.0 115.098 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -63.09 -37.26 86.51 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -80.15 -32.7 38.88 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.713 1.605 . . . . 0.0 114.022 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.35 144.19 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -166.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -120.25 163.87 17.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.602 1.561 . . . . 0.0 112.308 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -56.15 -32.55 64.39 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.583 -1.323 . . . . 0.0 113.033 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -62.37 -33.37 74.61 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -66.98 -36.21 81.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.494 1.118 . . . . 0.0 113.028 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.56 -22.6 63.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.192 1.397 . . . . 0.0 112.969 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.88 -26.78 62.57 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.48 1.036 . . . . 0.0 112.471 176.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -62.5 -31.77 72.58 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.237 0.471 . . . . 0.0 110.494 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.11 -56.27 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 120.591 -1.318 . . . . 0.0 110.841 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -59.27 -30.32 68.21 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.28 -3.49 88.55 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.906 1.241 . . . . 0.0 114.641 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -59.25 -31.06 68.74 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.384 1.592 . . . . 0.0 112.23 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -97.94 13.85 29.3 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.205 2.202 . . . . 0.0 111.678 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 15.4 t -131.03 139.73 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.919 1.688 . . . . 0.0 110.389 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.61 117.05 14.91 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.717 -0.615 . . . . 0.0 109.872 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.31 -13.81 32.65 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 118.716 2.858 . . . . 0.0 118.716 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.2 t -123.04 -33.48 3.32 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.4 m -67.66 110.83 3.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.951 0.796 . . . . 0.0 110.814 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -57.07 -46.4 82.53 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -13.55 2.57 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -92.91 -60.34 1.83 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.819 1.248 . . . . 0.0 110.374 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -70.81 -12.55 61.62 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.986 1.714 . . . . 0.0 114.114 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.02 -39.91 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 126.869 2.068 . . . . 0.0 112.968 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 11.8 mtm -83.96 -29.96 26.64 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.573 0.749 . . . . 0.0 109.669 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -66.43 131.15 45.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.04 1.336 . . . . 0.0 113.825 164.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -165.43 149.04 8.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.358 1.463 . . . . 0.0 108.809 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.2 mt -125.95 137.03 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.48 1.112 . . . . 0.0 111.424 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -126.53 129.37 48.49 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.945 1.298 . . . . 0.0 108.892 162.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 5.7 tt -109.1 115.97 31.06 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.225 1.41 . . . . 0.0 109.533 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 59.7 mtm -72.8 134.26 44.84 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.065 1.346 . . . . 0.0 111.575 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -123.93 14.94 9.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.492 1.517 . . . . 0.0 113.168 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -139.89 153.31 46.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.898 1.679 . . . . 0.0 112.241 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 59.33 -146.88 43.04 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.046 1.308 . . . . 0.0 116.318 168.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -7.59 47.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.819 2.048 . . . . 0.0 115.465 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . 0.256 13.1 mtm -120.25 19.25 12.19 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 173.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -55.58 120.22 6.89 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.273 -1.517 . . . . 0.0 111.513 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.01 30.17 29.42 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.16 1.362 . . . . 0.0 113.77 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -123.85 149.33 45.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.472 1.109 . . . . 0.0 109.288 168.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -137.94 141.52 40.57 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.437 -0.79 . . . . 0.0 112.656 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -101.64 135.06 43.8 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 172.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.82 122.83 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.29 1.436 . . . . 0.0 110.533 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -85.73 149.99 23.86 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 162.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 21.9 mt -125.21 158.34 64.06 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.401 1.08 . . . . 0.0 110.233 170.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.3 -8.27 21.67 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.545 2.163 . . . . 0.0 113.991 -175.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -155.78 144.24 20.19 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.033 1.333 . . . . 0.0 110.487 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -58.36 -31.95 68.1 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.613 1.165 . . . . 0.0 113.154 168.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -56.3 -45.69 80.13 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.394 -0.816 . . . . 0.0 111.978 171.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.73 -35.87 81.98 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.993 0.808 . . . . 0.0 112.914 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.38 -44.37 75.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.439 1.472 . . . . 0.0 112.586 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.83 -38.22 75.23 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.42 -0.8 . . . . 0.0 112.022 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -67.2 -53.7 27.88 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.721 1.208 . . . . 0.0 112.192 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.79 -32.95 69.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.979 0.911 . . . . 0.0 112.608 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 50.8 mt -69.81 -43.58 71.77 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.068 0.947 . . . . 0.0 111.742 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -65.97 -26.1 67.41 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.81 0.844 . . . . 0.0 111.688 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -100.65 -44.69 5.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -175.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -76.1 -24.45 55.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.519 1.128 . . . . 0.0 113.865 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -72.5 120.5 18.2 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.645 -0.659 . . . . 0.0 112.343 -169.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 108.96 -8.19 33.51 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 117.984 -1.454 . . . . 0.0 115.032 -170.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . 0.262 61.7 t80 -64.82 133.12 51.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.524 1.662 . . . . 0.0 115.164 -164.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.252 2.5 t -99.8 46.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.181 1.392 . . . . 0.0 113.768 -158.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 19.4 tp -50.49 126.28 14.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.123 1.369 . . . . 0.0 110.572 172.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.361 32.9 m-85 58.64 12.58 2.22 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 89.84 3.03 74.36 Favored Glycine 0 CA--C 1.536 1.355 0 O-C-N 120.683 -1.26 . . . . 0.0 114.519 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -119.35 118.1 32.68 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 119.477 1.639 . . . . 0.0 112.829 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.18 126.76 14.1 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.886 2.39 . . . . 0.0 113.216 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 71.7 mtp -81.72 134.47 35.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.652 1.581 . . . . 0.0 112.137 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.76 93.47 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 126.655 1.982 . . . . 0.0 110.528 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.8 t -94.67 118.25 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 126.814 2.045 . . . . 0.0 113.086 -173.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -134.41 160.8 36.86 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.65 1.18 . . . . 0.0 114.119 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -60.01 144.58 48.96 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.165 -0.96 . . . . 0.0 113.174 167.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -60.91 168.72 2.23 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.96 15.3 1.19 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -143.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 8.8 t -64.06 -48.56 75.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.428 1.013 . . . . 0.0 109.373 173.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -79.58 135.58 36.63 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.155 0.582 . . . . 0.0 110.207 155.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -118.26 49.85 1.09 Allowed Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.351 1.46 . . . . 0.0 113.575 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -65.51 165.86 21.45 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.715 2.277 . . . . 0.0 111.964 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -54.66 113.34 1.27 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.673 1.189 . . . . 0.0 112.297 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -81.14 -41.61 22.18 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.634 0.774 . . . . 0.0 110.085 166.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -156.89 159.34 31.34 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.631 1.972 . . . . 0.0 114.191 -168.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -70.97 -165.65 0.19 Allowed 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.135 2.557 . . . . 0.0 111.38 162.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.35 160.16 0.26 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.236 1.015 . . . . 0.0 113.264 160.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -63.75 148.32 49.48 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.409 -0.807 . . . . 0.0 112.012 -173.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -175.74 112.85 0.41 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.653 0.644 . . . . 0.0 112.286 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -153.74 175.66 13.02 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -162.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -123.12 120.25 32.67 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.328 1.451 . . . . 0.0 112.464 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 18.9 pttp . . . . . 0 C--O 1.251 1.152 0 C-N-CA 127.375 2.27 . . . . 0.0 112.562 172.709 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 76.0 p . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 120.3 0.095 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -86.41 -39.35 16.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.781 0.832 . . . . 0.0 112.225 174.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -145.47 151.05 37.59 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.725 1.21 . . . . 0.0 111.223 172.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 23.0 ptm -151.66 158.03 34.33 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.15 1.38 . . . . 0.0 110.435 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -92.05 39.33 0.28 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.926 2.417 . . . . 0.0 112.298 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 33.7 t -162.32 156.44 21.45 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.882 1.273 . . . . 0.0 113.167 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -142.6 144.41 32.84 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 129.206 3.002 . . . . 0.0 106.81 167.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 30.1 p -144.82 164.78 30.01 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.3 tt -72.64 171.14 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.647 2.379 . . . . 0.0 111.701 -175.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 34.5 m -110.67 166.85 10.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.425 1.09 . . . . 0.0 111.834 167.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 14.1 ttm-85 -59.15 -48.33 81.99 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.037 -1.039 . . . . 0.0 112.48 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -61.78 -37.16 83.3 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.591 1.157 . . . . 0.0 113.398 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -70.31 -38.66 75.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.696 1.198 . . . . 0.0 113.226 173.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.06 -41.08 82.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.889 1.276 . . . . 0.0 112.982 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.33 -17.84 32.89 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.172 1.789 . . . . 0.0 115.101 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -70.29 -16.23 62.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.961 0.905 . . . . 0.0 113.357 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -127.29 87.6 0.33 Allowed Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.84 1.686 . . . . 0.0 113.166 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -167.7 147.25 4.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.629 1.172 . . . . 0.0 111.372 -170.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 10.8 pt -125.28 152.71 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 69.3 m -100.82 164.44 11.84 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.963 2.505 . . . . 0.0 111.111 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -55.46 -33.81 63.97 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -169.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -76.86 -10.56 59.45 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.588 1.086 . . . . 0.0 112.877 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -96.61 -33.19 11.87 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.001 -1.062 . . . . 0.0 111.208 163.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 17.5 ttp -63.29 -40.47 97.47 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.881 -1.137 . . . . 0.0 111.352 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -79.68 30.62 0.24 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.148 0.979 . . . . 0.0 112.723 171.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.12 -29.02 0.41 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 176.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.8 mp -72.27 134.31 45.51 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.17 0.988 . . . . 0.0 109.842 167.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 9.2 t -66.94 -29.48 69.36 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.444 -0.785 . . . . 0.0 111.923 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.7 m -66.63 -7.77 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 170.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.261 83.5 m-85 -119.74 3.68 11.1 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 118.553 2.797 . . . . 0.0 118.553 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -14.08 62.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -169.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.7 t -130.76 -25.9 2.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.218 1.007 . . . . 0.0 111.681 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -70.36 137.76 50.82 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.284 1.586 . . . . 0.0 115.284 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -142.81 125.79 9.14 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.22 179.71 5.68 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 125.045 3.83 . . . . 0.0 113.513 167.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 121.25 -19.68 8.62 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 156.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -82.03 150.2 64.5 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.13 96.98 1.09 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 124.109 3.206 . . . . 0.0 112.725 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.83 137.47 45.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.069 1.747 . . . . 0.0 106.903 161.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.9 p -72.99 -0.67 14.43 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -124.43 149.88 46.28 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.331 1.453 . . . . 0.0 110.849 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.6 pt -140.15 161.22 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.61 1.964 . . . . 0.0 109.654 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -131.35 156.97 44.6 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.5 t -127.2 143.76 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 125.349 1.46 . . . . 0.0 111.575 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -127.34 166.95 16.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.364 1.865 . . . . 0.0 109.569 173.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 34.6 t30 66.24 32.45 7.9 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.8 1.24 . . . . 0.0 113.109 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -71.33 157.23 38.46 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.318 -0.864 . . . . 0.0 111.49 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -71.46 166.52 21.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.255 1.422 . . . . 0.0 114.804 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -76.36 -42.1 45.87 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.204 -0.935 . . . . 0.0 113.034 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -70.98 -35.79 72.26 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.38 156.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -130.24 158.32 40.08 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.994 1.718 . . . . 0.0 110.55 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -56.15 -29.82 61.3 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.155 -1.59 . . . . 0.0 113.454 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -57.18 -37.71 72.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.066 1.747 . . . . 0.0 114.26 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -68.13 -33.98 75.5 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.65 -21.41 66.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.136 0.974 . . . . 0.0 112.547 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -24.12 62.27 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.841 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -59.39 -29.46 67.73 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.708 0.803 . . . . 0.0 110.96 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.41 -55.0 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 120.866 -1.147 . . . . 0.0 111.207 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -59.53 -29.64 68.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.73 -4.71 89.47 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.409 1.004 . . . . 0.0 114.43 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -65.36 -36.22 83.34 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 119.974 1.887 . . . . 0.0 111.527 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -79.26 6.29 10.24 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.623 1.969 . . . . 0.0 113.08 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 16.1 t -131.57 135.06 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.469 1.908 . . . . 0.0 110.862 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -91.13 113.32 25.55 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -63.77 -18.51 64.15 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 69.5 m -90.88 -0.58 57.77 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.3 t -118.5 107.22 13.52 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.29 1.036 . . . . 0.0 110.629 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -61.24 -43.16 99.33 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.186 -0.946 . . . . 0.0 111.998 -176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.91 -14.11 5.65 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 117.189 2.292 . . . . 0.0 117.189 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -88.27 -62.21 1.54 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.016 0.926 . . . . 0.0 110.095 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -69.92 -24.74 63.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.754 1.222 . . . . 0.0 114.227 -173.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 16.4 tt -54.19 -36.71 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.694 1.197 . . . . 0.0 112.28 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.2 mtm -84.71 -12.83 53.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.267 1.027 . . . . 0.0 112.483 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -94.36 134.13 37.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.859 1.664 . . . . 0.0 114.777 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -167.86 141.26 3.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.872 1.669 . . . . 0.0 107.303 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.8 mt -116.24 138.1 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.958 1.703 . . . . 0.0 110.149 174.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -132.13 133.98 44.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.023 1.329 . . . . 0.0 110.163 166.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 1.4 tt -112.2 124.8 53.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.098 1.359 . . . . 0.0 110.943 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 35.2 mtm -72.27 135.02 45.88 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.648 1.579 . . . . 0.0 111.172 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -134.51 -26.06 1.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.657 1.583 . . . . 0.0 115.136 -163.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -101.15 139.39 36.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.596 1.558 . . . . 0.0 111.512 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 72.5 -158.32 53.16 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.38 1.312 . . . . 0.0 116.38 163.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -13.97 62.32 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -169.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 75.9 mtm -110.63 12.42 22.68 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -61.17 148.82 39.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.844 -1.16 . . . . 0.0 111.949 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.77 24.61 76.45 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.737 0.684 . . . . 0.0 112.156 -175.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -104.23 160.04 15.21 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.758 1.223 . . . . 0.0 109.697 158.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -152.51 157.11 40.64 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.829 -1.17 . . . . 0.0 112.77 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -116.86 143.39 45.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.98 127.05 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.617 1.567 . . . . 0.0 109.071 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -97.18 145.6 17.92 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 162.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 27.1 mt -126.29 156.66 72.14 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.592 1.557 . . . . 0.0 110.412 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -73.06 -7.7 21.03 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.747 2.298 . . . . 0.0 114.579 -171.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -151.22 143.43 24.07 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.469 1.108 . . . . 0.0 111.397 -172.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.19 -41.93 69.15 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.559 -0.713 . . . . 0.0 111.394 166.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -67.16 -28.01 67.76 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.493 1.117 . . . . 0.0 113.381 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -71.24 -43.35 67.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.664 0.386 . . . . 0.0 110.777 174.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.81 -44.06 74.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.36 0.527 . . . . 0.0 112.056 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.79 -37.73 71.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.38 0.672 . . . . 0.0 111.923 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -73.15 -48.4 35.75 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.783 0.833 . . . . 0.0 112.744 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.96 -29.57 70.33 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.15 -34.13 70.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.106 -0.996 . . . . 0.0 112.461 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -63.92 -39.45 94.18 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.312 0.505 . . . . 0.0 111.429 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.06 -47.49 8.87 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -171.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -79.02 -20.89 47.86 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -69.1 109.48 4.04 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.277 -0.89 . . . . 0.0 110.699 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 108.96 -3.31 31.74 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 117.684 -1.62 . . . . 0.0 116.435 -174.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -65.89 131.23 45.77 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.779 1.789 . . . . 0.0 112.356 -172.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.299 1.2 t -93.31 44.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 -161.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 16.8 tp -50.01 122.26 6.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.016 1.726 . . . . 0.0 111.489 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.309 76.1 m-85 49.57 30.34 3.48 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 117.361 2.356 . . . . 0.0 117.361 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 77.37 24.36 65.9 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.125 -0.984 . . . . 0.0 114.171 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -132.43 116.62 15.24 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 119.028 1.414 . . . . 0.0 110.33 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.96 114.88 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.313 2.009 . . . . 0.0 112.003 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 61.9 mtp -71.25 127.81 33.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.723 1.609 . . . . 0.0 112.347 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 30.8 t -93.52 94.16 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.992 2.117 . . . . 0.0 109.63 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 3.7 t -100.4 120.49 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 127.142 2.177 . . . . 0.0 113.08 -171.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -137.95 158.95 43.29 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.399 1.479 . . . . 0.0 113.644 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -57.71 142.19 46.06 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 167.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -62.63 163.82 8.51 Favored 'General case' 0 CA--C 1.556 1.178 0 CA-C-N 118.507 0.594 . . . . 0.0 112.462 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -103.42 13.14 34.28 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 -148.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 4.3 t -116.33 37.66 3.65 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.878 1.671 . . . . 0.0 111.902 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -163.95 99.67 0.87 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.113 1.765 . . . . 0.0 111.524 173.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 18.9 tpt85 -145.37 68.56 13.59 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 125.66 1.584 . . . . 0.0 111.384 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.99 158.19 53.0 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.768 2.979 . . . . 0.0 112.939 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -112.05 137.06 50.6 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.9 1.28 . . . . 0.0 111.402 -171.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -161.53 150.73 16.21 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.711 1.604 . . . . 0.0 110.889 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -79.83 147.08 65.69 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -80.44 172.66 13.29 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.318 3.345 . . . . 0.0 112.479 164.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 146.94 28.25 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.373 1.069 . . . . 0.0 113.433 175.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -72.66 132.13 43.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.124 0.969 . . . . 0.0 112.992 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -88.96 -31.28 12.41 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.572 1.082 . . . . 0.0 112.672 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -55.6 144.22 27.3 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.937 1.695 . . . . 0.0 111.627 169.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -61.86 147.21 47.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.212 1.405 . . . . 0.0 112.116 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 14.3 tttt . . . . . 0 C--O 1.251 1.163 0 CA-C-O 116.204 -1.855 . . . . 0.0 114.463 177.326 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.728 0.299 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -61.84 -36.37 80.98 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.985 0.914 . . . . 0.0 113.135 164.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -84.34 15.35 3.67 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.443 1.497 . . . . 0.0 113.558 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -58.23 148.06 64.21 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.907 0.883 . . . . 0.0 111.852 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.49 122.98 7.81 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.781 2.321 . . . . 0.0 112.246 -173.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 55.8 m -89.4 92.5 9.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.962 1.305 . . . . 0.0 109.573 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -152.37 127.73 9.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.274 1.03 . . . . 0.0 111.719 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.4 p -161.54 159.82 28.28 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.7 1.2 . . . . 0.0 113.403 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.8 tt -75.67 166.15 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.203 1.401 . . . . 0.0 112.441 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 19.9 m -115.39 161.49 18.46 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.199 1.4 . . . . 0.0 111.711 169.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -63.99 -39.36 93.95 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.616 -0.678 . . . . 0.0 112.132 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -58.8 -34.72 71.81 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -79.56 -38.77 33.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.759 1.624 . . . . 0.0 113.864 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.14 -41.62 97.11 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.768 1.227 . . . . 0.0 113.137 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -58.47 -23.32 57.47 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.637 1.575 . . . . 0.0 114.486 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.52 -18.43 64.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.611 1.164 . . . . 0.0 112.1 173.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -123.96 82.05 0.35 Allowed Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.986 2.232 . . . . 0.0 111.482 167.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -157.28 139.61 14.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.936 1.694 . . . . 0.0 109.346 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.8 pt -122.58 150.6 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 123.391 1.567 . . . . 0.0 115.002 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.6 m -78.58 160.86 27.38 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.796 2.039 . . . . 0.0 112.045 167.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -55.3 -30.05 59.41 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.371 -0.831 . . . . 0.0 112.092 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -65.1 -22.73 66.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.619 1.168 . . . . 0.0 113.826 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -93.06 -33.46 14.08 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.236 1.014 . . . . 0.0 111.24 168.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 37.8 ttm -59.59 -42.25 92.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 122.454 1.121 . . . . 0.0 111.574 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -85.96 33.79 0.6 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.587 1.555 . . . . 0.0 110.827 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.98 -41.24 0.35 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 128.099 2.56 . . . . 0.0 114.852 173.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.6 mp -66.88 136.83 55.98 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.354 1.062 . . . . 0.0 110.02 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 21.0 m -65.24 -34.33 78.1 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 169.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 17.5 m -59.0 -29.94 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 119.906 1.23 . . . . 0.0 112.704 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -101.68 11.16 39.31 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -19.17 49.48 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 47.3 t -142.57 -28.81 0.58 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.301 1.04 . . . . 0.0 113.015 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -71.72 146.52 48.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.2 1.4 . . . . 0.0 114.768 169.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.65 130.5 3.74 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 121.298 -0.876 . . . . 0.0 113.031 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -69.89 165.06 32.37 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 125.278 3.986 . . . . 0.0 114.66 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 143.86 -27.87 2.03 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.184 1.233 . . . . 0.0 116.184 152.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -72.42 139.67 81.54 Favored Pre-proline 0 CA--C 1.552 1.053 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -165.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.06 105.41 1.79 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.591 2.861 . . . . 0.0 112.988 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -134.17 150.52 51.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.689 1.995 . . . . 0.0 108.215 163.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 29.8 p -72.27 -2.18 18.05 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 38.7 mtm-85 -134.15 148.83 51.01 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.891 2.076 . . . . 0.0 110.082 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 4.4 pt -131.22 159.4 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.139 2.176 . . . . 0.0 110.456 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -128.86 158.48 38.62 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.32 139.58 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.512 1.525 . . . . 0.0 111.515 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -121.71 167.52 12.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.166 1.387 . . . . 0.0 110.116 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 31.4 t30 68.08 31.7 5.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.052 1.341 . . . . 0.0 112.859 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -66.64 145.95 55.02 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.41 -0.806 . . . . 0.0 110.617 173.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.24 163.61 12.51 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.49 1.516 . . . . 0.0 114.413 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -64.64 -47.98 76.5 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -71.42 -29.5 64.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.4 p -65.28 145.53 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -166.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -119.48 163.95 16.5 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.312 1.845 . . . . 0.0 111.906 170.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.36 -26.27 64.94 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.749 -1.219 . . . . 0.0 113.459 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -60.36 -37.03 79.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.656 1.182 . . . . 0.0 114.038 171.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -72.36 -26.93 62.1 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.87 1.268 . . . . 0.0 114.308 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -73.41 -21.47 60.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.229 1.812 . . . . 0.0 112.744 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -27.57 58.79 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.436 1.016 . . . . 0.0 112.585 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -60.99 -30.95 70.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.439 1.096 . . . . 0.0 111.56 -173.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.2 mp -104.48 -54.78 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.018 -1.051 . . . . 0.0 111.218 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -58.03 -27.68 63.78 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.24 -11.73 84.71 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 118.83 -0.983 . . . . 0.0 114.598 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -62.58 -30.99 71.73 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 120.792 2.296 . . . . 0.0 112.1 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -79.29 2.06 22.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.114 1.766 . . . . 0.0 112.858 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.58 136.22 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.35 1.86 . . . . 0.0 110.818 -172.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -79.73 119.64 22.92 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.898 -1.126 . . . . 0.0 108.056 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.329 49.5 m-85 -67.91 -16.91 64.29 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 167.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.0 t -94.03 -38.04 11.34 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.252 0.933 . . . . 0.0 113.469 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.1 m -83.27 118.62 23.77 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.394 -0.816 . . . . 0.0 111.588 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -57.89 -45.07 86.97 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.482 -0.761 . . . . 0.0 112.328 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.36 -16.02 1.98 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -89.75 -62.5 1.46 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.151 0.98 . . . . 0.0 110.562 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -68.39 -21.47 64.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.931 1.292 . . . . 0.0 113.295 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.74 -33.86 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.753 1.621 . . . . 0.0 112.261 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -93.85 3.13 55.86 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.938 1.295 . . . . 0.0 112.886 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -110.44 136.01 50.25 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.869 2.068 . . . . 0.0 115.81 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -166.53 152.31 8.4 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.411 1.885 . . . . 0.0 106.596 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.9 mt -126.11 137.32 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.238 1.015 . . . . 0.0 110.226 171.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 52.7 ttm-85 -125.3 133.8 52.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.115 0.966 . . . . 0.0 110.446 163.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.5 tp -118.15 124.1 47.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.582 1.553 . . . . 0.0 108.846 168.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 39.7 mtm -74.68 116.97 15.98 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.161 0.585 . . . . 0.0 110.083 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -103.0 5.28 38.15 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.014 1.726 . . . . 0.0 112.56 174.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -126.96 149.12 50.0 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.654 1.582 . . . . 0.0 112.952 -174.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.06 -156.51 52.01 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.241 1.4 . . . . 0.0 115.604 164.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -51.91 -34.47 41.64 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.305 1.442 . . . . 0.0 114.094 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 72.3 mtp -97.3 12.27 33.6 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -51.21 123.75 10.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.214 1.006 . . . . 0.0 111.448 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.03 31.47 31.82 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.586 1.565 . . . . 0.0 113.979 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -125.18 145.2 50.07 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.355 1.062 . . . . 0.0 112.224 169.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -135.15 156.05 49.66 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.938 1.295 . . . . 0.0 114.147 -169.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.8 132.8 52.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.585 1.954 . . . . 0.0 115.451 171.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.6 mp -132.34 122.07 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.891 1.676 . . . . 0.0 110.042 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.92 145.48 18.25 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 33.6 mt -126.3 158.96 65.09 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.012 1.325 . . . . 0.0 110.42 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -75.34 -9.08 20.17 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.418 2.745 . . . . 0.0 114.556 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -150.82 143.01 24.15 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.588 0.755 . . . . 0.0 111.388 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -59.01 -37.25 76.47 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.004 0.922 . . . . 0.0 111.803 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 18.6 mtmm -62.89 -35.88 81.48 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.85 92.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.411 0.55 . . . . 0.0 110.915 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -69.44 -44.44 71.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.247 0.93 . . . . 0.0 112.746 172.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.33 69.12 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.806 0.73 . . . . 0.0 112.122 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -75.48 -48.44 22.6 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.874 1.67 . . . . 0.0 113.069 170.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.78 70.33 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.845 0.748 . . . . 0.0 112.765 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 50.1 mt -68.67 -37.5 79.66 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.94 0.896 . . . . 0.0 112.178 174.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -65.3 -41.32 94.2 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.637 0.775 . . . . 0.0 111.463 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.9 -48.57 11.36 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -174.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.14 -16.74 59.03 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -63.75 107.4 1.18 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.025 0.93 . . . . 0.0 112.114 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 106.94 3.54 36.39 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.578 -1.123 . . . . 0.0 115.254 -174.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -71.57 112.99 8.13 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.184 1.492 . . . . 0.0 108.892 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.97 79.43 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.923 1.689 . . . . 0.0 108.029 -169.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 51.6 tp -79.05 132.83 36.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.058 1.743 . . . . 0.0 110.464 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.258 65.7 m-85 55.74 19.43 3.41 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -174.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 81.84 18.56 67.51 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.187 -1.341 . . . . 0.0 115.464 -171.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -128.42 120.64 21.03 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 119.833 1.816 . . . . 0.0 112.508 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.5 121.85 8.36 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 123.547 2.831 . . . . 0.0 112.305 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 38.6 mtp -79.14 132.0 36.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.828 1.251 . . . . 0.0 111.829 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.8 t -94.23 101.18 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.112 1.365 . . . . 0.0 109.816 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.15 127.3 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 126.716 2.006 . . . . 0.0 112.908 -173.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -146.3 161.35 40.5 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -64.26 143.56 57.8 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 121.038 -1.039 . . . . 0.0 108.962 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -55.39 142.23 33.25 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.084 0.953 . . . . 0.0 112.696 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -63.43 108.62 1.38 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.705 0.802 . . . . 0.0 111.603 -165.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 8.4 t -167.61 161.29 13.53 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.82 1.248 . . . . 0.0 111.143 -163.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -63.35 136.92 57.97 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.955 -1.091 . . . . 0.0 113.385 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -127.92 93.14 40.33 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 125.255 1.422 . . . . 0.0 110.139 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.33 164.67 28.64 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 124.213 3.275 . . . . 0.0 113.122 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -89.19 10.36 22.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.255 1.822 . . . . 0.0 114.747 175.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -59.62 149.36 30.55 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -59.7 148.61 74.8 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.99 145.67 22.42 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 122.757 2.304 . . . . 0.0 111.726 167.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.72 158.46 27.46 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.681 0.753 . . . . 0.0 112.85 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -87.41 151.17 23.29 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.492 1.117 . . . . 0.0 113.881 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 88.01 165.71 41.59 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.545 1.545 . . . . 0.0 115.781 170.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -158.25 153.29 25.36 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.388 1.875 . . . . 0.0 111.301 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 8.5 ptm85 -137.82 -14.78 1.39 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.251 1.162 0 C-N-CA 124.215 1.006 . . . . 0.0 112.93 -173.745 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 53.0 p . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 120.719 0.295 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -71.82 -3.44 22.21 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 168.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -126.03 14.93 7.92 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.367 1.867 . . . . 0.0 113.776 -165.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 75.9 mtp -65.93 131.71 94.61 Favored Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 121.176 -0.952 . . . . 0.0 111.561 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.3 142.58 41.61 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.105 2.536 . . . . 0.0 111.587 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 33.6 t -84.88 83.35 8.08 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 166.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -144.1 100.63 3.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.661 1.985 . . . . 0.0 108.55 -172.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 28.2 p -158.03 160.21 37.19 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -164.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.7 tt -76.6 161.05 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.268 1.427 . . . . 0.0 112.44 -170.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 18.5 m -114.33 162.33 16.76 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.821 1.649 . . . . 0.0 113.11 168.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -55.25 -43.26 74.45 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.809 0.844 . . . . 0.0 112.469 -172.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -61.76 -33.54 74.26 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -82.83 -37.21 24.73 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.779 0.832 . . . . 0.0 112.715 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.22 -42.16 96.71 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.404 1.082 . . . . 0.0 113.659 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.89 -24.0 48.79 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.635 1.574 . . . . 0.0 114.247 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -70.81 -13.0 61.88 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.979 1.712 . . . . 0.0 112.825 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -123.34 77.66 0.36 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 126.303 1.906 . . . . 0.0 112.63 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -161.39 142.69 11.44 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.386 1.075 . . . . 0.0 111.529 -174.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 20.7 pt -127.91 161.28 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.556 1.542 . . . . 0.0 112.2 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.9 m -110.7 179.36 4.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.144 1.378 . . . . 0.0 111.975 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 32.3 mtm105 -54.25 -27.3 33.92 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.267 -0.895 . . . . 0.0 113.292 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -58.67 -32.56 69.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.537 1.535 . . . . 0.0 112.672 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -98.93 -40.06 8.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.892 0.877 . . . . 0.0 111.209 168.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.88 -40.63 98.1 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.704 -1.248 . . . . 0.0 112.244 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -80.46 11.03 3.94 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 121.319 -0.863 . . . . 0.0 112.672 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.89 -27.08 5.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.584 2.353 . . . . 0.0 113.454 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 43.9 mt -77.51 135.87 38.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.305 1.442 . . . . 0.0 112.654 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 55.3 p -60.14 -34.26 73.28 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.048 0.939 . . . . 0.0 112.325 167.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . 0.255 1.8 m -67.32 -15.28 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 173.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.356 83.2 m-85 -112.52 9.16 19.5 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 118.852 2.908 . . . . 0.0 118.852 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -57.78 0.11 0.06 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 118.51 2.781 . . . . 0.0 118.51 -172.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.4 m -157.25 8.98 0.18 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -132.59 132.13 42.2 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.36 -0.838 . . . . 0.0 109.353 -155.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -138.5 131.04 16.02 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -164.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -90.09 176.09 2.78 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 125.168 3.912 . . . . 0.0 115.006 175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.77 -10.02 72.81 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.657 1.599 . . . . 0.0 116.572 161.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.34 142.39 74.88 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 118.749 1.275 . . . . 0.0 113.45 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -85.71 60.86 5.19 Favored 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 124.86 3.707 . . . . 0.0 114.757 -166.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . 0.456 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 34.0 t30 -96.5 151.29 19.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.08 0.952 . . . . 0.0 110.722 164.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.1 p -77.51 -4.05 43.62 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . 0.456 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 77.5 mtt180 -130.64 149.31 52.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.454 1.502 . . . . 0.0 111.883 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 12.9 pt -134.92 161.73 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.755 2.022 . . . . 0.0 110.141 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -131.52 159.93 36.72 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.81 138.21 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.565 1.546 . . . . 0.0 112.425 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -122.25 168.94 11.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.37 1.468 . . . . 0.0 110.545 170.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 33.0 t30 68.05 40.37 2.25 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.914 1.685 . . . . 0.0 112.533 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.85 153.16 40.01 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.45 -0.782 . . . . 0.0 110.92 171.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.7 154.36 41.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.928 1.291 . . . . 0.0 113.296 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -64.82 -36.31 83.93 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -77.3 -17.24 58.5 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 120.581 1.537 . . . . 0.0 115.097 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.4 p -75.08 151.39 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -165.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -126.02 160.86 28.95 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.869 1.668 . . . . 0.0 111.216 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -53.98 -34.09 58.8 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.408 -1.433 . . . . 0.0 113.46 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -63.8 -20.38 65.74 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -77.51 -43.31 32.52 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.949 0.899 . . . . 0.0 111.72 166.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.1 mp -61.65 -31.29 71.39 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.389 1.075 . . . . 0.0 111.836 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -47.58 -36.89 11.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.267 1.427 . . . . 0.0 113.06 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -62.25 -35.02 77.67 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.027 0.931 . . . . 0.0 112.383 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 4.2 mt -96.26 -58.46 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 121.254 -0.904 . . . . 0.0 110.679 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -57.16 -29.93 64.05 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.16 -14.51 82.52 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 118.43 -1.206 . . . . 0.0 114.619 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -25.1 67.17 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.976 2.388 . . . . 0.0 112.022 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -81.21 5.38 17.17 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.238 1.815 . . . . 0.0 113.19 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 12.7 t -130.52 122.29 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.256 1.823 . . . . 0.0 110.668 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -76.32 103.66 6.44 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -58.44 -16.24 14.18 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 t -82.89 -15.95 49.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.151 0.98 . . . . 0.0 113.021 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 36.1 t -111.24 120.04 40.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.558 1.143 . . . . 0.0 111.617 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -58.02 -48.76 79.09 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.587 -0.696 . . . . 0.0 112.032 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.63 -14.87 2.4 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -92.82 -63.91 1.16 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.851 1.261 . . . . 0.0 110.075 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -25.49 67.92 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.561 1.544 . . . . 0.0 113.361 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.8 tt -57.89 -37.96 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.24 1.416 . . . . 0.0 111.995 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.4 mmm -89.2 0.29 56.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.991 1.716 . . . . 0.0 113.259 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -109.57 132.39 54.19 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -164.43 144.67 7.81 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.527 1.531 . . . . 0.0 111.074 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 5.1 mt -123.81 140.01 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 119.419 1.009 . . . . 0.0 111.373 169.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -121.03 134.54 55.29 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.596 1.558 . . . . 0.0 107.945 154.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 32.1 tp -107.65 91.13 3.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.719 1.247 . . . . 0.0 108.097 166.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -59.43 123.7 17.64 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.66 1.584 . . . . 0.0 110.782 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . 0.304 51.5 mtmt -129.71 35.47 4.18 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -174.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -133.07 148.18 52.19 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.092 0.957 . . . . 0.0 113.565 174.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 69.62 -177.41 30.3 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.58 1.562 . . . . 0.0 114.266 -173.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -15.92 49.26 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.811 -1.406 . . . . 0.0 113.597 177.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 73.4 mtm -87.07 11.2 14.36 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.785 1.634 . . . . 0.0 113.698 171.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -64.83 152.31 43.18 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 119.555 -1.966 . . . . 0.0 111.819 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.35 26.13 52.59 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.152 0.882 . . . . 0.0 112.726 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -121.48 147.37 45.85 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.301 1.041 . . . . 0.0 110.265 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -133.39 148.98 51.84 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -172.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -107.13 139.56 41.37 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 162.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.4 mp -136.88 124.11 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.721 1.208 . . . . 0.0 109.865 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -92.68 146.63 18.24 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 162.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 24.2 mt -126.16 159.61 61.45 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.211 1.404 . . . . 0.0 111.347 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.55 -7.89 19.01 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.991 2.46 . . . . 0.0 115.317 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -150.55 147.59 27.65 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.643 1.177 . . . . 0.0 110.322 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -56.98 -38.98 73.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.564 1.146 . . . . 0.0 111.626 170.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.48 -42.04 95.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.113 0.965 . . . . 0.0 112.878 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.39 -40.39 96.32 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.19 -0.433 . . . . 0.0 111.592 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.98 -44.6 72.57 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.172 0.896 . . . . 0.0 112.832 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.22 83.84 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.869 0.758 . . . . 0.0 111.141 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -64.45 -48.95 73.37 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.154 1.382 . . . . 0.0 112.23 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.11 -32.34 70.9 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 177.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 58.1 mt -68.7 -45.6 71.19 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.105 -0.997 . . . . 0.0 111.341 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -63.22 -33.78 76.23 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.556 0.617 . . . . 0.0 111.837 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.3 -48.0 11.71 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.73 -18.24 45.01 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.21 105.59 1.13 Allowed 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.843 -1.16 . . . . 0.0 110.194 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 111.44 6.05 25.73 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 117.541 -1.7 . . . . 0.0 116.061 -172.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -73.34 126.85 31.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.07 1.935 . . . . 0.0 110.749 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 1.7 t -101.19 48.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 127.002 2.121 . . . . 0.0 114.298 -163.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.8 tp -48.84 123.68 7.36 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.186 1.395 . . . . 0.0 110.308 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.352 62.4 t80 63.92 -2.7 0.52 Allowed 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 107.24 -5.31 35.81 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 125.773 1.654 . . . . 0.0 114.134 -166.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -104.41 119.4 54.0 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 127.686 2.394 . . . . 0.0 111.14 -174.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -79.77 114.88 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.235 2.623 . . . . 0.0 113.137 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 66.5 mtp -73.21 131.32 41.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.112 1.365 . . . . 0.0 112.572 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 56.5 t -91.08 91.0 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.004 1.722 . . . . 0.0 109.38 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.4 t -91.3 125.81 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.93 1.692 . . . . 0.0 111.9 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -142.12 155.94 45.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.671 1.188 . . . . 0.0 113.816 -169.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -63.28 147.35 51.3 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.299 -0.876 . . . . 0.0 112.423 166.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -58.52 157.96 8.28 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -175.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -87.92 -33.68 18.4 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.289 1.436 . . . . 0.0 114.496 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 4.7 t -92.46 19.55 7.12 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.595 1.558 . . . . 0.0 112.576 173.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -61.32 140.82 57.92 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.542 1.137 . . . . 0.0 111.867 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 48.1 ttm-85 -149.14 61.3 5.27 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 124.548 1.139 . . . . 0.0 110.276 167.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.7 151.57 74.66 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.234 2.623 . . . . 0.0 112.954 -171.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -145.82 138.15 25.51 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.69 1.596 . . . . 0.0 110.42 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -82.84 154.54 24.61 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.264 0.626 . . . . 0.0 111.515 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -54.76 146.7 35.04 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 160.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -68.34 167.93 20.9 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.744 2.296 . . . . 0.0 112.138 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.71 178.72 4.59 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.119 0.962 . . . . 0.0 112.966 173.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -123.47 157.68 32.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.392 1.877 . . . . 0.0 110.391 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -70.88 144.5 38.28 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 121.288 -0.883 . . . . 0.0 113.462 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -63.35 141.64 58.69 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.944 1.298 . . . . 0.0 112.317 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -146.09 -19.06 0.45 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -174.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 85.2 tttt . . . . . 0 C--O 1.255 1.362 0 C-N-CA 128.136 2.574 . . . . 0.0 109.502 -174.259 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 88.8 p . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 120.908 0.385 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 23.0 p30 -151.02 -57.91 0.16 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -173.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -150.32 -39.11 0.14 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 128.256 2.622 . . . . 0.0 111.797 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . 0.251 3.4 ptm 67.45 142.41 0.08 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 130.778 3.631 . . . . 0.0 115.114 -175.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.96 144.82 93.64 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.421 2.747 . . . . 0.0 111.925 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 71.2 m -152.15 139.57 19.53 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -148.35 89.06 1.68 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.76 1.624 . . . . 0.0 107.838 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 7.8 p -152.52 155.29 37.16 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.669 1.588 . . . . 0.0 113.333 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.3 tt -75.85 153.16 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.923 0.889 . . . . 0.0 111.994 -163.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 60.4 m -89.05 153.25 21.15 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.405 0.682 . . . . 0.0 110.349 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -61.71 -35.05 76.92 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 118.175 -0.917 . . . . 0.0 112.629 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -41.5 79.63 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 170.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -74.13 -34.31 63.85 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.976 1.311 . . . . 0.0 112.714 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.5 tt -66.76 -50.97 60.99 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.164 1.386 . . . . 0.0 111.661 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -57.62 -26.57 61.74 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.854 1.662 . . . . 0.0 114.792 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -46.61 80.43 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.273 1.029 . . . . 0.0 109.908 171.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -92.63 59.59 2.52 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 127.636 2.541 . . . . 0.0 112.511 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -150.14 157.06 42.72 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.876 1.27 . . . . 0.0 109.837 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.7 pt -136.98 162.57 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.95 1.7 . . . . 0.0 110.791 176.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.7 m -110.09 170.41 8.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.481 1.912 . . . . 0.0 111.154 172.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -43.67 -45.77 7.09 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -170.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.45 -26.0 68.53 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.01 -30.78 20.97 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.306 -0.871 . . . . 0.0 111.55 169.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 13.9 ttm -66.18 -27.53 68.07 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.424 -1.422 . . . . 0.0 113.248 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -85.58 0.88 51.27 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.2 -35.27 6.88 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.25 2.22 . . . . 0.0 116.857 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 3.5 mp -72.83 133.96 44.68 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.261 1.025 . . . . 0.0 111.908 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 78.3 p -62.41 -18.61 62.05 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 173.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.2 m -88.17 -10.84 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -122.83 -10.49 8.25 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -34.73 56.58 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.754 -1.216 . . . . 0.0 113.875 173.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 23.7 p -113.42 -3.58 13.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.286 2.235 . . . . 0.0 114.641 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -134.87 114.44 12.57 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.02 1.728 . . . . 0.0 113.681 -167.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -130.52 120.12 18.68 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -159.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.13 164.76 30.8 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 124.313 3.342 . . . . 0.0 113.114 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 116.28 -1.53 20.72 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 117.075 1.59 . . . . 0.0 117.075 163.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -78.2 145.56 69.13 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.948 1.374 . . . . 0.0 113.992 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.94 103.92 1.78 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.092 3.195 . . . . 0.0 112.015 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -143.13 147.28 34.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.752 1.221 . . . . 0.0 108.515 166.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 19.7 p -81.02 5.76 15.5 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.889 -1.132 . . . . 0.0 113.389 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -137.26 148.71 46.62 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.482 1.913 . . . . 0.0 110.604 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.0 164.65 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 126.678 1.991 . . . . 0.0 109.524 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -136.98 164.44 28.35 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.3 p -143.66 142.33 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.06 1.344 . . . . 0.0 111.543 -176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -118.77 171.03 8.49 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.745 2.018 . . . . 0.0 110.519 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 72.51 25.62 2.67 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.01 157.13 37.4 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.831 -1.168 . . . . 0.0 111.115 172.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -62.46 158.84 16.82 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.425 1.09 . . . . 0.0 113.548 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -68.28 -33.61 74.66 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.507 -0.746 . . . . 0.0 112.445 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -81.47 -40.56 23.09 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.14 155.78 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.884 1.673 . . . . 0.0 115.034 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -128.68 162.09 28.16 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.001 1.32 . . . . 0.0 112.837 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -33.8 57.69 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.81 -1.181 . . . . 0.0 113.237 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -58.05 -34.29 69.93 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.841 1.256 . . . . 0.0 114.213 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -77.46 -29.97 53.0 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -174.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.59 -20.73 66.43 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.923 1.689 . . . . 0.0 112.955 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.75 -17.23 21.29 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.351 0.978 . . . . 0.0 113.233 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -62.64 -36.72 83.73 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.557 1.143 . . . . 0.0 111.613 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 7.2 mt -105.97 -58.09 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.442 0.697 . . . . 0.0 110.089 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -54.67 -36.95 65.17 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.92 -10.58 85.06 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.939 0.781 . . . . 0.0 114.54 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -62.31 -29.11 70.2 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.584 1.692 . . . . 0.0 111.009 172.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -82.76 1.16 40.24 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.047 1.739 . . . . 0.0 115.533 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 32.1 t -132.12 132.14 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.03 1.732 . . . . 0.0 110.12 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -90.14 106.2 18.33 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.68 -0.637 . . . . 0.0 111.964 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -58.39 -18.17 25.96 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 92.3 p -77.52 -21.65 52.35 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 22.7 t -109.09 118.23 36.22 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.578 0.704 . . . . 0.0 110.974 -165.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -58.83 -51.07 71.56 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.307 0.643 . . . . 0.0 112.268 -170.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.37 -16.19 13.65 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.944 2.201 . . . . 0.0 116.944 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -85.65 -58.83 2.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.538 0.685 . . . . 0.0 109.966 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 15.0 ptt85 -75.62 -23.95 56.43 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.624 1.169 . . . . 0.0 113.662 -171.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.7 tt -54.01 -35.17 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.042 1.337 . . . . 0.0 112.442 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.3 mmm -86.07 -10.64 54.6 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.569 1.148 . . . . 0.0 112.83 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.86 109.04 20.85 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -169.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -154.08 149.49 27.21 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.161 1.384 . . . . 0.0 109.946 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 11.4 mt -128.98 134.64 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.372 1.469 . . . . 0.0 110.882 -173.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -116.6 145.33 43.45 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.764 1.226 . . . . 0.0 109.836 158.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.3 tp -125.21 120.22 30.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.943 2.097 . . . . 0.0 109.313 168.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 47.1 mtm -73.19 135.3 44.59 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 125.029 1.332 . . . . 0.0 110.851 166.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -134.12 -4.42 2.74 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -170.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.89 144.64 47.3 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.566 1.546 . . . . 0.0 111.36 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 60.47 -165.17 14.0 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.94 1.257 . . . . 0.0 114.412 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -19.29 48.53 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 96.0 mmm -85.87 1.68 48.89 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -58.98 149.66 26.71 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.651 1.114 . . . . 0.0 112.097 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 76.36 17.74 79.73 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.934 1.254 . . . . 0.0 112.952 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -114.33 134.21 55.12 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 123.803 0.841 . . . . 0.0 113.112 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -135.53 150.89 49.88 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -109.05 141.88 40.56 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.326 1.85 . . . . 0.0 114.013 167.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.4 mp -138.88 127.02 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.358 1.463 . . . . 0.0 109.872 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -91.93 146.87 18.47 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.522 -0.736 . . . . 0.0 112.167 165.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 39.7 mt -127.32 158.24 70.08 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.052 1.341 . . . . 0.0 110.927 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -74.22 -6.31 18.23 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.883 2.389 . . . . 0.0 114.737 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -153.28 146.01 24.31 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.249 -0.907 . . . . 0.0 111.153 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -65.39 -30.16 70.95 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.213 1.005 . . . . 0.0 111.523 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -63.94 -44.71 92.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.746 0.818 . . . . 0.0 113.014 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -60.74 -39.07 87.31 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.11 -0.472 . . . . 0.0 111.374 174.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.35 -47.51 76.18 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.089 0.859 . . . . 0.0 112.595 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.39 80.95 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.782 1.174 . . . . 0.0 112.174 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -67.71 -51.91 43.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.396 1.078 . . . . 0.0 112.164 175.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.48 70.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.953 0.501 . . . . 0.0 112.224 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.9 mt -69.0 -51.08 43.11 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.286 -0.884 . . . . 0.0 111.427 172.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -68.0 -14.91 63.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.865 0.866 . . . . 0.0 112.412 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -94.74 -50.79 5.0 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.705 1.602 . . . . 0.0 115.114 168.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.19 -19.72 42.71 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -173.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.32 100.82 0.86 Allowed 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.978 -1.076 . . . . 0.0 109.35 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 127.15 -5.97 7.26 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.313 -1.27 . . . . 0.0 114.912 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -72.31 129.63 38.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.257 1.529 . . . . 0.0 112.766 -170.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 3.3 t -96.03 110.25 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.444 1.097 . . . . 0.0 112.164 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 44.6 tp -121.22 141.82 50.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.536 1.934 . . . . 0.0 108.105 169.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.421 28.5 t80 61.77 17.83 9.13 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 73.54 15.59 79.16 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.332 1.444 . . . . 0.0 114.272 -168.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -127.4 133.39 25.03 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.165 1.386 . . . . 0.0 112.328 -170.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.36 120.27 6.85 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.182 2.588 . . . . 0.0 112.266 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 66.2 mtp -75.65 129.91 37.91 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.737 1.615 . . . . 0.0 112.089 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.09 73.5 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -171.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 1.4 t -76.56 120.51 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.294 1.038 . . . . 0.0 112.765 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -142.3 161.39 38.15 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.433 1.493 . . . . 0.0 112.92 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -61.53 144.3 54.52 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -55.69 149.79 13.69 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -172.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -75.61 -7.24 53.76 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 12.5 m -58.42 163.11 3.26 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.994 2.117 . . . . 0.0 112.377 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -63.76 102.81 0.49 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.762 0.825 . . . . 0.0 112.141 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -151.27 96.85 3.2 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 126.464 1.906 . . . . 0.0 109.572 -174.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.15 136.26 59.42 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.173 2.582 . . . . 0.0 112.896 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -85.5 137.9 32.58 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.197 0.999 . . . . 0.0 111.74 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -163.23 155.05 17.64 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.88 2.072 . . . . 0.0 111.235 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -53.01 154.44 5.2 Favored Pre-proline 0 CA--C 1.559 1.289 0 C-N-CA 127.486 2.314 . . . . 0.0 116.7 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.35 172.65 15.66 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 124.274 3.316 . . . . 0.0 115.603 -166.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 150.69 21.52 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.599 1.559 . . . . 0.0 114.19 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -79.81 177.02 9.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.677 1.591 . . . . 0.0 113.635 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 78.82 -133.01 12.06 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.361 -0.837 . . . . 0.0 114.94 166.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -147.56 160.93 42.08 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.317 2.247 . . . . 0.0 112.546 -171.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 59.72 28.11 17.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.041 2.136 . . . . 0.0 115.592 170.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 24.5 tptp . . . . . 0 C--O 1.251 1.142 0 C-N-CA 126.671 1.988 . . . . 0.0 111.714 179.878 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -59.6 -20.48 56.14 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -70.1 -27.84 64.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.502 1.521 . . . . 0.0 113.867 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 94.6 mtp -81.77 149.91 64.82 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.783 1.233 . . . . 0.0 112.518 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.96 152.91 46.93 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.289 2.659 . . . . 0.0 112.979 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 94.7 p -93.93 131.31 39.49 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.261 1.424 . . . . 0.0 111.163 168.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -153.03 126.49 8.71 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.344 1.458 . . . . 0.0 109.11 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.3 p -146.56 159.04 43.95 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -170.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.5 tt -76.64 148.29 7.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.974 1.71 . . . . 0.0 110.122 -172.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 39.9 t -80.0 151.1 30.19 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.345 0.593 . . . . 0.0 110.197 164.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -47.23 -43.86 22.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.729 161.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -64.94 -30.05 71.02 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -75.27 -46.09 35.87 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.916 0.886 . . . . 0.0 112.865 167.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 27.5 tp -63.74 -38.19 90.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.749 1.62 . . . . 0.0 112.606 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -57.01 -24.26 52.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.084 1.354 . . . . 0.0 114.261 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -68.46 -20.66 64.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.374 1.07 . . . . 0.0 113.073 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.87 68.7 0.32 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.198 1.856 . . . . 0.0 111.814 174.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -159.23 136.56 9.84 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.048 1.339 . . . . 0.0 109.976 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.9 pt -112.6 150.75 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.682 0.793 . . . . 0.0 111.099 174.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 30.8 m -74.78 160.85 30.19 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.707 1.203 . . . . 0.0 111.666 163.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.38 -25.79 60.06 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.133 -0.979 . . . . 0.0 112.751 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.25 -28.79 69.0 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.113 1.365 . . . . 0.0 113.215 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.35 -30.64 23.51 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.692 -1.255 . . . . 0.0 110.72 167.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 27.3 ttp -62.8 -37.53 87.1 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 120.984 -1.072 . . . . 0.0 111.207 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -84.05 34.57 0.51 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.356 1.462 . . . . 0.0 111.889 170.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.78 -31.42 0.43 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.434 2.294 . . . . 0.0 114.142 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 11.3 mt -74.0 131.92 41.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.002 1.321 . . . . 0.0 111.596 174.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 98.2 p -65.96 -27.67 68.33 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.215 1.406 . . . . 0.0 112.383 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.16 -19.99 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.195 -0.94 . . . . 0.0 112.782 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.261 51.7 m-85 -113.91 12.29 18.07 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 119.133 3.012 . . . . 0.0 119.133 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -14.24 62.62 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 46.7 t -136.73 -39.46 0.63 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.172 1.389 . . . . 0.0 113.227 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -73.29 144.67 46.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -132.95 126.9 19.95 Favored Pre-proline 0 N--CA 1.478 0.948 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -163.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -84.79 -176.69 2.56 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.503 3.468 . . . . 0.0 113.132 164.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 83.41 -26.74 4.39 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.787 1.661 . . . . 0.0 116.712 164.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -60.41 140.83 91.81 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 117.828 0.814 . . . . 0.0 112.999 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.26 104.41 1.9 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.25 3.3 . . . . 0.0 112.826 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -150.25 144.52 25.64 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.373 1.069 . . . . 0.0 110.129 161.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 27.9 p -77.55 8.55 4.19 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.719 -1.238 . . . . 0.0 114.118 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -139.08 142.57 38.13 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.525 1.93 . . . . 0.0 109.463 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 10.7 pt -131.67 165.25 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 126.539 1.936 . . . . 0.0 109.125 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -132.08 162.05 31.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 123.285 1.517 . . . . 0.0 107.994 164.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 9.7 t -124.18 136.9 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 126.035 1.734 . . . . 0.0 109.952 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -115.9 165.84 12.64 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.335 1.454 . . . . 0.0 109.06 169.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 5.6 t30 66.0 35.09 6.59 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.08 0.552 . . . . 0.0 111.731 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -69.62 154.18 42.37 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.286 -0.884 . . . . 0.0 109.938 162.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -56.12 154.7 7.4 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.047 0.939 . . . . 0.0 111.873 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -74.84 -37.75 62.17 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.385 -0.822 . . . . 0.0 111.638 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -70.33 -41.79 72.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.027 1.731 . . . . 0.0 114.124 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.8 p -55.39 148.05 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -112.16 161.65 16.32 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.643 1.177 . . . . 0.0 113.057 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -56.51 -29.62 62.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.475 1.11 . . . . 0.0 113.277 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -64.48 -36.18 83.35 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 174.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.27 -30.79 68.98 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.319 1.448 . . . . 0.0 113.762 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.83 -19.93 62.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.996 1.718 . . . . 0.0 112.633 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.4 -26.49 63.3 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.383 0.992 . . . . 0.0 112.579 176.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -57.98 -37.55 74.42 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.429 0.558 . . . . 0.0 110.917 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.4 mt -95.16 -59.43 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.184 -0.948 . . . . 0.0 111.711 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -58.62 -29.56 66.59 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.04 -16.05 81.09 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.271 0.939 . . . . 0.0 114.469 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -14.32 62.02 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 119.879 1.84 . . . . 0.0 112.817 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -86.66 -4.77 59.22 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.873 2.069 . . . . 0.0 115.633 172.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.18 125.24 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.908 1.683 . . . . 0.0 110.83 -166.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -78.6 105.12 9.67 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.753 -0.592 . . . . 0.0 110.439 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -60.18 -10.83 4.94 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 70.2 m -93.9 -6.67 45.1 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.294 1.038 . . . . 0.0 113.709 172.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 40.0 t -115.22 115.61 26.98 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.345 1.058 . . . . 0.0 110.536 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -58.92 -48.49 81.28 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.721 0.808 . . . . 0.0 112.385 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.1 t -56.79 -16.63 6.92 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -87.9 -60.7 1.9 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.576 0.75 . . . . 0.0 110.03 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.6 ptt85 -72.17 -22.96 61.22 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.139 0.976 . . . . 0.0 112.971 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 18.7 tt -54.83 -41.68 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.824 1.25 . . . . 0.0 112.093 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.8 mtm -83.43 -6.85 59.59 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.761 0.71 . . . . 0.0 112.33 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -100.79 126.4 47.36 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -164.16 151.5 12.02 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.941 2.096 . . . . 0.0 108.28 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 10.5 mt -125.41 134.7 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.757 1.223 . . . . 0.0 110.538 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -133.72 90.3 2.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.899 0.88 . . . . 0.0 112.842 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.02 125.57 31.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.178 1.791 . . . . 0.0 111.273 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 34.9 mtm -79.31 127.01 31.54 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.835 2.454 . . . . 0.0 111.39 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -118.36 -3.41 10.98 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.725 1.61 . . . . 0.0 115.225 -173.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -130.37 148.57 52.21 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.653 1.181 . . . . 0.0 112.768 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 70.34 -159.21 53.57 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.771 1.177 . . . . 0.0 115.046 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -33.13 73.01 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.588 1.155 . . . . 0.0 113.521 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 73.3 mtm -85.96 12.41 9.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -54.81 106.34 0.21 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.157 0.889 . . . . 0.0 110.53 168.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.47 27.23 7.73 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.362 1.458 . . . . 0.0 115.401 -172.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -113.62 154.64 26.86 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.608 1.204 . . . . 0.0 110.131 163.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.57 139.69 21.12 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.462 -1.399 . . . . 0.0 113.973 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -90.68 144.24 25.94 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 166.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.72 122.58 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.118 1.767 . . . . 0.0 110.136 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.0 145.51 17.63 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 164.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 26.1 mt -126.93 156.3 74.29 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.794 1.238 . . . . 0.0 110.867 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.16 -4.32 15.19 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.578 2.852 . . . . 0.0 114.838 -173.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -153.88 130.87 10.99 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.461 1.104 . . . . 0.0 110.564 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -52.9 -38.49 61.8 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.1 1.36 . . . . 0.0 112.507 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -32.64 74.18 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.33 -37.49 74.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.117 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.54 72.31 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.41 1.004 . . . . 0.0 112.151 171.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.7 71.14 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 118.738 0.699 . . . . 0.0 111.914 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -69.9 -48.51 58.34 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.509 1.124 . . . . 0.0 112.96 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.2 -31.34 71.1 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.7 -0.625 . . . . 0.0 112.359 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 76.8 mt -67.31 -36.96 82.57 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.35 -0.844 . . . . 0.0 112.33 173.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -67.21 -33.1 74.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.601 0.76 . . . . 0.0 111.686 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -93.85 -34.05 13.3 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -170.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -91.01 -13.85 32.52 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.091 1.356 . . . . 0.0 113.931 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -65.3 105.94 1.24 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.212 1.005 . . . . 0.0 110.36 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 111.64 0.7 27.58 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.495 -1.17 . . . . 0.0 115.876 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -73.04 129.33 37.85 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 4.9 p -128.38 67.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 124.171 1.938 . . . . 0.0 109.521 -163.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.32 127.67 33.16 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 113.235 -1.802 . . . . 0.0 110.594 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.43 11.2 m-85 58.8 24.44 12.35 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 74.82 3.92 69.51 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.691 1.139 . . . . 0.0 114.422 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -95.37 104.4 15.43 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.025 1.73 . . . . 0.0 108.816 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.75 110.99 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.376 2.051 . . . . 0.0 110.025 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 28.0 mtp -74.13 124.06 25.62 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.748 1.619 . . . . 0.0 111.841 -169.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 97.1 t -90.26 91.92 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.736 1.614 . . . . 0.0 109.492 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.75 123.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 126.12 1.768 . . . . 0.0 112.323 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -153.67 152.19 30.54 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -164.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -61.4 150.14 36.27 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.737 -1.227 . . . . 0.0 111.153 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -59.22 154.13 16.92 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -68.15 25.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 128.835 2.854 . . . . 0.0 118.518 -158.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 3.6 t -62.38 147.55 48.11 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.778 -1.201 . . . . 0.0 111.228 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -59.29 115.96 3.58 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.415 0.686 . . . . 0.0 112.698 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -160.04 106.62 1.41 Allowed Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 126.144 1.778 . . . . 0.0 110.512 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -65.05 -179.69 1.13 Allowed 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 123.731 2.954 . . . . 0.0 112.819 170.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -69.34 62.03 0.14 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.283 -0.886 . . . . 0.0 111.641 157.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -91.71 151.14 20.78 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.753 2.021 . . . . 0.0 109.621 165.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.55 142.23 83.68 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.9 -37.15 95.17 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.917 3.078 . . . . 0.0 114.223 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.17 169.53 21.09 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.921 1.289 . . . . 0.0 110.395 162.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -75.88 -50.5 14.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.365 1.066 . . . . 0.0 113.738 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -95.76 140.3 14.97 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.795 1.188 . . . . 0.0 115.294 -169.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -121.01 146.98 46.12 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.832 1.653 . . . . 0.0 111.796 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.8 -32.18 0.58 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.679 1.192 . . . . 0.0 113.373 174.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 38.3 pttt . . . . . 0 C--O 1.256 1.424 0 C-N-CA 124.544 1.137 . . . . 0.0 112.428 177.936 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -75.73 -16.76 60.1 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -159.47 174.3 14.89 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.2 1.4 . . . . 0.0 112.556 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 55.4 54.87 9.96 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.522 1.929 . . . . 0.0 116.129 175.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.04 156.94 63.68 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.814 3.009 . . . . 0.0 111.348 169.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 64.1 p -148.2 151.16 35.04 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -141.17 140.14 33.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.616 1.567 . . . . 0.0 108.761 164.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 11.1 p -149.15 163.14 38.45 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -171.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.5 tt -74.33 149.63 7.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 125.692 1.597 . . . . 0.0 111.313 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 17.7 m -86.55 152.11 22.91 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -63.36 -29.63 70.9 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.322 -0.861 . . . . 0.0 110.75 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -34.85 75.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.719 1.607 . . . . 0.0 114.64 174.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -78.58 -48.28 15.5 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.397 0.679 . . . . 0.0 111.636 170.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 16.5 tp -57.53 -37.66 73.4 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -57.41 -25.65 59.9 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.124 1.37 . . . . 0.0 113.941 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -73.99 -20.07 60.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.859 1.264 . . . . 0.0 112.506 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -120.36 63.94 0.47 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.532 2.015 . . . . 0.0 112.327 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -151.14 143.59 24.24 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.738 1.615 . . . . 0.0 110.006 -176.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 18.2 pt -125.04 163.08 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 44.6 t -110.54 172.43 6.87 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.691 1.596 . . . . 0.0 110.36 165.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 32.5 mtt-85 -49.96 -30.42 10.38 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.852 1.261 . . . . 0.0 113.899 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.25 -13.79 21.23 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 125.989 1.715 . . . . 0.0 113.187 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -123.1 -37.3 2.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.051 1.74 . . . . 0.0 112.289 167.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 53.7 ttp -61.18 -40.17 92.9 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.707 -1.246 . . . . 0.0 111.551 -176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.24 2.36 28.26 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.461 -0.774 . . . . 0.0 112.177 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.59 -34.28 10.29 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.415 2.286 . . . . 0.0 113.771 169.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 29.8 mt -77.88 129.07 34.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.363 1.865 . . . . 0.0 113.06 -174.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 88.4 p -58.17 -33.31 69.1 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.168 -0.958 . . . . 0.0 113.58 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.4 m -64.07 -12.64 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 175.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -125.64 14.89 8.14 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -61.28 -23.42 65.67 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.9 t -135.85 -16.15 1.75 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.096 0.958 . . . . 0.0 113.292 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -71.88 144.31 49.07 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -141.45 124.59 9.75 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -169.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.32 -176.49 3.29 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.785 2.99 . . . . 0.0 112.841 171.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 76.15 -4.83 45.68 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.779 1.872 . . . . 0.0 117.779 165.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -72.38 148.13 90.58 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 118.98 1.39 . . . . 0.0 113.384 174.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.39 110.58 3.13 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.775 2.983 . . . . 0.0 113.872 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . 0.424 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 40.6 t30 -157.01 154.77 30.13 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.254 1.822 . . . . 0.0 109.478 161.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 27.4 p -80.43 -3.52 50.15 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . 0.424 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 69.9 mtt180 -130.64 150.85 51.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.931 1.692 . . . . 0.0 110.408 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.4 pt -131.06 160.99 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.387 1.875 . . . . 0.0 109.965 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -135.11 162.09 33.48 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 173.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.9 t -136.35 135.36 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 125.673 1.589 . . . . 0.0 112.056 -174.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -117.61 169.03 9.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.44 1.896 . . . . 0.0 108.395 168.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.26 13.1 m-20 68.13 29.73 6.1 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -171.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.66 143.43 40.11 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 119.868 -1.77 . . . . 0.0 110.535 166.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.52 25.82 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 118.418 2.747 . . . . 0.0 118.418 -165.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp 59.58 -65.6 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 128.703 2.801 . . . . 0.0 113.863 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -58.16 -41.38 83.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.325 1.85 . . . . 0.0 113.89 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 9.1 p -51.12 140.76 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.291 1.037 . . . . 0.0 113.526 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -104.12 157.76 16.9 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.061 0.945 . . . . 0.0 113.102 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -61.02 -26.78 67.85 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.797 -1.814 . . . . 0.0 112.77 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -70.7 -22.05 62.5 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -74.41 -33.82 63.1 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.524 1.129 . . . . 0.0 112.97 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.6 mp -73.64 -23.79 59.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.193 1.797 . . . . 0.0 113.733 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -56.59 -28.78 61.11 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 118.842 0.747 . . . . 0.0 110.876 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -57.68 -33.22 68.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.758 1.623 . . . . 0.0 111.854 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.7 mt -98.33 -58.24 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.361 -0.837 . . . . 0.0 110.795 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -59.59 -25.91 64.99 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -80.74 -7.61 88.38 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.766 1.174 . . . . 0.0 114.379 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 36.7 ttp85 -61.03 -23.8 65.69 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.946 1.873 . . . . 0.0 112.049 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -95.72 2.16 53.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.026 2.131 . . . . 0.0 112.594 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.8 110.39 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.035 1.734 . . . . 0.0 110.701 -172.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -71.41 90.17 0.95 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.281 53.7 m-85 -58.32 -24.05 58.46 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 119.307 3.077 . . . . 0.0 119.307 -171.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.5 m -64.96 -22.48 67.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 17.4 m -101.08 122.66 43.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.122 1.369 . . . . 0.0 112.816 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -55.65 -48.46 74.97 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.453 -0.78 . . . . 0.0 112.181 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 2.8 t -54.05 -18.01 3.21 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -88.21 -63.64 1.27 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.592 0.757 . . . . 0.0 110.778 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -65.08 -29.57 70.46 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.696 1.198 . . . . 0.0 112.2 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.0 tt -58.02 -32.92 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.246 1.419 . . . . 0.0 112.679 173.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 9.1 mmm -84.93 -10.25 57.27 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.097 0.959 . . . . 0.0 112.499 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -105.85 135.03 48.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.136 1.774 . . . . 0.0 115.092 -172.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -168.0 145.16 4.2 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.984 1.314 . . . . 0.0 108.464 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.3 mt -117.13 132.52 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.738 1.215 . . . . 0.0 110.087 174.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -121.23 122.8 40.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.695 1.198 . . . . 0.0 109.976 166.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 3.3 tt -107.58 123.52 48.57 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.145 1.378 . . . . 0.0 110.352 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 45.7 mtm -79.88 130.51 35.36 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.117 1.367 . . . . 0.0 111.973 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -118.04 -7.03 10.9 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.851 1.66 . . . . 0.0 114.472 -168.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -117.25 154.67 30.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.533 1.133 . . . . 0.0 112.061 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 57.89 -142.12 44.28 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 161.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 29.0 tpt85 -57.67 -31.56 66.44 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.01 2.124 . . . . 0.0 115.11 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 20.8 mtm -111.44 18.79 18.83 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.065 1.346 . . . . 0.0 113.791 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -57.5 112.53 1.45 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.089 -1.007 . . . . 0.0 110.813 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 91.05 24.0 28.36 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 124.384 0.992 . . . . 0.0 114.805 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -112.32 155.65 23.75 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.668 1.187 . . . . 0.0 110.619 165.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -148.35 153.51 38.71 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -116.29 141.33 48.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.064 1.745 . . . . 0.0 115.346 170.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.3 124.02 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.275 1.43 . . . . 0.0 110.704 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -90.87 147.55 18.99 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.33 0.49 . . . . 0.0 112.028 163.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 19.3 mt -128.01 160.69 60.2 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.866 1.266 . . . . 0.0 111.105 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.58 -5.23 16.29 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.318 2.679 . . . . 0.0 115.05 -173.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -157.9 146.25 18.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.515 1.526 . . . . 0.0 109.993 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -56.38 -32.78 65.11 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.416 -0.802 . . . . 0.0 112.81 166.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -56.98 -44.69 82.92 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.417 -0.802 . . . . 0.0 113.163 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -64.16 -38.3 90.56 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.435 0.694 . . . . 0.0 111.097 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.83 -43.91 82.49 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.319 0.963 . . . . 0.0 112.25 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.67 85.32 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.197 0.908 . . . . 0.0 112.312 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -70.96 -46.73 61.86 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.316 1.047 . . . . 0.0 112.306 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.57 72.13 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 45.7 mt -66.25 -47.58 73.27 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.246 -0.909 . . . . 0.0 110.229 173.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -30.64 71.69 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.586 0.63 . . . . 0.0 112.242 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -84.77 -40.23 17.5 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -91.89 -22.47 20.05 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -67.12 106.58 2.03 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.871 -1.143 . . . . 0.0 109.498 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 120.88 -8.46 10.69 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.89 1.233 . . . . 0.0 115.579 -171.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -73.22 129.28 37.7 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.44 1.62 . . . . 0.0 109.169 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.305 7.3 p -115.44 55.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 124.183 1.944 . . . . 0.0 110.871 -163.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 26.2 tp -48.01 123.84 6.75 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.442 2.697 . . . . 0.0 111.475 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.307 68.7 m-85 55.08 8.39 0.24 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -174.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 101.67 0.52 52.75 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.994 1.283 . . . . 0.0 115.251 -173.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -107.35 113.6 61.81 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.202 1.501 . . . . 0.0 110.471 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.0 115.45 4.36 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 122.397 2.064 . . . . 0.0 110.23 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 32.4 mtp -75.19 129.15 37.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.812 1.645 . . . . 0.0 111.957 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.5 t -87.95 94.47 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.384 1.073 . . . . 0.0 109.035 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.57 123.35 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.05 1.74 . . . . 0.0 111.856 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -149.95 156.15 41.23 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.724 0.81 . . . . 0.0 112.291 -167.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -56.89 144.78 32.15 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.396 -0.815 . . . . 0.0 109.787 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -55.83 147.07 19.96 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -173.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -71.84 145.51 48.56 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.567 -168.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 50.2 m 66.98 9.27 6.75 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.465 2.306 . . . . 0.0 115.791 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -69.54 153.76 43.01 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.471 -0.768 . . . . 0.0 110.68 161.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 45.3 mtp180 -115.71 45.61 0.43 Allowed Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 125.165 1.386 . . . . 0.0 114.233 -176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.38 -31.5 34.63 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.629 2.219 . . . . 0.0 114.173 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -129.28 -33.92 1.89 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.277 1.431 . . . . 0.0 113.797 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -149.79 148.78 29.6 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.66 1.984 . . . . 0.0 112.089 -168.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -66.54 143.13 98.03 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 172.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -71.51 156.32 58.26 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.031 2.488 . . . . 0.0 113.146 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 153.42 43.07 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 171.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -58.7 -36.06 73.63 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.476 1.51 . . . . 0.0 114.665 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 83.47 -166.37 43.63 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.357 0.98 . . . . 0.0 113.67 -173.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -150.77 123.69 8.69 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.899 1.68 . . . . 0.0 109.225 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -67.36 143.66 56.23 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.253 1.268 0 C-N-CA 127.874 2.469 . . . . 0.0 110.937 167.885 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -72.41 -77.89 0.09 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.784 2.034 . . . . 0.0 115.049 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.61 -15.26 21.65 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.914 1.285 . . . . 0.0 113.937 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 62.7 mtp -96.27 160.37 29.93 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 126.073 1.749 . . . . 0.0 109.042 162.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.58 155.56 20.98 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.732 2.955 . . . . 0.0 114.125 -172.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 40.0 t -62.77 123.35 18.22 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 122.673 0.389 . . . . 0.0 110.689 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -137.72 95.92 3.14 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 123.128 1.442 . . . . 0.0 110.933 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.8 p -154.51 155.16 34.35 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.543 1.137 . . . . 0.0 112.527 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.4 tt -70.94 155.37 7.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 125.139 1.376 . . . . 0.0 110.53 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 30.2 t -86.66 150.67 24.03 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 121.442 -0.787 . . . . 0.0 110.756 161.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -43.96 -39.54 4.11 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.531 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -46.25 86.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -79.6 -33.7 41.36 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.031 0.933 . . . . 0.0 112.91 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.17 -48.61 80.99 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.252 1.421 . . . . 0.0 111.192 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -57.6 -23.29 50.09 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.866 1.266 . . . . 0.0 114.363 -176.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -65.42 -25.91 67.74 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.983 1.313 . . . . 0.0 113.042 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.51 89.28 0.46 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.66 1.6 . . . . 0.0 109.946 173.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -167.01 131.75 2.02 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.799 1.239 . . . . 0.0 109.334 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.2 pt -109.42 155.93 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.11 165.6 13.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.08 1.752 . . . . 0.0 110.575 161.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -57.3 -33.59 67.84 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.127 1.371 . . . . 0.0 111.442 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -59.92 -35.28 74.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.853 1.261 . . . . 0.0 113.272 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -79.74 -40.23 29.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.419 0.688 . . . . 0.0 110.602 167.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 31.3 ttm -55.28 -42.41 73.57 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.151 -0.968 . . . . 0.0 112.486 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -79.81 -14.24 58.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.034 0.934 . . . . 0.0 112.974 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.31 -37.27 45.09 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.95 1.7 . . . . 0.0 111.14 168.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 65.3 mt -77.31 121.16 23.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.658 1.583 . . . . 0.0 112.579 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 55.9 p -56.12 -29.64 60.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.233 1.013 . . . . 0.0 113.296 168.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.2 m -63.48 -31.92 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 175.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.311 58.6 m-85 -85.29 -5.66 59.3 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 -175.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -57.75 -16.01 9.84 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 -160.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.9 t -127.37 6.42 6.35 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.626 1.17 . . . . 0.0 113.096 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -129.16 133.73 47.73 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.831 -1.168 . . . . 0.0 107.85 -160.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -147.39 123.31 5.41 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -168.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.99 -173.45 1.88 Allowed 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.946 3.098 . . . . 0.0 112.934 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 99.37 -18.43 56.41 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 116.376 1.311 . . . . 0.0 116.376 170.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -76.59 155.8 83.32 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 118.682 1.241 . . . . 0.0 113.142 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -90.56 113.78 0.46 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.586 3.524 . . . . 0.0 113.768 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -154.29 147.54 24.84 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.636 1.175 . . . . 0.0 109.7 168.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 19.9 p -78.64 11.83 2.36 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.158 -1.589 . . . . 0.0 114.074 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -142.94 146.67 34.2 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.984 2.114 . . . . 0.0 109.063 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 19.0 pt -129.23 167.86 23.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 125.426 1.49 . . . . 0.0 109.606 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -145.57 162.61 37.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.94 139.83 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.782 1.233 . . . . 0.0 111.982 -170.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -119.11 165.81 13.71 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.934 1.693 . . . . 0.0 109.837 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 8.4 t30 64.18 45.78 3.88 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.71 1.204 . . . . 0.0 111.915 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.54 153.31 29.61 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.313 -0.867 . . . . 0.0 111.445 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.32 169.8 8.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.334 1.454 . . . . 0.0 114.502 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -70.23 -48.12 58.38 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.139 -0.976 . . . . 0.0 112.924 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -72.91 -25.23 60.98 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.4 1.48 . . . . 0.0 114.209 -176.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.7 p -69.4 146.49 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -123.36 162.08 23.43 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.419 1.888 . . . . 0.0 110.538 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.38 -29.89 59.32 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.61 -1.306 . . . . 0.0 112.72 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -60.19 -35.44 75.4 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.03 -33.39 70.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.111 0.964 . . . . 0.0 112.918 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.3 mp -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.481 1.512 . . . . 0.0 112.533 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -55.51 -31.34 61.96 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.075 0.852 . . . . 0.0 112.848 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -61.78 -29.98 70.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.741 0.816 . . . . 0.0 110.792 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.92 -55.27 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 121.227 -0.92 . . . . 0.0 110.783 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.253 50.2 m-85 -62.66 -23.84 67.31 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.25 -15.69 81.29 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.015 0.817 . . . . 0.0 114.069 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 38.0 ttp85 -59.52 -25.93 64.9 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.331 1.452 . . . . 0.0 112.849 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -90.2 -0.22 57.51 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.229 1.812 . . . . 0.0 111.676 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 15.2 t -120.92 116.14 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.326 1.85 . . . . 0.0 110.654 -173.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -79.85 97.43 6.67 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.845 0.858 . . . . 0.0 110.761 -175.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.286 58.5 m-85 -62.44 -11.68 17.37 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 119.064 2.987 . . . . 0.0 119.064 -173.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 72.6 m -75.95 -6.73 52.31 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 168.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 47.3 t -116.68 113.42 22.62 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.053 1.741 . . . . 0.0 110.715 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -59.77 -47.22 86.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.845 -0.535 . . . . 0.0 110.975 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -17.02 6.96 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -86.11 -64.9 1.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.801 0.81 . . . . 0.0 109.472 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -68.01 -23.22 64.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.909 1.284 . . . . 0.0 113.889 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.3 tt -56.2 -40.03 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.081 1.352 . . . . 0.0 111.911 172.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -8.85 59.62 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.287 1.035 . . . . 0.0 112.244 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -100.5 125.14 46.8 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -173.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -162.58 155.12 19.23 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.843 1.657 . . . . 0.0 107.767 172.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 4.5 mt -115.95 146.7 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.558 1.143 . . . . 0.0 109.85 174.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -128.05 137.5 52.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.569 1.148 . . . . 0.0 109.72 161.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.1 tp -120.4 136.6 54.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.457 1.503 . . . . 0.0 109.644 168.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 41.8 mtm -91.05 127.97 36.68 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.853 1.661 . . . . 0.0 110.664 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -113.57 -1.79 13.99 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.003 1.721 . . . . 0.0 114.229 -170.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -151.85 -169.86 3.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.787 1.635 . . . . 0.0 111.572 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.36 -163.22 46.21 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.143 0.878 . . . . 0.0 114.484 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -68.95 -11.93 61.16 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.569 1.948 . . . . 0.0 115.344 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 18.0 ptm -137.2 43.23 2.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.759 1.224 . . . . 0.0 112.841 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -52.7 127.69 23.95 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.68 1.192 . . . . 0.0 110.645 168.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 77.61 34.76 38.5 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.423 1.011 . . . . 0.0 112.286 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -120.91 150.69 40.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.132 0.973 . . . . 0.0 112.466 164.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -138.7 157.17 46.61 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.672 1.589 . . . . 0.0 113.49 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -120.33 144.09 48.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.549 1.939 . . . . 0.0 115.079 166.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.91 119.75 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.388 1.475 . . . . 0.0 110.93 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -82.23 137.98 17.84 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.365 -0.834 . . . . 0.0 111.285 162.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 24.2 mt -118.2 160.95 37.3 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.756 1.222 . . . . 0.0 110.112 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 -6.57 15.73 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.092 1.862 . . . . 0.0 114.983 -172.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -156.37 143.99 19.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.506 1.523 . . . . 0.0 110.351 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -51.64 -36.96 48.2 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.789 1.636 . . . . 0.0 112.341 165.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -61.42 -40.38 94.21 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.276 1.03 . . . . 0.0 112.853 174.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.56 -39.32 91.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.118 0.567 . . . . 0.0 110.723 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.68 87.38 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.922 -0.486 . . . . 0.0 112.107 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.26 -43.53 78.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.981 0.81 . . . . 0.0 112.16 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -75.76 -45.08 38.37 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.82 1.248 . . . . 0.0 112.855 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.39 -33.83 73.04 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.626 0.648 . . . . 0.0 112.729 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 38.3 mt -67.8 -46.55 71.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.85 0.75 . . . . 0.0 110.915 172.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -64.49 -32.76 74.53 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 119.114 -0.47 . . . . 0.0 111.322 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -82.8 -54.67 4.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.17 -17.86 61.91 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.38 102.59 0.14 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.167 1.387 . . . . 0.0 111.965 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 105.18 -0.77 40.76 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 118.149 -1.361 . . . . 0.0 115.754 -175.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.63 128.75 37.15 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.556 1.678 . . . . 0.0 112.84 -173.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.314 1.4 t -93.55 49.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -163.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 58.9 tp -57.91 122.42 12.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.663 1.585 . . . . 0.0 111.677 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.403 56.4 m-85 59.16 20.3 8.3 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -175.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 83.16 13.47 76.95 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.335 0.969 . . . . 0.0 114.198 -172.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -119.78 119.86 30.92 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.042 1.337 . . . . 0.0 110.616 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.9 114.59 4.08 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.064 2.509 . . . . 0.0 111.003 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 63.1 mtp -74.72 134.78 41.85 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.529 1.132 . . . . 0.0 111.952 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.47 100.15 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.473 1.509 . . . . 0.0 108.458 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.93 132.38 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.019 1.728 . . . . 0.0 112.993 -170.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -150.43 156.77 42.1 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -170.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -56.16 144.71 28.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.793 0.837 . . . . 0.0 109.346 170.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -63.04 141.29 58.82 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.23 -0.919 . . . . 0.0 113.145 -176.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.1 119.31 23.87 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.652 1.181 . . . . 0.0 111.333 173.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 80.1 p -162.98 155.65 18.9 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 127.781 2.432 . . . . 0.0 109.681 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -77.58 37.42 0.22 Allowed 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -165.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -148.6 66.53 9.08 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 125.402 1.481 . . . . 0.0 112.661 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -67.67 150.55 79.5 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.435 2.757 . . . . 0.0 113.358 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -69.88 153.86 42.72 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.199 1.0 . . . . 0.0 111.687 172.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -49.22 155.67 0.66 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 122.097 0.951 . . . . 0.0 112.2 161.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -66.21 148.35 98.5 Favored Pre-proline 0 CA--C 1.555 1.149 0 O-C-N 121.203 -0.935 . . . . 0.0 112.755 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -81.98 -153.99 0.05 OUTLIER 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 125.169 3.913 . . . . 0.0 113.048 -174.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -84.55 167.76 16.03 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.107 1.363 . . . . 0.0 114.002 -174.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -65.18 154.88 36.74 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.995 1.318 . . . . 0.0 110.966 168.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -83.49 -133.99 2.34 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.378 0.99 . . . . 0.0 113.992 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.27 119.55 10.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.009 0.924 . . . . 0.0 112.03 -171.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 22.1 tpp85 -89.81 -15.47 32.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.202 1.401 . . . . 0.0 113.196 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 45.7 pttt . . . . . 0 C--O 1.251 1.162 0 CA-C-O 117.134 -1.412 . . . . 0.0 112.803 168.884 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . 0.303 74.8 m-20 71.43 -15.76 0.41 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 119.442 3.126 . . . . 0.0 119.442 169.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -93.05 -32.29 14.53 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.872 0.869 . . . . 0.0 112.538 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 90.8 mmm 60.39 146.69 0.07 OUTLIER Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 128.878 2.871 . . . . 0.0 116.836 170.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.99 -13.52 15.73 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.33 2.687 . . . . 0.0 114.678 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 97.9 p -68.94 162.91 25.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.644 1.178 . . . . 0.0 110.938 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -144.74 110.54 5.37 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.745 0.818 . . . . 0.0 111.706 -171.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 8.8 m -155.14 161.28 41.28 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.41 1.884 . . . . 0.0 112.568 171.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.5 tt -67.94 140.88 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 124.222 1.009 . . . . 0.0 110.892 -170.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 70.5 m -82.68 160.44 22.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.998 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -63.64 -33.2 75.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 118.889 -0.576 . . . . 0.0 111.809 -174.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -62.47 -55.72 24.91 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.67 0.788 . . . . 0.0 112.964 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -62.06 -38.37 88.51 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.25 -44.64 83.1 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -60.67 -21.16 62.52 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -61.29 -46.29 90.94 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.178 1.391 . . . . 0.0 111.892 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.9 75.55 0.39 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.477 1.037 . . . . 0.0 111.999 -170.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 6.1 ttp85 -155.5 152.97 29.54 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.212 1.005 . . . . 0.0 110.97 -173.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.6 pt -130.94 155.06 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.9 0.88 . . . . 0.0 112.031 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 74.5 p -86.65 172.12 10.47 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.321 1.048 . . . . 0.0 111.456 169.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -55.18 -32.92 62.55 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.567 -0.708 . . . . 0.0 111.43 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.12 -25.72 67.89 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.88 -32.05 14.74 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.767 0.712 . . . . 0.0 110.803 166.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 16.0 ttm -66.55 -42.26 87.41 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.444 -1.41 . . . . 0.0 112.598 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -78.43 12.48 1.96 Allowed 'General case' 0 CA--C 1.552 1.042 0 O-C-N 120.973 -1.079 . . . . 0.0 111.573 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -125.03 -30.31 3.24 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.116 2.166 . . . . 0.0 116.006 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 1.7 mp -75.7 130.67 39.08 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.916 -1.115 . . . . 0.0 109.753 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 38.1 m -66.07 -20.65 66.24 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 1.3 m -57.19 -25.91 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 167.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.15 21.22 17.02 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -63.87 -22.52 66.96 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.238 -1.539 . . . . 0.0 114.78 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 78.0 p -139.97 -19.49 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.741 1.616 . . . . 0.0 113.365 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.18 135.89 41.06 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -141.95 132.05 12.65 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -85.26 175.77 6.2 Favored 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.283 3.322 . . . . 0.0 113.683 168.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.26 -3.39 72.54 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 117.894 1.918 . . . . 0.0 117.894 165.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -81.7 144.37 52.26 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 119.096 1.448 . . . . 0.0 113.996 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.17 86.21 1.7 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.148 3.232 . . . . 0.0 112.686 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . 0.495 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 30.9 t30 -133.55 151.44 51.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.28 1.432 . . . . 0.0 110.257 165.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 24.2 p -82.07 -9.2 59.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . 0.495 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 82.7 mtt-85 -121.61 150.52 41.58 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.944 1.298 . . . . 0.0 110.629 177.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 19.7 pt -135.02 158.84 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.638 1.975 . . . . 0.0 110.37 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -133.79 158.11 44.18 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.24 131.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.246 1.418 . . . . 0.0 113.614 -171.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -108.63 172.66 6.71 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.262 1.425 . . . . 0.0 110.63 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.283 88.6 m-20 71.67 32.91 1.89 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.645 1.978 . . . . 0.0 116.029 -176.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.49 147.2 25.48 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.175 -0.953 . . . . 0.0 111.73 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.67 161.72 22.74 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.149 1.779 . . . . 0.0 115.109 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -67.14 -39.85 86.63 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.664 -1.272 . . . . 0.0 112.681 166.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -73.1 -27.83 61.93 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.752 1.621 . . . . 0.0 114.798 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.01 146.43 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -128.23 164.05 23.39 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.889 1.276 . . . . 0.0 112.584 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -33.99 68.21 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.63 -1.294 . . . . 0.0 113.021 -174.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -54.22 -30.82 51.43 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.191 1.797 . . . . 0.0 115.297 170.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -83.43 -34.18 25.52 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.877 1.671 . . . . 0.0 113.6 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.06 -22.32 66.88 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.323 1.049 . . . . 0.0 111.973 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -20.18 44.63 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -67.29 -30.52 70.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.83 0.741 . . . . 0.0 111.843 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.83 -55.47 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.27 -0.894 . . . . 0.0 110.46 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -57.61 -30.07 65.03 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.36 -12.07 82.14 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 123.997 0.808 . . . . 0.0 114.602 174.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 5.4 ttt85 -58.83 -27.89 65.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.334 1.567 . . . . 0.0 110.85 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -95.66 18.26 13.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.241 1.816 . . . . 0.0 113.558 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 27.3 t -140.54 124.56 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.099 1.76 . . . . 0.0 111.223 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -77.23 110.07 11.63 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -61.71 -12.42 16.51 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 118.178 2.658 . . . . 0.0 118.178 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 16.5 m -88.83 -18.95 26.6 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.455 0.702 . . . . 0.0 112.676 174.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 28.9 t -108.63 112.54 24.93 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.758 1.223 . . . . 0.0 111.754 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -54.11 -50.64 66.41 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.228 0.611 . . . . 0.0 111.016 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.45 -12.77 1.85 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -93.17 -61.76 1.51 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.978 1.311 . . . . 0.0 110.692 172.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -69.3 -20.41 63.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.796 1.239 . . . . 0.0 113.784 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.08 -28.97 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.773 1.629 . . . . 0.0 112.69 169.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 37.5 mtp -85.86 -13.1 48.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.958 1.303 . . . . 0.0 111.761 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -108.32 117.32 33.84 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -163.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -159.2 154.54 25.55 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.891 1.676 . . . . 0.0 110.065 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 8.4 mt -130.63 142.21 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.189 1.396 . . . . 0.0 110.797 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -123.37 142.64 50.76 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.028 1.331 . . . . 0.0 110.283 160.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 11.2 tp -133.47 115.68 15.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.842 2.057 . . . . 0.0 109.134 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 45.8 mtm -71.27 144.62 49.96 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 124.602 1.161 . . . . 0.0 111.751 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -128.64 -6.93 5.14 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -172.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.96 145.1 35.57 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.824 1.193 . . . . 0.0 114.122 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 75.37 -177.16 49.29 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.096 1.331 . . . . 0.0 113.216 -172.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -18.72 61.68 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -170.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 70.4 mtp -89.12 3.17 52.72 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -58.52 145.63 38.39 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.533 -1.354 . . . . 0.0 111.131 175.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.54 27.66 70.84 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.749 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -126.83 146.04 50.42 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.727 1.211 . . . . 0.0 111.339 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -137.07 155.26 49.87 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -167.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -125.71 134.0 51.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.678 1.991 . . . . 0.0 115.307 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.94 125.05 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.974 1.709 . . . . 0.0 109.952 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.07 137.62 14.27 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 162.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 25.2 mt -118.18 160.45 39.25 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.515 1.526 . . . . 0.0 109.26 173.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.03 -8.96 20.5 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.139 1.226 . . . . 0.0 114.642 -170.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -153.47 142.38 21.16 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.72 1.208 . . . . 0.0 111.059 -172.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -60.24 -37.19 79.63 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.389 -0.819 . . . . 0.0 111.147 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -65.25 -32.35 73.97 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.311 0.644 . . . . 0.0 112.591 176.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -73.58 -35.5 65.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.084 0.554 . . . . 0.0 111.777 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.97 -45.14 86.92 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.359 0.981 . . . . 0.0 111.696 168.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.56 77.83 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.767 1.167 . . . . 0.0 112.263 176.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.33 -50.97 61.78 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.207 1.403 . . . . 0.0 112.545 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.54 -33.53 72.8 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.862 0.865 . . . . 0.0 112.118 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 45.6 mt -71.19 -36.87 72.11 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.927 1.291 . . . . 0.0 111.521 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -67.28 -22.99 65.63 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.513 1.125 . . . . 0.0 112.698 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -112.15 -33.04 6.36 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -171.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -84.83 -17.54 37.73 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -66.56 109.29 2.73 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.263 1.025 . . . . 0.0 111.672 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 104.57 4.41 43.13 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 118.061 -1.41 . . . . 0.0 115.976 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -70.4 123.66 22.3 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.704 1.752 . . . . 0.0 110.956 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.27 2.0 t -92.31 52.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.196 1.398 . . . . 0.0 114.416 -163.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.08 126.01 25.82 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.739 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . . 4.9 t80 53.79 35.91 22.67 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.579 1.952 . . . . 0.0 110.14 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 76.89 11.53 85.4 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.664 -1.272 . . . . 0.0 115.068 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -127.11 123.35 23.43 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 119.253 1.526 . . . . 0.0 111.11 -176.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.2 118.15 5.41 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.566 2.177 . . . . 0.0 111.648 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 72.1 mtp -69.14 126.06 28.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.693 1.197 . . . . 0.0 112.304 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -86.23 83.11 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.674 1.589 . . . . 0.0 113.422 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 1.6 t -85.86 122.61 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.398 1.479 . . . . 0.0 112.895 -175.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -145.95 155.6 42.95 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.954 1.301 . . . . 0.0 111.693 -174.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -60.35 144.28 51.08 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.937 -1.102 . . . . 0.0 110.796 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -57.73 160.47 4.44 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -71.72 68.11 0.6 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.615 1.966 . . . . 0.0 112.817 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 29.9 m -146.04 161.59 39.77 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.959 2.104 . . . . 0.0 111.149 -167.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -68.03 137.08 54.79 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.528 -0.733 . . . . 0.0 111.478 170.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.93 45.14 1.22 Allowed Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -170.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -58.89 156.06 35.2 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.003 2.469 . . . . 0.0 112.618 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -49.33 142.91 6.93 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.087 1.355 . . . . 0.0 113.564 -172.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -155.72 118.54 4.24 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.397 1.479 . . . . 0.0 109.231 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -67.88 147.1 98.54 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 170.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -73.88 179.75 5.38 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.652 2.901 . . . . 0.0 111.423 166.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.29 162.7 2.59 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.896 1.331 . . . . 0.0 114.047 173.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.88 123.53 18.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.785 1.634 . . . . 0.0 113.461 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -83.05 -13.26 77.8 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.956 1.265 . . . . 0.0 115.216 -177.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -65.63 130.66 44.09 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.334 1.453 . . . . 0.0 111.219 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.42 136.45 53.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.913 0.885 . . . . 0.0 112.397 171.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 32.9 tttm . . . . . 0 C--O 1.254 1.325 0 C-N-CA 125.292 1.437 . . . . 0.0 110.184 163.952 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -79.72 -57.69 3.54 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 172.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -158.89 145.77 17.25 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.267 1.427 . . . . 0.0 110.17 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 92.2 mtp 63.23 167.99 0.1 Allowed Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 127.156 2.183 . . . . 0.0 115.3 -177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -72.95 -10.94 25.24 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.077 2.518 . . . . 0.0 115.646 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.6 p -78.0 48.74 0.74 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.734 2.014 . . . . 0.0 114.046 -173.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -78.07 61.22 2.57 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.812 1.645 . . . . 0.0 111.361 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 14.7 p -150.22 149.61 30.43 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.92 1.288 . . . . 0.0 114.332 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.5 tt -76.08 153.04 6.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 125.795 1.638 . . . . 0.0 111.516 -167.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 33.9 t -83.54 156.6 22.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.386 0.612 . . . . 0.0 110.745 165.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -53.92 -36.01 62.3 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.491 0.717 . . . . 0.0 111.029 163.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -45.4 86.78 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -71.1 -35.17 71.72 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.546 0.738 . . . . 0.0 112.85 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.431 HD13 ' CD2' ' A' ' 489' ' ' TYR . 31.4 tp -67.76 -44.68 76.9 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -54.91 -24.19 22.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.816 1.246 . . . . 0.0 114.03 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.68 -29.29 69.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.126 1.371 . . . . 0.0 112.855 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.22 97.94 0.76 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.436 1.017 . . . . 0.0 111.521 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -159.8 152.22 21.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.448 1.099 . . . . 0.0 110.635 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.44 150.21 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.428 0.632 . . . . 0.0 112.68 168.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 39.9 m -98.22 169.45 9.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.66 1.584 . . . . 0.0 111.694 168.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -54.57 -23.71 17.93 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -171.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -72.16 -28.43 63.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.798 0.839 . . . . 0.0 112.81 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.79 -32.9 14.49 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.527 1.131 . . . . 0.0 111.094 171.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 35.8 ttm -58.08 -46.3 85.69 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.08 -1.013 . . . . 0.0 111.239 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -85.04 37.16 0.65 Allowed 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.385 -0.822 . . . . 0.0 111.363 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.44 -37.52 0.31 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.948 2.099 . . . . 0.0 114.332 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.48 131.37 42.46 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.993 1.317 . . . . 0.0 110.008 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 53.1 p -69.01 -22.48 64.07 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.012 -1.055 . . . . 0.0 112.065 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.3 m -71.38 -7.53 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 168.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.286 89.4 m-85 -117.79 3.93 12.25 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 173.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -66.01 -15.07 62.71 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -174.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 79.9 p -141.1 -16.12 0.86 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.907 1.283 . . . . 0.0 114.187 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -80.75 141.27 34.96 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 170.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -140.59 129.8 13.09 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -169.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -84.91 -174.86 1.86 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 124.263 3.309 . . . . 0.0 114.242 171.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.83 -44.99 2.34 Favored Glycine 0 N--CA 1.466 0.659 0 C-N-CA 126.488 1.994 . . . . 0.0 115.774 164.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -65.85 142.37 98.08 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -164.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.2 106.5 2.29 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.53 2.82 . . . . 0.0 112.199 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -144.37 151.21 38.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.222 2.209 . . . . 0.0 107.752 159.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 28.9 p -75.06 2.55 10.35 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.476 -1.39 . . . . 0.0 114.361 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -137.53 147.69 45.36 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.124 1.77 . . . . 0.0 110.333 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 43.9 pt -134.43 159.97 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.203 2.201 . . . . 0.0 110.123 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -139.86 159.86 41.22 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.19 140.24 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.694 1.597 . . . . 0.0 113.412 -164.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -119.5 175.59 5.76 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.331 1.452 . . . . 0.0 111.168 167.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.279 13.6 m-20 69.07 25.42 5.85 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.322 1.849 . . . . 0.0 115.824 -172.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -74.68 146.53 42.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.262 -1.524 . . . . 0.0 111.043 173.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.18 173.65 3.69 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -173.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -77.98 -50.58 11.87 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.518 1.127 . . . . 0.0 111.78 -176.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -81.97 -23.68 35.94 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.24 1.816 . . . . 0.0 113.251 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.58 152.07 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -122.53 168.27 12.34 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.697 1.599 . . . . 0.0 113.346 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -57.2 -35.21 69.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.542 1.137 . . . . 0.0 112.616 174.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -62.35 -36.42 82.19 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -71.92 -25.18 61.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.641 1.176 . . . . 0.0 113.636 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.23 -15.4 59.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.099 2.16 . . . . 0.0 114.024 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.67 -22.75 57.75 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.324 0.966 . . . . 0.0 112.857 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -55.31 -37.23 67.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.076 1.351 . . . . 0.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.79 -57.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 121.253 -0.904 . . . . 0.0 111.659 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.274 58.9 m-85 -59.68 -31.83 69.92 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -175.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.76 -19.84 79.74 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 123.668 0.652 . . . . 0.0 114.072 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -55.0 -35.82 64.77 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.713 1.605 . . . . 0.0 112.506 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -77.71 0.79 22.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.431 1.892 . . . . 0.0 114.873 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 11.7 t -124.59 121.99 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.742 2.017 . . . . 0.0 109.946 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.254 3.2 m-20 -66.78 90.56 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 175.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -52.64 -21.42 3.93 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 173.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 15.8 m -65.2 -22.29 66.88 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.346 1.058 . . . . 0.0 113.176 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 31.2 m -124.45 117.84 25.31 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.697 1.599 . . . . 0.0 112.733 -170.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -63.09 -40.67 98.33 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.234 -0.916 . . . . 0.0 113.278 -174.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 2.9 t -54.48 -15.23 1.58 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -88.75 -62.65 1.44 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.213 1.405 . . . . 0.0 110.714 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -67.02 -24.55 66.03 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.14 1.376 . . . . 0.0 113.169 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.3 tt -58.53 -36.58 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.3 1.04 . . . . 0.0 112.366 171.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 16.6 mtm -87.52 -2.59 58.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.089 1.355 . . . . 0.0 112.439 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.56 143.81 31.77 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.938 2.495 . . . . 0.0 115.212 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -168.7 154.85 6.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.08 1.752 . . . . 0.0 107.006 168.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.08 126.75 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.599 1.16 . . . . 0.0 109.544 172.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -104.3 137.65 41.89 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.845 1.258 . . . . 0.0 108.899 165.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.2 tp -128.1 127.75 43.63 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.886 1.274 . . . . 0.0 109.191 164.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 48.0 mtm -93.17 125.04 37.57 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.808 1.643 . . . . 0.0 109.948 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -122.14 -0.46 9.43 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.963 2.105 . . . . 0.0 112.925 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.9 148.79 23.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.832 1.653 . . . . 0.0 112.512 173.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 90.57 -168.77 33.56 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 163.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -20.55 64.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.344 1.858 . . . . 0.0 113.772 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 62.7 mtp -115.92 24.28 11.59 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.282 2.233 . . . . 0.0 112.202 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -65.46 151.95 45.11 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.792 -1.193 . . . . 0.0 113.204 -172.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.66 36.83 18.5 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 126.194 1.854 . . . . 0.0 112.798 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -120.19 142.01 49.37 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.189 0.996 . . . . 0.0 112.128 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -129.93 153.37 48.41 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -168.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -126.83 129.63 48.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.0 2.12 . . . . 0.0 114.733 171.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.5 mp -126.42 120.56 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.674 1.59 . . . . 0.0 109.856 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -83.14 141.03 20.45 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 162.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 21.4 mt -124.51 158.82 60.41 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.726 1.61 . . . . 0.0 109.686 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.88 -15.62 26.39 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.948 2.432 . . . . 0.0 114.085 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -150.07 143.74 25.31 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.035 0.934 . . . . 0.0 110.623 -175.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -57.6 -37.67 73.61 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.41 1.084 . . . . 0.0 111.61 170.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -69.78 -23.23 63.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.346 1.058 . . . . 0.0 113.575 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -77.56 -38.22 48.98 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.774 171.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.06 79.27 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.254 0.933 . . . . 0.0 112.259 170.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -54.64 -43.19 72.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.4 1.0 . . . . 0.0 111.614 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -64.77 -50.05 68.35 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.962 1.305 . . . . 0.0 113.009 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.38 -31.54 72.22 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.359 0.664 . . . . 0.0 111.816 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 89.7 mt -77.87 -31.58 51.45 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.099 -1.001 . . . . 0.0 112.346 173.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -60.62 -33.29 72.55 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.617 1.167 . . . . 0.0 110.606 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -101.9 -54.45 2.72 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -174.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -75.52 -14.45 60.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -168.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -65.46 104.43 0.98 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.207 1.003 . . . . 0.0 110.323 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 107.31 1.5 35.46 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 117.583 -1.676 . . . . 0.0 116.18 -172.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.431 ' CD2' HD13 ' A' ' 394' ' ' LEU 0.314 92.2 t80 -64.65 128.86 37.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.672 2.236 . . . . 0.0 115.925 -168.285 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.325 2.0 t -91.68 45.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -160.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 23.2 tp -52.8 138.87 28.35 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.156 1.382 . . . . 0.0 110.183 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.356 7.0 t80 62.91 -4.08 0.28 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 94.7 9.57 58.57 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 124.958 1.266 . . . . 0.0 114.358 -166.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -127.21 128.48 24.09 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 126.686 1.995 . . . . 0.0 111.581 -173.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.86 119.04 5.51 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.544 2.162 . . . . 0.0 112.511 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 56.9 mtp -75.58 130.81 39.4 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.729 1.612 . . . . 0.0 112.419 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.95 76.79 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.857 1.663 . . . . 0.0 115.131 -175.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 1.7 t -79.83 122.72 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.355 1.062 . . . . 0.0 113.789 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -141.63 155.7 45.7 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.175 1.79 . . . . 0.0 112.514 -173.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -59.7 143.28 51.18 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.346 -1.471 . . . . 0.0 113.193 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -60.91 146.06 48.02 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -169.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -74.95 115.2 14.29 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.85 157.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 38.5 m -169.88 157.39 6.72 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.867 1.667 . . . . 0.0 111.909 -170.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -59.71 135.3 57.64 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.85 0.46 . . . . 0.0 110.807 161.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 55.5 ttp85 -149.01 83.06 6.85 Favored Pre-proline 0 N--CA 1.47 0.555 0 C-N-CA 125.218 1.407 . . . . 0.0 109.744 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -60.39 -35.2 91.95 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.126 1.884 . . . . 0.0 113.142 174.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -64.54 127.13 30.21 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.419 1.088 . . . . 0.0 112.317 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -147.23 151.55 36.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.681 1.592 . . . . 0.0 110.66 170.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -49.77 140.96 14.4 Favored Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.93 173.11 9.74 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.381 2.721 . . . . 0.0 112.117 173.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 135.58 39.8 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 174.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -149.85 62.61 0.99 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.3 1.44 . . . . 0.0 109.833 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -63.25 133.59 42.51 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 121.278 -0.889 . . . . 0.0 111.094 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -155.77 167.64 29.76 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.731 1.212 . . . . 0.0 113.147 -167.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -61.95 135.68 57.65 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.432 1.493 . . . . 0.0 113.921 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.924 2.09 . . . . 0.0 112.276 159.567 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 28.5 p . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 121.571 0.7 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . 0.271 49.9 m-20 -114.21 -135.63 0.36 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.954 2.102 . . . . 0.0 111.879 168.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -132.15 159.06 40.04 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.757 1.617 . . . . 0.0 113.316 -174.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.12 170.75 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 126.173 1.789 . . . . 0.0 114.156 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.93 155.74 37.07 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.677 2.251 . . . . 0.0 113.55 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.1 t 55.23 54.9 8.12 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.093 1.757 . . . . 0.0 112.695 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -79.67 73.27 6.38 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.817 -1.177 . . . . 0.0 111.991 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 28.0 p -139.05 159.81 41.26 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.9 tt -70.06 152.37 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.863 1.665 . . . . 0.0 110.94 -174.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 1.6 m -86.65 152.6 22.44 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 7.2 ttm-85 -59.06 -35.79 73.95 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.1 -1.0 . . . . 0.0 111.124 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -41.51 98.26 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.838 1.655 . . . . 0.0 113.733 174.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.85 -38.91 92.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.095 0.958 . . . . 0.0 112.692 174.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.4 tt -70.2 -39.99 74.86 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.412 1.485 . . . . 0.0 111.943 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.36 -17.17 18.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.488 1.915 . . . . 0.0 115.153 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -63.95 -64.61 0.84 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.74 -0.6 . . . . 0.0 110.88 164.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -78.99 72.09 2.51 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.497 1.999 . . . . 0.0 114.072 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -159.66 143.33 14.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.763 1.225 . . . . 0.0 110.973 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.4 pt -123.3 153.74 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.356 1.063 . . . . 0.0 113.866 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 77.3 p -85.02 169.87 13.55 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.54 1.536 . . . . 0.0 111.828 168.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 -58.37 -28.92 65.6 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.326 -0.859 . . . . 0.0 113.288 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.83 -30.94 71.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.543 0.737 . . . . 0.0 112.265 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.44 -36.59 26.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.641 1.176 . . . . 0.0 111.775 168.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 20.3 ttp -63.06 -40.6 98.18 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.919 -1.113 . . . . 0.0 111.829 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -83.29 25.12 0.75 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.441 0.696 . . . . 0.0 112.609 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.69 -38.23 1.51 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.892 2.077 . . . . 0.0 115.933 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.58 127.58 33.44 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.509 1.524 . . . . 0.0 110.131 172.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 27.9 t -59.48 -32.12 69.96 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.543 -0.723 . . . . 0.0 112.314 168.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 18.5 m -60.21 -21.64 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 120.753 -1.217 . . . . 0.0 114.08 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.263 79.7 m-85 -109.52 6.8 24.39 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -69.67 -22.33 63.45 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 46.6 t -123.43 -42.16 2.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.426 1.09 . . . . 0.0 112.381 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -72.56 150.79 42.84 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.898 1.279 . . . . 0.0 114.319 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -140.24 125.49 11.36 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -163.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -92.74 177.01 1.55 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 124.958 3.772 . . . . 0.0 114.887 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 98.58 -8.86 62.2 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.302 1.906 . . . . 0.0 116.843 163.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -85.69 139.79 35.52 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 119.294 1.547 . . . . 0.0 114.556 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -83.55 65.43 7.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 1 C-N-CA 125.392 4.061 . . . . 0.0 113.038 -174.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 46.6 t30 -89.79 153.98 20.26 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.551 -0.718 . . . . 0.0 110.485 162.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 28.4 p -76.05 -3.63 36.94 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.088 -1.633 . . . . 0.0 115.068 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . 0.431 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 87.7 mtt-85 -136.44 152.52 50.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.352 1.861 . . . . 0.0 111.833 176.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.6 pt -135.4 164.14 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.671 1.989 . . . . 0.0 109.588 176.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -138.47 161.21 37.59 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.62 150.52 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.241 1.816 . . . . 0.0 112.018 -171.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -138.01 -178.25 5.18 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.292 0.496 . . . . 0.0 112.158 162.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 69.61 21.73 6.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.215 1.806 . . . . 0.0 114.516 -165.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.87 154.64 41.65 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.991 -1.068 . . . . 0.0 110.912 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -68.26 173.7 4.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.172 0.989 . . . . 0.0 113.03 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.02 -30.43 13.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.225 1.41 . . . . 0.0 112.285 170.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -73.69 -14.81 61.21 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.107 1.363 . . . . 0.0 113.92 172.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.8 p -86.16 147.16 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.807 1.643 . . . . 0.0 113.898 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -117.49 164.81 14.34 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.333 1.053 . . . . 0.0 111.953 173.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -58.67 -30.51 67.41 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.6 -1.313 . . . . 0.0 111.966 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -20.93 63.8 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.842 1.657 . . . . 0.0 114.84 174.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -76.78 -37.86 55.09 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.269 1.028 . . . . 0.0 113.533 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.18 -18.31 63.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.595 1.558 . . . . 0.0 112.541 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -49.14 -33.13 11.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.176 1.391 . . . . 0.0 112.869 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -66.14 -31.2 71.91 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -169.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.9 mt -98.75 -56.15 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.821 -1.174 . . . . 0.0 111.151 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.265 75.6 m-85 -60.79 -22.52 64.2 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.73 -6.88 88.89 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.399 0.999 . . . . 0.0 114.519 170.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -63.05 -26.39 68.82 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 120.794 2.297 . . . . 0.0 112.09 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -94.51 3.83 54.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.081 2.152 . . . . 0.0 111.424 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.8 107.8 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.355 1.462 . . . . 0.0 109.432 -174.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -72.15 104.96 3.79 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -170.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -50.3 -40.31 48.19 Favored 'General case' 0 C--N 1.338 0.109 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 -170.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.0 p -68.16 -4.08 12.66 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 14.9 t -118.02 116.05 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.747 1.158 . . . . 0.0 111.782 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -60.3 -43.78 96.0 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.209 -0.932 . . . . 0.0 112.25 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.2 t -54.83 -16.08 2.38 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -90.09 -60.28 1.97 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.186 0.994 . . . . 0.0 110.032 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -68.13 -23.86 64.94 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.785 1.234 . . . . 0.0 113.286 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.0 tt -61.36 -31.84 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.938 1.695 . . . . 0.0 112.96 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.7 mtm -97.85 2.39 49.25 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.23 1.412 . . . . 0.0 112.698 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -111.6 112.23 23.79 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.372 1.869 . . . . 0.0 115.85 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -154.62 131.85 11.07 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.573 -0.704 . . . . 0.0 109.419 -168.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 5.1 mt -113.47 142.96 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.654 1.182 . . . . 0.0 110.407 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -134.37 129.64 35.71 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.992 1.717 . . . . 0.0 109.322 165.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 4.2 tt -115.53 139.73 49.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.345 1.858 . . . . 0.0 111.005 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -101.67 131.78 47.73 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 125.234 1.414 . . . . 0.0 112.463 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -113.9 1.76 14.84 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -171.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -145.9 154.82 42.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.211 1.004 . . . . 0.0 113.042 -174.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 77.23 -162.08 51.03 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.207 1.384 . . . . 0.0 113.809 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -22.27 66.07 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 121.483 -1.01 . . . . 0.0 112.743 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 23.2 ptp -87.18 8.84 22.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.112 1.365 . . . . 0.0 114.395 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -56.77 115.85 2.81 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.825 1.193 . . . . 0.0 110.838 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.16 22.79 58.48 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.732 1.634 . . . . 0.0 113.859 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -93.79 155.98 16.92 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.353 0.661 . . . . 0.0 110.697 158.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -149.74 152.8 35.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.224 1.009 . . . . 0.0 113.179 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -105.63 144.53 32.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.145 1.778 . . . . 0.0 114.123 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.9 mp -139.62 115.01 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.198 1.399 . . . . 0.0 109.244 169.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -81.69 144.15 23.97 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 158.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.1 mt -123.5 159.83 53.44 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.712 1.205 . . . . 0.0 110.332 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.01 -8.78 24.44 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.658 2.906 . . . . 0.0 114.321 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -156.71 144.11 19.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.582 0.706 . . . . 0.0 112.125 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -49.77 -44.79 49.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.406 1.882 . . . . 0.0 112.579 166.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -68.01 -28.75 67.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.706 1.202 . . . . 0.0 113.779 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.52 73.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.563 174.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.0 88.03 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.939 0.79 . . . . 0.0 112.776 174.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.68 71.11 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.722 0.692 . . . . 0.0 112.371 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.16 -52.0 15.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.134 1.374 . . . . 0.0 112.885 172.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.08 -30.54 69.3 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.094 0.958 . . . . 0.0 113.293 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 28.8 mt -64.17 -49.32 72.56 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.379 0.671 . . . . 0.0 111.028 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -21.6 48.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.614 0.766 . . . . 0.0 112.729 -176.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -72.01 -54.57 9.48 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.397 0.999 . . . . 0.0 112.62 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.67 -14.67 59.56 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -172.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -61.8 99.07 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.013 1.325 . . . . 0.0 111.657 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 119.34 -1.5 14.29 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 117.778 -1.568 . . . . 0.0 115.405 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -71.23 131.0 42.85 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.354 1.577 . . . . 0.0 111.254 -172.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.18 67.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.971 1.708 . . . . 0.0 113.437 -168.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 23.6 tp -66.28 142.8 57.54 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.363 162.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.4 27.3 t80 63.8 7.81 3.44 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 118.228 2.677 . . . . 0.0 118.228 167.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 78.93 14.97 81.42 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.1 1.333 . . . . 0.0 114.277 -169.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -133.87 125.65 18.37 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.66 1.584 . . . . 0.0 110.689 -171.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.4 125.18 11.54 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.121 1.881 . . . . 0.0 112.167 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 63.7 mtp -73.15 127.3 32.2 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.817 1.247 . . . . 0.0 111.696 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.24 98.86 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.901 0.88 . . . . 0.0 109.712 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.0 t -94.18 124.27 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.641 1.577 . . . . 0.0 112.337 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -148.28 152.81 37.77 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.61 0.764 . . . . 0.0 112.765 -168.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . 0.31 17.6 p90 -57.85 144.66 37.98 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 173.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -60.35 163.3 5.25 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -171.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -77.69 -34.3 52.91 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.462 1.505 . . . . 0.0 112.136 172.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 92.3 p -74.88 162.8 28.3 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.412 1.085 . . . . 0.0 111.138 159.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -151.53 132.45 14.21 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -175.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -152.3 73.49 7.58 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 127.692 2.397 . . . . 0.0 110.549 160.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -65.53 168.25 15.14 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.002 2.468 . . . . 0.0 114.113 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -73.58 136.93 44.01 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 121.478 -0.764 . . . . 0.0 111.509 173.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -70.35 -16.09 62.94 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 -165.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -148.89 170.66 7.3 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 126.322 1.849 . . . . 0.0 115.909 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -60.12 -22.08 68.4 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.59 2.86 . . . . 0.0 114.475 174.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.39 161.46 22.1 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.154 1.782 . . . . 0.0 114.088 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -137.78 -32.31 0.75 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.261 1.824 . . . . 0.0 111.965 170.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 75.69 -35.57 1.2 Allowed Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.358 1.932 . . . . 0.0 115.592 168.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.16 129.91 42.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.868 1.267 . . . . 0.0 109.309 168.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 21.2 mmt-85 -82.93 175.96 9.65 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -168.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 22.9 pttm . . . . . 0 C--O 1.252 1.235 0 C-N-CA 126.39 1.876 . . . . 0.0 114.333 -172.396 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.444 ' HA ' ' HG3' ' A' ' 384' ' ' MET . 21.1 t . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.641 0.734 . . . . 0.0 109.914 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -112.18 -19.62 12.19 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.928 1.691 . . . . 0.0 112.837 170.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -152.47 30.14 0.54 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.877 1.271 . . . . 0.0 113.28 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' MET . . . . . 0.444 ' HG3' ' HA ' ' A' ' 381' ' ' SER . 82.6 mtp -71.31 160.17 83.33 Favored Pre-proline 0 CA--C 1.548 0.883 0 O-C-N 121.168 -0.958 . . . . 0.0 111.925 173.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.3 144.59 81.58 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.281 2.654 . . . . 0.0 113.844 172.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 17.2 t -80.42 161.93 24.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.492 1.117 . . . . 0.0 112.332 174.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -156.4 154.06 29.89 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.489 2.716 . . . . 0.0 107.429 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 23.2 p -135.85 162.5 32.64 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 12.5 tt -76.66 144.03 12.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 125.694 1.597 . . . . 0.0 111.971 -162.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 69.3 m -90.05 155.96 18.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.506 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -53.48 -38.77 63.97 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.929 0.892 . . . . 0.0 111.655 -174.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -62.53 -47.97 81.58 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -69.67 -34.11 73.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -42.52 94.41 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.8 0.84 . . . . 0.0 112.408 169.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -57.91 -27.14 63.06 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.659 -1.276 . . . . 0.0 114.443 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -68.93 -21.84 64.18 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 118.996 0.816 . . . . 0.0 112.412 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -116.52 62.95 0.37 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.088 1.804 . . . . 0.0 112.888 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -148.21 166.25 28.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.832 1.653 . . . . 0.0 109.371 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.2 pt -144.83 148.88 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.125 0.97 . . . . 0.0 112.143 167.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.6 m -74.17 160.38 31.27 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.4 1.88 . . . . 0.0 112.815 165.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -53.76 -35.62 61.47 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.804 1.242 . . . . 0.0 112.323 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -60.3 -30.08 69.25 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.299 1.04 . . . . 0.0 113.258 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.33 -26.24 18.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.568 1.147 . . . . 0.0 112.123 172.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 8.2 ttm -61.77 -38.98 90.05 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 120.785 -1.197 . . . . 0.0 111.366 174.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -80.15 22.18 0.54 Allowed 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 171.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.38 -31.46 1.09 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 5.5 mp -74.5 137.85 42.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.64 1.176 . . . . 0.0 111.402 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 81.1 p -63.64 -31.89 73.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 1.5 m -63.54 -19.54 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.38 1.472 . . . . 0.0 114.677 173.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.308 65.7 m-85 -109.41 3.08 21.06 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 119.152 3.019 . . . . 0.0 119.152 -176.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -29.12 67.05 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 37.5 t -126.43 -34.94 2.42 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.064 1.346 . . . . 0.0 112.829 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -72.02 139.61 48.63 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -142.41 130.32 11.47 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.709 1.204 . . . . 0.0 112.15 -170.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -76.48 -166.28 0.36 Allowed 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 124.3 3.334 . . . . 0.0 113.156 164.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.16 13.8 58.35 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 117.688 1.835 . . . . 0.0 117.688 156.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -102.38 149.87 37.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 119.613 1.706 . . . . 0.0 113.088 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.54 109.53 2.92 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.583 2.856 . . . . 0.0 112.355 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -148.38 145.0 27.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.347 1.059 . . . . 0.0 109.098 164.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 24.2 p -76.0 -2.66 31.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 33.8 mtp85 -130.09 147.08 51.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.888 2.075 . . . . 0.0 108.901 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 3.3 pt -131.81 161.18 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 126.386 1.875 . . . . 0.0 109.431 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -136.8 161.44 35.98 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.7 t -131.65 140.68 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.453 1.501 . . . . 0.0 111.655 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -120.56 166.23 13.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.544 1.537 . . . . 0.0 109.36 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 69.49 36.88 2.1 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -171.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.8 160.2 26.23 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 120.148 -1.595 . . . . 0.0 112.221 168.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -79.02 176.15 9.92 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.002 1.721 . . . . 0.0 115.282 -171.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -77.93 -48.04 17.24 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 171.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -72.8 -36.04 67.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.656 1.182 . . . . 0.0 113.179 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.64 153.95 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -130.93 163.55 27.24 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.467 1.507 . . . . 0.0 111.566 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -52.62 -31.06 34.71 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.548 1.139 . . . . 0.0 113.408 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -60.08 -33.04 71.53 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 171.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -76.88 -26.82 54.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.427 1.491 . . . . 0.0 114.494 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.44 -19.98 60.83 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.044 1.738 . . . . 0.0 113.549 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.76 -25.88 61.08 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.587 1.085 . . . . 0.0 112.358 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -59.29 -38.87 81.25 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.552 0.741 . . . . 0.0 111.5 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mt -94.47 -56.97 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 121.26 -0.9 . . . . 0.0 110.632 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -60.25 -28.33 67.95 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.57 -12.75 84.21 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.437 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -55.12 -40.4 70.46 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.135 1.467 . . . . 0.0 112.064 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -80.89 -5.96 58.04 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.403 1.881 . . . . 0.0 112.022 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.61 117.54 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.154 1.782 . . . . 0.0 110.726 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -69.07 90.87 0.47 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.299 30.7 m-85 -59.14 -16.05 17.73 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 118.198 2.666 . . . . 0.0 118.198 177.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.9 t -66.73 -26.26 66.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.854 1.207 . . . . 0.0 112.295 171.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.1 m -110.23 120.76 43.46 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.636 1.574 . . . . 0.0 112.303 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -58.23 -44.11 88.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.005 -1.059 . . . . 0.0 112.826 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.11 -7.14 0.46 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -100.0 -55.6 2.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.842 1.257 . . . . 0.0 109.768 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -70.58 -24.13 62.71 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.485 1.114 . . . . 0.0 112.691 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.5 tt -59.24 -31.91 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.8 1.64 . . . . 0.0 112.694 171.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 36.1 mtp -86.71 -9.24 56.37 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.23 1.412 . . . . 0.0 112.485 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.22 122.23 46.51 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -170.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -159.62 119.33 2.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.215 1.006 . . . . 0.0 110.981 -170.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 8.1 mt -102.59 133.03 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.986 0.914 . . . . 0.0 111.323 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -133.19 120.46 21.2 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.004 0.921 . . . . 0.0 110.388 170.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 7.8 tt -108.76 129.63 55.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.132 1.773 . . . . 0.0 110.101 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -77.96 109.53 12.09 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.421 1.489 . . . . 0.0 110.982 176.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -85.0 -8.95 58.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pm0 -130.92 159.62 36.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -167.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 65.02 -160.25 42.62 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.965 1.269 . . . . 0.0 114.98 164.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -18.64 60.52 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 40.9 mtp -99.71 11.65 38.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.054 1.341 . . . . 0.0 113.029 174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -54.03 113.01 1.07 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.512 1.125 . . . . 0.0 110.306 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.81 31.39 23.97 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.282 0.944 . . . . 0.0 113.875 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -106.4 155.35 19.63 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.517 1.127 . . . . 0.0 110.412 157.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.2 154.48 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.962 -1.086 . . . . 0.0 113.604 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -116.23 144.41 44.23 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.653 1.981 . . . . 0.0 115.58 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.25 118.27 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.554 1.941 . . . . 0.0 110.026 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -81.95 142.02 22.12 Favored Glycine 0 CA--C 1.534 1.249 0 O-C-N 121.447 -0.783 . . . . 0.0 111.383 159.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.6 mt -120.87 160.8 43.25 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.059 1.344 . . . . 0.0 109.986 174.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.78 -6.19 17.84 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.527 2.152 . . . . 0.0 114.447 -175.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -155.59 143.56 19.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.563 0.745 . . . . 0.0 111.466 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.31 -43.31 32.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.407 1.483 . . . . 0.0 112.469 162.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -62.54 -34.96 77.96 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.466 -0.771 . . . . 0.0 113.017 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.03 -37.43 75.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.413 0.685 . . . . 0.0 111.816 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.74 80.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.394 0.997 . . . . 0.0 111.783 170.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.03 -34.07 67.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.583 0.753 . . . . 0.0 112.398 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -75.11 -49.39 19.76 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.849 1.26 . . . . 0.0 112.848 170.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.7 -29.73 68.3 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.575 -0.703 . . . . 0.0 112.602 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.9 mt -71.71 -28.84 63.97 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.299 1.04 . . . . 0.0 113.412 173.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -67.57 -37.72 83.04 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.575 0.75 . . . . 0.0 111.033 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -91.71 -56.49 3.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -169.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -74.35 -18.22 60.72 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -75.65 111.6 11.15 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.221 -0.924 . . . . 0.0 111.002 -174.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 107.12 8.49 31.36 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.022 -168.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -75.79 126.73 31.56 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.444 1.622 . . . . 0.0 110.082 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.316 1.2 t -97.76 45.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.473 1.509 . . . . 0.0 114.704 -162.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 36.0 tp -52.8 123.72 12.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.027 1.731 . . . . 0.0 111.218 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.37 65.7 m-85 57.84 11.58 1.42 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 118.345 2.72 . . . . 0.0 118.345 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 87.06 18.87 57.07 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 120.871 -1.143 . . . . 0.0 114.234 -171.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -121.69 118.95 29.34 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.536 1.535 . . . . 0.0 109.384 175.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -72.92 117.11 4.98 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.831 1.687 . . . . 0.0 111.893 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 32.2 mtp -71.65 130.97 42.49 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.974 1.71 . . . . 0.0 111.272 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.32 106.42 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.055 1.342 . . . . 0.0 108.088 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 11.6 t -98.95 123.72 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.302 1.441 . . . . 0.0 110.331 -176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -138.94 160.47 39.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.057 0.932 . . . . 0.0 112.972 -175.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -55.2 140.92 37.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.507 0.723 . . . . 0.0 111.611 167.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -62.84 149.7 43.59 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.721 -0.612 . . . . 0.0 112.245 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -73.33 -19.06 61.11 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.834 1.791 . . . . 0.0 115.834 -168.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 48.0 t -158.52 -36.03 0.07 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -85.97 139.47 31.17 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -164.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -152.98 42.67 0.22 Allowed Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 126.364 1.865 . . . . 0.0 114.823 170.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.51 179.3 5.69 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 124.626 3.551 . . . . 0.0 114.97 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -142.43 101.6 3.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.946 2.099 . . . . 0.0 110.714 169.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -72.53 135.2 45.57 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.381 -0.824 . . . . 0.0 112.666 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -70.47 148.72 95.49 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.09 149.43 36.32 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.288 2.659 . . . . 0.0 113.82 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 153.04 28.0 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.101 1.761 . . . . 0.0 113.889 173.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -78.29 65.44 3.63 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.418 1.487 . . . . 0.0 112.907 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -99.79 -171.3 30.2 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.67 1.605 . . . . 0.0 113.614 173.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -142.01 150.77 41.75 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.879 1.271 . . . . 0.0 112.612 173.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.35 -35.74 15.05 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.895 1.278 . . . . 0.0 113.235 177.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt . . . . . 0 C--O 1.251 1.136 0 C-N-CA 126.075 1.75 . . . . 0.0 113.34 173.387 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.46 166.84 19.58 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 16.2 pm0 -66.83 -19.31 65.72 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 98.5 mtp -66.06 138.3 96.16 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.553 1.141 . . . . 0.0 111.616 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.68 134.95 36.92 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 122.643 2.229 . . . . 0.0 112.477 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 43.1 t -153.76 129.76 10.28 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.911 1.285 . . . . 0.0 110.918 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -149.77 129.0 12.81 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.916 0.886 . . . . 0.0 110.141 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 8.1 p -148.03 167.69 24.27 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -173.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.03 146.23 8.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 123.654 0.782 . . . . 0.0 111.133 -169.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 31.6 m -87.67 149.8 24.03 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -66.31 -27.81 68.2 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.976 -1.077 . . . . 0.0 112.704 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -67.34 -23.41 65.61 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 171.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -74.39 -52.43 12.16 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.307 0.958 . . . . 0.0 110.917 163.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.8 -45.12 78.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.914 1.286 . . . . 0.0 112.895 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -56.04 -17.98 8.32 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.597 1.959 . . . . 0.0 115.481 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -72.26 -30.63 65.04 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.936 -1.102 . . . . 0.0 112.811 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.62 90.63 0.5 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.612 1.101 . . . . 0.0 113.468 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 -164.71 147.73 8.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.504 1.122 . . . . 0.0 111.343 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.7 pt -126.76 158.7 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.671 1.188 . . . . 0.0 112.88 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.59 179.23 4.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.975 1.31 . . . . 0.0 111.074 163.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -61.84 -20.9 64.17 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 120.558 -1.339 . . . . 0.0 114.259 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -78.03 -29.09 49.24 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.063 0.945 . . . . 0.0 112.002 -173.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.87 -33.17 24.87 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.712 -1.243 . . . . 0.0 110.982 161.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 29.4 ttm -63.02 -38.45 91.22 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.438 -1.414 . . . . 0.0 113.371 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -83.22 12.83 4.74 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.285 -0.884 . . . . 0.0 112.196 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.62 -29.69 5.0 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.233 2.213 . . . . 0.0 115.119 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.82 128.1 34.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.908 1.283 . . . . 0.0 109.898 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 75.6 p -63.43 -27.01 69.0 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.299 -0.875 . . . . 0.0 111.38 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . 0.273 2.2 m -68.97 -16.02 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 171.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -119.6 -17.07 8.75 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 119.189 3.033 . . . . 0.0 119.189 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.24 -8.84 0.35 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 54.1 p -137.47 12.77 3.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.949 1.3 . . . . 0.0 113.456 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -131.55 137.91 48.67 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.39 1.876 . . . . 0.0 114.41 -173.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -142.66 129.02 10.68 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -157.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -86.47 -174.28 1.42 Allowed 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 124.736 3.624 . . . . 0.0 113.413 171.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.69 71.77 1.04 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 125.144 1.354 . . . . 0.0 116.13 164.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -145.59 151.96 48.02 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.377 1.471 . . . . 0.0 111.862 172.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.81 95.6 1.07 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.964 3.109 . . . . 0.0 113.0 -172.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . 0.548 HD22 ' HB2' ' A' ' 500' ' ' PHE . 0.3 OUTLIER -163.06 147.83 11.44 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.7 2.0 . . . . 0.0 111.431 166.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.2 p -82.11 18.72 1.3 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -135.16 150.24 50.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.985 1.314 . . . . 0.0 109.99 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.77 157.84 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 126.375 1.87 . . . . 0.0 109.929 -177.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -131.79 162.1 31.33 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.08 140.18 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 125.582 1.553 . . . . 0.0 111.631 -174.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -122.03 170.65 9.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.116 1.367 . . . . 0.0 109.951 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 22.8 t30 66.62 38.73 3.93 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.839 1.256 . . . . 0.0 111.717 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -77.12 139.56 40.0 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.963 -1.086 . . . . 0.0 110.318 167.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.41 142.09 58.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.485 1.514 . . . . 0.0 112.83 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.27 -29.15 60.76 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.649 -1.282 . . . . 0.0 113.932 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -73.35 -31.09 63.76 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -79.69 160.0 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -169.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -134.29 166.94 21.64 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.906 1.283 . . . . 0.0 111.326 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -59.89 -33.09 71.38 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.526 -1.359 . . . . 0.0 113.018 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -57.42 -22.04 40.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.871 1.668 . . . . 0.0 115.018 170.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.64 -33.08 18.95 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.749 1.619 . . . . 0.0 115.094 169.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.81 -25.27 67.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.89 0.876 . . . . 0.0 112.272 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -53.56 -30.97 44.66 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.341 1.056 . . . . 0.0 111.472 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.36 -41.59 97.32 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.945 1.298 . . . . 0.0 111.781 -173.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mt -91.81 -57.49 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 120.64 -1.287 . . . . 0.0 110.826 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -55.98 -36.04 67.42 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.69 -9.19 82.54 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.145 -0.808 . . . . 0.0 114.454 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -60.08 -29.03 68.29 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.36 1.58 . . . . 0.0 111.543 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -93.91 16.26 14.74 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.117 1.767 . . . . 0.0 114.341 -174.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 96.7 t -128.47 119.23 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.228 1.811 . . . . 0.0 107.52 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.257 57.3 m-20 -68.89 73.6 0.27 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 173.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -49.78 -22.49 1.44 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 120.044 3.35 . . . . 0.0 120.044 -169.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 17.2 m -71.99 -13.55 61.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.742 1.61 . . . . 0.0 112.935 172.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 4.8 t -104.39 123.38 47.32 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.19 1.396 . . . . 0.0 110.887 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -56.79 -45.39 82.22 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.394 -0.816 . . . . 0.0 112.068 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.3 t -55.18 -15.1 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -88.86 -61.75 1.64 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.905 0.882 . . . . 0.0 109.854 173.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -69.13 -24.52 64.11 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.854 1.262 . . . . 0.0 113.518 -172.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 11.3 tt -64.22 -33.45 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.505 1.522 . . . . 0.0 112.413 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 62.8 mmm -80.6 -13.71 58.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.104 1.362 . . . . 0.0 111.453 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -107.66 127.35 53.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.774 2.03 . . . . 0.0 113.804 -171.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -162.56 138.5 7.34 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.2 mt -119.85 136.79 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.69 1.196 . . . . 0.0 110.543 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -130.19 138.58 50.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.646 1.178 . . . . 0.0 111.071 164.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 2.1 tt -109.74 131.95 54.59 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.63 1.572 . . . . 0.0 109.127 172.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -90.57 134.81 34.12 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.667 1.587 . . . . 0.0 111.547 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -130.71 9.19 4.97 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -158.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -148.47 156.31 42.3 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.558 1.143 . . . . 0.0 111.975 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 61.34 -161.13 26.55 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.626 1.107 . . . . 0.0 114.911 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.71 -27.13 62.66 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.249 -1.148 . . . . 0.0 113.425 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 28.0 ttm -85.25 -2.8 58.45 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.423 1.089 . . . . 0.0 113.359 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -54.04 128.03 28.92 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.48 1.112 . . . . 0.0 111.868 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.3 27.22 66.36 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.403 1.001 . . . . 0.0 112.913 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -109.7 161.93 14.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.302 1.441 . . . . 0.0 110.71 160.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.12 157.19 42.86 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.94 1.296 . . . . 0.0 112.876 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -118.35 147.04 43.91 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 168.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.17 126.09 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.724 1.609 . . . . 0.0 110.339 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.62 150.09 19.72 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.482 -0.761 . . . . 0.0 112.001 161.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.7 mt -128.64 163.2 46.55 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.098 1.759 . . . . 0.0 110.758 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.53 -3.36 13.26 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.484 2.789 . . . . 0.0 115.552 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -155.72 150.82 26.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.881 1.272 . . . . 0.0 111.602 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -53.77 -43.52 69.28 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.513 -0.742 . . . . 0.0 112.859 163.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -60.38 -40.33 90.44 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.581 1.152 . . . . 0.0 113.003 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.59 99.1 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.588 0.555 . . . . 0.0 111.412 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.62 -42.64 77.81 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.212 0.915 . . . . 0.0 112.164 174.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.24 -43.69 83.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.48 0.712 . . . . 0.0 111.746 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -68.3 -51.96 39.03 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.084 0.954 . . . . 0.0 111.339 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.53 -29.8 66.59 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 29.4 mt -70.69 -47.67 58.64 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.56 1.073 . . . . 0.0 111.144 172.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -57.89 -34.55 69.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.945 0.898 . . . . 0.0 112.149 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.49 -49.13 7.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.208 1.003 . . . . 0.0 112.925 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -82.14 -20.06 38.72 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -66.37 105.14 1.37 Allowed 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.171 -0.956 . . . . 0.0 110.588 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 110.27 -0.92 29.63 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.004 -1.442 . . . . 0.0 116.148 -173.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -68.23 122.48 18.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.921 1.86 . . . . 0.0 113.836 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.299 1.7 t -86.43 57.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -166.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 15.2 tp -55.11 114.16 1.65 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.832 2.053 . . . . 0.0 111.436 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.332 61.3 m-85 58.42 23.17 10.33 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 -178.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 85.31 15.31 66.84 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 121.393 -0.817 . . . . 0.0 114.53 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.32 115.59 18.54 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.397 1.479 . . . . 0.0 110.672 -176.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.35 114.92 4.1 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.889 2.392 . . . . 0.0 112.149 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 72.3 mtp -68.98 128.07 35.38 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.834 1.254 . . . . 0.0 112.393 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 34.9 t -90.92 79.44 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.66 1.584 . . . . 0.0 110.799 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.6 t -83.24 126.93 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.627 1.971 . . . . 0.0 112.534 -174.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -145.19 157.64 44.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.996 1.318 . . . . 0.0 113.652 -170.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . 0.548 ' HB2' HD22 ' A' ' 419' ' ' ASN . 44.1 p90 -63.05 146.39 53.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.679 0.792 . . . . 0.0 110.936 173.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.1 131.77 48.48 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.562 -0.711 . . . . 0.0 111.004 173.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -99.24 -40.37 7.98 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -123.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 1.2 t 46.81 26.86 0.61 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.82 2.048 . . . . 0.0 115.983 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . 53.44 31.17 11.66 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.32 1.848 . . . . 0.0 115.837 -170.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -119.99 50.22 1.61 Allowed Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -163.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.51 142.4 53.79 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.511 2.14 . . . . 0.0 112.318 173.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.76 157.49 40.24 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.485 1.514 . . . . 0.0 111.615 169.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.3 tp60 -71.05 151.2 44.8 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.5 0.72 . . . . 0.0 111.44 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -56.9 140.24 76.96 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 -164.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -73.75 -35.06 4.82 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.021 2.48 . . . . 0.0 114.559 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.61 159.39 27.55 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.357 1.463 . . . . 0.0 112.107 174.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 21.8 pm0 -63.59 -22.87 67.13 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -176.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 76.8 -56.83 3.48 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.593 -1.317 . . . . 0.0 112.455 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt 60.09 -45.97 0.09 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 130.205 3.402 . . . . 0.0 117.029 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -56.46 135.5 54.24 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.174 2.19 . . . . 0.0 110.279 172.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.409 1.484 . . . . 0.0 110.381 175.966 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 9.2 m . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.62 -41.12 79.96 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 117.117 2.266 . . . . 0.0 117.117 -175.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -150.56 16.35 0.8 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -171.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 97.7 mtp -69.15 148.01 97.56 Favored Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 120.528 -1.357 . . . . 0.0 112.169 170.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.5 9.41 2.21 Favored 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 124.125 3.216 . . . . 0.0 115.042 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 87.8 p -146.82 167.3 24.24 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.886 2.474 . . . . 0.0 109.709 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -123.28 126.38 46.79 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 120.824 -1.172 . . . . 0.0 111.395 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.4 p -147.97 160.41 42.86 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.008 1.323 . . . . 0.0 111.697 172.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.9 tt -70.95 145.89 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 125.707 1.603 . . . . 0.0 111.071 -166.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 10.6 m -78.54 146.3 34.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -56.57 -41.63 77.22 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.624 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -62.59 -32.48 73.48 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -73.5 -41.73 62.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.835 0.854 . . . . 0.0 113.179 170.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.22 -46.9 88.54 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.866 0.866 . . . . 0.0 110.661 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -58.49 -24.72 61.16 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.425 1.89 . . . . 0.0 115.16 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 48.0 mmtt -62.56 -49.9 73.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.995 0.816 . . . . 0.0 111.333 168.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.87 65.27 3.28 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.175 1.845 . . . . 0.0 112.351 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -153.41 137.57 16.48 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.916 1.286 . . . . 0.0 110.873 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.3 pt -121.57 157.43 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.597 1.159 . . . . 0.0 113.284 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.0 m -95.8 169.01 10.3 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.267 1.427 . . . . 0.0 112.199 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -54.3 -31.07 53.12 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.902 -1.124 . . . . 0.0 113.433 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -60.68 -25.64 66.53 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.561 1.145 . . . . 0.0 113.167 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.0 -41.5 10.51 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.671 1.188 . . . . 0.0 110.988 169.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 15.9 ttm -65.87 -30.93 71.61 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.817 -1.177 . . . . 0.0 113.098 -172.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -82.97 6.35 19.0 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.318 -0.864 . . . . 0.0 112.823 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.93 -30.53 4.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.989 2.116 . . . . 0.0 114.051 -176.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 40.3 mt -74.12 129.5 37.96 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.581 1.552 . . . . 0.0 111.343 174.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 88.3 p -59.29 -34.2 72.0 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.628 -0.67 . . . . 0.0 111.989 171.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 33.7 m -60.38 -22.98 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 117.559 -1.21 . . . . 0.0 113.523 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.339 69.7 m-85 -94.55 2.0 55.66 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 119.113 3.005 . . . . 0.0 119.113 174.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -50.27 -23.58 2.37 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 -164.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 19.0 m -143.23 20.95 1.91 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.484 1.114 . . . . 0.0 112.926 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -135.71 133.87 38.51 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.343 1.457 . . . . 0.0 109.244 -161.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 415' ' ' PRO . 45.0 mt-10 -136.33 92.92 15.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -165.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 414' ' ' GLU . 54.3 Cg_endo -64.76 159.65 44.48 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.201 3.267 . . . . 0.0 113.608 165.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 84.32 0.67 89.49 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.021 1.296 . . . . 0.0 113.305 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -77.3 136.11 65.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.409 1.484 . . . . 0.0 112.447 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.51 126.6 9.11 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.33 2.687 . . . . 0.0 112.48 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -160.41 152.39 20.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.537 1.535 . . . . 0.0 109.156 158.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.9 p -77.87 3.15 15.15 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.101 -1.624 . . . . 0.0 114.59 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -135.91 145.58 46.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.669 2.387 . . . . 0.0 108.961 171.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 12.7 pt -124.46 165.82 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.496 1.918 . . . . 0.0 110.071 174.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.86 159.09 42.9 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 174.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 8.6 t -132.07 132.93 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.409 1.483 . . . . 0.0 110.897 -174.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -106.56 164.53 11.99 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.693 1.197 . . . . 0.0 109.936 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 16.5 t30 68.2 39.36 2.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.839 1.256 . . . . 0.0 113.394 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.67 150.02 41.55 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.421 -0.799 . . . . 0.0 111.459 171.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.51 160.56 8.74 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.168 1.387 . . . . 0.0 114.471 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -62.26 -43.36 99.01 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.99 -1.069 . . . . 0.0 112.491 169.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -70.61 -35.33 72.92 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.1 p -71.51 149.3 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -170.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -123.2 166.84 14.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.423 1.489 . . . . 0.0 112.556 170.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -55.39 -33.58 63.61 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.826 -1.171 . . . . 0.0 112.719 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 9.1 pttm -62.87 -28.99 70.41 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.77 -37.44 48.98 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.189 0.996 . . . . 0.0 113.469 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.01 -20.54 54.0 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.404 1.882 . . . . 0.0 113.39 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.99 -18.97 5.77 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 171.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -61.81 -38.97 90.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.829 0.852 . . . . 0.0 112.009 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.29 -51.86 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.297 -0.877 . . . . 0.0 110.032 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -63.37 -33.1 74.81 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.2 -12.8 83.27 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 123.478 0.561 . . . . 0.0 114.121 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -58.8 -34.61 71.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.926 1.291 . . . . 0.0 112.565 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -79.93 -6.41 57.43 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.897 1.679 . . . . 0.0 113.548 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.27 111.24 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.984 1.714 . . . . 0.0 111.085 -172.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -69.84 86.78 0.51 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -54.04 -23.94 15.39 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 118.482 2.771 . . . . 0.0 118.482 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 61.2 m -65.75 -21.72 66.54 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.1 m -109.87 121.99 46.51 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.327 1.851 . . . . 0.0 111.88 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.75 -45.91 88.63 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.275 -0.891 . . . . 0.0 113.037 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -17.15 5.48 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -89.87 -57.01 3.01 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.64 0.776 . . . . 0.0 108.984 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -72.58 -21.06 61.2 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.265 1.426 . . . . 0.0 113.539 -173.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 17.0 tt -62.89 -36.26 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.295 1.838 . . . . 0.0 112.265 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.4 mtm -87.36 -8.0 57.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.829 0.851 . . . . 0.0 112.208 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -102.91 124.67 48.86 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -173.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.42 158.98 21.74 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.978 1.311 . . . . 0.0 108.626 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.0 mt -123.24 147.99 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.002 1.321 . . . . 0.0 111.224 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -134.93 132.37 38.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.31 2.244 . . . . 0.0 109.457 169.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.4 tp -124.93 113.13 17.44 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.877 2.071 . . . . 0.0 110.776 172.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 57.3 mtm -70.68 108.34 4.36 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.649 1.18 . . . . 0.0 111.454 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -96.48 10.8 37.19 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -147.23 154.16 40.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.158 1.783 . . . . 0.0 110.821 -174.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 85.18 -166.8 40.82 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.286 1.422 . . . . 0.0 116.273 168.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -11.17 2.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.622 1.969 . . . . 0.0 116.007 -172.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 24.7 ptp -140.7 41.53 1.86 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.948 1.699 . . . . 0.0 112.468 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -52.81 133.39 37.3 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.465 1.106 . . . . 0.0 111.709 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.07 31.71 34.16 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 124.476 1.036 . . . . 0.0 113.34 -177.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -125.99 147.76 49.45 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.539 0.736 . . . . 0.0 111.389 172.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -139.48 155.42 47.57 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.93 1.292 . . . . 0.0 114.038 -165.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -119.87 142.48 48.62 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.757 2.023 . . . . 0.0 114.96 171.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.2 mp -141.44 120.4 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.812 1.645 . . . . 0.0 110.893 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -83.01 140.02 19.69 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.433 -0.792 . . . . 0.0 111.397 163.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 20.8 mt -120.33 158.0 52.1 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.428 1.091 . . . . 0.0 110.766 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.53 -11.75 28.56 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.01 2.473 . . . . 0.0 114.405 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -151.27 142.45 23.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.821 0.849 . . . . 0.0 110.804 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -53.7 -35.46 61.15 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.204 1.402 . . . . 0.0 112.391 167.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -65.91 -38.5 88.87 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.99 85.86 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.309 0.504 . . . . 0.0 110.695 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.38 78.76 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 170.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.64 -36.46 69.53 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.243 0.929 . . . . 0.0 112.553 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -73.52 -53.62 10.17 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.096 1.359 . . . . 0.0 112.694 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.17 -31.75 69.27 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 49.1 mt -69.22 -42.6 75.49 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.573 -0.705 . . . . 0.0 112.387 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.1 -34.47 78.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.446 0.698 . . . . 0.0 111.991 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -82.1 -51.28 8.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.116 1.366 . . . . 0.0 114.37 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.61 -16.31 61.73 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.19 106.08 0.48 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.003 1.721 . . . . 0.0 112.361 174.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 112.23 -6.73 26.89 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 118.49 -1.172 . . . . 0.0 114.949 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -71.7 128.39 35.65 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.154 1.477 . . . . 0.0 107.324 -174.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.253 5.8 p -122.72 63.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 124.185 1.945 . . . . 0.0 110.427 -162.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.16 131.22 50.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.485 1.914 . . . . 0.0 110.913 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.371 52.1 m-85 56.05 21.72 5.31 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -175.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 77.93 8.03 87.39 Favored Glycine 0 CA--C 1.537 1.466 0 O-C-N 121.027 -1.046 . . . . 0.0 114.351 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -112.78 112.59 50.61 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.861 1.664 . . . . 0.0 110.196 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.9 121.28 7.2 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.713 2.275 . . . . 0.0 110.965 -174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 41.7 mtp -79.77 124.44 28.61 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.614 1.566 . . . . 0.0 110.747 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 36.0 t -93.83 84.16 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.99 1.316 . . . . 0.0 110.719 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.78 131.84 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.012 1.725 . . . . 0.0 112.605 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -145.01 158.44 43.81 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.021 1.328 . . . . 0.0 113.469 -172.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -61.88 147.32 47.05 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.18 -0.95 . . . . 0.0 108.441 164.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -62.38 138.97 58.55 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.452 -0.78 . . . . 0.0 112.975 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 13.3 tpp85 -54.92 111.14 0.77 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.617 1.567 . . . . 0.0 113.811 -158.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 35.7 t -158.84 169.82 23.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.438 2.695 . . . . 0.0 109.898 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -141.0 49.39 1.67 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.131 1.373 . . . . 0.0 113.134 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -135.23 78.04 53.27 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.535 1.534 . . . . 0.0 112.439 -173.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -59.18 148.33 86.38 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.136 2.557 . . . . 0.0 115.574 -170.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -137.2 22.95 3.01 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.351 2.66 . . . . 0.0 110.998 172.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -152.47 145.22 24.31 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.324 2.65 . . . . 0.0 110.448 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.23 147.12 76.38 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.92 -17.84 24.96 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.831 2.354 . . . . 0.0 115.936 -167.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -120.28 154.74 34.52 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.027 1.331 . . . . 0.0 112.556 168.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -85.45 24.21 1.21 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.335 1.854 . . . . 0.0 114.346 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 77.34 173.65 39.74 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.635 1.588 . . . . 0.0 114.565 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.88 145.98 25.31 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.818 1.247 . . . . 0.0 112.459 176.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -108.48 -12.09 15.06 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 174.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 92.5 mttt . . . . . 0 C--O 1.251 1.153 0 CA-C-O 117.546 -1.216 . . . . 0.0 113.208 176.907 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 95.8 p . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . 0.33 53.2 m-20 60.73 7.0 1.27 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 120.404 3.483 . . . . 0.0 120.404 169.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -139.46 137.3 35.45 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.357 1.063 . . . . 0.0 112.09 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 5.8 mtp -155.8 157.97 31.59 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.464 1.506 . . . . 0.0 111.637 175.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -61.3 140.67 89.68 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.269 2.646 . . . . 0.0 114.508 -173.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 9.9 m -83.5 60.55 5.72 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.057 1.743 . . . . 0.0 110.99 -178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -134.75 136.55 42.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.037 1.335 . . . . 0.0 111.101 -175.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 25.7 p -151.43 163.26 39.38 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.052 1.741 . . . . 0.0 113.3 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 3.1 tt -72.44 158.35 6.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.199 1.399 . . . . 0.0 111.196 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 66.2 m -96.41 150.87 20.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.052 0.941 . . . . 0.0 110.797 168.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -56.75 -39.45 74.03 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 111.281 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -68.58 -26.4 65.37 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -78.68 -38.62 38.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.973 1.26 . . . . 0.0 112.811 166.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.08 -45.83 91.62 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.857 0.863 . . . . 0.0 112.385 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -56.1 -25.55 46.2 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.938 1.295 . . . . 0.0 114.091 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -69.8 -25.36 63.75 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.053 0.941 . . . . 0.0 112.98 176.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -105.17 72.95 0.23 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.088 1.328 . . . . 0.0 110.969 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -156.11 141.52 17.63 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.568 1.147 . . . . 0.0 109.316 -174.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.7 pt -115.3 155.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 83.4 p -67.4 160.14 28.0 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.393 1.477 . . . . 0.0 111.749 161.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 52.2 mmt-85 -61.87 -30.64 70.99 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.606 -0.684 . . . . 0.0 111.139 168.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.49 -42.34 95.92 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.451 0.7 . . . . 0.0 112.103 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -36.01 77.51 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.671 0.669 . . . . 0.0 109.621 172.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 11.3 ttp -65.01 -39.88 94.09 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 120.556 -1.34 . . . . 0.0 112.078 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -81.03 15.86 1.7 Allowed 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.73 -35.95 2.98 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.798 2.039 . . . . 0.0 116.485 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.31 125.21 25.71 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.694 1.197 . . . . 0.0 108.994 172.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.2 m -65.12 -17.76 64.73 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.89 -25.49 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 170.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.31 75.8 m-85 -98.35 10.49 40.63 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 118.565 2.802 . . . . 0.0 118.565 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -60.31 -19.0 53.42 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 9.6 t -139.13 -35.58 0.55 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.816 1.646 . . . . 0.0 112.68 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -76.12 145.8 39.73 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -138.46 129.82 15.57 Favored Pre-proline 0 N--CA 1.478 0.951 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -168.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.6 172.33 13.54 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.586 2.857 . . . . 0.0 113.983 170.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 95.8 -21.33 45.43 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 116.954 1.541 . . . . 0.0 116.954 164.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.09 138.54 96.2 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 119.019 1.41 . . . . 0.0 112.588 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.27 116.85 4.77 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.283 2.655 . . . . 0.0 113.23 -174.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -153.66 146.93 24.75 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.201 1.4 . . . . 0.0 108.595 164.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.1 p -73.8 6.21 3.43 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -144.47 145.46 31.89 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.306 1.842 . . . . 0.0 108.921 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 27.7 pt -133.99 164.13 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.554 1.942 . . . . 0.0 109.865 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -136.01 162.23 33.45 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 172.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.4 p -140.03 146.95 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.934 1.294 . . . . 0.0 110.696 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -131.13 -175.38 3.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.283 0.633 . . . . 0.0 111.062 165.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.0 t30 66.44 38.33 4.33 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.072 1.349 . . . . 0.0 111.305 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.17 148.14 34.21 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.819 0.848 . . . . 0.0 110.447 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.68 173.83 9.94 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.636 1.975 . . . . 0.0 115.062 -173.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -60.88 -53.98 50.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.747 1.219 . . . . 0.0 113.507 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -78.39 -19.18 53.87 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.436 1.494 . . . . 0.0 114.731 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.55 148.72 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -173.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -129.32 162.88 26.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.186 1.794 . . . . 0.0 110.399 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -59.16 -28.67 66.81 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 119.47 -2.019 . . . . 0.0 112.403 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -58.13 -30.97 66.75 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -72.7 -36.28 67.81 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 173.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.25 -27.35 66.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.626 0.77 . . . . 0.0 111.692 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.34 -31.33 61.63 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.823 0.849 . . . . 0.0 112.748 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -61.35 -30.03 70.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.013 1.325 . . . . 0.0 111.697 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.7 mt -106.6 -57.66 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.682 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -58.85 -30.77 67.95 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -76.53 -8.74 86.1 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.87 -0.961 . . . . 0.0 114.661 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -64.82 -21.74 66.85 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.376 1.588 . . . . 0.0 112.63 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -92.64 4.46 53.63 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.874 1.67 . . . . 0.0 113.566 -177.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.7 108.73 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.289 1.836 . . . . 0.0 110.622 -171.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -64.53 99.86 0.33 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.311 17.8 m-85 -62.62 -16.18 55.4 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 64.7 m -64.83 -16.12 62.7 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 169.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 16.4 m -130.49 117.82 20.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.443 1.097 . . . . 0.0 112.713 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -60.44 -39.94 89.29 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.007 -1.058 . . . . 0.0 112.39 -174.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.6 t -56.44 -13.95 2.66 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -86.91 -63.84 1.25 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.983 0.913 . . . . 0.0 109.546 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.9 ptt85 -69.81 -22.78 63.28 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.517 1.527 . . . . 0.0 114.16 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.8 tt -57.87 -35.39 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.257 1.023 . . . . 0.0 111.899 171.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 21.6 mtm -90.37 -2.95 58.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.948 1.299 . . . . 0.0 112.228 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -105.89 129.56 54.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.77 2.028 . . . . 0.0 116.086 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -166.14 149.03 7.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.963 1.305 . . . . 0.0 109.399 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.9 mt -120.65 136.53 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.494 1.518 . . . . 0.0 111.807 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -114.74 141.33 47.99 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.974 1.31 . . . . 0.0 110.571 158.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 13.7 tp -120.61 114.54 21.87 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.562 1.545 . . . . 0.0 109.212 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -71.28 120.33 16.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.98 1.312 . . . . 0.0 109.274 169.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . 0.423 ' O ' ' HE2' ' A' ' 466' ' ' LYS . 10.1 mtpt -113.51 12.86 18.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.753 1.621 . . . . 0.0 113.035 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -142.23 152.65 43.29 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.306 1.843 . . . . 0.0 112.126 -167.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 59.58 -144.08 46.14 Favored Glycine 0 CA--C 1.534 1.269 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 161.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.75 -12.71 2.02 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.065 2.146 . . . . 0.0 116.335 -172.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 24.9 ptp -145.44 41.13 1.23 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.507 1.123 . . . . 0.0 112.539 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 461' ' ' LYS . 23.6 ttmt -60.38 122.44 14.56 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.409 1.084 . . . . 0.0 112.256 175.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.65 37.91 18.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.411 1.958 . . . . 0.0 112.858 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -125.83 148.33 49.18 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.211 1.004 . . . . 0.0 110.892 173.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -138.94 151.59 47.02 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -109.08 137.98 46.14 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.829 2.051 . . . . 0.0 114.394 169.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.5 119.77 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.197 1.399 . . . . 0.0 109.968 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -85.2 142.04 19.5 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 162.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 19.3 mt -122.64 160.87 46.78 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.35 1.46 . . . . 0.0 110.343 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.01 -13.07 21.49 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.045 2.497 . . . . 0.0 114.55 -174.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -153.07 146.13 24.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.513 1.125 . . . . 0.0 110.254 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -52.31 -38.82 59.51 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.933 0.893 . . . . 0.0 111.95 165.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -61.42 -37.16 82.48 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.288 1.035 . . . . 0.0 113.122 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.36 90.84 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.262 -0.274 . . . . 0.0 110.947 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.3 -48.43 67.64 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.605 -0.684 . . . . 0.0 112.741 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.66 -28.05 68.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.306 1.042 . . . . 0.0 112.689 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -85.22 -44.27 13.06 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.048 0.939 . . . . 0.0 113.348 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.51 -33.21 71.08 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.881 1.219 . . . . 0.0 112.709 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.2 mt -65.47 -40.04 92.69 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.424 1.09 . . . . 0.0 112.989 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -63.34 -42.18 98.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.077 0.551 . . . . 0.0 111.454 174.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -78.87 -43.83 24.17 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -175.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.39 57.54 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -64.12 99.23 0.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.701 1.2 . . . . 0.0 112.245 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 115.45 1.6 21.65 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.469 -1.184 . . . . 0.0 115.044 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -74.44 110.4 8.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.944 1.372 . . . . 0.0 108.929 -169.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.275 6.4 p -93.71 65.77 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.054 1.742 . . . . 0.0 110.372 -170.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.79 129.42 39.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.199 1.8 . . . . 0.0 110.66 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.272 64.0 m-85 54.18 21.81 3.25 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -176.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 86.35 10.22 74.5 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 117.983 -1.454 . . . . 0.0 115.566 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -121.78 115.65 30.66 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 120.217 2.008 . . . . 0.0 111.751 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.44 112.41 3.54 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 123.868 3.045 . . . . 0.0 111.696 -174.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 80.1 mtp -73.64 131.44 41.67 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.855 1.262 . . . . 0.0 113.566 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 24.8 t -90.15 90.07 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.599 1.56 . . . . 0.0 111.502 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.17 129.47 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.889 1.276 . . . . 0.0 114.308 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -149.47 155.57 40.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.847 0.859 . . . . 0.0 112.953 -170.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -53.96 142.05 25.96 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 169.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -58.74 159.4 6.8 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.729 -0.607 . . . . 0.0 112.236 177.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -72.14 10.97 0.63 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -166.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 49.2 m -76.12 150.0 37.28 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.625 2.37 . . . . 0.0 112.98 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -64.47 159.38 21.6 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.775 1.23 . . . . 0.0 113.434 172.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -147.07 84.15 7.54 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 123.619 0.767 . . . . 0.0 112.719 173.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.39 162.9 16.2 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.529 2.82 . . . . 0.0 113.477 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 41.7 tptt 51.85 41.59 29.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.799 1.64 . . . . 0.0 114.084 168.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -104.59 -176.73 3.16 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.92 -1.113 . . . . 0.0 112.79 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.79 141.24 92.96 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 173.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.8 158.22 53.55 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.051 2.5 . . . . 0.0 112.664 177.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 153.39 10.66 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.37 1.068 . . . . 0.0 113.471 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -155.62 137.7 14.62 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.039 1.336 . . . . 0.0 111.19 -176.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 166.29 -177.04 41.42 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.509 0.576 . . . . 0.0 114.422 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -73.55 154.2 39.93 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.334 1.054 . . . . 0.0 110.945 168.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -138.51 120.92 16.02 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.83 1.252 . . . . 0.0 112.099 -171.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 25.4 pttm . . . . . 0 C--O 1.253 1.242 0 C-N-CA 125.25 1.42 . . . . 0.0 113.699 -178.909 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 111.41 0.152 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -124.43 -28.25 3.65 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 117.484 2.402 . . . . 0.0 117.484 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -134.27 -177.69 4.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.46 1.504 . . . . 0.0 111.715 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 88.5 mmm 58.51 88.16 0.13 Allowed Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 115.567 1.692 . . . . 0.0 115.567 169.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.71 164.21 34.16 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.683 2.922 . . . . 0.0 113.004 173.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 48.8 m -138.65 51.76 1.82 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.341 1.856 . . . . 0.0 110.611 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -156.25 124.13 5.61 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.759 1.224 . . . . 0.0 111.198 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 14.0 p -142.56 165.07 28.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.65 1.18 . . . . 0.0 113.474 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.3 tt -69.02 152.31 9.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 125.65 1.58 . . . . 0.0 111.678 -168.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 59.4 m -84.67 147.87 26.71 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.435 0.694 . . . . 0.0 110.429 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -58.06 -43.01 86.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.414 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -61.43 -29.87 70.21 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.324 1.45 . . . . 0.0 114.52 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -78.14 -49.69 13.4 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.39 1.076 . . . . 0.0 112.696 171.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 26.1 tp -57.89 -42.29 84.35 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.56 0.744 . . . . 0.0 112.096 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -58.67 -21.22 53.72 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.592 1.557 . . . . 0.0 114.977 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -75.76 -34.01 60.23 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.184 0.994 . . . . 0.0 112.753 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -93.66 75.26 1.13 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.026 1.298 . . . . 0.0 112.183 170.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -158.04 146.82 19.19 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.246 1.018 . . . . 0.0 111.008 -171.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 9.1 pt -128.66 157.84 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.45 1.5 . . . . 0.0 111.819 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 21.6 t -105.03 174.74 5.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.538 1.535 . . . . 0.0 111.047 166.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 21.6 mtp85 -57.93 -23.53 53.86 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.007 1.323 . . . . 0.0 113.402 175.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -54.61 -35.88 63.86 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.076 1.751 . . . . 0.0 111.856 171.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -99.18 -35.4 10.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.419 1.088 . . . . 0.0 112.526 169.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 26.3 ttp -65.18 -38.42 90.47 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.49 -1.381 . . . . 0.0 112.36 -172.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -80.23 17.26 1.06 Allowed 'General case' 0 CA--C 1.55 0.962 0 O-C-N 121.349 -0.845 . . . . 0.0 112.123 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.98 -30.37 2.72 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.405 2.282 . . . . 0.0 115.005 176.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 35.6 mt -74.22 137.92 43.36 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.59 1.956 . . . . 0.0 112.48 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 47.0 t -67.98 -36.61 80.34 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.036 0.934 . . . . 0.0 111.834 172.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.5 m -59.16 -14.41 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.261 94.0 m-85 -116.58 16.74 15.48 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 170.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -8.47 12.53 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 16.7 p -148.52 -46.05 0.15 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.828 2.051 . . . . 0.0 112.527 -159.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -81.79 140.52 34.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.222 1.809 . . . . 0.0 113.783 -175.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -134.57 123.0 16.04 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.792 0.837 . . . . 0.0 112.921 -169.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.3 174.49 9.87 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.354 3.37 . . . . 0.0 113.357 170.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.1 -16.71 20.94 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.671 1.605 . . . . 0.0 116.798 170.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -57.53 139.21 81.22 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 118.801 1.3 . . . . 0.0 112.661 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.48 108.73 2.09 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.773 2.315 . . . . 0.0 112.083 -172.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 7.5 t30 -156.64 149.41 23.75 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.693 1.597 . . . . 0.0 109.269 167.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.4 p -86.1 -10.71 54.39 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 173.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . 0.448 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 33.6 mtm180 -106.26 142.32 36.13 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.957 0.903 . . . . 0.0 110.022 172.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.16 162.59 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.373 1.469 . . . . 0.0 110.44 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -144.47 161.07 39.98 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.0 t -139.22 131.92 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.196 1.399 . . . . 0.0 113.422 -165.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -98.81 163.77 12.48 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.582 1.153 . . . . 0.0 111.904 167.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.287 98.0 m-20 75.78 34.9 0.54 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.925 2.09 . . . . 0.0 116.592 172.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.95 160.59 29.05 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.182 -0.949 . . . . 0.0 111.143 167.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.33 177.7 5.7 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.074 1.75 . . . . 0.0 114.172 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -82.41 -48.44 11.12 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.983 -1.073 . . . . 0.0 110.544 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -69.49 -18.98 63.74 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.2 p -77.08 139.84 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 121.008 -1.057 . . . . 0.0 113.08 171.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -120.65 167.22 12.67 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.189 1.396 . . . . 0.0 111.703 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.97 -34.1 58.81 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.94 -1.1 . . . . 0.0 112.657 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -59.97 -23.44 63.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.163 1.385 . . . . 0.0 114.675 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -87.57 -33.43 18.9 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.05 -19.69 64.63 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.699 1.6 . . . . 0.0 112.645 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -25.16 49.19 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.381 1.073 . . . . 0.0 112.869 174.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -60.01 -34.78 73.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.573 0.749 . . . . 0.0 112.4 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 4.4 mt -103.3 -57.0 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.635 -0.666 . . . . 0.0 110.739 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -59.55 -29.49 67.96 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.95 -11.41 84.73 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.806 -0.997 . . . . 0.0 114.847 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -62.49 -36.2 81.77 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.015 1.407 . . . . 0.0 111.435 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -77.47 3.37 13.59 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.926 1.69 . . . . 0.0 114.989 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 14.9 t -123.94 126.08 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.942 1.697 . . . . 0.0 110.593 -173.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -59.63 133.3 55.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -73.43 -23.14 60.09 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 99.0 p -92.14 -51.72 5.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.695 1.198 . . . . 0.0 113.262 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.2 m -76.45 118.78 19.48 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.412 0.685 . . . . 0.0 111.718 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -54.65 -49.59 70.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.115 1.366 . . . . 0.0 112.098 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.7 t -54.97 -15.2 1.85 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -88.75 -62.97 1.37 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.239 1.015 . . . . 0.0 110.228 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.17 -26.27 63.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.048 0.939 . . . . 0.0 113.253 -175.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.9 tt -58.18 -40.34 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.816 0.847 . . . . 0.0 111.857 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 9.2 mtm -86.93 -9.12 56.42 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.944 0.898 . . . . 0.0 112.334 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -87.6 125.83 34.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.853 1.661 . . . . 0.0 115.281 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -163.11 136.15 5.63 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.322 1.449 . . . . 0.0 110.195 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 10.7 mt -113.06 143.14 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.769 1.228 . . . . 0.0 111.55 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -129.57 143.21 50.73 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.822 1.649 . . . . 0.0 110.623 160.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 19.1 tp -123.59 119.65 30.52 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.871 2.069 . . . . 0.0 110.098 174.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -81.84 143.38 31.77 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.487 1.515 . . . . 0.0 112.25 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -130.9 8.99 4.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.107 1.763 . . . . 0.0 114.816 -167.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -145.49 143.38 29.96 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.615 1.166 . . . . 0.0 113.292 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 78.92 -160.58 46.8 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 126.514 2.007 . . . . 0.0 114.521 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.02 -18.05 59.28 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.833 -1.393 . . . . 0.0 113.269 172.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 98.2 mmm -83.86 -1.49 54.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.153 1.781 . . . . 0.0 114.546 171.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.6 127.0 29.34 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.701 -1.249 . . . . 0.0 111.834 176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.71 17.93 80.04 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.779 -175.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -108.33 139.77 42.56 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.799 0.8 . . . . 0.0 112.188 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -123.06 147.42 46.73 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.876 1.27 . . . . 0.0 112.736 -174.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -107.14 140.59 39.75 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.323 1.449 . . . . 0.0 114.629 161.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.61 113.81 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.239 1.816 . . . . 0.0 109.032 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -76.38 125.24 7.58 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 160.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 37.4 mt -101.15 159.77 28.54 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.126 0.963 . . . . 0.0 109.484 165.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.3 -10.46 17.61 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.895 1.73 . . . . 0.0 114.222 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -151.16 138.67 19.55 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.467 1.107 . . . . 0.0 110.583 -171.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -56.18 -35.23 66.99 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 171.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -62.07 -42.29 99.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.844 0.747 . . . . 0.0 112.608 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.9 92.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.127 0.571 . . . . 0.0 111.24 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.56 -50.43 63.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.437 0.562 . . . . 0.0 112.418 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.24 72.63 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.75 1.159 . . . . 0.0 112.047 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -70.9 -46.58 62.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.085 1.354 . . . . 0.0 112.834 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.15 -37.4 77.2 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.771 0.714 . . . . 0.0 112.415 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 79.8 mt -70.41 -25.84 63.41 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.667 1.187 . . . . 0.0 112.548 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.61 -24.29 36.51 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.711 1.204 . . . . 0.0 112.647 175.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -104.87 -48.08 3.85 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.74 -15.88 58.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.621 1.168 . . . . 0.0 113.468 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -73.65 112.66 9.96 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.442 -0.787 . . . . 0.0 109.666 -174.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 110.32 -4.82 29.9 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 118.858 -0.968 . . . . 0.0 115.298 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -69.48 129.43 39.69 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.492 1.146 . . . . 0.0 108.54 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.252 3.5 p -120.81 68.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 124.394 2.045 . . . . 0.0 108.87 -162.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 39.2 tp -61.25 139.15 58.2 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 112.763 -2.017 . . . . 0.0 109.588 168.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.324 75.5 t80 61.05 13.97 5.04 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 173.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 80.1 11.02 84.87 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.476 1.512 . . . . 0.0 114.896 -171.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -121.86 120.57 28.48 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 126.472 1.909 . . . . 0.0 110.832 -173.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.71 121.84 7.71 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 C-N-CA 122.774 2.316 . . . . 0.0 110.79 -175.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 59.9 mtp -76.89 129.79 36.68 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.919 1.688 . . . . 0.0 112.293 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 4.4 t -92.46 90.42 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.681 1.592 . . . . 0.0 112.306 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.6 t -85.67 120.52 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.989 1.315 . . . . 0.0 112.102 -172.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -135.99 157.38 46.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.22 1.008 . . . . 0.0 113.63 -168.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -59.74 145.41 45.23 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 163.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -56.03 140.76 42.44 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -82.21 49.29 1.39 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.614 1.166 . . . . 0.0 112.693 -173.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 16.4 m -68.07 -30.31 69.48 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.903 1.281 . . . . 0.0 114.146 -165.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -79.76 -14.96 58.35 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.188 0.995 . . . . 0.0 113.682 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 43.58 54.66 11.21 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 126.637 1.975 . . . . 0.0 114.03 169.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.11 144.36 81.48 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.1 2.533 . . . . 0.0 113.348 -172.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -54.3 121.77 8.94 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.719 1.608 . . . . 0.0 113.976 -168.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -63.18 133.28 54.07 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.228 1.411 . . . . 0.0 112.039 175.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -61.46 145.14 91.44 Favored Pre-proline 0 N--CA 1.475 0.81 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 170.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.0 158.02 38.39 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.868 2.379 . . . . 0.0 113.566 -173.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.01 160.04 0.79 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.895 -1.502 . . . . 0.0 114.053 161.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -83.8 169.31 15.31 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.872 1.269 . . . . 0.0 111.188 162.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -70.96 19.01 0.77 Allowed Glycine 0 CA--C 1.539 1.553 0 N-CA-C 116.553 1.381 . . . . 0.0 116.553 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -64.09 110.33 2.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.729 1.611 . . . . 0.0 109.938 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -152.95 135.99 15.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.567 1.947 . . . . 0.0 110.855 -167.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 53.8 mttp . . . . . 0 C--O 1.253 1.242 0 C-N-CA 124.864 1.266 . . . . 0.0 113.645 176.196 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 19.5 p -129.79 167.37 18.2 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.58 1.952 . . . . 0.0 109.951 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.3 tt -68.92 144.38 14.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 O-C-N 121.511 -0.743 . . . . 0.0 111.106 -160.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 62.0 m -84.11 150.63 25.42 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.159 -0.338 . . . . 0.0 111.471 172.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 42.5 ttp85 -59.37 -41.24 88.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.54 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -61.67 -29.83 70.33 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -80.29 -44.39 19.67 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.449 1.1 . . . . 0.0 113.121 171.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.416 HD12 ' CD2' ' A' ' 489' ' ' TYR . 22.3 tp -59.18 -46.07 89.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.725 0.81 . . . . 0.0 112.145 175.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -60.3 -21.9 62.53 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -63.26 -33.87 76.43 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.889 0.768 . . . . 0.0 112.328 171.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -107.41 84.19 0.37 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.999 1.285 . . . . 0.0 110.958 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -161.34 152.51 18.59 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.259 0.624 . . . . 0.0 110.555 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.6 pt -127.76 151.07 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.131 0.972 . . . . 0.0 112.868 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 92.1 p -76.75 166.13 23.79 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.203 1.401 . . . . 0.0 112.057 162.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -57.03 -24.51 54.26 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 168.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -71.89 -37.28 70.17 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.493 1.517 . . . . 0.0 111.815 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -80.08 -37.04 34.61 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.487 0.715 . . . . 0.0 110.548 167.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 27.6 ttm -59.74 -46.86 87.84 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.614 -1.304 . . . . 0.0 112.161 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -78.8 15.0 1.15 Allowed 'General case' 0 CA--C 1.552 1.032 0 O-C-N 120.627 -1.296 . . . . 0.0 112.74 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.69 -31.92 5.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.28 2.632 . . . . 0.0 114.474 171.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 34.1 mt -75.54 133.69 40.93 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.857 1.663 . . . . 0.0 111.755 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 91.5 p -63.31 -32.32 73.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.277 1.031 . . . . 0.0 112.17 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.71 -15.34 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.328 78.0 m-85 -106.66 8.38 31.07 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -54.06 -16.27 1.88 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 118.105 2.632 . . . . 0.0 118.105 -165.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.4 m -147.6 14.19 1.07 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.589 1.155 . . . . 0.0 113.98 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -130.49 130.72 44.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.221 1.008 . . . . 0.0 109.465 -162.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -143.87 133.01 11.41 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.153 1.381 . . . . 0.0 113.183 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.02 -178.77 4.0 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 125.207 3.938 . . . . 0.0 114.982 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 96.52 -9.7 66.8 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 164.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -68.92 150.74 97.53 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 119.031 1.416 . . . . 0.0 113.204 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.11 114.35 4.01 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.767 2.978 . . . . 0.0 111.923 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.51 142.65 12.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.25 1.42 . . . . 0.0 107.579 168.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.5 p -77.51 -14.02 59.78 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.406 1.082 . . . . 0.0 112.691 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -107.33 141.09 39.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.531 1.132 . . . . 0.0 109.029 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 4.8 pt -126.94 159.21 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 125.504 1.522 . . . . 0.0 109.429 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -140.63 160.17 40.59 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.9 t -134.25 137.19 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.191 1.396 . . . . 0.0 111.261 -172.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -112.11 165.83 11.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.136 0.974 . . . . 0.0 109.961 166.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.3 t30 65.81 36.07 6.36 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.721 1.209 . . . . 0.0 113.491 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.95 153.78 42.81 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.422 -0.798 . . . . 0.0 110.294 163.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.76 148.45 49.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.857 0.863 . . . . 0.0 113.029 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -62.06 -34.04 75.52 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.767 -1.208 . . . . 0.0 111.141 158.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -60.86 -10.2 5.27 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.545 1.938 . . . . 0.0 115.418 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.1 p -121.13 155.99 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -170.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -119.53 161.65 20.23 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.619 1.567 . . . . 0.0 111.122 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -55.08 -35.38 64.51 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.955 -1.091 . . . . 0.0 113.059 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -63.63 -16.68 61.6 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.108 1.363 . . . . 0.0 114.585 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -91.64 -31.68 15.76 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.15 -21.36 66.52 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.319 -0.863 . . . . 0.0 112.315 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -48.57 -35.14 12.8 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.068 1.347 . . . . 0.0 112.813 169.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -58.6 -35.34 72.29 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.0 mt -98.6 -57.88 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.284 0.634 . . . . 0.0 110.298 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.291 59.6 m-85 -60.7 -30.38 69.92 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.44 -6.91 86.96 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.104 0.859 . . . . 0.0 114.669 173.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -56.36 -34.02 66.24 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.341 1.57 . . . . 0.0 111.412 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.96 9.8 26.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.106 1.762 . . . . 0.0 113.855 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.36 113.49 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.554 1.541 . . . . 0.0 109.535 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.77 80.17 0.19 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -54.7 -18.2 4.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 119.013 2.968 . . . . 0.0 119.013 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.4 m -71.75 -12.64 61.41 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.563 1.074 . . . . 0.0 112.857 170.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.7 m -115.15 116.49 28.47 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.191 1.796 . . . . 0.0 111.867 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -59.06 -43.41 91.74 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.216 -0.928 . . . . 0.0 112.704 -173.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.3 t -55.96 -14.56 2.59 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -88.09 -60.99 1.82 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.697 0.761 . . . . 0.0 110.018 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -69.69 -25.82 64.06 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.127 1.371 . . . . 0.0 113.876 -173.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.8 tt -55.25 -35.91 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.057 1.343 . . . . 0.0 112.098 170.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 10.5 mtm -90.03 -3.93 57.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.343 1.057 . . . . 0.0 112.614 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -101.12 134.21 44.48 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.244 2.217 . . . . 0.0 115.994 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -166.16 156.71 12.73 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.212 1.405 . . . . 0.0 108.183 174.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.2 mt -130.82 134.94 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.741 1.216 . . . . 0.0 110.283 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -120.81 132.8 55.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.891 0.876 . . . . 0.0 109.873 159.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 4.1 tt -103.2 133.29 48.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.155 1.382 . . . . 0.0 110.006 168.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.61 91.68 3.43 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 125.767 1.627 . . . . 0.0 110.846 171.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -67.95 -23.82 65.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 -174.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.415 ' HA ' ' HE3' ' A' ' 466' ' ' LYS . 26.0 pt-20 -154.76 175.03 14.23 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -175.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 87.79 -169.05 38.34 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.669 1.604 . . . . 0.0 114.15 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 4.02 1.99 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 74.1 mtp -129.98 20.21 5.44 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.965 2.506 . . . . 0.0 112.437 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 462' ' ' GLU . 35.9 ttmt -52.08 138.85 24.47 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.994 1.318 . . . . 0.0 111.803 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.78 32.56 61.16 Favored Glycine 0 CA--C 1.524 0.619 0 O-C-N 121.809 -0.557 . . . . 0.0 111.81 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.71 155.49 20.13 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.683 1.193 . . . . 0.0 110.79 165.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -148.27 148.19 30.19 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.143 -0.973 . . . . 0.0 112.733 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -113.05 138.24 50.2 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.761 1.624 . . . . 0.0 114.768 167.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.7 112.72 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.164 1.786 . . . . 0.0 109.482 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -78.79 134.55 14.14 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 159.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 20.2 mt -109.39 161.96 21.99 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.226 1.41 . . . . 0.0 109.913 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.53 -12.3 29.17 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.031 2.487 . . . . 0.0 113.654 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -153.5 142.66 21.4 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.703 0.683 . . . . 0.0 112.013 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -60.12 -29.88 68.91 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -67.94 -36.42 80.1 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 170.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -66.48 -39.32 88.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.79 0.436 . . . . 0.0 110.663 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.39 -43.16 86.63 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.512 -0.743 . . . . 0.0 112.638 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -55.78 -43.52 76.85 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.35 0.977 . . . . 0.0 111.78 176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -65.69 -52.86 48.14 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.081 1.352 . . . . 0.0 111.773 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.27 71.44 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.54 HD23 HG12 ' A' ' 498' ' ' VAL . 51.3 mt -68.95 -39.05 79.76 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.929 -1.107 . . . . 0.0 110.712 173.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -68.07 -22.77 64.91 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.794 1.238 . . . . 0.0 112.44 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -110.14 -39.73 4.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -84.45 -17.75 38.17 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -75.45 117.33 17.12 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.097 -1.002 . . . . 0.0 112.308 -168.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 101.47 3.24 53.44 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.231 -1.316 . . . . 0.0 115.043 -169.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.416 ' CD2' HD12 ' A' ' 394' ' ' LEU . 72.7 t80 -69.08 125.49 26.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.482 1.641 . . . . 0.0 113.48 -169.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.266 1.9 t -86.01 46.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.632 1.573 . . . . 0.0 114.836 -162.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 57.3 tp -58.85 120.26 8.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.47 1.508 . . . . 0.0 111.71 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.334 72.1 m-85 55.22 21.25 3.89 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -173.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 98.31 -6.41 61.42 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.689 1.614 . . . . 0.0 115.015 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -106.15 122.11 43.33 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.182 1.491 . . . . 0.0 111.864 -170.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.75 105.92 2.17 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.416 2.744 . . . . 0.0 112.548 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 44.1 mtp -67.41 131.82 46.44 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.999 1.32 . . . . 0.0 113.403 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.52 84.7 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.901 2.081 . . . . 0.0 110.945 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.54 HG12 HD23 ' A' ' 483' ' ' LEU . 4.0 t -87.28 125.79 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 126.578 1.951 . . . . 0.0 112.321 -170.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -141.63 158.73 43.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.654 1.181 . . . . 0.0 113.046 -170.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -61.24 146.41 47.92 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 166.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 122.586 1.184 . . . . 0.0 112.233 -175.901 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 122.418 1.104 . . . . 0.0 111.99 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -143.28 167.66 21.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.132 1.373 . . . . 0.0 112.151 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.8 tt -78.68 154.29 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.855 1.262 . . . . 0.0 111.989 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 30.6 t -91.01 154.07 19.69 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.235 0.614 . . . . 0.0 111.101 167.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -44.26 -43.09 7.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.034 1.333 . . . . 0.0 112.502 164.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -71.55 -18.19 62.27 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -89.44 -39.34 13.44 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.177 -0.952 . . . . 0.0 113.445 165.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.38 -48.65 69.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.201 1.0 . . . . 0.0 112.788 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -56.8 -25.89 56.72 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.76 1.624 . . . . 0.0 113.941 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.86 -44.87 84.12 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.91 1.284 . . . . 0.0 110.832 175.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.55 78.08 0.73 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.308 1.432 . . . . 0.0 113.196 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -157.48 149.47 22.39 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.642 1.577 . . . . 0.0 109.642 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.7 pt -127.83 149.97 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.9 0.88 . . . . 0.0 111.567 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 8.8 m -80.41 167.78 19.78 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.89 0.876 . . . . 0.0 112.228 169.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -55.92 -29.22 59.73 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.271 -0.893 . . . . 0.0 112.765 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.63 -31.79 69.83 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.56 1.944 . . . . 0.0 113.309 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.57 -34.29 14.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.502 1.121 . . . . 0.0 110.947 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 9.7 ttm -61.26 -39.29 89.81 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.952 -1.092 . . . . 0.0 111.279 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.15 26.41 0.88 Allowed 'General case' 0 CA--C 1.552 1.056 0 O-C-N 120.846 -1.159 . . . . 0.0 112.455 172.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.51 -34.81 1.17 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.109 2.563 . . . . 0.0 113.858 174.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.37 134.0 42.48 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.803 1.641 . . . . 0.0 112.613 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 27.1 t -59.43 -37.86 79.18 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.707 0.803 . . . . 0.0 113.092 172.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.421 HG23 ' CD2' ' A' ' 410' ' ' PHE 0.27 3.1 m -60.44 -11.05 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 171.68 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.421 ' CD2' HG23 ' A' ' 409' ' ' VAL . 79.0 m-85 -122.49 11.2 9.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 119.237 3.051 . . . . 0.0 119.237 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -14.28 16.27 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -173.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.53 -27.48 1.18 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.556 1.542 . . . . 0.0 114.423 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -69.83 136.56 50.92 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -144.86 124.98 7.25 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.53 171.97 16.66 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.128 3.219 . . . . 0.0 111.629 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.48 -4.79 33.02 Favored Glycine 0 N--CA 1.48 1.594 0 N-CA-C 117.33 1.692 . . . . 0.0 117.33 170.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -74.58 131.75 79.41 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 119.079 1.439 . . . . 0.0 111.817 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.12 112.92 2.43 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.105 2.537 . . . . 0.0 111.032 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -159.9 145.7 15.61 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.605 1.162 . . . . 0.0 109.498 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 21.3 p -86.1 -8.35 57.94 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -117.95 148.54 42.09 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.667 1.187 . . . . 0.0 110.07 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 17.8 pt -135.01 166.35 28.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.474 1.91 . . . . 0.0 110.046 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -137.93 163.64 31.0 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.88 143.85 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.652 1.581 . . . . 0.0 111.573 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -126.65 168.81 13.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.658 1.983 . . . . 0.0 109.905 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 12.9 t30 68.5 31.25 4.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.817 1.247 . . . . 0.0 112.808 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -74.54 144.51 44.01 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.018 -1.051 . . . . 0.0 111.856 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.34 156.98 17.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.928 1.691 . . . . 0.0 114.778 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -59.55 -45.74 90.93 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.238 -0.914 . . . . 0.0 112.964 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -70.87 -26.94 63.47 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -175.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.15 152.65 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -172.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -129.41 162.1 28.83 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.732 2.013 . . . . 0.0 111.038 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -53.22 -30.84 40.12 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.096 1.358 . . . . 0.0 113.401 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -58.06 -25.85 61.77 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.166 1.787 . . . . 0.0 115.282 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -90.02 -28.55 19.0 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.5 mp -66.47 -19.99 65.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.32 1.448 . . . . 0.0 112.206 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.44 -25.24 59.34 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 174.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -61.47 -36.33 80.12 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.941 0.791 . . . . 0.0 111.477 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.4 mp -96.78 -56.58 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.202 0.601 . . . . 0.0 110.679 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.258 70.1 m-85 -60.11 -32.99 71.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.82 -7.24 87.41 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.062 0.839 . . . . 0.0 114.522 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -61.2 -39.71 91.2 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.842 1.321 . . . . 0.0 111.46 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -81.06 -0.79 41.41 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.585 1.954 . . . . 0.0 113.815 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 36.0 t -115.09 116.53 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.718 1.207 . . . . 0.0 109.996 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.262 4.2 m-20 -68.72 90.97 0.42 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 176.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -61.74 -16.53 50.12 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 119.006 2.965 . . . . 0.0 119.006 -173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 71.0 m -79.09 1.5 24.0 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.01 0.924 . . . . 0.0 113.361 168.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 11.1 t -126.89 112.68 15.6 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.65 1.18 . . . . 0.0 110.947 -173.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -59.86 -47.14 86.95 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.243 -0.911 . . . . 0.0 112.274 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 3.9 t -55.92 -15.24 3.13 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -89.21 -58.39 2.55 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.221 1.008 . . . . 0.0 110.685 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -71.59 -25.58 62.24 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.716 1.206 . . . . 0.0 113.432 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.3 tt -56.65 -33.12 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.263 1.425 . . . . 0.0 112.151 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -87.51 -5.81 58.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.308 1.443 . . . . 0.0 112.964 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -115.81 120.11 38.19 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -162.41 155.34 19.87 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.327 1.451 . . . . 0.0 107.61 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.1 mt -125.05 137.6 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.767 1.627 . . . . 0.0 110.499 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 -127.51 128.78 46.24 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.395 1.478 . . . . 0.0 109.485 165.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 14.1 tp -111.18 134.91 52.41 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.439 1.896 . . . . 0.0 109.308 170.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 50.7 mtm -89.38 133.18 34.62 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 126.518 1.927 . . . . 0.0 111.151 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -129.45 11.53 5.83 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -167.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -136.98 153.16 50.76 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.555 1.142 . . . . 0.0 112.476 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 70.66 -160.75 53.8 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.659 1.123 . . . . 0.0 115.379 171.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -6.11 27.37 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.732 1.613 . . . . 0.0 115.269 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 95.8 mmm -102.39 1.23 35.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.563 1.545 . . . . 0.0 114.611 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -62.31 132.99 54.48 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.639 1.563 . . . . 0.0 110.651 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.56 29.36 36.21 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.98 0.8 . . . . 0.0 113.597 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -121.09 148.05 44.7 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.444 1.098 . . . . 0.0 112.265 165.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -140.35 155.24 46.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.427 1.491 . . . . 0.0 114.02 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -113.46 140.35 48.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.415 1.886 . . . . 0.0 115.711 167.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -138.06 128.28 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.764 1.626 . . . . 0.0 111.223 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.76 143.94 17.44 Favored Glycine 0 CA--C 1.534 1.246 0 O-C-N 121.434 -0.792 . . . . 0.0 111.955 164.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 31.7 mt -126.67 155.17 75.37 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.579 1.152 . . . . 0.0 110.799 172.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.47 -6.17 17.93 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.835 2.357 . . . . 0.0 114.94 -168.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -154.25 143.15 21.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.92 0.888 . . . . 0.0 110.606 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -56.29 -30.9 63.09 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.044 -1.035 . . . . 0.0 112.859 169.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -66.26 -41.17 90.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.274 0.943 . . . . 0.0 113.394 171.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.62 96.89 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 119.423 -0.322 . . . . 0.0 110.797 174.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.84 -46.62 77.84 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.763 0.711 . . . . 0.0 112.338 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.9 -41.97 83.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.277 0.944 . . . . 0.0 112.101 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -69.96 -45.8 66.63 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.527 1.131 . . . . 0.0 112.159 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -63.12 -31.56 72.73 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.609 HD23 HG12 ' A' ' 498' ' ' VAL . 26.6 mt -69.32 -45.98 68.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.634 1.106 . . . . 0.0 110.549 172.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -59.92 -34.38 73.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.97 1.308 . . . . 0.0 111.86 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -88.11 -49.52 6.97 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.22 -23.87 37.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -167.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -73.08 104.62 4.22 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.816 -0.553 . . . . 0.0 109.602 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 117.82 -6.8 15.59 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 117.829 -1.539 . . . . 0.0 116.134 -167.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -65.67 132.64 49.29 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.064 1.932 . . . . 0.0 113.874 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.281 0.2 OUTLIER -94.06 47.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -157.505 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 31.5 tp -54.9 122.02 9.91 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.016 1.326 . . . . 0.0 111.342 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.385 50.5 m-85 59.42 12.97 2.95 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 -173.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 89.15 1.42 79.15 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.046 -1.034 . . . . 0.0 114.306 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -107.06 125.13 33.28 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 126.235 1.814 . . . . 0.0 111.012 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.05 121.06 7.5 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.034 2.49 . . . . 0.0 112.644 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 71.5 mtp -73.01 127.58 32.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.163 1.385 . . . . 0.0 111.347 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 92.7 t -92.55 95.89 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.352 1.861 . . . . 0.0 109.041 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.609 HG12 HD23 ' A' ' 483' ' ' LEU . 15.2 t -100.07 114.54 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.399 2.28 . . . . 0.0 112.296 -172.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.09 162.5 32.75 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -56.91 144.98 31.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.418 1.087 . . . . 0.0 110.27 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -176.007 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 . . . . . 0 C--O 1.236 0.361 0 CA-C-O 121.396 0.617 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.3 p -148.0 161.9 40.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.328 1.451 . . . . 0.0 114.761 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.3 tt -69.87 158.64 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 126.177 1.791 . . . . 0.0 111.8 -172.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 73.8 m -92.33 152.38 19.8 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.953 -0.467 . . . . 0.0 111.399 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -56.56 -41.31 76.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.2 0.6 . . . . 0.0 111.365 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.09 -35.86 79.96 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -77.71 -30.87 52.0 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.2 tt -65.17 -48.96 71.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.378 1.071 . . . . 0.0 111.274 171.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -54.42 -24.69 20.95 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.376 1.871 . . . . 0.0 115.711 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -67.53 -36.01 80.19 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.568 1.147 . . . . 0.0 111.959 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.61 76.37 0.73 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 125.992 1.758 . . . . 0.0 111.372 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -163.65 145.98 9.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.24 1.016 . . . . 0.0 110.155 -172.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.7 pt -124.8 148.97 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.116 0.966 . . . . 0.0 112.509 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 33.7 t -81.28 166.97 20.05 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.643 1.177 . . . . 0.0 110.695 165.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -53.29 -31.96 46.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.41 1.084 . . . . 0.0 112.905 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -59.15 -19.68 47.0 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.927 1.691 . . . . 0.0 113.075 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -111.83 -28.56 8.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.342 1.857 . . . . 0.0 111.934 171.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 15.7 ttm -67.01 -38.38 85.87 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.195 -1.566 . . . . 0.0 111.936 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -83.89 31.51 0.48 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.815 0.846 . . . . 0.0 111.062 169.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.98 -42.18 0.53 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.313 1.845 . . . . 0.0 115.404 171.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.39 128.43 35.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.648 0.779 . . . . 0.0 109.308 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 50.9 m -59.97 -33.53 72.07 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.329 0.651 . . . . 0.0 112.34 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 5.3 m -63.41 -25.58 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.288 82.6 m-85 -94.07 -9.71 35.77 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -21.5 0.85 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 -163.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 15.6 m -143.9 24.82 1.65 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.476 1.91 . . . . 0.0 112.081 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -122.0 132.3 54.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.428 2.291 . . . . 0.0 112.371 -173.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -142.28 131.98 12.3 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -164.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.1 176.73 8.57 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.566 2.844 . . . . 0.0 111.685 161.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.01 69.16 1.41 Allowed Glycine 0 CA--C 1.532 1.098 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 172.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -145.7 155.16 52.62 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 126.463 1.905 . . . . 0.0 110.833 165.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -82.24 84.74 1.78 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.978 3.119 . . . . 0.0 112.371 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -139.4 143.46 37.68 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.232 -0.917 . . . . 0.0 111.792 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 29.8 p -84.33 7.21 20.16 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -135.11 145.49 47.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.682 1.593 . . . . 0.0 110.082 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 24.1 pt -139.53 162.21 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.507 1.923 . . . . 0.0 109.706 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -133.4 161.77 33.64 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 123.193 1.473 . . . . 0.0 107.722 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.414 HG22 HG13 ' A' ' 498' ' ' VAL . 10.5 t -130.27 139.35 51.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.769 1.628 . . . . 0.0 110.834 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -119.68 168.23 11.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.184 1.794 . . . . 0.0 109.916 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 9.8 t30 68.31 32.38 4.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.657 1.183 . . . . 0.0 111.602 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.96 134.51 41.5 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.522 -0.736 . . . . 0.0 109.972 167.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.9 170.82 1.91 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -173.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -65.52 -50.04 66.74 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.772 1.229 . . . . 0.0 112.92 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -68.06 -42.17 80.88 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.46 152.45 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 127.258 2.223 . . . . 0.0 116.231 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -139.69 170.39 15.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.975 1.31 . . . . 0.0 112.488 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -54.51 -33.77 60.49 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.435 -1.415 . . . . 0.0 113.565 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 34.6 pttt -58.75 -39.46 80.99 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 171.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.28 -32.75 72.11 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.737 1.215 . . . . 0.0 113.538 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.6 mp -69.57 -27.61 65.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.677 1.191 . . . . 0.0 112.805 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -30.67 63.55 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.023 0.829 . . . . 0.0 112.293 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.08 -34.18 74.51 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.46 1.104 . . . . 0.0 111.845 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.12 -58.34 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.127 -0.983 . . . . 0.0 110.827 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -57.68 -29.57 64.75 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.51 -14.78 82.11 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.077 -0.846 . . . . 0.0 114.581 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -56.97 -37.05 71.05 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.263 1.531 . . . . 0.0 111.959 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.63 -7.48 53.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.353 1.461 . . . . 0.0 113.686 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 18.1 t -118.54 123.11 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.72 2.008 . . . . 0.0 110.929 -171.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -75.69 111.6 11.19 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -65.42 -15.13 62.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 70.5 m -89.23 -12.47 40.69 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.197 0.999 . . . . 0.0 113.402 172.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 24.1 t -111.72 109.44 19.3 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.252 1.021 . . . . 0.0 110.845 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -57.92 -45.33 86.68 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.563 -0.711 . . . . 0.0 111.739 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.74 -17.2 5.48 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -87.34 -61.21 1.77 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.31 1.044 . . . . 0.0 110.28 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -70.5 -19.31 62.93 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.084 1.353 . . . . 0.0 113.986 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.1 tt -63.66 -32.62 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.468 1.507 . . . . 0.0 112.531 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.1 mmm -86.88 -14.52 41.77 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.639 1.176 . . . . 0.0 112.42 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -96.13 124.59 40.19 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -171.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -160.51 146.3 15.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.31 143.94 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.305 1.042 . . . . 0.0 110.57 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 73.0 mtp85 -126.66 138.76 53.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.573 1.549 . . . . 0.0 109.858 164.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 2.1 tt -118.96 125.0 48.41 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.057 1.343 . . . . 0.0 110.153 167.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -82.01 125.93 31.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.053 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -115.48 4.92 14.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.065 1.346 . . . . 0.0 112.998 -165.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.6 157.16 34.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.105 2.162 . . . . 0.0 110.457 -170.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 72.22 -164.62 54.41 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.507 1.051 . . . . 0.0 115.445 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -21.57 55.67 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 82.8 mtp -101.32 12.0 38.24 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -55.27 122.57 11.4 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.552 1.523 . . . . 0.0 111.154 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.23 28.05 56.7 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.599 1.095 . . . . 0.0 112.835 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -112.84 155.75 24.11 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.704 1.202 . . . . 0.0 110.909 163.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -149.08 155.62 41.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.508 1.123 . . . . 0.0 112.764 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.46 137.78 54.41 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.58 124.96 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.814 1.645 . . . . 0.0 110.623 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.65 141.19 15.42 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 160.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.6 mt -119.45 157.42 51.62 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.878 1.271 . . . . 0.0 110.187 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.59 -5.99 17.64 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.515 2.143 . . . . 0.0 114.242 -173.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -148.93 138.82 22.06 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.979 1.312 . . . . 0.0 110.102 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.07 -37.39 71.79 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.7 -0.625 . . . . 0.0 111.753 168.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -60.61 -37.66 82.14 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -69.23 -38.02 78.31 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.674 0.79 . . . . 0.0 111.701 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.82 -45.77 81.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.55 1.068 . . . . 0.0 111.86 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.05 76.12 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.766 0.712 . . . . 0.0 112.284 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -69.2 -47.78 63.89 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.998 0.919 . . . . 0.0 112.336 173.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.52 -31.52 71.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.484 0.714 . . . . 0.0 112.65 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.646 HD23 HG12 ' A' ' 498' ' ' VAL . 66.7 mt -73.28 -31.94 64.36 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.514 1.126 . . . . 0.0 112.468 172.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -71.03 -34.29 71.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.304 0.642 . . . . 0.0 111.34 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -89.85 -54.86 3.87 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -73.52 -17.05 61.26 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -69.22 101.92 1.59 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.281 1.032 . . . . 0.0 110.225 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 114.66 -2.1 23.27 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 117.919 -1.49 . . . . 0.0 116.103 -172.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -68.71 120.53 14.84 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.316 2.058 . . . . 0.0 109.367 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.32 69.83 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 124.067 1.889 . . . . 0.0 110.225 -167.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 22.7 tp -76.03 130.22 38.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.181 175.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.341 55.6 m-85 58.01 31.93 21.3 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 76.81 0.21 68.0 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.097 1.332 . . . . 0.0 115.594 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 27.4 tptt -112.78 108.61 53.6 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.653 1.581 . . . . 0.0 110.628 -169.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.39 113.44 3.32 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.756 2.304 . . . . 0.0 110.705 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 48.6 mtp -72.7 128.55 35.87 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.059 1.743 . . . . 0.0 111.891 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.5 t -93.59 99.0 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.078 1.751 . . . . 0.0 109.314 -176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 483' ' ' LEU . 2.8 t -101.69 124.24 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.444 1.898 . . . . 0.0 112.266 -173.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -147.82 155.17 41.37 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.098 1.359 . . . . 0.0 111.707 -170.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -54.23 148.19 11.84 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.835 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 177.373 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 122.054 0.931 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.3 p -155.02 160.27 40.93 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.595 1.158 . . . . 0.0 111.715 169.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.8 tt -68.39 145.99 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.328 1.451 . . . . 0.0 110.492 -174.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 37.1 t -82.63 157.08 23.55 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 122.107 0.956 . . . . 0.0 109.021 163.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -56.73 -30.14 63.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.699 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -63.82 -37.17 86.39 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 175.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -81.33 -27.84 34.78 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.44 -46.94 62.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.096 1.358 . . . . 0.0 113.042 174.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -55.88 -22.04 23.43 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.594 1.958 . . . . 0.0 114.411 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -62.9 -30.78 71.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.064 1.346 . . . . 0.0 112.704 173.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.22 80.66 0.31 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.55 1.548 . . . . 0.0 111.108 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -162.01 145.52 12.08 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.958 1.703 . . . . 0.0 109.908 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.8 pt -120.61 152.13 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 63.6 m -74.67 159.56 31.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.35 1.46 . . . . 0.0 111.823 161.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 33.3 mtm105 -58.84 -27.11 64.81 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.879 -1.138 . . . . 0.0 112.728 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -61.87 -31.56 71.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.949 1.3 . . . . 0.0 112.019 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.78 -32.18 21.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.672 1.189 . . . . 0.0 111.254 170.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 37.4 ttm -62.23 -43.52 98.64 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.653 -1.279 . . . . 0.0 111.483 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -78.99 29.47 0.21 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.568 0.747 . . . . 0.0 112.162 171.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.05 -39.7 0.44 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.049 1.74 . . . . 0.0 115.388 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 5.3 mp -68.19 134.96 51.3 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.052 1.341 . . . . 0.0 110.586 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 82.4 p -62.94 -27.64 69.53 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.412 HG23 ' CD2' ' A' ' 410' ' ' PHE . 11.4 m -65.79 -22.77 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 172.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.412 ' CD2' HG23 ' A' ' 409' ' ' VAL 0.401 66.4 m-85 -101.25 14.23 32.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 118.482 2.771 . . . . 0.0 118.482 -177.108 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -23.01 62.5 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 4.3 m -140.06 -33.72 0.57 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.847 1.659 . . . . 0.0 113.735 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.58 144.99 56.09 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -147.96 143.24 17.44 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -83.18 -171.67 1.18 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.757 3.638 . . . . 0.0 111.226 157.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.46 -0.48 32.71 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 117.494 1.758 . . . . 0.0 117.494 163.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -102.77 143.51 26.74 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 119.236 1.518 . . . . 0.0 113.91 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.31 82.74 2.42 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.849 3.7 . . . . 0.0 112.435 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -128.29 146.59 50.71 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.552 -1.343 . . . . 0.0 111.026 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 32.0 p -77.34 -9.89 59.11 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 36.3 mtm180 -119.59 146.4 45.55 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.715 1.206 . . . . 0.0 111.586 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 10.3 pt -134.82 151.11 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.997 1.719 . . . . 0.0 110.125 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -114.24 154.67 27.52 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.309 1.052 . . . . 0.0 108.486 166.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.412 HG22 HG13 ' A' ' 498' ' ' VAL . 2.5 t -128.82 147.45 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.531 1.532 . . . . 0.0 112.693 176.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -134.99 165.99 24.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.092 1.757 . . . . 0.0 111.011 -174.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.291 12.6 m-20 71.55 24.4 3.59 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -174.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.29 131.55 42.83 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.289 -1.507 . . . . 0.0 112.12 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -56.17 152.6 10.51 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.57 1.948 . . . . 0.0 115.513 -172.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -58.36 -40.23 81.67 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -84.52 -21.77 30.43 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.08 150.26 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -117.35 167.26 11.4 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.547 1.139 . . . . 0.0 112.125 171.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 459' ' ' LEU . 5.2 pm0 -53.94 -34.36 59.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.606 1.162 . . . . 0.0 112.613 170.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -66.58 -32.85 74.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.799 1.24 . . . . 0.0 114.115 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -68.02 -29.66 68.72 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.24 -18.25 60.76 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.01 1.324 . . . . 0.0 113.681 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -58.19 -29.29 65.54 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.361 0.982 . . . . 0.0 112.873 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.66 -32.21 72.36 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.398 0.545 . . . . 0.0 110.733 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.2 mt -99.16 -60.13 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.526 0.73 . . . . 0.0 110.844 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.294 81.5 m-85 -62.92 -23.98 67.63 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 117.349 2.352 . . . . 0.0 117.349 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -82.51 -5.51 89.45 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.737 1.16 . . . . 0.0 114.22 171.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -58.0 -31.8 67.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.656 1.728 . . . . 0.0 111.378 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -93.81 6.77 47.29 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.908 1.683 . . . . 0.0 111.572 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 19.0 t -118.37 120.29 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 120.209 1.368 . . . . 0.0 110.828 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -75.59 103.36 5.67 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.45 1.1 . . . . 0.0 110.422 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -56.42 -29.28 61.4 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 4.2 m -77.81 -2.6 37.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.293 1.837 . . . . 0.0 113.898 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.8 m -130.44 98.0 4.56 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.358 1.463 . . . . 0.0 110.468 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -51.93 -41.05 61.73 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.2 t -48.63 -16.67 0.12 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 118.688 2.847 . . . . 0.0 118.688 173.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -93.07 -58.65 2.26 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.463 -0.773 . . . . 0.0 111.575 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -71.14 -17.07 62.57 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.077 1.351 . . . . 0.0 113.78 -175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.7 tt -63.3 -35.15 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.557 1.543 . . . . 0.0 111.803 168.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.5 mtm -85.04 -27.64 26.22 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.52 0.328 . . . . 0.0 110.891 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . 0.28 32.4 t80 -83.75 128.64 34.68 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 -173.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -162.28 155.85 20.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.778 1.631 . . . . 0.0 107.716 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 11.3 mt -130.78 135.88 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.617 1.167 . . . . 0.0 109.77 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -122.3 125.16 45.4 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.487 1.515 . . . . 0.0 108.044 163.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' A' ' 433' ' ' GLU . 7.1 tp -99.73 113.37 25.8 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.278 1.431 . . . . 0.0 108.203 165.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -77.7 107.04 9.9 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 126.355 1.862 . . . . 0.0 110.034 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -98.28 2.15 47.88 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.354 1.062 . . . . 0.0 113.763 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -118.68 157.16 27.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.4 1.88 . . . . 0.0 112.89 -171.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 74.07 174.55 30.91 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.997 1.284 . . . . 0.0 113.174 -171.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -28.77 68.46 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.445 -1.032 . . . . 0.0 113.068 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -91.89 34.64 0.99 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.55 1.14 . . . . 0.0 112.927 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -70.59 166.25 21.05 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.283 1.033 . . . . 0.0 113.139 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 68.7 38.16 85.41 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 124.891 1.234 . . . . 0.0 110.605 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -125.74 156.92 38.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.079 0.952 . . . . 0.0 110.525 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -143.77 136.99 27.75 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -93.85 127.06 39.4 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 165.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.17 135.83 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.327 1.451 . . . . 0.0 109.378 171.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.89 133.4 11.58 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 160.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 17.9 mt -106.58 160.27 26.87 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.349 1.46 . . . . 0.0 109.868 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.26 -10.46 20.8 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.579 2.186 . . . . 0.0 113.842 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -153.42 145.51 23.74 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.159 0.984 . . . . 0.0 110.249 -174.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -55.67 -36.37 67.02 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.977 -0.452 . . . . 0.0 111.756 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -62.68 -33.99 76.21 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -69.6 -39.87 77.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.203 0.601 . . . . 0.0 111.084 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -69.73 -42.87 73.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.05 0.841 . . . . 0.0 111.618 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.24 -31.11 67.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.984 0.914 . . . . 0.0 112.778 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -78.72 -49.08 13.69 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.328 -0.858 . . . . 0.0 112.617 168.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.87 -27.74 69.55 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.57 HD23 HG12 ' A' ' 498' ' ' VAL . 54.1 mt -76.49 -28.3 56.4 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.192 -0.943 . . . . 0.0 112.736 174.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -71.12 -40.36 71.5 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.108 0.563 . . . . 0.0 110.681 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.44 -55.01 5.18 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.36 -16.26 52.83 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -68.49 108.79 3.42 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.931 -1.106 . . . . 0.0 110.835 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 115.52 -6.09 20.87 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 117.987 -1.452 . . . . 0.0 115.42 -171.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.78 120.41 12.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.292 2.046 . . . . 0.0 114.99 -160.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.287 1.9 t -85.63 46.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.102 1.761 . . . . 0.0 115.507 -163.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 32.5 tp -52.9 130.06 32.18 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.353 1.061 . . . . 0.0 110.335 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . . 81.2 t80 60.31 16.04 5.89 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 86.77 10.3 72.95 Favored Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.464 -1.398 . . . . 0.0 114.656 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -127.66 125.55 23.77 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 126.031 1.732 . . . . 0.0 111.934 -172.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.54 127.51 12.56 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.09 1.86 . . . . 0.0 112.651 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 61.4 mtp -78.42 131.76 37.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.538 1.535 . . . . 0.0 112.524 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.28 97.05 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.356 1.862 . . . . 0.0 109.554 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.57 HG12 HD23 ' A' ' 483' ' ' LEU . 2.9 t -98.51 119.87 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 127.481 2.312 . . . . 0.0 112.774 -176.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -139.41 158.76 43.58 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.825 1.25 . . . . 0.0 113.525 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -58.5 145.89 37.38 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.615 -0.678 . . . . 0.0 112.817 166.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 123.829 0.851 . . . . 0.0 112.606 179.304 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 121.52 0.676 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.1 p -141.9 175.69 9.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.657 1.183 . . . . 0.0 112.828 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.5 tt -82.62 150.42 4.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 126.063 1.745 . . . . 0.0 111.964 -172.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 6.5 m -81.77 161.02 23.44 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.511 0.725 . . . . 0.0 109.709 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -65.04 -39.63 93.61 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.113 -0.992 . . . . 0.0 110.769 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -54.89 -43.72 73.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.351 1.46 . . . . 0.0 112.785 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.87 -37.73 70.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.098 1.359 . . . . 0.0 114.551 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 19.8 tp -69.05 -39.6 79.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.251 1.021 . . . . 0.0 112.528 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -59.97 -18.03 42.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -65.66 -21.41 66.55 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.057 0.943 . . . . 0.0 112.253 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -134.96 86.49 0.25 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.656 1.598 . . . . 0.0 111.495 173.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -155.7 151.08 26.93 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.751 1.221 . . . . 0.0 109.658 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.3 pt -136.41 148.64 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 13.0 m -86.97 164.17 16.67 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.98 1.712 . . . . 0.0 110.178 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -50.24 -38.76 42.15 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.38 -27.35 66.16 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.54 -31.42 42.06 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.142 -0.974 . . . . 0.0 111.821 167.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 4.5 ttm -58.93 -38.7 79.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.784 0.834 . . . . 0.0 110.076 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -74.65 11.2 1.09 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.764 1.626 . . . . 0.0 114.059 171.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.47 -22.05 3.4 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.209 1.803 . . . . 0.0 115.227 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.0 mp -91.17 130.82 37.02 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.253 1.821 . . . . 0.0 111.202 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 14.5 p -62.41 -24.25 67.29 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.441 HG23 ' CD2' ' A' ' 410' ' ' PHE . 6.1 m -66.18 -23.22 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 119.501 1.046 . . . . 0.0 113.595 169.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.441 ' CD2' HG23 ' A' ' 409' ' ' VAL 0.27 42.2 m-85 -100.44 -10.35 21.22 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 121.276 3.806 . . . . 0.0 121.276 -171.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.79 -19.59 29.42 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 -169.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 4.4 m -142.54 28.28 1.64 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.451 1.9 . . . . 0.0 111.799 -176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -134.12 137.72 44.73 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.192 2.197 . . . . 0.0 115.924 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -142.11 121.01 7.76 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -171.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -74.84 176.79 9.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.178 3.252 . . . . 0.0 113.282 160.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.55 31.61 10.19 Favored Glycine 0 N--CA 1.468 0.787 0 C-N-CA 124.532 1.063 . . . . 0.0 114.853 167.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -125.82 149.87 67.06 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.693 1.197 . . . . 0.0 113.255 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.53 109.93 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.027 3.151 . . . . 0.0 114.056 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -158.17 159.96 36.71 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.807 1.643 . . . . 0.0 109.669 160.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 25.4 p -80.59 -7.52 59.28 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -130.92 152.39 50.3 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.086 1.754 . . . . 0.0 110.084 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 6.6 pt -137.88 165.13 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 126.725 2.01 . . . . 0.0 109.404 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -135.56 164.18 28.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.606 1.193 . . . . 0.0 107.818 167.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.4 143.34 34.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.608 1.163 . . . . 0.0 110.522 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -126.43 168.78 13.73 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.227 1.811 . . . . 0.0 110.868 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 38.8 t30 67.32 32.8 5.72 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.663 1.585 . . . . 0.0 113.085 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.56 139.79 53.77 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.449 1.1 . . . . 0.0 110.919 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -59.47 161.86 5.43 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.871 1.669 . . . . 0.0 115.098 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -63.09 -37.26 86.51 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -80.15 -32.7 38.88 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.713 1.605 . . . . 0.0 114.022 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.35 144.19 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -166.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -120.25 163.87 17.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.602 1.561 . . . . 0.0 112.308 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -56.15 -32.55 64.39 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.583 -1.323 . . . . 0.0 113.033 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -62.37 -33.37 74.61 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -66.98 -36.21 81.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.494 1.118 . . . . 0.0 113.028 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.56 -22.6 63.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.192 1.397 . . . . 0.0 112.969 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.88 -26.78 62.57 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.48 1.036 . . . . 0.0 112.471 176.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -62.5 -31.77 72.58 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.237 0.471 . . . . 0.0 110.494 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.11 -56.27 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 120.591 -1.318 . . . . 0.0 110.841 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -59.27 -30.32 68.21 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.28 -3.49 88.55 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.906 1.241 . . . . 0.0 114.641 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -59.25 -31.06 68.74 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.384 1.592 . . . . 0.0 112.23 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -97.94 13.85 29.3 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.205 2.202 . . . . 0.0 111.678 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 15.4 t -131.03 139.73 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.919 1.688 . . . . 0.0 110.389 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.61 117.05 14.91 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.717 -0.615 . . . . 0.0 109.872 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.31 -13.81 32.65 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 118.716 2.858 . . . . 0.0 118.716 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.2 t -123.04 -33.48 3.32 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.4 m -67.66 110.83 3.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.951 0.796 . . . . 0.0 110.814 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -57.07 -46.4 82.53 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -13.55 2.57 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -92.91 -60.34 1.83 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.819 1.248 . . . . 0.0 110.374 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -70.81 -12.55 61.62 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.986 1.714 . . . . 0.0 114.114 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.02 -39.91 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 126.869 2.068 . . . . 0.0 112.968 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 11.8 mtm -83.96 -29.96 26.64 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.573 0.749 . . . . 0.0 109.669 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -66.43 131.15 45.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.04 1.336 . . . . 0.0 113.825 164.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -165.43 149.04 8.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.358 1.463 . . . . 0.0 108.809 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.2 mt -125.95 137.03 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.48 1.112 . . . . 0.0 111.424 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -126.53 129.37 48.49 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.945 1.298 . . . . 0.0 108.892 162.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 5.7 tt -109.1 115.97 31.06 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.225 1.41 . . . . 0.0 109.533 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 59.7 mtm -72.8 134.26 44.84 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.065 1.346 . . . . 0.0 111.575 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -123.93 14.94 9.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.492 1.517 . . . . 0.0 113.168 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -139.89 153.31 46.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.898 1.679 . . . . 0.0 112.241 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 59.33 -146.88 43.04 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.046 1.308 . . . . 0.0 116.318 168.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -7.59 47.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.819 2.048 . . . . 0.0 115.465 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . 0.256 13.1 mtm -120.25 19.25 12.19 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 173.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -55.58 120.22 6.89 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.273 -1.517 . . . . 0.0 111.513 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.01 30.17 29.42 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.16 1.362 . . . . 0.0 113.77 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -123.85 149.33 45.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.472 1.109 . . . . 0.0 109.288 168.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -137.94 141.52 40.57 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.437 -0.79 . . . . 0.0 112.656 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -101.64 135.06 43.8 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 172.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.82 122.83 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.29 1.436 . . . . 0.0 110.533 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -85.73 149.99 23.86 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 162.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 21.9 mt -125.21 158.34 64.06 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.401 1.08 . . . . 0.0 110.233 170.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.3 -8.27 21.67 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.545 2.163 . . . . 0.0 113.991 -175.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -155.78 144.24 20.19 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.033 1.333 . . . . 0.0 110.487 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -58.36 -31.95 68.1 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.613 1.165 . . . . 0.0 113.154 168.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -56.3 -45.69 80.13 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.394 -0.816 . . . . 0.0 111.978 171.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.73 -35.87 81.98 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.993 0.808 . . . . 0.0 112.914 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.38 -44.37 75.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.439 1.472 . . . . 0.0 112.586 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.83 -38.22 75.23 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.42 -0.8 . . . . 0.0 112.022 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -67.2 -53.7 27.88 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.721 1.208 . . . . 0.0 112.192 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.79 -32.95 69.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.979 0.911 . . . . 0.0 112.608 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.561 HD23 HG12 ' A' ' 498' ' ' VAL . 50.8 mt -69.81 -43.58 71.77 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.068 0.947 . . . . 0.0 111.742 175.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -65.97 -26.1 67.41 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.81 0.844 . . . . 0.0 111.688 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -100.65 -44.69 5.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -175.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -76.1 -24.45 55.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.519 1.128 . . . . 0.0 113.865 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -72.5 120.5 18.2 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.645 -0.659 . . . . 0.0 112.343 -169.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 108.96 -8.19 33.51 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 117.984 -1.454 . . . . 0.0 115.032 -170.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . 0.262 61.7 t80 -64.82 133.12 51.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.524 1.662 . . . . 0.0 115.164 -164.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.252 2.5 t -99.8 46.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.181 1.392 . . . . 0.0 113.768 -158.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 19.4 tp -50.49 126.28 14.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.123 1.369 . . . . 0.0 110.572 172.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.361 32.9 m-85 58.64 12.58 2.22 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 89.84 3.03 74.36 Favored Glycine 0 CA--C 1.536 1.355 0 O-C-N 120.683 -1.26 . . . . 0.0 114.519 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -119.35 118.1 32.68 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 119.477 1.639 . . . . 0.0 112.829 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.18 126.76 14.1 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.886 2.39 . . . . 0.0 113.216 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 71.7 mtp -81.72 134.47 35.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.652 1.581 . . . . 0.0 112.137 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.76 93.47 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 126.655 1.982 . . . . 0.0 110.528 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.561 HG12 HD23 ' A' ' 483' ' ' LEU . 2.8 t -94.67 118.25 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 126.814 2.045 . . . . 0.0 113.086 -173.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -134.41 160.8 36.86 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.65 1.18 . . . . 0.0 114.119 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -60.01 144.58 48.96 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.165 -0.96 . . . . 0.0 113.174 167.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.713 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 30.1 p -144.82 164.78 30.01 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.3 tt -72.64 171.14 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.647 2.379 . . . . 0.0 111.701 -175.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 34.5 m -110.67 166.85 10.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.425 1.09 . . . . 0.0 111.834 167.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 14.1 ttm-85 -59.15 -48.33 81.99 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.037 -1.039 . . . . 0.0 112.48 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -61.78 -37.16 83.3 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.591 1.157 . . . . 0.0 113.398 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -70.31 -38.66 75.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.696 1.198 . . . . 0.0 113.226 173.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.06 -41.08 82.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.889 1.276 . . . . 0.0 112.982 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.33 -17.84 32.89 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.172 1.789 . . . . 0.0 115.101 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -70.29 -16.23 62.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.961 0.905 . . . . 0.0 113.357 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -127.29 87.6 0.33 Allowed Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.84 1.686 . . . . 0.0 113.166 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -167.7 147.25 4.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.629 1.172 . . . . 0.0 111.372 -170.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 10.8 pt -125.28 152.71 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 69.3 m -100.82 164.44 11.84 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.963 2.505 . . . . 0.0 111.111 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -55.46 -33.81 63.97 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -169.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -76.86 -10.56 59.45 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.588 1.086 . . . . 0.0 112.877 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -96.61 -33.19 11.87 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.001 -1.062 . . . . 0.0 111.208 163.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 17.5 ttp -63.29 -40.47 97.47 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.881 -1.137 . . . . 0.0 111.352 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -79.68 30.62 0.24 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.148 0.979 . . . . 0.0 112.723 171.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.12 -29.02 0.41 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 176.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.8 mp -72.27 134.31 45.51 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.17 0.988 . . . . 0.0 109.842 167.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 9.2 t -66.94 -29.48 69.36 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.444 -0.785 . . . . 0.0 111.923 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.7 m -66.63 -7.77 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 170.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.261 83.5 m-85 -119.74 3.68 11.1 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 118.553 2.797 . . . . 0.0 118.553 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -14.08 62.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -169.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.7 t -130.76 -25.9 2.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.218 1.007 . . . . 0.0 111.681 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -70.36 137.76 50.82 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.284 1.586 . . . . 0.0 115.284 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -142.81 125.79 9.14 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.22 179.71 5.68 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 125.045 3.83 . . . . 0.0 113.513 167.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 121.25 -19.68 8.62 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 156.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -82.03 150.2 64.5 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.13 96.98 1.09 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 124.109 3.206 . . . . 0.0 112.725 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -133.83 137.47 45.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.069 1.747 . . . . 0.0 106.903 161.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.9 p -72.99 -0.67 14.43 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -124.43 149.88 46.28 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.331 1.453 . . . . 0.0 110.849 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.6 pt -140.15 161.22 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.61 1.964 . . . . 0.0 109.654 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -131.35 156.97 44.6 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.5 t -127.2 143.76 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 125.349 1.46 . . . . 0.0 111.575 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -127.34 166.95 16.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.364 1.865 . . . . 0.0 109.569 173.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 34.6 t30 66.24 32.45 7.9 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.8 1.24 . . . . 0.0 113.109 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -71.33 157.23 38.46 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.318 -0.864 . . . . 0.0 111.49 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -71.46 166.52 21.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.255 1.422 . . . . 0.0 114.804 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -76.36 -42.1 45.87 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.204 -0.935 . . . . 0.0 113.034 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -70.98 -35.79 72.26 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.38 156.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -130.24 158.32 40.08 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.994 1.718 . . . . 0.0 110.55 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -56.15 -29.82 61.3 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.155 -1.59 . . . . 0.0 113.454 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -57.18 -37.71 72.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.066 1.747 . . . . 0.0 114.26 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -68.13 -33.98 75.5 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.65 -21.41 66.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.136 0.974 . . . . 0.0 112.547 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -24.12 62.27 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.841 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -59.39 -29.46 67.73 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.708 0.803 . . . . 0.0 110.96 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.41 -55.0 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 120.866 -1.147 . . . . 0.0 111.207 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -59.53 -29.64 68.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.73 -4.71 89.47 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.409 1.004 . . . . 0.0 114.43 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -65.36 -36.22 83.34 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 119.974 1.887 . . . . 0.0 111.527 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -79.26 6.29 10.24 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.623 1.969 . . . . 0.0 113.08 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 16.1 t -131.57 135.06 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.469 1.908 . . . . 0.0 110.862 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -91.13 113.32 25.55 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -63.77 -18.51 64.15 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 69.5 m -90.88 -0.58 57.77 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.3 t -118.5 107.22 13.52 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.29 1.036 . . . . 0.0 110.629 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -61.24 -43.16 99.33 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.186 -0.946 . . . . 0.0 111.998 -176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.91 -14.11 5.65 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 117.189 2.292 . . . . 0.0 117.189 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -88.27 -62.21 1.54 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.016 0.926 . . . . 0.0 110.095 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -69.92 -24.74 63.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.754 1.222 . . . . 0.0 114.227 -173.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 16.4 tt -54.19 -36.71 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.694 1.197 . . . . 0.0 112.28 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.2 mtm -84.71 -12.83 53.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.267 1.027 . . . . 0.0 112.483 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -94.36 134.13 37.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.859 1.664 . . . . 0.0 114.777 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -167.86 141.26 3.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.872 1.669 . . . . 0.0 107.303 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.8 mt -116.24 138.1 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.958 1.703 . . . . 0.0 110.149 174.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -132.13 133.98 44.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.023 1.329 . . . . 0.0 110.163 166.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 1.4 tt -112.2 124.8 53.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.098 1.359 . . . . 0.0 110.943 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 35.2 mtm -72.27 135.02 45.88 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.648 1.579 . . . . 0.0 111.172 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -134.51 -26.06 1.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.657 1.583 . . . . 0.0 115.136 -163.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -101.15 139.39 36.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.596 1.558 . . . . 0.0 111.512 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 72.5 -158.32 53.16 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.38 1.312 . . . . 0.0 116.38 163.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -13.97 62.32 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -169.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 75.9 mtm -110.63 12.42 22.68 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -61.17 148.82 39.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.844 -1.16 . . . . 0.0 111.949 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.77 24.61 76.45 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.737 0.684 . . . . 0.0 112.156 -175.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -104.23 160.04 15.21 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.758 1.223 . . . . 0.0 109.697 158.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -152.51 157.11 40.64 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.829 -1.17 . . . . 0.0 112.77 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -116.86 143.39 45.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.98 127.05 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.617 1.567 . . . . 0.0 109.071 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -97.18 145.6 17.92 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 162.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 27.1 mt -126.29 156.66 72.14 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.592 1.557 . . . . 0.0 110.412 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -73.06 -7.7 21.03 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.747 2.298 . . . . 0.0 114.579 -171.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -151.22 143.43 24.07 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.469 1.108 . . . . 0.0 111.397 -172.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.19 -41.93 69.15 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.559 -0.713 . . . . 0.0 111.394 166.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -67.16 -28.01 67.76 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.493 1.117 . . . . 0.0 113.381 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -71.24 -43.35 67.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.664 0.386 . . . . 0.0 110.777 174.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.81 -44.06 74.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.36 0.527 . . . . 0.0 112.056 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.79 -37.73 71.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.38 0.672 . . . . 0.0 111.923 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -73.15 -48.4 35.75 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.783 0.833 . . . . 0.0 112.744 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.96 -29.57 70.33 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.559 HD23 HG12 ' A' ' 498' ' ' VAL . 47.2 mt -71.15 -34.13 70.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.106 -0.996 . . . . 0.0 112.461 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -63.92 -39.45 94.18 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.312 0.505 . . . . 0.0 111.429 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.06 -47.49 8.87 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -171.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -79.02 -20.89 47.86 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -69.1 109.48 4.04 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.277 -0.89 . . . . 0.0 110.699 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 108.96 -3.31 31.74 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 117.684 -1.62 . . . . 0.0 116.435 -174.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -65.89 131.23 45.77 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.779 1.789 . . . . 0.0 112.356 -172.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.299 1.2 t -93.31 44.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 -161.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 16.8 tp -50.01 122.26 6.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.016 1.726 . . . . 0.0 111.489 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.309 76.1 m-85 49.57 30.34 3.48 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 117.361 2.356 . . . . 0.0 117.361 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 77.37 24.36 65.9 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.125 -0.984 . . . . 0.0 114.171 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -132.43 116.62 15.24 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 119.028 1.414 . . . . 0.0 110.33 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.96 114.88 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.313 2.009 . . . . 0.0 112.003 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 61.9 mtp -71.25 127.81 33.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.723 1.609 . . . . 0.0 112.347 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 30.8 t -93.52 94.16 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.992 2.117 . . . . 0.0 109.63 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.559 HG12 HD23 ' A' ' 483' ' ' LEU . 3.7 t -100.4 120.49 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 127.142 2.177 . . . . 0.0 113.08 -171.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -137.95 158.95 43.29 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.399 1.479 . . . . 0.0 113.644 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -57.71 142.19 46.06 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 167.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.178 0 CA-C-N 118.507 0.594 . . . . 0.0 112.462 177.133 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.4 p -161.54 159.82 28.28 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.7 1.2 . . . . 0.0 113.403 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.8 tt -75.67 166.15 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.203 1.401 . . . . 0.0 112.441 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 19.9 m -115.39 161.49 18.46 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.199 1.4 . . . . 0.0 111.711 169.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -63.99 -39.36 93.95 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.616 -0.678 . . . . 0.0 112.132 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -58.8 -34.72 71.81 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -79.56 -38.77 33.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.759 1.624 . . . . 0.0 113.864 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.14 -41.62 97.11 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.768 1.227 . . . . 0.0 113.137 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -58.47 -23.32 57.47 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.637 1.575 . . . . 0.0 114.486 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.52 -18.43 64.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.611 1.164 . . . . 0.0 112.1 173.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -123.96 82.05 0.35 Allowed Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.986 2.232 . . . . 0.0 111.482 167.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -157.28 139.61 14.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.936 1.694 . . . . 0.0 109.346 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.8 pt -122.58 150.6 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 123.391 1.567 . . . . 0.0 115.002 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.6 m -78.58 160.86 27.38 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.796 2.039 . . . . 0.0 112.045 167.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -55.3 -30.05 59.41 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.371 -0.831 . . . . 0.0 112.092 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -65.1 -22.73 66.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.619 1.168 . . . . 0.0 113.826 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -93.06 -33.46 14.08 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.236 1.014 . . . . 0.0 111.24 168.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 37.8 ttm -59.59 -42.25 92.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 122.454 1.121 . . . . 0.0 111.574 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -85.96 33.79 0.6 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.587 1.555 . . . . 0.0 110.827 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.98 -41.24 0.35 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 128.099 2.56 . . . . 0.0 114.852 173.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.6 mp -66.88 136.83 55.98 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.354 1.062 . . . . 0.0 110.02 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 21.0 m -65.24 -34.33 78.1 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 169.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 17.5 m -59.0 -29.94 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 119.906 1.23 . . . . 0.0 112.704 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -101.68 11.16 39.31 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -19.17 49.48 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 47.3 t -142.57 -28.81 0.58 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.301 1.04 . . . . 0.0 113.015 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -71.72 146.52 48.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.2 1.4 . . . . 0.0 114.768 169.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 415' ' ' PRO . 0.8 OUTLIER -159.65 130.5 3.74 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 121.298 -0.876 . . . . 0.0 113.031 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 415' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 414' ' ' GLU . 6.8 Cg_exo -69.89 165.06 32.37 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 125.278 3.986 . . . . 0.0 114.66 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 143.86 -27.87 2.03 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.184 1.233 . . . . 0.0 116.184 152.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -72.42 139.67 81.54 Favored Pre-proline 0 CA--C 1.552 1.053 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -165.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.06 105.41 1.79 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.591 2.861 . . . . 0.0 112.988 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -134.17 150.52 51.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.689 1.995 . . . . 0.0 108.215 163.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 29.8 p -72.27 -2.18 18.05 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 38.7 mtm-85 -134.15 148.83 51.01 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.891 2.076 . . . . 0.0 110.082 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 4.4 pt -131.22 159.4 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.139 2.176 . . . . 0.0 110.456 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -128.86 158.48 38.62 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.32 139.58 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.512 1.525 . . . . 0.0 111.515 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -121.71 167.52 12.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.166 1.387 . . . . 0.0 110.116 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 31.4 t30 68.08 31.7 5.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.052 1.341 . . . . 0.0 112.859 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -66.64 145.95 55.02 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.41 -0.806 . . . . 0.0 110.617 173.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.24 163.61 12.51 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.49 1.516 . . . . 0.0 114.413 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -64.64 -47.98 76.5 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -71.42 -29.5 64.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.4 p -65.28 145.53 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -166.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -119.48 163.95 16.5 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.312 1.845 . . . . 0.0 111.906 170.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.36 -26.27 64.94 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.749 -1.219 . . . . 0.0 113.459 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -60.36 -37.03 79.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.656 1.182 . . . . 0.0 114.038 171.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -72.36 -26.93 62.1 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.87 1.268 . . . . 0.0 114.308 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -73.41 -21.47 60.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.229 1.812 . . . . 0.0 112.744 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -27.57 58.79 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.436 1.016 . . . . 0.0 112.585 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -60.99 -30.95 70.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.439 1.096 . . . . 0.0 111.56 -173.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.2 mp -104.48 -54.78 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.018 -1.051 . . . . 0.0 111.218 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -58.03 -27.68 63.78 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.24 -11.73 84.71 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 118.83 -0.983 . . . . 0.0 114.598 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -62.58 -30.99 71.73 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 120.792 2.296 . . . . 0.0 112.1 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -79.29 2.06 22.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.114 1.766 . . . . 0.0 112.858 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.58 136.22 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.35 1.86 . . . . 0.0 110.818 -172.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -79.73 119.64 22.92 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.898 -1.126 . . . . 0.0 108.056 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.329 49.5 m-85 -67.91 -16.91 64.29 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 167.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.0 t -94.03 -38.04 11.34 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.252 0.933 . . . . 0.0 113.469 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.1 m -83.27 118.62 23.77 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.394 -0.816 . . . . 0.0 111.588 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -57.89 -45.07 86.97 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.482 -0.761 . . . . 0.0 112.328 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.36 -16.02 1.98 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -89.75 -62.5 1.46 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.151 0.98 . . . . 0.0 110.562 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -68.39 -21.47 64.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.931 1.292 . . . . 0.0 113.295 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.74 -33.86 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.753 1.621 . . . . 0.0 112.261 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -93.85 3.13 55.86 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.938 1.295 . . . . 0.0 112.886 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -110.44 136.01 50.25 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.869 2.068 . . . . 0.0 115.81 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -166.53 152.31 8.4 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.411 1.885 . . . . 0.0 106.596 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.9 mt -126.11 137.32 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.238 1.015 . . . . 0.0 110.226 171.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 52.7 ttm-85 -125.3 133.8 52.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.115 0.966 . . . . 0.0 110.446 163.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.5 tp -118.15 124.1 47.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.582 1.553 . . . . 0.0 108.846 168.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 39.7 mtm -74.68 116.97 15.98 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.161 0.585 . . . . 0.0 110.083 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -103.0 5.28 38.15 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.014 1.726 . . . . 0.0 112.56 174.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -126.96 149.12 50.0 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.654 1.582 . . . . 0.0 112.952 -174.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.06 -156.51 52.01 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.241 1.4 . . . . 0.0 115.604 164.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -51.91 -34.47 41.64 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.305 1.442 . . . . 0.0 114.094 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 72.3 mtp -97.3 12.27 33.6 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -51.21 123.75 10.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.214 1.006 . . . . 0.0 111.448 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.03 31.47 31.82 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.586 1.565 . . . . 0.0 113.979 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -125.18 145.2 50.07 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.355 1.062 . . . . 0.0 112.224 169.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -135.15 156.05 49.66 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.938 1.295 . . . . 0.0 114.147 -169.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.8 132.8 52.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.585 1.954 . . . . 0.0 115.451 171.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.6 mp -132.34 122.07 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.891 1.676 . . . . 0.0 110.042 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.92 145.48 18.25 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 33.6 mt -126.3 158.96 65.09 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.012 1.325 . . . . 0.0 110.42 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -75.34 -9.08 20.17 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.418 2.745 . . . . 0.0 114.556 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -150.82 143.01 24.15 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.588 0.755 . . . . 0.0 111.388 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -59.01 -37.25 76.47 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.004 0.922 . . . . 0.0 111.803 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 18.6 mtmm -62.89 -35.88 81.48 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.85 92.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.411 0.55 . . . . 0.0 110.915 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -69.44 -44.44 71.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.247 0.93 . . . . 0.0 112.746 172.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.33 69.12 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.806 0.73 . . . . 0.0 112.122 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -75.48 -48.44 22.6 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.874 1.67 . . . . 0.0 113.069 170.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.78 70.33 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.845 0.748 . . . . 0.0 112.765 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.46 HD23 HG12 ' A' ' 498' ' ' VAL . 50.1 mt -68.67 -37.5 79.66 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.94 0.896 . . . . 0.0 112.178 174.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -65.3 -41.32 94.2 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.637 0.775 . . . . 0.0 111.463 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.9 -48.57 11.36 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -174.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.14 -16.74 59.03 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -63.75 107.4 1.18 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.025 0.93 . . . . 0.0 112.114 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 106.94 3.54 36.39 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.578 -1.123 . . . . 0.0 115.254 -174.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -71.57 112.99 8.13 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.184 1.492 . . . . 0.0 108.892 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.97 79.43 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.923 1.689 . . . . 0.0 108.029 -169.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 51.6 tp -79.05 132.83 36.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.058 1.743 . . . . 0.0 110.464 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.258 65.7 m-85 55.74 19.43 3.41 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -174.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 81.84 18.56 67.51 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.187 -1.341 . . . . 0.0 115.464 -171.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -128.42 120.64 21.03 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 119.833 1.816 . . . . 0.0 112.508 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.5 121.85 8.36 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 123.547 2.831 . . . . 0.0 112.305 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 38.6 mtp -79.14 132.0 36.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.828 1.251 . . . . 0.0 111.829 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.8 t -94.23 101.18 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.112 1.365 . . . . 0.0 109.816 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.46 HG12 HD23 ' A' ' 483' ' ' LEU . 2.4 t -97.15 127.3 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 126.716 2.006 . . . . 0.0 112.908 -173.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -146.3 161.35 40.5 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -64.26 143.56 57.8 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 121.038 -1.039 . . . . 0.0 108.962 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.395 0 C-N-CA 124.084 0.953 . . . . 0.0 112.696 -177.058 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 28.2 p -158.03 160.21 37.19 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -164.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.7 tt -76.6 161.05 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.268 1.427 . . . . 0.0 112.44 -170.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 18.5 m -114.33 162.33 16.76 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.821 1.649 . . . . 0.0 113.11 168.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -55.25 -43.26 74.45 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.809 0.844 . . . . 0.0 112.469 -172.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -61.76 -33.54 74.26 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -82.83 -37.21 24.73 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.779 0.832 . . . . 0.0 112.715 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.22 -42.16 96.71 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.404 1.082 . . . . 0.0 113.659 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.89 -24.0 48.79 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.635 1.574 . . . . 0.0 114.247 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -70.81 -13.0 61.88 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.979 1.712 . . . . 0.0 112.825 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -123.34 77.66 0.36 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 126.303 1.906 . . . . 0.0 112.63 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -161.39 142.69 11.44 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.386 1.075 . . . . 0.0 111.529 -174.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 20.7 pt -127.91 161.28 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.556 1.542 . . . . 0.0 112.2 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.9 m -110.7 179.36 4.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.144 1.378 . . . . 0.0 111.975 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 32.3 mtm105 -54.25 -27.3 33.92 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.267 -0.895 . . . . 0.0 113.292 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -58.67 -32.56 69.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.537 1.535 . . . . 0.0 112.672 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -98.93 -40.06 8.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.892 0.877 . . . . 0.0 111.209 168.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.88 -40.63 98.1 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.704 -1.248 . . . . 0.0 112.244 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -80.46 11.03 3.94 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 121.319 -0.863 . . . . 0.0 112.672 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.89 -27.08 5.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.584 2.353 . . . . 0.0 113.454 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 43.9 mt -77.51 135.87 38.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.305 1.442 . . . . 0.0 112.654 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 55.3 p -60.14 -34.26 73.28 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.048 0.939 . . . . 0.0 112.325 167.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.406 HG23 ' CD2' ' A' ' 410' ' ' PHE 0.255 1.8 m -67.32 -15.28 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 173.673 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.406 ' CD2' HG23 ' A' ' 409' ' ' VAL 0.356 83.2 m-85 -112.52 9.16 19.5 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 118.852 2.908 . . . . 0.0 118.852 178.063 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -57.78 0.11 0.06 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 118.51 2.781 . . . . 0.0 118.51 -172.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.4 m -157.25 8.98 0.18 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -132.59 132.13 42.2 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.36 -0.838 . . . . 0.0 109.353 -155.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -138.5 131.04 16.02 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -164.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -90.09 176.09 2.78 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 125.168 3.912 . . . . 0.0 115.006 175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.77 -10.02 72.81 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.657 1.599 . . . . 0.0 116.572 161.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.34 142.39 74.88 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 118.749 1.275 . . . . 0.0 113.45 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -85.71 60.86 5.19 Favored 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 124.86 3.707 . . . . 0.0 114.757 -166.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -96.5 151.29 19.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.08 0.952 . . . . 0.0 110.722 164.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.1 p -77.51 -4.05 43.62 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -130.64 149.31 52.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.454 1.502 . . . . 0.0 111.883 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 12.9 pt -134.92 161.73 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.755 2.022 . . . . 0.0 110.141 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -131.52 159.93 36.72 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.417 HG22 HG13 ' A' ' 498' ' ' VAL . 2.6 t -130.81 138.21 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.565 1.546 . . . . 0.0 112.425 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -122.25 168.94 11.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.37 1.468 . . . . 0.0 110.545 170.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 33.0 t30 68.05 40.37 2.25 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.914 1.685 . . . . 0.0 112.533 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.85 153.16 40.01 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.45 -0.782 . . . . 0.0 110.92 171.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.45 ' O ' HG12 ' A' ' 431' ' ' VAL . . . -67.7 154.36 41.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.928 1.291 . . . . 0.0 113.296 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -64.82 -36.31 83.93 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -77.3 -17.24 58.5 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 120.581 1.537 . . . . 0.0 115.097 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 428' ' ' ALA . 2.4 p -75.08 151.39 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -165.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -126.02 160.86 28.95 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.869 1.668 . . . . 0.0 111.216 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -53.98 -34.09 58.8 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.408 -1.433 . . . . 0.0 113.46 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -63.8 -20.38 65.74 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -77.51 -43.31 32.52 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.949 0.899 . . . . 0.0 111.72 166.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.1 mp -61.65 -31.29 71.39 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.389 1.075 . . . . 0.0 111.836 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' LYS . . . . . 0.521 ' HD2' HD12 ' A' ' 457' ' ' ILE . 1.5 mptm? -47.58 -36.89 11.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.267 1.427 . . . . 0.0 113.06 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -62.25 -35.02 77.67 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.027 0.931 . . . . 0.0 112.383 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 4.2 mt -96.26 -58.46 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 121.254 -0.904 . . . . 0.0 110.679 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -57.16 -29.93 64.05 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.16 -14.51 82.52 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 118.43 -1.206 . . . . 0.0 114.619 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -25.1 67.17 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.976 2.388 . . . . 0.0 112.022 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -81.21 5.38 17.17 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.238 1.815 . . . . 0.0 113.19 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 12.7 t -130.52 122.29 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.256 1.823 . . . . 0.0 110.668 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -76.32 103.66 6.44 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -58.44 -16.24 14.18 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 t -82.89 -15.95 49.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.151 0.98 . . . . 0.0 113.021 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 36.1 t -111.24 120.04 40.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.558 1.143 . . . . 0.0 111.617 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -58.02 -48.76 79.09 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.587 -0.696 . . . . 0.0 112.032 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.63 -14.87 2.4 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -92.82 -63.91 1.16 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.851 1.261 . . . . 0.0 110.075 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -25.49 67.92 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.561 1.544 . . . . 0.0 113.361 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.8 tt -57.89 -37.96 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.24 1.416 . . . . 0.0 111.995 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.4 mmm -89.2 0.29 56.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.991 1.716 . . . . 0.0 113.259 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -109.57 132.39 54.19 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -164.43 144.67 7.81 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.527 1.531 . . . . 0.0 111.074 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.521 HD12 ' HD2' ' A' ' 437' ' ' LYS . 5.1 mt -123.81 140.01 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 119.419 1.009 . . . . 0.0 111.373 169.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -121.03 134.54 55.29 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.596 1.558 . . . . 0.0 107.945 154.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 32.1 tp -107.65 91.13 3.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.719 1.247 . . . . 0.0 108.097 166.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -59.43 123.7 17.64 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.66 1.584 . . . . 0.0 110.782 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . 0.304 51.5 mtmt -129.71 35.47 4.18 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -174.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -133.07 148.18 52.19 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.092 0.957 . . . . 0.0 113.565 174.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 69.62 -177.41 30.3 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.58 1.562 . . . . 0.0 114.266 -173.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -15.92 49.26 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.811 -1.406 . . . . 0.0 113.597 177.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 73.4 mtm -87.07 11.2 14.36 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.785 1.634 . . . . 0.0 113.698 171.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -64.83 152.31 43.18 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 119.555 -1.966 . . . . 0.0 111.819 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.35 26.13 52.59 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.152 0.882 . . . . 0.0 112.726 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -121.48 147.37 45.85 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.301 1.041 . . . . 0.0 110.265 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -133.39 148.98 51.84 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -172.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -107.13 139.56 41.37 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 162.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.4 mp -136.88 124.11 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.721 1.208 . . . . 0.0 109.865 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -92.68 146.63 18.24 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 162.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 24.2 mt -126.16 159.61 61.45 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.211 1.404 . . . . 0.0 111.347 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.55 -7.89 19.01 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.991 2.46 . . . . 0.0 115.317 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -150.55 147.59 27.65 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.643 1.177 . . . . 0.0 110.322 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -56.98 -38.98 73.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.564 1.146 . . . . 0.0 111.626 170.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.48 -42.04 95.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.113 0.965 . . . . 0.0 112.878 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.39 -40.39 96.32 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.19 -0.433 . . . . 0.0 111.592 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.98 -44.6 72.57 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.172 0.896 . . . . 0.0 112.832 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.22 83.84 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.869 0.758 . . . . 0.0 111.141 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -64.45 -48.95 73.37 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.154 1.382 . . . . 0.0 112.23 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.11 -32.34 70.9 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.653 HD23 HG12 ' A' ' 498' ' ' VAL . 58.1 mt -68.7 -45.6 71.19 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.105 -0.997 . . . . 0.0 111.341 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -63.22 -33.78 76.23 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.556 0.617 . . . . 0.0 111.837 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.3 -48.0 11.71 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.73 -18.24 45.01 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.21 105.59 1.13 Allowed 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.843 -1.16 . . . . 0.0 110.194 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 111.44 6.05 25.73 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 117.541 -1.7 . . . . 0.0 116.061 -172.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -73.34 126.85 31.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.07 1.935 . . . . 0.0 110.749 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 1.7 t -101.19 48.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 127.002 2.121 . . . . 0.0 114.298 -163.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.8 tp -48.84 123.68 7.36 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.186 1.395 . . . . 0.0 110.308 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.352 62.4 t80 63.92 -2.7 0.52 Allowed 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 107.24 -5.31 35.81 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 125.773 1.654 . . . . 0.0 114.134 -166.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -104.41 119.4 54.0 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 127.686 2.394 . . . . 0.0 111.14 -174.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -79.77 114.88 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.235 2.623 . . . . 0.0 113.137 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 66.5 mtp -73.21 131.32 41.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.112 1.365 . . . . 0.0 112.572 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 56.5 t -91.08 91.0 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.004 1.722 . . . . 0.0 109.38 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.653 HG12 HD23 ' A' ' 483' ' ' LEU . 2.4 t -91.3 125.81 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.93 1.692 . . . . 0.0 111.9 -177.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -142.12 155.94 45.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.671 1.188 . . . . 0.0 113.816 -169.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -63.28 147.35 51.3 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.299 -0.876 . . . . 0.0 112.423 166.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.014 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -175.381 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 7.8 p -152.52 155.29 37.16 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.669 1.588 . . . . 0.0 113.333 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.3 tt -75.85 153.16 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.923 0.889 . . . . 0.0 111.994 -163.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 60.4 m -89.05 153.25 21.15 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.405 0.682 . . . . 0.0 110.349 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -61.71 -35.05 76.92 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 118.175 -0.917 . . . . 0.0 112.629 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -41.5 79.63 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 170.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -74.13 -34.31 63.85 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.976 1.311 . . . . 0.0 112.714 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.5 tt -66.76 -50.97 60.99 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.164 1.386 . . . . 0.0 111.661 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -57.62 -26.57 61.74 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.854 1.662 . . . . 0.0 114.792 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -46.61 80.43 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.273 1.029 . . . . 0.0 109.908 171.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -92.63 59.59 2.52 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 127.636 2.541 . . . . 0.0 112.511 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -150.14 157.06 42.72 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.876 1.27 . . . . 0.0 109.837 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.7 pt -136.98 162.57 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.95 1.7 . . . . 0.0 110.791 176.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.7 m -110.09 170.41 8.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.481 1.912 . . . . 0.0 111.154 172.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -43.67 -45.77 7.09 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -170.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.45 -26.0 68.53 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.01 -30.78 20.97 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.306 -0.871 . . . . 0.0 111.55 169.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 13.9 ttm -66.18 -27.53 68.07 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.424 -1.422 . . . . 0.0 113.248 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -85.58 0.88 51.27 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.2 -35.27 6.88 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.25 2.22 . . . . 0.0 116.857 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 3.5 mp -72.83 133.96 44.68 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.261 1.025 . . . . 0.0 111.908 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 78.3 p -62.41 -18.61 62.05 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 173.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.2 m -88.17 -10.84 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -122.83 -10.49 8.25 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -34.73 56.58 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.754 -1.216 . . . . 0.0 113.875 173.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 23.7 p -113.42 -3.58 13.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.286 2.235 . . . . 0.0 114.641 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -134.87 114.44 12.57 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.02 1.728 . . . . 0.0 113.681 -167.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -130.52 120.12 18.68 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -159.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.13 164.76 30.8 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 124.313 3.342 . . . . 0.0 113.114 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 116.28 -1.53 20.72 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 117.075 1.59 . . . . 0.0 117.075 163.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -78.2 145.56 69.13 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.948 1.374 . . . . 0.0 113.992 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.94 103.92 1.78 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.092 3.195 . . . . 0.0 112.015 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -143.13 147.28 34.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.752 1.221 . . . . 0.0 108.515 166.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 19.7 p -81.02 5.76 15.5 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.889 -1.132 . . . . 0.0 113.389 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -137.26 148.71 46.62 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.482 1.913 . . . . 0.0 110.604 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.0 164.65 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 126.678 1.991 . . . . 0.0 109.524 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -136.98 164.44 28.35 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.3 p -143.66 142.33 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.06 1.344 . . . . 0.0 111.543 -176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -118.77 171.03 8.49 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.745 2.018 . . . . 0.0 110.519 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 72.51 25.62 2.67 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.01 157.13 37.4 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.831 -1.168 . . . . 0.0 111.115 172.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -62.46 158.84 16.82 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.425 1.09 . . . . 0.0 113.548 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -68.28 -33.61 74.66 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.507 -0.746 . . . . 0.0 112.445 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -81.47 -40.56 23.09 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.14 155.78 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.884 1.673 . . . . 0.0 115.034 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -128.68 162.09 28.16 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.001 1.32 . . . . 0.0 112.837 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -33.8 57.69 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.81 -1.181 . . . . 0.0 113.237 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -58.05 -34.29 69.93 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.841 1.256 . . . . 0.0 114.213 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -77.46 -29.97 53.0 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -174.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.59 -20.73 66.43 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.923 1.689 . . . . 0.0 112.955 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.75 -17.23 21.29 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.351 0.978 . . . . 0.0 113.233 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -62.64 -36.72 83.73 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.557 1.143 . . . . 0.0 111.613 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 7.2 mt -105.97 -58.09 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.442 0.697 . . . . 0.0 110.089 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -54.67 -36.95 65.17 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.92 -10.58 85.06 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.939 0.781 . . . . 0.0 114.54 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -62.31 -29.11 70.2 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.584 1.692 . . . . 0.0 111.009 172.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -82.76 1.16 40.24 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.047 1.739 . . . . 0.0 115.533 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 32.1 t -132.12 132.14 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.03 1.732 . . . . 0.0 110.12 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -90.14 106.2 18.33 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.68 -0.637 . . . . 0.0 111.964 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -58.39 -18.17 25.96 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 92.3 p -77.52 -21.65 52.35 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 22.7 t -109.09 118.23 36.22 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.578 0.704 . . . . 0.0 110.974 -165.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -58.83 -51.07 71.56 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.307 0.643 . . . . 0.0 112.268 -170.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.37 -16.19 13.65 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.944 2.201 . . . . 0.0 116.944 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -85.65 -58.83 2.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.538 0.685 . . . . 0.0 109.966 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 15.0 ptt85 -75.62 -23.95 56.43 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.624 1.169 . . . . 0.0 113.662 -171.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.7 tt -54.01 -35.17 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.042 1.337 . . . . 0.0 112.442 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.3 mmm -86.07 -10.64 54.6 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.569 1.148 . . . . 0.0 112.83 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.86 109.04 20.85 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -169.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -154.08 149.49 27.21 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.161 1.384 . . . . 0.0 109.946 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 11.4 mt -128.98 134.64 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.372 1.469 . . . . 0.0 110.882 -173.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -116.6 145.33 43.45 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.764 1.226 . . . . 0.0 109.836 158.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.3 tp -125.21 120.22 30.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.943 2.097 . . . . 0.0 109.313 168.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 47.1 mtm -73.19 135.3 44.59 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 125.029 1.332 . . . . 0.0 110.851 166.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -134.12 -4.42 2.74 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -170.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.89 144.64 47.3 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.566 1.546 . . . . 0.0 111.36 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 60.47 -165.17 14.0 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.94 1.257 . . . . 0.0 114.412 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -19.29 48.53 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 96.0 mmm -85.87 1.68 48.89 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -58.98 149.66 26.71 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.651 1.114 . . . . 0.0 112.097 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 76.36 17.74 79.73 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.934 1.254 . . . . 0.0 112.952 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -114.33 134.21 55.12 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 123.803 0.841 . . . . 0.0 113.112 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -135.53 150.89 49.88 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -109.05 141.88 40.56 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.326 1.85 . . . . 0.0 114.013 167.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.4 mp -138.88 127.02 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.358 1.463 . . . . 0.0 109.872 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -91.93 146.87 18.47 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.522 -0.736 . . . . 0.0 112.167 165.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 39.7 mt -127.32 158.24 70.08 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.052 1.341 . . . . 0.0 110.927 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -74.22 -6.31 18.23 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.883 2.389 . . . . 0.0 114.737 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -153.28 146.01 24.31 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.249 -0.907 . . . . 0.0 111.153 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -65.39 -30.16 70.95 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.213 1.005 . . . . 0.0 111.523 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -63.94 -44.71 92.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.746 0.818 . . . . 0.0 113.014 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -60.74 -39.07 87.31 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.11 -0.472 . . . . 0.0 111.374 174.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.35 -47.51 76.18 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.089 0.859 . . . . 0.0 112.595 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.39 80.95 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.782 1.174 . . . . 0.0 112.174 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -67.71 -51.91 43.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.396 1.078 . . . . 0.0 112.164 175.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.48 70.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.953 0.501 . . . . 0.0 112.224 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.535 HD23 HG12 ' A' ' 498' ' ' VAL . 60.9 mt -69.0 -51.08 43.11 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.286 -0.884 . . . . 0.0 111.427 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -68.0 -14.91 63.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.865 0.866 . . . . 0.0 112.412 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -94.74 -50.79 5.0 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.705 1.602 . . . . 0.0 115.114 168.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.19 -19.72 42.71 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -173.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.32 100.82 0.86 Allowed 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.978 -1.076 . . . . 0.0 109.35 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 127.15 -5.97 7.26 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.313 -1.27 . . . . 0.0 114.912 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -72.31 129.63 38.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.257 1.529 . . . . 0.0 112.766 -170.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 3.3 t -96.03 110.25 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.444 1.097 . . . . 0.0 112.164 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 44.6 tp -121.22 141.82 50.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.536 1.934 . . . . 0.0 108.105 169.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.421 28.5 t80 61.77 17.83 9.13 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 73.54 15.59 79.16 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.332 1.444 . . . . 0.0 114.272 -168.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -127.4 133.39 25.03 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.165 1.386 . . . . 0.0 112.328 -170.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.36 120.27 6.85 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.182 2.588 . . . . 0.0 112.266 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 66.2 mtp -75.65 129.91 37.91 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.737 1.615 . . . . 0.0 112.089 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.09 73.5 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -171.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.535 HG12 HD23 ' A' ' 483' ' ' LEU . 1.4 t -76.56 120.51 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.294 1.038 . . . . 0.0 112.765 -175.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -142.3 161.39 38.15 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.433 1.493 . . . . 0.0 112.92 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -61.53 144.3 54.52 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -172.257 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.3 p -146.56 159.04 43.95 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -170.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.5 tt -76.64 148.29 7.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.974 1.71 . . . . 0.0 110.122 -172.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 39.9 t -80.0 151.1 30.19 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.345 0.593 . . . . 0.0 110.197 164.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -47.23 -43.86 22.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.729 161.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -64.94 -30.05 71.02 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -75.27 -46.09 35.87 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.916 0.886 . . . . 0.0 112.865 167.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 27.5 tp -63.74 -38.19 90.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.749 1.62 . . . . 0.0 112.606 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -57.01 -24.26 52.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.084 1.354 . . . . 0.0 114.261 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -68.46 -20.66 64.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.374 1.07 . . . . 0.0 113.073 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.87 68.7 0.32 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.198 1.856 . . . . 0.0 111.814 174.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -159.23 136.56 9.84 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.048 1.339 . . . . 0.0 109.976 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.9 pt -112.6 150.75 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.682 0.793 . . . . 0.0 111.099 174.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 30.8 m -74.78 160.85 30.19 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.707 1.203 . . . . 0.0 111.666 163.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.38 -25.79 60.06 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.133 -0.979 . . . . 0.0 112.751 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.25 -28.79 69.0 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.113 1.365 . . . . 0.0 113.215 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.35 -30.64 23.51 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.692 -1.255 . . . . 0.0 110.72 167.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 27.3 ttp -62.8 -37.53 87.1 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 120.984 -1.072 . . . . 0.0 111.207 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -84.05 34.57 0.51 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.356 1.462 . . . . 0.0 111.889 170.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.78 -31.42 0.43 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.434 2.294 . . . . 0.0 114.142 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 11.3 mt -74.0 131.92 41.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.002 1.321 . . . . 0.0 111.596 174.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 98.2 p -65.96 -27.67 68.33 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.215 1.406 . . . . 0.0 112.383 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.16 -19.99 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.195 -0.94 . . . . 0.0 112.782 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.261 51.7 m-85 -113.91 12.29 18.07 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 119.133 3.012 . . . . 0.0 119.133 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -14.24 62.62 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 46.7 t -136.73 -39.46 0.63 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.172 1.389 . . . . 0.0 113.227 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -73.29 144.67 46.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -132.95 126.9 19.95 Favored Pre-proline 0 N--CA 1.478 0.948 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -163.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -84.79 -176.69 2.56 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.503 3.468 . . . . 0.0 113.132 164.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 83.41 -26.74 4.39 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.787 1.661 . . . . 0.0 116.712 164.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -60.41 140.83 91.81 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 117.828 0.814 . . . . 0.0 112.999 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.26 104.41 1.9 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.25 3.3 . . . . 0.0 112.826 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -150.25 144.52 25.64 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.373 1.069 . . . . 0.0 110.129 161.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 27.9 p -77.55 8.55 4.19 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.719 -1.238 . . . . 0.0 114.118 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -139.08 142.57 38.13 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.525 1.93 . . . . 0.0 109.463 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 10.7 pt -131.67 165.25 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 126.539 1.936 . . . . 0.0 109.125 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -132.08 162.05 31.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 123.285 1.517 . . . . 0.0 107.994 164.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 498' ' ' VAL . 9.7 t -124.18 136.9 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 126.035 1.734 . . . . 0.0 109.952 175.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -115.9 165.84 12.64 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.335 1.454 . . . . 0.0 109.06 169.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 5.6 t30 66.0 35.09 6.59 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.08 0.552 . . . . 0.0 111.731 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -69.62 154.18 42.37 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.286 -0.884 . . . . 0.0 109.938 162.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -56.12 154.7 7.4 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.047 0.939 . . . . 0.0 111.873 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -74.84 -37.75 62.17 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.385 -0.822 . . . . 0.0 111.638 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -70.33 -41.79 72.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.027 1.731 . . . . 0.0 114.124 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.8 p -55.39 148.05 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -112.16 161.65 16.32 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.643 1.177 . . . . 0.0 113.057 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -56.51 -29.62 62.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.475 1.11 . . . . 0.0 113.277 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -64.48 -36.18 83.35 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 174.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.27 -30.79 68.98 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.319 1.448 . . . . 0.0 113.762 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.83 -19.93 62.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.996 1.718 . . . . 0.0 112.633 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.4 -26.49 63.3 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.383 0.992 . . . . 0.0 112.579 176.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -57.98 -37.55 74.42 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.429 0.558 . . . . 0.0 110.917 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.4 mt -95.16 -59.43 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.184 -0.948 . . . . 0.0 111.711 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -58.62 -29.56 66.59 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.04 -16.05 81.09 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.271 0.939 . . . . 0.0 114.469 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -14.32 62.02 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 119.879 1.84 . . . . 0.0 112.817 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -86.66 -4.77 59.22 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.873 2.069 . . . . 0.0 115.633 172.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.18 125.24 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.908 1.683 . . . . 0.0 110.83 -166.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -78.6 105.12 9.67 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.753 -0.592 . . . . 0.0 110.439 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -60.18 -10.83 4.94 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 70.2 m -93.9 -6.67 45.1 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.294 1.038 . . . . 0.0 113.709 172.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 40.0 t -115.22 115.61 26.98 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.345 1.058 . . . . 0.0 110.536 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -58.92 -48.49 81.28 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.721 0.808 . . . . 0.0 112.385 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.1 t -56.79 -16.63 6.92 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -87.9 -60.7 1.9 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.576 0.75 . . . . 0.0 110.03 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.6 ptt85 -72.17 -22.96 61.22 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.139 0.976 . . . . 0.0 112.971 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 18.7 tt -54.83 -41.68 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.824 1.25 . . . . 0.0 112.093 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.8 mtm -83.43 -6.85 59.59 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.761 0.71 . . . . 0.0 112.33 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -100.79 126.4 47.36 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -164.16 151.5 12.02 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.941 2.096 . . . . 0.0 108.28 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 10.5 mt -125.41 134.7 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.757 1.223 . . . . 0.0 110.538 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -133.72 90.3 2.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.899 0.88 . . . . 0.0 112.842 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.02 125.57 31.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.178 1.791 . . . . 0.0 111.273 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 34.9 mtm -79.31 127.01 31.54 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.835 2.454 . . . . 0.0 111.39 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -118.36 -3.41 10.98 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.725 1.61 . . . . 0.0 115.225 -173.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -130.37 148.57 52.21 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.653 1.181 . . . . 0.0 112.768 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 70.34 -159.21 53.57 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.771 1.177 . . . . 0.0 115.046 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -33.13 73.01 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.588 1.155 . . . . 0.0 113.521 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 73.3 mtm -85.96 12.41 9.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -54.81 106.34 0.21 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.157 0.889 . . . . 0.0 110.53 168.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.47 27.23 7.73 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.362 1.458 . . . . 0.0 115.401 -172.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -113.62 154.64 26.86 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.608 1.204 . . . . 0.0 110.131 163.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.57 139.69 21.12 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.462 -1.399 . . . . 0.0 113.973 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -90.68 144.24 25.94 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 166.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.72 122.58 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.118 1.767 . . . . 0.0 110.136 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.0 145.51 17.63 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 164.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 26.1 mt -126.93 156.3 74.29 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.794 1.238 . . . . 0.0 110.867 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.16 -4.32 15.19 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.578 2.852 . . . . 0.0 114.838 -173.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -153.88 130.87 10.99 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.461 1.104 . . . . 0.0 110.564 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -52.9 -38.49 61.8 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.1 1.36 . . . . 0.0 112.507 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -32.64 74.18 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.33 -37.49 74.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.117 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.54 72.31 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.41 1.004 . . . . 0.0 112.151 171.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.7 71.14 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 118.738 0.699 . . . . 0.0 111.914 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -69.9 -48.51 58.34 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.509 1.124 . . . . 0.0 112.96 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.2 -31.34 71.1 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.7 -0.625 . . . . 0.0 112.359 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.68 HD23 HG12 ' A' ' 498' ' ' VAL . 76.8 mt -67.31 -36.96 82.57 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.35 -0.844 . . . . 0.0 112.33 173.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -67.21 -33.1 74.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.601 0.76 . . . . 0.0 111.686 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -93.85 -34.05 13.3 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -170.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -91.01 -13.85 32.52 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.091 1.356 . . . . 0.0 113.931 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -65.3 105.94 1.24 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.212 1.005 . . . . 0.0 110.36 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 111.64 0.7 27.58 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.495 -1.17 . . . . 0.0 115.876 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -73.04 129.33 37.85 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 4.9 p -128.38 67.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 124.171 1.938 . . . . 0.0 109.521 -163.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.32 127.67 33.16 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 113.235 -1.802 . . . . 0.0 110.594 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.43 11.2 m-85 58.8 24.44 12.35 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 74.82 3.92 69.51 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.691 1.139 . . . . 0.0 114.422 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -95.37 104.4 15.43 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.025 1.73 . . . . 0.0 108.816 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.75 110.99 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.376 2.051 . . . . 0.0 110.025 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 28.0 mtp -74.13 124.06 25.62 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.748 1.619 . . . . 0.0 111.841 -169.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 97.1 t -90.26 91.92 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.736 1.614 . . . . 0.0 109.492 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.68 HG12 HD23 ' A' ' 483' ' ' LEU . 2.2 t -87.75 123.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 126.12 1.768 . . . . 0.0 112.323 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -153.67 152.19 30.54 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -164.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -61.4 150.14 36.27 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.737 -1.227 . . . . 0.0 111.153 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.029 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -175.975 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 11.1 p -149.15 163.14 38.45 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -171.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.5 tt -74.33 149.63 7.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 125.692 1.597 . . . . 0.0 111.313 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 17.7 m -86.55 152.11 22.91 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -63.36 -29.63 70.9 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.322 -0.861 . . . . 0.0 110.75 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -34.85 75.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.719 1.607 . . . . 0.0 114.64 174.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -78.58 -48.28 15.5 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.397 0.679 . . . . 0.0 111.636 170.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 16.5 tp -57.53 -37.66 73.4 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -57.41 -25.65 59.9 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.124 1.37 . . . . 0.0 113.941 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -73.99 -20.07 60.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.859 1.264 . . . . 0.0 112.506 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -120.36 63.94 0.47 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.532 2.015 . . . . 0.0 112.327 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -151.14 143.59 24.24 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.738 1.615 . . . . 0.0 110.006 -176.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 18.2 pt -125.04 163.08 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 44.6 t -110.54 172.43 6.87 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.691 1.596 . . . . 0.0 110.36 165.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 32.5 mtt-85 -49.96 -30.42 10.38 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.852 1.261 . . . . 0.0 113.899 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.25 -13.79 21.23 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 125.989 1.715 . . . . 0.0 113.187 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -123.1 -37.3 2.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.051 1.74 . . . . 0.0 112.289 167.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 53.7 ttp -61.18 -40.17 92.9 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.707 -1.246 . . . . 0.0 111.551 -176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.24 2.36 28.26 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.461 -0.774 . . . . 0.0 112.177 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.59 -34.28 10.29 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.415 2.286 . . . . 0.0 113.771 169.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 29.8 mt -77.88 129.07 34.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.363 1.865 . . . . 0.0 113.06 -174.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 88.4 p -58.17 -33.31 69.1 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.168 -0.958 . . . . 0.0 113.58 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.448 HG23 ' CD2' ' A' ' 410' ' ' PHE . 3.4 m -64.07 -12.64 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.448 ' CD2' HG23 ' A' ' 409' ' ' VAL . 83.9 m-85 -125.64 14.89 8.14 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -61.28 -23.42 65.67 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.9 t -135.85 -16.15 1.75 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.096 0.958 . . . . 0.0 113.292 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -71.88 144.31 49.07 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -141.45 124.59 9.75 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -169.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.32 -176.49 3.29 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.785 2.99 . . . . 0.0 112.841 171.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.512 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 76.15 -4.83 45.68 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.779 1.872 . . . . 0.0 117.779 165.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -72.38 148.13 90.58 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 118.98 1.39 . . . . 0.0 113.384 174.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.39 110.58 3.13 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.775 2.983 . . . . 0.0 113.872 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -157.01 154.77 30.13 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.254 1.822 . . . . 0.0 109.478 161.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 27.4 p -80.43 -3.52 50.15 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -130.64 150.85 51.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.931 1.692 . . . . 0.0 110.408 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.4 pt -131.06 160.99 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.387 1.875 . . . . 0.0 109.965 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -135.11 162.09 33.48 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 173.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.9 t -136.35 135.36 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 125.673 1.589 . . . . 0.0 112.056 -174.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -117.61 169.03 9.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.44 1.896 . . . . 0.0 108.395 168.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.26 13.1 m-20 68.13 29.73 6.1 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -171.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.66 143.43 40.11 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 119.868 -1.77 . . . . 0.0 110.535 166.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.52 25.82 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 118.418 2.747 . . . . 0.0 118.418 -165.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp 59.58 -65.6 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 128.703 2.801 . . . . 0.0 113.863 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -58.16 -41.38 83.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.325 1.85 . . . . 0.0 113.89 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 9.1 p -51.12 140.76 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.291 1.037 . . . . 0.0 113.526 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -104.12 157.76 16.9 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.061 0.945 . . . . 0.0 113.102 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -61.02 -26.78 67.85 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.797 -1.814 . . . . 0.0 112.77 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -70.7 -22.05 62.5 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -74.41 -33.82 63.1 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.524 1.129 . . . . 0.0 112.97 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.6 mp -73.64 -23.79 59.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.193 1.797 . . . . 0.0 113.733 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 437' ' ' LYS . . . . . 0.424 ' HD3' HD12 ' A' ' 457' ' ' ILE . 26.9 mmtp -56.59 -28.78 61.11 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 118.842 0.747 . . . . 0.0 110.876 -177.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -57.68 -33.22 68.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.758 1.623 . . . . 0.0 111.854 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.7 mt -98.33 -58.24 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.361 -0.837 . . . . 0.0 110.795 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -59.59 -25.91 64.99 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -80.74 -7.61 88.38 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.766 1.174 . . . . 0.0 114.379 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 36.7 ttp85 -61.03 -23.8 65.69 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.946 1.873 . . . . 0.0 112.049 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -95.72 2.16 53.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.026 2.131 . . . . 0.0 112.594 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.8 110.39 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.035 1.734 . . . . 0.0 110.701 -172.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -71.41 90.17 0.95 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.281 53.7 m-85 -58.32 -24.05 58.46 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 119.307 3.077 . . . . 0.0 119.307 -171.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.5 m -64.96 -22.48 67.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 17.4 m -101.08 122.66 43.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.122 1.369 . . . . 0.0 112.816 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -55.65 -48.46 74.97 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.453 -0.78 . . . . 0.0 112.181 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 2.8 t -54.05 -18.01 3.21 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -88.21 -63.64 1.27 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.592 0.757 . . . . 0.0 110.778 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -65.08 -29.57 70.46 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.696 1.198 . . . . 0.0 112.2 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.0 tt -58.02 -32.92 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.246 1.419 . . . . 0.0 112.679 173.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 9.1 mmm -84.93 -10.25 57.27 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.097 0.959 . . . . 0.0 112.499 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -105.85 135.03 48.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.136 1.774 . . . . 0.0 115.092 -172.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -168.0 145.16 4.2 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.984 1.314 . . . . 0.0 108.464 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.424 HD12 ' HD3' ' A' ' 437' ' ' LYS . 6.3 mt -117.13 132.52 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.738 1.215 . . . . 0.0 110.087 174.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -121.23 122.8 40.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.695 1.198 . . . . 0.0 109.976 166.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 3.3 tt -107.58 123.52 48.57 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.145 1.378 . . . . 0.0 110.352 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 45.7 mtm -79.88 130.51 35.36 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.117 1.367 . . . . 0.0 111.973 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -118.04 -7.03 10.9 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.851 1.66 . . . . 0.0 114.472 -168.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -117.25 154.67 30.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.533 1.133 . . . . 0.0 112.061 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 57.89 -142.12 44.28 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 161.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 29.0 tpt85 -57.67 -31.56 66.44 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.01 2.124 . . . . 0.0 115.11 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 20.8 mtm -111.44 18.79 18.83 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.065 1.346 . . . . 0.0 113.791 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -57.5 112.53 1.45 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.089 -1.007 . . . . 0.0 110.813 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 91.05 24.0 28.36 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 124.384 0.992 . . . . 0.0 114.805 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -112.32 155.65 23.75 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.668 1.187 . . . . 0.0 110.619 165.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -148.35 153.51 38.71 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -116.29 141.33 48.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.064 1.745 . . . . 0.0 115.346 170.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.3 124.02 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.275 1.43 . . . . 0.0 110.704 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -90.87 147.55 18.99 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.33 0.49 . . . . 0.0 112.028 163.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 19.3 mt -128.01 160.69 60.2 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.866 1.266 . . . . 0.0 111.105 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.58 -5.23 16.29 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.318 2.679 . . . . 0.0 115.05 -173.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -157.9 146.25 18.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.515 1.526 . . . . 0.0 109.993 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -56.38 -32.78 65.11 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.416 -0.802 . . . . 0.0 112.81 166.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -56.98 -44.69 82.92 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.417 -0.802 . . . . 0.0 113.163 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -64.16 -38.3 90.56 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.435 0.694 . . . . 0.0 111.097 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.83 -43.91 82.49 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.319 0.963 . . . . 0.0 112.25 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.67 85.32 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.197 0.908 . . . . 0.0 112.312 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -70.96 -46.73 61.86 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.316 1.047 . . . . 0.0 112.306 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.57 72.13 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.542 HD23 HG12 ' A' ' 498' ' ' VAL . 45.7 mt -66.25 -47.58 73.27 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.246 -0.909 . . . . 0.0 110.229 173.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -30.64 71.69 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.586 0.63 . . . . 0.0 112.242 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -84.77 -40.23 17.5 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -91.89 -22.47 20.05 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -67.12 106.58 2.03 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.871 -1.143 . . . . 0.0 109.498 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 120.88 -8.46 10.69 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.89 1.233 . . . . 0.0 115.579 -171.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -73.22 129.28 37.7 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.44 1.62 . . . . 0.0 109.169 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.305 7.3 p -115.44 55.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 124.183 1.944 . . . . 0.0 110.871 -163.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 26.2 tp -48.01 123.84 6.75 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.442 2.697 . . . . 0.0 111.475 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.307 68.7 m-85 55.08 8.39 0.24 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -174.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 101.67 0.52 52.75 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.994 1.283 . . . . 0.0 115.251 -173.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -107.35 113.6 61.81 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.202 1.501 . . . . 0.0 110.471 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.0 115.45 4.36 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 122.397 2.064 . . . . 0.0 110.23 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 32.4 mtp -75.19 129.15 37.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.812 1.645 . . . . 0.0 111.957 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.5 t -87.95 94.47 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.384 1.073 . . . . 0.0 109.035 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.542 HG12 HD23 ' A' ' 483' ' ' LEU . 2.5 t -91.57 123.35 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.05 1.74 . . . . 0.0 111.856 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -149.95 156.15 41.23 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.724 0.81 . . . . 0.0 112.291 -167.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -56.89 144.78 32.15 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.396 -0.815 . . . . 0.0 109.787 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -173.019 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 123.128 1.442 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.8 p -154.51 155.16 34.35 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.543 1.137 . . . . 0.0 112.527 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.4 tt -70.94 155.37 7.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 125.139 1.376 . . . . 0.0 110.53 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 30.2 t -86.66 150.67 24.03 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 121.442 -0.787 . . . . 0.0 110.756 161.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -43.96 -39.54 4.11 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.531 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -46.25 86.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -79.6 -33.7 41.36 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.031 0.933 . . . . 0.0 112.91 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.17 -48.61 80.99 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.252 1.421 . . . . 0.0 111.192 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -57.6 -23.29 50.09 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.866 1.266 . . . . 0.0 114.363 -176.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -65.42 -25.91 67.74 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.983 1.313 . . . . 0.0 113.042 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.51 89.28 0.46 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.66 1.6 . . . . 0.0 109.946 173.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -167.01 131.75 2.02 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.799 1.239 . . . . 0.0 109.334 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.2 pt -109.42 155.93 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.11 165.6 13.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.08 1.752 . . . . 0.0 110.575 161.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -57.3 -33.59 67.84 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.127 1.371 . . . . 0.0 111.442 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -59.92 -35.28 74.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.853 1.261 . . . . 0.0 113.272 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -79.74 -40.23 29.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.419 0.688 . . . . 0.0 110.602 167.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 31.3 ttm -55.28 -42.41 73.57 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.151 -0.968 . . . . 0.0 112.486 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -79.81 -14.24 58.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.034 0.934 . . . . 0.0 112.974 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.31 -37.27 45.09 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.95 1.7 . . . . 0.0 111.14 168.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 65.3 mt -77.31 121.16 23.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.658 1.583 . . . . 0.0 112.579 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 55.9 p -56.12 -29.64 60.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.233 1.013 . . . . 0.0 113.296 168.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.2 m -63.48 -31.92 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 175.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.311 58.6 m-85 -85.29 -5.66 59.3 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 -175.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -57.75 -16.01 9.84 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 -160.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.9 t -127.37 6.42 6.35 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.626 1.17 . . . . 0.0 113.096 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -129.16 133.73 47.73 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.831 -1.168 . . . . 0.0 107.85 -160.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -147.39 123.31 5.41 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -168.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.99 -173.45 1.88 Allowed 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.946 3.098 . . . . 0.0 112.934 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 99.37 -18.43 56.41 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 116.376 1.311 . . . . 0.0 116.376 170.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -76.59 155.8 83.32 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 118.682 1.241 . . . . 0.0 113.142 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -90.56 113.78 0.46 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.586 3.524 . . . . 0.0 113.768 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -154.29 147.54 24.84 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.636 1.175 . . . . 0.0 109.7 168.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 19.9 p -78.64 11.83 2.36 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.158 -1.589 . . . . 0.0 114.074 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -142.94 146.67 34.2 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.984 2.114 . . . . 0.0 109.063 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 19.0 pt -129.23 167.86 23.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 125.426 1.49 . . . . 0.0 109.606 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -145.57 162.61 37.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.94 139.83 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.782 1.233 . . . . 0.0 111.982 -170.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -119.11 165.81 13.71 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.934 1.693 . . . . 0.0 109.837 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 8.4 t30 64.18 45.78 3.88 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.71 1.204 . . . . 0.0 111.915 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.54 153.31 29.61 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.313 -0.867 . . . . 0.0 111.445 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.32 169.8 8.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.334 1.454 . . . . 0.0 114.502 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -70.23 -48.12 58.38 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.139 -0.976 . . . . 0.0 112.924 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -72.91 -25.23 60.98 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.4 1.48 . . . . 0.0 114.209 -176.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.7 p -69.4 146.49 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -123.36 162.08 23.43 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.419 1.888 . . . . 0.0 110.538 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.38 -29.89 59.32 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.61 -1.306 . . . . 0.0 112.72 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -60.19 -35.44 75.4 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.03 -33.39 70.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.111 0.964 . . . . 0.0 112.918 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.3 mp -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.481 1.512 . . . . 0.0 112.533 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -55.51 -31.34 61.96 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.075 0.852 . . . . 0.0 112.848 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -61.78 -29.98 70.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.741 0.816 . . . . 0.0 110.792 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.92 -55.27 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 121.227 -0.92 . . . . 0.0 110.783 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.253 50.2 m-85 -62.66 -23.84 67.31 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.25 -15.69 81.29 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.015 0.817 . . . . 0.0 114.069 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 38.0 ttp85 -59.52 -25.93 64.9 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.331 1.452 . . . . 0.0 112.849 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -90.2 -0.22 57.51 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.229 1.812 . . . . 0.0 111.676 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 15.2 t -120.92 116.14 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.326 1.85 . . . . 0.0 110.654 -173.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -79.85 97.43 6.67 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.845 0.858 . . . . 0.0 110.761 -175.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.286 58.5 m-85 -62.44 -11.68 17.37 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 119.064 2.987 . . . . 0.0 119.064 -173.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 72.6 m -75.95 -6.73 52.31 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 168.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 47.3 t -116.68 113.42 22.62 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.053 1.741 . . . . 0.0 110.715 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -59.77 -47.22 86.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.845 -0.535 . . . . 0.0 110.975 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -17.02 6.96 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -86.11 -64.9 1.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.801 0.81 . . . . 0.0 109.472 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -68.01 -23.22 64.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.909 1.284 . . . . 0.0 113.889 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.3 tt -56.2 -40.03 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.081 1.352 . . . . 0.0 111.911 172.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -8.85 59.62 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.287 1.035 . . . . 0.0 112.244 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -100.5 125.14 46.8 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -173.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -162.58 155.12 19.23 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.843 1.657 . . . . 0.0 107.767 172.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 4.5 mt -115.95 146.7 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.558 1.143 . . . . 0.0 109.85 174.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -128.05 137.5 52.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.569 1.148 . . . . 0.0 109.72 161.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.1 tp -120.4 136.6 54.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.457 1.503 . . . . 0.0 109.644 168.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 41.8 mtm -91.05 127.97 36.68 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.853 1.661 . . . . 0.0 110.664 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -113.57 -1.79 13.99 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.003 1.721 . . . . 0.0 114.229 -170.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -151.85 -169.86 3.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.787 1.635 . . . . 0.0 111.572 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.36 -163.22 46.21 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.143 0.878 . . . . 0.0 114.484 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -68.95 -11.93 61.16 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.569 1.948 . . . . 0.0 115.344 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 18.0 ptm -137.2 43.23 2.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.759 1.224 . . . . 0.0 112.841 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -52.7 127.69 23.95 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.68 1.192 . . . . 0.0 110.645 168.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 77.61 34.76 38.5 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.423 1.011 . . . . 0.0 112.286 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -120.91 150.69 40.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.132 0.973 . . . . 0.0 112.466 164.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -138.7 157.17 46.61 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.672 1.589 . . . . 0.0 113.49 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -120.33 144.09 48.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.549 1.939 . . . . 0.0 115.079 166.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.91 119.75 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.388 1.475 . . . . 0.0 110.93 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -82.23 137.98 17.84 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.365 -0.834 . . . . 0.0 111.285 162.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 24.2 mt -118.2 160.95 37.3 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.756 1.222 . . . . 0.0 110.112 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 -6.57 15.73 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.092 1.862 . . . . 0.0 114.983 -172.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -156.37 143.99 19.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.506 1.523 . . . . 0.0 110.351 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -51.64 -36.96 48.2 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.789 1.636 . . . . 0.0 112.341 165.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -61.42 -40.38 94.21 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.276 1.03 . . . . 0.0 112.853 174.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.56 -39.32 91.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.118 0.567 . . . . 0.0 110.723 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.68 87.38 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.922 -0.486 . . . . 0.0 112.107 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.26 -43.53 78.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.981 0.81 . . . . 0.0 112.16 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -75.76 -45.08 38.37 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.82 1.248 . . . . 0.0 112.855 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.39 -33.83 73.04 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.626 0.648 . . . . 0.0 112.729 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 498' ' ' VAL . 38.3 mt -67.8 -46.55 71.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.85 0.75 . . . . 0.0 110.915 172.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -64.49 -32.76 74.53 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 119.114 -0.47 . . . . 0.0 111.322 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -82.8 -54.67 4.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.17 -17.86 61.91 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.38 102.59 0.14 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.167 1.387 . . . . 0.0 111.965 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 105.18 -0.77 40.76 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 118.149 -1.361 . . . . 0.0 115.754 -175.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.63 128.75 37.15 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.556 1.678 . . . . 0.0 112.84 -173.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.314 1.4 t -93.55 49.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -163.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 58.9 tp -57.91 122.42 12.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.663 1.585 . . . . 0.0 111.677 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.403 56.4 m-85 59.16 20.3 8.3 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -175.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 83.16 13.47 76.95 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.335 0.969 . . . . 0.0 114.198 -172.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -119.78 119.86 30.92 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.042 1.337 . . . . 0.0 110.616 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.9 114.59 4.08 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.064 2.509 . . . . 0.0 111.003 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 63.1 mtp -74.72 134.78 41.85 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.529 1.132 . . . . 0.0 111.952 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.47 100.15 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.473 1.509 . . . . 0.0 108.458 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.501 HG12 HD23 ' A' ' 483' ' ' LEU . 2.4 t -101.93 132.38 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.019 1.728 . . . . 0.0 112.993 -170.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -150.43 156.77 42.1 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -170.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -56.16 144.71 28.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.793 0.837 . . . . 0.0 109.346 170.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.479 0 O-C-N 121.23 -0.919 . . . . 0.0 113.145 -176.561 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 8.8 m -155.14 161.28 41.28 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.41 1.884 . . . . 0.0 112.568 171.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.5 tt -67.94 140.88 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 124.222 1.009 . . . . 0.0 110.892 -170.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 70.5 m -82.68 160.44 22.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.998 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -63.64 -33.2 75.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 118.889 -0.576 . . . . 0.0 111.809 -174.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -62.47 -55.72 24.91 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.67 0.788 . . . . 0.0 112.964 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -62.06 -38.37 88.51 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.25 -44.64 83.1 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -60.67 -21.16 62.52 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -61.29 -46.29 90.94 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.178 1.391 . . . . 0.0 111.892 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.9 75.55 0.39 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.477 1.037 . . . . 0.0 111.999 -170.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 6.1 ttp85 -155.5 152.97 29.54 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.212 1.005 . . . . 0.0 110.97 -173.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.6 pt -130.94 155.06 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.9 0.88 . . . . 0.0 112.031 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 74.5 p -86.65 172.12 10.47 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.321 1.048 . . . . 0.0 111.456 169.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -55.18 -32.92 62.55 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.567 -0.708 . . . . 0.0 111.43 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.12 -25.72 67.89 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.88 -32.05 14.74 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.767 0.712 . . . . 0.0 110.803 166.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 16.0 ttm -66.55 -42.26 87.41 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.444 -1.41 . . . . 0.0 112.598 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -78.43 12.48 1.96 Allowed 'General case' 0 CA--C 1.552 1.042 0 O-C-N 120.973 -1.079 . . . . 0.0 111.573 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -125.03 -30.31 3.24 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.116 2.166 . . . . 0.0 116.006 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 1.7 mp -75.7 130.67 39.08 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.916 -1.115 . . . . 0.0 109.753 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 38.1 m -66.07 -20.65 66.24 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 1.3 m -57.19 -25.91 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 167.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.15 21.22 17.02 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -63.87 -22.52 66.96 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.238 -1.539 . . . . 0.0 114.78 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 78.0 p -139.97 -19.49 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.741 1.616 . . . . 0.0 113.365 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.18 135.89 41.06 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -141.95 132.05 12.65 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -85.26 175.77 6.2 Favored 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.283 3.322 . . . . 0.0 113.683 168.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.26 -3.39 72.54 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 117.894 1.918 . . . . 0.0 117.894 165.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -81.7 144.37 52.26 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 119.096 1.448 . . . . 0.0 113.996 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.17 86.21 1.7 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.148 3.232 . . . . 0.0 112.686 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -133.55 151.44 51.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.28 1.432 . . . . 0.0 110.257 165.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 24.2 p -82.07 -9.2 59.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -121.61 150.52 41.58 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.944 1.298 . . . . 0.0 110.629 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 19.7 pt -135.02 158.84 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.638 1.975 . . . . 0.0 110.37 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -133.79 158.11 44.18 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.24 131.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.246 1.418 . . . . 0.0 113.614 -171.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -108.63 172.66 6.71 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.262 1.425 . . . . 0.0 110.63 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.283 88.6 m-20 71.67 32.91 1.89 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.645 1.978 . . . . 0.0 116.029 -176.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.49 147.2 25.48 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.175 -0.953 . . . . 0.0 111.73 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.67 161.72 22.74 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.149 1.779 . . . . 0.0 115.109 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -67.14 -39.85 86.63 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.664 -1.272 . . . . 0.0 112.681 166.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -73.1 -27.83 61.93 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.752 1.621 . . . . 0.0 114.798 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.01 146.43 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -128.23 164.05 23.39 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.889 1.276 . . . . 0.0 112.584 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -33.99 68.21 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.63 -1.294 . . . . 0.0 113.021 -174.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -54.22 -30.82 51.43 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.191 1.797 . . . . 0.0 115.297 170.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -83.43 -34.18 25.52 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.877 1.671 . . . . 0.0 113.6 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.06 -22.32 66.88 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.323 1.049 . . . . 0.0 111.973 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -20.18 44.63 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -67.29 -30.52 70.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.83 0.741 . . . . 0.0 111.843 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.83 -55.47 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.27 -0.894 . . . . 0.0 110.46 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -57.61 -30.07 65.03 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.36 -12.07 82.14 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 123.997 0.808 . . . . 0.0 114.602 174.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 5.4 ttt85 -58.83 -27.89 65.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.334 1.567 . . . . 0.0 110.85 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -95.66 18.26 13.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.241 1.816 . . . . 0.0 113.558 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 27.3 t -140.54 124.56 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.099 1.76 . . . . 0.0 111.223 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -77.23 110.07 11.63 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -61.71 -12.42 16.51 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 118.178 2.658 . . . . 0.0 118.178 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 16.5 m -88.83 -18.95 26.6 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.455 0.702 . . . . 0.0 112.676 174.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 28.9 t -108.63 112.54 24.93 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.758 1.223 . . . . 0.0 111.754 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -54.11 -50.64 66.41 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.228 0.611 . . . . 0.0 111.016 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.45 -12.77 1.85 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -93.17 -61.76 1.51 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.978 1.311 . . . . 0.0 110.692 172.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -69.3 -20.41 63.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.796 1.239 . . . . 0.0 113.784 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.08 -28.97 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.773 1.629 . . . . 0.0 112.69 169.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 37.5 mtp -85.86 -13.1 48.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.958 1.303 . . . . 0.0 111.761 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -108.32 117.32 33.84 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -163.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -159.2 154.54 25.55 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.891 1.676 . . . . 0.0 110.065 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 8.4 mt -130.63 142.21 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.189 1.396 . . . . 0.0 110.797 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -123.37 142.64 50.76 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.028 1.331 . . . . 0.0 110.283 160.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 11.2 tp -133.47 115.68 15.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.842 2.057 . . . . 0.0 109.134 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 45.8 mtm -71.27 144.62 49.96 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 124.602 1.161 . . . . 0.0 111.751 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -128.64 -6.93 5.14 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -172.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.96 145.1 35.57 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.824 1.193 . . . . 0.0 114.122 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 75.37 -177.16 49.29 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.096 1.331 . . . . 0.0 113.216 -172.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -18.72 61.68 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -170.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 70.4 mtp -89.12 3.17 52.72 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -58.52 145.63 38.39 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.533 -1.354 . . . . 0.0 111.131 175.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.54 27.66 70.84 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.749 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -126.83 146.04 50.42 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.727 1.211 . . . . 0.0 111.339 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -137.07 155.26 49.87 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -167.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -125.71 134.0 51.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.678 1.991 . . . . 0.0 115.307 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.94 125.05 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.974 1.709 . . . . 0.0 109.952 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.07 137.62 14.27 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 162.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 25.2 mt -118.18 160.45 39.25 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.515 1.526 . . . . 0.0 109.26 173.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.03 -8.96 20.5 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.139 1.226 . . . . 0.0 114.642 -170.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' ASN . . . . . 0.402 ' OD1' ' HE2' ' A' ' 477' ' ' LYS . 64.1 t-20 -153.47 142.38 21.16 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.72 1.208 . . . . 0.0 111.059 -172.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -60.24 -37.19 79.63 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.389 -0.819 . . . . 0.0 111.147 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.402 ' HE2' ' OD1' ' A' ' 475' ' ' ASN . 3.0 mppt? -65.25 -32.35 73.97 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.311 0.644 . . . . 0.0 112.591 176.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -73.58 -35.5 65.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.084 0.554 . . . . 0.0 111.777 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.97 -45.14 86.92 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.359 0.981 . . . . 0.0 111.696 168.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.56 77.83 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.767 1.167 . . . . 0.0 112.263 176.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.33 -50.97 61.78 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.207 1.403 . . . . 0.0 112.545 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.54 -33.53 72.8 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.862 0.865 . . . . 0.0 112.118 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.523 HD23 HG12 ' A' ' 498' ' ' VAL . 45.6 mt -71.19 -36.87 72.11 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.927 1.291 . . . . 0.0 111.521 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -67.28 -22.99 65.63 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.513 1.125 . . . . 0.0 112.698 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -112.15 -33.04 6.36 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -171.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -84.83 -17.54 37.73 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -66.56 109.29 2.73 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.263 1.025 . . . . 0.0 111.672 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 104.57 4.41 43.13 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 118.061 -1.41 . . . . 0.0 115.976 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -70.4 123.66 22.3 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.704 1.752 . . . . 0.0 110.956 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.27 2.0 t -92.31 52.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.196 1.398 . . . . 0.0 114.416 -163.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.08 126.01 25.82 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.739 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . . 4.9 t80 53.79 35.91 22.67 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.579 1.952 . . . . 0.0 110.14 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 76.89 11.53 85.4 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.664 -1.272 . . . . 0.0 115.068 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -127.11 123.35 23.43 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 119.253 1.526 . . . . 0.0 111.11 -176.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.2 118.15 5.41 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.566 2.177 . . . . 0.0 111.648 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 72.1 mtp -69.14 126.06 28.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.693 1.197 . . . . 0.0 112.304 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -86.23 83.11 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.674 1.589 . . . . 0.0 113.422 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.523 HG12 HD23 ' A' ' 483' ' ' LEU . 1.6 t -85.86 122.61 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.398 1.479 . . . . 0.0 112.895 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -145.95 155.6 42.95 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.954 1.301 . . . . 0.0 111.693 -174.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -60.35 144.28 51.08 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.937 -1.102 . . . . 0.0 110.796 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.458 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 . . . . . 0 CA--C 1.544 0.722 0 CA-C-O 122.229 1.014 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 14.7 p -150.22 149.61 30.43 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.92 1.288 . . . . 0.0 114.332 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.5 tt -76.08 153.04 6.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 125.795 1.638 . . . . 0.0 111.516 -167.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 33.9 t -83.54 156.6 22.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.386 0.612 . . . . 0.0 110.745 165.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -53.92 -36.01 62.3 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.491 0.717 . . . . 0.0 111.029 163.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -45.4 86.78 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -71.1 -35.17 71.72 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.546 0.738 . . . . 0.0 112.85 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.422 HD12 ' CD2' ' A' ' 489' ' ' TYR . 31.4 tp -67.76 -44.68 76.9 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -54.91 -24.19 22.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.816 1.246 . . . . 0.0 114.03 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.68 -29.29 69.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.126 1.371 . . . . 0.0 112.855 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.22 97.94 0.76 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.436 1.017 . . . . 0.0 111.521 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -159.8 152.22 21.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.448 1.099 . . . . 0.0 110.635 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.44 150.21 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.428 0.632 . . . . 0.0 112.68 168.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 39.9 m -98.22 169.45 9.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.66 1.584 . . . . 0.0 111.694 168.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -54.57 -23.71 17.93 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -171.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -72.16 -28.43 63.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.798 0.839 . . . . 0.0 112.81 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.79 -32.9 14.49 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.527 1.131 . . . . 0.0 111.094 171.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 35.8 ttm -58.08 -46.3 85.69 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.08 -1.013 . . . . 0.0 111.239 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -85.04 37.16 0.65 Allowed 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.385 -0.822 . . . . 0.0 111.363 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.44 -37.52 0.31 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.948 2.099 . . . . 0.0 114.332 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.48 131.37 42.46 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.993 1.317 . . . . 0.0 110.008 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 53.1 p -69.01 -22.48 64.07 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.012 -1.055 . . . . 0.0 112.065 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.3 m -71.38 -7.53 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 168.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.426 ' CE1' HG13 ' A' ' 497' ' ' VAL 0.286 89.4 m-85 -117.79 3.93 12.25 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 173.718 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -66.01 -15.07 62.71 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -174.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 79.9 p -141.1 -16.12 0.86 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.907 1.283 . . . . 0.0 114.187 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -80.75 141.27 34.96 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 170.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -140.59 129.8 13.09 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -169.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -84.91 -174.86 1.86 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 124.263 3.309 . . . . 0.0 114.242 171.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.83 -44.99 2.34 Favored Glycine 0 N--CA 1.466 0.659 0 C-N-CA 126.488 1.994 . . . . 0.0 115.774 164.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -65.85 142.37 98.08 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -164.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.2 106.5 2.29 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.53 2.82 . . . . 0.0 112.199 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -144.37 151.21 38.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.222 2.209 . . . . 0.0 107.752 159.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 28.9 p -75.06 2.55 10.35 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.476 -1.39 . . . . 0.0 114.361 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -137.53 147.69 45.36 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.124 1.77 . . . . 0.0 110.333 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 43.9 pt -134.43 159.97 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.203 2.201 . . . . 0.0 110.123 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -139.86 159.86 41.22 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.19 140.24 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.694 1.597 . . . . 0.0 113.412 -164.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -119.5 175.59 5.76 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.331 1.452 . . . . 0.0 111.168 167.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.279 13.6 m-20 69.07 25.42 5.85 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.322 1.849 . . . . 0.0 115.824 -172.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -74.68 146.53 42.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.262 -1.524 . . . . 0.0 111.043 173.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.18 173.65 3.69 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -173.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -77.98 -50.58 11.87 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.518 1.127 . . . . 0.0 111.78 -176.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -81.97 -23.68 35.94 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.24 1.816 . . . . 0.0 113.251 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.58 152.07 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -122.53 168.27 12.34 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.697 1.599 . . . . 0.0 113.346 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -57.2 -35.21 69.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.542 1.137 . . . . 0.0 112.616 174.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -62.35 -36.42 82.19 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -71.92 -25.18 61.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.641 1.176 . . . . 0.0 113.636 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.23 -15.4 59.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.099 2.16 . . . . 0.0 114.024 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.67 -22.75 57.75 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.324 0.966 . . . . 0.0 112.857 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -55.31 -37.23 67.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.076 1.351 . . . . 0.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.79 -57.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 121.253 -0.904 . . . . 0.0 111.659 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.274 58.9 m-85 -59.68 -31.83 69.92 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -175.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.76 -19.84 79.74 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 123.668 0.652 . . . . 0.0 114.072 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -55.0 -35.82 64.77 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.713 1.605 . . . . 0.0 112.506 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -77.71 0.79 22.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.431 1.892 . . . . 0.0 114.873 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 11.7 t -124.59 121.99 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.742 2.017 . . . . 0.0 109.946 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.254 3.2 m-20 -66.78 90.56 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 175.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -52.64 -21.42 3.93 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 173.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 15.8 m -65.2 -22.29 66.88 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.346 1.058 . . . . 0.0 113.176 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 31.2 m -124.45 117.84 25.31 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.697 1.599 . . . . 0.0 112.733 -170.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -63.09 -40.67 98.33 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.234 -0.916 . . . . 0.0 113.278 -174.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 2.9 t -54.48 -15.23 1.58 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -88.75 -62.65 1.44 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.213 1.405 . . . . 0.0 110.714 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -67.02 -24.55 66.03 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.14 1.376 . . . . 0.0 113.169 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.3 tt -58.53 -36.58 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.3 1.04 . . . . 0.0 112.366 171.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 16.6 mtm -87.52 -2.59 58.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.089 1.355 . . . . 0.0 112.439 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.56 143.81 31.77 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.938 2.495 . . . . 0.0 115.212 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -168.7 154.85 6.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.08 1.752 . . . . 0.0 107.006 168.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.08 126.75 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.599 1.16 . . . . 0.0 109.544 172.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -104.3 137.65 41.89 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.845 1.258 . . . . 0.0 108.899 165.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.2 tp -128.1 127.75 43.63 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.886 1.274 . . . . 0.0 109.191 164.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 48.0 mtm -93.17 125.04 37.57 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.808 1.643 . . . . 0.0 109.948 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -122.14 -0.46 9.43 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.963 2.105 . . . . 0.0 112.925 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.9 148.79 23.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.832 1.653 . . . . 0.0 112.512 173.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 90.57 -168.77 33.56 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 163.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -20.55 64.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.344 1.858 . . . . 0.0 113.772 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 62.7 mtp -115.92 24.28 11.59 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.282 2.233 . . . . 0.0 112.202 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -65.46 151.95 45.11 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.792 -1.193 . . . . 0.0 113.204 -172.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.66 36.83 18.5 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 126.194 1.854 . . . . 0.0 112.798 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -120.19 142.01 49.37 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.189 0.996 . . . . 0.0 112.128 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -129.93 153.37 48.41 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -168.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -126.83 129.63 48.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.0 2.12 . . . . 0.0 114.733 171.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.5 mp -126.42 120.56 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.674 1.59 . . . . 0.0 109.856 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -83.14 141.03 20.45 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 162.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 21.4 mt -124.51 158.82 60.41 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.726 1.61 . . . . 0.0 109.686 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.88 -15.62 26.39 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.948 2.432 . . . . 0.0 114.085 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -150.07 143.74 25.31 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.035 0.934 . . . . 0.0 110.623 -175.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -57.6 -37.67 73.61 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.41 1.084 . . . . 0.0 111.61 170.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -69.78 -23.23 63.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.346 1.058 . . . . 0.0 113.575 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -77.56 -38.22 48.98 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.774 171.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.06 79.27 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.254 0.933 . . . . 0.0 112.259 170.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -54.64 -43.19 72.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.4 1.0 . . . . 0.0 111.614 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -64.77 -50.05 68.35 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.962 1.305 . . . . 0.0 113.009 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.38 -31.54 72.22 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.359 0.664 . . . . 0.0 111.816 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.511 HD23 HG12 ' A' ' 498' ' ' VAL . 89.7 mt -77.87 -31.58 51.45 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.099 -1.001 . . . . 0.0 112.346 173.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -60.62 -33.29 72.55 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.617 1.167 . . . . 0.0 110.606 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -101.9 -54.45 2.72 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -174.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -75.52 -14.45 60.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -168.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -65.46 104.43 0.98 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.207 1.003 . . . . 0.0 110.323 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 107.31 1.5 35.46 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 117.583 -1.676 . . . . 0.0 116.18 -172.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.422 ' CD2' HD12 ' A' ' 394' ' ' LEU 0.314 92.2 t80 -64.65 128.86 37.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.672 2.236 . . . . 0.0 115.925 -168.285 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.325 2.0 t -91.68 45.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -160.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 23.2 tp -52.8 138.87 28.35 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.156 1.382 . . . . 0.0 110.183 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.356 7.0 t80 62.91 -4.08 0.28 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 94.7 9.57 58.57 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 124.958 1.266 . . . . 0.0 114.358 -166.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -127.21 128.48 24.09 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 126.686 1.995 . . . . 0.0 111.581 -173.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.86 119.04 5.51 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.544 2.162 . . . . 0.0 112.511 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 56.9 mtp -75.58 130.81 39.4 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.729 1.612 . . . . 0.0 112.419 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 497' ' ' VAL . . . . . 0.426 HG13 ' CE1' ' A' ' 410' ' ' PHE . 2.5 t -87.95 76.79 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.857 1.663 . . . . 0.0 115.131 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.511 HG12 HD23 ' A' ' 483' ' ' LEU . 1.7 t -79.83 122.72 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.355 1.062 . . . . 0.0 113.789 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -141.63 155.7 45.7 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.175 1.79 . . . . 0.0 112.514 -173.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -59.7 143.28 51.18 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.346 -1.471 . . . . 0.0 113.193 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -169.99 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 121.892 0.853 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 28.0 p -139.05 159.81 41.26 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.9 tt -70.06 152.37 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.863 1.665 . . . . 0.0 110.94 -174.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 1.6 m -86.65 152.6 22.44 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 7.2 ttm-85 -59.06 -35.79 73.95 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.1 -1.0 . . . . 0.0 111.124 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -41.51 98.26 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.838 1.655 . . . . 0.0 113.733 174.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.85 -38.91 92.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.095 0.958 . . . . 0.0 112.692 174.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.4 tt -70.2 -39.99 74.86 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.412 1.485 . . . . 0.0 111.943 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.36 -17.17 18.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.488 1.915 . . . . 0.0 115.153 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -63.95 -64.61 0.84 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.74 -0.6 . . . . 0.0 110.88 164.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -78.99 72.09 2.51 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.497 1.999 . . . . 0.0 114.072 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -159.66 143.33 14.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.763 1.225 . . . . 0.0 110.973 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.4 pt -123.3 153.74 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.356 1.063 . . . . 0.0 113.866 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 77.3 p -85.02 169.87 13.55 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.54 1.536 . . . . 0.0 111.828 168.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 -58.37 -28.92 65.6 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.326 -0.859 . . . . 0.0 113.288 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.83 -30.94 71.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.543 0.737 . . . . 0.0 112.265 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.44 -36.59 26.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.641 1.176 . . . . 0.0 111.775 168.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 20.3 ttp -63.06 -40.6 98.18 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.919 -1.113 . . . . 0.0 111.829 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -83.29 25.12 0.75 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.441 0.696 . . . . 0.0 112.609 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.69 -38.23 1.51 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.892 2.077 . . . . 0.0 115.933 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.58 127.58 33.44 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.509 1.524 . . . . 0.0 110.131 172.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 27.9 t -59.48 -32.12 69.96 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.543 -0.723 . . . . 0.0 112.314 168.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 18.5 m -60.21 -21.64 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 120.753 -1.217 . . . . 0.0 114.08 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.263 79.7 m-85 -109.52 6.8 24.39 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -69.67 -22.33 63.45 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 46.6 t -123.43 -42.16 2.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.426 1.09 . . . . 0.0 112.381 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -72.56 150.79 42.84 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.898 1.279 . . . . 0.0 114.319 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -140.24 125.49 11.36 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -163.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -92.74 177.01 1.55 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 124.958 3.772 . . . . 0.0 114.887 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.438 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 98.58 -8.86 62.2 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.302 1.906 . . . . 0.0 116.843 163.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -85.69 139.79 35.52 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 119.294 1.547 . . . . 0.0 114.556 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -83.55 65.43 7.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 1 C-N-CA 125.392 4.061 . . . . 0.0 113.038 -174.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -89.79 153.98 20.26 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.551 -0.718 . . . . 0.0 110.485 162.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 28.4 p -76.05 -3.63 36.94 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.088 -1.633 . . . . 0.0 115.068 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -136.44 152.52 50.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.352 1.861 . . . . 0.0 111.833 176.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.6 pt -135.4 164.14 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.671 1.989 . . . . 0.0 109.588 176.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -138.47 161.21 37.59 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.447 HG22 HG13 ' A' ' 498' ' ' VAL . 2.7 t -135.62 150.52 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.241 1.816 . . . . 0.0 112.018 -171.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -138.01 -178.25 5.18 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.292 0.496 . . . . 0.0 112.158 162.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 69.61 21.73 6.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.215 1.806 . . . . 0.0 114.516 -165.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.87 154.64 41.65 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.991 -1.068 . . . . 0.0 110.912 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -68.26 173.7 4.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.172 0.989 . . . . 0.0 113.03 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.02 -30.43 13.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.225 1.41 . . . . 0.0 112.285 170.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -73.69 -14.81 61.21 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.107 1.363 . . . . 0.0 113.92 172.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.8 p -86.16 147.16 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.807 1.643 . . . . 0.0 113.898 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -117.49 164.81 14.34 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.333 1.053 . . . . 0.0 111.953 173.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -58.67 -30.51 67.41 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.6 -1.313 . . . . 0.0 111.966 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -20.93 63.8 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.842 1.657 . . . . 0.0 114.84 174.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -76.78 -37.86 55.09 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.269 1.028 . . . . 0.0 113.533 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.18 -18.31 63.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.595 1.558 . . . . 0.0 112.541 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -49.14 -33.13 11.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.176 1.391 . . . . 0.0 112.869 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -66.14 -31.2 71.91 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -169.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.9 mt -98.75 -56.15 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.821 -1.174 . . . . 0.0 111.151 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.265 75.6 m-85 -60.79 -22.52 64.2 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.73 -6.88 88.89 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.399 0.999 . . . . 0.0 114.519 170.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -63.05 -26.39 68.82 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 120.794 2.297 . . . . 0.0 112.09 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -94.51 3.83 54.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.081 2.152 . . . . 0.0 111.424 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.8 107.8 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.355 1.462 . . . . 0.0 109.432 -174.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -72.15 104.96 3.79 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -170.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -50.3 -40.31 48.19 Favored 'General case' 0 C--N 1.338 0.109 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 -170.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.0 p -68.16 -4.08 12.66 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 14.9 t -118.02 116.05 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.747 1.158 . . . . 0.0 111.782 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -60.3 -43.78 96.0 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.209 -0.932 . . . . 0.0 112.25 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.2 t -54.83 -16.08 2.38 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -90.09 -60.28 1.97 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.186 0.994 . . . . 0.0 110.032 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -68.13 -23.86 64.94 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.785 1.234 . . . . 0.0 113.286 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.0 tt -61.36 -31.84 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.938 1.695 . . . . 0.0 112.96 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.7 mtm -97.85 2.39 49.25 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.23 1.412 . . . . 0.0 112.698 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -111.6 112.23 23.79 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.372 1.869 . . . . 0.0 115.85 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -154.62 131.85 11.07 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.573 -0.704 . . . . 0.0 109.419 -168.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 5.1 mt -113.47 142.96 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.654 1.182 . . . . 0.0 110.407 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -134.37 129.64 35.71 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.992 1.717 . . . . 0.0 109.322 165.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 4.2 tt -115.53 139.73 49.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.345 1.858 . . . . 0.0 111.005 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -101.67 131.78 47.73 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 125.234 1.414 . . . . 0.0 112.463 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -113.9 1.76 14.84 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -171.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -145.9 154.82 42.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.211 1.004 . . . . 0.0 113.042 -174.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 77.23 -162.08 51.03 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.207 1.384 . . . . 0.0 113.809 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -22.27 66.07 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 121.483 -1.01 . . . . 0.0 112.743 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 23.2 ptp -87.18 8.84 22.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.112 1.365 . . . . 0.0 114.395 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -56.77 115.85 2.81 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.825 1.193 . . . . 0.0 110.838 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.16 22.79 58.48 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.732 1.634 . . . . 0.0 113.859 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -93.79 155.98 16.92 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.353 0.661 . . . . 0.0 110.697 158.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -149.74 152.8 35.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.224 1.009 . . . . 0.0 113.179 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -105.63 144.53 32.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.145 1.778 . . . . 0.0 114.123 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.9 mp -139.62 115.01 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.198 1.399 . . . . 0.0 109.244 169.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -81.69 144.15 23.97 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 158.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.1 mt -123.5 159.83 53.44 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.712 1.205 . . . . 0.0 110.332 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.01 -8.78 24.44 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.658 2.906 . . . . 0.0 114.321 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -156.71 144.11 19.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.582 0.706 . . . . 0.0 112.125 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -49.77 -44.79 49.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.406 1.882 . . . . 0.0 112.579 166.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -68.01 -28.75 67.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.706 1.202 . . . . 0.0 113.779 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.52 73.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.563 174.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.0 88.03 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.939 0.79 . . . . 0.0 112.776 174.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.68 71.11 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.722 0.692 . . . . 0.0 112.371 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.16 -52.0 15.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.134 1.374 . . . . 0.0 112.885 172.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.08 -30.54 69.3 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.094 0.958 . . . . 0.0 113.293 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.597 HD23 HG12 ' A' ' 498' ' ' VAL . 28.8 mt -64.17 -49.32 72.56 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.379 0.671 . . . . 0.0 111.028 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -21.6 48.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.614 0.766 . . . . 0.0 112.729 -176.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -72.01 -54.57 9.48 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.397 0.999 . . . . 0.0 112.62 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.67 -14.67 59.56 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -172.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -61.8 99.07 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.013 1.325 . . . . 0.0 111.657 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 119.34 -1.5 14.29 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 117.778 -1.568 . . . . 0.0 115.405 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -71.23 131.0 42.85 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.354 1.577 . . . . 0.0 111.254 -172.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.18 67.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.971 1.708 . . . . 0.0 113.437 -168.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 23.6 tp -66.28 142.8 57.54 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.363 162.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.4 27.3 t80 63.8 7.81 3.44 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 118.228 2.677 . . . . 0.0 118.228 167.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 78.93 14.97 81.42 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.1 1.333 . . . . 0.0 114.277 -169.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -133.87 125.65 18.37 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.66 1.584 . . . . 0.0 110.689 -171.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.4 125.18 11.54 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.121 1.881 . . . . 0.0 112.167 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 63.7 mtp -73.15 127.3 32.2 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.817 1.247 . . . . 0.0 111.696 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.24 98.86 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.901 0.88 . . . . 0.0 109.712 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.597 HG12 HD23 ' A' ' 483' ' ' LEU . 2.0 t -94.18 124.27 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.641 1.577 . . . . 0.0 112.337 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -148.28 152.81 37.77 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.61 0.764 . . . . 0.0 112.765 -168.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . 0.31 17.6 p90 -57.85 144.66 37.98 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 173.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -171.312 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 . . . . . 0 CA--C 1.542 0.639 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 23.2 p -135.85 162.5 32.64 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 12.5 tt -76.66 144.03 12.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 125.694 1.597 . . . . 0.0 111.971 -162.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 69.3 m -90.05 155.96 18.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.506 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -53.48 -38.77 63.97 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.929 0.892 . . . . 0.0 111.655 -174.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -62.53 -47.97 81.58 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -69.67 -34.11 73.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -42.52 94.41 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.8 0.84 . . . . 0.0 112.408 169.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -57.91 -27.14 63.06 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.659 -1.276 . . . . 0.0 114.443 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -68.93 -21.84 64.18 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 118.996 0.816 . . . . 0.0 112.412 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -116.52 62.95 0.37 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.088 1.804 . . . . 0.0 112.888 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -148.21 166.25 28.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.832 1.653 . . . . 0.0 109.371 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.2 pt -144.83 148.88 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.125 0.97 . . . . 0.0 112.143 167.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.6 m -74.17 160.38 31.27 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.4 1.88 . . . . 0.0 112.815 165.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -53.76 -35.62 61.47 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.804 1.242 . . . . 0.0 112.323 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -60.3 -30.08 69.25 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.299 1.04 . . . . 0.0 113.258 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.33 -26.24 18.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.568 1.147 . . . . 0.0 112.123 172.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 8.2 ttm -61.77 -38.98 90.05 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 120.785 -1.197 . . . . 0.0 111.366 174.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -80.15 22.18 0.54 Allowed 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 171.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.38 -31.46 1.09 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 5.5 mp -74.5 137.85 42.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.64 1.176 . . . . 0.0 111.402 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 81.1 p -63.64 -31.89 73.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.429 HG23 ' CD2' ' A' ' 410' ' ' PHE . 1.5 m -63.54 -19.54 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.38 1.472 . . . . 0.0 114.677 173.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.429 ' CD2' HG23 ' A' ' 409' ' ' VAL 0.308 65.7 m-85 -109.41 3.08 21.06 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 119.152 3.019 . . . . 0.0 119.152 -176.41 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -29.12 67.05 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 37.5 t -126.43 -34.94 2.42 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.064 1.346 . . . . 0.0 112.829 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -72.02 139.61 48.63 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -142.41 130.32 11.47 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.709 1.204 . . . . 0.0 112.15 -170.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -76.48 -166.28 0.36 Allowed 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 124.3 3.334 . . . . 0.0 113.156 164.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.411 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 91.16 13.8 58.35 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 117.688 1.835 . . . . 0.0 117.688 156.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -102.38 149.87 37.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 119.613 1.706 . . . . 0.0 113.088 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.54 109.53 2.92 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.583 2.856 . . . . 0.0 112.355 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -148.38 145.0 27.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.347 1.059 . . . . 0.0 109.098 164.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 24.2 p -76.0 -2.66 31.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 33.8 mtp85 -130.09 147.08 51.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.888 2.075 . . . . 0.0 108.901 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 3.3 pt -131.81 161.18 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 126.386 1.875 . . . . 0.0 109.431 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -136.8 161.44 35.98 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.7 t -131.65 140.68 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.453 1.501 . . . . 0.0 111.655 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -120.56 166.23 13.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.544 1.537 . . . . 0.0 109.36 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 69.49 36.88 2.1 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -171.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.8 160.2 26.23 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 120.148 -1.595 . . . . 0.0 112.221 168.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -79.02 176.15 9.92 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.002 1.721 . . . . 0.0 115.282 -171.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -77.93 -48.04 17.24 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 171.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -72.8 -36.04 67.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.656 1.182 . . . . 0.0 113.179 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.64 153.95 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -130.93 163.55 27.24 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.467 1.507 . . . . 0.0 111.566 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -52.62 -31.06 34.71 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.548 1.139 . . . . 0.0 113.408 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -60.08 -33.04 71.53 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 171.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -76.88 -26.82 54.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.427 1.491 . . . . 0.0 114.494 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.44 -19.98 60.83 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.044 1.738 . . . . 0.0 113.549 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.76 -25.88 61.08 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.587 1.085 . . . . 0.0 112.358 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -59.29 -38.87 81.25 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.552 0.741 . . . . 0.0 111.5 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mt -94.47 -56.97 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 121.26 -0.9 . . . . 0.0 110.632 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -60.25 -28.33 67.95 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.57 -12.75 84.21 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.437 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -55.12 -40.4 70.46 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.135 1.467 . . . . 0.0 112.064 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -80.89 -5.96 58.04 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.403 1.881 . . . . 0.0 112.022 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.61 117.54 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.154 1.782 . . . . 0.0 110.726 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -69.07 90.87 0.47 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.299 30.7 m-85 -59.14 -16.05 17.73 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 118.198 2.666 . . . . 0.0 118.198 177.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.9 t -66.73 -26.26 66.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.854 1.207 . . . . 0.0 112.295 171.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.1 m -110.23 120.76 43.46 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.636 1.574 . . . . 0.0 112.303 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -58.23 -44.11 88.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.005 -1.059 . . . . 0.0 112.826 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.11 -7.14 0.46 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -100.0 -55.6 2.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.842 1.257 . . . . 0.0 109.768 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -70.58 -24.13 62.71 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.485 1.114 . . . . 0.0 112.691 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.5 tt -59.24 -31.91 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.8 1.64 . . . . 0.0 112.694 171.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 36.1 mtp -86.71 -9.24 56.37 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.23 1.412 . . . . 0.0 112.485 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.22 122.23 46.51 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -170.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -159.62 119.33 2.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.215 1.006 . . . . 0.0 110.981 -170.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 8.1 mt -102.59 133.03 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.986 0.914 . . . . 0.0 111.323 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -133.19 120.46 21.2 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.004 0.921 . . . . 0.0 110.388 170.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 7.8 tt -108.76 129.63 55.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.132 1.773 . . . . 0.0 110.101 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -77.96 109.53 12.09 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.421 1.489 . . . . 0.0 110.982 176.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -85.0 -8.95 58.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pm0 -130.92 159.62 36.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -167.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 65.02 -160.25 42.62 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.965 1.269 . . . . 0.0 114.98 164.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -18.64 60.52 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 40.9 mtp -99.71 11.65 38.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.054 1.341 . . . . 0.0 113.029 174.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -54.03 113.01 1.07 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.512 1.125 . . . . 0.0 110.306 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.81 31.39 23.97 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.282 0.944 . . . . 0.0 113.875 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -106.4 155.35 19.63 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.517 1.127 . . . . 0.0 110.412 157.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.2 154.48 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.962 -1.086 . . . . 0.0 113.604 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -116.23 144.41 44.23 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.653 1.981 . . . . 0.0 115.58 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.25 118.27 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.554 1.941 . . . . 0.0 110.026 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -81.95 142.02 22.12 Favored Glycine 0 CA--C 1.534 1.249 0 O-C-N 121.447 -0.783 . . . . 0.0 111.383 159.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.6 mt -120.87 160.8 43.25 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.059 1.344 . . . . 0.0 109.986 174.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.78 -6.19 17.84 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.527 2.152 . . . . 0.0 114.447 -175.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -155.59 143.56 19.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.563 0.745 . . . . 0.0 111.466 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.31 -43.31 32.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.407 1.483 . . . . 0.0 112.469 162.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -62.54 -34.96 77.96 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.466 -0.771 . . . . 0.0 113.017 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.03 -37.43 75.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.413 0.685 . . . . 0.0 111.816 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.74 80.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.394 0.997 . . . . 0.0 111.783 170.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.03 -34.07 67.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.583 0.753 . . . . 0.0 112.398 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -75.11 -49.39 19.76 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.849 1.26 . . . . 0.0 112.848 170.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.7 -29.73 68.3 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.575 -0.703 . . . . 0.0 112.602 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.471 HD23 HG12 ' A' ' 498' ' ' VAL . 65.9 mt -71.71 -28.84 63.97 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.299 1.04 . . . . 0.0 113.412 173.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -67.57 -37.72 83.04 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.575 0.75 . . . . 0.0 111.033 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -91.71 -56.49 3.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -169.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -74.35 -18.22 60.72 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -75.65 111.6 11.15 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.221 -0.924 . . . . 0.0 111.002 -174.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 107.12 8.49 31.36 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.022 -168.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -75.79 126.73 31.56 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.444 1.622 . . . . 0.0 110.082 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.316 1.2 t -97.76 45.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.473 1.509 . . . . 0.0 114.704 -162.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 36.0 tp -52.8 123.72 12.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.027 1.731 . . . . 0.0 111.218 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.37 65.7 m-85 57.84 11.58 1.42 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 118.345 2.72 . . . . 0.0 118.345 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 87.06 18.87 57.07 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 120.871 -1.143 . . . . 0.0 114.234 -171.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -121.69 118.95 29.34 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.536 1.535 . . . . 0.0 109.384 175.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -72.92 117.11 4.98 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.831 1.687 . . . . 0.0 111.893 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 32.2 mtp -71.65 130.97 42.49 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.974 1.71 . . . . 0.0 111.272 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.32 106.42 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.055 1.342 . . . . 0.0 108.088 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.471 HG12 HD23 ' A' ' 483' ' ' LEU . 11.6 t -98.95 123.72 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.302 1.441 . . . . 0.0 110.331 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -138.94 160.47 39.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.057 0.932 . . . . 0.0 112.972 -175.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -55.2 140.92 37.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.507 0.723 . . . . 0.0 111.611 167.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.609 0 O-C-N 121.721 -0.612 . . . . 0.0 112.245 -179.699 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 . . . . . 0 C--O 1.241 0.606 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 8.1 p -148.03 167.69 24.27 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -173.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.03 146.23 8.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 123.654 0.782 . . . . 0.0 111.133 -169.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 31.6 m -87.67 149.8 24.03 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -66.31 -27.81 68.2 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.976 -1.077 . . . . 0.0 112.704 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -67.34 -23.41 65.61 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 171.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -74.39 -52.43 12.16 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.307 0.958 . . . . 0.0 110.917 163.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.8 -45.12 78.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.914 1.286 . . . . 0.0 112.895 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -56.04 -17.98 8.32 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.597 1.959 . . . . 0.0 115.481 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -72.26 -30.63 65.04 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.936 -1.102 . . . . 0.0 112.811 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.62 90.63 0.5 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.612 1.101 . . . . 0.0 113.468 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 -164.71 147.73 8.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.504 1.122 . . . . 0.0 111.343 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.7 pt -126.76 158.7 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.671 1.188 . . . . 0.0 112.88 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.59 179.23 4.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.975 1.31 . . . . 0.0 111.074 163.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -61.84 -20.9 64.17 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 120.558 -1.339 . . . . 0.0 114.259 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -78.03 -29.09 49.24 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.063 0.945 . . . . 0.0 112.002 -173.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.87 -33.17 24.87 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.712 -1.243 . . . . 0.0 110.982 161.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 29.4 ttm -63.02 -38.45 91.22 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.438 -1.414 . . . . 0.0 113.371 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -83.22 12.83 4.74 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.285 -0.884 . . . . 0.0 112.196 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.62 -29.69 5.0 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.233 2.213 . . . . 0.0 115.119 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.82 128.1 34.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.908 1.283 . . . . 0.0 109.898 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 75.6 p -63.43 -27.01 69.0 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.299 -0.875 . . . . 0.0 111.38 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . 0.273 2.2 m -68.97 -16.02 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 171.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -119.6 -17.07 8.75 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 119.189 3.033 . . . . 0.0 119.189 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.24 -8.84 0.35 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 54.1 p -137.47 12.77 3.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.949 1.3 . . . . 0.0 113.456 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -131.55 137.91 48.67 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.39 1.876 . . . . 0.0 114.41 -173.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -142.66 129.02 10.68 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -157.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -86.47 -174.28 1.42 Allowed 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 124.736 3.624 . . . . 0.0 113.413 171.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.427 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 72.69 71.77 1.04 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 125.144 1.354 . . . . 0.0 116.13 164.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -145.59 151.96 48.02 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.377 1.471 . . . . 0.0 111.862 172.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.81 95.6 1.07 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.964 3.109 . . . . 0.0 113.0 -172.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -163.06 147.83 11.44 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.7 2.0 . . . . 0.0 111.431 166.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.2 p -82.11 18.72 1.3 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -135.16 150.24 50.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.985 1.314 . . . . 0.0 109.99 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.77 157.84 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 126.375 1.87 . . . . 0.0 109.929 -177.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -131.79 162.1 31.33 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.08 140.18 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 125.582 1.553 . . . . 0.0 111.631 -174.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -122.03 170.65 9.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.116 1.367 . . . . 0.0 109.951 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 22.8 t30 66.62 38.73 3.93 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.839 1.256 . . . . 0.0 111.717 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -77.12 139.56 40.0 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.963 -1.086 . . . . 0.0 110.318 167.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.41 142.09 58.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.485 1.514 . . . . 0.0 112.83 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.27 -29.15 60.76 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.649 -1.282 . . . . 0.0 113.932 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -73.35 -31.09 63.76 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.412 HG21 HD21 ' A' ' 491' ' ' LEU . 1.0 OUTLIER -79.69 160.0 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -169.873 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -134.29 166.94 21.64 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.906 1.283 . . . . 0.0 111.326 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -59.89 -33.09 71.38 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.526 -1.359 . . . . 0.0 113.018 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -57.42 -22.04 40.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.871 1.668 . . . . 0.0 115.018 170.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.64 -33.08 18.95 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.749 1.619 . . . . 0.0 115.094 169.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.81 -25.27 67.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.89 0.876 . . . . 0.0 112.272 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -53.56 -30.97 44.66 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.341 1.056 . . . . 0.0 111.472 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.36 -41.59 97.32 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.945 1.298 . . . . 0.0 111.781 -173.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mt -91.81 -57.49 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 120.64 -1.287 . . . . 0.0 110.826 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -55.98 -36.04 67.42 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.69 -9.19 82.54 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.145 -0.808 . . . . 0.0 114.454 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -60.08 -29.03 68.29 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.36 1.58 . . . . 0.0 111.543 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -93.91 16.26 14.74 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.117 1.767 . . . . 0.0 114.341 -174.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 451' ' ' GLN . 96.7 t -128.47 119.23 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.228 1.811 . . . . 0.0 107.52 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.257 57.3 m-20 -68.89 73.6 0.27 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 173.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -49.78 -22.49 1.44 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 120.044 3.35 . . . . 0.0 120.044 -169.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 17.2 m -71.99 -13.55 61.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.742 1.61 . . . . 0.0 112.935 172.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 4.8 t -104.39 123.38 47.32 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.19 1.396 . . . . 0.0 110.887 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -56.79 -45.39 82.22 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.394 -0.816 . . . . 0.0 112.068 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.3 t -55.18 -15.1 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' GLN . . . . . 0.456 ' HB3' HG13 ' A' ' 444' ' ' VAL . 43.4 mm-40 -88.86 -61.75 1.64 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.905 0.882 . . . . 0.0 109.854 173.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -69.13 -24.52 64.11 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.854 1.262 . . . . 0.0 113.518 -172.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 11.3 tt -64.22 -33.45 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.505 1.522 . . . . 0.0 112.413 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 62.8 mmm -80.6 -13.71 58.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.104 1.362 . . . . 0.0 111.453 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -107.66 127.35 53.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.774 2.03 . . . . 0.0 113.804 -171.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -162.56 138.5 7.34 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.2 mt -119.85 136.79 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.69 1.196 . . . . 0.0 110.543 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -130.19 138.58 50.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.646 1.178 . . . . 0.0 111.071 164.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 2.1 tt -109.74 131.95 54.59 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.63 1.572 . . . . 0.0 109.127 172.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -90.57 134.81 34.12 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.667 1.587 . . . . 0.0 111.547 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -130.71 9.19 4.97 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -158.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -148.47 156.31 42.3 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.558 1.143 . . . . 0.0 111.975 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 61.34 -161.13 26.55 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.626 1.107 . . . . 0.0 114.911 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.71 -27.13 62.66 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.249 -1.148 . . . . 0.0 113.425 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 28.0 ttm -85.25 -2.8 58.45 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.423 1.089 . . . . 0.0 113.359 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -54.04 128.03 28.92 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.48 1.112 . . . . 0.0 111.868 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.3 27.22 66.36 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.403 1.001 . . . . 0.0 112.913 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -109.7 161.93 14.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.302 1.441 . . . . 0.0 110.71 160.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.12 157.19 42.86 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.94 1.296 . . . . 0.0 112.876 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -118.35 147.04 43.91 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 168.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.17 126.09 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.724 1.609 . . . . 0.0 110.339 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.62 150.09 19.72 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.482 -0.761 . . . . 0.0 112.001 161.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.7 mt -128.64 163.2 46.55 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.098 1.759 . . . . 0.0 110.758 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.53 -3.36 13.26 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.484 2.789 . . . . 0.0 115.552 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -155.72 150.82 26.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.881 1.272 . . . . 0.0 111.602 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -53.77 -43.52 69.28 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.513 -0.742 . . . . 0.0 112.859 163.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -60.38 -40.33 90.44 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.581 1.152 . . . . 0.0 113.003 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.59 99.1 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.588 0.555 . . . . 0.0 111.412 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.62 -42.64 77.81 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.212 0.915 . . . . 0.0 112.164 174.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.24 -43.69 83.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.48 0.712 . . . . 0.0 111.746 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -68.3 -51.96 39.03 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.084 0.954 . . . . 0.0 111.339 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.53 -29.8 66.59 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.545 HD23 HG12 ' A' ' 498' ' ' VAL . 29.4 mt -70.69 -47.67 58.64 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.56 1.073 . . . . 0.0 111.144 172.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -57.89 -34.55 69.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.945 0.898 . . . . 0.0 112.149 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.49 -49.13 7.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.208 1.003 . . . . 0.0 112.925 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -82.14 -20.06 38.72 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -66.37 105.14 1.37 Allowed 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.171 -0.956 . . . . 0.0 110.588 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 110.27 -0.92 29.63 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.004 -1.442 . . . . 0.0 116.148 -173.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -68.23 122.48 18.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.921 1.86 . . . . 0.0 113.836 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.299 1.7 t -86.43 57.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -166.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 431' ' ' VAL . 15.2 tp -55.11 114.16 1.65 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.832 2.053 . . . . 0.0 111.436 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.332 61.3 m-85 58.42 23.17 10.33 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 -178.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 85.31 15.31 66.84 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 121.393 -0.817 . . . . 0.0 114.53 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.32 115.59 18.54 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.397 1.479 . . . . 0.0 110.672 -176.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.35 114.92 4.1 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.889 2.392 . . . . 0.0 112.149 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 72.3 mtp -68.98 128.07 35.38 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.834 1.254 . . . . 0.0 112.393 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 34.9 t -90.92 79.44 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.66 1.584 . . . . 0.0 110.799 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.545 HG12 HD23 ' A' ' 483' ' ' LEU . 2.6 t -83.24 126.93 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.627 1.971 . . . . 0.0 112.534 -174.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -145.19 157.64 44.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.996 1.318 . . . . 0.0 113.652 -170.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -63.05 146.39 53.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.679 0.792 . . . . 0.0 110.936 173.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.696 0 O-C-N 121.562 -0.711 . . . . 0.0 111.004 173.56 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 . . . . . 0 C--O 1.237 0.4 0 CA-C-O 122.264 1.031 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.4 p -147.97 160.41 42.86 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.008 1.323 . . . . 0.0 111.697 172.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.9 tt -70.95 145.89 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 125.707 1.603 . . . . 0.0 111.071 -166.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 10.6 m -78.54 146.3 34.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -56.57 -41.63 77.22 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.624 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -62.59 -32.48 73.48 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -73.5 -41.73 62.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.835 0.854 . . . . 0.0 113.179 170.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.22 -46.9 88.54 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.866 0.866 . . . . 0.0 110.661 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -58.49 -24.72 61.16 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.425 1.89 . . . . 0.0 115.16 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 48.0 mmtt -62.56 -49.9 73.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.995 0.816 . . . . 0.0 111.333 168.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.87 65.27 3.28 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.175 1.845 . . . . 0.0 112.351 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -153.41 137.57 16.48 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.916 1.286 . . . . 0.0 110.873 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.3 pt -121.57 157.43 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.597 1.159 . . . . 0.0 113.284 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.0 m -95.8 169.01 10.3 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.267 1.427 . . . . 0.0 112.199 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -54.3 -31.07 53.12 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.902 -1.124 . . . . 0.0 113.433 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -60.68 -25.64 66.53 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.561 1.145 . . . . 0.0 113.167 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.0 -41.5 10.51 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.671 1.188 . . . . 0.0 110.988 169.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 15.9 ttm -65.87 -30.93 71.61 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.817 -1.177 . . . . 0.0 113.098 -172.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -82.97 6.35 19.0 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.318 -0.864 . . . . 0.0 112.823 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.93 -30.53 4.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.989 2.116 . . . . 0.0 114.051 -176.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.403 ' HB3' HG22 ' A' ' 409' ' ' VAL . 40.3 mt -74.12 129.5 37.96 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.581 1.552 . . . . 0.0 111.343 174.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 88.3 p -59.29 -34.2 72.0 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.628 -0.67 . . . . 0.0 111.989 171.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 407' ' ' LEU . 33.7 m -60.38 -22.98 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 117.559 -1.21 . . . . 0.0 113.523 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.339 69.7 m-85 -94.55 2.0 55.66 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 119.113 3.005 . . . . 0.0 119.113 174.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -50.27 -23.58 2.37 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 -164.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 19.0 m -143.23 20.95 1.91 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.484 1.114 . . . . 0.0 112.926 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -135.71 133.87 38.51 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.343 1.457 . . . . 0.0 109.244 -161.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 414' ' ' GLU . . . . . 0.412 ' HA ' ' HD2' ' A' ' 415' ' ' PRO . 45.0 mt-10 -136.33 92.92 15.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -165.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 415' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 414' ' ' GLU . 54.3 Cg_endo -64.76 159.65 44.48 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.201 3.267 . . . . 0.0 113.608 165.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 84.32 0.67 89.49 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.021 1.296 . . . . 0.0 113.305 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -77.3 136.11 65.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.409 1.484 . . . . 0.0 112.447 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.51 126.6 9.11 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.33 2.687 . . . . 0.0 112.48 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -160.41 152.39 20.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.537 1.535 . . . . 0.0 109.156 158.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.9 p -77.87 3.15 15.15 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.101 -1.624 . . . . 0.0 114.59 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -135.91 145.58 46.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.669 2.387 . . . . 0.0 108.961 171.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 12.7 pt -124.46 165.82 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.496 1.918 . . . . 0.0 110.071 174.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.86 159.09 42.9 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 174.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.489 HG22 HG13 ' A' ' 498' ' ' VAL . 8.6 t -132.07 132.93 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.409 1.483 . . . . 0.0 110.897 -174.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -106.56 164.53 11.99 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.693 1.197 . . . . 0.0 109.936 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 16.5 t30 68.2 39.36 2.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.839 1.256 . . . . 0.0 113.394 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.67 150.02 41.55 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.421 -0.799 . . . . 0.0 111.459 171.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.51 160.56 8.74 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.168 1.387 . . . . 0.0 114.471 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -62.26 -43.36 99.01 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.99 -1.069 . . . . 0.0 112.491 169.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -70.61 -35.33 72.92 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.1 p -71.51 149.3 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -170.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -123.2 166.84 14.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.423 1.489 . . . . 0.0 112.556 170.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -55.39 -33.58 63.61 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.826 -1.171 . . . . 0.0 112.719 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 9.1 pttm -62.87 -28.99 70.41 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.77 -37.44 48.98 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.189 0.996 . . . . 0.0 113.469 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.01 -20.54 54.0 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.404 1.882 . . . . 0.0 113.39 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.99 -18.97 5.77 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 171.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -61.81 -38.97 90.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.829 0.852 . . . . 0.0 112.009 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.29 -51.86 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.297 -0.877 . . . . 0.0 110.032 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -63.37 -33.1 74.81 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.2 -12.8 83.27 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 123.478 0.561 . . . . 0.0 114.121 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -58.8 -34.61 71.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.926 1.291 . . . . 0.0 112.565 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -79.93 -6.41 57.43 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.897 1.679 . . . . 0.0 113.548 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.27 111.24 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.984 1.714 . . . . 0.0 111.085 -172.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -69.84 86.78 0.51 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -54.04 -23.94 15.39 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 118.482 2.771 . . . . 0.0 118.482 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 61.2 m -65.75 -21.72 66.54 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.1 m -109.87 121.99 46.51 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.327 1.851 . . . . 0.0 111.88 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.75 -45.91 88.63 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.275 -0.891 . . . . 0.0 113.037 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -17.15 5.48 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -89.87 -57.01 3.01 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.64 0.776 . . . . 0.0 108.984 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -72.58 -21.06 61.2 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.265 1.426 . . . . 0.0 113.539 -173.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 17.0 tt -62.89 -36.26 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.295 1.838 . . . . 0.0 112.265 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.4 mtm -87.36 -8.0 57.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.829 0.851 . . . . 0.0 112.208 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -102.91 124.67 48.86 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -173.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.42 158.98 21.74 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.978 1.311 . . . . 0.0 108.626 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.0 mt -123.24 147.99 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.002 1.321 . . . . 0.0 111.224 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -134.93 132.37 38.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.31 2.244 . . . . 0.0 109.457 169.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.4 tp -124.93 113.13 17.44 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.877 2.071 . . . . 0.0 110.776 172.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 57.3 mtm -70.68 108.34 4.36 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.649 1.18 . . . . 0.0 111.454 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -96.48 10.8 37.19 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -147.23 154.16 40.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.158 1.783 . . . . 0.0 110.821 -174.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 85.18 -166.8 40.82 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.286 1.422 . . . . 0.0 116.273 168.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -11.17 2.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.622 1.969 . . . . 0.0 116.007 -172.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 24.7 ptp -140.7 41.53 1.86 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.948 1.699 . . . . 0.0 112.468 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -52.81 133.39 37.3 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.465 1.106 . . . . 0.0 111.709 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.07 31.71 34.16 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 124.476 1.036 . . . . 0.0 113.34 -177.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -125.99 147.76 49.45 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.539 0.736 . . . . 0.0 111.389 172.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -139.48 155.42 47.57 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.93 1.292 . . . . 0.0 114.038 -165.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -119.87 142.48 48.62 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.757 2.023 . . . . 0.0 114.96 171.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.2 mp -141.44 120.4 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.812 1.645 . . . . 0.0 110.893 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -83.01 140.02 19.69 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.433 -0.792 . . . . 0.0 111.397 163.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 20.8 mt -120.33 158.0 52.1 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.428 1.091 . . . . 0.0 110.766 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.53 -11.75 28.56 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.01 2.473 . . . . 0.0 114.405 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -151.27 142.45 23.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.821 0.849 . . . . 0.0 110.804 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -53.7 -35.46 61.15 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.204 1.402 . . . . 0.0 112.391 167.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -65.91 -38.5 88.87 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.99 85.86 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.309 0.504 . . . . 0.0 110.695 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.38 78.76 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 170.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.64 -36.46 69.53 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.243 0.929 . . . . 0.0 112.553 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -73.52 -53.62 10.17 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.096 1.359 . . . . 0.0 112.694 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.17 -31.75 69.27 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.614 HD23 HG12 ' A' ' 498' ' ' VAL . 49.1 mt -69.22 -42.6 75.49 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.573 -0.705 . . . . 0.0 112.387 176.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.1 -34.47 78.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.446 0.698 . . . . 0.0 111.991 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -82.1 -51.28 8.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.116 1.366 . . . . 0.0 114.37 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.61 -16.31 61.73 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.19 106.08 0.48 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.003 1.721 . . . . 0.0 112.361 174.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 112.23 -6.73 26.89 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 118.49 -1.172 . . . . 0.0 114.949 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -71.7 128.39 35.65 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.154 1.477 . . . . 0.0 107.324 -174.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.253 5.8 p -122.72 63.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 124.185 1.945 . . . . 0.0 110.427 -162.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.16 131.22 50.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.485 1.914 . . . . 0.0 110.913 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.371 52.1 m-85 56.05 21.72 5.31 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -175.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 77.93 8.03 87.39 Favored Glycine 0 CA--C 1.537 1.466 0 O-C-N 121.027 -1.046 . . . . 0.0 114.351 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -112.78 112.59 50.61 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.861 1.664 . . . . 0.0 110.196 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.9 121.28 7.2 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.713 2.275 . . . . 0.0 110.965 -174.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 41.7 mtp -79.77 124.44 28.61 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.614 1.566 . . . . 0.0 110.747 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 36.0 t -93.83 84.16 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.99 1.316 . . . . 0.0 110.719 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.614 HG12 HD23 ' A' ' 483' ' ' LEU . 2.0 t -77.78 131.84 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.012 1.725 . . . . 0.0 112.605 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -145.01 158.44 43.81 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.021 1.328 . . . . 0.0 113.469 -172.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -61.88 147.32 47.05 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.18 -0.95 . . . . 0.0 108.441 164.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.481 0 O-C-N 121.452 -0.78 . . . . 0.0 112.975 -177.274 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 121.882 0.848 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 25.7 p -151.43 163.26 39.38 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.052 1.741 . . . . 0.0 113.3 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 3.1 tt -72.44 158.35 6.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.199 1.399 . . . . 0.0 111.196 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 66.2 m -96.41 150.87 20.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.052 0.941 . . . . 0.0 110.797 168.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -56.75 -39.45 74.03 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 111.281 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -68.58 -26.4 65.37 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -78.68 -38.62 38.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.973 1.26 . . . . 0.0 112.811 166.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.08 -45.83 91.62 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.857 0.863 . . . . 0.0 112.385 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -56.1 -25.55 46.2 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.938 1.295 . . . . 0.0 114.091 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -69.8 -25.36 63.75 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.053 0.941 . . . . 0.0 112.98 176.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -105.17 72.95 0.23 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.088 1.328 . . . . 0.0 110.969 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -156.11 141.52 17.63 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.568 1.147 . . . . 0.0 109.316 -174.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.7 pt -115.3 155.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 83.4 p -67.4 160.14 28.0 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.393 1.477 . . . . 0.0 111.749 161.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 52.2 mmt-85 -61.87 -30.64 70.99 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.606 -0.684 . . . . 0.0 111.139 168.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.49 -42.34 95.92 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.451 0.7 . . . . 0.0 112.103 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -36.01 77.51 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.671 0.669 . . . . 0.0 109.621 172.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 11.3 ttp -65.01 -39.88 94.09 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 120.556 -1.34 . . . . 0.0 112.078 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -81.03 15.86 1.7 Allowed 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.73 -35.95 2.98 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.798 2.039 . . . . 0.0 116.485 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.31 125.21 25.71 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.694 1.197 . . . . 0.0 108.994 172.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.2 m -65.12 -17.76 64.73 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.89 -25.49 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 170.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.31 75.8 m-85 -98.35 10.49 40.63 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 118.565 2.802 . . . . 0.0 118.565 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -60.31 -19.0 53.42 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 9.6 t -139.13 -35.58 0.55 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.816 1.646 . . . . 0.0 112.68 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -76.12 145.8 39.73 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -138.46 129.82 15.57 Favored Pre-proline 0 N--CA 1.478 0.951 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -168.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.6 172.33 13.54 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.586 2.857 . . . . 0.0 113.983 170.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.426 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 95.8 -21.33 45.43 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 116.954 1.541 . . . . 0.0 116.954 164.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.09 138.54 96.2 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 119.019 1.41 . . . . 0.0 112.588 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.27 116.85 4.77 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.283 2.655 . . . . 0.0 113.23 -174.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -153.66 146.93 24.75 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.201 1.4 . . . . 0.0 108.595 164.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.1 p -73.8 6.21 3.43 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -144.47 145.46 31.89 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.306 1.842 . . . . 0.0 108.921 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 27.7 pt -133.99 164.13 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.554 1.942 . . . . 0.0 109.865 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -136.01 162.23 33.45 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 172.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.4 p -140.03 146.95 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.934 1.294 . . . . 0.0 110.696 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' LYS . . . . . 0.514 ' HB2' ' HG2' ' A' ' 468' ' ' GLN . 17.1 ptpt -131.13 -175.38 3.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.283 0.633 . . . . 0.0 111.062 165.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.0 t30 66.44 38.33 4.33 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.072 1.349 . . . . 0.0 111.305 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.17 148.14 34.21 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.819 0.848 . . . . 0.0 110.447 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.68 173.83 9.94 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.636 1.975 . . . . 0.0 115.062 -173.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -60.88 -53.98 50.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.747 1.219 . . . . 0.0 113.507 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -78.39 -19.18 53.87 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.436 1.494 . . . . 0.0 114.731 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.55 148.72 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -173.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -129.32 162.88 26.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.186 1.794 . . . . 0.0 110.399 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -59.16 -28.67 66.81 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 119.47 -2.019 . . . . 0.0 112.403 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -58.13 -30.97 66.75 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -72.7 -36.28 67.81 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 173.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.25 -27.35 66.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.626 0.77 . . . . 0.0 111.692 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.34 -31.33 61.63 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.823 0.849 . . . . 0.0 112.748 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -61.35 -30.03 70.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.013 1.325 . . . . 0.0 111.697 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.7 mt -106.6 -57.66 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.682 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -58.85 -30.77 67.95 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -76.53 -8.74 86.1 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.87 -0.961 . . . . 0.0 114.661 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -64.82 -21.74 66.85 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.376 1.588 . . . . 0.0 112.63 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -92.64 4.46 53.63 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.874 1.67 . . . . 0.0 113.566 -177.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.7 108.73 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.289 1.836 . . . . 0.0 110.622 -171.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -64.53 99.86 0.33 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.311 17.8 m-85 -62.62 -16.18 55.4 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 64.7 m -64.83 -16.12 62.7 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 169.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 16.4 m -130.49 117.82 20.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.443 1.097 . . . . 0.0 112.713 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -60.44 -39.94 89.29 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.007 -1.058 . . . . 0.0 112.39 -174.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.6 t -56.44 -13.95 2.66 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -86.91 -63.84 1.25 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.983 0.913 . . . . 0.0 109.546 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.9 ptt85 -69.81 -22.78 63.28 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.517 1.527 . . . . 0.0 114.16 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.8 tt -57.87 -35.39 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.257 1.023 . . . . 0.0 111.899 171.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 21.6 mtm -90.37 -2.95 58.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.948 1.299 . . . . 0.0 112.228 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -105.89 129.56 54.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.77 2.028 . . . . 0.0 116.086 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -166.14 149.03 7.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.963 1.305 . . . . 0.0 109.399 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.9 mt -120.65 136.53 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.494 1.518 . . . . 0.0 111.807 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -114.74 141.33 47.99 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.974 1.31 . . . . 0.0 110.571 158.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 13.7 tp -120.61 114.54 21.87 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.562 1.545 . . . . 0.0 109.212 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -71.28 120.33 16.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.98 1.312 . . . . 0.0 109.274 169.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' LYS . . . . . 0.413 ' O ' ' HE2' ' A' ' 466' ' ' LYS . 10.1 mtpt -113.51 12.86 18.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.753 1.621 . . . . 0.0 113.035 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -142.23 152.65 43.29 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.306 1.843 . . . . 0.0 112.126 -167.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 59.58 -144.08 46.14 Favored Glycine 0 CA--C 1.534 1.269 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 161.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.75 -12.71 2.02 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.065 2.146 . . . . 0.0 116.335 -172.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 24.9 ptp -145.44 41.13 1.23 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.507 1.123 . . . . 0.0 112.539 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 461' ' ' LYS . 23.6 ttmt -60.38 122.44 14.56 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.409 1.084 . . . . 0.0 112.256 175.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.65 37.91 18.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.411 1.958 . . . . 0.0 112.858 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 468' ' ' GLN . . . . . 0.514 ' HG2' ' HB2' ' A' ' 425' ' ' LYS . 43.1 mt-30 -125.83 148.33 49.18 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.211 1.004 . . . . 0.0 110.892 173.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -138.94 151.59 47.02 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -109.08 137.98 46.14 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.829 2.051 . . . . 0.0 114.394 169.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.5 119.77 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.197 1.399 . . . . 0.0 109.968 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -85.2 142.04 19.5 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 162.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 19.3 mt -122.64 160.87 46.78 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.35 1.46 . . . . 0.0 110.343 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.01 -13.07 21.49 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.045 2.497 . . . . 0.0 114.55 -174.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -153.07 146.13 24.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.513 1.125 . . . . 0.0 110.254 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -52.31 -38.82 59.51 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.933 0.893 . . . . 0.0 111.95 165.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -61.42 -37.16 82.48 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.288 1.035 . . . . 0.0 113.122 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.36 90.84 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.262 -0.274 . . . . 0.0 110.947 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.3 -48.43 67.64 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.605 -0.684 . . . . 0.0 112.741 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.66 -28.05 68.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.306 1.042 . . . . 0.0 112.689 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -85.22 -44.27 13.06 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.048 0.939 . . . . 0.0 113.348 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.51 -33.21 71.08 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.881 1.219 . . . . 0.0 112.709 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.449 HD23 HG12 ' A' ' 498' ' ' VAL . 57.2 mt -65.47 -40.04 92.69 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.424 1.09 . . . . 0.0 112.989 174.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -63.34 -42.18 98.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.077 0.551 . . . . 0.0 111.454 174.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -78.87 -43.83 24.17 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -175.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.39 57.54 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -64.12 99.23 0.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.701 1.2 . . . . 0.0 112.245 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 115.45 1.6 21.65 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.469 -1.184 . . . . 0.0 115.044 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -74.44 110.4 8.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.944 1.372 . . . . 0.0 108.929 -169.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.275 6.4 p -93.71 65.77 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.054 1.742 . . . . 0.0 110.372 -170.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.79 129.42 39.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.199 1.8 . . . . 0.0 110.66 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.272 64.0 m-85 54.18 21.81 3.25 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -176.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 86.35 10.22 74.5 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 117.983 -1.454 . . . . 0.0 115.566 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -121.78 115.65 30.66 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 120.217 2.008 . . . . 0.0 111.751 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.44 112.41 3.54 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 123.868 3.045 . . . . 0.0 111.696 -174.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 80.1 mtp -73.64 131.44 41.67 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.855 1.262 . . . . 0.0 113.566 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 24.8 t -90.15 90.07 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.599 1.56 . . . . 0.0 111.502 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.449 HG12 HD23 ' A' ' 483' ' ' LEU . 1.4 t -90.17 129.47 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.889 1.276 . . . . 0.0 114.308 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -149.47 155.57 40.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.847 0.859 . . . . 0.0 112.953 -170.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -53.96 142.05 25.96 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 169.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.613 0 O-C-N 121.729 -0.607 . . . . 0.0 112.236 177.178 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 120.484 0.183 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 14.0 p -142.56 165.07 28.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.65 1.18 . . . . 0.0 113.474 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.3 tt -69.02 152.31 9.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 125.65 1.58 . . . . 0.0 111.678 -168.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 59.4 m -84.67 147.87 26.71 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.435 0.694 . . . . 0.0 110.429 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -58.06 -43.01 86.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.414 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -61.43 -29.87 70.21 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.324 1.45 . . . . 0.0 114.52 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -78.14 -49.69 13.4 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.39 1.076 . . . . 0.0 112.696 171.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 26.1 tp -57.89 -42.29 84.35 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.56 0.744 . . . . 0.0 112.096 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -58.67 -21.22 53.72 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.592 1.557 . . . . 0.0 114.977 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -75.76 -34.01 60.23 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.184 0.994 . . . . 0.0 112.753 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -93.66 75.26 1.13 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.026 1.298 . . . . 0.0 112.183 170.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -158.04 146.82 19.19 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.246 1.018 . . . . 0.0 111.008 -171.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 9.1 pt -128.66 157.84 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.45 1.5 . . . . 0.0 111.819 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 21.6 t -105.03 174.74 5.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.538 1.535 . . . . 0.0 111.047 166.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 21.6 mtp85 -57.93 -23.53 53.86 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.007 1.323 . . . . 0.0 113.402 175.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -54.61 -35.88 63.86 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.076 1.751 . . . . 0.0 111.856 171.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -99.18 -35.4 10.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.419 1.088 . . . . 0.0 112.526 169.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 26.3 ttp -65.18 -38.42 90.47 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.49 -1.381 . . . . 0.0 112.36 -172.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -80.23 17.26 1.06 Allowed 'General case' 0 CA--C 1.55 0.962 0 O-C-N 121.349 -0.845 . . . . 0.0 112.123 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.98 -30.37 2.72 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.405 2.282 . . . . 0.0 115.005 176.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 35.6 mt -74.22 137.92 43.36 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.59 1.956 . . . . 0.0 112.48 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 47.0 t -67.98 -36.61 80.34 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.036 0.934 . . . . 0.0 111.834 172.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.5 m -59.16 -14.41 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.403 ' CE1' HG13 ' A' ' 497' ' ' VAL 0.261 94.0 m-85 -116.58 16.74 15.48 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 170.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -8.47 12.53 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 16.7 p -148.52 -46.05 0.15 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.828 2.051 . . . . 0.0 112.527 -159.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -81.79 140.52 34.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.222 1.809 . . . . 0.0 113.783 -175.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -134.57 123.0 16.04 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.792 0.837 . . . . 0.0 112.921 -169.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.3 174.49 9.87 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.354 3.37 . . . . 0.0 113.357 170.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.485 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 82.1 -16.71 20.94 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.671 1.605 . . . . 0.0 116.798 170.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -57.53 139.21 81.22 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 118.801 1.3 . . . . 0.0 112.661 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.48 108.73 2.09 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.773 2.315 . . . . 0.0 112.083 -172.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -156.64 149.41 23.75 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.693 1.597 . . . . 0.0 109.269 167.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.4 p -86.1 -10.71 54.39 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 173.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -106.26 142.32 36.13 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.957 0.903 . . . . 0.0 110.022 172.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.16 162.59 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.373 1.469 . . . . 0.0 110.44 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -144.47 161.07 39.98 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.0 t -139.22 131.92 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.196 1.399 . . . . 0.0 113.422 -165.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -98.81 163.77 12.48 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.582 1.153 . . . . 0.0 111.904 167.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.287 98.0 m-20 75.78 34.9 0.54 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.925 2.09 . . . . 0.0 116.592 172.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.95 160.59 29.05 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.182 -0.949 . . . . 0.0 111.143 167.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.33 177.7 5.7 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.074 1.75 . . . . 0.0 114.172 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -82.41 -48.44 11.12 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.983 -1.073 . . . . 0.0 110.544 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -69.49 -18.98 63.74 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.2 p -77.08 139.84 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 121.008 -1.057 . . . . 0.0 113.08 171.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -120.65 167.22 12.67 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.189 1.396 . . . . 0.0 111.703 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.97 -34.1 58.81 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.94 -1.1 . . . . 0.0 112.657 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -59.97 -23.44 63.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.163 1.385 . . . . 0.0 114.675 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -87.57 -33.43 18.9 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.05 -19.69 64.63 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.699 1.6 . . . . 0.0 112.645 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -25.16 49.19 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.381 1.073 . . . . 0.0 112.869 174.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -60.01 -34.78 73.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.573 0.749 . . . . 0.0 112.4 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 4.4 mt -103.3 -57.0 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.635 -0.666 . . . . 0.0 110.739 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -59.55 -29.49 67.96 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.95 -11.41 84.73 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.806 -0.997 . . . . 0.0 114.847 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -62.49 -36.2 81.77 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.015 1.407 . . . . 0.0 111.435 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -77.47 3.37 13.59 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.926 1.69 . . . . 0.0 114.989 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 14.9 t -123.94 126.08 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.942 1.697 . . . . 0.0 110.593 -173.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -59.63 133.3 55.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -73.43 -23.14 60.09 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 99.0 p -92.14 -51.72 5.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.695 1.198 . . . . 0.0 113.262 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.2 m -76.45 118.78 19.48 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.412 0.685 . . . . 0.0 111.718 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -54.65 -49.59 70.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.115 1.366 . . . . 0.0 112.098 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.7 t -54.97 -15.2 1.85 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -88.75 -62.97 1.37 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.239 1.015 . . . . 0.0 110.228 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.17 -26.27 63.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.048 0.939 . . . . 0.0 113.253 -175.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.9 tt -58.18 -40.34 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.816 0.847 . . . . 0.0 111.857 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 9.2 mtm -86.93 -9.12 56.42 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.944 0.898 . . . . 0.0 112.334 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -87.6 125.83 34.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.853 1.661 . . . . 0.0 115.281 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -163.11 136.15 5.63 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.322 1.449 . . . . 0.0 110.195 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 10.7 mt -113.06 143.14 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.769 1.228 . . . . 0.0 111.55 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -129.57 143.21 50.73 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.822 1.649 . . . . 0.0 110.623 160.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 0.522 HD23 ' HE2' ' A' ' 461' ' ' LYS . 19.1 tp -123.59 119.65 30.52 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.871 2.069 . . . . 0.0 110.098 174.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -81.84 143.38 31.77 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.487 1.515 . . . . 0.0 112.25 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' LYS . . . . . 0.522 ' HE2' HD23 ' A' ' 459' ' ' LEU . 53.5 mmtt -130.9 8.99 4.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.107 1.763 . . . . 0.0 114.816 -167.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -145.49 143.38 29.96 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.615 1.166 . . . . 0.0 113.292 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 78.92 -160.58 46.8 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 126.514 2.007 . . . . 0.0 114.521 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.02 -18.05 59.28 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.833 -1.393 . . . . 0.0 113.269 172.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 98.2 mmm -83.86 -1.49 54.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.153 1.781 . . . . 0.0 114.546 171.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.6 127.0 29.34 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.701 -1.249 . . . . 0.0 111.834 176.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.71 17.93 80.04 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.779 -175.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -108.33 139.77 42.56 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.799 0.8 . . . . 0.0 112.188 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -123.06 147.42 46.73 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.876 1.27 . . . . 0.0 112.736 -174.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -107.14 140.59 39.75 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.323 1.449 . . . . 0.0 114.629 161.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.61 113.81 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.239 1.816 . . . . 0.0 109.032 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -76.38 125.24 7.58 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 160.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 37.4 mt -101.15 159.77 28.54 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.126 0.963 . . . . 0.0 109.484 165.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.3 -10.46 17.61 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.895 1.73 . . . . 0.0 114.222 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -151.16 138.67 19.55 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.467 1.107 . . . . 0.0 110.583 -171.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -56.18 -35.23 66.99 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 171.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -62.07 -42.29 99.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.844 0.747 . . . . 0.0 112.608 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.9 92.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.127 0.571 . . . . 0.0 111.24 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.56 -50.43 63.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.437 0.562 . . . . 0.0 112.418 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.24 72.63 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.75 1.159 . . . . 0.0 112.047 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -70.9 -46.58 62.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.085 1.354 . . . . 0.0 112.834 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.15 -37.4 77.2 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.771 0.714 . . . . 0.0 112.415 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.518 HD23 HG12 ' A' ' 498' ' ' VAL . 79.8 mt -70.41 -25.84 63.41 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.667 1.187 . . . . 0.0 112.548 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.61 -24.29 36.51 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.711 1.204 . . . . 0.0 112.647 175.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -104.87 -48.08 3.85 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.74 -15.88 58.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.621 1.168 . . . . 0.0 113.468 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -73.65 112.66 9.96 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.442 -0.787 . . . . 0.0 109.666 -174.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 110.32 -4.82 29.9 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 118.858 -0.968 . . . . 0.0 115.298 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -69.48 129.43 39.69 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.492 1.146 . . . . 0.0 108.54 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.252 3.5 p -120.81 68.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 124.394 2.045 . . . . 0.0 108.87 -162.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 39.2 tp -61.25 139.15 58.2 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 112.763 -2.017 . . . . 0.0 109.588 168.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.324 75.5 t80 61.05 13.97 5.04 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 173.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 80.1 11.02 84.87 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.476 1.512 . . . . 0.0 114.896 -171.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -121.86 120.57 28.48 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 126.472 1.909 . . . . 0.0 110.832 -173.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.71 121.84 7.71 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 C-N-CA 122.774 2.316 . . . . 0.0 110.79 -175.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 59.9 mtp -76.89 129.79 36.68 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.919 1.688 . . . . 0.0 112.293 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 497' ' ' VAL . . . . . 0.403 HG13 ' CE1' ' A' ' 410' ' ' PHE . 4.4 t -92.46 90.42 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.681 1.592 . . . . 0.0 112.306 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.518 HG12 HD23 ' A' ' 483' ' ' LEU . 2.6 t -85.67 120.52 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.989 1.315 . . . . 0.0 112.102 -172.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -135.99 157.38 46.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.22 1.008 . . . . 0.0 113.63 -168.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -59.74 145.41 45.23 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 163.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.822 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -152.41 29.67 0.55 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.874 1.27 . . . . 0.0 110.043 -174.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -134.09 142.53 47.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.9 1.68 . . . . 0.0 110.209 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 50.2 mtp 61.63 156.38 0.11 Allowed Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.478 1.511 . . . . 0.0 114.917 -161.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.63 147.72 28.4 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.591 2.194 . . . . 0.0 112.417 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 37.0 m -73.08 39.7 0.09 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.645 1.978 . . . . 0.0 115.0 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -149.72 127.05 11.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.51 1.524 . . . . 0.0 109.578 164.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 19.5 p -129.79 167.37 18.2 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.58 1.952 . . . . 0.0 109.951 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.3 tt -68.92 144.38 14.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 O-C-N 121.511 -0.743 . . . . 0.0 111.106 -160.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 62.0 m -84.11 150.63 25.42 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.159 -0.338 . . . . 0.0 111.471 172.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 42.5 ttp85 -59.37 -41.24 88.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.54 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -61.67 -29.83 70.33 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -80.29 -44.39 19.67 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.449 1.1 . . . . 0.0 113.121 171.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.416 HD12 ' CD2' ' A' ' 489' ' ' TYR . 22.3 tp -59.18 -46.07 89.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.725 0.81 . . . . 0.0 112.145 175.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -60.3 -21.9 62.53 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -63.26 -33.87 76.43 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.889 0.768 . . . . 0.0 112.328 171.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -107.41 84.19 0.37 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.999 1.285 . . . . 0.0 110.958 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -161.34 152.51 18.59 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.259 0.624 . . . . 0.0 110.555 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.6 pt -127.76 151.07 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.131 0.972 . . . . 0.0 112.868 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 92.1 p -76.75 166.13 23.79 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.203 1.401 . . . . 0.0 112.057 162.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -57.03 -24.51 54.26 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 168.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -71.89 -37.28 70.17 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.493 1.517 . . . . 0.0 111.815 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -80.08 -37.04 34.61 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.487 0.715 . . . . 0.0 110.548 167.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 27.6 ttm -59.74 -46.86 87.84 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.614 -1.304 . . . . 0.0 112.161 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -78.8 15.0 1.15 Allowed 'General case' 0 CA--C 1.552 1.032 0 O-C-N 120.627 -1.296 . . . . 0.0 112.74 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.69 -31.92 5.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.28 2.632 . . . . 0.0 114.474 171.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 34.1 mt -75.54 133.69 40.93 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.857 1.663 . . . . 0.0 111.755 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 91.5 p -63.31 -32.32 73.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.277 1.031 . . . . 0.0 112.17 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.71 -15.34 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.328 78.0 m-85 -106.66 8.38 31.07 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -54.06 -16.27 1.88 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 118.105 2.632 . . . . 0.0 118.105 -165.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.4 m -147.6 14.19 1.07 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.589 1.155 . . . . 0.0 113.98 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -130.49 130.72 44.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.221 1.008 . . . . 0.0 109.465 -162.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -143.87 133.01 11.41 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.153 1.381 . . . . 0.0 113.183 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.02 -178.77 4.0 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 125.207 3.938 . . . . 0.0 114.982 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 96.52 -9.7 66.8 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 164.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -68.92 150.74 97.53 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 119.031 1.416 . . . . 0.0 113.204 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.11 114.35 4.01 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.767 2.978 . . . . 0.0 111.923 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.51 142.65 12.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.25 1.42 . . . . 0.0 107.579 168.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.5 p -77.51 -14.02 59.78 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.406 1.082 . . . . 0.0 112.691 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -107.33 141.09 39.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.531 1.132 . . . . 0.0 109.029 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 4.8 pt -126.94 159.21 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 125.504 1.522 . . . . 0.0 109.429 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -140.63 160.17 40.59 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.9 t -134.25 137.19 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.191 1.396 . . . . 0.0 111.261 -172.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -112.11 165.83 11.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.136 0.974 . . . . 0.0 109.961 166.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.3 t30 65.81 36.07 6.36 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.721 1.209 . . . . 0.0 113.491 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.95 153.78 42.81 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.422 -0.798 . . . . 0.0 110.294 163.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.76 148.45 49.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.857 0.863 . . . . 0.0 113.029 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -62.06 -34.04 75.52 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.767 -1.208 . . . . 0.0 111.141 158.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -60.86 -10.2 5.27 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.545 1.938 . . . . 0.0 115.418 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.1 p -121.13 155.99 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -170.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -119.53 161.65 20.23 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.619 1.567 . . . . 0.0 111.122 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -55.08 -35.38 64.51 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.955 -1.091 . . . . 0.0 113.059 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -63.63 -16.68 61.6 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.108 1.363 . . . . 0.0 114.585 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -91.64 -31.68 15.76 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.15 -21.36 66.52 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.319 -0.863 . . . . 0.0 112.315 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -48.57 -35.14 12.8 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.068 1.347 . . . . 0.0 112.813 169.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -58.6 -35.34 72.29 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.0 mt -98.6 -57.88 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.284 0.634 . . . . 0.0 110.298 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.291 59.6 m-85 -60.7 -30.38 69.92 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.44 -6.91 86.96 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.104 0.859 . . . . 0.0 114.669 173.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -56.36 -34.02 66.24 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.341 1.57 . . . . 0.0 111.412 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.96 9.8 26.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.106 1.762 . . . . 0.0 113.855 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.36 113.49 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.554 1.541 . . . . 0.0 109.535 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.77 80.17 0.19 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -54.7 -18.2 4.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 119.013 2.968 . . . . 0.0 119.013 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.4 m -71.75 -12.64 61.41 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.563 1.074 . . . . 0.0 112.857 170.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.7 m -115.15 116.49 28.47 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.191 1.796 . . . . 0.0 111.867 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -59.06 -43.41 91.74 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.216 -0.928 . . . . 0.0 112.704 -173.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.3 t -55.96 -14.56 2.59 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -88.09 -60.99 1.82 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.697 0.761 . . . . 0.0 110.018 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -69.69 -25.82 64.06 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.127 1.371 . . . . 0.0 113.876 -173.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.8 tt -55.25 -35.91 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.057 1.343 . . . . 0.0 112.098 170.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 10.5 mtm -90.03 -3.93 57.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.343 1.057 . . . . 0.0 112.614 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -101.12 134.21 44.48 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.244 2.217 . . . . 0.0 115.994 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -166.16 156.71 12.73 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.212 1.405 . . . . 0.0 108.183 174.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.2 mt -130.82 134.94 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.741 1.216 . . . . 0.0 110.283 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -120.81 132.8 55.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.891 0.876 . . . . 0.0 109.873 159.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 4.1 tt -103.2 133.29 48.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.155 1.382 . . . . 0.0 110.006 168.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.61 91.68 3.43 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 125.767 1.627 . . . . 0.0 110.846 171.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -67.95 -23.82 65.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 -174.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.415 ' HA ' ' HE3' ' A' ' 466' ' ' LYS . 26.0 pt-20 -154.76 175.03 14.23 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -175.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 87.79 -169.05 38.34 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.669 1.604 . . . . 0.0 114.15 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 4.02 1.99 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 74.1 mtp -129.98 20.21 5.44 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.965 2.506 . . . . 0.0 112.437 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 462' ' ' GLU . 35.9 ttmt -52.08 138.85 24.47 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.994 1.318 . . . . 0.0 111.803 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.78 32.56 61.16 Favored Glycine 0 CA--C 1.524 0.619 0 O-C-N 121.809 -0.557 . . . . 0.0 111.81 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.71 155.49 20.13 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.683 1.193 . . . . 0.0 110.79 165.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -148.27 148.19 30.19 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.143 -0.973 . . . . 0.0 112.733 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -113.05 138.24 50.2 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.761 1.624 . . . . 0.0 114.768 167.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.7 112.72 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.164 1.786 . . . . 0.0 109.482 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -78.79 134.55 14.14 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 159.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 20.2 mt -109.39 161.96 21.99 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.226 1.41 . . . . 0.0 109.913 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.53 -12.3 29.17 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.031 2.487 . . . . 0.0 113.654 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -153.5 142.66 21.4 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.703 0.683 . . . . 0.0 112.013 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -60.12 -29.88 68.91 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -67.94 -36.42 80.1 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 170.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -66.48 -39.32 88.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.79 0.436 . . . . 0.0 110.663 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.39 -43.16 86.63 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.512 -0.743 . . . . 0.0 112.638 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -55.78 -43.52 76.85 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.35 0.977 . . . . 0.0 111.78 176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -65.69 -52.86 48.14 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.081 1.352 . . . . 0.0 111.773 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.27 71.44 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.54 HD23 HG12 ' A' ' 498' ' ' VAL . 51.3 mt -68.95 -39.05 79.76 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.929 -1.107 . . . . 0.0 110.712 173.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -68.07 -22.77 64.91 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.794 1.238 . . . . 0.0 112.44 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -110.14 -39.73 4.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -84.45 -17.75 38.17 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -75.45 117.33 17.12 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.097 -1.002 . . . . 0.0 112.308 -168.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 101.47 3.24 53.44 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.231 -1.316 . . . . 0.0 115.043 -169.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.416 ' CD2' HD12 ' A' ' 394' ' ' LEU . 72.7 t80 -69.08 125.49 26.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.482 1.641 . . . . 0.0 113.48 -169.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.266 1.9 t -86.01 46.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.632 1.573 . . . . 0.0 114.836 -162.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 57.3 tp -58.85 120.26 8.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.47 1.508 . . . . 0.0 111.71 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.334 72.1 m-85 55.22 21.25 3.89 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -173.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 98.31 -6.41 61.42 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.689 1.614 . . . . 0.0 115.015 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -106.15 122.11 43.33 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.182 1.491 . . . . 0.0 111.864 -170.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.75 105.92 2.17 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.416 2.744 . . . . 0.0 112.548 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 44.1 mtp -67.41 131.82 46.44 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.999 1.32 . . . . 0.0 113.403 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.52 84.7 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.901 2.081 . . . . 0.0 110.945 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.54 HG12 HD23 ' A' ' 483' ' ' LEU . 4.0 t -87.28 125.79 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 126.578 1.951 . . . . 0.0 112.321 -170.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -141.63 158.73 43.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.654 1.181 . . . . 0.0 113.046 -170.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -61.24 146.41 47.92 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 166.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -59.12 132.6 54.5 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 122.586 1.184 . . . . 0.0 112.233 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 8.1 tpp85 -74.03 -46.67 41.89 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.551 -166.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 43.9 t -160.95 143.92 12.88 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.616 1.166 . . . . 0.0 111.302 165.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -154.14 155.84 36.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.1 1.76 . . . . 0.0 109.022 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 51.4 mmm-85 -117.9 53.14 1.53 Allowed Pre-proline 0 N--CA 1.476 0.867 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -170.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -69.05 170.54 15.5 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.638 2.225 . . . . 0.0 111.535 166.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -84.47 -32.3 24.08 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.639 1.575 . . . . 0.0 112.972 173.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -152.08 142.82 22.88 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.723 1.209 . . . . 0.0 112.666 -169.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -60.04 152.05 62.83 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 164.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -81.3 -176.17 2.98 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.504 2.802 . . . . 0.0 112.941 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 175.96 9.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.68 1.992 . . . . 0.0 111.896 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -70.29 133.2 46.75 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.667 1.187 . . . . 0.0 112.005 172.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -72.98 -36.29 57.29 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.037 -0.868 . . . . 0.0 114.973 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -85.77 108.85 18.27 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.287 1.044 . . . . 0.0 111.514 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 47.05 62.68 2.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 128.44 2.696 . . . . 0.0 114.31 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.319 0 CA-C-O 116.841 -1.552 . . . . 0.0 110.174 171.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . 0.269 4.2 p30 -139.32 -0.47 1.8 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -134.46 27.19 3.75 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.373 1.469 . . . . 0.0 113.632 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 86.6 mmm -68.62 136.88 90.5 Favored Pre-proline 0 CA--C 1.547 0.838 0 O-C-N 121.063 -1.023 . . . . 0.0 112.845 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -64.05 170.89 8.32 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.433 3.422 . . . . 0.0 113.353 167.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 31.4 t -120.16 124.2 45.17 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.697 1.199 . . . . 0.0 112.703 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -159.32 85.43 0.79 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.123 1.369 . . . . 0.0 111.99 170.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -143.28 167.66 21.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.132 1.373 . . . . 0.0 112.151 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.8 tt -78.68 154.29 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.855 1.262 . . . . 0.0 111.989 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 30.6 t -91.01 154.07 19.69 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.235 0.614 . . . . 0.0 111.101 167.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -44.26 -43.09 7.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.034 1.333 . . . . 0.0 112.502 164.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -71.55 -18.19 62.27 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -89.44 -39.34 13.44 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.177 -0.952 . . . . 0.0 113.445 165.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.38 -48.65 69.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.201 1.0 . . . . 0.0 112.788 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -56.8 -25.89 56.72 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.76 1.624 . . . . 0.0 113.941 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.86 -44.87 84.12 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.91 1.284 . . . . 0.0 110.832 175.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.55 78.08 0.73 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.308 1.432 . . . . 0.0 113.196 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -157.48 149.47 22.39 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.642 1.577 . . . . 0.0 109.642 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.7 pt -127.83 149.97 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.9 0.88 . . . . 0.0 111.567 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 8.8 m -80.41 167.78 19.78 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.89 0.876 . . . . 0.0 112.228 169.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -55.92 -29.22 59.73 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.271 -0.893 . . . . 0.0 112.765 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.63 -31.79 69.83 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.56 1.944 . . . . 0.0 113.309 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.57 -34.29 14.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.502 1.121 . . . . 0.0 110.947 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 9.7 ttm -61.26 -39.29 89.81 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.952 -1.092 . . . . 0.0 111.279 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.15 26.41 0.88 Allowed 'General case' 0 CA--C 1.552 1.056 0 O-C-N 120.846 -1.159 . . . . 0.0 112.455 172.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.51 -34.81 1.17 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.109 2.563 . . . . 0.0 113.858 174.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.37 134.0 42.48 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.803 1.641 . . . . 0.0 112.613 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 27.1 t -59.43 -37.86 79.18 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.707 0.803 . . . . 0.0 113.092 172.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.421 HG23 ' CD2' ' A' ' 410' ' ' PHE 0.27 3.1 m -60.44 -11.05 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 171.68 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.421 ' CD2' HG23 ' A' ' 409' ' ' VAL . 79.0 m-85 -122.49 11.2 9.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 119.237 3.051 . . . . 0.0 119.237 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -14.28 16.27 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -173.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.53 -27.48 1.18 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.556 1.542 . . . . 0.0 114.423 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -69.83 136.56 50.92 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -144.86 124.98 7.25 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.53 171.97 16.66 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.128 3.219 . . . . 0.0 111.629 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.48 -4.79 33.02 Favored Glycine 0 N--CA 1.48 1.594 0 N-CA-C 117.33 1.692 . . . . 0.0 117.33 170.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -74.58 131.75 79.41 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 119.079 1.439 . . . . 0.0 111.817 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.12 112.92 2.43 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.105 2.537 . . . . 0.0 111.032 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' ASN . . . . . 0.459 HD22 ' H ' ' A' ' 421' ' ' ARG . 4.6 t30 -159.9 145.7 15.61 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.605 1.162 . . . . 0.0 109.498 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 21.3 p -86.1 -8.35 57.94 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' ARG . . . . . 0.459 ' H ' HD22 ' A' ' 419' ' ' ASN . 41.7 mtt180 -117.95 148.54 42.09 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.667 1.187 . . . . 0.0 110.07 176.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 17.8 pt -135.01 166.35 28.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.474 1.91 . . . . 0.0 110.046 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -137.93 163.64 31.0 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.88 143.85 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.652 1.581 . . . . 0.0 111.573 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -126.65 168.81 13.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.658 1.983 . . . . 0.0 109.905 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 12.9 t30 68.5 31.25 4.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.817 1.247 . . . . 0.0 112.808 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -74.54 144.51 44.01 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.018 -1.051 . . . . 0.0 111.856 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.34 156.98 17.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.928 1.691 . . . . 0.0 114.778 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -59.55 -45.74 90.93 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.238 -0.914 . . . . 0.0 112.964 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -70.87 -26.94 63.47 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -175.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.15 152.65 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -172.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -129.41 162.1 28.83 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.732 2.013 . . . . 0.0 111.038 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -53.22 -30.84 40.12 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.096 1.358 . . . . 0.0 113.401 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -58.06 -25.85 61.77 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.166 1.787 . . . . 0.0 115.282 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -90.02 -28.55 19.0 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.5 mp -66.47 -19.99 65.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.32 1.448 . . . . 0.0 112.206 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.44 -25.24 59.34 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 174.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -61.47 -36.33 80.12 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.941 0.791 . . . . 0.0 111.477 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.4 mp -96.78 -56.58 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.202 0.601 . . . . 0.0 110.679 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.258 70.1 m-85 -60.11 -32.99 71.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.82 -7.24 87.41 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.062 0.839 . . . . 0.0 114.522 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -61.2 -39.71 91.2 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.842 1.321 . . . . 0.0 111.46 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -81.06 -0.79 41.41 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.585 1.954 . . . . 0.0 113.815 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 36.0 t -115.09 116.53 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.718 1.207 . . . . 0.0 109.996 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.262 4.2 m-20 -68.72 90.97 0.42 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 176.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -61.74 -16.53 50.12 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 119.006 2.965 . . . . 0.0 119.006 -173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 71.0 m -79.09 1.5 24.0 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.01 0.924 . . . . 0.0 113.361 168.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 11.1 t -126.89 112.68 15.6 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.65 1.18 . . . . 0.0 110.947 -173.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -59.86 -47.14 86.95 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.243 -0.911 . . . . 0.0 112.274 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 3.9 t -55.92 -15.24 3.13 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -89.21 -58.39 2.55 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.221 1.008 . . . . 0.0 110.685 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -71.59 -25.58 62.24 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.716 1.206 . . . . 0.0 113.432 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.3 tt -56.65 -33.12 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.263 1.425 . . . . 0.0 112.151 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -87.51 -5.81 58.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.308 1.443 . . . . 0.0 112.964 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -115.81 120.11 38.19 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -162.41 155.34 19.87 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.327 1.451 . . . . 0.0 107.61 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.1 mt -125.05 137.6 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.767 1.627 . . . . 0.0 110.499 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 -127.51 128.78 46.24 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.395 1.478 . . . . 0.0 109.485 165.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 14.1 tp -111.18 134.91 52.41 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.439 1.896 . . . . 0.0 109.308 170.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 50.7 mtm -89.38 133.18 34.62 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 126.518 1.927 . . . . 0.0 111.151 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -129.45 11.53 5.83 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -167.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -136.98 153.16 50.76 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.555 1.142 . . . . 0.0 112.476 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 70.66 -160.75 53.8 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.659 1.123 . . . . 0.0 115.379 171.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -6.11 27.37 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.732 1.613 . . . . 0.0 115.269 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 95.8 mmm -102.39 1.23 35.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.563 1.545 . . . . 0.0 114.611 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -62.31 132.99 54.48 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.639 1.563 . . . . 0.0 110.651 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.56 29.36 36.21 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.98 0.8 . . . . 0.0 113.597 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -121.09 148.05 44.7 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.444 1.098 . . . . 0.0 112.265 165.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -140.35 155.24 46.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.427 1.491 . . . . 0.0 114.02 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -113.46 140.35 48.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.415 1.886 . . . . 0.0 115.711 167.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -138.06 128.28 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.764 1.626 . . . . 0.0 111.223 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.76 143.94 17.44 Favored Glycine 0 CA--C 1.534 1.246 0 O-C-N 121.434 -0.792 . . . . 0.0 111.955 164.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 31.7 mt -126.67 155.17 75.37 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.579 1.152 . . . . 0.0 110.799 172.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.47 -6.17 17.93 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.835 2.357 . . . . 0.0 114.94 -168.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -154.25 143.15 21.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.92 0.888 . . . . 0.0 110.606 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -56.29 -30.9 63.09 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.044 -1.035 . . . . 0.0 112.859 169.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -66.26 -41.17 90.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.274 0.943 . . . . 0.0 113.394 171.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.62 96.89 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 119.423 -0.322 . . . . 0.0 110.797 174.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.84 -46.62 77.84 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.763 0.711 . . . . 0.0 112.338 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.9 -41.97 83.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.277 0.944 . . . . 0.0 112.101 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -69.96 -45.8 66.63 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.527 1.131 . . . . 0.0 112.159 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -63.12 -31.56 72.73 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.609 HD23 HG12 ' A' ' 498' ' ' VAL . 26.6 mt -69.32 -45.98 68.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.634 1.106 . . . . 0.0 110.549 172.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -59.92 -34.38 73.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.97 1.308 . . . . 0.0 111.86 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -88.11 -49.52 6.97 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.22 -23.87 37.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -167.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -73.08 104.62 4.22 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.816 -0.553 . . . . 0.0 109.602 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 117.82 -6.8 15.59 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 117.829 -1.539 . . . . 0.0 116.134 -167.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -65.67 132.64 49.29 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.064 1.932 . . . . 0.0 113.874 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.281 0.2 OUTLIER -94.06 47.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -157.505 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 31.5 tp -54.9 122.02 9.91 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.016 1.326 . . . . 0.0 111.342 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.385 50.5 m-85 59.42 12.97 2.95 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 -173.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 89.15 1.42 79.15 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.046 -1.034 . . . . 0.0 114.306 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -107.06 125.13 33.28 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 126.235 1.814 . . . . 0.0 111.012 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.05 121.06 7.5 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.034 2.49 . . . . 0.0 112.644 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 71.5 mtp -73.01 127.58 32.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.163 1.385 . . . . 0.0 111.347 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 92.7 t -92.55 95.89 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.352 1.861 . . . . 0.0 109.041 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.609 HG12 HD23 ' A' ' 483' ' ' LEU . 15.2 t -100.07 114.54 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.399 2.28 . . . . 0.0 112.296 -172.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.09 162.5 32.75 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -56.91 144.98 31.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.418 1.087 . . . . 0.0 110.27 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -59.37 154.18 17.35 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -73.06 -1.47 17.41 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 1.7 t -149.19 171.93 15.65 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.859 1.208 . . . . 0.0 111.732 160.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -87.48 132.88 33.87 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -161.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -149.15 103.09 3.34 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.774 1.63 . . . . 0.0 111.341 167.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -67.52 143.52 63.28 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 124.129 3.219 . . . . 0.0 111.375 165.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 37.4 tptt -169.24 122.44 0.78 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.806 1.242 . . . . 0.0 109.717 171.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -158.9 138.82 11.99 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -79.63 158.78 72.98 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 167.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.29 148.47 61.67 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.816 2.344 . . . . 0.0 112.358 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 155.45 21.19 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.053 0.93 . . . . 0.0 112.46 173.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 15.4 pm0 -65.11 124.35 21.9 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.916 1.686 . . . . 0.0 113.65 -167.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -81.42 -16.17 74.45 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.49 1.043 . . . . 0.0 114.475 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -82.96 128.88 34.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.986 1.315 . . . . 0.0 111.659 173.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.48 154.62 42.43 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.898 1.679 . . . . 0.0 111.191 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 82.3 tttt . . . . . 0 C--O 1.253 1.244 0 C-N-CA 123.809 0.844 . . . . 0.0 113.046 -170.507 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -73.02 -48.9 32.17 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -153.17 157.93 41.04 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.237 2.215 . . . . 0.0 111.228 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 17.1 ptm -150.22 166.2 15.71 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.734 1.614 . . . . 0.0 110.33 173.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -53.79 149.67 32.26 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.386 2.724 . . . . 0.0 114.649 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 67.5 m -106.93 -2.62 21.07 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 -164.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -157.89 156.88 32.14 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.868 1.267 . . . . 0.0 111.323 -166.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.3 p -148.0 161.9 40.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.328 1.451 . . . . 0.0 114.761 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.3 tt -69.87 158.64 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 126.177 1.791 . . . . 0.0 111.8 -172.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 73.8 m -92.33 152.38 19.8 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.953 -0.467 . . . . 0.0 111.399 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -56.56 -41.31 76.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.2 0.6 . . . . 0.0 111.365 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.09 -35.86 79.96 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -77.71 -30.87 52.0 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.2 tt -65.17 -48.96 71.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.378 1.071 . . . . 0.0 111.274 171.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -54.42 -24.69 20.95 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.376 1.871 . . . . 0.0 115.711 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -67.53 -36.01 80.19 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.568 1.147 . . . . 0.0 111.959 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.61 76.37 0.73 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 125.992 1.758 . . . . 0.0 111.372 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -163.65 145.98 9.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.24 1.016 . . . . 0.0 110.155 -172.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.7 pt -124.8 148.97 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.116 0.966 . . . . 0.0 112.509 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 33.7 t -81.28 166.97 20.05 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.643 1.177 . . . . 0.0 110.695 165.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -53.29 -31.96 46.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.41 1.084 . . . . 0.0 112.905 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -59.15 -19.68 47.0 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.927 1.691 . . . . 0.0 113.075 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -111.83 -28.56 8.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.342 1.857 . . . . 0.0 111.934 171.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 15.7 ttm -67.01 -38.38 85.87 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.195 -1.566 . . . . 0.0 111.936 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -83.89 31.51 0.48 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.815 0.846 . . . . 0.0 111.062 169.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.98 -42.18 0.53 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.313 1.845 . . . . 0.0 115.404 171.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.39 128.43 35.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.648 0.779 . . . . 0.0 109.308 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 50.9 m -59.97 -33.53 72.07 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.329 0.651 . . . . 0.0 112.34 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 5.3 m -63.41 -25.58 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.288 82.6 m-85 -94.07 -9.71 35.77 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -21.5 0.85 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 -163.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 15.6 m -143.9 24.82 1.65 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.476 1.91 . . . . 0.0 112.081 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -122.0 132.3 54.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.428 2.291 . . . . 0.0 112.371 -173.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -142.28 131.98 12.3 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -164.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.1 176.73 8.57 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.566 2.844 . . . . 0.0 111.685 161.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.01 69.16 1.41 Allowed Glycine 0 CA--C 1.532 1.098 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 172.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -145.7 155.16 52.62 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 126.463 1.905 . . . . 0.0 110.833 165.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -82.24 84.74 1.78 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.978 3.119 . . . . 0.0 112.371 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -139.4 143.46 37.68 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.232 -0.917 . . . . 0.0 111.792 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 29.8 p -84.33 7.21 20.16 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -135.11 145.49 47.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.682 1.593 . . . . 0.0 110.082 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 24.1 pt -139.53 162.21 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.507 1.923 . . . . 0.0 109.706 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -133.4 161.77 33.64 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 123.193 1.473 . . . . 0.0 107.722 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.414 HG22 HG13 ' A' ' 498' ' ' VAL . 10.5 t -130.27 139.35 51.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.769 1.628 . . . . 0.0 110.834 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -119.68 168.23 11.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.184 1.794 . . . . 0.0 109.916 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 9.8 t30 68.31 32.38 4.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.657 1.183 . . . . 0.0 111.602 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.96 134.51 41.5 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.522 -0.736 . . . . 0.0 109.972 167.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.9 170.82 1.91 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -173.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -65.52 -50.04 66.74 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.772 1.229 . . . . 0.0 112.92 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -68.06 -42.17 80.88 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.46 152.45 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 127.258 2.223 . . . . 0.0 116.231 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -139.69 170.39 15.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.975 1.31 . . . . 0.0 112.488 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -54.51 -33.77 60.49 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.435 -1.415 . . . . 0.0 113.565 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 34.6 pttt -58.75 -39.46 80.99 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 171.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.28 -32.75 72.11 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.737 1.215 . . . . 0.0 113.538 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.6 mp -69.57 -27.61 65.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.677 1.191 . . . . 0.0 112.805 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -30.67 63.55 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.023 0.829 . . . . 0.0 112.293 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.08 -34.18 74.51 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.46 1.104 . . . . 0.0 111.845 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.12 -58.34 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.127 -0.983 . . . . 0.0 110.827 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -57.68 -29.57 64.75 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.51 -14.78 82.11 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.077 -0.846 . . . . 0.0 114.581 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -56.97 -37.05 71.05 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.263 1.531 . . . . 0.0 111.959 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.63 -7.48 53.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.353 1.461 . . . . 0.0 113.686 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 18.1 t -118.54 123.11 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.72 2.008 . . . . 0.0 110.929 -171.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -75.69 111.6 11.19 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -65.42 -15.13 62.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 70.5 m -89.23 -12.47 40.69 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.197 0.999 . . . . 0.0 113.402 172.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 24.1 t -111.72 109.44 19.3 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.252 1.021 . . . . 0.0 110.845 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -57.92 -45.33 86.68 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.563 -0.711 . . . . 0.0 111.739 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.74 -17.2 5.48 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -87.34 -61.21 1.77 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.31 1.044 . . . . 0.0 110.28 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -70.5 -19.31 62.93 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.084 1.353 . . . . 0.0 113.986 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.1 tt -63.66 -32.62 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.468 1.507 . . . . 0.0 112.531 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.1 mmm -86.88 -14.52 41.77 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.639 1.176 . . . . 0.0 112.42 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -96.13 124.59 40.19 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -171.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -160.51 146.3 15.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.31 143.94 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.305 1.042 . . . . 0.0 110.57 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 73.0 mtp85 -126.66 138.76 53.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.573 1.549 . . . . 0.0 109.858 164.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 2.1 tt -118.96 125.0 48.41 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.057 1.343 . . . . 0.0 110.153 167.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -82.01 125.93 31.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.053 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -115.48 4.92 14.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.065 1.346 . . . . 0.0 112.998 -165.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.6 157.16 34.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.105 2.162 . . . . 0.0 110.457 -170.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 72.22 -164.62 54.41 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.507 1.051 . . . . 0.0 115.445 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -21.57 55.67 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 82.8 mtp -101.32 12.0 38.24 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -55.27 122.57 11.4 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.552 1.523 . . . . 0.0 111.154 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.23 28.05 56.7 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.599 1.095 . . . . 0.0 112.835 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -112.84 155.75 24.11 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.704 1.202 . . . . 0.0 110.909 163.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -149.08 155.62 41.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.508 1.123 . . . . 0.0 112.764 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.46 137.78 54.41 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.58 124.96 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.814 1.645 . . . . 0.0 110.623 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.65 141.19 15.42 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 160.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.6 mt -119.45 157.42 51.62 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.878 1.271 . . . . 0.0 110.187 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.59 -5.99 17.64 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.515 2.143 . . . . 0.0 114.242 -173.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -148.93 138.82 22.06 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.979 1.312 . . . . 0.0 110.102 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.07 -37.39 71.79 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.7 -0.625 . . . . 0.0 111.753 168.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -60.61 -37.66 82.14 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -69.23 -38.02 78.31 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.674 0.79 . . . . 0.0 111.701 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.82 -45.77 81.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.55 1.068 . . . . 0.0 111.86 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.05 76.12 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.766 0.712 . . . . 0.0 112.284 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -69.2 -47.78 63.89 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.998 0.919 . . . . 0.0 112.336 173.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.52 -31.52 71.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.484 0.714 . . . . 0.0 112.65 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.646 HD23 HG12 ' A' ' 498' ' ' VAL . 66.7 mt -73.28 -31.94 64.36 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.514 1.126 . . . . 0.0 112.468 172.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -71.03 -34.29 71.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.304 0.642 . . . . 0.0 111.34 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -89.85 -54.86 3.87 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -73.52 -17.05 61.26 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -69.22 101.92 1.59 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.281 1.032 . . . . 0.0 110.225 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 114.66 -2.1 23.27 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 117.919 -1.49 . . . . 0.0 116.103 -172.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -68.71 120.53 14.84 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.316 2.058 . . . . 0.0 109.367 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.32 69.83 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 124.067 1.889 . . . . 0.0 110.225 -167.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 22.7 tp -76.03 130.22 38.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.181 175.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.341 55.6 m-85 58.01 31.93 21.3 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 76.81 0.21 68.0 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.097 1.332 . . . . 0.0 115.594 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 27.4 tptt -112.78 108.61 53.6 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.653 1.581 . . . . 0.0 110.628 -169.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.39 113.44 3.32 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.756 2.304 . . . . 0.0 110.705 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 48.6 mtp -72.7 128.55 35.87 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.059 1.743 . . . . 0.0 111.891 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.5 t -93.59 99.0 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.078 1.751 . . . . 0.0 109.314 -176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 483' ' ' LEU . 2.8 t -101.69 124.24 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.444 1.898 . . . . 0.0 112.266 -173.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -147.82 155.17 41.37 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.098 1.359 . . . . 0.0 111.707 -170.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -54.23 148.19 11.84 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -61.58 158.01 16.1 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 16.2 mmm-85 -121.01 -21.64 6.43 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -160.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 30.2 t -104.09 88.51 3.02 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.121 1.768 . . . . 0.0 107.431 162.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -155.5 160.19 40.37 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -165.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.38 86.76 34.27 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.545 1.538 . . . . 0.0 107.664 161.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -57.34 138.43 86.18 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 123.456 2.771 . . . . 0.0 112.694 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -157.23 133.37 9.61 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.489 1.916 . . . . 0.0 109.305 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -73.66 139.83 45.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.938 1.295 . . . . 0.0 112.933 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -79.13 147.68 69.94 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 170.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.87 159.64 53.0 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.742 2.961 . . . . 0.0 114.422 -171.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 166.67 11.83 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.343 1.457 . . . . 0.0 114.272 175.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -67.27 -28.98 68.48 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.773 1.629 . . . . 0.0 114.564 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 91.26 22.19 32.98 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.094 1.33 . . . . 0.0 113.647 -172.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -151.93 130.84 12.52 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.896 2.478 . . . . 0.0 109.889 -172.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.35 130.1 40.5 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.655 0.782 . . . . 0.0 111.98 -172.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt . . . . . 0 C--O 1.252 1.199 0 C-N-CA 127.675 2.39 . . . . 0.0 112.706 -177.482 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 N--CA 1.475 0.788 0 CA-C-O 119.534 -0.27 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -74.22 175.81 7.22 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -174.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -75.52 -54.04 7.65 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.181 1.392 . . . . 0.0 113.505 -165.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 68.8 mtp 59.64 157.76 0.1 Allowed Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 129.772 3.229 . . . . 0.0 118.188 171.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -93.16 165.64 2.48 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 124.089 3.193 . . . . 0.0 113.258 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 59.1 p -78.43 46.55 0.64 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.615 1.566 . . . . 0.0 114.028 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -88.81 71.39 8.67 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.038 -1.663 . . . . 0.0 111.57 -173.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.3 p -155.02 160.27 40.93 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.595 1.158 . . . . 0.0 111.715 169.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.8 tt -68.39 145.99 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.328 1.451 . . . . 0.0 110.492 -174.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 37.1 t -82.63 157.08 23.55 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 122.107 0.956 . . . . 0.0 109.021 163.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -56.73 -30.14 63.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.699 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -63.82 -37.17 86.39 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 175.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -81.33 -27.84 34.78 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.44 -46.94 62.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.096 1.358 . . . . 0.0 113.042 174.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -55.88 -22.04 23.43 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.594 1.958 . . . . 0.0 114.411 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -62.9 -30.78 71.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.064 1.346 . . . . 0.0 112.704 173.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.22 80.66 0.31 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.55 1.548 . . . . 0.0 111.108 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -162.01 145.52 12.08 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.958 1.703 . . . . 0.0 109.908 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.8 pt -120.61 152.13 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 63.6 m -74.67 159.56 31.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.35 1.46 . . . . 0.0 111.823 161.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 33.3 mtm105 -58.84 -27.11 64.81 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.879 -1.138 . . . . 0.0 112.728 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -61.87 -31.56 71.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.949 1.3 . . . . 0.0 112.019 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.78 -32.18 21.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.672 1.189 . . . . 0.0 111.254 170.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 37.4 ttm -62.23 -43.52 98.64 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.653 -1.279 . . . . 0.0 111.483 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -78.99 29.47 0.21 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.568 0.747 . . . . 0.0 112.162 171.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.05 -39.7 0.44 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.049 1.74 . . . . 0.0 115.388 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 5.3 mp -68.19 134.96 51.3 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.052 1.341 . . . . 0.0 110.586 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 82.4 p -62.94 -27.64 69.53 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.412 HG23 ' CD2' ' A' ' 410' ' ' PHE . 11.4 m -65.79 -22.77 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 172.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.412 ' CD2' HG23 ' A' ' 409' ' ' VAL 0.401 66.4 m-85 -101.25 14.23 32.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 118.482 2.771 . . . . 0.0 118.482 -177.108 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -23.01 62.5 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 4.3 m -140.06 -33.72 0.57 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.847 1.659 . . . . 0.0 113.735 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.58 144.99 56.09 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -147.96 143.24 17.44 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -83.18 -171.67 1.18 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.757 3.638 . . . . 0.0 111.226 157.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.46 -0.48 32.71 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 117.494 1.758 . . . . 0.0 117.494 163.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -102.77 143.51 26.74 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 119.236 1.518 . . . . 0.0 113.91 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.31 82.74 2.42 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.849 3.7 . . . . 0.0 112.435 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -128.29 146.59 50.71 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.552 -1.343 . . . . 0.0 111.026 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 32.0 p -77.34 -9.89 59.11 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 36.3 mtm180 -119.59 146.4 45.55 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.715 1.206 . . . . 0.0 111.586 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 10.3 pt -134.82 151.11 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.997 1.719 . . . . 0.0 110.125 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -114.24 154.67 27.52 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.309 1.052 . . . . 0.0 108.486 166.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.412 HG22 HG13 ' A' ' 498' ' ' VAL . 2.5 t -128.82 147.45 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.531 1.532 . . . . 0.0 112.693 176.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -134.99 165.99 24.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.092 1.757 . . . . 0.0 111.011 -174.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.291 12.6 m-20 71.55 24.4 3.59 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -174.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.29 131.55 42.83 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.289 -1.507 . . . . 0.0 112.12 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -56.17 152.6 10.51 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.57 1.948 . . . . 0.0 115.513 -172.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -58.36 -40.23 81.67 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -84.52 -21.77 30.43 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.08 150.26 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -117.35 167.26 11.4 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.547 1.139 . . . . 0.0 112.125 171.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 459' ' ' LEU . 5.2 pm0 -53.94 -34.36 59.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.606 1.162 . . . . 0.0 112.613 170.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -66.58 -32.85 74.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.799 1.24 . . . . 0.0 114.115 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -68.02 -29.66 68.72 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.24 -18.25 60.76 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.01 1.324 . . . . 0.0 113.681 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -58.19 -29.29 65.54 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.361 0.982 . . . . 0.0 112.873 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.66 -32.21 72.36 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.398 0.545 . . . . 0.0 110.733 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.2 mt -99.16 -60.13 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.526 0.73 . . . . 0.0 110.844 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.294 81.5 m-85 -62.92 -23.98 67.63 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 117.349 2.352 . . . . 0.0 117.349 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -82.51 -5.51 89.45 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.737 1.16 . . . . 0.0 114.22 171.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -58.0 -31.8 67.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.656 1.728 . . . . 0.0 111.378 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -93.81 6.77 47.29 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.908 1.683 . . . . 0.0 111.572 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 19.0 t -118.37 120.29 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 120.209 1.368 . . . . 0.0 110.828 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -75.59 103.36 5.67 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.45 1.1 . . . . 0.0 110.422 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -56.42 -29.28 61.4 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 4.2 m -77.81 -2.6 37.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.293 1.837 . . . . 0.0 113.898 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.8 m -130.44 98.0 4.56 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.358 1.463 . . . . 0.0 110.468 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -51.93 -41.05 61.73 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.2 t -48.63 -16.67 0.12 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 118.688 2.847 . . . . 0.0 118.688 173.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -93.07 -58.65 2.26 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.463 -0.773 . . . . 0.0 111.575 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -71.14 -17.07 62.57 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.077 1.351 . . . . 0.0 113.78 -175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.7 tt -63.3 -35.15 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.557 1.543 . . . . 0.0 111.803 168.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.5 mtm -85.04 -27.64 26.22 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.52 0.328 . . . . 0.0 110.891 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . 0.28 32.4 t80 -83.75 128.64 34.68 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 -173.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -162.28 155.85 20.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.778 1.631 . . . . 0.0 107.716 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 11.3 mt -130.78 135.88 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.617 1.167 . . . . 0.0 109.77 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -122.3 125.16 45.4 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.487 1.515 . . . . 0.0 108.044 163.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' A' ' 433' ' ' GLU . 7.1 tp -99.73 113.37 25.8 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.278 1.431 . . . . 0.0 108.203 165.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -77.7 107.04 9.9 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 126.355 1.862 . . . . 0.0 110.034 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -98.28 2.15 47.88 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.354 1.062 . . . . 0.0 113.763 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -118.68 157.16 27.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.4 1.88 . . . . 0.0 112.89 -171.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 74.07 174.55 30.91 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.997 1.284 . . . . 0.0 113.174 -171.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -28.77 68.46 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.445 -1.032 . . . . 0.0 113.068 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -91.89 34.64 0.99 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.55 1.14 . . . . 0.0 112.927 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -70.59 166.25 21.05 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.283 1.033 . . . . 0.0 113.139 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 68.7 38.16 85.41 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 124.891 1.234 . . . . 0.0 110.605 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -125.74 156.92 38.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.079 0.952 . . . . 0.0 110.525 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -143.77 136.99 27.75 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -93.85 127.06 39.4 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 165.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.17 135.83 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.327 1.451 . . . . 0.0 109.378 171.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.89 133.4 11.58 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 160.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 17.9 mt -106.58 160.27 26.87 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.349 1.46 . . . . 0.0 109.868 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.26 -10.46 20.8 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.579 2.186 . . . . 0.0 113.842 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -153.42 145.51 23.74 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.159 0.984 . . . . 0.0 110.249 -174.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -55.67 -36.37 67.02 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.977 -0.452 . . . . 0.0 111.756 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -62.68 -33.99 76.21 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -69.6 -39.87 77.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.203 0.601 . . . . 0.0 111.084 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -69.73 -42.87 73.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.05 0.841 . . . . 0.0 111.618 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.24 -31.11 67.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.984 0.914 . . . . 0.0 112.778 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -78.72 -49.08 13.69 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.328 -0.858 . . . . 0.0 112.617 168.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.87 -27.74 69.55 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.57 HD23 HG12 ' A' ' 498' ' ' VAL . 54.1 mt -76.49 -28.3 56.4 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.192 -0.943 . . . . 0.0 112.736 174.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -71.12 -40.36 71.5 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.108 0.563 . . . . 0.0 110.681 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.44 -55.01 5.18 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.36 -16.26 52.83 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -68.49 108.79 3.42 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.931 -1.106 . . . . 0.0 110.835 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 115.52 -6.09 20.87 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 117.987 -1.452 . . . . 0.0 115.42 -171.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.78 120.41 12.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.292 2.046 . . . . 0.0 114.99 -160.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.287 1.9 t -85.63 46.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.102 1.761 . . . . 0.0 115.507 -163.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 32.5 tp -52.9 130.06 32.18 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.353 1.061 . . . . 0.0 110.335 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . . 81.2 t80 60.31 16.04 5.89 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 86.77 10.3 72.95 Favored Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.464 -1.398 . . . . 0.0 114.656 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -127.66 125.55 23.77 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 126.031 1.732 . . . . 0.0 111.934 -172.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.54 127.51 12.56 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.09 1.86 . . . . 0.0 112.651 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 61.4 mtp -78.42 131.76 37.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.538 1.535 . . . . 0.0 112.524 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.28 97.05 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.356 1.862 . . . . 0.0 109.554 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.57 HG12 HD23 ' A' ' 483' ' ' LEU . 2.9 t -98.51 119.87 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 127.481 2.312 . . . . 0.0 112.774 -176.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -139.41 158.76 43.58 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.825 1.25 . . . . 0.0 113.525 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -58.5 145.89 37.38 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.615 -0.678 . . . . 0.0 112.817 166.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -52.69 142.72 17.83 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.829 0.851 . . . . 0.0 112.606 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -80.56 -12.73 59.48 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -166.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 21.7 m -72.23 142.92 48.97 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.585 1.954 . . . . 0.0 110.702 170.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -60.22 151.99 25.85 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -174.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 31.0 tpt85 -124.78 82.35 60.38 Favored Pre-proline 0 N--CA 1.48 1.053 0 C-N-CA 126.936 2.094 . . . . 0.0 110.915 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.44 -176.94 2.45 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.634 2.889 . . . . 0.0 112.617 177.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -53.1 126.15 19.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.329 1.051 . . . . 0.0 109.18 161.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -160.24 179.97 8.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.391 1.076 . . . . 0.0 110.169 -162.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -63.68 144.31 97.87 Favored Pre-proline 0 CA--C 1.545 0.782 0 O-C-N 120.474 -1.391 . . . . 0.0 112.006 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.83 166.54 28.61 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.988 2.458 . . . . 0.0 113.103 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 168.67 6.19 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.548 1.139 . . . . 0.0 112.599 168.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -125.09 173.15 8.91 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -172.86 -165.95 30.63 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.404 1.002 . . . . 0.0 112.843 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -160.41 167.44 27.33 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.958 1.303 . . . . 0.0 112.258 160.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.76 -44.7 8.83 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.84 1.656 . . . . 0.0 111.001 171.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 15.7 pttp . . . . . 0 C--O 1.252 1.197 0 C-N-CA 128.325 2.65 . . . . 0.0 112.841 170.131 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.568 ' N ' ' HG ' ' A' ' 386' ' ' SER . 26.4 p . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 117.958 -1.02 . . . . 0.0 111.625 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -129.81 -70.55 0.64 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.52 -22.76 54.0 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 69.3 mmm -136.63 162.68 54.71 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.872 1.669 . . . . 0.0 112.834 -172.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.71 164.36 11.69 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.801 3.001 . . . . 0.0 113.393 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' SER . . . . . 0.568 ' HG ' ' N ' ' A' ' 381' ' ' SER . 5.6 m -117.36 149.36 40.62 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.199 1.4 . . . . 0.0 114.311 177.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -159.83 156.78 28.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.14 2.176 . . . . 0.0 109.804 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.1 p -141.9 175.69 9.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.657 1.183 . . . . 0.0 112.828 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.5 tt -82.62 150.42 4.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 126.063 1.745 . . . . 0.0 111.964 -172.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 6.5 m -81.77 161.02 23.44 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.511 0.725 . . . . 0.0 109.709 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -65.04 -39.63 93.61 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.113 -0.992 . . . . 0.0 110.769 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -54.89 -43.72 73.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.351 1.46 . . . . 0.0 112.785 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.87 -37.73 70.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.098 1.359 . . . . 0.0 114.551 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 19.8 tp -69.05 -39.6 79.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.251 1.021 . . . . 0.0 112.528 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -59.97 -18.03 42.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -65.66 -21.41 66.55 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.057 0.943 . . . . 0.0 112.253 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -134.96 86.49 0.25 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.656 1.598 . . . . 0.0 111.495 173.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -155.7 151.08 26.93 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.751 1.221 . . . . 0.0 109.658 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.3 pt -136.41 148.64 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 13.0 m -86.97 164.17 16.67 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.98 1.712 . . . . 0.0 110.178 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -50.24 -38.76 42.15 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.38 -27.35 66.16 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.54 -31.42 42.06 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.142 -0.974 . . . . 0.0 111.821 167.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 4.5 ttm -58.93 -38.7 79.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.784 0.834 . . . . 0.0 110.076 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -74.65 11.2 1.09 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.764 1.626 . . . . 0.0 114.059 171.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.47 -22.05 3.4 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.209 1.803 . . . . 0.0 115.227 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.0 mp -91.17 130.82 37.02 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.253 1.821 . . . . 0.0 111.202 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 14.5 p -62.41 -24.25 67.29 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.441 HG23 ' CD2' ' A' ' 410' ' ' PHE . 6.1 m -66.18 -23.22 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 119.501 1.046 . . . . 0.0 113.595 169.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.441 ' CD2' HG23 ' A' ' 409' ' ' VAL 0.27 42.2 m-85 -100.44 -10.35 21.22 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 121.276 3.806 . . . . 0.0 121.276 -171.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.79 -19.59 29.42 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 -169.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 4.4 m -142.54 28.28 1.64 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.451 1.9 . . . . 0.0 111.799 -176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -134.12 137.72 44.73 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.192 2.197 . . . . 0.0 115.924 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -142.11 121.01 7.76 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -171.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -74.84 176.79 9.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.178 3.252 . . . . 0.0 113.282 160.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.55 31.61 10.19 Favored Glycine 0 N--CA 1.468 0.787 0 C-N-CA 124.532 1.063 . . . . 0.0 114.853 167.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -125.82 149.87 67.06 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.693 1.197 . . . . 0.0 113.255 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.53 109.93 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.027 3.151 . . . . 0.0 114.056 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -158.17 159.96 36.71 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.807 1.643 . . . . 0.0 109.669 160.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 25.4 p -80.59 -7.52 59.28 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -130.92 152.39 50.3 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.086 1.754 . . . . 0.0 110.084 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 6.6 pt -137.88 165.13 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 126.725 2.01 . . . . 0.0 109.404 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -135.56 164.18 28.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.606 1.193 . . . . 0.0 107.818 167.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.4 143.34 34.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.608 1.163 . . . . 0.0 110.522 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -126.43 168.78 13.73 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.227 1.811 . . . . 0.0 110.868 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 38.8 t30 67.32 32.8 5.72 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.663 1.585 . . . . 0.0 113.085 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.56 139.79 53.77 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.449 1.1 . . . . 0.0 110.919 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -59.47 161.86 5.43 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.871 1.669 . . . . 0.0 115.098 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -63.09 -37.26 86.51 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -80.15 -32.7 38.88 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.713 1.605 . . . . 0.0 114.022 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.35 144.19 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -166.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -120.25 163.87 17.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.602 1.561 . . . . 0.0 112.308 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -56.15 -32.55 64.39 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.583 -1.323 . . . . 0.0 113.033 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -62.37 -33.37 74.61 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -66.98 -36.21 81.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.494 1.118 . . . . 0.0 113.028 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.56 -22.6 63.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.192 1.397 . . . . 0.0 112.969 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.88 -26.78 62.57 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.48 1.036 . . . . 0.0 112.471 176.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -62.5 -31.77 72.58 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.237 0.471 . . . . 0.0 110.494 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.11 -56.27 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 120.591 -1.318 . . . . 0.0 110.841 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -59.27 -30.32 68.21 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.28 -3.49 88.55 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.906 1.241 . . . . 0.0 114.641 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -59.25 -31.06 68.74 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.384 1.592 . . . . 0.0 112.23 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -97.94 13.85 29.3 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.205 2.202 . . . . 0.0 111.678 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 15.4 t -131.03 139.73 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.919 1.688 . . . . 0.0 110.389 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.61 117.05 14.91 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.717 -0.615 . . . . 0.0 109.872 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.31 -13.81 32.65 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 118.716 2.858 . . . . 0.0 118.716 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.2 t -123.04 -33.48 3.32 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.4 m -67.66 110.83 3.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.951 0.796 . . . . 0.0 110.814 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -57.07 -46.4 82.53 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -13.55 2.57 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -92.91 -60.34 1.83 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.819 1.248 . . . . 0.0 110.374 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -70.81 -12.55 61.62 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.986 1.714 . . . . 0.0 114.114 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.02 -39.91 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 126.869 2.068 . . . . 0.0 112.968 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 11.8 mtm -83.96 -29.96 26.64 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.573 0.749 . . . . 0.0 109.669 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -66.43 131.15 45.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.04 1.336 . . . . 0.0 113.825 164.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -165.43 149.04 8.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.358 1.463 . . . . 0.0 108.809 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.2 mt -125.95 137.03 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.48 1.112 . . . . 0.0 111.424 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -126.53 129.37 48.49 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.945 1.298 . . . . 0.0 108.892 162.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 5.7 tt -109.1 115.97 31.06 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.225 1.41 . . . . 0.0 109.533 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 59.7 mtm -72.8 134.26 44.84 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.065 1.346 . . . . 0.0 111.575 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -123.93 14.94 9.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.492 1.517 . . . . 0.0 113.168 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -139.89 153.31 46.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.898 1.679 . . . . 0.0 112.241 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 59.33 -146.88 43.04 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.046 1.308 . . . . 0.0 116.318 168.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -7.59 47.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.819 2.048 . . . . 0.0 115.465 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . 0.256 13.1 mtm -120.25 19.25 12.19 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 173.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -55.58 120.22 6.89 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.273 -1.517 . . . . 0.0 111.513 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.01 30.17 29.42 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.16 1.362 . . . . 0.0 113.77 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -123.85 149.33 45.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.472 1.109 . . . . 0.0 109.288 168.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -137.94 141.52 40.57 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.437 -0.79 . . . . 0.0 112.656 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -101.64 135.06 43.8 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 172.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.82 122.83 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.29 1.436 . . . . 0.0 110.533 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -85.73 149.99 23.86 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 162.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 21.9 mt -125.21 158.34 64.06 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.401 1.08 . . . . 0.0 110.233 170.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.3 -8.27 21.67 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.545 2.163 . . . . 0.0 113.991 -175.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -155.78 144.24 20.19 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.033 1.333 . . . . 0.0 110.487 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -58.36 -31.95 68.1 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.613 1.165 . . . . 0.0 113.154 168.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -56.3 -45.69 80.13 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.394 -0.816 . . . . 0.0 111.978 171.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.73 -35.87 81.98 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.993 0.808 . . . . 0.0 112.914 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.38 -44.37 75.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.439 1.472 . . . . 0.0 112.586 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.83 -38.22 75.23 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.42 -0.8 . . . . 0.0 112.022 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -67.2 -53.7 27.88 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.721 1.208 . . . . 0.0 112.192 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.79 -32.95 69.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.979 0.911 . . . . 0.0 112.608 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.561 HD23 HG12 ' A' ' 498' ' ' VAL . 50.8 mt -69.81 -43.58 71.77 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.068 0.947 . . . . 0.0 111.742 175.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -65.97 -26.1 67.41 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.81 0.844 . . . . 0.0 111.688 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -100.65 -44.69 5.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -175.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -76.1 -24.45 55.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.519 1.128 . . . . 0.0 113.865 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -72.5 120.5 18.2 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.645 -0.659 . . . . 0.0 112.343 -169.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 108.96 -8.19 33.51 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 117.984 -1.454 . . . . 0.0 115.032 -170.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . 0.262 61.7 t80 -64.82 133.12 51.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.524 1.662 . . . . 0.0 115.164 -164.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.252 2.5 t -99.8 46.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.181 1.392 . . . . 0.0 113.768 -158.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 19.4 tp -50.49 126.28 14.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.123 1.369 . . . . 0.0 110.572 172.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.361 32.9 m-85 58.64 12.58 2.22 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 89.84 3.03 74.36 Favored Glycine 0 CA--C 1.536 1.355 0 O-C-N 120.683 -1.26 . . . . 0.0 114.519 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -119.35 118.1 32.68 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 119.477 1.639 . . . . 0.0 112.829 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.18 126.76 14.1 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.886 2.39 . . . . 0.0 113.216 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 71.7 mtp -81.72 134.47 35.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.652 1.581 . . . . 0.0 112.137 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.76 93.47 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 126.655 1.982 . . . . 0.0 110.528 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.561 HG12 HD23 ' A' ' 483' ' ' LEU . 2.8 t -94.67 118.25 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 126.814 2.045 . . . . 0.0 113.086 -173.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -134.41 160.8 36.86 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.65 1.18 . . . . 0.0 114.119 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -60.01 144.58 48.96 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.165 -0.96 . . . . 0.0 113.174 167.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -60.91 168.72 2.23 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.96 15.3 1.19 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -143.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 8.8 t -64.06 -48.56 75.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.428 1.013 . . . . 0.0 109.373 173.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -79.58 135.58 36.63 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.155 0.582 . . . . 0.0 110.207 155.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -118.26 49.85 1.09 Allowed Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.351 1.46 . . . . 0.0 113.575 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -65.51 165.86 21.45 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.715 2.277 . . . . 0.0 111.964 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -54.66 113.34 1.27 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.673 1.189 . . . . 0.0 112.297 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -81.14 -41.61 22.18 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.634 0.774 . . . . 0.0 110.085 166.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -156.89 159.34 31.34 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.631 1.972 . . . . 0.0 114.191 -168.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -70.97 -165.65 0.19 Allowed 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.135 2.557 . . . . 0.0 111.38 162.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.35 160.16 0.26 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.236 1.015 . . . . 0.0 113.264 160.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -63.75 148.32 49.48 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.409 -0.807 . . . . 0.0 112.012 -173.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -175.74 112.85 0.41 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.653 0.644 . . . . 0.0 112.286 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -153.74 175.66 13.02 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -162.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -123.12 120.25 32.67 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.328 1.451 . . . . 0.0 112.464 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 18.9 pttp . . . . . 0 C--O 1.251 1.152 0 C-N-CA 127.375 2.27 . . . . 0.0 112.562 172.709 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 76.0 p . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 120.3 0.095 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -86.41 -39.35 16.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.781 0.832 . . . . 0.0 112.225 174.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -145.47 151.05 37.59 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.725 1.21 . . . . 0.0 111.223 172.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 23.0 ptm -151.66 158.03 34.33 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.15 1.38 . . . . 0.0 110.435 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -92.05 39.33 0.28 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.926 2.417 . . . . 0.0 112.298 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 33.7 t -162.32 156.44 21.45 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.882 1.273 . . . . 0.0 113.167 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -142.6 144.41 32.84 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 129.206 3.002 . . . . 0.0 106.81 167.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 30.1 p -144.82 164.78 30.01 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.3 tt -72.64 171.14 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.647 2.379 . . . . 0.0 111.701 -175.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 34.5 m -110.67 166.85 10.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.425 1.09 . . . . 0.0 111.834 167.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 14.1 ttm-85 -59.15 -48.33 81.99 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.037 -1.039 . . . . 0.0 112.48 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -61.78 -37.16 83.3 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.591 1.157 . . . . 0.0 113.398 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -70.31 -38.66 75.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.696 1.198 . . . . 0.0 113.226 173.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.06 -41.08 82.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.889 1.276 . . . . 0.0 112.982 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.33 -17.84 32.89 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.172 1.789 . . . . 0.0 115.101 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -70.29 -16.23 62.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.961 0.905 . . . . 0.0 113.357 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -127.29 87.6 0.33 Allowed Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.84 1.686 . . . . 0.0 113.166 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -167.7 147.25 4.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.629 1.172 . . . . 0.0 111.372 -170.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 10.8 pt -125.28 152.71 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 69.3 m -100.82 164.44 11.84 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.963 2.505 . . . . 0.0 111.111 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -55.46 -33.81 63.97 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -169.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -76.86 -10.56 59.45 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.588 1.086 . . . . 0.0 112.877 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -96.61 -33.19 11.87 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.001 -1.062 . . . . 0.0 111.208 163.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 17.5 ttp -63.29 -40.47 97.47 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.881 -1.137 . . . . 0.0 111.352 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -79.68 30.62 0.24 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.148 0.979 . . . . 0.0 112.723 171.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.12 -29.02 0.41 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 176.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.8 mp -72.27 134.31 45.51 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.17 0.988 . . . . 0.0 109.842 167.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 9.2 t -66.94 -29.48 69.36 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.444 -0.785 . . . . 0.0 111.923 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.7 m -66.63 -7.77 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 170.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.261 83.5 m-85 -119.74 3.68 11.1 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 118.553 2.797 . . . . 0.0 118.553 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -14.08 62.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -169.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.7 t -130.76 -25.9 2.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.218 1.007 . . . . 0.0 111.681 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -70.36 137.76 50.82 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.284 1.586 . . . . 0.0 115.284 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -142.81 125.79 9.14 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.22 179.71 5.68 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 125.045 3.83 . . . . 0.0 113.513 167.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 121.25 -19.68 8.62 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 156.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -82.03 150.2 64.5 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.13 96.98 1.09 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 124.109 3.206 . . . . 0.0 112.725 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -133.83 137.47 45.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.069 1.747 . . . . 0.0 106.903 161.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.9 p -72.99 -0.67 14.43 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -124.43 149.88 46.28 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.331 1.453 . . . . 0.0 110.849 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.6 pt -140.15 161.22 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.61 1.964 . . . . 0.0 109.654 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -131.35 156.97 44.6 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.5 t -127.2 143.76 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 125.349 1.46 . . . . 0.0 111.575 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -127.34 166.95 16.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.364 1.865 . . . . 0.0 109.569 173.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 34.6 t30 66.24 32.45 7.9 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.8 1.24 . . . . 0.0 113.109 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -71.33 157.23 38.46 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.318 -0.864 . . . . 0.0 111.49 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -71.46 166.52 21.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.255 1.422 . . . . 0.0 114.804 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -76.36 -42.1 45.87 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.204 -0.935 . . . . 0.0 113.034 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -70.98 -35.79 72.26 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.38 156.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -130.24 158.32 40.08 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.994 1.718 . . . . 0.0 110.55 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -56.15 -29.82 61.3 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.155 -1.59 . . . . 0.0 113.454 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -57.18 -37.71 72.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.066 1.747 . . . . 0.0 114.26 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -68.13 -33.98 75.5 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.65 -21.41 66.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.136 0.974 . . . . 0.0 112.547 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -24.12 62.27 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.841 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -59.39 -29.46 67.73 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.708 0.803 . . . . 0.0 110.96 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.41 -55.0 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 120.866 -1.147 . . . . 0.0 111.207 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -59.53 -29.64 68.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.73 -4.71 89.47 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.409 1.004 . . . . 0.0 114.43 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -65.36 -36.22 83.34 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 119.974 1.887 . . . . 0.0 111.527 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -79.26 6.29 10.24 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.623 1.969 . . . . 0.0 113.08 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 16.1 t -131.57 135.06 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.469 1.908 . . . . 0.0 110.862 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -91.13 113.32 25.55 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -63.77 -18.51 64.15 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 69.5 m -90.88 -0.58 57.77 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.3 t -118.5 107.22 13.52 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.29 1.036 . . . . 0.0 110.629 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -61.24 -43.16 99.33 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.186 -0.946 . . . . 0.0 111.998 -176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.91 -14.11 5.65 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 117.189 2.292 . . . . 0.0 117.189 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -88.27 -62.21 1.54 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.016 0.926 . . . . 0.0 110.095 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -69.92 -24.74 63.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.754 1.222 . . . . 0.0 114.227 -173.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 16.4 tt -54.19 -36.71 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.694 1.197 . . . . 0.0 112.28 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.2 mtm -84.71 -12.83 53.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.267 1.027 . . . . 0.0 112.483 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -94.36 134.13 37.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.859 1.664 . . . . 0.0 114.777 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -167.86 141.26 3.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.872 1.669 . . . . 0.0 107.303 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.8 mt -116.24 138.1 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.958 1.703 . . . . 0.0 110.149 174.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -132.13 133.98 44.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.023 1.329 . . . . 0.0 110.163 166.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 1.4 tt -112.2 124.8 53.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.098 1.359 . . . . 0.0 110.943 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 35.2 mtm -72.27 135.02 45.88 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.648 1.579 . . . . 0.0 111.172 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -134.51 -26.06 1.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.657 1.583 . . . . 0.0 115.136 -163.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -101.15 139.39 36.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.596 1.558 . . . . 0.0 111.512 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 72.5 -158.32 53.16 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.38 1.312 . . . . 0.0 116.38 163.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -13.97 62.32 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -169.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 75.9 mtm -110.63 12.42 22.68 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -61.17 148.82 39.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.844 -1.16 . . . . 0.0 111.949 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.77 24.61 76.45 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.737 0.684 . . . . 0.0 112.156 -175.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -104.23 160.04 15.21 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.758 1.223 . . . . 0.0 109.697 158.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -152.51 157.11 40.64 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.829 -1.17 . . . . 0.0 112.77 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -116.86 143.39 45.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.98 127.05 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.617 1.567 . . . . 0.0 109.071 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -97.18 145.6 17.92 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 162.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 27.1 mt -126.29 156.66 72.14 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.592 1.557 . . . . 0.0 110.412 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -73.06 -7.7 21.03 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.747 2.298 . . . . 0.0 114.579 -171.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -151.22 143.43 24.07 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.469 1.108 . . . . 0.0 111.397 -172.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.19 -41.93 69.15 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.559 -0.713 . . . . 0.0 111.394 166.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -67.16 -28.01 67.76 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.493 1.117 . . . . 0.0 113.381 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -71.24 -43.35 67.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.664 0.386 . . . . 0.0 110.777 174.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.81 -44.06 74.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.36 0.527 . . . . 0.0 112.056 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.79 -37.73 71.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.38 0.672 . . . . 0.0 111.923 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -73.15 -48.4 35.75 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.783 0.833 . . . . 0.0 112.744 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.96 -29.57 70.33 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.559 HD23 HG12 ' A' ' 498' ' ' VAL . 47.2 mt -71.15 -34.13 70.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.106 -0.996 . . . . 0.0 112.461 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -63.92 -39.45 94.18 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.312 0.505 . . . . 0.0 111.429 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.06 -47.49 8.87 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -171.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -79.02 -20.89 47.86 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -69.1 109.48 4.04 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.277 -0.89 . . . . 0.0 110.699 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 108.96 -3.31 31.74 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 117.684 -1.62 . . . . 0.0 116.435 -174.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -65.89 131.23 45.77 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.779 1.789 . . . . 0.0 112.356 -172.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.299 1.2 t -93.31 44.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 -161.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 16.8 tp -50.01 122.26 6.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.016 1.726 . . . . 0.0 111.489 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.309 76.1 m-85 49.57 30.34 3.48 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 117.361 2.356 . . . . 0.0 117.361 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 77.37 24.36 65.9 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.125 -0.984 . . . . 0.0 114.171 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -132.43 116.62 15.24 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 119.028 1.414 . . . . 0.0 110.33 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.96 114.88 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.313 2.009 . . . . 0.0 112.003 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 61.9 mtp -71.25 127.81 33.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.723 1.609 . . . . 0.0 112.347 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 30.8 t -93.52 94.16 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.992 2.117 . . . . 0.0 109.63 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.559 HG12 HD23 ' A' ' 483' ' ' LEU . 3.7 t -100.4 120.49 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 127.142 2.177 . . . . 0.0 113.08 -171.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -137.95 158.95 43.29 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.399 1.479 . . . . 0.0 113.644 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -57.71 142.19 46.06 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 167.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -62.63 163.82 8.51 Favored 'General case' 0 CA--C 1.556 1.178 0 CA-C-N 118.507 0.594 . . . . 0.0 112.462 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -103.42 13.14 34.28 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 -148.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 4.3 t -116.33 37.66 3.65 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.878 1.671 . . . . 0.0 111.902 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -163.95 99.67 0.87 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.113 1.765 . . . . 0.0 111.524 173.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 18.9 tpt85 -145.37 68.56 13.59 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 125.66 1.584 . . . . 0.0 111.384 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.99 158.19 53.0 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.768 2.979 . . . . 0.0 112.939 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -112.05 137.06 50.6 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.9 1.28 . . . . 0.0 111.402 -171.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -161.53 150.73 16.21 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.711 1.604 . . . . 0.0 110.889 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -79.83 147.08 65.69 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -80.44 172.66 13.29 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.318 3.345 . . . . 0.0 112.479 164.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 146.94 28.25 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.373 1.069 . . . . 0.0 113.433 175.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -72.66 132.13 43.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.124 0.969 . . . . 0.0 112.992 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -88.96 -31.28 12.41 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.572 1.082 . . . . 0.0 112.672 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -55.6 144.22 27.3 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.937 1.695 . . . . 0.0 111.627 169.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -61.86 147.21 47.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.212 1.405 . . . . 0.0 112.116 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 14.3 tttt . . . . . 0 C--O 1.251 1.163 0 CA-C-O 116.204 -1.855 . . . . 0.0 114.463 177.326 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.728 0.299 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -61.84 -36.37 80.98 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.985 0.914 . . . . 0.0 113.135 164.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -84.34 15.35 3.67 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.443 1.497 . . . . 0.0 113.558 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -58.23 148.06 64.21 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.907 0.883 . . . . 0.0 111.852 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.49 122.98 7.81 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.781 2.321 . . . . 0.0 112.246 -173.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 55.8 m -89.4 92.5 9.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.962 1.305 . . . . 0.0 109.573 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -152.37 127.73 9.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.274 1.03 . . . . 0.0 111.719 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.4 p -161.54 159.82 28.28 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.7 1.2 . . . . 0.0 113.403 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.8 tt -75.67 166.15 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.203 1.401 . . . . 0.0 112.441 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 19.9 m -115.39 161.49 18.46 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.199 1.4 . . . . 0.0 111.711 169.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -63.99 -39.36 93.95 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.616 -0.678 . . . . 0.0 112.132 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -58.8 -34.72 71.81 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -79.56 -38.77 33.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.759 1.624 . . . . 0.0 113.864 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.14 -41.62 97.11 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.768 1.227 . . . . 0.0 113.137 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -58.47 -23.32 57.47 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.637 1.575 . . . . 0.0 114.486 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.52 -18.43 64.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.611 1.164 . . . . 0.0 112.1 173.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -123.96 82.05 0.35 Allowed Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.986 2.232 . . . . 0.0 111.482 167.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -157.28 139.61 14.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.936 1.694 . . . . 0.0 109.346 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.8 pt -122.58 150.6 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 123.391 1.567 . . . . 0.0 115.002 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.6 m -78.58 160.86 27.38 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.796 2.039 . . . . 0.0 112.045 167.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -55.3 -30.05 59.41 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.371 -0.831 . . . . 0.0 112.092 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -65.1 -22.73 66.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.619 1.168 . . . . 0.0 113.826 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -93.06 -33.46 14.08 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.236 1.014 . . . . 0.0 111.24 168.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 37.8 ttm -59.59 -42.25 92.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 122.454 1.121 . . . . 0.0 111.574 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -85.96 33.79 0.6 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.587 1.555 . . . . 0.0 110.827 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.98 -41.24 0.35 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 128.099 2.56 . . . . 0.0 114.852 173.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.6 mp -66.88 136.83 55.98 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.354 1.062 . . . . 0.0 110.02 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 21.0 m -65.24 -34.33 78.1 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 169.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 17.5 m -59.0 -29.94 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 119.906 1.23 . . . . 0.0 112.704 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -101.68 11.16 39.31 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -19.17 49.48 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 47.3 t -142.57 -28.81 0.58 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.301 1.04 . . . . 0.0 113.015 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -71.72 146.52 48.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.2 1.4 . . . . 0.0 114.768 169.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 415' ' ' PRO . 0.8 OUTLIER -159.65 130.5 3.74 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 121.298 -0.876 . . . . 0.0 113.031 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 415' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 414' ' ' GLU . 6.8 Cg_exo -69.89 165.06 32.37 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 125.278 3.986 . . . . 0.0 114.66 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 143.86 -27.87 2.03 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.184 1.233 . . . . 0.0 116.184 152.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -72.42 139.67 81.54 Favored Pre-proline 0 CA--C 1.552 1.053 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -165.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.06 105.41 1.79 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.591 2.861 . . . . 0.0 112.988 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -134.17 150.52 51.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.689 1.995 . . . . 0.0 108.215 163.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 29.8 p -72.27 -2.18 18.05 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 38.7 mtm-85 -134.15 148.83 51.01 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.891 2.076 . . . . 0.0 110.082 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 4.4 pt -131.22 159.4 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.139 2.176 . . . . 0.0 110.456 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -128.86 158.48 38.62 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.32 139.58 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.512 1.525 . . . . 0.0 111.515 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -121.71 167.52 12.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.166 1.387 . . . . 0.0 110.116 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 31.4 t30 68.08 31.7 5.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.052 1.341 . . . . 0.0 112.859 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -66.64 145.95 55.02 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.41 -0.806 . . . . 0.0 110.617 173.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.24 163.61 12.51 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.49 1.516 . . . . 0.0 114.413 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -64.64 -47.98 76.5 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -71.42 -29.5 64.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.4 p -65.28 145.53 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -166.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -119.48 163.95 16.5 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.312 1.845 . . . . 0.0 111.906 170.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.36 -26.27 64.94 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.749 -1.219 . . . . 0.0 113.459 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -60.36 -37.03 79.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.656 1.182 . . . . 0.0 114.038 171.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -72.36 -26.93 62.1 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.87 1.268 . . . . 0.0 114.308 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -73.41 -21.47 60.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.229 1.812 . . . . 0.0 112.744 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -27.57 58.79 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.436 1.016 . . . . 0.0 112.585 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -60.99 -30.95 70.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.439 1.096 . . . . 0.0 111.56 -173.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.2 mp -104.48 -54.78 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.018 -1.051 . . . . 0.0 111.218 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -58.03 -27.68 63.78 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.24 -11.73 84.71 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 118.83 -0.983 . . . . 0.0 114.598 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -62.58 -30.99 71.73 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 120.792 2.296 . . . . 0.0 112.1 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -79.29 2.06 22.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.114 1.766 . . . . 0.0 112.858 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.58 136.22 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.35 1.86 . . . . 0.0 110.818 -172.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -79.73 119.64 22.92 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.898 -1.126 . . . . 0.0 108.056 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.329 49.5 m-85 -67.91 -16.91 64.29 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 167.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.0 t -94.03 -38.04 11.34 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.252 0.933 . . . . 0.0 113.469 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.1 m -83.27 118.62 23.77 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.394 -0.816 . . . . 0.0 111.588 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -57.89 -45.07 86.97 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.482 -0.761 . . . . 0.0 112.328 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.36 -16.02 1.98 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -89.75 -62.5 1.46 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.151 0.98 . . . . 0.0 110.562 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -68.39 -21.47 64.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.931 1.292 . . . . 0.0 113.295 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.74 -33.86 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.753 1.621 . . . . 0.0 112.261 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -93.85 3.13 55.86 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.938 1.295 . . . . 0.0 112.886 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -110.44 136.01 50.25 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.869 2.068 . . . . 0.0 115.81 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -166.53 152.31 8.4 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.411 1.885 . . . . 0.0 106.596 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.9 mt -126.11 137.32 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.238 1.015 . . . . 0.0 110.226 171.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 52.7 ttm-85 -125.3 133.8 52.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.115 0.966 . . . . 0.0 110.446 163.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.5 tp -118.15 124.1 47.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.582 1.553 . . . . 0.0 108.846 168.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 39.7 mtm -74.68 116.97 15.98 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.161 0.585 . . . . 0.0 110.083 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -103.0 5.28 38.15 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.014 1.726 . . . . 0.0 112.56 174.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -126.96 149.12 50.0 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.654 1.582 . . . . 0.0 112.952 -174.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.06 -156.51 52.01 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.241 1.4 . . . . 0.0 115.604 164.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -51.91 -34.47 41.64 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.305 1.442 . . . . 0.0 114.094 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 72.3 mtp -97.3 12.27 33.6 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -51.21 123.75 10.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.214 1.006 . . . . 0.0 111.448 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.03 31.47 31.82 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.586 1.565 . . . . 0.0 113.979 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -125.18 145.2 50.07 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.355 1.062 . . . . 0.0 112.224 169.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -135.15 156.05 49.66 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.938 1.295 . . . . 0.0 114.147 -169.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.8 132.8 52.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.585 1.954 . . . . 0.0 115.451 171.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.6 mp -132.34 122.07 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.891 1.676 . . . . 0.0 110.042 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.92 145.48 18.25 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 33.6 mt -126.3 158.96 65.09 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.012 1.325 . . . . 0.0 110.42 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -75.34 -9.08 20.17 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.418 2.745 . . . . 0.0 114.556 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -150.82 143.01 24.15 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.588 0.755 . . . . 0.0 111.388 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -59.01 -37.25 76.47 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.004 0.922 . . . . 0.0 111.803 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 18.6 mtmm -62.89 -35.88 81.48 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.85 92.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.411 0.55 . . . . 0.0 110.915 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -69.44 -44.44 71.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.247 0.93 . . . . 0.0 112.746 172.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.33 69.12 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.806 0.73 . . . . 0.0 112.122 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -75.48 -48.44 22.6 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.874 1.67 . . . . 0.0 113.069 170.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.78 70.33 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.845 0.748 . . . . 0.0 112.765 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.46 HD23 HG12 ' A' ' 498' ' ' VAL . 50.1 mt -68.67 -37.5 79.66 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.94 0.896 . . . . 0.0 112.178 174.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -65.3 -41.32 94.2 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.637 0.775 . . . . 0.0 111.463 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.9 -48.57 11.36 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -174.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.14 -16.74 59.03 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -63.75 107.4 1.18 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.025 0.93 . . . . 0.0 112.114 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 106.94 3.54 36.39 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.578 -1.123 . . . . 0.0 115.254 -174.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -71.57 112.99 8.13 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.184 1.492 . . . . 0.0 108.892 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.97 79.43 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.923 1.689 . . . . 0.0 108.029 -169.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 51.6 tp -79.05 132.83 36.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.058 1.743 . . . . 0.0 110.464 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.258 65.7 m-85 55.74 19.43 3.41 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -174.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 81.84 18.56 67.51 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.187 -1.341 . . . . 0.0 115.464 -171.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -128.42 120.64 21.03 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 119.833 1.816 . . . . 0.0 112.508 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.5 121.85 8.36 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 123.547 2.831 . . . . 0.0 112.305 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 38.6 mtp -79.14 132.0 36.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.828 1.251 . . . . 0.0 111.829 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.8 t -94.23 101.18 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.112 1.365 . . . . 0.0 109.816 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.46 HG12 HD23 ' A' ' 483' ' ' LEU . 2.4 t -97.15 127.3 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 126.716 2.006 . . . . 0.0 112.908 -173.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -146.3 161.35 40.5 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -64.26 143.56 57.8 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 121.038 -1.039 . . . . 0.0 108.962 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -55.39 142.23 33.25 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.084 0.953 . . . . 0.0 112.696 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -63.43 108.62 1.38 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.705 0.802 . . . . 0.0 111.603 -165.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 8.4 t -167.61 161.29 13.53 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.82 1.248 . . . . 0.0 111.143 -163.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -63.35 136.92 57.97 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.955 -1.091 . . . . 0.0 113.385 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -127.92 93.14 40.33 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 125.255 1.422 . . . . 0.0 110.139 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.33 164.67 28.64 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 124.213 3.275 . . . . 0.0 113.122 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -89.19 10.36 22.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.255 1.822 . . . . 0.0 114.747 175.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -59.62 149.36 30.55 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -59.7 148.61 74.8 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.99 145.67 22.42 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 122.757 2.304 . . . . 0.0 111.726 167.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.72 158.46 27.46 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.681 0.753 . . . . 0.0 112.85 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -87.41 151.17 23.29 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.492 1.117 . . . . 0.0 113.881 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 88.01 165.71 41.59 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.545 1.545 . . . . 0.0 115.781 170.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -158.25 153.29 25.36 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.388 1.875 . . . . 0.0 111.301 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 8.5 ptm85 -137.82 -14.78 1.39 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.251 1.162 0 C-N-CA 124.215 1.006 . . . . 0.0 112.93 -173.745 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 53.0 p . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 120.719 0.295 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -71.82 -3.44 22.21 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 168.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -126.03 14.93 7.92 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.367 1.867 . . . . 0.0 113.776 -165.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 75.9 mtp -65.93 131.71 94.61 Favored Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 121.176 -0.952 . . . . 0.0 111.561 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.3 142.58 41.61 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.105 2.536 . . . . 0.0 111.587 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 33.6 t -84.88 83.35 8.08 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 166.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -144.1 100.63 3.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.661 1.985 . . . . 0.0 108.55 -172.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 28.2 p -158.03 160.21 37.19 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -164.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.7 tt -76.6 161.05 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.268 1.427 . . . . 0.0 112.44 -170.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 18.5 m -114.33 162.33 16.76 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.821 1.649 . . . . 0.0 113.11 168.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -55.25 -43.26 74.45 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.809 0.844 . . . . 0.0 112.469 -172.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -61.76 -33.54 74.26 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -82.83 -37.21 24.73 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.779 0.832 . . . . 0.0 112.715 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.22 -42.16 96.71 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.404 1.082 . . . . 0.0 113.659 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.89 -24.0 48.79 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.635 1.574 . . . . 0.0 114.247 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -70.81 -13.0 61.88 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.979 1.712 . . . . 0.0 112.825 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -123.34 77.66 0.36 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 126.303 1.906 . . . . 0.0 112.63 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -161.39 142.69 11.44 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.386 1.075 . . . . 0.0 111.529 -174.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 20.7 pt -127.91 161.28 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.556 1.542 . . . . 0.0 112.2 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.9 m -110.7 179.36 4.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.144 1.378 . . . . 0.0 111.975 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 32.3 mtm105 -54.25 -27.3 33.92 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.267 -0.895 . . . . 0.0 113.292 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -58.67 -32.56 69.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.537 1.535 . . . . 0.0 112.672 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -98.93 -40.06 8.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.892 0.877 . . . . 0.0 111.209 168.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.88 -40.63 98.1 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.704 -1.248 . . . . 0.0 112.244 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -80.46 11.03 3.94 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 121.319 -0.863 . . . . 0.0 112.672 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.89 -27.08 5.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.584 2.353 . . . . 0.0 113.454 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 43.9 mt -77.51 135.87 38.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.305 1.442 . . . . 0.0 112.654 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 55.3 p -60.14 -34.26 73.28 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.048 0.939 . . . . 0.0 112.325 167.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.406 HG23 ' CD2' ' A' ' 410' ' ' PHE 0.255 1.8 m -67.32 -15.28 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 173.673 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.406 ' CD2' HG23 ' A' ' 409' ' ' VAL 0.356 83.2 m-85 -112.52 9.16 19.5 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 118.852 2.908 . . . . 0.0 118.852 178.063 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -57.78 0.11 0.06 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 118.51 2.781 . . . . 0.0 118.51 -172.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.4 m -157.25 8.98 0.18 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -132.59 132.13 42.2 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.36 -0.838 . . . . 0.0 109.353 -155.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -138.5 131.04 16.02 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -164.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -90.09 176.09 2.78 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 125.168 3.912 . . . . 0.0 115.006 175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.77 -10.02 72.81 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.657 1.599 . . . . 0.0 116.572 161.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.34 142.39 74.88 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 118.749 1.275 . . . . 0.0 113.45 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -85.71 60.86 5.19 Favored 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 124.86 3.707 . . . . 0.0 114.757 -166.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -96.5 151.29 19.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.08 0.952 . . . . 0.0 110.722 164.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.1 p -77.51 -4.05 43.62 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -130.64 149.31 52.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.454 1.502 . . . . 0.0 111.883 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 12.9 pt -134.92 161.73 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.755 2.022 . . . . 0.0 110.141 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -131.52 159.93 36.72 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.417 HG22 HG13 ' A' ' 498' ' ' VAL . 2.6 t -130.81 138.21 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.565 1.546 . . . . 0.0 112.425 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -122.25 168.94 11.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.37 1.468 . . . . 0.0 110.545 170.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 33.0 t30 68.05 40.37 2.25 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.914 1.685 . . . . 0.0 112.533 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.85 153.16 40.01 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.45 -0.782 . . . . 0.0 110.92 171.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.45 ' O ' HG12 ' A' ' 431' ' ' VAL . . . -67.7 154.36 41.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.928 1.291 . . . . 0.0 113.296 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -64.82 -36.31 83.93 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -77.3 -17.24 58.5 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 120.581 1.537 . . . . 0.0 115.097 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 428' ' ' ALA . 2.4 p -75.08 151.39 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -165.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -126.02 160.86 28.95 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.869 1.668 . . . . 0.0 111.216 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -53.98 -34.09 58.8 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.408 -1.433 . . . . 0.0 113.46 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -63.8 -20.38 65.74 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -77.51 -43.31 32.52 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.949 0.899 . . . . 0.0 111.72 166.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.1 mp -61.65 -31.29 71.39 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.389 1.075 . . . . 0.0 111.836 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' LYS . . . . . 0.521 ' HD2' HD12 ' A' ' 457' ' ' ILE . 1.5 mptm? -47.58 -36.89 11.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.267 1.427 . . . . 0.0 113.06 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -62.25 -35.02 77.67 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.027 0.931 . . . . 0.0 112.383 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 4.2 mt -96.26 -58.46 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 121.254 -0.904 . . . . 0.0 110.679 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -57.16 -29.93 64.05 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.16 -14.51 82.52 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 118.43 -1.206 . . . . 0.0 114.619 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -25.1 67.17 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.976 2.388 . . . . 0.0 112.022 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -81.21 5.38 17.17 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.238 1.815 . . . . 0.0 113.19 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 12.7 t -130.52 122.29 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.256 1.823 . . . . 0.0 110.668 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -76.32 103.66 6.44 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -58.44 -16.24 14.18 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 t -82.89 -15.95 49.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.151 0.98 . . . . 0.0 113.021 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 36.1 t -111.24 120.04 40.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.558 1.143 . . . . 0.0 111.617 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -58.02 -48.76 79.09 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.587 -0.696 . . . . 0.0 112.032 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.63 -14.87 2.4 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -92.82 -63.91 1.16 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.851 1.261 . . . . 0.0 110.075 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -25.49 67.92 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.561 1.544 . . . . 0.0 113.361 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.8 tt -57.89 -37.96 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.24 1.416 . . . . 0.0 111.995 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.4 mmm -89.2 0.29 56.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.991 1.716 . . . . 0.0 113.259 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -109.57 132.39 54.19 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -164.43 144.67 7.81 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.527 1.531 . . . . 0.0 111.074 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.521 HD12 ' HD2' ' A' ' 437' ' ' LYS . 5.1 mt -123.81 140.01 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 119.419 1.009 . . . . 0.0 111.373 169.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -121.03 134.54 55.29 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.596 1.558 . . . . 0.0 107.945 154.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 32.1 tp -107.65 91.13 3.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.719 1.247 . . . . 0.0 108.097 166.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -59.43 123.7 17.64 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.66 1.584 . . . . 0.0 110.782 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . 0.304 51.5 mtmt -129.71 35.47 4.18 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -174.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -133.07 148.18 52.19 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.092 0.957 . . . . 0.0 113.565 174.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 69.62 -177.41 30.3 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.58 1.562 . . . . 0.0 114.266 -173.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -15.92 49.26 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.811 -1.406 . . . . 0.0 113.597 177.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 73.4 mtm -87.07 11.2 14.36 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.785 1.634 . . . . 0.0 113.698 171.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -64.83 152.31 43.18 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 119.555 -1.966 . . . . 0.0 111.819 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.35 26.13 52.59 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.152 0.882 . . . . 0.0 112.726 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -121.48 147.37 45.85 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.301 1.041 . . . . 0.0 110.265 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -133.39 148.98 51.84 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -172.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -107.13 139.56 41.37 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 162.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.4 mp -136.88 124.11 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.721 1.208 . . . . 0.0 109.865 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -92.68 146.63 18.24 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 162.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 24.2 mt -126.16 159.61 61.45 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.211 1.404 . . . . 0.0 111.347 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.55 -7.89 19.01 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.991 2.46 . . . . 0.0 115.317 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -150.55 147.59 27.65 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.643 1.177 . . . . 0.0 110.322 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -56.98 -38.98 73.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.564 1.146 . . . . 0.0 111.626 170.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.48 -42.04 95.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.113 0.965 . . . . 0.0 112.878 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.39 -40.39 96.32 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.19 -0.433 . . . . 0.0 111.592 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.98 -44.6 72.57 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.172 0.896 . . . . 0.0 112.832 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.22 83.84 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.869 0.758 . . . . 0.0 111.141 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -64.45 -48.95 73.37 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.154 1.382 . . . . 0.0 112.23 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.11 -32.34 70.9 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.653 HD23 HG12 ' A' ' 498' ' ' VAL . 58.1 mt -68.7 -45.6 71.19 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.105 -0.997 . . . . 0.0 111.341 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -63.22 -33.78 76.23 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.556 0.617 . . . . 0.0 111.837 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.3 -48.0 11.71 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.73 -18.24 45.01 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.21 105.59 1.13 Allowed 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.843 -1.16 . . . . 0.0 110.194 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 111.44 6.05 25.73 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 117.541 -1.7 . . . . 0.0 116.061 -172.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -73.34 126.85 31.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.07 1.935 . . . . 0.0 110.749 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 1.7 t -101.19 48.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 127.002 2.121 . . . . 0.0 114.298 -163.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.8 tp -48.84 123.68 7.36 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.186 1.395 . . . . 0.0 110.308 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.352 62.4 t80 63.92 -2.7 0.52 Allowed 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 107.24 -5.31 35.81 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 125.773 1.654 . . . . 0.0 114.134 -166.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -104.41 119.4 54.0 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 127.686 2.394 . . . . 0.0 111.14 -174.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -79.77 114.88 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.235 2.623 . . . . 0.0 113.137 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 66.5 mtp -73.21 131.32 41.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.112 1.365 . . . . 0.0 112.572 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 56.5 t -91.08 91.0 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.004 1.722 . . . . 0.0 109.38 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.653 HG12 HD23 ' A' ' 483' ' ' LEU . 2.4 t -91.3 125.81 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.93 1.692 . . . . 0.0 111.9 -177.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -142.12 155.94 45.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.671 1.188 . . . . 0.0 113.816 -169.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -63.28 147.35 51.3 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.299 -0.876 . . . . 0.0 112.423 166.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -58.52 157.96 8.28 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -175.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -87.92 -33.68 18.4 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.289 1.436 . . . . 0.0 114.496 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 4.7 t -92.46 19.55 7.12 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.595 1.558 . . . . 0.0 112.576 173.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -61.32 140.82 57.92 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.542 1.137 . . . . 0.0 111.867 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 48.1 ttm-85 -149.14 61.3 5.27 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 124.548 1.139 . . . . 0.0 110.276 167.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.7 151.57 74.66 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.234 2.623 . . . . 0.0 112.954 -171.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -145.82 138.15 25.51 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.69 1.596 . . . . 0.0 110.42 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -82.84 154.54 24.61 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.264 0.626 . . . . 0.0 111.515 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -54.76 146.7 35.04 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 160.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -68.34 167.93 20.9 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.744 2.296 . . . . 0.0 112.138 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.71 178.72 4.59 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.119 0.962 . . . . 0.0 112.966 173.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -123.47 157.68 32.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.392 1.877 . . . . 0.0 110.391 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -70.88 144.5 38.28 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 121.288 -0.883 . . . . 0.0 113.462 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -63.35 141.64 58.69 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.944 1.298 . . . . 0.0 112.317 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -146.09 -19.06 0.45 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -174.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 85.2 tttt . . . . . 0 C--O 1.255 1.362 0 C-N-CA 128.136 2.574 . . . . 0.0 109.502 -174.259 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 88.8 p . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 120.908 0.385 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 23.0 p30 -151.02 -57.91 0.16 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -173.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -150.32 -39.11 0.14 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 128.256 2.622 . . . . 0.0 111.797 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . 0.251 3.4 ptm 67.45 142.41 0.08 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 130.778 3.631 . . . . 0.0 115.114 -175.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.96 144.82 93.64 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.421 2.747 . . . . 0.0 111.925 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 71.2 m -152.15 139.57 19.53 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -148.35 89.06 1.68 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.76 1.624 . . . . 0.0 107.838 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 7.8 p -152.52 155.29 37.16 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.669 1.588 . . . . 0.0 113.333 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.3 tt -75.85 153.16 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.923 0.889 . . . . 0.0 111.994 -163.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 60.4 m -89.05 153.25 21.15 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.405 0.682 . . . . 0.0 110.349 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -61.71 -35.05 76.92 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 118.175 -0.917 . . . . 0.0 112.629 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -41.5 79.63 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 170.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -74.13 -34.31 63.85 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.976 1.311 . . . . 0.0 112.714 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.5 tt -66.76 -50.97 60.99 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.164 1.386 . . . . 0.0 111.661 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -57.62 -26.57 61.74 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.854 1.662 . . . . 0.0 114.792 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -46.61 80.43 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.273 1.029 . . . . 0.0 109.908 171.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -92.63 59.59 2.52 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 127.636 2.541 . . . . 0.0 112.511 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -150.14 157.06 42.72 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.876 1.27 . . . . 0.0 109.837 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.7 pt -136.98 162.57 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.95 1.7 . . . . 0.0 110.791 176.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.7 m -110.09 170.41 8.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.481 1.912 . . . . 0.0 111.154 172.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -43.67 -45.77 7.09 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -170.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.45 -26.0 68.53 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.01 -30.78 20.97 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.306 -0.871 . . . . 0.0 111.55 169.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 13.9 ttm -66.18 -27.53 68.07 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.424 -1.422 . . . . 0.0 113.248 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -85.58 0.88 51.27 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.2 -35.27 6.88 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.25 2.22 . . . . 0.0 116.857 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 3.5 mp -72.83 133.96 44.68 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.261 1.025 . . . . 0.0 111.908 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 78.3 p -62.41 -18.61 62.05 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 173.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.2 m -88.17 -10.84 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -122.83 -10.49 8.25 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -34.73 56.58 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.754 -1.216 . . . . 0.0 113.875 173.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 23.7 p -113.42 -3.58 13.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.286 2.235 . . . . 0.0 114.641 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -134.87 114.44 12.57 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.02 1.728 . . . . 0.0 113.681 -167.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -130.52 120.12 18.68 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -159.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.13 164.76 30.8 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 124.313 3.342 . . . . 0.0 113.114 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 116.28 -1.53 20.72 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 117.075 1.59 . . . . 0.0 117.075 163.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -78.2 145.56 69.13 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.948 1.374 . . . . 0.0 113.992 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.94 103.92 1.78 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.092 3.195 . . . . 0.0 112.015 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -143.13 147.28 34.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.752 1.221 . . . . 0.0 108.515 166.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 19.7 p -81.02 5.76 15.5 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.889 -1.132 . . . . 0.0 113.389 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -137.26 148.71 46.62 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.482 1.913 . . . . 0.0 110.604 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.0 164.65 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 126.678 1.991 . . . . 0.0 109.524 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -136.98 164.44 28.35 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.3 p -143.66 142.33 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.06 1.344 . . . . 0.0 111.543 -176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -118.77 171.03 8.49 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.745 2.018 . . . . 0.0 110.519 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 72.51 25.62 2.67 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.01 157.13 37.4 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.831 -1.168 . . . . 0.0 111.115 172.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -62.46 158.84 16.82 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.425 1.09 . . . . 0.0 113.548 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -68.28 -33.61 74.66 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.507 -0.746 . . . . 0.0 112.445 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -81.47 -40.56 23.09 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.14 155.78 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.884 1.673 . . . . 0.0 115.034 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -128.68 162.09 28.16 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.001 1.32 . . . . 0.0 112.837 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -33.8 57.69 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.81 -1.181 . . . . 0.0 113.237 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -58.05 -34.29 69.93 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.841 1.256 . . . . 0.0 114.213 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -77.46 -29.97 53.0 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -174.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.59 -20.73 66.43 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.923 1.689 . . . . 0.0 112.955 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.75 -17.23 21.29 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.351 0.978 . . . . 0.0 113.233 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -62.64 -36.72 83.73 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.557 1.143 . . . . 0.0 111.613 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 7.2 mt -105.97 -58.09 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.442 0.697 . . . . 0.0 110.089 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -54.67 -36.95 65.17 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.92 -10.58 85.06 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.939 0.781 . . . . 0.0 114.54 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -62.31 -29.11 70.2 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.584 1.692 . . . . 0.0 111.009 172.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -82.76 1.16 40.24 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.047 1.739 . . . . 0.0 115.533 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 32.1 t -132.12 132.14 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.03 1.732 . . . . 0.0 110.12 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -90.14 106.2 18.33 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.68 -0.637 . . . . 0.0 111.964 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -58.39 -18.17 25.96 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 92.3 p -77.52 -21.65 52.35 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 22.7 t -109.09 118.23 36.22 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.578 0.704 . . . . 0.0 110.974 -165.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -58.83 -51.07 71.56 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.307 0.643 . . . . 0.0 112.268 -170.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.37 -16.19 13.65 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.944 2.201 . . . . 0.0 116.944 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -85.65 -58.83 2.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.538 0.685 . . . . 0.0 109.966 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 15.0 ptt85 -75.62 -23.95 56.43 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.624 1.169 . . . . 0.0 113.662 -171.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.7 tt -54.01 -35.17 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.042 1.337 . . . . 0.0 112.442 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.3 mmm -86.07 -10.64 54.6 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.569 1.148 . . . . 0.0 112.83 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.86 109.04 20.85 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -169.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -154.08 149.49 27.21 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.161 1.384 . . . . 0.0 109.946 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 11.4 mt -128.98 134.64 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.372 1.469 . . . . 0.0 110.882 -173.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -116.6 145.33 43.45 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.764 1.226 . . . . 0.0 109.836 158.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.3 tp -125.21 120.22 30.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.943 2.097 . . . . 0.0 109.313 168.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 47.1 mtm -73.19 135.3 44.59 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 125.029 1.332 . . . . 0.0 110.851 166.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -134.12 -4.42 2.74 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -170.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.89 144.64 47.3 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.566 1.546 . . . . 0.0 111.36 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 60.47 -165.17 14.0 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.94 1.257 . . . . 0.0 114.412 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -19.29 48.53 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 96.0 mmm -85.87 1.68 48.89 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -58.98 149.66 26.71 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.651 1.114 . . . . 0.0 112.097 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 76.36 17.74 79.73 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.934 1.254 . . . . 0.0 112.952 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -114.33 134.21 55.12 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 123.803 0.841 . . . . 0.0 113.112 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -135.53 150.89 49.88 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -109.05 141.88 40.56 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.326 1.85 . . . . 0.0 114.013 167.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.4 mp -138.88 127.02 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.358 1.463 . . . . 0.0 109.872 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -91.93 146.87 18.47 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.522 -0.736 . . . . 0.0 112.167 165.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 39.7 mt -127.32 158.24 70.08 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.052 1.341 . . . . 0.0 110.927 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -74.22 -6.31 18.23 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.883 2.389 . . . . 0.0 114.737 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -153.28 146.01 24.31 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.249 -0.907 . . . . 0.0 111.153 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -65.39 -30.16 70.95 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.213 1.005 . . . . 0.0 111.523 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -63.94 -44.71 92.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.746 0.818 . . . . 0.0 113.014 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -60.74 -39.07 87.31 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.11 -0.472 . . . . 0.0 111.374 174.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.35 -47.51 76.18 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.089 0.859 . . . . 0.0 112.595 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.39 80.95 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.782 1.174 . . . . 0.0 112.174 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -67.71 -51.91 43.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.396 1.078 . . . . 0.0 112.164 175.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.48 70.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.953 0.501 . . . . 0.0 112.224 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.535 HD23 HG12 ' A' ' 498' ' ' VAL . 60.9 mt -69.0 -51.08 43.11 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.286 -0.884 . . . . 0.0 111.427 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -68.0 -14.91 63.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.865 0.866 . . . . 0.0 112.412 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -94.74 -50.79 5.0 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.705 1.602 . . . . 0.0 115.114 168.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.19 -19.72 42.71 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -173.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.32 100.82 0.86 Allowed 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.978 -1.076 . . . . 0.0 109.35 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 127.15 -5.97 7.26 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.313 -1.27 . . . . 0.0 114.912 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -72.31 129.63 38.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.257 1.529 . . . . 0.0 112.766 -170.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 3.3 t -96.03 110.25 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.444 1.097 . . . . 0.0 112.164 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 44.6 tp -121.22 141.82 50.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.536 1.934 . . . . 0.0 108.105 169.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.421 28.5 t80 61.77 17.83 9.13 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 73.54 15.59 79.16 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.332 1.444 . . . . 0.0 114.272 -168.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -127.4 133.39 25.03 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.165 1.386 . . . . 0.0 112.328 -170.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.36 120.27 6.85 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.182 2.588 . . . . 0.0 112.266 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 66.2 mtp -75.65 129.91 37.91 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.737 1.615 . . . . 0.0 112.089 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.09 73.5 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -171.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.535 HG12 HD23 ' A' ' 483' ' ' LEU . 1.4 t -76.56 120.51 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.294 1.038 . . . . 0.0 112.765 -175.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -142.3 161.39 38.15 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.433 1.493 . . . . 0.0 112.92 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -61.53 144.3 54.52 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -55.69 149.79 13.69 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -172.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -75.61 -7.24 53.76 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 12.5 m -58.42 163.11 3.26 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.994 2.117 . . . . 0.0 112.377 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -63.76 102.81 0.49 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.762 0.825 . . . . 0.0 112.141 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -151.27 96.85 3.2 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 126.464 1.906 . . . . 0.0 109.572 -174.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.15 136.26 59.42 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.173 2.582 . . . . 0.0 112.896 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -85.5 137.9 32.58 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.197 0.999 . . . . 0.0 111.74 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -163.23 155.05 17.64 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.88 2.072 . . . . 0.0 111.235 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -53.01 154.44 5.2 Favored Pre-proline 0 CA--C 1.559 1.289 0 C-N-CA 127.486 2.314 . . . . 0.0 116.7 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.35 172.65 15.66 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 124.274 3.316 . . . . 0.0 115.603 -166.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 150.69 21.52 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.599 1.559 . . . . 0.0 114.19 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -79.81 177.02 9.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.677 1.591 . . . . 0.0 113.635 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 78.82 -133.01 12.06 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.361 -0.837 . . . . 0.0 114.94 166.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -147.56 160.93 42.08 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.317 2.247 . . . . 0.0 112.546 -171.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 59.72 28.11 17.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.041 2.136 . . . . 0.0 115.592 170.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 24.5 tptp . . . . . 0 C--O 1.251 1.142 0 C-N-CA 126.671 1.988 . . . . 0.0 111.714 179.878 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -59.6 -20.48 56.14 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -70.1 -27.84 64.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.502 1.521 . . . . 0.0 113.867 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 94.6 mtp -81.77 149.91 64.82 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.783 1.233 . . . . 0.0 112.518 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.96 152.91 46.93 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.289 2.659 . . . . 0.0 112.979 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 94.7 p -93.93 131.31 39.49 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.261 1.424 . . . . 0.0 111.163 168.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -153.03 126.49 8.71 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.344 1.458 . . . . 0.0 109.11 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.3 p -146.56 159.04 43.95 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -170.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.5 tt -76.64 148.29 7.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.974 1.71 . . . . 0.0 110.122 -172.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 39.9 t -80.0 151.1 30.19 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.345 0.593 . . . . 0.0 110.197 164.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -47.23 -43.86 22.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.729 161.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -64.94 -30.05 71.02 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -75.27 -46.09 35.87 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.916 0.886 . . . . 0.0 112.865 167.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 27.5 tp -63.74 -38.19 90.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.749 1.62 . . . . 0.0 112.606 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -57.01 -24.26 52.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.084 1.354 . . . . 0.0 114.261 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -68.46 -20.66 64.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.374 1.07 . . . . 0.0 113.073 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.87 68.7 0.32 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.198 1.856 . . . . 0.0 111.814 174.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -159.23 136.56 9.84 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.048 1.339 . . . . 0.0 109.976 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.9 pt -112.6 150.75 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.682 0.793 . . . . 0.0 111.099 174.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 30.8 m -74.78 160.85 30.19 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.707 1.203 . . . . 0.0 111.666 163.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.38 -25.79 60.06 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.133 -0.979 . . . . 0.0 112.751 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.25 -28.79 69.0 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.113 1.365 . . . . 0.0 113.215 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.35 -30.64 23.51 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.692 -1.255 . . . . 0.0 110.72 167.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 27.3 ttp -62.8 -37.53 87.1 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 120.984 -1.072 . . . . 0.0 111.207 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -84.05 34.57 0.51 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.356 1.462 . . . . 0.0 111.889 170.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.78 -31.42 0.43 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.434 2.294 . . . . 0.0 114.142 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 11.3 mt -74.0 131.92 41.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.002 1.321 . . . . 0.0 111.596 174.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 98.2 p -65.96 -27.67 68.33 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.215 1.406 . . . . 0.0 112.383 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.16 -19.99 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.195 -0.94 . . . . 0.0 112.782 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.261 51.7 m-85 -113.91 12.29 18.07 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 119.133 3.012 . . . . 0.0 119.133 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -14.24 62.62 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 46.7 t -136.73 -39.46 0.63 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.172 1.389 . . . . 0.0 113.227 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -73.29 144.67 46.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -132.95 126.9 19.95 Favored Pre-proline 0 N--CA 1.478 0.948 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -163.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -84.79 -176.69 2.56 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.503 3.468 . . . . 0.0 113.132 164.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 83.41 -26.74 4.39 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.787 1.661 . . . . 0.0 116.712 164.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -60.41 140.83 91.81 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 117.828 0.814 . . . . 0.0 112.999 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.26 104.41 1.9 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.25 3.3 . . . . 0.0 112.826 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -150.25 144.52 25.64 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.373 1.069 . . . . 0.0 110.129 161.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 27.9 p -77.55 8.55 4.19 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.719 -1.238 . . . . 0.0 114.118 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -139.08 142.57 38.13 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.525 1.93 . . . . 0.0 109.463 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 10.7 pt -131.67 165.25 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 126.539 1.936 . . . . 0.0 109.125 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -132.08 162.05 31.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 123.285 1.517 . . . . 0.0 107.994 164.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 498' ' ' VAL . 9.7 t -124.18 136.9 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 126.035 1.734 . . . . 0.0 109.952 175.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -115.9 165.84 12.64 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.335 1.454 . . . . 0.0 109.06 169.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 5.6 t30 66.0 35.09 6.59 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.08 0.552 . . . . 0.0 111.731 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -69.62 154.18 42.37 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.286 -0.884 . . . . 0.0 109.938 162.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -56.12 154.7 7.4 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.047 0.939 . . . . 0.0 111.873 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -74.84 -37.75 62.17 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.385 -0.822 . . . . 0.0 111.638 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -70.33 -41.79 72.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.027 1.731 . . . . 0.0 114.124 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.8 p -55.39 148.05 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -112.16 161.65 16.32 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.643 1.177 . . . . 0.0 113.057 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -56.51 -29.62 62.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.475 1.11 . . . . 0.0 113.277 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -64.48 -36.18 83.35 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 174.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.27 -30.79 68.98 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.319 1.448 . . . . 0.0 113.762 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.83 -19.93 62.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.996 1.718 . . . . 0.0 112.633 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.4 -26.49 63.3 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.383 0.992 . . . . 0.0 112.579 176.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -57.98 -37.55 74.42 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.429 0.558 . . . . 0.0 110.917 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.4 mt -95.16 -59.43 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.184 -0.948 . . . . 0.0 111.711 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -58.62 -29.56 66.59 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.04 -16.05 81.09 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.271 0.939 . . . . 0.0 114.469 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -14.32 62.02 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 119.879 1.84 . . . . 0.0 112.817 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -86.66 -4.77 59.22 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.873 2.069 . . . . 0.0 115.633 172.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.18 125.24 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.908 1.683 . . . . 0.0 110.83 -166.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -78.6 105.12 9.67 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.753 -0.592 . . . . 0.0 110.439 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -60.18 -10.83 4.94 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 70.2 m -93.9 -6.67 45.1 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.294 1.038 . . . . 0.0 113.709 172.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 40.0 t -115.22 115.61 26.98 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.345 1.058 . . . . 0.0 110.536 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -58.92 -48.49 81.28 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.721 0.808 . . . . 0.0 112.385 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.1 t -56.79 -16.63 6.92 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -87.9 -60.7 1.9 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.576 0.75 . . . . 0.0 110.03 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.6 ptt85 -72.17 -22.96 61.22 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.139 0.976 . . . . 0.0 112.971 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 18.7 tt -54.83 -41.68 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.824 1.25 . . . . 0.0 112.093 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.8 mtm -83.43 -6.85 59.59 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.761 0.71 . . . . 0.0 112.33 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -100.79 126.4 47.36 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -164.16 151.5 12.02 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.941 2.096 . . . . 0.0 108.28 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 10.5 mt -125.41 134.7 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.757 1.223 . . . . 0.0 110.538 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -133.72 90.3 2.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.899 0.88 . . . . 0.0 112.842 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.02 125.57 31.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.178 1.791 . . . . 0.0 111.273 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 34.9 mtm -79.31 127.01 31.54 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.835 2.454 . . . . 0.0 111.39 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -118.36 -3.41 10.98 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.725 1.61 . . . . 0.0 115.225 -173.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -130.37 148.57 52.21 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.653 1.181 . . . . 0.0 112.768 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 70.34 -159.21 53.57 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.771 1.177 . . . . 0.0 115.046 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -33.13 73.01 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.588 1.155 . . . . 0.0 113.521 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 73.3 mtm -85.96 12.41 9.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -54.81 106.34 0.21 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.157 0.889 . . . . 0.0 110.53 168.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.47 27.23 7.73 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.362 1.458 . . . . 0.0 115.401 -172.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -113.62 154.64 26.86 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.608 1.204 . . . . 0.0 110.131 163.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.57 139.69 21.12 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.462 -1.399 . . . . 0.0 113.973 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -90.68 144.24 25.94 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 166.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.72 122.58 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.118 1.767 . . . . 0.0 110.136 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.0 145.51 17.63 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 164.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 26.1 mt -126.93 156.3 74.29 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.794 1.238 . . . . 0.0 110.867 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.16 -4.32 15.19 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.578 2.852 . . . . 0.0 114.838 -173.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -153.88 130.87 10.99 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.461 1.104 . . . . 0.0 110.564 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -52.9 -38.49 61.8 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.1 1.36 . . . . 0.0 112.507 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -32.64 74.18 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.33 -37.49 74.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.117 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.54 72.31 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.41 1.004 . . . . 0.0 112.151 171.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.7 71.14 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 118.738 0.699 . . . . 0.0 111.914 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -69.9 -48.51 58.34 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.509 1.124 . . . . 0.0 112.96 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.2 -31.34 71.1 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.7 -0.625 . . . . 0.0 112.359 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.68 HD23 HG12 ' A' ' 498' ' ' VAL . 76.8 mt -67.31 -36.96 82.57 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.35 -0.844 . . . . 0.0 112.33 173.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -67.21 -33.1 74.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.601 0.76 . . . . 0.0 111.686 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -93.85 -34.05 13.3 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -170.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -91.01 -13.85 32.52 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.091 1.356 . . . . 0.0 113.931 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -65.3 105.94 1.24 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.212 1.005 . . . . 0.0 110.36 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 111.64 0.7 27.58 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.495 -1.17 . . . . 0.0 115.876 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -73.04 129.33 37.85 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 4.9 p -128.38 67.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 124.171 1.938 . . . . 0.0 109.521 -163.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.32 127.67 33.16 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 113.235 -1.802 . . . . 0.0 110.594 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.43 11.2 m-85 58.8 24.44 12.35 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 74.82 3.92 69.51 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.691 1.139 . . . . 0.0 114.422 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -95.37 104.4 15.43 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.025 1.73 . . . . 0.0 108.816 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.75 110.99 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.376 2.051 . . . . 0.0 110.025 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 28.0 mtp -74.13 124.06 25.62 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.748 1.619 . . . . 0.0 111.841 -169.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 97.1 t -90.26 91.92 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.736 1.614 . . . . 0.0 109.492 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.68 HG12 HD23 ' A' ' 483' ' ' LEU . 2.2 t -87.75 123.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 126.12 1.768 . . . . 0.0 112.323 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -153.67 152.19 30.54 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -164.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -61.4 150.14 36.27 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.737 -1.227 . . . . 0.0 111.153 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -59.22 154.13 16.92 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -68.15 25.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 128.835 2.854 . . . . 0.0 118.518 -158.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 3.6 t -62.38 147.55 48.11 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.778 -1.201 . . . . 0.0 111.228 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -59.29 115.96 3.58 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.415 0.686 . . . . 0.0 112.698 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -160.04 106.62 1.41 Allowed Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 126.144 1.778 . . . . 0.0 110.512 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -65.05 -179.69 1.13 Allowed 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 123.731 2.954 . . . . 0.0 112.819 170.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -69.34 62.03 0.14 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.283 -0.886 . . . . 0.0 111.641 157.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -91.71 151.14 20.78 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.753 2.021 . . . . 0.0 109.621 165.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.55 142.23 83.68 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.9 -37.15 95.17 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.917 3.078 . . . . 0.0 114.223 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.17 169.53 21.09 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.921 1.289 . . . . 0.0 110.395 162.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -75.88 -50.5 14.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.365 1.066 . . . . 0.0 113.738 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -95.76 140.3 14.97 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.795 1.188 . . . . 0.0 115.294 -169.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -121.01 146.98 46.12 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.832 1.653 . . . . 0.0 111.796 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.8 -32.18 0.58 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.679 1.192 . . . . 0.0 113.373 174.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 38.3 pttt . . . . . 0 C--O 1.256 1.424 0 C-N-CA 124.544 1.137 . . . . 0.0 112.428 177.936 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -75.73 -16.76 60.1 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -159.47 174.3 14.89 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.2 1.4 . . . . 0.0 112.556 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 55.4 54.87 9.96 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.522 1.929 . . . . 0.0 116.129 175.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.04 156.94 63.68 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.814 3.009 . . . . 0.0 111.348 169.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 64.1 p -148.2 151.16 35.04 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -141.17 140.14 33.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.616 1.567 . . . . 0.0 108.761 164.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 11.1 p -149.15 163.14 38.45 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -171.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.5 tt -74.33 149.63 7.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 125.692 1.597 . . . . 0.0 111.313 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 17.7 m -86.55 152.11 22.91 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -63.36 -29.63 70.9 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.322 -0.861 . . . . 0.0 110.75 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -34.85 75.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.719 1.607 . . . . 0.0 114.64 174.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -78.58 -48.28 15.5 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.397 0.679 . . . . 0.0 111.636 170.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 16.5 tp -57.53 -37.66 73.4 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -57.41 -25.65 59.9 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.124 1.37 . . . . 0.0 113.941 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -73.99 -20.07 60.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.859 1.264 . . . . 0.0 112.506 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -120.36 63.94 0.47 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.532 2.015 . . . . 0.0 112.327 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -151.14 143.59 24.24 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.738 1.615 . . . . 0.0 110.006 -176.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 18.2 pt -125.04 163.08 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 44.6 t -110.54 172.43 6.87 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.691 1.596 . . . . 0.0 110.36 165.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 32.5 mtt-85 -49.96 -30.42 10.38 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.852 1.261 . . . . 0.0 113.899 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.25 -13.79 21.23 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 125.989 1.715 . . . . 0.0 113.187 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -123.1 -37.3 2.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.051 1.74 . . . . 0.0 112.289 167.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 53.7 ttp -61.18 -40.17 92.9 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.707 -1.246 . . . . 0.0 111.551 -176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.24 2.36 28.26 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.461 -0.774 . . . . 0.0 112.177 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.59 -34.28 10.29 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.415 2.286 . . . . 0.0 113.771 169.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 29.8 mt -77.88 129.07 34.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.363 1.865 . . . . 0.0 113.06 -174.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 88.4 p -58.17 -33.31 69.1 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.168 -0.958 . . . . 0.0 113.58 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.448 HG23 ' CD2' ' A' ' 410' ' ' PHE . 3.4 m -64.07 -12.64 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.448 ' CD2' HG23 ' A' ' 409' ' ' VAL . 83.9 m-85 -125.64 14.89 8.14 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -61.28 -23.42 65.67 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.9 t -135.85 -16.15 1.75 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.096 0.958 . . . . 0.0 113.292 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -71.88 144.31 49.07 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -141.45 124.59 9.75 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -169.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.32 -176.49 3.29 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.785 2.99 . . . . 0.0 112.841 171.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.512 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 76.15 -4.83 45.68 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.779 1.872 . . . . 0.0 117.779 165.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -72.38 148.13 90.58 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 118.98 1.39 . . . . 0.0 113.384 174.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.39 110.58 3.13 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.775 2.983 . . . . 0.0 113.872 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -157.01 154.77 30.13 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.254 1.822 . . . . 0.0 109.478 161.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 27.4 p -80.43 -3.52 50.15 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -130.64 150.85 51.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.931 1.692 . . . . 0.0 110.408 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.4 pt -131.06 160.99 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.387 1.875 . . . . 0.0 109.965 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -135.11 162.09 33.48 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 173.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.9 t -136.35 135.36 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 125.673 1.589 . . . . 0.0 112.056 -174.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -117.61 169.03 9.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.44 1.896 . . . . 0.0 108.395 168.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.26 13.1 m-20 68.13 29.73 6.1 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -171.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.66 143.43 40.11 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 119.868 -1.77 . . . . 0.0 110.535 166.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.52 25.82 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 118.418 2.747 . . . . 0.0 118.418 -165.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp 59.58 -65.6 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 128.703 2.801 . . . . 0.0 113.863 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -58.16 -41.38 83.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.325 1.85 . . . . 0.0 113.89 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 9.1 p -51.12 140.76 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.291 1.037 . . . . 0.0 113.526 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -104.12 157.76 16.9 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.061 0.945 . . . . 0.0 113.102 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -61.02 -26.78 67.85 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.797 -1.814 . . . . 0.0 112.77 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -70.7 -22.05 62.5 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -74.41 -33.82 63.1 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.524 1.129 . . . . 0.0 112.97 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.6 mp -73.64 -23.79 59.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.193 1.797 . . . . 0.0 113.733 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' LYS . . . . . 0.424 ' HD3' HD12 ' A' ' 457' ' ' ILE . 26.9 mmtp -56.59 -28.78 61.11 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 118.842 0.747 . . . . 0.0 110.876 -177.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -57.68 -33.22 68.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.758 1.623 . . . . 0.0 111.854 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.7 mt -98.33 -58.24 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.361 -0.837 . . . . 0.0 110.795 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -59.59 -25.91 64.99 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -80.74 -7.61 88.38 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.766 1.174 . . . . 0.0 114.379 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 36.7 ttp85 -61.03 -23.8 65.69 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.946 1.873 . . . . 0.0 112.049 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -95.72 2.16 53.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.026 2.131 . . . . 0.0 112.594 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.8 110.39 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.035 1.734 . . . . 0.0 110.701 -172.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -71.41 90.17 0.95 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.281 53.7 m-85 -58.32 -24.05 58.46 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 119.307 3.077 . . . . 0.0 119.307 -171.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.5 m -64.96 -22.48 67.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 17.4 m -101.08 122.66 43.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.122 1.369 . . . . 0.0 112.816 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -55.65 -48.46 74.97 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.453 -0.78 . . . . 0.0 112.181 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 2.8 t -54.05 -18.01 3.21 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -88.21 -63.64 1.27 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.592 0.757 . . . . 0.0 110.778 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -65.08 -29.57 70.46 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.696 1.198 . . . . 0.0 112.2 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.0 tt -58.02 -32.92 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.246 1.419 . . . . 0.0 112.679 173.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 9.1 mmm -84.93 -10.25 57.27 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.097 0.959 . . . . 0.0 112.499 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -105.85 135.03 48.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.136 1.774 . . . . 0.0 115.092 -172.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -168.0 145.16 4.2 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.984 1.314 . . . . 0.0 108.464 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.424 HD12 ' HD3' ' A' ' 437' ' ' LYS . 6.3 mt -117.13 132.52 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.738 1.215 . . . . 0.0 110.087 174.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -121.23 122.8 40.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.695 1.198 . . . . 0.0 109.976 166.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 3.3 tt -107.58 123.52 48.57 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.145 1.378 . . . . 0.0 110.352 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 45.7 mtm -79.88 130.51 35.36 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.117 1.367 . . . . 0.0 111.973 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -118.04 -7.03 10.9 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.851 1.66 . . . . 0.0 114.472 -168.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -117.25 154.67 30.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.533 1.133 . . . . 0.0 112.061 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 57.89 -142.12 44.28 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 161.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 29.0 tpt85 -57.67 -31.56 66.44 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.01 2.124 . . . . 0.0 115.11 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 20.8 mtm -111.44 18.79 18.83 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.065 1.346 . . . . 0.0 113.791 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -57.5 112.53 1.45 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.089 -1.007 . . . . 0.0 110.813 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 91.05 24.0 28.36 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 124.384 0.992 . . . . 0.0 114.805 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -112.32 155.65 23.75 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.668 1.187 . . . . 0.0 110.619 165.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -148.35 153.51 38.71 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -116.29 141.33 48.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.064 1.745 . . . . 0.0 115.346 170.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.3 124.02 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.275 1.43 . . . . 0.0 110.704 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -90.87 147.55 18.99 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.33 0.49 . . . . 0.0 112.028 163.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 19.3 mt -128.01 160.69 60.2 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.866 1.266 . . . . 0.0 111.105 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.58 -5.23 16.29 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.318 2.679 . . . . 0.0 115.05 -173.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -157.9 146.25 18.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.515 1.526 . . . . 0.0 109.993 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -56.38 -32.78 65.11 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.416 -0.802 . . . . 0.0 112.81 166.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -56.98 -44.69 82.92 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.417 -0.802 . . . . 0.0 113.163 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -64.16 -38.3 90.56 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.435 0.694 . . . . 0.0 111.097 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.83 -43.91 82.49 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.319 0.963 . . . . 0.0 112.25 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.67 85.32 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.197 0.908 . . . . 0.0 112.312 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -70.96 -46.73 61.86 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.316 1.047 . . . . 0.0 112.306 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.57 72.13 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.542 HD23 HG12 ' A' ' 498' ' ' VAL . 45.7 mt -66.25 -47.58 73.27 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.246 -0.909 . . . . 0.0 110.229 173.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -30.64 71.69 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.586 0.63 . . . . 0.0 112.242 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -84.77 -40.23 17.5 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -91.89 -22.47 20.05 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -67.12 106.58 2.03 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.871 -1.143 . . . . 0.0 109.498 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 120.88 -8.46 10.69 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.89 1.233 . . . . 0.0 115.579 -171.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -73.22 129.28 37.7 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.44 1.62 . . . . 0.0 109.169 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.305 7.3 p -115.44 55.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 124.183 1.944 . . . . 0.0 110.871 -163.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 26.2 tp -48.01 123.84 6.75 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.442 2.697 . . . . 0.0 111.475 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.307 68.7 m-85 55.08 8.39 0.24 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -174.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 101.67 0.52 52.75 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.994 1.283 . . . . 0.0 115.251 -173.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -107.35 113.6 61.81 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.202 1.501 . . . . 0.0 110.471 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.0 115.45 4.36 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 122.397 2.064 . . . . 0.0 110.23 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 32.4 mtp -75.19 129.15 37.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.812 1.645 . . . . 0.0 111.957 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.5 t -87.95 94.47 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.384 1.073 . . . . 0.0 109.035 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.542 HG12 HD23 ' A' ' 483' ' ' LEU . 2.5 t -91.57 123.35 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.05 1.74 . . . . 0.0 111.856 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -149.95 156.15 41.23 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.724 0.81 . . . . 0.0 112.291 -167.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -56.89 144.78 32.15 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.396 -0.815 . . . . 0.0 109.787 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -55.83 147.07 19.96 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -173.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -71.84 145.51 48.56 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.567 -168.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 50.2 m 66.98 9.27 6.75 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.465 2.306 . . . . 0.0 115.791 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -69.54 153.76 43.01 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.471 -0.768 . . . . 0.0 110.68 161.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 45.3 mtp180 -115.71 45.61 0.43 Allowed Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 125.165 1.386 . . . . 0.0 114.233 -176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.38 -31.5 34.63 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.629 2.219 . . . . 0.0 114.173 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -129.28 -33.92 1.89 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.277 1.431 . . . . 0.0 113.797 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -149.79 148.78 29.6 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.66 1.984 . . . . 0.0 112.089 -168.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -66.54 143.13 98.03 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 172.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -71.51 156.32 58.26 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.031 2.488 . . . . 0.0 113.146 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 153.42 43.07 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 171.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -58.7 -36.06 73.63 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.476 1.51 . . . . 0.0 114.665 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 83.47 -166.37 43.63 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.357 0.98 . . . . 0.0 113.67 -173.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -150.77 123.69 8.69 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.899 1.68 . . . . 0.0 109.225 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -67.36 143.66 56.23 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.253 1.268 0 C-N-CA 127.874 2.469 . . . . 0.0 110.937 167.885 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -72.41 -77.89 0.09 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.784 2.034 . . . . 0.0 115.049 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.61 -15.26 21.65 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.914 1.285 . . . . 0.0 113.937 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 62.7 mtp -96.27 160.37 29.93 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 126.073 1.749 . . . . 0.0 109.042 162.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.58 155.56 20.98 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.732 2.955 . . . . 0.0 114.125 -172.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 40.0 t -62.77 123.35 18.22 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 122.673 0.389 . . . . 0.0 110.689 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -137.72 95.92 3.14 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 123.128 1.442 . . . . 0.0 110.933 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.8 p -154.51 155.16 34.35 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.543 1.137 . . . . 0.0 112.527 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.4 tt -70.94 155.37 7.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 125.139 1.376 . . . . 0.0 110.53 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 30.2 t -86.66 150.67 24.03 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 121.442 -0.787 . . . . 0.0 110.756 161.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -43.96 -39.54 4.11 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.531 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -46.25 86.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -79.6 -33.7 41.36 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.031 0.933 . . . . 0.0 112.91 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.17 -48.61 80.99 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.252 1.421 . . . . 0.0 111.192 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -57.6 -23.29 50.09 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.866 1.266 . . . . 0.0 114.363 -176.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -65.42 -25.91 67.74 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.983 1.313 . . . . 0.0 113.042 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.51 89.28 0.46 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.66 1.6 . . . . 0.0 109.946 173.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -167.01 131.75 2.02 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.799 1.239 . . . . 0.0 109.334 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.2 pt -109.42 155.93 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.11 165.6 13.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.08 1.752 . . . . 0.0 110.575 161.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -57.3 -33.59 67.84 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.127 1.371 . . . . 0.0 111.442 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -59.92 -35.28 74.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.853 1.261 . . . . 0.0 113.272 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -79.74 -40.23 29.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.419 0.688 . . . . 0.0 110.602 167.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 31.3 ttm -55.28 -42.41 73.57 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.151 -0.968 . . . . 0.0 112.486 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -79.81 -14.24 58.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.034 0.934 . . . . 0.0 112.974 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.31 -37.27 45.09 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.95 1.7 . . . . 0.0 111.14 168.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 65.3 mt -77.31 121.16 23.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.658 1.583 . . . . 0.0 112.579 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 55.9 p -56.12 -29.64 60.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.233 1.013 . . . . 0.0 113.296 168.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.2 m -63.48 -31.92 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 175.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.311 58.6 m-85 -85.29 -5.66 59.3 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 -175.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -57.75 -16.01 9.84 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 -160.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.9 t -127.37 6.42 6.35 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.626 1.17 . . . . 0.0 113.096 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -129.16 133.73 47.73 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.831 -1.168 . . . . 0.0 107.85 -160.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -147.39 123.31 5.41 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -168.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.99 -173.45 1.88 Allowed 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.946 3.098 . . . . 0.0 112.934 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 99.37 -18.43 56.41 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 116.376 1.311 . . . . 0.0 116.376 170.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -76.59 155.8 83.32 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 118.682 1.241 . . . . 0.0 113.142 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -90.56 113.78 0.46 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.586 3.524 . . . . 0.0 113.768 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -154.29 147.54 24.84 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.636 1.175 . . . . 0.0 109.7 168.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 19.9 p -78.64 11.83 2.36 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.158 -1.589 . . . . 0.0 114.074 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -142.94 146.67 34.2 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.984 2.114 . . . . 0.0 109.063 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 19.0 pt -129.23 167.86 23.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 125.426 1.49 . . . . 0.0 109.606 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -145.57 162.61 37.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.94 139.83 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.782 1.233 . . . . 0.0 111.982 -170.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -119.11 165.81 13.71 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.934 1.693 . . . . 0.0 109.837 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 8.4 t30 64.18 45.78 3.88 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.71 1.204 . . . . 0.0 111.915 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.54 153.31 29.61 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.313 -0.867 . . . . 0.0 111.445 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.32 169.8 8.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.334 1.454 . . . . 0.0 114.502 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -70.23 -48.12 58.38 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.139 -0.976 . . . . 0.0 112.924 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -72.91 -25.23 60.98 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.4 1.48 . . . . 0.0 114.209 -176.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.7 p -69.4 146.49 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -123.36 162.08 23.43 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.419 1.888 . . . . 0.0 110.538 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.38 -29.89 59.32 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.61 -1.306 . . . . 0.0 112.72 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -60.19 -35.44 75.4 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.03 -33.39 70.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.111 0.964 . . . . 0.0 112.918 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.3 mp -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.481 1.512 . . . . 0.0 112.533 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -55.51 -31.34 61.96 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.075 0.852 . . . . 0.0 112.848 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -61.78 -29.98 70.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.741 0.816 . . . . 0.0 110.792 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.92 -55.27 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 121.227 -0.92 . . . . 0.0 110.783 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.253 50.2 m-85 -62.66 -23.84 67.31 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.25 -15.69 81.29 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.015 0.817 . . . . 0.0 114.069 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 38.0 ttp85 -59.52 -25.93 64.9 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.331 1.452 . . . . 0.0 112.849 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -90.2 -0.22 57.51 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.229 1.812 . . . . 0.0 111.676 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 15.2 t -120.92 116.14 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.326 1.85 . . . . 0.0 110.654 -173.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -79.85 97.43 6.67 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.845 0.858 . . . . 0.0 110.761 -175.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.286 58.5 m-85 -62.44 -11.68 17.37 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 119.064 2.987 . . . . 0.0 119.064 -173.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 72.6 m -75.95 -6.73 52.31 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 168.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 47.3 t -116.68 113.42 22.62 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.053 1.741 . . . . 0.0 110.715 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -59.77 -47.22 86.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.845 -0.535 . . . . 0.0 110.975 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -17.02 6.96 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -86.11 -64.9 1.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.801 0.81 . . . . 0.0 109.472 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -68.01 -23.22 64.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.909 1.284 . . . . 0.0 113.889 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.3 tt -56.2 -40.03 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.081 1.352 . . . . 0.0 111.911 172.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -8.85 59.62 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.287 1.035 . . . . 0.0 112.244 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -100.5 125.14 46.8 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -173.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -162.58 155.12 19.23 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.843 1.657 . . . . 0.0 107.767 172.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 4.5 mt -115.95 146.7 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.558 1.143 . . . . 0.0 109.85 174.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -128.05 137.5 52.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.569 1.148 . . . . 0.0 109.72 161.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.1 tp -120.4 136.6 54.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.457 1.503 . . . . 0.0 109.644 168.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 41.8 mtm -91.05 127.97 36.68 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.853 1.661 . . . . 0.0 110.664 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -113.57 -1.79 13.99 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.003 1.721 . . . . 0.0 114.229 -170.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -151.85 -169.86 3.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.787 1.635 . . . . 0.0 111.572 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.36 -163.22 46.21 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.143 0.878 . . . . 0.0 114.484 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -68.95 -11.93 61.16 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.569 1.948 . . . . 0.0 115.344 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 18.0 ptm -137.2 43.23 2.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.759 1.224 . . . . 0.0 112.841 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -52.7 127.69 23.95 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.68 1.192 . . . . 0.0 110.645 168.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 77.61 34.76 38.5 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.423 1.011 . . . . 0.0 112.286 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -120.91 150.69 40.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.132 0.973 . . . . 0.0 112.466 164.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -138.7 157.17 46.61 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.672 1.589 . . . . 0.0 113.49 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -120.33 144.09 48.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.549 1.939 . . . . 0.0 115.079 166.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.91 119.75 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.388 1.475 . . . . 0.0 110.93 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -82.23 137.98 17.84 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.365 -0.834 . . . . 0.0 111.285 162.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 24.2 mt -118.2 160.95 37.3 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.756 1.222 . . . . 0.0 110.112 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 -6.57 15.73 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.092 1.862 . . . . 0.0 114.983 -172.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -156.37 143.99 19.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.506 1.523 . . . . 0.0 110.351 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -51.64 -36.96 48.2 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.789 1.636 . . . . 0.0 112.341 165.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -61.42 -40.38 94.21 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.276 1.03 . . . . 0.0 112.853 174.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.56 -39.32 91.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.118 0.567 . . . . 0.0 110.723 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.68 87.38 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.922 -0.486 . . . . 0.0 112.107 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.26 -43.53 78.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.981 0.81 . . . . 0.0 112.16 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -75.76 -45.08 38.37 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.82 1.248 . . . . 0.0 112.855 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.39 -33.83 73.04 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.626 0.648 . . . . 0.0 112.729 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 498' ' ' VAL . 38.3 mt -67.8 -46.55 71.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.85 0.75 . . . . 0.0 110.915 172.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -64.49 -32.76 74.53 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 119.114 -0.47 . . . . 0.0 111.322 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -82.8 -54.67 4.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.17 -17.86 61.91 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.38 102.59 0.14 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.167 1.387 . . . . 0.0 111.965 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 105.18 -0.77 40.76 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 118.149 -1.361 . . . . 0.0 115.754 -175.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.63 128.75 37.15 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.556 1.678 . . . . 0.0 112.84 -173.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.314 1.4 t -93.55 49.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -163.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 58.9 tp -57.91 122.42 12.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.663 1.585 . . . . 0.0 111.677 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.403 56.4 m-85 59.16 20.3 8.3 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -175.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 83.16 13.47 76.95 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.335 0.969 . . . . 0.0 114.198 -172.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -119.78 119.86 30.92 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.042 1.337 . . . . 0.0 110.616 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.9 114.59 4.08 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.064 2.509 . . . . 0.0 111.003 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 63.1 mtp -74.72 134.78 41.85 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.529 1.132 . . . . 0.0 111.952 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.47 100.15 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.473 1.509 . . . . 0.0 108.458 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.501 HG12 HD23 ' A' ' 483' ' ' LEU . 2.4 t -101.93 132.38 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.019 1.728 . . . . 0.0 112.993 -170.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -150.43 156.77 42.1 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -170.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -56.16 144.71 28.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.793 0.837 . . . . 0.0 109.346 170.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -63.04 141.29 58.82 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.23 -0.919 . . . . 0.0 113.145 -176.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.1 119.31 23.87 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.652 1.181 . . . . 0.0 111.333 173.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 80.1 p -162.98 155.65 18.9 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 127.781 2.432 . . . . 0.0 109.681 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -77.58 37.42 0.22 Allowed 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -165.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -148.6 66.53 9.08 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 125.402 1.481 . . . . 0.0 112.661 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -67.67 150.55 79.5 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.435 2.757 . . . . 0.0 113.358 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -69.88 153.86 42.72 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.199 1.0 . . . . 0.0 111.687 172.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -49.22 155.67 0.66 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 122.097 0.951 . . . . 0.0 112.2 161.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -66.21 148.35 98.5 Favored Pre-proline 0 CA--C 1.555 1.149 0 O-C-N 121.203 -0.935 . . . . 0.0 112.755 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -81.98 -153.99 0.05 OUTLIER 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 125.169 3.913 . . . . 0.0 113.048 -174.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -84.55 167.76 16.03 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.107 1.363 . . . . 0.0 114.002 -174.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -65.18 154.88 36.74 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.995 1.318 . . . . 0.0 110.966 168.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -83.49 -133.99 2.34 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.378 0.99 . . . . 0.0 113.992 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.27 119.55 10.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.009 0.924 . . . . 0.0 112.03 -171.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 22.1 tpp85 -89.81 -15.47 32.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.202 1.401 . . . . 0.0 113.196 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 45.7 pttt . . . . . 0 C--O 1.251 1.162 0 CA-C-O 117.134 -1.412 . . . . 0.0 112.803 168.884 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . 0.303 74.8 m-20 71.43 -15.76 0.41 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 119.442 3.126 . . . . 0.0 119.442 169.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -93.05 -32.29 14.53 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.872 0.869 . . . . 0.0 112.538 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 90.8 mmm 60.39 146.69 0.07 OUTLIER Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 128.878 2.871 . . . . 0.0 116.836 170.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.99 -13.52 15.73 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.33 2.687 . . . . 0.0 114.678 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 97.9 p -68.94 162.91 25.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.644 1.178 . . . . 0.0 110.938 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -144.74 110.54 5.37 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.745 0.818 . . . . 0.0 111.706 -171.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 8.8 m -155.14 161.28 41.28 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.41 1.884 . . . . 0.0 112.568 171.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.5 tt -67.94 140.88 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 124.222 1.009 . . . . 0.0 110.892 -170.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 70.5 m -82.68 160.44 22.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.998 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -63.64 -33.2 75.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 118.889 -0.576 . . . . 0.0 111.809 -174.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -62.47 -55.72 24.91 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.67 0.788 . . . . 0.0 112.964 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -62.06 -38.37 88.51 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.25 -44.64 83.1 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -60.67 -21.16 62.52 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -61.29 -46.29 90.94 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.178 1.391 . . . . 0.0 111.892 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.9 75.55 0.39 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.477 1.037 . . . . 0.0 111.999 -170.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 6.1 ttp85 -155.5 152.97 29.54 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.212 1.005 . . . . 0.0 110.97 -173.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.6 pt -130.94 155.06 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.9 0.88 . . . . 0.0 112.031 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 74.5 p -86.65 172.12 10.47 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.321 1.048 . . . . 0.0 111.456 169.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -55.18 -32.92 62.55 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.567 -0.708 . . . . 0.0 111.43 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.12 -25.72 67.89 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.88 -32.05 14.74 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.767 0.712 . . . . 0.0 110.803 166.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 16.0 ttm -66.55 -42.26 87.41 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.444 -1.41 . . . . 0.0 112.598 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -78.43 12.48 1.96 Allowed 'General case' 0 CA--C 1.552 1.042 0 O-C-N 120.973 -1.079 . . . . 0.0 111.573 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -125.03 -30.31 3.24 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.116 2.166 . . . . 0.0 116.006 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 1.7 mp -75.7 130.67 39.08 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.916 -1.115 . . . . 0.0 109.753 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 38.1 m -66.07 -20.65 66.24 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 1.3 m -57.19 -25.91 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 167.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.15 21.22 17.02 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -63.87 -22.52 66.96 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.238 -1.539 . . . . 0.0 114.78 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 78.0 p -139.97 -19.49 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.741 1.616 . . . . 0.0 113.365 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.18 135.89 41.06 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -141.95 132.05 12.65 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -85.26 175.77 6.2 Favored 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.283 3.322 . . . . 0.0 113.683 168.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.26 -3.39 72.54 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 117.894 1.918 . . . . 0.0 117.894 165.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -81.7 144.37 52.26 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 119.096 1.448 . . . . 0.0 113.996 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.17 86.21 1.7 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.148 3.232 . . . . 0.0 112.686 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -133.55 151.44 51.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.28 1.432 . . . . 0.0 110.257 165.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 24.2 p -82.07 -9.2 59.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -121.61 150.52 41.58 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.944 1.298 . . . . 0.0 110.629 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 19.7 pt -135.02 158.84 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.638 1.975 . . . . 0.0 110.37 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -133.79 158.11 44.18 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.24 131.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.246 1.418 . . . . 0.0 113.614 -171.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -108.63 172.66 6.71 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.262 1.425 . . . . 0.0 110.63 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.283 88.6 m-20 71.67 32.91 1.89 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.645 1.978 . . . . 0.0 116.029 -176.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.49 147.2 25.48 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.175 -0.953 . . . . 0.0 111.73 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.67 161.72 22.74 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.149 1.779 . . . . 0.0 115.109 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -67.14 -39.85 86.63 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.664 -1.272 . . . . 0.0 112.681 166.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -73.1 -27.83 61.93 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.752 1.621 . . . . 0.0 114.798 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.01 146.43 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -128.23 164.05 23.39 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.889 1.276 . . . . 0.0 112.584 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -33.99 68.21 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.63 -1.294 . . . . 0.0 113.021 -174.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -54.22 -30.82 51.43 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.191 1.797 . . . . 0.0 115.297 170.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -83.43 -34.18 25.52 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.877 1.671 . . . . 0.0 113.6 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.06 -22.32 66.88 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.323 1.049 . . . . 0.0 111.973 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -20.18 44.63 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -67.29 -30.52 70.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.83 0.741 . . . . 0.0 111.843 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.83 -55.47 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.27 -0.894 . . . . 0.0 110.46 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -57.61 -30.07 65.03 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.36 -12.07 82.14 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 123.997 0.808 . . . . 0.0 114.602 174.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 5.4 ttt85 -58.83 -27.89 65.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.334 1.567 . . . . 0.0 110.85 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -95.66 18.26 13.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.241 1.816 . . . . 0.0 113.558 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 27.3 t -140.54 124.56 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.099 1.76 . . . . 0.0 111.223 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -77.23 110.07 11.63 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -61.71 -12.42 16.51 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 118.178 2.658 . . . . 0.0 118.178 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 16.5 m -88.83 -18.95 26.6 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.455 0.702 . . . . 0.0 112.676 174.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 28.9 t -108.63 112.54 24.93 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.758 1.223 . . . . 0.0 111.754 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -54.11 -50.64 66.41 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.228 0.611 . . . . 0.0 111.016 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.45 -12.77 1.85 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -93.17 -61.76 1.51 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.978 1.311 . . . . 0.0 110.692 172.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -69.3 -20.41 63.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.796 1.239 . . . . 0.0 113.784 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.08 -28.97 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.773 1.629 . . . . 0.0 112.69 169.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 37.5 mtp -85.86 -13.1 48.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.958 1.303 . . . . 0.0 111.761 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -108.32 117.32 33.84 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -163.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -159.2 154.54 25.55 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.891 1.676 . . . . 0.0 110.065 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 8.4 mt -130.63 142.21 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.189 1.396 . . . . 0.0 110.797 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -123.37 142.64 50.76 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.028 1.331 . . . . 0.0 110.283 160.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 11.2 tp -133.47 115.68 15.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.842 2.057 . . . . 0.0 109.134 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 45.8 mtm -71.27 144.62 49.96 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 124.602 1.161 . . . . 0.0 111.751 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -128.64 -6.93 5.14 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -172.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.96 145.1 35.57 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.824 1.193 . . . . 0.0 114.122 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 75.37 -177.16 49.29 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.096 1.331 . . . . 0.0 113.216 -172.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -18.72 61.68 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -170.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 70.4 mtp -89.12 3.17 52.72 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -58.52 145.63 38.39 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.533 -1.354 . . . . 0.0 111.131 175.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.54 27.66 70.84 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.749 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -126.83 146.04 50.42 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.727 1.211 . . . . 0.0 111.339 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -137.07 155.26 49.87 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -167.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -125.71 134.0 51.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.678 1.991 . . . . 0.0 115.307 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.94 125.05 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.974 1.709 . . . . 0.0 109.952 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.07 137.62 14.27 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 162.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 25.2 mt -118.18 160.45 39.25 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.515 1.526 . . . . 0.0 109.26 173.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.03 -8.96 20.5 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.139 1.226 . . . . 0.0 114.642 -170.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' ASN . . . . . 0.402 ' OD1' ' HE2' ' A' ' 477' ' ' LYS . 64.1 t-20 -153.47 142.38 21.16 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.72 1.208 . . . . 0.0 111.059 -172.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -60.24 -37.19 79.63 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.389 -0.819 . . . . 0.0 111.147 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.402 ' HE2' ' OD1' ' A' ' 475' ' ' ASN . 3.0 mppt? -65.25 -32.35 73.97 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.311 0.644 . . . . 0.0 112.591 176.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -73.58 -35.5 65.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.084 0.554 . . . . 0.0 111.777 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.97 -45.14 86.92 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.359 0.981 . . . . 0.0 111.696 168.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.56 77.83 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.767 1.167 . . . . 0.0 112.263 176.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.33 -50.97 61.78 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.207 1.403 . . . . 0.0 112.545 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.54 -33.53 72.8 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.862 0.865 . . . . 0.0 112.118 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.523 HD23 HG12 ' A' ' 498' ' ' VAL . 45.6 mt -71.19 -36.87 72.11 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.927 1.291 . . . . 0.0 111.521 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -67.28 -22.99 65.63 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.513 1.125 . . . . 0.0 112.698 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -112.15 -33.04 6.36 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -171.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -84.83 -17.54 37.73 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -66.56 109.29 2.73 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.263 1.025 . . . . 0.0 111.672 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 104.57 4.41 43.13 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 118.061 -1.41 . . . . 0.0 115.976 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -70.4 123.66 22.3 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.704 1.752 . . . . 0.0 110.956 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.27 2.0 t -92.31 52.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.196 1.398 . . . . 0.0 114.416 -163.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.08 126.01 25.82 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.739 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . . 4.9 t80 53.79 35.91 22.67 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.579 1.952 . . . . 0.0 110.14 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 76.89 11.53 85.4 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.664 -1.272 . . . . 0.0 115.068 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -127.11 123.35 23.43 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 119.253 1.526 . . . . 0.0 111.11 -176.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.2 118.15 5.41 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.566 2.177 . . . . 0.0 111.648 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 72.1 mtp -69.14 126.06 28.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.693 1.197 . . . . 0.0 112.304 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -86.23 83.11 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.674 1.589 . . . . 0.0 113.422 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.523 HG12 HD23 ' A' ' 483' ' ' LEU . 1.6 t -85.86 122.61 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.398 1.479 . . . . 0.0 112.895 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -145.95 155.6 42.95 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.954 1.301 . . . . 0.0 111.693 -174.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -60.35 144.28 51.08 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.937 -1.102 . . . . 0.0 110.796 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -57.73 160.47 4.44 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -71.72 68.11 0.6 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.615 1.966 . . . . 0.0 112.817 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 29.9 m -146.04 161.59 39.77 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.959 2.104 . . . . 0.0 111.149 -167.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -68.03 137.08 54.79 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.528 -0.733 . . . . 0.0 111.478 170.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.93 45.14 1.22 Allowed Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -170.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -58.89 156.06 35.2 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.003 2.469 . . . . 0.0 112.618 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -49.33 142.91 6.93 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.087 1.355 . . . . 0.0 113.564 -172.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -155.72 118.54 4.24 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.397 1.479 . . . . 0.0 109.231 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -67.88 147.1 98.54 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 170.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -73.88 179.75 5.38 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.652 2.901 . . . . 0.0 111.423 166.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 511' ' ' LYS . . . . . 0.452 ' H ' ' HE2' ' A' ' 511' ' ' LYS . 0.0 OUTLIER -57.29 162.7 2.59 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.896 1.331 . . . . 0.0 114.047 173.026 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.88 123.53 18.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.785 1.634 . . . . 0.0 113.461 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -83.05 -13.26 77.8 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.956 1.265 . . . . 0.0 115.216 -177.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -65.63 130.66 44.09 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.334 1.453 . . . . 0.0 111.219 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.42 136.45 53.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.913 0.885 . . . . 0.0 112.397 171.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 32.9 tttm . . . . . 0 C--O 1.254 1.325 0 C-N-CA 125.292 1.437 . . . . 0.0 110.184 163.952 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -79.72 -57.69 3.54 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 172.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -158.89 145.77 17.25 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.267 1.427 . . . . 0.0 110.17 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 92.2 mtp 63.23 167.99 0.1 Allowed Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 127.156 2.183 . . . . 0.0 115.3 -177.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -72.95 -10.94 25.24 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.077 2.518 . . . . 0.0 115.646 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.6 p -78.0 48.74 0.74 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.734 2.014 . . . . 0.0 114.046 -173.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -78.07 61.22 2.57 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.812 1.645 . . . . 0.0 111.361 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 14.7 p -150.22 149.61 30.43 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.92 1.288 . . . . 0.0 114.332 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.5 tt -76.08 153.04 6.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 125.795 1.638 . . . . 0.0 111.516 -167.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 33.9 t -83.54 156.6 22.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.386 0.612 . . . . 0.0 110.745 165.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -53.92 -36.01 62.3 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.491 0.717 . . . . 0.0 111.029 163.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -45.4 86.78 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -71.1 -35.17 71.72 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.546 0.738 . . . . 0.0 112.85 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.422 HD12 ' CD2' ' A' ' 489' ' ' TYR . 31.4 tp -67.76 -44.68 76.9 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -54.91 -24.19 22.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.816 1.246 . . . . 0.0 114.03 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.68 -29.29 69.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.126 1.371 . . . . 0.0 112.855 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.22 97.94 0.76 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.436 1.017 . . . . 0.0 111.521 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -159.8 152.22 21.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.448 1.099 . . . . 0.0 110.635 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.44 150.21 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.428 0.632 . . . . 0.0 112.68 168.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 39.9 m -98.22 169.45 9.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.66 1.584 . . . . 0.0 111.694 168.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -54.57 -23.71 17.93 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -171.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -72.16 -28.43 63.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.798 0.839 . . . . 0.0 112.81 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.79 -32.9 14.49 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.527 1.131 . . . . 0.0 111.094 171.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 35.8 ttm -58.08 -46.3 85.69 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.08 -1.013 . . . . 0.0 111.239 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -85.04 37.16 0.65 Allowed 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.385 -0.822 . . . . 0.0 111.363 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.44 -37.52 0.31 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.948 2.099 . . . . 0.0 114.332 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.48 131.37 42.46 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.993 1.317 . . . . 0.0 110.008 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 53.1 p -69.01 -22.48 64.07 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.012 -1.055 . . . . 0.0 112.065 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.3 m -71.38 -7.53 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 168.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.426 ' CE1' HG13 ' A' ' 497' ' ' VAL 0.286 89.4 m-85 -117.79 3.93 12.25 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 173.718 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -66.01 -15.07 62.71 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -174.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 79.9 p -141.1 -16.12 0.86 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.907 1.283 . . . . 0.0 114.187 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -80.75 141.27 34.96 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 170.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -140.59 129.8 13.09 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -169.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -84.91 -174.86 1.86 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 124.263 3.309 . . . . 0.0 114.242 171.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.83 -44.99 2.34 Favored Glycine 0 N--CA 1.466 0.659 0 C-N-CA 126.488 1.994 . . . . 0.0 115.774 164.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -65.85 142.37 98.08 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -164.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.2 106.5 2.29 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.53 2.82 . . . . 0.0 112.199 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -144.37 151.21 38.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.222 2.209 . . . . 0.0 107.752 159.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 28.9 p -75.06 2.55 10.35 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.476 -1.39 . . . . 0.0 114.361 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -137.53 147.69 45.36 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.124 1.77 . . . . 0.0 110.333 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 43.9 pt -134.43 159.97 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.203 2.201 . . . . 0.0 110.123 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -139.86 159.86 41.22 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.19 140.24 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.694 1.597 . . . . 0.0 113.412 -164.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -119.5 175.59 5.76 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.331 1.452 . . . . 0.0 111.168 167.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.279 13.6 m-20 69.07 25.42 5.85 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.322 1.849 . . . . 0.0 115.824 -172.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -74.68 146.53 42.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.262 -1.524 . . . . 0.0 111.043 173.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.18 173.65 3.69 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -173.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -77.98 -50.58 11.87 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.518 1.127 . . . . 0.0 111.78 -176.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -81.97 -23.68 35.94 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.24 1.816 . . . . 0.0 113.251 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.58 152.07 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -122.53 168.27 12.34 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.697 1.599 . . . . 0.0 113.346 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -57.2 -35.21 69.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.542 1.137 . . . . 0.0 112.616 174.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -62.35 -36.42 82.19 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -71.92 -25.18 61.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.641 1.176 . . . . 0.0 113.636 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.23 -15.4 59.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.099 2.16 . . . . 0.0 114.024 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.67 -22.75 57.75 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.324 0.966 . . . . 0.0 112.857 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -55.31 -37.23 67.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.076 1.351 . . . . 0.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.79 -57.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 121.253 -0.904 . . . . 0.0 111.659 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.274 58.9 m-85 -59.68 -31.83 69.92 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -175.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.76 -19.84 79.74 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 123.668 0.652 . . . . 0.0 114.072 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -55.0 -35.82 64.77 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.713 1.605 . . . . 0.0 112.506 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -77.71 0.79 22.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.431 1.892 . . . . 0.0 114.873 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 11.7 t -124.59 121.99 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.742 2.017 . . . . 0.0 109.946 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.254 3.2 m-20 -66.78 90.56 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 175.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -52.64 -21.42 3.93 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 173.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 15.8 m -65.2 -22.29 66.88 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.346 1.058 . . . . 0.0 113.176 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 31.2 m -124.45 117.84 25.31 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.697 1.599 . . . . 0.0 112.733 -170.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -63.09 -40.67 98.33 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.234 -0.916 . . . . 0.0 113.278 -174.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 2.9 t -54.48 -15.23 1.58 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -88.75 -62.65 1.44 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.213 1.405 . . . . 0.0 110.714 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -67.02 -24.55 66.03 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.14 1.376 . . . . 0.0 113.169 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.3 tt -58.53 -36.58 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.3 1.04 . . . . 0.0 112.366 171.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 16.6 mtm -87.52 -2.59 58.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.089 1.355 . . . . 0.0 112.439 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.56 143.81 31.77 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.938 2.495 . . . . 0.0 115.212 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -168.7 154.85 6.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.08 1.752 . . . . 0.0 107.006 168.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.08 126.75 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.599 1.16 . . . . 0.0 109.544 172.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -104.3 137.65 41.89 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.845 1.258 . . . . 0.0 108.899 165.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.2 tp -128.1 127.75 43.63 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.886 1.274 . . . . 0.0 109.191 164.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 48.0 mtm -93.17 125.04 37.57 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.808 1.643 . . . . 0.0 109.948 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -122.14 -0.46 9.43 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.963 2.105 . . . . 0.0 112.925 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.9 148.79 23.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.832 1.653 . . . . 0.0 112.512 173.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 90.57 -168.77 33.56 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 163.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -20.55 64.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.344 1.858 . . . . 0.0 113.772 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 62.7 mtp -115.92 24.28 11.59 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.282 2.233 . . . . 0.0 112.202 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -65.46 151.95 45.11 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.792 -1.193 . . . . 0.0 113.204 -172.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.66 36.83 18.5 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 126.194 1.854 . . . . 0.0 112.798 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -120.19 142.01 49.37 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.189 0.996 . . . . 0.0 112.128 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -129.93 153.37 48.41 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -168.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -126.83 129.63 48.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.0 2.12 . . . . 0.0 114.733 171.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.5 mp -126.42 120.56 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.674 1.59 . . . . 0.0 109.856 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -83.14 141.03 20.45 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 162.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 21.4 mt -124.51 158.82 60.41 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.726 1.61 . . . . 0.0 109.686 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.88 -15.62 26.39 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.948 2.432 . . . . 0.0 114.085 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -150.07 143.74 25.31 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.035 0.934 . . . . 0.0 110.623 -175.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -57.6 -37.67 73.61 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.41 1.084 . . . . 0.0 111.61 170.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -69.78 -23.23 63.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.346 1.058 . . . . 0.0 113.575 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -77.56 -38.22 48.98 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.774 171.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.06 79.27 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.254 0.933 . . . . 0.0 112.259 170.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -54.64 -43.19 72.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.4 1.0 . . . . 0.0 111.614 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -64.77 -50.05 68.35 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.962 1.305 . . . . 0.0 113.009 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.38 -31.54 72.22 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.359 0.664 . . . . 0.0 111.816 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.511 HD23 HG12 ' A' ' 498' ' ' VAL . 89.7 mt -77.87 -31.58 51.45 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.099 -1.001 . . . . 0.0 112.346 173.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -60.62 -33.29 72.55 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.617 1.167 . . . . 0.0 110.606 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -101.9 -54.45 2.72 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -174.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -75.52 -14.45 60.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -168.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -65.46 104.43 0.98 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.207 1.003 . . . . 0.0 110.323 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 107.31 1.5 35.46 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 117.583 -1.676 . . . . 0.0 116.18 -172.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.422 ' CD2' HD12 ' A' ' 394' ' ' LEU 0.314 92.2 t80 -64.65 128.86 37.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.672 2.236 . . . . 0.0 115.925 -168.285 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.325 2.0 t -91.68 45.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -160.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 23.2 tp -52.8 138.87 28.35 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.156 1.382 . . . . 0.0 110.183 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.356 7.0 t80 62.91 -4.08 0.28 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 94.7 9.57 58.57 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 124.958 1.266 . . . . 0.0 114.358 -166.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -127.21 128.48 24.09 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 126.686 1.995 . . . . 0.0 111.581 -173.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.86 119.04 5.51 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.544 2.162 . . . . 0.0 112.511 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 56.9 mtp -75.58 130.81 39.4 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.729 1.612 . . . . 0.0 112.419 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 497' ' ' VAL . . . . . 0.426 HG13 ' CE1' ' A' ' 410' ' ' PHE . 2.5 t -87.95 76.79 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.857 1.663 . . . . 0.0 115.131 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.511 HG12 HD23 ' A' ' 483' ' ' LEU . 1.7 t -79.83 122.72 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.355 1.062 . . . . 0.0 113.789 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -141.63 155.7 45.7 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.175 1.79 . . . . 0.0 112.514 -173.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -59.7 143.28 51.18 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.346 -1.471 . . . . 0.0 113.193 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -60.91 146.06 48.02 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -169.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -74.95 115.2 14.29 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.85 157.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 38.5 m -169.88 157.39 6.72 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.867 1.667 . . . . 0.0 111.909 -170.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -59.71 135.3 57.64 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.85 0.46 . . . . 0.0 110.807 161.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 55.5 ttp85 -149.01 83.06 6.85 Favored Pre-proline 0 N--CA 1.47 0.555 0 C-N-CA 125.218 1.407 . . . . 0.0 109.744 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -60.39 -35.2 91.95 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.126 1.884 . . . . 0.0 113.142 174.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -64.54 127.13 30.21 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.419 1.088 . . . . 0.0 112.317 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -147.23 151.55 36.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.681 1.592 . . . . 0.0 110.66 170.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -49.77 140.96 14.4 Favored Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.93 173.11 9.74 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.381 2.721 . . . . 0.0 112.117 173.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 135.58 39.8 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 174.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -149.85 62.61 0.99 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.3 1.44 . . . . 0.0 109.833 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -63.25 133.59 42.51 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 121.278 -0.889 . . . . 0.0 111.094 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -155.77 167.64 29.76 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.731 1.212 . . . . 0.0 113.147 -167.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -61.95 135.68 57.65 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.432 1.493 . . . . 0.0 113.921 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.924 2.09 . . . . 0.0 112.276 159.567 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 28.5 p . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 121.571 0.7 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . 0.271 49.9 m-20 -114.21 -135.63 0.36 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.954 2.102 . . . . 0.0 111.879 168.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -132.15 159.06 40.04 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.757 1.617 . . . . 0.0 113.316 -174.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.12 170.75 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 126.173 1.789 . . . . 0.0 114.156 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.93 155.74 37.07 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.677 2.251 . . . . 0.0 113.55 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.1 t 55.23 54.9 8.12 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.093 1.757 . . . . 0.0 112.695 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -79.67 73.27 6.38 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.817 -1.177 . . . . 0.0 111.991 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 28.0 p -139.05 159.81 41.26 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.9 tt -70.06 152.37 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.863 1.665 . . . . 0.0 110.94 -174.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 1.6 m -86.65 152.6 22.44 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 7.2 ttm-85 -59.06 -35.79 73.95 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.1 -1.0 . . . . 0.0 111.124 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -41.51 98.26 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.838 1.655 . . . . 0.0 113.733 174.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.85 -38.91 92.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.095 0.958 . . . . 0.0 112.692 174.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.4 tt -70.2 -39.99 74.86 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.412 1.485 . . . . 0.0 111.943 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.36 -17.17 18.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.488 1.915 . . . . 0.0 115.153 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -63.95 -64.61 0.84 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.74 -0.6 . . . . 0.0 110.88 164.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -78.99 72.09 2.51 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.497 1.999 . . . . 0.0 114.072 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -159.66 143.33 14.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.763 1.225 . . . . 0.0 110.973 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.4 pt -123.3 153.74 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.356 1.063 . . . . 0.0 113.866 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 77.3 p -85.02 169.87 13.55 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.54 1.536 . . . . 0.0 111.828 168.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 -58.37 -28.92 65.6 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.326 -0.859 . . . . 0.0 113.288 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.83 -30.94 71.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.543 0.737 . . . . 0.0 112.265 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.44 -36.59 26.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.641 1.176 . . . . 0.0 111.775 168.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 20.3 ttp -63.06 -40.6 98.18 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.919 -1.113 . . . . 0.0 111.829 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -83.29 25.12 0.75 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.441 0.696 . . . . 0.0 112.609 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.69 -38.23 1.51 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.892 2.077 . . . . 0.0 115.933 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.58 127.58 33.44 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.509 1.524 . . . . 0.0 110.131 172.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 27.9 t -59.48 -32.12 69.96 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.543 -0.723 . . . . 0.0 112.314 168.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 18.5 m -60.21 -21.64 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 120.753 -1.217 . . . . 0.0 114.08 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.263 79.7 m-85 -109.52 6.8 24.39 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -69.67 -22.33 63.45 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 46.6 t -123.43 -42.16 2.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.426 1.09 . . . . 0.0 112.381 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -72.56 150.79 42.84 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.898 1.279 . . . . 0.0 114.319 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -140.24 125.49 11.36 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -163.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -92.74 177.01 1.55 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 124.958 3.772 . . . . 0.0 114.887 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.438 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 98.58 -8.86 62.2 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.302 1.906 . . . . 0.0 116.843 163.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -85.69 139.79 35.52 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 119.294 1.547 . . . . 0.0 114.556 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -83.55 65.43 7.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 1 C-N-CA 125.392 4.061 . . . . 0.0 113.038 -174.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 46.6 t30 -89.79 153.98 20.26 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.551 -0.718 . . . . 0.0 110.485 162.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 28.4 p -76.05 -3.63 36.94 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.088 -1.633 . . . . 0.0 115.068 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' ARG . . . . . 0.48 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 87.7 mtt-85 -136.44 152.52 50.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.352 1.861 . . . . 0.0 111.833 176.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.6 pt -135.4 164.14 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.671 1.989 . . . . 0.0 109.588 176.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -138.47 161.21 37.59 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.447 HG22 HG13 ' A' ' 498' ' ' VAL . 2.7 t -135.62 150.52 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.241 1.816 . . . . 0.0 112.018 -171.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -138.01 -178.25 5.18 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.292 0.496 . . . . 0.0 112.158 162.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 69.61 21.73 6.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.215 1.806 . . . . 0.0 114.516 -165.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.87 154.64 41.65 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.991 -1.068 . . . . 0.0 110.912 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -68.26 173.7 4.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.172 0.989 . . . . 0.0 113.03 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.02 -30.43 13.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.225 1.41 . . . . 0.0 112.285 170.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -73.69 -14.81 61.21 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.107 1.363 . . . . 0.0 113.92 172.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.8 p -86.16 147.16 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.807 1.643 . . . . 0.0 113.898 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -117.49 164.81 14.34 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.333 1.053 . . . . 0.0 111.953 173.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -58.67 -30.51 67.41 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.6 -1.313 . . . . 0.0 111.966 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -20.93 63.8 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.842 1.657 . . . . 0.0 114.84 174.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -76.78 -37.86 55.09 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.269 1.028 . . . . 0.0 113.533 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.18 -18.31 63.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.595 1.558 . . . . 0.0 112.541 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -49.14 -33.13 11.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.176 1.391 . . . . 0.0 112.869 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -66.14 -31.2 71.91 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -169.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.9 mt -98.75 -56.15 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.821 -1.174 . . . . 0.0 111.151 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.265 75.6 m-85 -60.79 -22.52 64.2 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.73 -6.88 88.89 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.399 0.999 . . . . 0.0 114.519 170.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -63.05 -26.39 68.82 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 120.794 2.297 . . . . 0.0 112.09 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -94.51 3.83 54.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.081 2.152 . . . . 0.0 111.424 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.8 107.8 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.355 1.462 . . . . 0.0 109.432 -174.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -72.15 104.96 3.79 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -170.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -50.3 -40.31 48.19 Favored 'General case' 0 C--N 1.338 0.109 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 -170.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.0 p -68.16 -4.08 12.66 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 14.9 t -118.02 116.05 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.747 1.158 . . . . 0.0 111.782 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -60.3 -43.78 96.0 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.209 -0.932 . . . . 0.0 112.25 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.2 t -54.83 -16.08 2.38 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -90.09 -60.28 1.97 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.186 0.994 . . . . 0.0 110.032 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -68.13 -23.86 64.94 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.785 1.234 . . . . 0.0 113.286 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.0 tt -61.36 -31.84 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.938 1.695 . . . . 0.0 112.96 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.7 mtm -97.85 2.39 49.25 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.23 1.412 . . . . 0.0 112.698 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -111.6 112.23 23.79 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.372 1.869 . . . . 0.0 115.85 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -154.62 131.85 11.07 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.573 -0.704 . . . . 0.0 109.419 -168.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 5.1 mt -113.47 142.96 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.654 1.182 . . . . 0.0 110.407 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -134.37 129.64 35.71 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.992 1.717 . . . . 0.0 109.322 165.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 4.2 tt -115.53 139.73 49.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.345 1.858 . . . . 0.0 111.005 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -101.67 131.78 47.73 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 125.234 1.414 . . . . 0.0 112.463 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -113.9 1.76 14.84 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -171.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -145.9 154.82 42.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.211 1.004 . . . . 0.0 113.042 -174.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 77.23 -162.08 51.03 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.207 1.384 . . . . 0.0 113.809 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -22.27 66.07 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 121.483 -1.01 . . . . 0.0 112.743 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 23.2 ptp -87.18 8.84 22.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.112 1.365 . . . . 0.0 114.395 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -56.77 115.85 2.81 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.825 1.193 . . . . 0.0 110.838 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.16 22.79 58.48 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.732 1.634 . . . . 0.0 113.859 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -93.79 155.98 16.92 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.353 0.661 . . . . 0.0 110.697 158.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -149.74 152.8 35.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.224 1.009 . . . . 0.0 113.179 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -105.63 144.53 32.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.145 1.778 . . . . 0.0 114.123 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.9 mp -139.62 115.01 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.198 1.399 . . . . 0.0 109.244 169.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -81.69 144.15 23.97 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 158.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.1 mt -123.5 159.83 53.44 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.712 1.205 . . . . 0.0 110.332 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.01 -8.78 24.44 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.658 2.906 . . . . 0.0 114.321 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -156.71 144.11 19.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.582 0.706 . . . . 0.0 112.125 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -49.77 -44.79 49.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.406 1.882 . . . . 0.0 112.579 166.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -68.01 -28.75 67.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.706 1.202 . . . . 0.0 113.779 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.52 73.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.563 174.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.0 88.03 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.939 0.79 . . . . 0.0 112.776 174.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.68 71.11 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.722 0.692 . . . . 0.0 112.371 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.16 -52.0 15.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.134 1.374 . . . . 0.0 112.885 172.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.08 -30.54 69.3 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.094 0.958 . . . . 0.0 113.293 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.597 HD23 HG12 ' A' ' 498' ' ' VAL . 28.8 mt -64.17 -49.32 72.56 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.379 0.671 . . . . 0.0 111.028 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -21.6 48.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.614 0.766 . . . . 0.0 112.729 -176.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -72.01 -54.57 9.48 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.397 0.999 . . . . 0.0 112.62 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.67 -14.67 59.56 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -172.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -61.8 99.07 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.013 1.325 . . . . 0.0 111.657 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 119.34 -1.5 14.29 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 117.778 -1.568 . . . . 0.0 115.405 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -71.23 131.0 42.85 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.354 1.577 . . . . 0.0 111.254 -172.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.18 67.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.971 1.708 . . . . 0.0 113.437 -168.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 23.6 tp -66.28 142.8 57.54 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.363 162.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.4 27.3 t80 63.8 7.81 3.44 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 118.228 2.677 . . . . 0.0 118.228 167.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 78.93 14.97 81.42 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.1 1.333 . . . . 0.0 114.277 -169.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -133.87 125.65 18.37 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.66 1.584 . . . . 0.0 110.689 -171.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.4 125.18 11.54 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.121 1.881 . . . . 0.0 112.167 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 63.7 mtp -73.15 127.3 32.2 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.817 1.247 . . . . 0.0 111.696 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.24 98.86 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.901 0.88 . . . . 0.0 109.712 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.597 HG12 HD23 ' A' ' 483' ' ' LEU . 2.0 t -94.18 124.27 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.641 1.577 . . . . 0.0 112.337 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -148.28 152.81 37.77 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.61 0.764 . . . . 0.0 112.765 -168.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . 0.31 17.6 p90 -57.85 144.66 37.98 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 173.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -60.35 163.3 5.25 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -171.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -77.69 -34.3 52.91 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.462 1.505 . . . . 0.0 112.136 172.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 92.3 p -74.88 162.8 28.3 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.412 1.085 . . . . 0.0 111.138 159.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -151.53 132.45 14.21 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -175.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -152.3 73.49 7.58 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 127.692 2.397 . . . . 0.0 110.549 160.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -65.53 168.25 15.14 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.002 2.468 . . . . 0.0 114.113 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -73.58 136.93 44.01 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 121.478 -0.764 . . . . 0.0 111.509 173.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -70.35 -16.09 62.94 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 -165.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -148.89 170.66 7.3 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 126.322 1.849 . . . . 0.0 115.909 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -60.12 -22.08 68.4 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.59 2.86 . . . . 0.0 114.475 174.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.39 161.46 22.1 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.154 1.782 . . . . 0.0 114.088 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -137.78 -32.31 0.75 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.261 1.824 . . . . 0.0 111.965 170.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 75.69 -35.57 1.2 Allowed Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.358 1.932 . . . . 0.0 115.592 168.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.16 129.91 42.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.868 1.267 . . . . 0.0 109.309 168.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 21.2 mmt-85 -82.93 175.96 9.65 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -168.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 22.9 pttm . . . . . 0 C--O 1.252 1.235 0 C-N-CA 126.39 1.876 . . . . 0.0 114.333 -172.396 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 384' ' ' MET . 21.1 t . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.641 0.734 . . . . 0.0 109.914 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -112.18 -19.62 12.19 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.928 1.691 . . . . 0.0 112.837 170.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -152.47 30.14 0.54 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.877 1.271 . . . . 0.0 113.28 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' MET . . . . . 0.453 ' HG3' ' HA ' ' A' ' 381' ' ' SER . 82.6 mtp -71.31 160.17 83.33 Favored Pre-proline 0 CA--C 1.548 0.883 0 O-C-N 121.168 -0.958 . . . . 0.0 111.925 173.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.3 144.59 81.58 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.281 2.654 . . . . 0.0 113.844 172.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 17.2 t -80.42 161.93 24.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.492 1.117 . . . . 0.0 112.332 174.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -156.4 154.06 29.89 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.489 2.716 . . . . 0.0 107.429 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 23.2 p -135.85 162.5 32.64 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 12.5 tt -76.66 144.03 12.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 125.694 1.597 . . . . 0.0 111.971 -162.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 69.3 m -90.05 155.96 18.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.506 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -53.48 -38.77 63.97 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.929 0.892 . . . . 0.0 111.655 -174.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -62.53 -47.97 81.58 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -69.67 -34.11 73.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -42.52 94.41 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.8 0.84 . . . . 0.0 112.408 169.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -57.91 -27.14 63.06 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.659 -1.276 . . . . 0.0 114.443 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -68.93 -21.84 64.18 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 118.996 0.816 . . . . 0.0 112.412 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -116.52 62.95 0.37 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.088 1.804 . . . . 0.0 112.888 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -148.21 166.25 28.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.832 1.653 . . . . 0.0 109.371 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.2 pt -144.83 148.88 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.125 0.97 . . . . 0.0 112.143 167.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.6 m -74.17 160.38 31.27 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.4 1.88 . . . . 0.0 112.815 165.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -53.76 -35.62 61.47 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.804 1.242 . . . . 0.0 112.323 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -60.3 -30.08 69.25 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.299 1.04 . . . . 0.0 113.258 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.33 -26.24 18.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.568 1.147 . . . . 0.0 112.123 172.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 8.2 ttm -61.77 -38.98 90.05 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 120.785 -1.197 . . . . 0.0 111.366 174.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -80.15 22.18 0.54 Allowed 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 171.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.38 -31.46 1.09 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 5.5 mp -74.5 137.85 42.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.64 1.176 . . . . 0.0 111.402 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 81.1 p -63.64 -31.89 73.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.429 HG23 ' CD2' ' A' ' 410' ' ' PHE . 1.5 m -63.54 -19.54 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.38 1.472 . . . . 0.0 114.677 173.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.429 ' CD2' HG23 ' A' ' 409' ' ' VAL 0.308 65.7 m-85 -109.41 3.08 21.06 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 119.152 3.019 . . . . 0.0 119.152 -176.41 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -29.12 67.05 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 37.5 t -126.43 -34.94 2.42 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.064 1.346 . . . . 0.0 112.829 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -72.02 139.61 48.63 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -142.41 130.32 11.47 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.709 1.204 . . . . 0.0 112.15 -170.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -76.48 -166.28 0.36 Allowed 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 124.3 3.334 . . . . 0.0 113.156 164.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.411 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 91.16 13.8 58.35 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 117.688 1.835 . . . . 0.0 117.688 156.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -102.38 149.87 37.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 119.613 1.706 . . . . 0.0 113.088 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.54 109.53 2.92 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.583 2.856 . . . . 0.0 112.355 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -148.38 145.0 27.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.347 1.059 . . . . 0.0 109.098 164.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 24.2 p -76.0 -2.66 31.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 33.8 mtp85 -130.09 147.08 51.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.888 2.075 . . . . 0.0 108.901 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 3.3 pt -131.81 161.18 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 126.386 1.875 . . . . 0.0 109.431 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -136.8 161.44 35.98 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.7 t -131.65 140.68 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.453 1.501 . . . . 0.0 111.655 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -120.56 166.23 13.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.544 1.537 . . . . 0.0 109.36 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 69.49 36.88 2.1 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -171.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.8 160.2 26.23 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 120.148 -1.595 . . . . 0.0 112.221 168.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -79.02 176.15 9.92 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.002 1.721 . . . . 0.0 115.282 -171.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -77.93 -48.04 17.24 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 171.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -72.8 -36.04 67.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.656 1.182 . . . . 0.0 113.179 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.64 153.95 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -130.93 163.55 27.24 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.467 1.507 . . . . 0.0 111.566 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -52.62 -31.06 34.71 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.548 1.139 . . . . 0.0 113.408 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -60.08 -33.04 71.53 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 171.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -76.88 -26.82 54.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.427 1.491 . . . . 0.0 114.494 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.44 -19.98 60.83 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.044 1.738 . . . . 0.0 113.549 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.76 -25.88 61.08 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.587 1.085 . . . . 0.0 112.358 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -59.29 -38.87 81.25 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.552 0.741 . . . . 0.0 111.5 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mt -94.47 -56.97 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 121.26 -0.9 . . . . 0.0 110.632 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -60.25 -28.33 67.95 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.57 -12.75 84.21 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.437 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -55.12 -40.4 70.46 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.135 1.467 . . . . 0.0 112.064 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -80.89 -5.96 58.04 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.403 1.881 . . . . 0.0 112.022 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.61 117.54 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.154 1.782 . . . . 0.0 110.726 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -69.07 90.87 0.47 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.299 30.7 m-85 -59.14 -16.05 17.73 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 118.198 2.666 . . . . 0.0 118.198 177.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.9 t -66.73 -26.26 66.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.854 1.207 . . . . 0.0 112.295 171.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.1 m -110.23 120.76 43.46 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.636 1.574 . . . . 0.0 112.303 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -58.23 -44.11 88.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.005 -1.059 . . . . 0.0 112.826 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.11 -7.14 0.46 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -100.0 -55.6 2.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.842 1.257 . . . . 0.0 109.768 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -70.58 -24.13 62.71 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.485 1.114 . . . . 0.0 112.691 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.5 tt -59.24 -31.91 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.8 1.64 . . . . 0.0 112.694 171.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 36.1 mtp -86.71 -9.24 56.37 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.23 1.412 . . . . 0.0 112.485 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.22 122.23 46.51 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -170.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -159.62 119.33 2.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.215 1.006 . . . . 0.0 110.981 -170.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 8.1 mt -102.59 133.03 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.986 0.914 . . . . 0.0 111.323 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -133.19 120.46 21.2 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.004 0.921 . . . . 0.0 110.388 170.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 7.8 tt -108.76 129.63 55.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.132 1.773 . . . . 0.0 110.101 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -77.96 109.53 12.09 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.421 1.489 . . . . 0.0 110.982 176.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -85.0 -8.95 58.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pm0 -130.92 159.62 36.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -167.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 65.02 -160.25 42.62 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.965 1.269 . . . . 0.0 114.98 164.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -18.64 60.52 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 40.9 mtp -99.71 11.65 38.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.054 1.341 . . . . 0.0 113.029 174.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -54.03 113.01 1.07 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.512 1.125 . . . . 0.0 110.306 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.81 31.39 23.97 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.282 0.944 . . . . 0.0 113.875 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -106.4 155.35 19.63 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.517 1.127 . . . . 0.0 110.412 157.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.2 154.48 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.962 -1.086 . . . . 0.0 113.604 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -116.23 144.41 44.23 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.653 1.981 . . . . 0.0 115.58 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.25 118.27 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.554 1.941 . . . . 0.0 110.026 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -81.95 142.02 22.12 Favored Glycine 0 CA--C 1.534 1.249 0 O-C-N 121.447 -0.783 . . . . 0.0 111.383 159.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.6 mt -120.87 160.8 43.25 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.059 1.344 . . . . 0.0 109.986 174.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.78 -6.19 17.84 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.527 2.152 . . . . 0.0 114.447 -175.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -155.59 143.56 19.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.563 0.745 . . . . 0.0 111.466 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.31 -43.31 32.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.407 1.483 . . . . 0.0 112.469 162.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -62.54 -34.96 77.96 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.466 -0.771 . . . . 0.0 113.017 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.03 -37.43 75.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.413 0.685 . . . . 0.0 111.816 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.74 80.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.394 0.997 . . . . 0.0 111.783 170.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.03 -34.07 67.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.583 0.753 . . . . 0.0 112.398 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -75.11 -49.39 19.76 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.849 1.26 . . . . 0.0 112.848 170.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.7 -29.73 68.3 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.575 -0.703 . . . . 0.0 112.602 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.471 HD23 HG12 ' A' ' 498' ' ' VAL . 65.9 mt -71.71 -28.84 63.97 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.299 1.04 . . . . 0.0 113.412 173.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -67.57 -37.72 83.04 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.575 0.75 . . . . 0.0 111.033 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -91.71 -56.49 3.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -169.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -74.35 -18.22 60.72 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -75.65 111.6 11.15 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.221 -0.924 . . . . 0.0 111.002 -174.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 107.12 8.49 31.36 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.022 -168.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -75.79 126.73 31.56 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.444 1.622 . . . . 0.0 110.082 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.316 1.2 t -97.76 45.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.473 1.509 . . . . 0.0 114.704 -162.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 36.0 tp -52.8 123.72 12.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.027 1.731 . . . . 0.0 111.218 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.37 65.7 m-85 57.84 11.58 1.42 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 118.345 2.72 . . . . 0.0 118.345 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 87.06 18.87 57.07 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 120.871 -1.143 . . . . 0.0 114.234 -171.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -121.69 118.95 29.34 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.536 1.535 . . . . 0.0 109.384 175.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -72.92 117.11 4.98 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.831 1.687 . . . . 0.0 111.893 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 32.2 mtp -71.65 130.97 42.49 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.974 1.71 . . . . 0.0 111.272 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.32 106.42 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.055 1.342 . . . . 0.0 108.088 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.471 HG12 HD23 ' A' ' 483' ' ' LEU . 11.6 t -98.95 123.72 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.302 1.441 . . . . 0.0 110.331 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -138.94 160.47 39.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.057 0.932 . . . . 0.0 112.972 -175.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -55.2 140.92 37.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.507 0.723 . . . . 0.0 111.611 167.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -62.84 149.7 43.59 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.721 -0.612 . . . . 0.0 112.245 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -73.33 -19.06 61.11 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.834 1.791 . . . . 0.0 115.834 -168.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 48.0 t -158.52 -36.03 0.07 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -85.97 139.47 31.17 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -164.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -152.98 42.67 0.22 Allowed Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 126.364 1.865 . . . . 0.0 114.823 170.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.51 179.3 5.69 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 124.626 3.551 . . . . 0.0 114.97 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -142.43 101.6 3.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.946 2.099 . . . . 0.0 110.714 169.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -72.53 135.2 45.57 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.381 -0.824 . . . . 0.0 112.666 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -70.47 148.72 95.49 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.09 149.43 36.32 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.288 2.659 . . . . 0.0 113.82 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 153.04 28.0 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.101 1.761 . . . . 0.0 113.889 173.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -78.29 65.44 3.63 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.418 1.487 . . . . 0.0 112.907 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -99.79 -171.3 30.2 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.67 1.605 . . . . 0.0 113.614 173.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -142.01 150.77 41.75 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.879 1.271 . . . . 0.0 112.612 173.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.35 -35.74 15.05 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.895 1.278 . . . . 0.0 113.235 177.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt . . . . . 0 C--O 1.251 1.136 0 C-N-CA 126.075 1.75 . . . . 0.0 113.34 173.387 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.46 166.84 19.58 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 16.2 pm0 -66.83 -19.31 65.72 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 98.5 mtp -66.06 138.3 96.16 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.553 1.141 . . . . 0.0 111.616 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.68 134.95 36.92 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 122.643 2.229 . . . . 0.0 112.477 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 43.1 t -153.76 129.76 10.28 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.911 1.285 . . . . 0.0 110.918 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -149.77 129.0 12.81 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.916 0.886 . . . . 0.0 110.141 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 8.1 p -148.03 167.69 24.27 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -173.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.03 146.23 8.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 123.654 0.782 . . . . 0.0 111.133 -169.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 31.6 m -87.67 149.8 24.03 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -66.31 -27.81 68.2 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.976 -1.077 . . . . 0.0 112.704 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -67.34 -23.41 65.61 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 171.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -74.39 -52.43 12.16 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.307 0.958 . . . . 0.0 110.917 163.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.8 -45.12 78.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.914 1.286 . . . . 0.0 112.895 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -56.04 -17.98 8.32 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.597 1.959 . . . . 0.0 115.481 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -72.26 -30.63 65.04 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.936 -1.102 . . . . 0.0 112.811 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.62 90.63 0.5 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.612 1.101 . . . . 0.0 113.468 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 -164.71 147.73 8.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.504 1.122 . . . . 0.0 111.343 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.7 pt -126.76 158.7 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.671 1.188 . . . . 0.0 112.88 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.59 179.23 4.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.975 1.31 . . . . 0.0 111.074 163.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -61.84 -20.9 64.17 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 120.558 -1.339 . . . . 0.0 114.259 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -78.03 -29.09 49.24 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.063 0.945 . . . . 0.0 112.002 -173.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.87 -33.17 24.87 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.712 -1.243 . . . . 0.0 110.982 161.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 29.4 ttm -63.02 -38.45 91.22 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.438 -1.414 . . . . 0.0 113.371 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -83.22 12.83 4.74 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.285 -0.884 . . . . 0.0 112.196 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.62 -29.69 5.0 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.233 2.213 . . . . 0.0 115.119 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.82 128.1 34.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.908 1.283 . . . . 0.0 109.898 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 75.6 p -63.43 -27.01 69.0 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.299 -0.875 . . . . 0.0 111.38 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . 0.273 2.2 m -68.97 -16.02 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 171.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -119.6 -17.07 8.75 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 119.189 3.033 . . . . 0.0 119.189 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.24 -8.84 0.35 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 54.1 p -137.47 12.77 3.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.949 1.3 . . . . 0.0 113.456 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -131.55 137.91 48.67 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.39 1.876 . . . . 0.0 114.41 -173.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -142.66 129.02 10.68 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -157.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -86.47 -174.28 1.42 Allowed 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 124.736 3.624 . . . . 0.0 113.413 171.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.427 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 72.69 71.77 1.04 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 125.144 1.354 . . . . 0.0 116.13 164.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -145.59 151.96 48.02 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.377 1.471 . . . . 0.0 111.862 172.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.81 95.6 1.07 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.964 3.109 . . . . 0.0 113.0 -172.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -163.06 147.83 11.44 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.7 2.0 . . . . 0.0 111.431 166.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.2 p -82.11 18.72 1.3 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -135.16 150.24 50.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.985 1.314 . . . . 0.0 109.99 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.77 157.84 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 126.375 1.87 . . . . 0.0 109.929 -177.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -131.79 162.1 31.33 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.08 140.18 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 125.582 1.553 . . . . 0.0 111.631 -174.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -122.03 170.65 9.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.116 1.367 . . . . 0.0 109.951 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 22.8 t30 66.62 38.73 3.93 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.839 1.256 . . . . 0.0 111.717 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -77.12 139.56 40.0 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.963 -1.086 . . . . 0.0 110.318 167.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.41 142.09 58.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.485 1.514 . . . . 0.0 112.83 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.27 -29.15 60.76 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.649 -1.282 . . . . 0.0 113.932 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -73.35 -31.09 63.76 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.412 HG21 HD21 ' A' ' 491' ' ' LEU . 1.0 OUTLIER -79.69 160.0 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -169.873 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -134.29 166.94 21.64 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.906 1.283 . . . . 0.0 111.326 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -59.89 -33.09 71.38 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.526 -1.359 . . . . 0.0 113.018 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -57.42 -22.04 40.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.871 1.668 . . . . 0.0 115.018 170.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.64 -33.08 18.95 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.749 1.619 . . . . 0.0 115.094 169.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.81 -25.27 67.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.89 0.876 . . . . 0.0 112.272 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -53.56 -30.97 44.66 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.341 1.056 . . . . 0.0 111.472 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.36 -41.59 97.32 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.945 1.298 . . . . 0.0 111.781 -173.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mt -91.81 -57.49 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 120.64 -1.287 . . . . 0.0 110.826 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -55.98 -36.04 67.42 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.69 -9.19 82.54 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.145 -0.808 . . . . 0.0 114.454 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -60.08 -29.03 68.29 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.36 1.58 . . . . 0.0 111.543 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -93.91 16.26 14.74 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.117 1.767 . . . . 0.0 114.341 -174.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 451' ' ' GLN . 96.7 t -128.47 119.23 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.228 1.811 . . . . 0.0 107.52 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.257 57.3 m-20 -68.89 73.6 0.27 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 173.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -49.78 -22.49 1.44 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 120.044 3.35 . . . . 0.0 120.044 -169.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 17.2 m -71.99 -13.55 61.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.742 1.61 . . . . 0.0 112.935 172.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 4.8 t -104.39 123.38 47.32 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.19 1.396 . . . . 0.0 110.887 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -56.79 -45.39 82.22 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.394 -0.816 . . . . 0.0 112.068 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.3 t -55.18 -15.1 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' GLN . . . . . 0.456 ' HB3' HG13 ' A' ' 444' ' ' VAL . 43.4 mm-40 -88.86 -61.75 1.64 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.905 0.882 . . . . 0.0 109.854 173.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -69.13 -24.52 64.11 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.854 1.262 . . . . 0.0 113.518 -172.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 11.3 tt -64.22 -33.45 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.505 1.522 . . . . 0.0 112.413 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 62.8 mmm -80.6 -13.71 58.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.104 1.362 . . . . 0.0 111.453 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -107.66 127.35 53.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.774 2.03 . . . . 0.0 113.804 -171.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -162.56 138.5 7.34 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.2 mt -119.85 136.79 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.69 1.196 . . . . 0.0 110.543 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -130.19 138.58 50.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.646 1.178 . . . . 0.0 111.071 164.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 2.1 tt -109.74 131.95 54.59 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.63 1.572 . . . . 0.0 109.127 172.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -90.57 134.81 34.12 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.667 1.587 . . . . 0.0 111.547 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -130.71 9.19 4.97 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -158.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -148.47 156.31 42.3 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.558 1.143 . . . . 0.0 111.975 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 61.34 -161.13 26.55 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.626 1.107 . . . . 0.0 114.911 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.71 -27.13 62.66 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.249 -1.148 . . . . 0.0 113.425 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 28.0 ttm -85.25 -2.8 58.45 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.423 1.089 . . . . 0.0 113.359 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -54.04 128.03 28.92 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.48 1.112 . . . . 0.0 111.868 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.3 27.22 66.36 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.403 1.001 . . . . 0.0 112.913 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -109.7 161.93 14.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.302 1.441 . . . . 0.0 110.71 160.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.12 157.19 42.86 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.94 1.296 . . . . 0.0 112.876 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -118.35 147.04 43.91 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 168.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.17 126.09 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.724 1.609 . . . . 0.0 110.339 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.62 150.09 19.72 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.482 -0.761 . . . . 0.0 112.001 161.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.7 mt -128.64 163.2 46.55 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.098 1.759 . . . . 0.0 110.758 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.53 -3.36 13.26 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.484 2.789 . . . . 0.0 115.552 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -155.72 150.82 26.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.881 1.272 . . . . 0.0 111.602 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -53.77 -43.52 69.28 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.513 -0.742 . . . . 0.0 112.859 163.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -60.38 -40.33 90.44 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.581 1.152 . . . . 0.0 113.003 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.59 99.1 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.588 0.555 . . . . 0.0 111.412 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.62 -42.64 77.81 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.212 0.915 . . . . 0.0 112.164 174.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.24 -43.69 83.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.48 0.712 . . . . 0.0 111.746 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -68.3 -51.96 39.03 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.084 0.954 . . . . 0.0 111.339 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.53 -29.8 66.59 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.545 HD23 HG12 ' A' ' 498' ' ' VAL . 29.4 mt -70.69 -47.67 58.64 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.56 1.073 . . . . 0.0 111.144 172.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -57.89 -34.55 69.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.945 0.898 . . . . 0.0 112.149 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.49 -49.13 7.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.208 1.003 . . . . 0.0 112.925 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -82.14 -20.06 38.72 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -66.37 105.14 1.37 Allowed 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.171 -0.956 . . . . 0.0 110.588 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 110.27 -0.92 29.63 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.004 -1.442 . . . . 0.0 116.148 -173.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -68.23 122.48 18.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.921 1.86 . . . . 0.0 113.836 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.299 1.7 t -86.43 57.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -166.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 431' ' ' VAL . 15.2 tp -55.11 114.16 1.65 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.832 2.053 . . . . 0.0 111.436 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.332 61.3 m-85 58.42 23.17 10.33 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 -178.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 85.31 15.31 66.84 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 121.393 -0.817 . . . . 0.0 114.53 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.32 115.59 18.54 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.397 1.479 . . . . 0.0 110.672 -176.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.35 114.92 4.1 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.889 2.392 . . . . 0.0 112.149 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 72.3 mtp -68.98 128.07 35.38 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.834 1.254 . . . . 0.0 112.393 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 34.9 t -90.92 79.44 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.66 1.584 . . . . 0.0 110.799 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.545 HG12 HD23 ' A' ' 483' ' ' LEU . 2.6 t -83.24 126.93 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.627 1.971 . . . . 0.0 112.534 -174.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -145.19 157.64 44.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.996 1.318 . . . . 0.0 113.652 -170.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -63.05 146.39 53.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.679 0.792 . . . . 0.0 110.936 173.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.1 131.77 48.48 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.562 -0.711 . . . . 0.0 111.004 173.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -99.24 -40.37 7.98 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -123.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 1.2 t 46.81 26.86 0.61 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.82 2.048 . . . . 0.0 115.983 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . 53.44 31.17 11.66 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.32 1.848 . . . . 0.0 115.837 -170.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -119.99 50.22 1.61 Allowed Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -163.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.51 142.4 53.79 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.511 2.14 . . . . 0.0 112.318 173.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.76 157.49 40.24 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.485 1.514 . . . . 0.0 111.615 169.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.3 tp60 -71.05 151.2 44.8 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.5 0.72 . . . . 0.0 111.44 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -56.9 140.24 76.96 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 -164.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -73.75 -35.06 4.82 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.021 2.48 . . . . 0.0 114.559 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.61 159.39 27.55 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.357 1.463 . . . . 0.0 112.107 174.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 21.8 pm0 -63.59 -22.87 67.13 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -176.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 76.8 -56.83 3.48 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.593 -1.317 . . . . 0.0 112.455 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt 60.09 -45.97 0.09 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 130.205 3.402 . . . . 0.0 117.029 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -56.46 135.5 54.24 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.174 2.19 . . . . 0.0 110.279 172.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.409 1.484 . . . . 0.0 110.381 175.966 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 9.2 m . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.62 -41.12 79.96 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 117.117 2.266 . . . . 0.0 117.117 -175.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -150.56 16.35 0.8 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -171.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 97.7 mtp -69.15 148.01 97.56 Favored Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 120.528 -1.357 . . . . 0.0 112.169 170.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.5 9.41 2.21 Favored 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 124.125 3.216 . . . . 0.0 115.042 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 87.8 p -146.82 167.3 24.24 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.886 2.474 . . . . 0.0 109.709 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -123.28 126.38 46.79 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 120.824 -1.172 . . . . 0.0 111.395 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.4 p -147.97 160.41 42.86 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.008 1.323 . . . . 0.0 111.697 172.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.9 tt -70.95 145.89 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 125.707 1.603 . . . . 0.0 111.071 -166.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 10.6 m -78.54 146.3 34.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -56.57 -41.63 77.22 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.624 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -62.59 -32.48 73.48 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -73.5 -41.73 62.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.835 0.854 . . . . 0.0 113.179 170.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.22 -46.9 88.54 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.866 0.866 . . . . 0.0 110.661 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -58.49 -24.72 61.16 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.425 1.89 . . . . 0.0 115.16 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 48.0 mmtt -62.56 -49.9 73.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.995 0.816 . . . . 0.0 111.333 168.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.87 65.27 3.28 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.175 1.845 . . . . 0.0 112.351 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -153.41 137.57 16.48 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.916 1.286 . . . . 0.0 110.873 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.3 pt -121.57 157.43 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.597 1.159 . . . . 0.0 113.284 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.0 m -95.8 169.01 10.3 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.267 1.427 . . . . 0.0 112.199 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -54.3 -31.07 53.12 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.902 -1.124 . . . . 0.0 113.433 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -60.68 -25.64 66.53 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.561 1.145 . . . . 0.0 113.167 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.0 -41.5 10.51 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.671 1.188 . . . . 0.0 110.988 169.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 15.9 ttm -65.87 -30.93 71.61 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.817 -1.177 . . . . 0.0 113.098 -172.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -82.97 6.35 19.0 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.318 -0.864 . . . . 0.0 112.823 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.93 -30.53 4.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.989 2.116 . . . . 0.0 114.051 -176.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.403 ' HB3' HG22 ' A' ' 409' ' ' VAL . 40.3 mt -74.12 129.5 37.96 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.581 1.552 . . . . 0.0 111.343 174.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 88.3 p -59.29 -34.2 72.0 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.628 -0.67 . . . . 0.0 111.989 171.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 407' ' ' LEU . 33.7 m -60.38 -22.98 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 117.559 -1.21 . . . . 0.0 113.523 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.339 69.7 m-85 -94.55 2.0 55.66 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 119.113 3.005 . . . . 0.0 119.113 174.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -50.27 -23.58 2.37 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 -164.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 19.0 m -143.23 20.95 1.91 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.484 1.114 . . . . 0.0 112.926 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -135.71 133.87 38.51 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.343 1.457 . . . . 0.0 109.244 -161.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.412 ' HA ' ' HD2' ' A' ' 415' ' ' PRO . 45.0 mt-10 -136.33 92.92 15.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -165.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 415' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 414' ' ' GLU . 54.3 Cg_endo -64.76 159.65 44.48 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.201 3.267 . . . . 0.0 113.608 165.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 84.32 0.67 89.49 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.021 1.296 . . . . 0.0 113.305 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -77.3 136.11 65.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.409 1.484 . . . . 0.0 112.447 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.51 126.6 9.11 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.33 2.687 . . . . 0.0 112.48 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -160.41 152.39 20.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.537 1.535 . . . . 0.0 109.156 158.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.9 p -77.87 3.15 15.15 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.101 -1.624 . . . . 0.0 114.59 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -135.91 145.58 46.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.669 2.387 . . . . 0.0 108.961 171.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 12.7 pt -124.46 165.82 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.496 1.918 . . . . 0.0 110.071 174.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.86 159.09 42.9 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 174.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.489 HG22 HG13 ' A' ' 498' ' ' VAL . 8.6 t -132.07 132.93 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.409 1.483 . . . . 0.0 110.897 -174.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -106.56 164.53 11.99 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.693 1.197 . . . . 0.0 109.936 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 16.5 t30 68.2 39.36 2.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.839 1.256 . . . . 0.0 113.394 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.67 150.02 41.55 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.421 -0.799 . . . . 0.0 111.459 171.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.51 160.56 8.74 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.168 1.387 . . . . 0.0 114.471 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -62.26 -43.36 99.01 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.99 -1.069 . . . . 0.0 112.491 169.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -70.61 -35.33 72.92 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.1 p -71.51 149.3 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -170.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -123.2 166.84 14.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.423 1.489 . . . . 0.0 112.556 170.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -55.39 -33.58 63.61 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.826 -1.171 . . . . 0.0 112.719 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 9.1 pttm -62.87 -28.99 70.41 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.77 -37.44 48.98 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.189 0.996 . . . . 0.0 113.469 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.01 -20.54 54.0 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.404 1.882 . . . . 0.0 113.39 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.99 -18.97 5.77 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 171.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -61.81 -38.97 90.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.829 0.852 . . . . 0.0 112.009 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.29 -51.86 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.297 -0.877 . . . . 0.0 110.032 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -63.37 -33.1 74.81 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.2 -12.8 83.27 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 123.478 0.561 . . . . 0.0 114.121 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -58.8 -34.61 71.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.926 1.291 . . . . 0.0 112.565 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -79.93 -6.41 57.43 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.897 1.679 . . . . 0.0 113.548 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.27 111.24 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.984 1.714 . . . . 0.0 111.085 -172.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -69.84 86.78 0.51 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -54.04 -23.94 15.39 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 118.482 2.771 . . . . 0.0 118.482 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 61.2 m -65.75 -21.72 66.54 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.1 m -109.87 121.99 46.51 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.327 1.851 . . . . 0.0 111.88 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.75 -45.91 88.63 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.275 -0.891 . . . . 0.0 113.037 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -17.15 5.48 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -89.87 -57.01 3.01 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.64 0.776 . . . . 0.0 108.984 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -72.58 -21.06 61.2 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.265 1.426 . . . . 0.0 113.539 -173.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 17.0 tt -62.89 -36.26 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.295 1.838 . . . . 0.0 112.265 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.4 mtm -87.36 -8.0 57.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.829 0.851 . . . . 0.0 112.208 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -102.91 124.67 48.86 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -173.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.42 158.98 21.74 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.978 1.311 . . . . 0.0 108.626 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.0 mt -123.24 147.99 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.002 1.321 . . . . 0.0 111.224 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -134.93 132.37 38.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.31 2.244 . . . . 0.0 109.457 169.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.4 tp -124.93 113.13 17.44 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.877 2.071 . . . . 0.0 110.776 172.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 57.3 mtm -70.68 108.34 4.36 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.649 1.18 . . . . 0.0 111.454 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -96.48 10.8 37.19 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -147.23 154.16 40.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.158 1.783 . . . . 0.0 110.821 -174.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 85.18 -166.8 40.82 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.286 1.422 . . . . 0.0 116.273 168.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -11.17 2.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.622 1.969 . . . . 0.0 116.007 -172.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 24.7 ptp -140.7 41.53 1.86 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.948 1.699 . . . . 0.0 112.468 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -52.81 133.39 37.3 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.465 1.106 . . . . 0.0 111.709 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.07 31.71 34.16 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 124.476 1.036 . . . . 0.0 113.34 -177.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -125.99 147.76 49.45 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.539 0.736 . . . . 0.0 111.389 172.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -139.48 155.42 47.57 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.93 1.292 . . . . 0.0 114.038 -165.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -119.87 142.48 48.62 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.757 2.023 . . . . 0.0 114.96 171.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.2 mp -141.44 120.4 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.812 1.645 . . . . 0.0 110.893 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -83.01 140.02 19.69 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.433 -0.792 . . . . 0.0 111.397 163.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 20.8 mt -120.33 158.0 52.1 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.428 1.091 . . . . 0.0 110.766 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.53 -11.75 28.56 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.01 2.473 . . . . 0.0 114.405 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -151.27 142.45 23.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.821 0.849 . . . . 0.0 110.804 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -53.7 -35.46 61.15 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.204 1.402 . . . . 0.0 112.391 167.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -65.91 -38.5 88.87 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.99 85.86 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.309 0.504 . . . . 0.0 110.695 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.38 78.76 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 170.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.64 -36.46 69.53 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.243 0.929 . . . . 0.0 112.553 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -73.52 -53.62 10.17 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.096 1.359 . . . . 0.0 112.694 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.17 -31.75 69.27 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.614 HD23 HG12 ' A' ' 498' ' ' VAL . 49.1 mt -69.22 -42.6 75.49 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.573 -0.705 . . . . 0.0 112.387 176.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.1 -34.47 78.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.446 0.698 . . . . 0.0 111.991 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -82.1 -51.28 8.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.116 1.366 . . . . 0.0 114.37 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.61 -16.31 61.73 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.19 106.08 0.48 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.003 1.721 . . . . 0.0 112.361 174.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 112.23 -6.73 26.89 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 118.49 -1.172 . . . . 0.0 114.949 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -71.7 128.39 35.65 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.154 1.477 . . . . 0.0 107.324 -174.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.253 5.8 p -122.72 63.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 124.185 1.945 . . . . 0.0 110.427 -162.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.16 131.22 50.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.485 1.914 . . . . 0.0 110.913 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.371 52.1 m-85 56.05 21.72 5.31 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -175.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 77.93 8.03 87.39 Favored Glycine 0 CA--C 1.537 1.466 0 O-C-N 121.027 -1.046 . . . . 0.0 114.351 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -112.78 112.59 50.61 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.861 1.664 . . . . 0.0 110.196 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.9 121.28 7.2 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.713 2.275 . . . . 0.0 110.965 -174.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 41.7 mtp -79.77 124.44 28.61 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.614 1.566 . . . . 0.0 110.747 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 36.0 t -93.83 84.16 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.99 1.316 . . . . 0.0 110.719 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.614 HG12 HD23 ' A' ' 483' ' ' LEU . 2.0 t -77.78 131.84 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.012 1.725 . . . . 0.0 112.605 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -145.01 158.44 43.81 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.021 1.328 . . . . 0.0 113.469 -172.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -61.88 147.32 47.05 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.18 -0.95 . . . . 0.0 108.441 164.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -62.38 138.97 58.55 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.452 -0.78 . . . . 0.0 112.975 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 13.3 tpp85 -54.92 111.14 0.77 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.617 1.567 . . . . 0.0 113.811 -158.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 35.7 t -158.84 169.82 23.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.438 2.695 . . . . 0.0 109.898 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -141.0 49.39 1.67 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.131 1.373 . . . . 0.0 113.134 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -135.23 78.04 53.27 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.535 1.534 . . . . 0.0 112.439 -173.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -59.18 148.33 86.38 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.136 2.557 . . . . 0.0 115.574 -170.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -137.2 22.95 3.01 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.351 2.66 . . . . 0.0 110.998 172.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -152.47 145.22 24.31 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.324 2.65 . . . . 0.0 110.448 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.23 147.12 76.38 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.92 -17.84 24.96 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.831 2.354 . . . . 0.0 115.936 -167.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -120.28 154.74 34.52 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.027 1.331 . . . . 0.0 112.556 168.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -85.45 24.21 1.21 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.335 1.854 . . . . 0.0 114.346 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 77.34 173.65 39.74 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.635 1.588 . . . . 0.0 114.565 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.88 145.98 25.31 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.818 1.247 . . . . 0.0 112.459 176.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -108.48 -12.09 15.06 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 174.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 92.5 mttt . . . . . 0 C--O 1.251 1.153 0 CA-C-O 117.546 -1.216 . . . . 0.0 113.208 176.907 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 95.8 p . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . 0.33 53.2 m-20 60.73 7.0 1.27 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 120.404 3.483 . . . . 0.0 120.404 169.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -139.46 137.3 35.45 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.357 1.063 . . . . 0.0 112.09 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 5.8 mtp -155.8 157.97 31.59 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.464 1.506 . . . . 0.0 111.637 175.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -61.3 140.67 89.68 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.269 2.646 . . . . 0.0 114.508 -173.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 9.9 m -83.5 60.55 5.72 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.057 1.743 . . . . 0.0 110.99 -178.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -134.75 136.55 42.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.037 1.335 . . . . 0.0 111.101 -175.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 25.7 p -151.43 163.26 39.38 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.052 1.741 . . . . 0.0 113.3 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 3.1 tt -72.44 158.35 6.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.199 1.399 . . . . 0.0 111.196 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 66.2 m -96.41 150.87 20.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.052 0.941 . . . . 0.0 110.797 168.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -56.75 -39.45 74.03 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 111.281 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -68.58 -26.4 65.37 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -78.68 -38.62 38.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.973 1.26 . . . . 0.0 112.811 166.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.08 -45.83 91.62 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.857 0.863 . . . . 0.0 112.385 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -56.1 -25.55 46.2 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.938 1.295 . . . . 0.0 114.091 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -69.8 -25.36 63.75 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.053 0.941 . . . . 0.0 112.98 176.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -105.17 72.95 0.23 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.088 1.328 . . . . 0.0 110.969 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -156.11 141.52 17.63 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.568 1.147 . . . . 0.0 109.316 -174.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.7 pt -115.3 155.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 83.4 p -67.4 160.14 28.0 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.393 1.477 . . . . 0.0 111.749 161.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 52.2 mmt-85 -61.87 -30.64 70.99 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.606 -0.684 . . . . 0.0 111.139 168.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.49 -42.34 95.92 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.451 0.7 . . . . 0.0 112.103 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -36.01 77.51 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.671 0.669 . . . . 0.0 109.621 172.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 11.3 ttp -65.01 -39.88 94.09 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 120.556 -1.34 . . . . 0.0 112.078 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -81.03 15.86 1.7 Allowed 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.73 -35.95 2.98 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.798 2.039 . . . . 0.0 116.485 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.31 125.21 25.71 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.694 1.197 . . . . 0.0 108.994 172.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.2 m -65.12 -17.76 64.73 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.89 -25.49 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 170.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.31 75.8 m-85 -98.35 10.49 40.63 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 118.565 2.802 . . . . 0.0 118.565 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -60.31 -19.0 53.42 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 9.6 t -139.13 -35.58 0.55 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.816 1.646 . . . . 0.0 112.68 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -76.12 145.8 39.73 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -138.46 129.82 15.57 Favored Pre-proline 0 N--CA 1.478 0.951 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -168.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.6 172.33 13.54 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.586 2.857 . . . . 0.0 113.983 170.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.426 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 95.8 -21.33 45.43 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 116.954 1.541 . . . . 0.0 116.954 164.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.09 138.54 96.2 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 119.019 1.41 . . . . 0.0 112.588 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.27 116.85 4.77 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.283 2.655 . . . . 0.0 113.23 -174.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -153.66 146.93 24.75 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.201 1.4 . . . . 0.0 108.595 164.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.1 p -73.8 6.21 3.43 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -144.47 145.46 31.89 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.306 1.842 . . . . 0.0 108.921 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 27.7 pt -133.99 164.13 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.554 1.942 . . . . 0.0 109.865 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -136.01 162.23 33.45 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 172.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.4 p -140.03 146.95 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.934 1.294 . . . . 0.0 110.696 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' LYS . . . . . 0.514 ' HB2' ' HG2' ' A' ' 468' ' ' GLN . 17.1 ptpt -131.13 -175.38 3.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.283 0.633 . . . . 0.0 111.062 165.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.0 t30 66.44 38.33 4.33 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.072 1.349 . . . . 0.0 111.305 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.17 148.14 34.21 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.819 0.848 . . . . 0.0 110.447 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.68 173.83 9.94 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.636 1.975 . . . . 0.0 115.062 -173.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -60.88 -53.98 50.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.747 1.219 . . . . 0.0 113.507 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -78.39 -19.18 53.87 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.436 1.494 . . . . 0.0 114.731 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.55 148.72 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -173.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -129.32 162.88 26.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.186 1.794 . . . . 0.0 110.399 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -59.16 -28.67 66.81 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 119.47 -2.019 . . . . 0.0 112.403 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -58.13 -30.97 66.75 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -72.7 -36.28 67.81 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 173.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.25 -27.35 66.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.626 0.77 . . . . 0.0 111.692 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.34 -31.33 61.63 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.823 0.849 . . . . 0.0 112.748 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -61.35 -30.03 70.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.013 1.325 . . . . 0.0 111.697 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.7 mt -106.6 -57.66 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.682 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -58.85 -30.77 67.95 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -76.53 -8.74 86.1 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.87 -0.961 . . . . 0.0 114.661 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -64.82 -21.74 66.85 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.376 1.588 . . . . 0.0 112.63 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -92.64 4.46 53.63 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.874 1.67 . . . . 0.0 113.566 -177.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.7 108.73 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.289 1.836 . . . . 0.0 110.622 -171.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -64.53 99.86 0.33 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.311 17.8 m-85 -62.62 -16.18 55.4 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 64.7 m -64.83 -16.12 62.7 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 169.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 16.4 m -130.49 117.82 20.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.443 1.097 . . . . 0.0 112.713 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -60.44 -39.94 89.29 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.007 -1.058 . . . . 0.0 112.39 -174.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.6 t -56.44 -13.95 2.66 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -86.91 -63.84 1.25 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.983 0.913 . . . . 0.0 109.546 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.9 ptt85 -69.81 -22.78 63.28 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.517 1.527 . . . . 0.0 114.16 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.8 tt -57.87 -35.39 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.257 1.023 . . . . 0.0 111.899 171.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 21.6 mtm -90.37 -2.95 58.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.948 1.299 . . . . 0.0 112.228 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -105.89 129.56 54.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.77 2.028 . . . . 0.0 116.086 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -166.14 149.03 7.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.963 1.305 . . . . 0.0 109.399 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.9 mt -120.65 136.53 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.494 1.518 . . . . 0.0 111.807 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -114.74 141.33 47.99 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.974 1.31 . . . . 0.0 110.571 158.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 13.7 tp -120.61 114.54 21.87 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.562 1.545 . . . . 0.0 109.212 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -71.28 120.33 16.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.98 1.312 . . . . 0.0 109.274 169.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' LYS . . . . . 0.413 ' O ' ' HE2' ' A' ' 466' ' ' LYS . 10.1 mtpt -113.51 12.86 18.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.753 1.621 . . . . 0.0 113.035 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -142.23 152.65 43.29 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.306 1.843 . . . . 0.0 112.126 -167.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 59.58 -144.08 46.14 Favored Glycine 0 CA--C 1.534 1.269 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 161.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.75 -12.71 2.02 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.065 2.146 . . . . 0.0 116.335 -172.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 24.9 ptp -145.44 41.13 1.23 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.507 1.123 . . . . 0.0 112.539 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 461' ' ' LYS . 23.6 ttmt -60.38 122.44 14.56 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.409 1.084 . . . . 0.0 112.256 175.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.65 37.91 18.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.411 1.958 . . . . 0.0 112.858 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' GLN . . . . . 0.514 ' HG2' ' HB2' ' A' ' 425' ' ' LYS . 43.1 mt-30 -125.83 148.33 49.18 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.211 1.004 . . . . 0.0 110.892 173.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -138.94 151.59 47.02 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -109.08 137.98 46.14 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.829 2.051 . . . . 0.0 114.394 169.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.5 119.77 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.197 1.399 . . . . 0.0 109.968 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -85.2 142.04 19.5 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 162.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 19.3 mt -122.64 160.87 46.78 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.35 1.46 . . . . 0.0 110.343 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.01 -13.07 21.49 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.045 2.497 . . . . 0.0 114.55 -174.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -153.07 146.13 24.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.513 1.125 . . . . 0.0 110.254 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -52.31 -38.82 59.51 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.933 0.893 . . . . 0.0 111.95 165.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -61.42 -37.16 82.48 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.288 1.035 . . . . 0.0 113.122 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.36 90.84 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.262 -0.274 . . . . 0.0 110.947 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.3 -48.43 67.64 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.605 -0.684 . . . . 0.0 112.741 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.66 -28.05 68.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.306 1.042 . . . . 0.0 112.689 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -85.22 -44.27 13.06 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.048 0.939 . . . . 0.0 113.348 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.51 -33.21 71.08 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.881 1.219 . . . . 0.0 112.709 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.449 HD23 HG12 ' A' ' 498' ' ' VAL . 57.2 mt -65.47 -40.04 92.69 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.424 1.09 . . . . 0.0 112.989 174.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -63.34 -42.18 98.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.077 0.551 . . . . 0.0 111.454 174.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -78.87 -43.83 24.17 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -175.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.39 57.54 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -64.12 99.23 0.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.701 1.2 . . . . 0.0 112.245 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 115.45 1.6 21.65 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.469 -1.184 . . . . 0.0 115.044 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -74.44 110.4 8.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.944 1.372 . . . . 0.0 108.929 -169.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.275 6.4 p -93.71 65.77 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.054 1.742 . . . . 0.0 110.372 -170.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.79 129.42 39.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.199 1.8 . . . . 0.0 110.66 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.272 64.0 m-85 54.18 21.81 3.25 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -176.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 86.35 10.22 74.5 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 117.983 -1.454 . . . . 0.0 115.566 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -121.78 115.65 30.66 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 120.217 2.008 . . . . 0.0 111.751 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.44 112.41 3.54 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 123.868 3.045 . . . . 0.0 111.696 -174.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 80.1 mtp -73.64 131.44 41.67 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.855 1.262 . . . . 0.0 113.566 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 24.8 t -90.15 90.07 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.599 1.56 . . . . 0.0 111.502 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.449 HG12 HD23 ' A' ' 483' ' ' LEU . 1.4 t -90.17 129.47 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.889 1.276 . . . . 0.0 114.308 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -149.47 155.57 40.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.847 0.859 . . . . 0.0 112.953 -170.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -53.96 142.05 25.96 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 169.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -58.74 159.4 6.8 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.729 -0.607 . . . . 0.0 112.236 177.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -72.14 10.97 0.63 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -166.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 49.2 m -76.12 150.0 37.28 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.625 2.37 . . . . 0.0 112.98 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -64.47 159.38 21.6 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.775 1.23 . . . . 0.0 113.434 172.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -147.07 84.15 7.54 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 123.619 0.767 . . . . 0.0 112.719 173.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.39 162.9 16.2 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.529 2.82 . . . . 0.0 113.477 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 41.7 tptt 51.85 41.59 29.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.799 1.64 . . . . 0.0 114.084 168.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -104.59 -176.73 3.16 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.92 -1.113 . . . . 0.0 112.79 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.79 141.24 92.96 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 173.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.8 158.22 53.55 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.051 2.5 . . . . 0.0 112.664 177.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 153.39 10.66 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.37 1.068 . . . . 0.0 113.471 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -155.62 137.7 14.62 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.039 1.336 . . . . 0.0 111.19 -176.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 166.29 -177.04 41.42 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.509 0.576 . . . . 0.0 114.422 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -73.55 154.2 39.93 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.334 1.054 . . . . 0.0 110.945 168.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -138.51 120.92 16.02 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.83 1.252 . . . . 0.0 112.099 -171.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 25.4 pttm . . . . . 0 C--O 1.253 1.242 0 C-N-CA 125.25 1.42 . . . . 0.0 113.699 -178.909 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 111.41 0.152 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -124.43 -28.25 3.65 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 117.484 2.402 . . . . 0.0 117.484 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -134.27 -177.69 4.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.46 1.504 . . . . 0.0 111.715 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 88.5 mmm 58.51 88.16 0.13 Allowed Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 115.567 1.692 . . . . 0.0 115.567 169.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.71 164.21 34.16 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.683 2.922 . . . . 0.0 113.004 173.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 48.8 m -138.65 51.76 1.82 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.341 1.856 . . . . 0.0 110.611 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -156.25 124.13 5.61 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.759 1.224 . . . . 0.0 111.198 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 14.0 p -142.56 165.07 28.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.65 1.18 . . . . 0.0 113.474 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.3 tt -69.02 152.31 9.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 125.65 1.58 . . . . 0.0 111.678 -168.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 59.4 m -84.67 147.87 26.71 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.435 0.694 . . . . 0.0 110.429 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -58.06 -43.01 86.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.414 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -61.43 -29.87 70.21 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.324 1.45 . . . . 0.0 114.52 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -78.14 -49.69 13.4 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.39 1.076 . . . . 0.0 112.696 171.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 26.1 tp -57.89 -42.29 84.35 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.56 0.744 . . . . 0.0 112.096 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -58.67 -21.22 53.72 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.592 1.557 . . . . 0.0 114.977 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -75.76 -34.01 60.23 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.184 0.994 . . . . 0.0 112.753 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -93.66 75.26 1.13 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.026 1.298 . . . . 0.0 112.183 170.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -158.04 146.82 19.19 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.246 1.018 . . . . 0.0 111.008 -171.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 9.1 pt -128.66 157.84 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.45 1.5 . . . . 0.0 111.819 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 21.6 t -105.03 174.74 5.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.538 1.535 . . . . 0.0 111.047 166.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 21.6 mtp85 -57.93 -23.53 53.86 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.007 1.323 . . . . 0.0 113.402 175.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -54.61 -35.88 63.86 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.076 1.751 . . . . 0.0 111.856 171.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -99.18 -35.4 10.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.419 1.088 . . . . 0.0 112.526 169.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 26.3 ttp -65.18 -38.42 90.47 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.49 -1.381 . . . . 0.0 112.36 -172.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -80.23 17.26 1.06 Allowed 'General case' 0 CA--C 1.55 0.962 0 O-C-N 121.349 -0.845 . . . . 0.0 112.123 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.98 -30.37 2.72 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.405 2.282 . . . . 0.0 115.005 176.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 35.6 mt -74.22 137.92 43.36 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.59 1.956 . . . . 0.0 112.48 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 47.0 t -67.98 -36.61 80.34 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.036 0.934 . . . . 0.0 111.834 172.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.5 m -59.16 -14.41 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.403 ' CE1' HG13 ' A' ' 497' ' ' VAL 0.261 94.0 m-85 -116.58 16.74 15.48 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 170.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -8.47 12.53 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 16.7 p -148.52 -46.05 0.15 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.828 2.051 . . . . 0.0 112.527 -159.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -81.79 140.52 34.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.222 1.809 . . . . 0.0 113.783 -175.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -134.57 123.0 16.04 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.792 0.837 . . . . 0.0 112.921 -169.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.3 174.49 9.87 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.354 3.37 . . . . 0.0 113.357 170.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.485 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 82.1 -16.71 20.94 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.671 1.605 . . . . 0.0 116.798 170.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -57.53 139.21 81.22 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 118.801 1.3 . . . . 0.0 112.661 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.48 108.73 2.09 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.773 2.315 . . . . 0.0 112.083 -172.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -156.64 149.41 23.75 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.693 1.597 . . . . 0.0 109.269 167.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.4 p -86.1 -10.71 54.39 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 173.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -106.26 142.32 36.13 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.957 0.903 . . . . 0.0 110.022 172.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.16 162.59 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.373 1.469 . . . . 0.0 110.44 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -144.47 161.07 39.98 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.0 t -139.22 131.92 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.196 1.399 . . . . 0.0 113.422 -165.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -98.81 163.77 12.48 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.582 1.153 . . . . 0.0 111.904 167.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.287 98.0 m-20 75.78 34.9 0.54 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.925 2.09 . . . . 0.0 116.592 172.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.95 160.59 29.05 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.182 -0.949 . . . . 0.0 111.143 167.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.33 177.7 5.7 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.074 1.75 . . . . 0.0 114.172 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -82.41 -48.44 11.12 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.983 -1.073 . . . . 0.0 110.544 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -69.49 -18.98 63.74 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.2 p -77.08 139.84 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 121.008 -1.057 . . . . 0.0 113.08 171.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -120.65 167.22 12.67 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.189 1.396 . . . . 0.0 111.703 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.97 -34.1 58.81 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.94 -1.1 . . . . 0.0 112.657 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -59.97 -23.44 63.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.163 1.385 . . . . 0.0 114.675 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -87.57 -33.43 18.9 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.05 -19.69 64.63 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.699 1.6 . . . . 0.0 112.645 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -25.16 49.19 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.381 1.073 . . . . 0.0 112.869 174.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -60.01 -34.78 73.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.573 0.749 . . . . 0.0 112.4 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 4.4 mt -103.3 -57.0 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.635 -0.666 . . . . 0.0 110.739 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -59.55 -29.49 67.96 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.95 -11.41 84.73 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.806 -0.997 . . . . 0.0 114.847 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -62.49 -36.2 81.77 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.015 1.407 . . . . 0.0 111.435 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -77.47 3.37 13.59 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.926 1.69 . . . . 0.0 114.989 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 14.9 t -123.94 126.08 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.942 1.697 . . . . 0.0 110.593 -173.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -59.63 133.3 55.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -73.43 -23.14 60.09 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 99.0 p -92.14 -51.72 5.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.695 1.198 . . . . 0.0 113.262 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.2 m -76.45 118.78 19.48 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.412 0.685 . . . . 0.0 111.718 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -54.65 -49.59 70.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.115 1.366 . . . . 0.0 112.098 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.7 t -54.97 -15.2 1.85 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -88.75 -62.97 1.37 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.239 1.015 . . . . 0.0 110.228 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.17 -26.27 63.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.048 0.939 . . . . 0.0 113.253 -175.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.9 tt -58.18 -40.34 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.816 0.847 . . . . 0.0 111.857 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 9.2 mtm -86.93 -9.12 56.42 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.944 0.898 . . . . 0.0 112.334 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -87.6 125.83 34.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.853 1.661 . . . . 0.0 115.281 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -163.11 136.15 5.63 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.322 1.449 . . . . 0.0 110.195 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 10.7 mt -113.06 143.14 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.769 1.228 . . . . 0.0 111.55 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -129.57 143.21 50.73 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.822 1.649 . . . . 0.0 110.623 160.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 0.522 HD23 ' HE2' ' A' ' 461' ' ' LYS . 19.1 tp -123.59 119.65 30.52 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.871 2.069 . . . . 0.0 110.098 174.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -81.84 143.38 31.77 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.487 1.515 . . . . 0.0 112.25 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' LYS . . . . . 0.522 ' HE2' HD23 ' A' ' 459' ' ' LEU . 53.5 mmtt -130.9 8.99 4.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.107 1.763 . . . . 0.0 114.816 -167.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -145.49 143.38 29.96 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.615 1.166 . . . . 0.0 113.292 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 78.92 -160.58 46.8 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 126.514 2.007 . . . . 0.0 114.521 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.02 -18.05 59.28 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.833 -1.393 . . . . 0.0 113.269 172.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 98.2 mmm -83.86 -1.49 54.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.153 1.781 . . . . 0.0 114.546 171.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.6 127.0 29.34 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.701 -1.249 . . . . 0.0 111.834 176.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.71 17.93 80.04 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.779 -175.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -108.33 139.77 42.56 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.799 0.8 . . . . 0.0 112.188 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -123.06 147.42 46.73 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.876 1.27 . . . . 0.0 112.736 -174.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -107.14 140.59 39.75 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.323 1.449 . . . . 0.0 114.629 161.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.61 113.81 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.239 1.816 . . . . 0.0 109.032 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -76.38 125.24 7.58 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 160.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 37.4 mt -101.15 159.77 28.54 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.126 0.963 . . . . 0.0 109.484 165.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.3 -10.46 17.61 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.895 1.73 . . . . 0.0 114.222 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -151.16 138.67 19.55 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.467 1.107 . . . . 0.0 110.583 -171.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -56.18 -35.23 66.99 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 171.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -62.07 -42.29 99.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.844 0.747 . . . . 0.0 112.608 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.9 92.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.127 0.571 . . . . 0.0 111.24 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.56 -50.43 63.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.437 0.562 . . . . 0.0 112.418 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.24 72.63 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.75 1.159 . . . . 0.0 112.047 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -70.9 -46.58 62.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.085 1.354 . . . . 0.0 112.834 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.15 -37.4 77.2 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.771 0.714 . . . . 0.0 112.415 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.518 HD23 HG12 ' A' ' 498' ' ' VAL . 79.8 mt -70.41 -25.84 63.41 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.667 1.187 . . . . 0.0 112.548 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.61 -24.29 36.51 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.711 1.204 . . . . 0.0 112.647 175.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -104.87 -48.08 3.85 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.74 -15.88 58.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.621 1.168 . . . . 0.0 113.468 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -73.65 112.66 9.96 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.442 -0.787 . . . . 0.0 109.666 -174.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 110.32 -4.82 29.9 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 118.858 -0.968 . . . . 0.0 115.298 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -69.48 129.43 39.69 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.492 1.146 . . . . 0.0 108.54 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.252 3.5 p -120.81 68.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 124.394 2.045 . . . . 0.0 108.87 -162.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 39.2 tp -61.25 139.15 58.2 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 112.763 -2.017 . . . . 0.0 109.588 168.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.324 75.5 t80 61.05 13.97 5.04 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 173.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 80.1 11.02 84.87 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.476 1.512 . . . . 0.0 114.896 -171.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -121.86 120.57 28.48 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 126.472 1.909 . . . . 0.0 110.832 -173.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.71 121.84 7.71 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 C-N-CA 122.774 2.316 . . . . 0.0 110.79 -175.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 59.9 mtp -76.89 129.79 36.68 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.919 1.688 . . . . 0.0 112.293 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 497' ' ' VAL . . . . . 0.403 HG13 ' CE1' ' A' ' 410' ' ' PHE . 4.4 t -92.46 90.42 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.681 1.592 . . . . 0.0 112.306 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.518 HG12 HD23 ' A' ' 483' ' ' LEU . 2.6 t -85.67 120.52 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.989 1.315 . . . . 0.0 112.102 -172.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -135.99 157.38 46.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.22 1.008 . . . . 0.0 113.63 -168.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -59.74 145.41 45.23 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 163.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -56.03 140.76 42.44 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -82.21 49.29 1.39 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.614 1.166 . . . . 0.0 112.693 -173.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 16.4 m -68.07 -30.31 69.48 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.903 1.281 . . . . 0.0 114.146 -165.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -79.76 -14.96 58.35 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.188 0.995 . . . . 0.0 113.682 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 43.58 54.66 11.21 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 126.637 1.975 . . . . 0.0 114.03 169.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.11 144.36 81.48 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.1 2.533 . . . . 0.0 113.348 -172.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -54.3 121.77 8.94 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.719 1.608 . . . . 0.0 113.976 -168.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -63.18 133.28 54.07 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.228 1.411 . . . . 0.0 112.039 175.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -61.46 145.14 91.44 Favored Pre-proline 0 N--CA 1.475 0.81 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 170.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.0 158.02 38.39 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.868 2.379 . . . . 0.0 113.566 -173.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.01 160.04 0.79 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.895 -1.502 . . . . 0.0 114.053 161.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -83.8 169.31 15.31 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.872 1.269 . . . . 0.0 111.188 162.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -70.96 19.01 0.77 Allowed Glycine 0 CA--C 1.539 1.553 0 N-CA-C 116.553 1.381 . . . . 0.0 116.553 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -64.09 110.33 2.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.729 1.611 . . . . 0.0 109.938 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -152.95 135.99 15.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.567 1.947 . . . . 0.0 110.855 -167.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 53.8 mttp . . . . . 0 C--O 1.253 1.242 0 C-N-CA 124.864 1.266 . . . . 0.0 113.645 176.196 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 19.5 p -129.79 167.37 18.2 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.58 1.952 . . . . 0.0 109.951 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.3 tt -68.92 144.38 14.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 O-C-N 121.511 -0.743 . . . . 0.0 111.106 -160.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 62.0 m -84.11 150.63 25.42 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.159 -0.338 . . . . 0.0 111.471 172.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 42.5 ttp85 -59.37 -41.24 88.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.54 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -61.67 -29.83 70.33 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -80.29 -44.39 19.67 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.449 1.1 . . . . 0.0 113.121 171.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.416 HD12 ' CD2' ' A' ' 489' ' ' TYR . 22.3 tp -59.18 -46.07 89.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.725 0.81 . . . . 0.0 112.145 175.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -60.3 -21.9 62.53 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -63.26 -33.87 76.43 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.889 0.768 . . . . 0.0 112.328 171.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -107.41 84.19 0.37 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.999 1.285 . . . . 0.0 110.958 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -161.34 152.51 18.59 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.259 0.624 . . . . 0.0 110.555 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.6 pt -127.76 151.07 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.131 0.972 . . . . 0.0 112.868 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 92.1 p -76.75 166.13 23.79 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.203 1.401 . . . . 0.0 112.057 162.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -57.03 -24.51 54.26 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 168.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -71.89 -37.28 70.17 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.493 1.517 . . . . 0.0 111.815 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -80.08 -37.04 34.61 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.487 0.715 . . . . 0.0 110.548 167.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 27.6 ttm -59.74 -46.86 87.84 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.614 -1.304 . . . . 0.0 112.161 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -78.8 15.0 1.15 Allowed 'General case' 0 CA--C 1.552 1.032 0 O-C-N 120.627 -1.296 . . . . 0.0 112.74 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.69 -31.92 5.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.28 2.632 . . . . 0.0 114.474 171.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 34.1 mt -75.54 133.69 40.93 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.857 1.663 . . . . 0.0 111.755 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 91.5 p -63.31 -32.32 73.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.277 1.031 . . . . 0.0 112.17 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.71 -15.34 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.328 78.0 m-85 -106.66 8.38 31.07 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -54.06 -16.27 1.88 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 118.105 2.632 . . . . 0.0 118.105 -165.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.4 m -147.6 14.19 1.07 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.589 1.155 . . . . 0.0 113.98 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -130.49 130.72 44.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.221 1.008 . . . . 0.0 109.465 -162.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -143.87 133.01 11.41 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.153 1.381 . . . . 0.0 113.183 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.02 -178.77 4.0 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 125.207 3.938 . . . . 0.0 114.982 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 96.52 -9.7 66.8 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 164.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -68.92 150.74 97.53 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 119.031 1.416 . . . . 0.0 113.204 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.11 114.35 4.01 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.767 2.978 . . . . 0.0 111.923 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.51 142.65 12.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.25 1.42 . . . . 0.0 107.579 168.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.5 p -77.51 -14.02 59.78 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.406 1.082 . . . . 0.0 112.691 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -107.33 141.09 39.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.531 1.132 . . . . 0.0 109.029 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 4.8 pt -126.94 159.21 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 125.504 1.522 . . . . 0.0 109.429 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -140.63 160.17 40.59 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.9 t -134.25 137.19 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.191 1.396 . . . . 0.0 111.261 -172.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -112.11 165.83 11.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.136 0.974 . . . . 0.0 109.961 166.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.3 t30 65.81 36.07 6.36 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.721 1.209 . . . . 0.0 113.491 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.95 153.78 42.81 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.422 -0.798 . . . . 0.0 110.294 163.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.76 148.45 49.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.857 0.863 . . . . 0.0 113.029 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -62.06 -34.04 75.52 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.767 -1.208 . . . . 0.0 111.141 158.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -60.86 -10.2 5.27 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.545 1.938 . . . . 0.0 115.418 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.1 p -121.13 155.99 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -170.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -119.53 161.65 20.23 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.619 1.567 . . . . 0.0 111.122 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -55.08 -35.38 64.51 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.955 -1.091 . . . . 0.0 113.059 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -63.63 -16.68 61.6 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.108 1.363 . . . . 0.0 114.585 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -91.64 -31.68 15.76 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.15 -21.36 66.52 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.319 -0.863 . . . . 0.0 112.315 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -48.57 -35.14 12.8 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.068 1.347 . . . . 0.0 112.813 169.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -58.6 -35.34 72.29 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.0 mt -98.6 -57.88 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.284 0.634 . . . . 0.0 110.298 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.291 59.6 m-85 -60.7 -30.38 69.92 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.44 -6.91 86.96 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.104 0.859 . . . . 0.0 114.669 173.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -56.36 -34.02 66.24 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.341 1.57 . . . . 0.0 111.412 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.96 9.8 26.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.106 1.762 . . . . 0.0 113.855 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.36 113.49 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.554 1.541 . . . . 0.0 109.535 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.77 80.17 0.19 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -54.7 -18.2 4.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 119.013 2.968 . . . . 0.0 119.013 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.4 m -71.75 -12.64 61.41 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.563 1.074 . . . . 0.0 112.857 170.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.7 m -115.15 116.49 28.47 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.191 1.796 . . . . 0.0 111.867 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -59.06 -43.41 91.74 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.216 -0.928 . . . . 0.0 112.704 -173.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.3 t -55.96 -14.56 2.59 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -88.09 -60.99 1.82 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.697 0.761 . . . . 0.0 110.018 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -69.69 -25.82 64.06 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.127 1.371 . . . . 0.0 113.876 -173.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.8 tt -55.25 -35.91 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.057 1.343 . . . . 0.0 112.098 170.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 10.5 mtm -90.03 -3.93 57.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.343 1.057 . . . . 0.0 112.614 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -101.12 134.21 44.48 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.244 2.217 . . . . 0.0 115.994 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -166.16 156.71 12.73 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.212 1.405 . . . . 0.0 108.183 174.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.2 mt -130.82 134.94 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.741 1.216 . . . . 0.0 110.283 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -120.81 132.8 55.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.891 0.876 . . . . 0.0 109.873 159.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 4.1 tt -103.2 133.29 48.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.155 1.382 . . . . 0.0 110.006 168.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.61 91.68 3.43 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 125.767 1.627 . . . . 0.0 110.846 171.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -67.95 -23.82 65.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 -174.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.415 ' HA ' ' HE3' ' A' ' 466' ' ' LYS . 26.0 pt-20 -154.76 175.03 14.23 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -175.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 87.79 -169.05 38.34 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.669 1.604 . . . . 0.0 114.15 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 4.02 1.99 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 74.1 mtp -129.98 20.21 5.44 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.965 2.506 . . . . 0.0 112.437 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 462' ' ' GLU . 35.9 ttmt -52.08 138.85 24.47 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.994 1.318 . . . . 0.0 111.803 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.78 32.56 61.16 Favored Glycine 0 CA--C 1.524 0.619 0 O-C-N 121.809 -0.557 . . . . 0.0 111.81 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.71 155.49 20.13 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.683 1.193 . . . . 0.0 110.79 165.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -148.27 148.19 30.19 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.143 -0.973 . . . . 0.0 112.733 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -113.05 138.24 50.2 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.761 1.624 . . . . 0.0 114.768 167.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.7 112.72 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.164 1.786 . . . . 0.0 109.482 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -78.79 134.55 14.14 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 159.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 20.2 mt -109.39 161.96 21.99 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.226 1.41 . . . . 0.0 109.913 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.53 -12.3 29.17 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.031 2.487 . . . . 0.0 113.654 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -153.5 142.66 21.4 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.703 0.683 . . . . 0.0 112.013 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -60.12 -29.88 68.91 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -67.94 -36.42 80.1 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 170.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -66.48 -39.32 88.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.79 0.436 . . . . 0.0 110.663 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.39 -43.16 86.63 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.512 -0.743 . . . . 0.0 112.638 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -55.78 -43.52 76.85 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.35 0.977 . . . . 0.0 111.78 176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -65.69 -52.86 48.14 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.081 1.352 . . . . 0.0 111.773 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.27 71.44 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.54 HD23 HG12 ' A' ' 498' ' ' VAL . 51.3 mt -68.95 -39.05 79.76 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.929 -1.107 . . . . 0.0 110.712 173.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -68.07 -22.77 64.91 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.794 1.238 . . . . 0.0 112.44 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -110.14 -39.73 4.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -84.45 -17.75 38.17 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -75.45 117.33 17.12 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.097 -1.002 . . . . 0.0 112.308 -168.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 101.47 3.24 53.44 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.231 -1.316 . . . . 0.0 115.043 -169.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.416 ' CD2' HD12 ' A' ' 394' ' ' LEU . 72.7 t80 -69.08 125.49 26.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.482 1.641 . . . . 0.0 113.48 -169.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.266 1.9 t -86.01 46.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.632 1.573 . . . . 0.0 114.836 -162.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 57.3 tp -58.85 120.26 8.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.47 1.508 . . . . 0.0 111.71 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.334 72.1 m-85 55.22 21.25 3.89 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -173.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 98.31 -6.41 61.42 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.689 1.614 . . . . 0.0 115.015 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -106.15 122.11 43.33 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.182 1.491 . . . . 0.0 111.864 -170.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.75 105.92 2.17 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.416 2.744 . . . . 0.0 112.548 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 44.1 mtp -67.41 131.82 46.44 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.999 1.32 . . . . 0.0 113.403 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.52 84.7 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.901 2.081 . . . . 0.0 110.945 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.54 HG12 HD23 ' A' ' 483' ' ' LEU . 4.0 t -87.28 125.79 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 126.578 1.951 . . . . 0.0 112.321 -170.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -141.63 158.73 43.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.654 1.181 . . . . 0.0 113.046 -170.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -61.24 146.41 47.92 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 166.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 122.586 1.184 . . . . 0.0 112.233 -175.901 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 122.418 1.104 . . . . 0.0 111.99 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -143.28 167.66 21.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.132 1.373 . . . . 0.0 112.151 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.8 tt -78.68 154.29 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.855 1.262 . . . . 0.0 111.989 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 30.6 t -91.01 154.07 19.69 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.235 0.614 . . . . 0.0 111.101 167.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -44.26 -43.09 7.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.034 1.333 . . . . 0.0 112.502 164.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -71.55 -18.19 62.27 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -89.44 -39.34 13.44 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.177 -0.952 . . . . 0.0 113.445 165.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.38 -48.65 69.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.201 1.0 . . . . 0.0 112.788 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -56.8 -25.89 56.72 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.76 1.624 . . . . 0.0 113.941 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.86 -44.87 84.12 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.91 1.284 . . . . 0.0 110.832 175.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.55 78.08 0.73 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.308 1.432 . . . . 0.0 113.196 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -157.48 149.47 22.39 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.642 1.577 . . . . 0.0 109.642 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.7 pt -127.83 149.97 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.9 0.88 . . . . 0.0 111.567 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 8.8 m -80.41 167.78 19.78 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.89 0.876 . . . . 0.0 112.228 169.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -55.92 -29.22 59.73 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.271 -0.893 . . . . 0.0 112.765 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.63 -31.79 69.83 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.56 1.944 . . . . 0.0 113.309 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.57 -34.29 14.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.502 1.121 . . . . 0.0 110.947 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 9.7 ttm -61.26 -39.29 89.81 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.952 -1.092 . . . . 0.0 111.279 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.15 26.41 0.88 Allowed 'General case' 0 CA--C 1.552 1.056 0 O-C-N 120.846 -1.159 . . . . 0.0 112.455 172.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.51 -34.81 1.17 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.109 2.563 . . . . 0.0 113.858 174.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.37 134.0 42.48 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.803 1.641 . . . . 0.0 112.613 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 27.1 t -59.43 -37.86 79.18 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.707 0.803 . . . . 0.0 113.092 172.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.421 HG23 ' CD2' ' A' ' 410' ' ' PHE 0.27 3.1 m -60.44 -11.05 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 171.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.421 ' CD2' HG23 ' A' ' 409' ' ' VAL . 79.0 m-85 -122.49 11.2 9.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 119.237 3.051 . . . . 0.0 119.237 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -14.28 16.27 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -173.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.53 -27.48 1.18 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.556 1.542 . . . . 0.0 114.423 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -69.83 136.56 50.92 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -144.86 124.98 7.25 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.53 171.97 16.66 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.128 3.219 . . . . 0.0 111.629 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.48 -4.79 33.02 Favored Glycine 0 N--CA 1.48 1.594 0 N-CA-C 117.33 1.692 . . . . 0.0 117.33 170.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -74.58 131.75 79.41 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 119.079 1.439 . . . . 0.0 111.817 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.12 112.92 2.43 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.105 2.537 . . . . 0.0 111.032 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.459 HD22 ' H ' ' A' ' 421' ' ' ARG . 4.6 t30 -159.9 145.7 15.61 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.605 1.162 . . . . 0.0 109.498 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 21.3 p -86.1 -8.35 57.94 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.459 ' H ' HD22 ' A' ' 419' ' ' ASN . 41.7 mtt180 -117.95 148.54 42.09 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.667 1.187 . . . . 0.0 110.07 176.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 17.8 pt -135.01 166.35 28.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.474 1.91 . . . . 0.0 110.046 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -137.93 163.64 31.0 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.88 143.85 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.652 1.581 . . . . 0.0 111.573 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -126.65 168.81 13.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.658 1.983 . . . . 0.0 109.905 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 12.9 t30 68.5 31.25 4.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.817 1.247 . . . . 0.0 112.808 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -74.54 144.51 44.01 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.018 -1.051 . . . . 0.0 111.856 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.34 156.98 17.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.928 1.691 . . . . 0.0 114.778 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -59.55 -45.74 90.93 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.238 -0.914 . . . . 0.0 112.964 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -70.87 -26.94 63.47 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -175.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.15 152.65 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -172.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -129.41 162.1 28.83 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.732 2.013 . . . . 0.0 111.038 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -53.22 -30.84 40.12 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.096 1.358 . . . . 0.0 113.401 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -58.06 -25.85 61.77 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.166 1.787 . . . . 0.0 115.282 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -90.02 -28.55 19.0 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.5 mp -66.47 -19.99 65.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.32 1.448 . . . . 0.0 112.206 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.44 -25.24 59.34 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 174.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -61.47 -36.33 80.12 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.941 0.791 . . . . 0.0 111.477 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.4 mp -96.78 -56.58 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.202 0.601 . . . . 0.0 110.679 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.258 70.1 m-85 -60.11 -32.99 71.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.82 -7.24 87.41 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.062 0.839 . . . . 0.0 114.522 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -61.2 -39.71 91.2 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.842 1.321 . . . . 0.0 111.46 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -81.06 -0.79 41.41 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.585 1.954 . . . . 0.0 113.815 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 36.0 t -115.09 116.53 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.718 1.207 . . . . 0.0 109.996 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.262 4.2 m-20 -68.72 90.97 0.42 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 176.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -61.74 -16.53 50.12 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 119.006 2.965 . . . . 0.0 119.006 -173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 71.0 m -79.09 1.5 24.0 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.01 0.924 . . . . 0.0 113.361 168.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 11.1 t -126.89 112.68 15.6 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.65 1.18 . . . . 0.0 110.947 -173.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -59.86 -47.14 86.95 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.243 -0.911 . . . . 0.0 112.274 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 3.9 t -55.92 -15.24 3.13 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -89.21 -58.39 2.55 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.221 1.008 . . . . 0.0 110.685 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -71.59 -25.58 62.24 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.716 1.206 . . . . 0.0 113.432 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.3 tt -56.65 -33.12 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.263 1.425 . . . . 0.0 112.151 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -87.51 -5.81 58.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.308 1.443 . . . . 0.0 112.964 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -115.81 120.11 38.19 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -162.41 155.34 19.87 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.327 1.451 . . . . 0.0 107.61 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.1 mt -125.05 137.6 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.767 1.627 . . . . 0.0 110.499 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 -127.51 128.78 46.24 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.395 1.478 . . . . 0.0 109.485 165.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 14.1 tp -111.18 134.91 52.41 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.439 1.896 . . . . 0.0 109.308 170.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 50.7 mtm -89.38 133.18 34.62 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 126.518 1.927 . . . . 0.0 111.151 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -129.45 11.53 5.83 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -167.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -136.98 153.16 50.76 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.555 1.142 . . . . 0.0 112.476 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 70.66 -160.75 53.8 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.659 1.123 . . . . 0.0 115.379 171.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -6.11 27.37 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.732 1.613 . . . . 0.0 115.269 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 95.8 mmm -102.39 1.23 35.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.563 1.545 . . . . 0.0 114.611 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -62.31 132.99 54.48 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.639 1.563 . . . . 0.0 110.651 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.56 29.36 36.21 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.98 0.8 . . . . 0.0 113.597 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -121.09 148.05 44.7 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.444 1.098 . . . . 0.0 112.265 165.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -140.35 155.24 46.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.427 1.491 . . . . 0.0 114.02 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -113.46 140.35 48.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.415 1.886 . . . . 0.0 115.711 167.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -138.06 128.28 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.764 1.626 . . . . 0.0 111.223 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.76 143.94 17.44 Favored Glycine 0 CA--C 1.534 1.246 0 O-C-N 121.434 -0.792 . . . . 0.0 111.955 164.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 31.7 mt -126.67 155.17 75.37 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.579 1.152 . . . . 0.0 110.799 172.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.47 -6.17 17.93 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.835 2.357 . . . . 0.0 114.94 -168.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -154.25 143.15 21.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.92 0.888 . . . . 0.0 110.606 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -56.29 -30.9 63.09 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.044 -1.035 . . . . 0.0 112.859 169.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -66.26 -41.17 90.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.274 0.943 . . . . 0.0 113.394 171.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.62 96.89 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 119.423 -0.322 . . . . 0.0 110.797 174.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.84 -46.62 77.84 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.763 0.711 . . . . 0.0 112.338 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.9 -41.97 83.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.277 0.944 . . . . 0.0 112.101 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -69.96 -45.8 66.63 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.527 1.131 . . . . 0.0 112.159 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -63.12 -31.56 72.73 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.609 HD23 HG12 ' A' ' 498' ' ' VAL . 26.6 mt -69.32 -45.98 68.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.634 1.106 . . . . 0.0 110.549 172.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -59.92 -34.38 73.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.97 1.308 . . . . 0.0 111.86 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -88.11 -49.52 6.97 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.22 -23.87 37.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -167.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -73.08 104.62 4.22 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.816 -0.553 . . . . 0.0 109.602 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 117.82 -6.8 15.59 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 117.829 -1.539 . . . . 0.0 116.134 -167.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -65.67 132.64 49.29 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.064 1.932 . . . . 0.0 113.874 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.281 0.2 OUTLIER -94.06 47.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -157.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 31.5 tp -54.9 122.02 9.91 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.016 1.326 . . . . 0.0 111.342 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.385 50.5 m-85 59.42 12.97 2.95 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 -173.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 89.15 1.42 79.15 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.046 -1.034 . . . . 0.0 114.306 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -107.06 125.13 33.28 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 126.235 1.814 . . . . 0.0 111.012 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.05 121.06 7.5 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.034 2.49 . . . . 0.0 112.644 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 71.5 mtp -73.01 127.58 32.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.163 1.385 . . . . 0.0 111.347 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 92.7 t -92.55 95.89 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.352 1.861 . . . . 0.0 109.041 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.609 HG12 HD23 ' A' ' 483' ' ' LEU . 15.2 t -100.07 114.54 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.399 2.28 . . . . 0.0 112.296 -172.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.09 162.5 32.75 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -56.91 144.98 31.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.418 1.087 . . . . 0.0 110.27 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -176.007 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 . . . . . 0 C--O 1.236 0.361 0 CA-C-O 121.396 0.617 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.3 p -148.0 161.9 40.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.328 1.451 . . . . 0.0 114.761 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.3 tt -69.87 158.64 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 126.177 1.791 . . . . 0.0 111.8 -172.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 73.8 m -92.33 152.38 19.8 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.953 -0.467 . . . . 0.0 111.399 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -56.56 -41.31 76.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.2 0.6 . . . . 0.0 111.365 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.09 -35.86 79.96 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -77.71 -30.87 52.0 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.2 tt -65.17 -48.96 71.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.378 1.071 . . . . 0.0 111.274 171.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -54.42 -24.69 20.95 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.376 1.871 . . . . 0.0 115.711 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -67.53 -36.01 80.19 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.568 1.147 . . . . 0.0 111.959 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.61 76.37 0.73 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 125.992 1.758 . . . . 0.0 111.372 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -163.65 145.98 9.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.24 1.016 . . . . 0.0 110.155 -172.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.7 pt -124.8 148.97 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.116 0.966 . . . . 0.0 112.509 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 33.7 t -81.28 166.97 20.05 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.643 1.177 . . . . 0.0 110.695 165.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -53.29 -31.96 46.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.41 1.084 . . . . 0.0 112.905 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -59.15 -19.68 47.0 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.927 1.691 . . . . 0.0 113.075 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -111.83 -28.56 8.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.342 1.857 . . . . 0.0 111.934 171.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 15.7 ttm -67.01 -38.38 85.87 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.195 -1.566 . . . . 0.0 111.936 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -83.89 31.51 0.48 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.815 0.846 . . . . 0.0 111.062 169.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.98 -42.18 0.53 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.313 1.845 . . . . 0.0 115.404 171.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.39 128.43 35.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.648 0.779 . . . . 0.0 109.308 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 50.9 m -59.97 -33.53 72.07 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.329 0.651 . . . . 0.0 112.34 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 5.3 m -63.41 -25.58 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.288 82.6 m-85 -94.07 -9.71 35.77 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -21.5 0.85 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 -163.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 15.6 m -143.9 24.82 1.65 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.476 1.91 . . . . 0.0 112.081 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -122.0 132.3 54.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.428 2.291 . . . . 0.0 112.371 -173.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -142.28 131.98 12.3 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -164.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.1 176.73 8.57 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.566 2.844 . . . . 0.0 111.685 161.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.01 69.16 1.41 Allowed Glycine 0 CA--C 1.532 1.098 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 172.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -145.7 155.16 52.62 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 126.463 1.905 . . . . 0.0 110.833 165.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -82.24 84.74 1.78 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.978 3.119 . . . . 0.0 112.371 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -139.4 143.46 37.68 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.232 -0.917 . . . . 0.0 111.792 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 29.8 p -84.33 7.21 20.16 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -135.11 145.49 47.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.682 1.593 . . . . 0.0 110.082 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 24.1 pt -139.53 162.21 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.507 1.923 . . . . 0.0 109.706 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -133.4 161.77 33.64 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 123.193 1.473 . . . . 0.0 107.722 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.414 HG22 HG13 ' A' ' 498' ' ' VAL . 10.5 t -130.27 139.35 51.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.769 1.628 . . . . 0.0 110.834 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -119.68 168.23 11.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.184 1.794 . . . . 0.0 109.916 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 9.8 t30 68.31 32.38 4.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.657 1.183 . . . . 0.0 111.602 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.96 134.51 41.5 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.522 -0.736 . . . . 0.0 109.972 167.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.9 170.82 1.91 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -173.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -65.52 -50.04 66.74 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.772 1.229 . . . . 0.0 112.92 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -68.06 -42.17 80.88 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.46 152.45 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 127.258 2.223 . . . . 0.0 116.231 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -139.69 170.39 15.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.975 1.31 . . . . 0.0 112.488 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -54.51 -33.77 60.49 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.435 -1.415 . . . . 0.0 113.565 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 34.6 pttt -58.75 -39.46 80.99 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 171.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.28 -32.75 72.11 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.737 1.215 . . . . 0.0 113.538 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.6 mp -69.57 -27.61 65.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.677 1.191 . . . . 0.0 112.805 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -30.67 63.55 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.023 0.829 . . . . 0.0 112.293 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.08 -34.18 74.51 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.46 1.104 . . . . 0.0 111.845 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.12 -58.34 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.127 -0.983 . . . . 0.0 110.827 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -57.68 -29.57 64.75 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.51 -14.78 82.11 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.077 -0.846 . . . . 0.0 114.581 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -56.97 -37.05 71.05 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.263 1.531 . . . . 0.0 111.959 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.63 -7.48 53.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.353 1.461 . . . . 0.0 113.686 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 18.1 t -118.54 123.11 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.72 2.008 . . . . 0.0 110.929 -171.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -75.69 111.6 11.19 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -65.42 -15.13 62.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 70.5 m -89.23 -12.47 40.69 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.197 0.999 . . . . 0.0 113.402 172.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 24.1 t -111.72 109.44 19.3 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.252 1.021 . . . . 0.0 110.845 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -57.92 -45.33 86.68 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.563 -0.711 . . . . 0.0 111.739 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.74 -17.2 5.48 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -87.34 -61.21 1.77 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.31 1.044 . . . . 0.0 110.28 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -70.5 -19.31 62.93 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.084 1.353 . . . . 0.0 113.986 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.1 tt -63.66 -32.62 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.468 1.507 . . . . 0.0 112.531 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.1 mmm -86.88 -14.52 41.77 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.639 1.176 . . . . 0.0 112.42 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -96.13 124.59 40.19 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -171.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -160.51 146.3 15.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.31 143.94 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.305 1.042 . . . . 0.0 110.57 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 73.0 mtp85 -126.66 138.76 53.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.573 1.549 . . . . 0.0 109.858 164.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 2.1 tt -118.96 125.0 48.41 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.057 1.343 . . . . 0.0 110.153 167.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -82.01 125.93 31.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.053 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -115.48 4.92 14.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.065 1.346 . . . . 0.0 112.998 -165.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.6 157.16 34.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.105 2.162 . . . . 0.0 110.457 -170.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 72.22 -164.62 54.41 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.507 1.051 . . . . 0.0 115.445 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -21.57 55.67 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 82.8 mtp -101.32 12.0 38.24 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -55.27 122.57 11.4 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.552 1.523 . . . . 0.0 111.154 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.23 28.05 56.7 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.599 1.095 . . . . 0.0 112.835 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -112.84 155.75 24.11 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.704 1.202 . . . . 0.0 110.909 163.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -149.08 155.62 41.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.508 1.123 . . . . 0.0 112.764 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.46 137.78 54.41 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.58 124.96 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.814 1.645 . . . . 0.0 110.623 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.65 141.19 15.42 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 160.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.6 mt -119.45 157.42 51.62 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.878 1.271 . . . . 0.0 110.187 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.59 -5.99 17.64 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.515 2.143 . . . . 0.0 114.242 -173.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -148.93 138.82 22.06 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.979 1.312 . . . . 0.0 110.102 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.07 -37.39 71.79 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.7 -0.625 . . . . 0.0 111.753 168.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -60.61 -37.66 82.14 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -69.23 -38.02 78.31 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.674 0.79 . . . . 0.0 111.701 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.82 -45.77 81.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.55 1.068 . . . . 0.0 111.86 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.05 76.12 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.766 0.712 . . . . 0.0 112.284 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -69.2 -47.78 63.89 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.998 0.919 . . . . 0.0 112.336 173.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.52 -31.52 71.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.484 0.714 . . . . 0.0 112.65 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.646 HD23 HG12 ' A' ' 498' ' ' VAL . 66.7 mt -73.28 -31.94 64.36 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.514 1.126 . . . . 0.0 112.468 172.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -71.03 -34.29 71.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.304 0.642 . . . . 0.0 111.34 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -89.85 -54.86 3.87 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -73.52 -17.05 61.26 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -69.22 101.92 1.59 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.281 1.032 . . . . 0.0 110.225 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 114.66 -2.1 23.27 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 117.919 -1.49 . . . . 0.0 116.103 -172.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -68.71 120.53 14.84 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.316 2.058 . . . . 0.0 109.367 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.32 69.83 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 124.067 1.889 . . . . 0.0 110.225 -167.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 22.7 tp -76.03 130.22 38.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.181 175.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.341 55.6 m-85 58.01 31.93 21.3 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 76.81 0.21 68.0 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.097 1.332 . . . . 0.0 115.594 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 27.4 tptt -112.78 108.61 53.6 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.653 1.581 . . . . 0.0 110.628 -169.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.39 113.44 3.32 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.756 2.304 . . . . 0.0 110.705 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 48.6 mtp -72.7 128.55 35.87 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.059 1.743 . . . . 0.0 111.891 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.5 t -93.59 99.0 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.078 1.751 . . . . 0.0 109.314 -176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 483' ' ' LEU . 2.8 t -101.69 124.24 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.444 1.898 . . . . 0.0 112.266 -173.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -147.82 155.17 41.37 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.098 1.359 . . . . 0.0 111.707 -170.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -54.23 148.19 11.84 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.835 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 177.373 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 122.054 0.931 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.3 p -155.02 160.27 40.93 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.595 1.158 . . . . 0.0 111.715 169.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.8 tt -68.39 145.99 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.328 1.451 . . . . 0.0 110.492 -174.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 37.1 t -82.63 157.08 23.55 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 122.107 0.956 . . . . 0.0 109.021 163.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -56.73 -30.14 63.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.699 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -63.82 -37.17 86.39 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 175.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -81.33 -27.84 34.78 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.44 -46.94 62.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.096 1.358 . . . . 0.0 113.042 174.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -55.88 -22.04 23.43 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.594 1.958 . . . . 0.0 114.411 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -62.9 -30.78 71.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.064 1.346 . . . . 0.0 112.704 173.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.22 80.66 0.31 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.55 1.548 . . . . 0.0 111.108 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -162.01 145.52 12.08 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.958 1.703 . . . . 0.0 109.908 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.8 pt -120.61 152.13 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 63.6 m -74.67 159.56 31.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.35 1.46 . . . . 0.0 111.823 161.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 33.3 mtm105 -58.84 -27.11 64.81 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.879 -1.138 . . . . 0.0 112.728 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -61.87 -31.56 71.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.949 1.3 . . . . 0.0 112.019 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.78 -32.18 21.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.672 1.189 . . . . 0.0 111.254 170.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 37.4 ttm -62.23 -43.52 98.64 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.653 -1.279 . . . . 0.0 111.483 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -78.99 29.47 0.21 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.568 0.747 . . . . 0.0 112.162 171.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.05 -39.7 0.44 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.049 1.74 . . . . 0.0 115.388 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 5.3 mp -68.19 134.96 51.3 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.052 1.341 . . . . 0.0 110.586 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 82.4 p -62.94 -27.64 69.53 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.412 HG23 ' CD2' ' A' ' 410' ' ' PHE . 11.4 m -65.79 -22.77 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 172.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.412 ' CD2' HG23 ' A' ' 409' ' ' VAL 0.401 66.4 m-85 -101.25 14.23 32.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 118.482 2.771 . . . . 0.0 118.482 -177.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -23.01 62.5 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 4.3 m -140.06 -33.72 0.57 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.847 1.659 . . . . 0.0 113.735 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.58 144.99 56.09 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -147.96 143.24 17.44 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -83.18 -171.67 1.18 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.757 3.638 . . . . 0.0 111.226 157.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.46 -0.48 32.71 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 117.494 1.758 . . . . 0.0 117.494 163.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -102.77 143.51 26.74 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 119.236 1.518 . . . . 0.0 113.91 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.31 82.74 2.42 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.849 3.7 . . . . 0.0 112.435 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 18.1 t30 -128.29 146.59 50.71 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.552 -1.343 . . . . 0.0 111.026 174.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 32.0 p -77.34 -9.89 59.11 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.54 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 36.3 mtm180 -119.59 146.4 45.55 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.715 1.206 . . . . 0.0 111.586 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 10.3 pt -134.82 151.11 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.997 1.719 . . . . 0.0 110.125 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -114.24 154.67 27.52 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.309 1.052 . . . . 0.0 108.486 166.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.412 HG22 HG13 ' A' ' 498' ' ' VAL . 2.5 t -128.82 147.45 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.531 1.532 . . . . 0.0 112.693 176.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -134.99 165.99 24.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.092 1.757 . . . . 0.0 111.011 -174.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.291 12.6 m-20 71.55 24.4 3.59 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -174.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.29 131.55 42.83 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.289 -1.507 . . . . 0.0 112.12 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -56.17 152.6 10.51 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.57 1.948 . . . . 0.0 115.513 -172.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -58.36 -40.23 81.67 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -84.52 -21.77 30.43 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.08 150.26 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -117.35 167.26 11.4 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.547 1.139 . . . . 0.0 112.125 171.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 459' ' ' LEU . 5.2 pm0 -53.94 -34.36 59.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.606 1.162 . . . . 0.0 112.613 170.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -66.58 -32.85 74.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.799 1.24 . . . . 0.0 114.115 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -68.02 -29.66 68.72 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.24 -18.25 60.76 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.01 1.324 . . . . 0.0 113.681 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -58.19 -29.29 65.54 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.361 0.982 . . . . 0.0 112.873 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.66 -32.21 72.36 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.398 0.545 . . . . 0.0 110.733 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.2 mt -99.16 -60.13 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.526 0.73 . . . . 0.0 110.844 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.294 81.5 m-85 -62.92 -23.98 67.63 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 117.349 2.352 . . . . 0.0 117.349 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -82.51 -5.51 89.45 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.737 1.16 . . . . 0.0 114.22 171.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -58.0 -31.8 67.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.656 1.728 . . . . 0.0 111.378 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -93.81 6.77 47.29 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.908 1.683 . . . . 0.0 111.572 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 19.0 t -118.37 120.29 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 120.209 1.368 . . . . 0.0 110.828 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -75.59 103.36 5.67 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.45 1.1 . . . . 0.0 110.422 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -56.42 -29.28 61.4 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 4.2 m -77.81 -2.6 37.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.293 1.837 . . . . 0.0 113.898 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.8 m -130.44 98.0 4.56 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.358 1.463 . . . . 0.0 110.468 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -51.93 -41.05 61.73 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.2 t -48.63 -16.67 0.12 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 118.688 2.847 . . . . 0.0 118.688 173.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -93.07 -58.65 2.26 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.463 -0.773 . . . . 0.0 111.575 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -71.14 -17.07 62.57 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.077 1.351 . . . . 0.0 113.78 -175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.7 tt -63.3 -35.15 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.557 1.543 . . . . 0.0 111.803 168.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.5 mtm -85.04 -27.64 26.22 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.52 0.328 . . . . 0.0 110.891 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . 0.28 32.4 t80 -83.75 128.64 34.68 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 -173.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -162.28 155.85 20.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.778 1.631 . . . . 0.0 107.716 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 11.3 mt -130.78 135.88 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.617 1.167 . . . . 0.0 109.77 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -122.3 125.16 45.4 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.487 1.515 . . . . 0.0 108.044 163.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' A' ' 433' ' ' GLU . 7.1 tp -99.73 113.37 25.8 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.278 1.431 . . . . 0.0 108.203 165.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -77.7 107.04 9.9 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 126.355 1.862 . . . . 0.0 110.034 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -98.28 2.15 47.88 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.354 1.062 . . . . 0.0 113.763 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -118.68 157.16 27.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.4 1.88 . . . . 0.0 112.89 -171.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 74.07 174.55 30.91 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.997 1.284 . . . . 0.0 113.174 -171.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -28.77 68.46 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.445 -1.032 . . . . 0.0 113.068 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -91.89 34.64 0.99 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.55 1.14 . . . . 0.0 112.927 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -70.59 166.25 21.05 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.283 1.033 . . . . 0.0 113.139 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 68.7 38.16 85.41 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 124.891 1.234 . . . . 0.0 110.605 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -125.74 156.92 38.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.079 0.952 . . . . 0.0 110.525 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -143.77 136.99 27.75 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -93.85 127.06 39.4 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 165.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.17 135.83 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.327 1.451 . . . . 0.0 109.378 171.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.89 133.4 11.58 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 160.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 17.9 mt -106.58 160.27 26.87 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.349 1.46 . . . . 0.0 109.868 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.26 -10.46 20.8 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.579 2.186 . . . . 0.0 113.842 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -153.42 145.51 23.74 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.159 0.984 . . . . 0.0 110.249 -174.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -55.67 -36.37 67.02 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.977 -0.452 . . . . 0.0 111.756 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -62.68 -33.99 76.21 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -69.6 -39.87 77.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.203 0.601 . . . . 0.0 111.084 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -69.73 -42.87 73.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.05 0.841 . . . . 0.0 111.618 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.24 -31.11 67.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.984 0.914 . . . . 0.0 112.778 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -78.72 -49.08 13.69 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.328 -0.858 . . . . 0.0 112.617 168.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.87 -27.74 69.55 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.57 HD23 HG12 ' A' ' 498' ' ' VAL . 54.1 mt -76.49 -28.3 56.4 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.192 -0.943 . . . . 0.0 112.736 174.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -71.12 -40.36 71.5 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.108 0.563 . . . . 0.0 110.681 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.44 -55.01 5.18 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.36 -16.26 52.83 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -68.49 108.79 3.42 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.931 -1.106 . . . . 0.0 110.835 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 115.52 -6.09 20.87 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 117.987 -1.452 . . . . 0.0 115.42 -171.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.78 120.41 12.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.292 2.046 . . . . 0.0 114.99 -160.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.287 1.9 t -85.63 46.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.102 1.761 . . . . 0.0 115.507 -163.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 32.5 tp -52.9 130.06 32.18 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.353 1.061 . . . . 0.0 110.335 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . . 81.2 t80 60.31 16.04 5.89 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 86.77 10.3 72.95 Favored Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.464 -1.398 . . . . 0.0 114.656 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -127.66 125.55 23.77 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 126.031 1.732 . . . . 0.0 111.934 -172.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.54 127.51 12.56 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.09 1.86 . . . . 0.0 112.651 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 61.4 mtp -78.42 131.76 37.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.538 1.535 . . . . 0.0 112.524 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.28 97.05 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.356 1.862 . . . . 0.0 109.554 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.57 HG12 HD23 ' A' ' 483' ' ' LEU . 2.9 t -98.51 119.87 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 127.481 2.312 . . . . 0.0 112.774 -176.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -139.41 158.76 43.58 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.825 1.25 . . . . 0.0 113.525 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -58.5 145.89 37.38 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.615 -0.678 . . . . 0.0 112.817 166.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 123.829 0.851 . . . . 0.0 112.606 179.304 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 121.52 0.676 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.1 p -141.9 175.69 9.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.657 1.183 . . . . 0.0 112.828 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.5 tt -82.62 150.42 4.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 126.063 1.745 . . . . 0.0 111.964 -172.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 6.5 m -81.77 161.02 23.44 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.511 0.725 . . . . 0.0 109.709 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -65.04 -39.63 93.61 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.113 -0.992 . . . . 0.0 110.769 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -54.89 -43.72 73.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.351 1.46 . . . . 0.0 112.785 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.87 -37.73 70.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.098 1.359 . . . . 0.0 114.551 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 19.8 tp -69.05 -39.6 79.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.251 1.021 . . . . 0.0 112.528 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -59.97 -18.03 42.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -65.66 -21.41 66.55 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.057 0.943 . . . . 0.0 112.253 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -134.96 86.49 0.25 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.656 1.598 . . . . 0.0 111.495 173.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -155.7 151.08 26.93 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.751 1.221 . . . . 0.0 109.658 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.3 pt -136.41 148.64 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 13.0 m -86.97 164.17 16.67 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.98 1.712 . . . . 0.0 110.178 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -50.24 -38.76 42.15 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.38 -27.35 66.16 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.54 -31.42 42.06 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.142 -0.974 . . . . 0.0 111.821 167.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 4.5 ttm -58.93 -38.7 79.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.784 0.834 . . . . 0.0 110.076 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -74.65 11.2 1.09 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.764 1.626 . . . . 0.0 114.059 171.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.47 -22.05 3.4 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.209 1.803 . . . . 0.0 115.227 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.0 mp -91.17 130.82 37.02 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.253 1.821 . . . . 0.0 111.202 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 14.5 p -62.41 -24.25 67.29 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.441 HG23 ' CD2' ' A' ' 410' ' ' PHE . 6.1 m -66.18 -23.22 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 119.501 1.046 . . . . 0.0 113.595 169.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.441 ' CD2' HG23 ' A' ' 409' ' ' VAL 0.27 42.2 m-85 -100.44 -10.35 21.22 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 121.276 3.806 . . . . 0.0 121.276 -171.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.79 -19.59 29.42 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 -169.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 4.4 m -142.54 28.28 1.64 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.451 1.9 . . . . 0.0 111.799 -176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -134.12 137.72 44.73 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.192 2.197 . . . . 0.0 115.924 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -142.11 121.01 7.76 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -171.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -74.84 176.79 9.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.178 3.252 . . . . 0.0 113.282 160.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.55 31.61 10.19 Favored Glycine 0 N--CA 1.468 0.787 0 C-N-CA 124.532 1.063 . . . . 0.0 114.853 167.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -125.82 149.87 67.06 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.693 1.197 . . . . 0.0 113.255 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.53 109.93 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.027 3.151 . . . . 0.0 114.056 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.564 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 42.1 t30 -158.17 159.96 36.71 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.807 1.643 . . . . 0.0 109.669 160.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 25.4 p -80.59 -7.52 59.28 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.564 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 20.3 mtp180 -130.92 152.39 50.3 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.086 1.754 . . . . 0.0 110.084 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 6.6 pt -137.88 165.13 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 126.725 2.01 . . . . 0.0 109.404 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -135.56 164.18 28.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.606 1.193 . . . . 0.0 107.818 167.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.4 143.34 34.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.608 1.163 . . . . 0.0 110.522 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -126.43 168.78 13.73 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.227 1.811 . . . . 0.0 110.868 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 38.8 t30 67.32 32.8 5.72 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.663 1.585 . . . . 0.0 113.085 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.56 139.79 53.77 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.449 1.1 . . . . 0.0 110.919 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -59.47 161.86 5.43 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.871 1.669 . . . . 0.0 115.098 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -63.09 -37.26 86.51 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -80.15 -32.7 38.88 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.713 1.605 . . . . 0.0 114.022 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.35 144.19 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -166.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -120.25 163.87 17.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.602 1.561 . . . . 0.0 112.308 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -56.15 -32.55 64.39 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.583 -1.323 . . . . 0.0 113.033 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -62.37 -33.37 74.61 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -66.98 -36.21 81.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.494 1.118 . . . . 0.0 113.028 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.56 -22.6 63.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.192 1.397 . . . . 0.0 112.969 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.88 -26.78 62.57 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.48 1.036 . . . . 0.0 112.471 176.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -62.5 -31.77 72.58 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.237 0.471 . . . . 0.0 110.494 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.11 -56.27 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 120.591 -1.318 . . . . 0.0 110.841 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -59.27 -30.32 68.21 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.28 -3.49 88.55 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.906 1.241 . . . . 0.0 114.641 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -59.25 -31.06 68.74 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.384 1.592 . . . . 0.0 112.23 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -97.94 13.85 29.3 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.205 2.202 . . . . 0.0 111.678 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 15.4 t -131.03 139.73 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.919 1.688 . . . . 0.0 110.389 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.61 117.05 14.91 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.717 -0.615 . . . . 0.0 109.872 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.31 -13.81 32.65 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 118.716 2.858 . . . . 0.0 118.716 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.2 t -123.04 -33.48 3.32 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.4 m -67.66 110.83 3.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.951 0.796 . . . . 0.0 110.814 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -57.07 -46.4 82.53 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -13.55 2.57 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -92.91 -60.34 1.83 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.819 1.248 . . . . 0.0 110.374 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -70.81 -12.55 61.62 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.986 1.714 . . . . 0.0 114.114 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.02 -39.91 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 126.869 2.068 . . . . 0.0 112.968 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 11.8 mtm -83.96 -29.96 26.64 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.573 0.749 . . . . 0.0 109.669 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -66.43 131.15 45.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.04 1.336 . . . . 0.0 113.825 164.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -165.43 149.04 8.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.358 1.463 . . . . 0.0 108.809 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.2 mt -125.95 137.03 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.48 1.112 . . . . 0.0 111.424 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -126.53 129.37 48.49 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.945 1.298 . . . . 0.0 108.892 162.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 5.7 tt -109.1 115.97 31.06 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.225 1.41 . . . . 0.0 109.533 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 59.7 mtm -72.8 134.26 44.84 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.065 1.346 . . . . 0.0 111.575 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -123.93 14.94 9.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.492 1.517 . . . . 0.0 113.168 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -139.89 153.31 46.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.898 1.679 . . . . 0.0 112.241 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 59.33 -146.88 43.04 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.046 1.308 . . . . 0.0 116.318 168.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -7.59 47.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.819 2.048 . . . . 0.0 115.465 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . 0.256 13.1 mtm -120.25 19.25 12.19 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 173.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -55.58 120.22 6.89 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.273 -1.517 . . . . 0.0 111.513 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.01 30.17 29.42 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.16 1.362 . . . . 0.0 113.77 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -123.85 149.33 45.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.472 1.109 . . . . 0.0 109.288 168.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -137.94 141.52 40.57 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.437 -0.79 . . . . 0.0 112.656 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -101.64 135.06 43.8 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 172.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.82 122.83 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.29 1.436 . . . . 0.0 110.533 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -85.73 149.99 23.86 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 162.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 21.9 mt -125.21 158.34 64.06 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.401 1.08 . . . . 0.0 110.233 170.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.3 -8.27 21.67 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.545 2.163 . . . . 0.0 113.991 -175.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -155.78 144.24 20.19 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.033 1.333 . . . . 0.0 110.487 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -58.36 -31.95 68.1 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.613 1.165 . . . . 0.0 113.154 168.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -56.3 -45.69 80.13 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.394 -0.816 . . . . 0.0 111.978 171.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.73 -35.87 81.98 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.993 0.808 . . . . 0.0 112.914 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.38 -44.37 75.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.439 1.472 . . . . 0.0 112.586 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.83 -38.22 75.23 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.42 -0.8 . . . . 0.0 112.022 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -67.2 -53.7 27.88 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.721 1.208 . . . . 0.0 112.192 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.79 -32.95 69.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.979 0.911 . . . . 0.0 112.608 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.561 HD23 HG12 ' A' ' 498' ' ' VAL . 50.8 mt -69.81 -43.58 71.77 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.068 0.947 . . . . 0.0 111.742 175.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -65.97 -26.1 67.41 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.81 0.844 . . . . 0.0 111.688 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -100.65 -44.69 5.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -175.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -76.1 -24.45 55.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.519 1.128 . . . . 0.0 113.865 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -72.5 120.5 18.2 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.645 -0.659 . . . . 0.0 112.343 -169.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 108.96 -8.19 33.51 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 117.984 -1.454 . . . . 0.0 115.032 -170.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . 0.262 61.7 t80 -64.82 133.12 51.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.524 1.662 . . . . 0.0 115.164 -164.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.252 2.5 t -99.8 46.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.181 1.392 . . . . 0.0 113.768 -158.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 19.4 tp -50.49 126.28 14.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.123 1.369 . . . . 0.0 110.572 172.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.361 32.9 m-85 58.64 12.58 2.22 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 89.84 3.03 74.36 Favored Glycine 0 CA--C 1.536 1.355 0 O-C-N 120.683 -1.26 . . . . 0.0 114.519 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -119.35 118.1 32.68 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 119.477 1.639 . . . . 0.0 112.829 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.18 126.76 14.1 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.886 2.39 . . . . 0.0 113.216 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 71.7 mtp -81.72 134.47 35.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.652 1.581 . . . . 0.0 112.137 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.76 93.47 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 126.655 1.982 . . . . 0.0 110.528 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.561 HG12 HD23 ' A' ' 483' ' ' LEU . 2.8 t -94.67 118.25 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 126.814 2.045 . . . . 0.0 113.086 -173.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -134.41 160.8 36.86 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.65 1.18 . . . . 0.0 114.119 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -60.01 144.58 48.96 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.165 -0.96 . . . . 0.0 113.174 167.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.713 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 30.1 p -144.82 164.78 30.01 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.3 tt -72.64 171.14 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.647 2.379 . . . . 0.0 111.701 -175.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 34.5 m -110.67 166.85 10.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.425 1.09 . . . . 0.0 111.834 167.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 14.1 ttm-85 -59.15 -48.33 81.99 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.037 -1.039 . . . . 0.0 112.48 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -61.78 -37.16 83.3 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.591 1.157 . . . . 0.0 113.398 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -70.31 -38.66 75.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.696 1.198 . . . . 0.0 113.226 173.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.06 -41.08 82.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.889 1.276 . . . . 0.0 112.982 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.33 -17.84 32.89 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.172 1.789 . . . . 0.0 115.101 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -70.29 -16.23 62.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.961 0.905 . . . . 0.0 113.357 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -127.29 87.6 0.33 Allowed Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.84 1.686 . . . . 0.0 113.166 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -167.7 147.25 4.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.629 1.172 . . . . 0.0 111.372 -170.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 10.8 pt -125.28 152.71 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 69.3 m -100.82 164.44 11.84 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.963 2.505 . . . . 0.0 111.111 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -55.46 -33.81 63.97 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -169.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -76.86 -10.56 59.45 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.588 1.086 . . . . 0.0 112.877 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -96.61 -33.19 11.87 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.001 -1.062 . . . . 0.0 111.208 163.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 17.5 ttp -63.29 -40.47 97.47 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.881 -1.137 . . . . 0.0 111.352 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -79.68 30.62 0.24 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.148 0.979 . . . . 0.0 112.723 171.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.12 -29.02 0.41 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 176.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.8 mp -72.27 134.31 45.51 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.17 0.988 . . . . 0.0 109.842 167.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 9.2 t -66.94 -29.48 69.36 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.444 -0.785 . . . . 0.0 111.923 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.7 m -66.63 -7.77 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 170.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.261 83.5 m-85 -119.74 3.68 11.1 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 118.553 2.797 . . . . 0.0 118.553 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -14.08 62.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -169.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.7 t -130.76 -25.9 2.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.218 1.007 . . . . 0.0 111.681 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -70.36 137.76 50.82 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.284 1.586 . . . . 0.0 115.284 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -142.81 125.79 9.14 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.22 179.71 5.68 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 125.045 3.83 . . . . 0.0 113.513 167.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 121.25 -19.68 8.62 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 156.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -82.03 150.2 64.5 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.13 96.98 1.09 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 124.109 3.206 . . . . 0.0 112.725 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.83 137.47 45.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.069 1.747 . . . . 0.0 106.903 161.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.9 p -72.99 -0.67 14.43 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -124.43 149.88 46.28 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.331 1.453 . . . . 0.0 110.849 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.6 pt -140.15 161.22 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.61 1.964 . . . . 0.0 109.654 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -131.35 156.97 44.6 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.5 t -127.2 143.76 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 125.349 1.46 . . . . 0.0 111.575 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -127.34 166.95 16.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.364 1.865 . . . . 0.0 109.569 173.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 34.6 t30 66.24 32.45 7.9 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.8 1.24 . . . . 0.0 113.109 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -71.33 157.23 38.46 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.318 -0.864 . . . . 0.0 111.49 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -71.46 166.52 21.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.255 1.422 . . . . 0.0 114.804 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -76.36 -42.1 45.87 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.204 -0.935 . . . . 0.0 113.034 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -70.98 -35.79 72.26 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.38 156.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -130.24 158.32 40.08 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.994 1.718 . . . . 0.0 110.55 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -56.15 -29.82 61.3 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.155 -1.59 . . . . 0.0 113.454 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -57.18 -37.71 72.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.066 1.747 . . . . 0.0 114.26 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -68.13 -33.98 75.5 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.65 -21.41 66.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.136 0.974 . . . . 0.0 112.547 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -24.12 62.27 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.841 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -59.39 -29.46 67.73 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.708 0.803 . . . . 0.0 110.96 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.41 -55.0 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 120.866 -1.147 . . . . 0.0 111.207 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -59.53 -29.64 68.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.73 -4.71 89.47 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.409 1.004 . . . . 0.0 114.43 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -65.36 -36.22 83.34 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 119.974 1.887 . . . . 0.0 111.527 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -79.26 6.29 10.24 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.623 1.969 . . . . 0.0 113.08 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 16.1 t -131.57 135.06 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.469 1.908 . . . . 0.0 110.862 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -91.13 113.32 25.55 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -63.77 -18.51 64.15 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 69.5 m -90.88 -0.58 57.77 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.3 t -118.5 107.22 13.52 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.29 1.036 . . . . 0.0 110.629 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -61.24 -43.16 99.33 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.186 -0.946 . . . . 0.0 111.998 -176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.91 -14.11 5.65 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 117.189 2.292 . . . . 0.0 117.189 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -88.27 -62.21 1.54 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.016 0.926 . . . . 0.0 110.095 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -69.92 -24.74 63.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.754 1.222 . . . . 0.0 114.227 -173.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 16.4 tt -54.19 -36.71 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.694 1.197 . . . . 0.0 112.28 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.2 mtm -84.71 -12.83 53.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.267 1.027 . . . . 0.0 112.483 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -94.36 134.13 37.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.859 1.664 . . . . 0.0 114.777 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -167.86 141.26 3.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.872 1.669 . . . . 0.0 107.303 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.8 mt -116.24 138.1 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.958 1.703 . . . . 0.0 110.149 174.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -132.13 133.98 44.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.023 1.329 . . . . 0.0 110.163 166.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 1.4 tt -112.2 124.8 53.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.098 1.359 . . . . 0.0 110.943 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 35.2 mtm -72.27 135.02 45.88 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.648 1.579 . . . . 0.0 111.172 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -134.51 -26.06 1.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.657 1.583 . . . . 0.0 115.136 -163.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -101.15 139.39 36.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.596 1.558 . . . . 0.0 111.512 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 72.5 -158.32 53.16 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.38 1.312 . . . . 0.0 116.38 163.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -13.97 62.32 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -169.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 75.9 mtm -110.63 12.42 22.68 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -61.17 148.82 39.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.844 -1.16 . . . . 0.0 111.949 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.77 24.61 76.45 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.737 0.684 . . . . 0.0 112.156 -175.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -104.23 160.04 15.21 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.758 1.223 . . . . 0.0 109.697 158.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -152.51 157.11 40.64 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.829 -1.17 . . . . 0.0 112.77 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -116.86 143.39 45.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.98 127.05 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.617 1.567 . . . . 0.0 109.071 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -97.18 145.6 17.92 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 162.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 27.1 mt -126.29 156.66 72.14 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.592 1.557 . . . . 0.0 110.412 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -73.06 -7.7 21.03 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.747 2.298 . . . . 0.0 114.579 -171.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -151.22 143.43 24.07 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.469 1.108 . . . . 0.0 111.397 -172.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.19 -41.93 69.15 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.559 -0.713 . . . . 0.0 111.394 166.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -67.16 -28.01 67.76 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.493 1.117 . . . . 0.0 113.381 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -71.24 -43.35 67.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.664 0.386 . . . . 0.0 110.777 174.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.81 -44.06 74.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.36 0.527 . . . . 0.0 112.056 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.79 -37.73 71.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.38 0.672 . . . . 0.0 111.923 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -73.15 -48.4 35.75 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.783 0.833 . . . . 0.0 112.744 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.96 -29.57 70.33 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.559 HD23 HG12 ' A' ' 498' ' ' VAL . 47.2 mt -71.15 -34.13 70.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.106 -0.996 . . . . 0.0 112.461 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -63.92 -39.45 94.18 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.312 0.505 . . . . 0.0 111.429 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.06 -47.49 8.87 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -171.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -79.02 -20.89 47.86 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -69.1 109.48 4.04 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.277 -0.89 . . . . 0.0 110.699 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 108.96 -3.31 31.74 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 117.684 -1.62 . . . . 0.0 116.435 -174.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -65.89 131.23 45.77 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.779 1.789 . . . . 0.0 112.356 -172.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.299 1.2 t -93.31 44.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 -161.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 16.8 tp -50.01 122.26 6.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.016 1.726 . . . . 0.0 111.489 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.309 76.1 m-85 49.57 30.34 3.48 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 117.361 2.356 . . . . 0.0 117.361 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 77.37 24.36 65.9 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.125 -0.984 . . . . 0.0 114.171 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -132.43 116.62 15.24 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 119.028 1.414 . . . . 0.0 110.33 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.96 114.88 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.313 2.009 . . . . 0.0 112.003 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 61.9 mtp -71.25 127.81 33.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.723 1.609 . . . . 0.0 112.347 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 30.8 t -93.52 94.16 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.992 2.117 . . . . 0.0 109.63 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.559 HG12 HD23 ' A' ' 483' ' ' LEU . 3.7 t -100.4 120.49 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 127.142 2.177 . . . . 0.0 113.08 -171.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -137.95 158.95 43.29 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.399 1.479 . . . . 0.0 113.644 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -57.71 142.19 46.06 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 167.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.178 0 CA-C-N 118.507 0.594 . . . . 0.0 112.462 177.133 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.4 p -161.54 159.82 28.28 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.7 1.2 . . . . 0.0 113.403 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.8 tt -75.67 166.15 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.203 1.401 . . . . 0.0 112.441 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 19.9 m -115.39 161.49 18.46 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.199 1.4 . . . . 0.0 111.711 169.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -63.99 -39.36 93.95 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.616 -0.678 . . . . 0.0 112.132 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -58.8 -34.72 71.81 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -79.56 -38.77 33.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.759 1.624 . . . . 0.0 113.864 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.14 -41.62 97.11 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.768 1.227 . . . . 0.0 113.137 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -58.47 -23.32 57.47 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.637 1.575 . . . . 0.0 114.486 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.52 -18.43 64.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.611 1.164 . . . . 0.0 112.1 173.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -123.96 82.05 0.35 Allowed Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.986 2.232 . . . . 0.0 111.482 167.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -157.28 139.61 14.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.936 1.694 . . . . 0.0 109.346 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.8 pt -122.58 150.6 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 123.391 1.567 . . . . 0.0 115.002 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.6 m -78.58 160.86 27.38 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.796 2.039 . . . . 0.0 112.045 167.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -55.3 -30.05 59.41 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.371 -0.831 . . . . 0.0 112.092 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -65.1 -22.73 66.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.619 1.168 . . . . 0.0 113.826 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -93.06 -33.46 14.08 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.236 1.014 . . . . 0.0 111.24 168.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 37.8 ttm -59.59 -42.25 92.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 122.454 1.121 . . . . 0.0 111.574 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -85.96 33.79 0.6 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.587 1.555 . . . . 0.0 110.827 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.98 -41.24 0.35 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 128.099 2.56 . . . . 0.0 114.852 173.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.6 mp -66.88 136.83 55.98 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.354 1.062 . . . . 0.0 110.02 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 21.0 m -65.24 -34.33 78.1 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 169.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 17.5 m -59.0 -29.94 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 119.906 1.23 . . . . 0.0 112.704 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -101.68 11.16 39.31 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -19.17 49.48 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 47.3 t -142.57 -28.81 0.58 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.301 1.04 . . . . 0.0 113.015 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -71.72 146.52 48.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.2 1.4 . . . . 0.0 114.768 169.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 415' ' ' PRO . 0.8 OUTLIER -159.65 130.5 3.74 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 121.298 -0.876 . . . . 0.0 113.031 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 414' ' ' GLU . 6.8 Cg_exo -69.89 165.06 32.37 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 125.278 3.986 . . . . 0.0 114.66 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 143.86 -27.87 2.03 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.184 1.233 . . . . 0.0 116.184 152.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -72.42 139.67 81.54 Favored Pre-proline 0 CA--C 1.552 1.053 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -165.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.06 105.41 1.79 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.591 2.861 . . . . 0.0 112.988 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -134.17 150.52 51.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.689 1.995 . . . . 0.0 108.215 163.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 29.8 p -72.27 -2.18 18.05 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 38.7 mtm-85 -134.15 148.83 51.01 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.891 2.076 . . . . 0.0 110.082 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 4.4 pt -131.22 159.4 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.139 2.176 . . . . 0.0 110.456 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -128.86 158.48 38.62 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.32 139.58 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.512 1.525 . . . . 0.0 111.515 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -121.71 167.52 12.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.166 1.387 . . . . 0.0 110.116 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 31.4 t30 68.08 31.7 5.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.052 1.341 . . . . 0.0 112.859 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -66.64 145.95 55.02 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.41 -0.806 . . . . 0.0 110.617 173.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.24 163.61 12.51 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.49 1.516 . . . . 0.0 114.413 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -64.64 -47.98 76.5 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -71.42 -29.5 64.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.4 p -65.28 145.53 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -166.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -119.48 163.95 16.5 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.312 1.845 . . . . 0.0 111.906 170.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.36 -26.27 64.94 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.749 -1.219 . . . . 0.0 113.459 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -60.36 -37.03 79.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.656 1.182 . . . . 0.0 114.038 171.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -72.36 -26.93 62.1 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.87 1.268 . . . . 0.0 114.308 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -73.41 -21.47 60.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.229 1.812 . . . . 0.0 112.744 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -27.57 58.79 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.436 1.016 . . . . 0.0 112.585 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -60.99 -30.95 70.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.439 1.096 . . . . 0.0 111.56 -173.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.2 mp -104.48 -54.78 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.018 -1.051 . . . . 0.0 111.218 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -58.03 -27.68 63.78 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.24 -11.73 84.71 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 118.83 -0.983 . . . . 0.0 114.598 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -62.58 -30.99 71.73 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 120.792 2.296 . . . . 0.0 112.1 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -79.29 2.06 22.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.114 1.766 . . . . 0.0 112.858 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.58 136.22 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.35 1.86 . . . . 0.0 110.818 -172.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -79.73 119.64 22.92 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.898 -1.126 . . . . 0.0 108.056 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.329 49.5 m-85 -67.91 -16.91 64.29 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 167.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.0 t -94.03 -38.04 11.34 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.252 0.933 . . . . 0.0 113.469 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.1 m -83.27 118.62 23.77 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.394 -0.816 . . . . 0.0 111.588 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -57.89 -45.07 86.97 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.482 -0.761 . . . . 0.0 112.328 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.36 -16.02 1.98 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -89.75 -62.5 1.46 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.151 0.98 . . . . 0.0 110.562 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -68.39 -21.47 64.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.931 1.292 . . . . 0.0 113.295 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.74 -33.86 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.753 1.621 . . . . 0.0 112.261 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -93.85 3.13 55.86 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.938 1.295 . . . . 0.0 112.886 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -110.44 136.01 50.25 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.869 2.068 . . . . 0.0 115.81 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -166.53 152.31 8.4 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.411 1.885 . . . . 0.0 106.596 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.9 mt -126.11 137.32 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.238 1.015 . . . . 0.0 110.226 171.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 52.7 ttm-85 -125.3 133.8 52.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.115 0.966 . . . . 0.0 110.446 163.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.5 tp -118.15 124.1 47.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.582 1.553 . . . . 0.0 108.846 168.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 39.7 mtm -74.68 116.97 15.98 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.161 0.585 . . . . 0.0 110.083 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -103.0 5.28 38.15 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.014 1.726 . . . . 0.0 112.56 174.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -126.96 149.12 50.0 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.654 1.582 . . . . 0.0 112.952 -174.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.06 -156.51 52.01 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.241 1.4 . . . . 0.0 115.604 164.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -51.91 -34.47 41.64 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.305 1.442 . . . . 0.0 114.094 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 72.3 mtp -97.3 12.27 33.6 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -51.21 123.75 10.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.214 1.006 . . . . 0.0 111.448 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.03 31.47 31.82 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.586 1.565 . . . . 0.0 113.979 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -125.18 145.2 50.07 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.355 1.062 . . . . 0.0 112.224 169.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -135.15 156.05 49.66 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.938 1.295 . . . . 0.0 114.147 -169.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.8 132.8 52.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.585 1.954 . . . . 0.0 115.451 171.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.6 mp -132.34 122.07 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.891 1.676 . . . . 0.0 110.042 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.92 145.48 18.25 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 33.6 mt -126.3 158.96 65.09 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.012 1.325 . . . . 0.0 110.42 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -75.34 -9.08 20.17 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.418 2.745 . . . . 0.0 114.556 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -150.82 143.01 24.15 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.588 0.755 . . . . 0.0 111.388 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -59.01 -37.25 76.47 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.004 0.922 . . . . 0.0 111.803 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 18.6 mtmm -62.89 -35.88 81.48 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.85 92.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.411 0.55 . . . . 0.0 110.915 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -69.44 -44.44 71.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.247 0.93 . . . . 0.0 112.746 172.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.33 69.12 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.806 0.73 . . . . 0.0 112.122 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -75.48 -48.44 22.6 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.874 1.67 . . . . 0.0 113.069 170.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.78 70.33 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.845 0.748 . . . . 0.0 112.765 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.46 HD23 HG12 ' A' ' 498' ' ' VAL . 50.1 mt -68.67 -37.5 79.66 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.94 0.896 . . . . 0.0 112.178 174.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -65.3 -41.32 94.2 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.637 0.775 . . . . 0.0 111.463 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.9 -48.57 11.36 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -174.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.14 -16.74 59.03 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -63.75 107.4 1.18 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.025 0.93 . . . . 0.0 112.114 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 106.94 3.54 36.39 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.578 -1.123 . . . . 0.0 115.254 -174.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -71.57 112.99 8.13 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.184 1.492 . . . . 0.0 108.892 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.97 79.43 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.923 1.689 . . . . 0.0 108.029 -169.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 51.6 tp -79.05 132.83 36.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.058 1.743 . . . . 0.0 110.464 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.258 65.7 m-85 55.74 19.43 3.41 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -174.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 81.84 18.56 67.51 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.187 -1.341 . . . . 0.0 115.464 -171.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -128.42 120.64 21.03 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 119.833 1.816 . . . . 0.0 112.508 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.5 121.85 8.36 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 123.547 2.831 . . . . 0.0 112.305 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 38.6 mtp -79.14 132.0 36.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.828 1.251 . . . . 0.0 111.829 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.8 t -94.23 101.18 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.112 1.365 . . . . 0.0 109.816 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.46 HG12 HD23 ' A' ' 483' ' ' LEU . 2.4 t -97.15 127.3 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 126.716 2.006 . . . . 0.0 112.908 -173.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -146.3 161.35 40.5 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -64.26 143.56 57.8 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 121.038 -1.039 . . . . 0.0 108.962 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.395 0 C-N-CA 124.084 0.953 . . . . 0.0 112.696 -177.058 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 28.2 p -158.03 160.21 37.19 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -164.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.7 tt -76.6 161.05 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.268 1.427 . . . . 0.0 112.44 -170.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 18.5 m -114.33 162.33 16.76 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.821 1.649 . . . . 0.0 113.11 168.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -55.25 -43.26 74.45 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.809 0.844 . . . . 0.0 112.469 -172.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -61.76 -33.54 74.26 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -82.83 -37.21 24.73 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.779 0.832 . . . . 0.0 112.715 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.22 -42.16 96.71 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.404 1.082 . . . . 0.0 113.659 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.89 -24.0 48.79 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.635 1.574 . . . . 0.0 114.247 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -70.81 -13.0 61.88 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.979 1.712 . . . . 0.0 112.825 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -123.34 77.66 0.36 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 126.303 1.906 . . . . 0.0 112.63 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -161.39 142.69 11.44 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.386 1.075 . . . . 0.0 111.529 -174.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 20.7 pt -127.91 161.28 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.556 1.542 . . . . 0.0 112.2 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.9 m -110.7 179.36 4.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.144 1.378 . . . . 0.0 111.975 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 32.3 mtm105 -54.25 -27.3 33.92 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.267 -0.895 . . . . 0.0 113.292 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -58.67 -32.56 69.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.537 1.535 . . . . 0.0 112.672 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -98.93 -40.06 8.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.892 0.877 . . . . 0.0 111.209 168.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.88 -40.63 98.1 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.704 -1.248 . . . . 0.0 112.244 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -80.46 11.03 3.94 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 121.319 -0.863 . . . . 0.0 112.672 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.89 -27.08 5.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.584 2.353 . . . . 0.0 113.454 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 43.9 mt -77.51 135.87 38.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.305 1.442 . . . . 0.0 112.654 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 55.3 p -60.14 -34.26 73.28 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.048 0.939 . . . . 0.0 112.325 167.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.406 HG23 ' CD2' ' A' ' 410' ' ' PHE 0.255 1.8 m -67.32 -15.28 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 173.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.406 ' CD2' HG23 ' A' ' 409' ' ' VAL 0.356 83.2 m-85 -112.52 9.16 19.5 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 118.852 2.908 . . . . 0.0 118.852 178.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -57.78 0.11 0.06 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 118.51 2.781 . . . . 0.0 118.51 -172.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.4 m -157.25 8.98 0.18 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -132.59 132.13 42.2 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.36 -0.838 . . . . 0.0 109.353 -155.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -138.5 131.04 16.02 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -164.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -90.09 176.09 2.78 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 125.168 3.912 . . . . 0.0 115.006 175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.77 -10.02 72.81 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.657 1.599 . . . . 0.0 116.572 161.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.34 142.39 74.88 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 118.749 1.275 . . . . 0.0 113.45 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -85.71 60.86 5.19 Favored 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 124.86 3.707 . . . . 0.0 114.757 -166.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.504 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 34.0 t30 -96.5 151.29 19.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.08 0.952 . . . . 0.0 110.722 164.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.1 p -77.51 -4.05 43.62 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.504 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 77.5 mtt180 -130.64 149.31 52.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.454 1.502 . . . . 0.0 111.883 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 12.9 pt -134.92 161.73 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.755 2.022 . . . . 0.0 110.141 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -131.52 159.93 36.72 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.417 HG22 HG13 ' A' ' 498' ' ' VAL . 2.6 t -130.81 138.21 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.565 1.546 . . . . 0.0 112.425 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -122.25 168.94 11.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.37 1.468 . . . . 0.0 110.545 170.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 33.0 t30 68.05 40.37 2.25 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.914 1.685 . . . . 0.0 112.533 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.85 153.16 40.01 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.45 -0.782 . . . . 0.0 110.92 171.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.45 ' O ' HG12 ' A' ' 431' ' ' VAL . . . -67.7 154.36 41.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.928 1.291 . . . . 0.0 113.296 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -64.82 -36.31 83.93 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -77.3 -17.24 58.5 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 120.581 1.537 . . . . 0.0 115.097 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 428' ' ' ALA . 2.4 p -75.08 151.39 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -165.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -126.02 160.86 28.95 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.869 1.668 . . . . 0.0 111.216 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -53.98 -34.09 58.8 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.408 -1.433 . . . . 0.0 113.46 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -63.8 -20.38 65.74 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -77.51 -43.31 32.52 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.949 0.899 . . . . 0.0 111.72 166.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.1 mp -61.65 -31.29 71.39 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.389 1.075 . . . . 0.0 111.836 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . 0.521 ' HD2' HD12 ' A' ' 457' ' ' ILE . 1.5 mptm? -47.58 -36.89 11.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.267 1.427 . . . . 0.0 113.06 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -62.25 -35.02 77.67 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.027 0.931 . . . . 0.0 112.383 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 4.2 mt -96.26 -58.46 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 121.254 -0.904 . . . . 0.0 110.679 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -57.16 -29.93 64.05 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.16 -14.51 82.52 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 118.43 -1.206 . . . . 0.0 114.619 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -25.1 67.17 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.976 2.388 . . . . 0.0 112.022 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -81.21 5.38 17.17 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.238 1.815 . . . . 0.0 113.19 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 12.7 t -130.52 122.29 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.256 1.823 . . . . 0.0 110.668 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -76.32 103.66 6.44 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -58.44 -16.24 14.18 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 t -82.89 -15.95 49.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.151 0.98 . . . . 0.0 113.021 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 36.1 t -111.24 120.04 40.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.558 1.143 . . . . 0.0 111.617 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -58.02 -48.76 79.09 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.587 -0.696 . . . . 0.0 112.032 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.63 -14.87 2.4 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -92.82 -63.91 1.16 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.851 1.261 . . . . 0.0 110.075 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -25.49 67.92 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.561 1.544 . . . . 0.0 113.361 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.8 tt -57.89 -37.96 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.24 1.416 . . . . 0.0 111.995 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.4 mmm -89.2 0.29 56.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.991 1.716 . . . . 0.0 113.259 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -109.57 132.39 54.19 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -164.43 144.67 7.81 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.527 1.531 . . . . 0.0 111.074 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.521 HD12 ' HD2' ' A' ' 437' ' ' LYS . 5.1 mt -123.81 140.01 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 119.419 1.009 . . . . 0.0 111.373 169.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -121.03 134.54 55.29 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.596 1.558 . . . . 0.0 107.945 154.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 32.1 tp -107.65 91.13 3.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.719 1.247 . . . . 0.0 108.097 166.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -59.43 123.7 17.64 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.66 1.584 . . . . 0.0 110.782 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . 0.304 51.5 mtmt -129.71 35.47 4.18 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -174.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -133.07 148.18 52.19 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.092 0.957 . . . . 0.0 113.565 174.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 69.62 -177.41 30.3 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.58 1.562 . . . . 0.0 114.266 -173.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -15.92 49.26 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.811 -1.406 . . . . 0.0 113.597 177.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 73.4 mtm -87.07 11.2 14.36 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.785 1.634 . . . . 0.0 113.698 171.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -64.83 152.31 43.18 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 119.555 -1.966 . . . . 0.0 111.819 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.35 26.13 52.59 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.152 0.882 . . . . 0.0 112.726 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -121.48 147.37 45.85 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.301 1.041 . . . . 0.0 110.265 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -133.39 148.98 51.84 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -172.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -107.13 139.56 41.37 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 162.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.4 mp -136.88 124.11 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.721 1.208 . . . . 0.0 109.865 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -92.68 146.63 18.24 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 162.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 24.2 mt -126.16 159.61 61.45 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.211 1.404 . . . . 0.0 111.347 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.55 -7.89 19.01 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.991 2.46 . . . . 0.0 115.317 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -150.55 147.59 27.65 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.643 1.177 . . . . 0.0 110.322 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -56.98 -38.98 73.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.564 1.146 . . . . 0.0 111.626 170.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.48 -42.04 95.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.113 0.965 . . . . 0.0 112.878 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.39 -40.39 96.32 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.19 -0.433 . . . . 0.0 111.592 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.98 -44.6 72.57 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.172 0.896 . . . . 0.0 112.832 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.22 83.84 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.869 0.758 . . . . 0.0 111.141 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -64.45 -48.95 73.37 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.154 1.382 . . . . 0.0 112.23 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.11 -32.34 70.9 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.653 HD23 HG12 ' A' ' 498' ' ' VAL . 58.1 mt -68.7 -45.6 71.19 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.105 -0.997 . . . . 0.0 111.341 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -63.22 -33.78 76.23 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.556 0.617 . . . . 0.0 111.837 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.3 -48.0 11.71 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.73 -18.24 45.01 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.21 105.59 1.13 Allowed 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.843 -1.16 . . . . 0.0 110.194 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 111.44 6.05 25.73 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 117.541 -1.7 . . . . 0.0 116.061 -172.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -73.34 126.85 31.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.07 1.935 . . . . 0.0 110.749 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 1.7 t -101.19 48.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 127.002 2.121 . . . . 0.0 114.298 -163.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.8 tp -48.84 123.68 7.36 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.186 1.395 . . . . 0.0 110.308 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.352 62.4 t80 63.92 -2.7 0.52 Allowed 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 107.24 -5.31 35.81 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 125.773 1.654 . . . . 0.0 114.134 -166.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -104.41 119.4 54.0 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 127.686 2.394 . . . . 0.0 111.14 -174.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -79.77 114.88 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.235 2.623 . . . . 0.0 113.137 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 66.5 mtp -73.21 131.32 41.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.112 1.365 . . . . 0.0 112.572 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 56.5 t -91.08 91.0 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.004 1.722 . . . . 0.0 109.38 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.653 HG12 HD23 ' A' ' 483' ' ' LEU . 2.4 t -91.3 125.81 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.93 1.692 . . . . 0.0 111.9 -177.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -142.12 155.94 45.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.671 1.188 . . . . 0.0 113.816 -169.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -63.28 147.35 51.3 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.299 -0.876 . . . . 0.0 112.423 166.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.014 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -175.381 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 7.8 p -152.52 155.29 37.16 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.669 1.588 . . . . 0.0 113.333 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.3 tt -75.85 153.16 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.923 0.889 . . . . 0.0 111.994 -163.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 60.4 m -89.05 153.25 21.15 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.405 0.682 . . . . 0.0 110.349 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -61.71 -35.05 76.92 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 118.175 -0.917 . . . . 0.0 112.629 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -41.5 79.63 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 170.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -74.13 -34.31 63.85 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.976 1.311 . . . . 0.0 112.714 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.5 tt -66.76 -50.97 60.99 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.164 1.386 . . . . 0.0 111.661 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -57.62 -26.57 61.74 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.854 1.662 . . . . 0.0 114.792 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -46.61 80.43 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.273 1.029 . . . . 0.0 109.908 171.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -92.63 59.59 2.52 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 127.636 2.541 . . . . 0.0 112.511 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -150.14 157.06 42.72 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.876 1.27 . . . . 0.0 109.837 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.7 pt -136.98 162.57 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.95 1.7 . . . . 0.0 110.791 176.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.7 m -110.09 170.41 8.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.481 1.912 . . . . 0.0 111.154 172.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -43.67 -45.77 7.09 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -170.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.45 -26.0 68.53 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.01 -30.78 20.97 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.306 -0.871 . . . . 0.0 111.55 169.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 13.9 ttm -66.18 -27.53 68.07 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.424 -1.422 . . . . 0.0 113.248 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -85.58 0.88 51.27 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.2 -35.27 6.88 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.25 2.22 . . . . 0.0 116.857 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 3.5 mp -72.83 133.96 44.68 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.261 1.025 . . . . 0.0 111.908 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 78.3 p -62.41 -18.61 62.05 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 173.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.2 m -88.17 -10.84 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -122.83 -10.49 8.25 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -34.73 56.58 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.754 -1.216 . . . . 0.0 113.875 173.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 23.7 p -113.42 -3.58 13.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.286 2.235 . . . . 0.0 114.641 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -134.87 114.44 12.57 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.02 1.728 . . . . 0.0 113.681 -167.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -130.52 120.12 18.68 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -159.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.13 164.76 30.8 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 124.313 3.342 . . . . 0.0 113.114 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 116.28 -1.53 20.72 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 117.075 1.59 . . . . 0.0 117.075 163.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -78.2 145.56 69.13 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.948 1.374 . . . . 0.0 113.992 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.94 103.92 1.78 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.092 3.195 . . . . 0.0 112.015 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -143.13 147.28 34.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.752 1.221 . . . . 0.0 108.515 166.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 19.7 p -81.02 5.76 15.5 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.889 -1.132 . . . . 0.0 113.389 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -137.26 148.71 46.62 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.482 1.913 . . . . 0.0 110.604 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.0 164.65 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 126.678 1.991 . . . . 0.0 109.524 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -136.98 164.44 28.35 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.3 p -143.66 142.33 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.06 1.344 . . . . 0.0 111.543 -176.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -118.77 171.03 8.49 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.745 2.018 . . . . 0.0 110.519 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 72.51 25.62 2.67 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.01 157.13 37.4 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.831 -1.168 . . . . 0.0 111.115 172.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -62.46 158.84 16.82 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.425 1.09 . . . . 0.0 113.548 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -68.28 -33.61 74.66 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.507 -0.746 . . . . 0.0 112.445 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -81.47 -40.56 23.09 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.14 155.78 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.884 1.673 . . . . 0.0 115.034 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -128.68 162.09 28.16 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.001 1.32 . . . . 0.0 112.837 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -33.8 57.69 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.81 -1.181 . . . . 0.0 113.237 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -58.05 -34.29 69.93 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.841 1.256 . . . . 0.0 114.213 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -77.46 -29.97 53.0 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -174.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.59 -20.73 66.43 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.923 1.689 . . . . 0.0 112.955 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.75 -17.23 21.29 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.351 0.978 . . . . 0.0 113.233 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -62.64 -36.72 83.73 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.557 1.143 . . . . 0.0 111.613 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 7.2 mt -105.97 -58.09 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.442 0.697 . . . . 0.0 110.089 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -54.67 -36.95 65.17 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.92 -10.58 85.06 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.939 0.781 . . . . 0.0 114.54 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -62.31 -29.11 70.2 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.584 1.692 . . . . 0.0 111.009 172.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -82.76 1.16 40.24 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.047 1.739 . . . . 0.0 115.533 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 32.1 t -132.12 132.14 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.03 1.732 . . . . 0.0 110.12 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -90.14 106.2 18.33 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.68 -0.637 . . . . 0.0 111.964 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -58.39 -18.17 25.96 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 92.3 p -77.52 -21.65 52.35 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 22.7 t -109.09 118.23 36.22 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.578 0.704 . . . . 0.0 110.974 -165.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -58.83 -51.07 71.56 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.307 0.643 . . . . 0.0 112.268 -170.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.37 -16.19 13.65 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.944 2.201 . . . . 0.0 116.944 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -85.65 -58.83 2.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.538 0.685 . . . . 0.0 109.966 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 15.0 ptt85 -75.62 -23.95 56.43 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.624 1.169 . . . . 0.0 113.662 -171.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.7 tt -54.01 -35.17 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.042 1.337 . . . . 0.0 112.442 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.3 mmm -86.07 -10.64 54.6 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.569 1.148 . . . . 0.0 112.83 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.86 109.04 20.85 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -169.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -154.08 149.49 27.21 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.161 1.384 . . . . 0.0 109.946 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 11.4 mt -128.98 134.64 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.372 1.469 . . . . 0.0 110.882 -173.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -116.6 145.33 43.45 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.764 1.226 . . . . 0.0 109.836 158.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.3 tp -125.21 120.22 30.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.943 2.097 . . . . 0.0 109.313 168.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 47.1 mtm -73.19 135.3 44.59 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 125.029 1.332 . . . . 0.0 110.851 166.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -134.12 -4.42 2.74 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -170.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.89 144.64 47.3 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.566 1.546 . . . . 0.0 111.36 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 60.47 -165.17 14.0 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.94 1.257 . . . . 0.0 114.412 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -19.29 48.53 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 96.0 mmm -85.87 1.68 48.89 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -58.98 149.66 26.71 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.651 1.114 . . . . 0.0 112.097 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 76.36 17.74 79.73 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.934 1.254 . . . . 0.0 112.952 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -114.33 134.21 55.12 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 123.803 0.841 . . . . 0.0 113.112 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -135.53 150.89 49.88 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -109.05 141.88 40.56 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.326 1.85 . . . . 0.0 114.013 167.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.4 mp -138.88 127.02 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.358 1.463 . . . . 0.0 109.872 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -91.93 146.87 18.47 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.522 -0.736 . . . . 0.0 112.167 165.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 39.7 mt -127.32 158.24 70.08 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.052 1.341 . . . . 0.0 110.927 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -74.22 -6.31 18.23 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.883 2.389 . . . . 0.0 114.737 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -153.28 146.01 24.31 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.249 -0.907 . . . . 0.0 111.153 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -65.39 -30.16 70.95 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.213 1.005 . . . . 0.0 111.523 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -63.94 -44.71 92.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.746 0.818 . . . . 0.0 113.014 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -60.74 -39.07 87.31 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.11 -0.472 . . . . 0.0 111.374 174.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.35 -47.51 76.18 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.089 0.859 . . . . 0.0 112.595 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.39 80.95 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.782 1.174 . . . . 0.0 112.174 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -67.71 -51.91 43.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.396 1.078 . . . . 0.0 112.164 175.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.48 70.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.953 0.501 . . . . 0.0 112.224 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.535 HD23 HG12 ' A' ' 498' ' ' VAL . 60.9 mt -69.0 -51.08 43.11 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.286 -0.884 . . . . 0.0 111.427 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -68.0 -14.91 63.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.865 0.866 . . . . 0.0 112.412 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -94.74 -50.79 5.0 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.705 1.602 . . . . 0.0 115.114 168.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.19 -19.72 42.71 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -173.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.32 100.82 0.86 Allowed 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.978 -1.076 . . . . 0.0 109.35 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 127.15 -5.97 7.26 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.313 -1.27 . . . . 0.0 114.912 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -72.31 129.63 38.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.257 1.529 . . . . 0.0 112.766 -170.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 3.3 t -96.03 110.25 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.444 1.097 . . . . 0.0 112.164 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 44.6 tp -121.22 141.82 50.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.536 1.934 . . . . 0.0 108.105 169.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.421 28.5 t80 61.77 17.83 9.13 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 73.54 15.59 79.16 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.332 1.444 . . . . 0.0 114.272 -168.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -127.4 133.39 25.03 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.165 1.386 . . . . 0.0 112.328 -170.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.36 120.27 6.85 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.182 2.588 . . . . 0.0 112.266 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 66.2 mtp -75.65 129.91 37.91 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.737 1.615 . . . . 0.0 112.089 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.09 73.5 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -171.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.535 HG12 HD23 ' A' ' 483' ' ' LEU . 1.4 t -76.56 120.51 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.294 1.038 . . . . 0.0 112.765 -175.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -142.3 161.39 38.15 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.433 1.493 . . . . 0.0 112.92 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -61.53 144.3 54.52 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -172.257 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.3 p -146.56 159.04 43.95 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -170.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.5 tt -76.64 148.29 7.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.974 1.71 . . . . 0.0 110.122 -172.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 39.9 t -80.0 151.1 30.19 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.345 0.593 . . . . 0.0 110.197 164.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -47.23 -43.86 22.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.729 161.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -64.94 -30.05 71.02 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -75.27 -46.09 35.87 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.916 0.886 . . . . 0.0 112.865 167.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 27.5 tp -63.74 -38.19 90.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.749 1.62 . . . . 0.0 112.606 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -57.01 -24.26 52.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.084 1.354 . . . . 0.0 114.261 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -68.46 -20.66 64.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.374 1.07 . . . . 0.0 113.073 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.87 68.7 0.32 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.198 1.856 . . . . 0.0 111.814 174.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -159.23 136.56 9.84 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.048 1.339 . . . . 0.0 109.976 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.9 pt -112.6 150.75 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.682 0.793 . . . . 0.0 111.099 174.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 30.8 m -74.78 160.85 30.19 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.707 1.203 . . . . 0.0 111.666 163.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.38 -25.79 60.06 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.133 -0.979 . . . . 0.0 112.751 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.25 -28.79 69.0 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.113 1.365 . . . . 0.0 113.215 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.35 -30.64 23.51 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.692 -1.255 . . . . 0.0 110.72 167.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 27.3 ttp -62.8 -37.53 87.1 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 120.984 -1.072 . . . . 0.0 111.207 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -84.05 34.57 0.51 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.356 1.462 . . . . 0.0 111.889 170.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.78 -31.42 0.43 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.434 2.294 . . . . 0.0 114.142 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 11.3 mt -74.0 131.92 41.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.002 1.321 . . . . 0.0 111.596 174.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 98.2 p -65.96 -27.67 68.33 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.215 1.406 . . . . 0.0 112.383 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.16 -19.99 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.195 -0.94 . . . . 0.0 112.782 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.261 51.7 m-85 -113.91 12.29 18.07 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 119.133 3.012 . . . . 0.0 119.133 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -14.24 62.62 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 46.7 t -136.73 -39.46 0.63 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.172 1.389 . . . . 0.0 113.227 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -73.29 144.67 46.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -132.95 126.9 19.95 Favored Pre-proline 0 N--CA 1.478 0.948 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -163.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -84.79 -176.69 2.56 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.503 3.468 . . . . 0.0 113.132 164.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 83.41 -26.74 4.39 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.787 1.661 . . . . 0.0 116.712 164.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -60.41 140.83 91.81 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 117.828 0.814 . . . . 0.0 112.999 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.26 104.41 1.9 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.25 3.3 . . . . 0.0 112.826 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -150.25 144.52 25.64 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.373 1.069 . . . . 0.0 110.129 161.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 27.9 p -77.55 8.55 4.19 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.719 -1.238 . . . . 0.0 114.118 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -139.08 142.57 38.13 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.525 1.93 . . . . 0.0 109.463 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 10.7 pt -131.67 165.25 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 126.539 1.936 . . . . 0.0 109.125 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -132.08 162.05 31.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 123.285 1.517 . . . . 0.0 107.994 164.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 498' ' ' VAL . 9.7 t -124.18 136.9 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 126.035 1.734 . . . . 0.0 109.952 175.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -115.9 165.84 12.64 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.335 1.454 . . . . 0.0 109.06 169.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 5.6 t30 66.0 35.09 6.59 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.08 0.552 . . . . 0.0 111.731 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -69.62 154.18 42.37 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.286 -0.884 . . . . 0.0 109.938 162.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -56.12 154.7 7.4 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.047 0.939 . . . . 0.0 111.873 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -74.84 -37.75 62.17 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.385 -0.822 . . . . 0.0 111.638 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -70.33 -41.79 72.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.027 1.731 . . . . 0.0 114.124 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.8 p -55.39 148.05 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -112.16 161.65 16.32 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.643 1.177 . . . . 0.0 113.057 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -56.51 -29.62 62.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.475 1.11 . . . . 0.0 113.277 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -64.48 -36.18 83.35 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 174.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.27 -30.79 68.98 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.319 1.448 . . . . 0.0 113.762 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.83 -19.93 62.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.996 1.718 . . . . 0.0 112.633 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.4 -26.49 63.3 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.383 0.992 . . . . 0.0 112.579 176.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -57.98 -37.55 74.42 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.429 0.558 . . . . 0.0 110.917 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.4 mt -95.16 -59.43 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.184 -0.948 . . . . 0.0 111.711 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -58.62 -29.56 66.59 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.04 -16.05 81.09 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.271 0.939 . . . . 0.0 114.469 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -14.32 62.02 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 119.879 1.84 . . . . 0.0 112.817 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -86.66 -4.77 59.22 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.873 2.069 . . . . 0.0 115.633 172.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.18 125.24 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.908 1.683 . . . . 0.0 110.83 -166.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -78.6 105.12 9.67 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.753 -0.592 . . . . 0.0 110.439 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -60.18 -10.83 4.94 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 70.2 m -93.9 -6.67 45.1 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.294 1.038 . . . . 0.0 113.709 172.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 40.0 t -115.22 115.61 26.98 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.345 1.058 . . . . 0.0 110.536 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -58.92 -48.49 81.28 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.721 0.808 . . . . 0.0 112.385 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.1 t -56.79 -16.63 6.92 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -87.9 -60.7 1.9 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.576 0.75 . . . . 0.0 110.03 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.6 ptt85 -72.17 -22.96 61.22 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.139 0.976 . . . . 0.0 112.971 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 18.7 tt -54.83 -41.68 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.824 1.25 . . . . 0.0 112.093 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.8 mtm -83.43 -6.85 59.59 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.761 0.71 . . . . 0.0 112.33 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -100.79 126.4 47.36 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -164.16 151.5 12.02 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.941 2.096 . . . . 0.0 108.28 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 10.5 mt -125.41 134.7 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.757 1.223 . . . . 0.0 110.538 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -133.72 90.3 2.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.899 0.88 . . . . 0.0 112.842 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.02 125.57 31.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.178 1.791 . . . . 0.0 111.273 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 34.9 mtm -79.31 127.01 31.54 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.835 2.454 . . . . 0.0 111.39 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -118.36 -3.41 10.98 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.725 1.61 . . . . 0.0 115.225 -173.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -130.37 148.57 52.21 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.653 1.181 . . . . 0.0 112.768 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 70.34 -159.21 53.57 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.771 1.177 . . . . 0.0 115.046 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -33.13 73.01 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.588 1.155 . . . . 0.0 113.521 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 73.3 mtm -85.96 12.41 9.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -54.81 106.34 0.21 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.157 0.889 . . . . 0.0 110.53 168.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.47 27.23 7.73 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.362 1.458 . . . . 0.0 115.401 -172.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -113.62 154.64 26.86 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.608 1.204 . . . . 0.0 110.131 163.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.57 139.69 21.12 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.462 -1.399 . . . . 0.0 113.973 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -90.68 144.24 25.94 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 166.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.72 122.58 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.118 1.767 . . . . 0.0 110.136 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.0 145.51 17.63 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 164.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 26.1 mt -126.93 156.3 74.29 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.794 1.238 . . . . 0.0 110.867 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.16 -4.32 15.19 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.578 2.852 . . . . 0.0 114.838 -173.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -153.88 130.87 10.99 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.461 1.104 . . . . 0.0 110.564 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -52.9 -38.49 61.8 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.1 1.36 . . . . 0.0 112.507 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -32.64 74.18 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.33 -37.49 74.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.117 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.54 72.31 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.41 1.004 . . . . 0.0 112.151 171.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.7 71.14 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 118.738 0.699 . . . . 0.0 111.914 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -69.9 -48.51 58.34 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.509 1.124 . . . . 0.0 112.96 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.2 -31.34 71.1 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.7 -0.625 . . . . 0.0 112.359 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.68 HD23 HG12 ' A' ' 498' ' ' VAL . 76.8 mt -67.31 -36.96 82.57 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.35 -0.844 . . . . 0.0 112.33 173.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -67.21 -33.1 74.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.601 0.76 . . . . 0.0 111.686 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -93.85 -34.05 13.3 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -170.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -91.01 -13.85 32.52 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.091 1.356 . . . . 0.0 113.931 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -65.3 105.94 1.24 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.212 1.005 . . . . 0.0 110.36 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 111.64 0.7 27.58 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.495 -1.17 . . . . 0.0 115.876 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -73.04 129.33 37.85 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 4.9 p -128.38 67.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 124.171 1.938 . . . . 0.0 109.521 -163.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.32 127.67 33.16 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 113.235 -1.802 . . . . 0.0 110.594 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.43 11.2 m-85 58.8 24.44 12.35 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 74.82 3.92 69.51 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.691 1.139 . . . . 0.0 114.422 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -95.37 104.4 15.43 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.025 1.73 . . . . 0.0 108.816 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.75 110.99 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.376 2.051 . . . . 0.0 110.025 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 28.0 mtp -74.13 124.06 25.62 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.748 1.619 . . . . 0.0 111.841 -169.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 97.1 t -90.26 91.92 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.736 1.614 . . . . 0.0 109.492 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.68 HG12 HD23 ' A' ' 483' ' ' LEU . 2.2 t -87.75 123.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 126.12 1.768 . . . . 0.0 112.323 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -153.67 152.19 30.54 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -164.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -61.4 150.14 36.27 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.737 -1.227 . . . . 0.0 111.153 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.029 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -175.975 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 11.1 p -149.15 163.14 38.45 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -171.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.5 tt -74.33 149.63 7.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 125.692 1.597 . . . . 0.0 111.313 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 17.7 m -86.55 152.11 22.91 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -63.36 -29.63 70.9 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.322 -0.861 . . . . 0.0 110.75 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -34.85 75.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.719 1.607 . . . . 0.0 114.64 174.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -78.58 -48.28 15.5 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.397 0.679 . . . . 0.0 111.636 170.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 16.5 tp -57.53 -37.66 73.4 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -57.41 -25.65 59.9 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.124 1.37 . . . . 0.0 113.941 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -73.99 -20.07 60.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.859 1.264 . . . . 0.0 112.506 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -120.36 63.94 0.47 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.532 2.015 . . . . 0.0 112.327 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -151.14 143.59 24.24 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.738 1.615 . . . . 0.0 110.006 -176.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 18.2 pt -125.04 163.08 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 44.6 t -110.54 172.43 6.87 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.691 1.596 . . . . 0.0 110.36 165.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 32.5 mtt-85 -49.96 -30.42 10.38 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.852 1.261 . . . . 0.0 113.899 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.25 -13.79 21.23 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 125.989 1.715 . . . . 0.0 113.187 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -123.1 -37.3 2.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.051 1.74 . . . . 0.0 112.289 167.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 53.7 ttp -61.18 -40.17 92.9 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.707 -1.246 . . . . 0.0 111.551 -176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.24 2.36 28.26 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.461 -0.774 . . . . 0.0 112.177 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.59 -34.28 10.29 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.415 2.286 . . . . 0.0 113.771 169.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 29.8 mt -77.88 129.07 34.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.363 1.865 . . . . 0.0 113.06 -174.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 88.4 p -58.17 -33.31 69.1 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.168 -0.958 . . . . 0.0 113.58 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.448 HG23 ' CD2' ' A' ' 410' ' ' PHE . 3.4 m -64.07 -12.64 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.448 ' CD2' HG23 ' A' ' 409' ' ' VAL . 83.9 m-85 -125.64 14.89 8.14 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -61.28 -23.42 65.67 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.9 t -135.85 -16.15 1.75 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.096 0.958 . . . . 0.0 113.292 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -71.88 144.31 49.07 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -141.45 124.59 9.75 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -169.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.32 -176.49 3.29 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.785 2.99 . . . . 0.0 112.841 171.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.512 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 76.15 -4.83 45.68 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.779 1.872 . . . . 0.0 117.779 165.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -72.38 148.13 90.58 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 118.98 1.39 . . . . 0.0 113.384 174.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.39 110.58 3.13 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.775 2.983 . . . . 0.0 113.872 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.482 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 40.6 t30 -157.01 154.77 30.13 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.254 1.822 . . . . 0.0 109.478 161.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 27.4 p -80.43 -3.52 50.15 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.482 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 69.9 mtt180 -130.64 150.85 51.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.931 1.692 . . . . 0.0 110.408 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.4 pt -131.06 160.99 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.387 1.875 . . . . 0.0 109.965 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -135.11 162.09 33.48 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 173.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.9 t -136.35 135.36 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 125.673 1.589 . . . . 0.0 112.056 -174.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -117.61 169.03 9.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.44 1.896 . . . . 0.0 108.395 168.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.26 13.1 m-20 68.13 29.73 6.1 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -171.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.66 143.43 40.11 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 119.868 -1.77 . . . . 0.0 110.535 166.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.52 25.82 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 118.418 2.747 . . . . 0.0 118.418 -165.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp 59.58 -65.6 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 128.703 2.801 . . . . 0.0 113.863 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -58.16 -41.38 83.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.325 1.85 . . . . 0.0 113.89 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 9.1 p -51.12 140.76 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.291 1.037 . . . . 0.0 113.526 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -104.12 157.76 16.9 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.061 0.945 . . . . 0.0 113.102 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -61.02 -26.78 67.85 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.797 -1.814 . . . . 0.0 112.77 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -70.7 -22.05 62.5 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -74.41 -33.82 63.1 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.524 1.129 . . . . 0.0 112.97 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.6 mp -73.64 -23.79 59.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.193 1.797 . . . . 0.0 113.733 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . 0.424 ' HD3' HD12 ' A' ' 457' ' ' ILE . 26.9 mmtp -56.59 -28.78 61.11 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 118.842 0.747 . . . . 0.0 110.876 -177.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -57.68 -33.22 68.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.758 1.623 . . . . 0.0 111.854 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.7 mt -98.33 -58.24 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.361 -0.837 . . . . 0.0 110.795 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -59.59 -25.91 64.99 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -80.74 -7.61 88.38 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.766 1.174 . . . . 0.0 114.379 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 36.7 ttp85 -61.03 -23.8 65.69 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.946 1.873 . . . . 0.0 112.049 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -95.72 2.16 53.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.026 2.131 . . . . 0.0 112.594 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.8 110.39 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.035 1.734 . . . . 0.0 110.701 -172.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -71.41 90.17 0.95 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.281 53.7 m-85 -58.32 -24.05 58.46 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 119.307 3.077 . . . . 0.0 119.307 -171.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.5 m -64.96 -22.48 67.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 17.4 m -101.08 122.66 43.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.122 1.369 . . . . 0.0 112.816 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -55.65 -48.46 74.97 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.453 -0.78 . . . . 0.0 112.181 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 2.8 t -54.05 -18.01 3.21 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -88.21 -63.64 1.27 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.592 0.757 . . . . 0.0 110.778 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -65.08 -29.57 70.46 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.696 1.198 . . . . 0.0 112.2 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.0 tt -58.02 -32.92 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.246 1.419 . . . . 0.0 112.679 173.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 9.1 mmm -84.93 -10.25 57.27 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.097 0.959 . . . . 0.0 112.499 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -105.85 135.03 48.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.136 1.774 . . . . 0.0 115.092 -172.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -168.0 145.16 4.2 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.984 1.314 . . . . 0.0 108.464 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.424 HD12 ' HD3' ' A' ' 437' ' ' LYS . 6.3 mt -117.13 132.52 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.738 1.215 . . . . 0.0 110.087 174.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -121.23 122.8 40.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.695 1.198 . . . . 0.0 109.976 166.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 3.3 tt -107.58 123.52 48.57 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.145 1.378 . . . . 0.0 110.352 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 45.7 mtm -79.88 130.51 35.36 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.117 1.367 . . . . 0.0 111.973 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -118.04 -7.03 10.9 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.851 1.66 . . . . 0.0 114.472 -168.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -117.25 154.67 30.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.533 1.133 . . . . 0.0 112.061 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 57.89 -142.12 44.28 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 161.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 29.0 tpt85 -57.67 -31.56 66.44 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.01 2.124 . . . . 0.0 115.11 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 20.8 mtm -111.44 18.79 18.83 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.065 1.346 . . . . 0.0 113.791 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -57.5 112.53 1.45 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.089 -1.007 . . . . 0.0 110.813 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 91.05 24.0 28.36 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 124.384 0.992 . . . . 0.0 114.805 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -112.32 155.65 23.75 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.668 1.187 . . . . 0.0 110.619 165.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -148.35 153.51 38.71 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -116.29 141.33 48.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.064 1.745 . . . . 0.0 115.346 170.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.3 124.02 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.275 1.43 . . . . 0.0 110.704 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -90.87 147.55 18.99 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.33 0.49 . . . . 0.0 112.028 163.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 19.3 mt -128.01 160.69 60.2 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.866 1.266 . . . . 0.0 111.105 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.58 -5.23 16.29 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.318 2.679 . . . . 0.0 115.05 -173.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -157.9 146.25 18.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.515 1.526 . . . . 0.0 109.993 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -56.38 -32.78 65.11 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.416 -0.802 . . . . 0.0 112.81 166.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -56.98 -44.69 82.92 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.417 -0.802 . . . . 0.0 113.163 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -64.16 -38.3 90.56 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.435 0.694 . . . . 0.0 111.097 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.83 -43.91 82.49 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.319 0.963 . . . . 0.0 112.25 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.67 85.32 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.197 0.908 . . . . 0.0 112.312 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -70.96 -46.73 61.86 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.316 1.047 . . . . 0.0 112.306 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.57 72.13 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.542 HD23 HG12 ' A' ' 498' ' ' VAL . 45.7 mt -66.25 -47.58 73.27 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.246 -0.909 . . . . 0.0 110.229 173.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -30.64 71.69 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.586 0.63 . . . . 0.0 112.242 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -84.77 -40.23 17.5 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -91.89 -22.47 20.05 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -67.12 106.58 2.03 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.871 -1.143 . . . . 0.0 109.498 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 120.88 -8.46 10.69 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.89 1.233 . . . . 0.0 115.579 -171.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -73.22 129.28 37.7 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.44 1.62 . . . . 0.0 109.169 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.305 7.3 p -115.44 55.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 124.183 1.944 . . . . 0.0 110.871 -163.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 26.2 tp -48.01 123.84 6.75 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.442 2.697 . . . . 0.0 111.475 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.307 68.7 m-85 55.08 8.39 0.24 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -174.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 101.67 0.52 52.75 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.994 1.283 . . . . 0.0 115.251 -173.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -107.35 113.6 61.81 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.202 1.501 . . . . 0.0 110.471 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.0 115.45 4.36 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 122.397 2.064 . . . . 0.0 110.23 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 32.4 mtp -75.19 129.15 37.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.812 1.645 . . . . 0.0 111.957 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.5 t -87.95 94.47 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.384 1.073 . . . . 0.0 109.035 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.542 HG12 HD23 ' A' ' 483' ' ' LEU . 2.5 t -91.57 123.35 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.05 1.74 . . . . 0.0 111.856 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -149.95 156.15 41.23 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.724 0.81 . . . . 0.0 112.291 -167.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -56.89 144.78 32.15 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.396 -0.815 . . . . 0.0 109.787 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -173.019 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 123.128 1.442 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.8 p -154.51 155.16 34.35 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.543 1.137 . . . . 0.0 112.527 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.4 tt -70.94 155.37 7.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 125.139 1.376 . . . . 0.0 110.53 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 30.2 t -86.66 150.67 24.03 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 121.442 -0.787 . . . . 0.0 110.756 161.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -43.96 -39.54 4.11 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.531 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -46.25 86.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -79.6 -33.7 41.36 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.031 0.933 . . . . 0.0 112.91 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.17 -48.61 80.99 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.252 1.421 . . . . 0.0 111.192 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -57.6 -23.29 50.09 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.866 1.266 . . . . 0.0 114.363 -176.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -65.42 -25.91 67.74 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.983 1.313 . . . . 0.0 113.042 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.51 89.28 0.46 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.66 1.6 . . . . 0.0 109.946 173.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -167.01 131.75 2.02 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.799 1.239 . . . . 0.0 109.334 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.2 pt -109.42 155.93 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.11 165.6 13.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.08 1.752 . . . . 0.0 110.575 161.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -57.3 -33.59 67.84 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.127 1.371 . . . . 0.0 111.442 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -59.92 -35.28 74.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.853 1.261 . . . . 0.0 113.272 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -79.74 -40.23 29.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.419 0.688 . . . . 0.0 110.602 167.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 31.3 ttm -55.28 -42.41 73.57 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.151 -0.968 . . . . 0.0 112.486 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -79.81 -14.24 58.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.034 0.934 . . . . 0.0 112.974 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.31 -37.27 45.09 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.95 1.7 . . . . 0.0 111.14 168.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 65.3 mt -77.31 121.16 23.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.658 1.583 . . . . 0.0 112.579 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 55.9 p -56.12 -29.64 60.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.233 1.013 . . . . 0.0 113.296 168.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.2 m -63.48 -31.92 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 175.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.311 58.6 m-85 -85.29 -5.66 59.3 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 -175.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -57.75 -16.01 9.84 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 -160.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.9 t -127.37 6.42 6.35 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.626 1.17 . . . . 0.0 113.096 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -129.16 133.73 47.73 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.831 -1.168 . . . . 0.0 107.85 -160.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -147.39 123.31 5.41 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -168.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.99 -173.45 1.88 Allowed 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.946 3.098 . . . . 0.0 112.934 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 99.37 -18.43 56.41 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 116.376 1.311 . . . . 0.0 116.376 170.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -76.59 155.8 83.32 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 118.682 1.241 . . . . 0.0 113.142 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -90.56 113.78 0.46 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.586 3.524 . . . . 0.0 113.768 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -154.29 147.54 24.84 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.636 1.175 . . . . 0.0 109.7 168.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 19.9 p -78.64 11.83 2.36 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.158 -1.589 . . . . 0.0 114.074 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -142.94 146.67 34.2 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.984 2.114 . . . . 0.0 109.063 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 19.0 pt -129.23 167.86 23.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 125.426 1.49 . . . . 0.0 109.606 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -145.57 162.61 37.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.94 139.83 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.782 1.233 . . . . 0.0 111.982 -170.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -119.11 165.81 13.71 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.934 1.693 . . . . 0.0 109.837 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 8.4 t30 64.18 45.78 3.88 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.71 1.204 . . . . 0.0 111.915 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.54 153.31 29.61 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.313 -0.867 . . . . 0.0 111.445 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.32 169.8 8.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.334 1.454 . . . . 0.0 114.502 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -70.23 -48.12 58.38 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.139 -0.976 . . . . 0.0 112.924 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -72.91 -25.23 60.98 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.4 1.48 . . . . 0.0 114.209 -176.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.7 p -69.4 146.49 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -123.36 162.08 23.43 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.419 1.888 . . . . 0.0 110.538 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.38 -29.89 59.32 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.61 -1.306 . . . . 0.0 112.72 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -60.19 -35.44 75.4 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.03 -33.39 70.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.111 0.964 . . . . 0.0 112.918 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.3 mp -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.481 1.512 . . . . 0.0 112.533 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -55.51 -31.34 61.96 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.075 0.852 . . . . 0.0 112.848 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -61.78 -29.98 70.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.741 0.816 . . . . 0.0 110.792 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.92 -55.27 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 121.227 -0.92 . . . . 0.0 110.783 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.253 50.2 m-85 -62.66 -23.84 67.31 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.25 -15.69 81.29 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.015 0.817 . . . . 0.0 114.069 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 38.0 ttp85 -59.52 -25.93 64.9 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.331 1.452 . . . . 0.0 112.849 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -90.2 -0.22 57.51 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.229 1.812 . . . . 0.0 111.676 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 15.2 t -120.92 116.14 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.326 1.85 . . . . 0.0 110.654 -173.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -79.85 97.43 6.67 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.845 0.858 . . . . 0.0 110.761 -175.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.286 58.5 m-85 -62.44 -11.68 17.37 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 119.064 2.987 . . . . 0.0 119.064 -173.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 72.6 m -75.95 -6.73 52.31 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 168.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 47.3 t -116.68 113.42 22.62 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.053 1.741 . . . . 0.0 110.715 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -59.77 -47.22 86.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.845 -0.535 . . . . 0.0 110.975 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -17.02 6.96 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -86.11 -64.9 1.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.801 0.81 . . . . 0.0 109.472 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -68.01 -23.22 64.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.909 1.284 . . . . 0.0 113.889 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.3 tt -56.2 -40.03 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.081 1.352 . . . . 0.0 111.911 172.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -8.85 59.62 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.287 1.035 . . . . 0.0 112.244 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -100.5 125.14 46.8 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -173.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -162.58 155.12 19.23 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.843 1.657 . . . . 0.0 107.767 172.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 4.5 mt -115.95 146.7 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.558 1.143 . . . . 0.0 109.85 174.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -128.05 137.5 52.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.569 1.148 . . . . 0.0 109.72 161.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.1 tp -120.4 136.6 54.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.457 1.503 . . . . 0.0 109.644 168.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 41.8 mtm -91.05 127.97 36.68 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.853 1.661 . . . . 0.0 110.664 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -113.57 -1.79 13.99 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.003 1.721 . . . . 0.0 114.229 -170.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -151.85 -169.86 3.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.787 1.635 . . . . 0.0 111.572 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.36 -163.22 46.21 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.143 0.878 . . . . 0.0 114.484 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -68.95 -11.93 61.16 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.569 1.948 . . . . 0.0 115.344 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 18.0 ptm -137.2 43.23 2.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.759 1.224 . . . . 0.0 112.841 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -52.7 127.69 23.95 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.68 1.192 . . . . 0.0 110.645 168.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 77.61 34.76 38.5 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.423 1.011 . . . . 0.0 112.286 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -120.91 150.69 40.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.132 0.973 . . . . 0.0 112.466 164.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -138.7 157.17 46.61 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.672 1.589 . . . . 0.0 113.49 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -120.33 144.09 48.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.549 1.939 . . . . 0.0 115.079 166.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.91 119.75 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.388 1.475 . . . . 0.0 110.93 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -82.23 137.98 17.84 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.365 -0.834 . . . . 0.0 111.285 162.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 24.2 mt -118.2 160.95 37.3 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.756 1.222 . . . . 0.0 110.112 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 -6.57 15.73 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.092 1.862 . . . . 0.0 114.983 -172.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -156.37 143.99 19.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.506 1.523 . . . . 0.0 110.351 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -51.64 -36.96 48.2 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.789 1.636 . . . . 0.0 112.341 165.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -61.42 -40.38 94.21 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.276 1.03 . . . . 0.0 112.853 174.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.56 -39.32 91.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.118 0.567 . . . . 0.0 110.723 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.68 87.38 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.922 -0.486 . . . . 0.0 112.107 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.26 -43.53 78.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.981 0.81 . . . . 0.0 112.16 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -75.76 -45.08 38.37 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.82 1.248 . . . . 0.0 112.855 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.39 -33.83 73.04 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.626 0.648 . . . . 0.0 112.729 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 498' ' ' VAL . 38.3 mt -67.8 -46.55 71.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.85 0.75 . . . . 0.0 110.915 172.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -64.49 -32.76 74.53 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 119.114 -0.47 . . . . 0.0 111.322 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -82.8 -54.67 4.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.17 -17.86 61.91 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.38 102.59 0.14 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.167 1.387 . . . . 0.0 111.965 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 105.18 -0.77 40.76 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 118.149 -1.361 . . . . 0.0 115.754 -175.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.63 128.75 37.15 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.556 1.678 . . . . 0.0 112.84 -173.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.314 1.4 t -93.55 49.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -163.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 58.9 tp -57.91 122.42 12.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.663 1.585 . . . . 0.0 111.677 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.403 56.4 m-85 59.16 20.3 8.3 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -175.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 83.16 13.47 76.95 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.335 0.969 . . . . 0.0 114.198 -172.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -119.78 119.86 30.92 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.042 1.337 . . . . 0.0 110.616 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.9 114.59 4.08 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.064 2.509 . . . . 0.0 111.003 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 63.1 mtp -74.72 134.78 41.85 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.529 1.132 . . . . 0.0 111.952 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.47 100.15 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.473 1.509 . . . . 0.0 108.458 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.501 HG12 HD23 ' A' ' 483' ' ' LEU . 2.4 t -101.93 132.38 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.019 1.728 . . . . 0.0 112.993 -170.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -150.43 156.77 42.1 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -170.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -56.16 144.71 28.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.793 0.837 . . . . 0.0 109.346 170.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.479 0 O-C-N 121.23 -0.919 . . . . 0.0 113.145 -176.561 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 8.8 m -155.14 161.28 41.28 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.41 1.884 . . . . 0.0 112.568 171.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.5 tt -67.94 140.88 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 124.222 1.009 . . . . 0.0 110.892 -170.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 70.5 m -82.68 160.44 22.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.998 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -63.64 -33.2 75.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 118.889 -0.576 . . . . 0.0 111.809 -174.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -62.47 -55.72 24.91 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.67 0.788 . . . . 0.0 112.964 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -62.06 -38.37 88.51 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.25 -44.64 83.1 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -60.67 -21.16 62.52 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -61.29 -46.29 90.94 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.178 1.391 . . . . 0.0 111.892 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.9 75.55 0.39 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.477 1.037 . . . . 0.0 111.999 -170.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 6.1 ttp85 -155.5 152.97 29.54 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.212 1.005 . . . . 0.0 110.97 -173.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.6 pt -130.94 155.06 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.9 0.88 . . . . 0.0 112.031 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 74.5 p -86.65 172.12 10.47 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.321 1.048 . . . . 0.0 111.456 169.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -55.18 -32.92 62.55 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.567 -0.708 . . . . 0.0 111.43 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.12 -25.72 67.89 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.88 -32.05 14.74 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.767 0.712 . . . . 0.0 110.803 166.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 16.0 ttm -66.55 -42.26 87.41 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.444 -1.41 . . . . 0.0 112.598 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -78.43 12.48 1.96 Allowed 'General case' 0 CA--C 1.552 1.042 0 O-C-N 120.973 -1.079 . . . . 0.0 111.573 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -125.03 -30.31 3.24 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.116 2.166 . . . . 0.0 116.006 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 1.7 mp -75.7 130.67 39.08 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.916 -1.115 . . . . 0.0 109.753 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 38.1 m -66.07 -20.65 66.24 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 1.3 m -57.19 -25.91 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 167.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.15 21.22 17.02 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -63.87 -22.52 66.96 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.238 -1.539 . . . . 0.0 114.78 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 78.0 p -139.97 -19.49 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.741 1.616 . . . . 0.0 113.365 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.18 135.89 41.06 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -141.95 132.05 12.65 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -85.26 175.77 6.2 Favored 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.283 3.322 . . . . 0.0 113.683 168.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.26 -3.39 72.54 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 117.894 1.918 . . . . 0.0 117.894 165.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -81.7 144.37 52.26 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 119.096 1.448 . . . . 0.0 113.996 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.17 86.21 1.7 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.148 3.232 . . . . 0.0 112.686 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.536 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 30.9 t30 -133.55 151.44 51.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.28 1.432 . . . . 0.0 110.257 165.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 24.2 p -82.07 -9.2 59.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.536 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 82.7 mtt-85 -121.61 150.52 41.58 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.944 1.298 . . . . 0.0 110.629 177.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 19.7 pt -135.02 158.84 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.638 1.975 . . . . 0.0 110.37 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -133.79 158.11 44.18 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.24 131.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.246 1.418 . . . . 0.0 113.614 -171.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -108.63 172.66 6.71 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.262 1.425 . . . . 0.0 110.63 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.283 88.6 m-20 71.67 32.91 1.89 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.645 1.978 . . . . 0.0 116.029 -176.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.49 147.2 25.48 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.175 -0.953 . . . . 0.0 111.73 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.67 161.72 22.74 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.149 1.779 . . . . 0.0 115.109 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -67.14 -39.85 86.63 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.664 -1.272 . . . . 0.0 112.681 166.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -73.1 -27.83 61.93 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.752 1.621 . . . . 0.0 114.798 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.01 146.43 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -128.23 164.05 23.39 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.889 1.276 . . . . 0.0 112.584 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -33.99 68.21 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.63 -1.294 . . . . 0.0 113.021 -174.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -54.22 -30.82 51.43 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.191 1.797 . . . . 0.0 115.297 170.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -83.43 -34.18 25.52 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.877 1.671 . . . . 0.0 113.6 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.06 -22.32 66.88 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.323 1.049 . . . . 0.0 111.973 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -20.18 44.63 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -67.29 -30.52 70.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.83 0.741 . . . . 0.0 111.843 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.83 -55.47 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.27 -0.894 . . . . 0.0 110.46 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -57.61 -30.07 65.03 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.36 -12.07 82.14 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 123.997 0.808 . . . . 0.0 114.602 174.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 5.4 ttt85 -58.83 -27.89 65.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.334 1.567 . . . . 0.0 110.85 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -95.66 18.26 13.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.241 1.816 . . . . 0.0 113.558 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 27.3 t -140.54 124.56 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.099 1.76 . . . . 0.0 111.223 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -77.23 110.07 11.63 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -61.71 -12.42 16.51 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 118.178 2.658 . . . . 0.0 118.178 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 16.5 m -88.83 -18.95 26.6 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.455 0.702 . . . . 0.0 112.676 174.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 28.9 t -108.63 112.54 24.93 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.758 1.223 . . . . 0.0 111.754 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -54.11 -50.64 66.41 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.228 0.611 . . . . 0.0 111.016 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.45 -12.77 1.85 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -93.17 -61.76 1.51 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.978 1.311 . . . . 0.0 110.692 172.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -69.3 -20.41 63.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.796 1.239 . . . . 0.0 113.784 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.08 -28.97 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.773 1.629 . . . . 0.0 112.69 169.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 37.5 mtp -85.86 -13.1 48.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.958 1.303 . . . . 0.0 111.761 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -108.32 117.32 33.84 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -163.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -159.2 154.54 25.55 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.891 1.676 . . . . 0.0 110.065 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 8.4 mt -130.63 142.21 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.189 1.396 . . . . 0.0 110.797 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -123.37 142.64 50.76 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.028 1.331 . . . . 0.0 110.283 160.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 11.2 tp -133.47 115.68 15.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.842 2.057 . . . . 0.0 109.134 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 45.8 mtm -71.27 144.62 49.96 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 124.602 1.161 . . . . 0.0 111.751 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -128.64 -6.93 5.14 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -172.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.96 145.1 35.57 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.824 1.193 . . . . 0.0 114.122 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 75.37 -177.16 49.29 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.096 1.331 . . . . 0.0 113.216 -172.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -18.72 61.68 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -170.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 70.4 mtp -89.12 3.17 52.72 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -58.52 145.63 38.39 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.533 -1.354 . . . . 0.0 111.131 175.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.54 27.66 70.84 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.749 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -126.83 146.04 50.42 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.727 1.211 . . . . 0.0 111.339 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -137.07 155.26 49.87 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -167.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -125.71 134.0 51.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.678 1.991 . . . . 0.0 115.307 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.94 125.05 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.974 1.709 . . . . 0.0 109.952 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.07 137.62 14.27 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 162.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 25.2 mt -118.18 160.45 39.25 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.515 1.526 . . . . 0.0 109.26 173.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.03 -8.96 20.5 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.139 1.226 . . . . 0.0 114.642 -170.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.402 ' OD1' ' HE2' ' A' ' 477' ' ' LYS . 64.1 t-20 -153.47 142.38 21.16 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.72 1.208 . . . . 0.0 111.059 -172.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -60.24 -37.19 79.63 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.389 -0.819 . . . . 0.0 111.147 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.402 ' HE2' ' OD1' ' A' ' 475' ' ' ASN . 3.0 mppt? -65.25 -32.35 73.97 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.311 0.644 . . . . 0.0 112.591 176.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -73.58 -35.5 65.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.084 0.554 . . . . 0.0 111.777 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.97 -45.14 86.92 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.359 0.981 . . . . 0.0 111.696 168.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.56 77.83 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.767 1.167 . . . . 0.0 112.263 176.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.33 -50.97 61.78 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.207 1.403 . . . . 0.0 112.545 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.54 -33.53 72.8 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.862 0.865 . . . . 0.0 112.118 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.523 HD23 HG12 ' A' ' 498' ' ' VAL . 45.6 mt -71.19 -36.87 72.11 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.927 1.291 . . . . 0.0 111.521 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -67.28 -22.99 65.63 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.513 1.125 . . . . 0.0 112.698 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -112.15 -33.04 6.36 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -171.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -84.83 -17.54 37.73 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -66.56 109.29 2.73 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.263 1.025 . . . . 0.0 111.672 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 104.57 4.41 43.13 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 118.061 -1.41 . . . . 0.0 115.976 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -70.4 123.66 22.3 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.704 1.752 . . . . 0.0 110.956 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.27 2.0 t -92.31 52.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.196 1.398 . . . . 0.0 114.416 -163.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.08 126.01 25.82 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.739 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . . 4.9 t80 53.79 35.91 22.67 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.579 1.952 . . . . 0.0 110.14 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 76.89 11.53 85.4 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.664 -1.272 . . . . 0.0 115.068 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -127.11 123.35 23.43 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 119.253 1.526 . . . . 0.0 111.11 -176.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.2 118.15 5.41 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.566 2.177 . . . . 0.0 111.648 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 72.1 mtp -69.14 126.06 28.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.693 1.197 . . . . 0.0 112.304 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -86.23 83.11 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.674 1.589 . . . . 0.0 113.422 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.523 HG12 HD23 ' A' ' 483' ' ' LEU . 1.6 t -85.86 122.61 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.398 1.479 . . . . 0.0 112.895 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -145.95 155.6 42.95 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.954 1.301 . . . . 0.0 111.693 -174.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -60.35 144.28 51.08 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.937 -1.102 . . . . 0.0 110.796 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.458 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 . . . . . 0 CA--C 1.544 0.722 0 CA-C-O 122.229 1.014 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 14.7 p -150.22 149.61 30.43 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.92 1.288 . . . . 0.0 114.332 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.5 tt -76.08 153.04 6.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 125.795 1.638 . . . . 0.0 111.516 -167.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 33.9 t -83.54 156.6 22.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.386 0.612 . . . . 0.0 110.745 165.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -53.92 -36.01 62.3 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.491 0.717 . . . . 0.0 111.029 163.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -45.4 86.78 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -71.1 -35.17 71.72 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.546 0.738 . . . . 0.0 112.85 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.422 HD12 ' CD2' ' A' ' 489' ' ' TYR . 31.4 tp -67.76 -44.68 76.9 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -54.91 -24.19 22.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.816 1.246 . . . . 0.0 114.03 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.68 -29.29 69.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.126 1.371 . . . . 0.0 112.855 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.22 97.94 0.76 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.436 1.017 . . . . 0.0 111.521 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -159.8 152.22 21.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.448 1.099 . . . . 0.0 110.635 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.44 150.21 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.428 0.632 . . . . 0.0 112.68 168.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 39.9 m -98.22 169.45 9.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.66 1.584 . . . . 0.0 111.694 168.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -54.57 -23.71 17.93 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -171.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -72.16 -28.43 63.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.798 0.839 . . . . 0.0 112.81 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.79 -32.9 14.49 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.527 1.131 . . . . 0.0 111.094 171.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 35.8 ttm -58.08 -46.3 85.69 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.08 -1.013 . . . . 0.0 111.239 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -85.04 37.16 0.65 Allowed 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.385 -0.822 . . . . 0.0 111.363 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.44 -37.52 0.31 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.948 2.099 . . . . 0.0 114.332 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.48 131.37 42.46 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.993 1.317 . . . . 0.0 110.008 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 53.1 p -69.01 -22.48 64.07 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.012 -1.055 . . . . 0.0 112.065 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.3 m -71.38 -7.53 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 168.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.426 ' CE1' HG13 ' A' ' 497' ' ' VAL 0.286 89.4 m-85 -117.79 3.93 12.25 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 173.718 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -66.01 -15.07 62.71 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -174.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 79.9 p -141.1 -16.12 0.86 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.907 1.283 . . . . 0.0 114.187 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -80.75 141.27 34.96 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 170.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -140.59 129.8 13.09 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -169.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -84.91 -174.86 1.86 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 124.263 3.309 . . . . 0.0 114.242 171.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.83 -44.99 2.34 Favored Glycine 0 N--CA 1.466 0.659 0 C-N-CA 126.488 1.994 . . . . 0.0 115.774 164.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -65.85 142.37 98.08 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -164.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.2 106.5 2.29 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.53 2.82 . . . . 0.0 112.199 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 37.7 t30 -144.37 151.21 38.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.222 2.209 . . . . 0.0 107.752 159.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 28.9 p -75.06 2.55 10.35 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.476 -1.39 . . . . 0.0 114.361 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.405 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 61.3 mtt85 -137.53 147.69 45.36 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.124 1.77 . . . . 0.0 110.333 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 43.9 pt -134.43 159.97 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.203 2.201 . . . . 0.0 110.123 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -139.86 159.86 41.22 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.19 140.24 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.694 1.597 . . . . 0.0 113.412 -164.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -119.5 175.59 5.76 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.331 1.452 . . . . 0.0 111.168 167.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.279 13.6 m-20 69.07 25.42 5.85 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.322 1.849 . . . . 0.0 115.824 -172.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -74.68 146.53 42.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.262 -1.524 . . . . 0.0 111.043 173.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.18 173.65 3.69 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -173.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -77.98 -50.58 11.87 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.518 1.127 . . . . 0.0 111.78 -176.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -81.97 -23.68 35.94 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.24 1.816 . . . . 0.0 113.251 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.58 152.07 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -122.53 168.27 12.34 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.697 1.599 . . . . 0.0 113.346 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -57.2 -35.21 69.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.542 1.137 . . . . 0.0 112.616 174.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -62.35 -36.42 82.19 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -71.92 -25.18 61.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.641 1.176 . . . . 0.0 113.636 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.23 -15.4 59.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.099 2.16 . . . . 0.0 114.024 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.67 -22.75 57.75 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.324 0.966 . . . . 0.0 112.857 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -55.31 -37.23 67.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.076 1.351 . . . . 0.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.79 -57.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 121.253 -0.904 . . . . 0.0 111.659 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.274 58.9 m-85 -59.68 -31.83 69.92 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -175.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.76 -19.84 79.74 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 123.668 0.652 . . . . 0.0 114.072 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -55.0 -35.82 64.77 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.713 1.605 . . . . 0.0 112.506 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -77.71 0.79 22.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.431 1.892 . . . . 0.0 114.873 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 11.7 t -124.59 121.99 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.742 2.017 . . . . 0.0 109.946 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.254 3.2 m-20 -66.78 90.56 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 175.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -52.64 -21.42 3.93 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 173.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 15.8 m -65.2 -22.29 66.88 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.346 1.058 . . . . 0.0 113.176 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 31.2 m -124.45 117.84 25.31 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.697 1.599 . . . . 0.0 112.733 -170.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -63.09 -40.67 98.33 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.234 -0.916 . . . . 0.0 113.278 -174.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 2.9 t -54.48 -15.23 1.58 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -88.75 -62.65 1.44 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.213 1.405 . . . . 0.0 110.714 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -67.02 -24.55 66.03 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.14 1.376 . . . . 0.0 113.169 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.3 tt -58.53 -36.58 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.3 1.04 . . . . 0.0 112.366 171.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 16.6 mtm -87.52 -2.59 58.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.089 1.355 . . . . 0.0 112.439 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.56 143.81 31.77 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.938 2.495 . . . . 0.0 115.212 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -168.7 154.85 6.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.08 1.752 . . . . 0.0 107.006 168.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.08 126.75 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.599 1.16 . . . . 0.0 109.544 172.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -104.3 137.65 41.89 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.845 1.258 . . . . 0.0 108.899 165.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.2 tp -128.1 127.75 43.63 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.886 1.274 . . . . 0.0 109.191 164.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 48.0 mtm -93.17 125.04 37.57 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.808 1.643 . . . . 0.0 109.948 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -122.14 -0.46 9.43 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.963 2.105 . . . . 0.0 112.925 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.9 148.79 23.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.832 1.653 . . . . 0.0 112.512 173.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 90.57 -168.77 33.56 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 163.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -20.55 64.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.344 1.858 . . . . 0.0 113.772 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 62.7 mtp -115.92 24.28 11.59 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.282 2.233 . . . . 0.0 112.202 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -65.46 151.95 45.11 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.792 -1.193 . . . . 0.0 113.204 -172.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.66 36.83 18.5 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 126.194 1.854 . . . . 0.0 112.798 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -120.19 142.01 49.37 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.189 0.996 . . . . 0.0 112.128 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -129.93 153.37 48.41 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -168.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -126.83 129.63 48.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.0 2.12 . . . . 0.0 114.733 171.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.5 mp -126.42 120.56 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.674 1.59 . . . . 0.0 109.856 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -83.14 141.03 20.45 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 162.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 21.4 mt -124.51 158.82 60.41 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.726 1.61 . . . . 0.0 109.686 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.88 -15.62 26.39 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.948 2.432 . . . . 0.0 114.085 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -150.07 143.74 25.31 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.035 0.934 . . . . 0.0 110.623 -175.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -57.6 -37.67 73.61 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.41 1.084 . . . . 0.0 111.61 170.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -69.78 -23.23 63.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.346 1.058 . . . . 0.0 113.575 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -77.56 -38.22 48.98 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.774 171.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.06 79.27 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.254 0.933 . . . . 0.0 112.259 170.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -54.64 -43.19 72.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.4 1.0 . . . . 0.0 111.614 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -64.77 -50.05 68.35 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.962 1.305 . . . . 0.0 113.009 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.38 -31.54 72.22 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.359 0.664 . . . . 0.0 111.816 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.511 HD23 HG12 ' A' ' 498' ' ' VAL . 89.7 mt -77.87 -31.58 51.45 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.099 -1.001 . . . . 0.0 112.346 173.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -60.62 -33.29 72.55 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.617 1.167 . . . . 0.0 110.606 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -101.9 -54.45 2.72 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -174.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -75.52 -14.45 60.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -168.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -65.46 104.43 0.98 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.207 1.003 . . . . 0.0 110.323 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 107.31 1.5 35.46 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 117.583 -1.676 . . . . 0.0 116.18 -172.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.422 ' CD2' HD12 ' A' ' 394' ' ' LEU 0.314 92.2 t80 -64.65 128.86 37.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.672 2.236 . . . . 0.0 115.925 -168.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.325 2.0 t -91.68 45.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -160.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 23.2 tp -52.8 138.87 28.35 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.156 1.382 . . . . 0.0 110.183 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.356 7.0 t80 62.91 -4.08 0.28 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 94.7 9.57 58.57 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 124.958 1.266 . . . . 0.0 114.358 -166.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -127.21 128.48 24.09 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 126.686 1.995 . . . . 0.0 111.581 -173.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.86 119.04 5.51 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.544 2.162 . . . . 0.0 112.511 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 56.9 mtp -75.58 130.81 39.4 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.729 1.612 . . . . 0.0 112.419 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . 0.426 HG13 ' CE1' ' A' ' 410' ' ' PHE . 2.5 t -87.95 76.79 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.857 1.663 . . . . 0.0 115.131 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.511 HG12 HD23 ' A' ' 483' ' ' LEU . 1.7 t -79.83 122.72 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.355 1.062 . . . . 0.0 113.789 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -141.63 155.7 45.7 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.175 1.79 . . . . 0.0 112.514 -173.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -59.7 143.28 51.18 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.346 -1.471 . . . . 0.0 113.193 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -169.99 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 121.892 0.853 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 28.0 p -139.05 159.81 41.26 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.9 tt -70.06 152.37 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.863 1.665 . . . . 0.0 110.94 -174.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 1.6 m -86.65 152.6 22.44 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 7.2 ttm-85 -59.06 -35.79 73.95 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.1 -1.0 . . . . 0.0 111.124 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -41.51 98.26 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.838 1.655 . . . . 0.0 113.733 174.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.85 -38.91 92.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.095 0.958 . . . . 0.0 112.692 174.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.4 tt -70.2 -39.99 74.86 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.412 1.485 . . . . 0.0 111.943 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.36 -17.17 18.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.488 1.915 . . . . 0.0 115.153 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -63.95 -64.61 0.84 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.74 -0.6 . . . . 0.0 110.88 164.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -78.99 72.09 2.51 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.497 1.999 . . . . 0.0 114.072 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -159.66 143.33 14.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.763 1.225 . . . . 0.0 110.973 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.4 pt -123.3 153.74 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.356 1.063 . . . . 0.0 113.866 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 77.3 p -85.02 169.87 13.55 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.54 1.536 . . . . 0.0 111.828 168.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 -58.37 -28.92 65.6 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.326 -0.859 . . . . 0.0 113.288 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.83 -30.94 71.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.543 0.737 . . . . 0.0 112.265 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.44 -36.59 26.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.641 1.176 . . . . 0.0 111.775 168.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 20.3 ttp -63.06 -40.6 98.18 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.919 -1.113 . . . . 0.0 111.829 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -83.29 25.12 0.75 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.441 0.696 . . . . 0.0 112.609 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.69 -38.23 1.51 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.892 2.077 . . . . 0.0 115.933 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.58 127.58 33.44 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.509 1.524 . . . . 0.0 110.131 172.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 27.9 t -59.48 -32.12 69.96 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.543 -0.723 . . . . 0.0 112.314 168.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 18.5 m -60.21 -21.64 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 120.753 -1.217 . . . . 0.0 114.08 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.263 79.7 m-85 -109.52 6.8 24.39 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -69.67 -22.33 63.45 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 46.6 t -123.43 -42.16 2.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.426 1.09 . . . . 0.0 112.381 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -72.56 150.79 42.84 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.898 1.279 . . . . 0.0 114.319 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -140.24 125.49 11.36 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -163.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -92.74 177.01 1.55 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 124.958 3.772 . . . . 0.0 114.887 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.438 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 98.58 -8.86 62.2 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.302 1.906 . . . . 0.0 116.843 163.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -85.69 139.79 35.52 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 119.294 1.547 . . . . 0.0 114.556 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -83.55 65.43 7.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 1 C-N-CA 125.392 4.061 . . . . 0.0 113.038 -174.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 46.6 t30 -89.79 153.98 20.26 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.551 -0.718 . . . . 0.0 110.485 162.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 28.4 p -76.05 -3.63 36.94 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.088 -1.633 . . . . 0.0 115.068 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.48 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 87.7 mtt-85 -136.44 152.52 50.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.352 1.861 . . . . 0.0 111.833 176.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.6 pt -135.4 164.14 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.671 1.989 . . . . 0.0 109.588 176.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -138.47 161.21 37.59 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.447 HG22 HG13 ' A' ' 498' ' ' VAL . 2.7 t -135.62 150.52 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.241 1.816 . . . . 0.0 112.018 -171.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -138.01 -178.25 5.18 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.292 0.496 . . . . 0.0 112.158 162.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 69.61 21.73 6.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.215 1.806 . . . . 0.0 114.516 -165.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.87 154.64 41.65 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.991 -1.068 . . . . 0.0 110.912 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -68.26 173.7 4.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.172 0.989 . . . . 0.0 113.03 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.02 -30.43 13.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.225 1.41 . . . . 0.0 112.285 170.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -73.69 -14.81 61.21 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.107 1.363 . . . . 0.0 113.92 172.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.8 p -86.16 147.16 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.807 1.643 . . . . 0.0 113.898 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -117.49 164.81 14.34 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.333 1.053 . . . . 0.0 111.953 173.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -58.67 -30.51 67.41 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.6 -1.313 . . . . 0.0 111.966 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -20.93 63.8 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.842 1.657 . . . . 0.0 114.84 174.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -76.78 -37.86 55.09 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.269 1.028 . . . . 0.0 113.533 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.18 -18.31 63.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.595 1.558 . . . . 0.0 112.541 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -49.14 -33.13 11.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.176 1.391 . . . . 0.0 112.869 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -66.14 -31.2 71.91 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -169.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.9 mt -98.75 -56.15 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.821 -1.174 . . . . 0.0 111.151 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.265 75.6 m-85 -60.79 -22.52 64.2 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.73 -6.88 88.89 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.399 0.999 . . . . 0.0 114.519 170.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -63.05 -26.39 68.82 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 120.794 2.297 . . . . 0.0 112.09 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -94.51 3.83 54.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.081 2.152 . . . . 0.0 111.424 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.8 107.8 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.355 1.462 . . . . 0.0 109.432 -174.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -72.15 104.96 3.79 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -170.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -50.3 -40.31 48.19 Favored 'General case' 0 C--N 1.338 0.109 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 -170.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.0 p -68.16 -4.08 12.66 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 14.9 t -118.02 116.05 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.747 1.158 . . . . 0.0 111.782 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -60.3 -43.78 96.0 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.209 -0.932 . . . . 0.0 112.25 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.2 t -54.83 -16.08 2.38 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -90.09 -60.28 1.97 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.186 0.994 . . . . 0.0 110.032 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -68.13 -23.86 64.94 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.785 1.234 . . . . 0.0 113.286 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.0 tt -61.36 -31.84 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.938 1.695 . . . . 0.0 112.96 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.7 mtm -97.85 2.39 49.25 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.23 1.412 . . . . 0.0 112.698 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -111.6 112.23 23.79 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.372 1.869 . . . . 0.0 115.85 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -154.62 131.85 11.07 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.573 -0.704 . . . . 0.0 109.419 -168.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 5.1 mt -113.47 142.96 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.654 1.182 . . . . 0.0 110.407 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -134.37 129.64 35.71 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.992 1.717 . . . . 0.0 109.322 165.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 4.2 tt -115.53 139.73 49.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.345 1.858 . . . . 0.0 111.005 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -101.67 131.78 47.73 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 125.234 1.414 . . . . 0.0 112.463 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -113.9 1.76 14.84 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -171.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -145.9 154.82 42.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.211 1.004 . . . . 0.0 113.042 -174.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 77.23 -162.08 51.03 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.207 1.384 . . . . 0.0 113.809 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -22.27 66.07 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 121.483 -1.01 . . . . 0.0 112.743 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 23.2 ptp -87.18 8.84 22.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.112 1.365 . . . . 0.0 114.395 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -56.77 115.85 2.81 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.825 1.193 . . . . 0.0 110.838 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.16 22.79 58.48 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.732 1.634 . . . . 0.0 113.859 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -93.79 155.98 16.92 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.353 0.661 . . . . 0.0 110.697 158.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -149.74 152.8 35.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.224 1.009 . . . . 0.0 113.179 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -105.63 144.53 32.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.145 1.778 . . . . 0.0 114.123 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.9 mp -139.62 115.01 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.198 1.399 . . . . 0.0 109.244 169.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -81.69 144.15 23.97 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 158.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.1 mt -123.5 159.83 53.44 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.712 1.205 . . . . 0.0 110.332 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.01 -8.78 24.44 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.658 2.906 . . . . 0.0 114.321 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -156.71 144.11 19.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.582 0.706 . . . . 0.0 112.125 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -49.77 -44.79 49.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.406 1.882 . . . . 0.0 112.579 166.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -68.01 -28.75 67.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.706 1.202 . . . . 0.0 113.779 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.52 73.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.563 174.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.0 88.03 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.939 0.79 . . . . 0.0 112.776 174.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.68 71.11 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.722 0.692 . . . . 0.0 112.371 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.16 -52.0 15.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.134 1.374 . . . . 0.0 112.885 172.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.08 -30.54 69.3 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.094 0.958 . . . . 0.0 113.293 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.597 HD23 HG12 ' A' ' 498' ' ' VAL . 28.8 mt -64.17 -49.32 72.56 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.379 0.671 . . . . 0.0 111.028 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -21.6 48.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.614 0.766 . . . . 0.0 112.729 -176.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -72.01 -54.57 9.48 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.397 0.999 . . . . 0.0 112.62 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.67 -14.67 59.56 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -172.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -61.8 99.07 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.013 1.325 . . . . 0.0 111.657 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 119.34 -1.5 14.29 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 117.778 -1.568 . . . . 0.0 115.405 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -71.23 131.0 42.85 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.354 1.577 . . . . 0.0 111.254 -172.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.18 67.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.971 1.708 . . . . 0.0 113.437 -168.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 23.6 tp -66.28 142.8 57.54 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.363 162.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.4 27.3 t80 63.8 7.81 3.44 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 118.228 2.677 . . . . 0.0 118.228 167.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 78.93 14.97 81.42 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.1 1.333 . . . . 0.0 114.277 -169.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -133.87 125.65 18.37 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.66 1.584 . . . . 0.0 110.689 -171.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.4 125.18 11.54 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.121 1.881 . . . . 0.0 112.167 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 63.7 mtp -73.15 127.3 32.2 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.817 1.247 . . . . 0.0 111.696 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.24 98.86 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.901 0.88 . . . . 0.0 109.712 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.597 HG12 HD23 ' A' ' 483' ' ' LEU . 2.0 t -94.18 124.27 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.641 1.577 . . . . 0.0 112.337 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -148.28 152.81 37.77 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.61 0.764 . . . . 0.0 112.765 -168.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . 0.31 17.6 p90 -57.85 144.66 37.98 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 173.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -171.312 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 . . . . . 0 CA--C 1.542 0.639 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 23.2 p -135.85 162.5 32.64 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 12.5 tt -76.66 144.03 12.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 125.694 1.597 . . . . 0.0 111.971 -162.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 69.3 m -90.05 155.96 18.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.506 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -53.48 -38.77 63.97 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.929 0.892 . . . . 0.0 111.655 -174.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -62.53 -47.97 81.58 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -69.67 -34.11 73.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -42.52 94.41 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.8 0.84 . . . . 0.0 112.408 169.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -57.91 -27.14 63.06 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.659 -1.276 . . . . 0.0 114.443 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -68.93 -21.84 64.18 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 118.996 0.816 . . . . 0.0 112.412 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -116.52 62.95 0.37 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.088 1.804 . . . . 0.0 112.888 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -148.21 166.25 28.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.832 1.653 . . . . 0.0 109.371 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.2 pt -144.83 148.88 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.125 0.97 . . . . 0.0 112.143 167.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.6 m -74.17 160.38 31.27 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.4 1.88 . . . . 0.0 112.815 165.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -53.76 -35.62 61.47 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.804 1.242 . . . . 0.0 112.323 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -60.3 -30.08 69.25 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.299 1.04 . . . . 0.0 113.258 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.33 -26.24 18.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.568 1.147 . . . . 0.0 112.123 172.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 8.2 ttm -61.77 -38.98 90.05 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 120.785 -1.197 . . . . 0.0 111.366 174.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -80.15 22.18 0.54 Allowed 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 171.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.38 -31.46 1.09 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 5.5 mp -74.5 137.85 42.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.64 1.176 . . . . 0.0 111.402 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 81.1 p -63.64 -31.89 73.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.429 HG23 ' CD2' ' A' ' 410' ' ' PHE . 1.5 m -63.54 -19.54 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.38 1.472 . . . . 0.0 114.677 173.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.429 ' CD2' HG23 ' A' ' 409' ' ' VAL 0.308 65.7 m-85 -109.41 3.08 21.06 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 119.152 3.019 . . . . 0.0 119.152 -176.41 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -29.12 67.05 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 37.5 t -126.43 -34.94 2.42 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.064 1.346 . . . . 0.0 112.829 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -72.02 139.61 48.63 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -142.41 130.32 11.47 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.709 1.204 . . . . 0.0 112.15 -170.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -76.48 -166.28 0.36 Allowed 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 124.3 3.334 . . . . 0.0 113.156 164.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.411 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 91.16 13.8 58.35 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 117.688 1.835 . . . . 0.0 117.688 156.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -102.38 149.87 37.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 119.613 1.706 . . . . 0.0 113.088 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.54 109.53 2.92 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.583 2.856 . . . . 0.0 112.355 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.488 HD22 ' H ' ' A' ' 421' ' ' ARG . 7.0 t30 -148.38 145.0 27.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.347 1.059 . . . . 0.0 109.098 164.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 24.2 p -76.0 -2.66 31.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.488 ' H ' HD22 ' A' ' 419' ' ' ASN . 33.8 mtp85 -130.09 147.08 51.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.888 2.075 . . . . 0.0 108.901 177.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 3.3 pt -131.81 161.18 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 126.386 1.875 . . . . 0.0 109.431 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -136.8 161.44 35.98 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.7 t -131.65 140.68 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.453 1.501 . . . . 0.0 111.655 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -120.56 166.23 13.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.544 1.537 . . . . 0.0 109.36 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 69.49 36.88 2.1 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -171.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.8 160.2 26.23 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 120.148 -1.595 . . . . 0.0 112.221 168.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -79.02 176.15 9.92 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.002 1.721 . . . . 0.0 115.282 -171.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -77.93 -48.04 17.24 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 171.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -72.8 -36.04 67.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.656 1.182 . . . . 0.0 113.179 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.64 153.95 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -130.93 163.55 27.24 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.467 1.507 . . . . 0.0 111.566 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -52.62 -31.06 34.71 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.548 1.139 . . . . 0.0 113.408 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -60.08 -33.04 71.53 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 171.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -76.88 -26.82 54.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.427 1.491 . . . . 0.0 114.494 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.44 -19.98 60.83 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.044 1.738 . . . . 0.0 113.549 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.76 -25.88 61.08 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.587 1.085 . . . . 0.0 112.358 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -59.29 -38.87 81.25 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.552 0.741 . . . . 0.0 111.5 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mt -94.47 -56.97 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 121.26 -0.9 . . . . 0.0 110.632 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -60.25 -28.33 67.95 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.57 -12.75 84.21 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.437 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -55.12 -40.4 70.46 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.135 1.467 . . . . 0.0 112.064 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -80.89 -5.96 58.04 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.403 1.881 . . . . 0.0 112.022 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.61 117.54 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.154 1.782 . . . . 0.0 110.726 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -69.07 90.87 0.47 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.299 30.7 m-85 -59.14 -16.05 17.73 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 118.198 2.666 . . . . 0.0 118.198 177.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.9 t -66.73 -26.26 66.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.854 1.207 . . . . 0.0 112.295 171.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.1 m -110.23 120.76 43.46 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.636 1.574 . . . . 0.0 112.303 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -58.23 -44.11 88.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.005 -1.059 . . . . 0.0 112.826 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.11 -7.14 0.46 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -100.0 -55.6 2.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.842 1.257 . . . . 0.0 109.768 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -70.58 -24.13 62.71 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.485 1.114 . . . . 0.0 112.691 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.5 tt -59.24 -31.91 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.8 1.64 . . . . 0.0 112.694 171.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 36.1 mtp -86.71 -9.24 56.37 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.23 1.412 . . . . 0.0 112.485 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.22 122.23 46.51 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -170.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -159.62 119.33 2.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.215 1.006 . . . . 0.0 110.981 -170.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 8.1 mt -102.59 133.03 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.986 0.914 . . . . 0.0 111.323 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -133.19 120.46 21.2 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.004 0.921 . . . . 0.0 110.388 170.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 7.8 tt -108.76 129.63 55.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.132 1.773 . . . . 0.0 110.101 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -77.96 109.53 12.09 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.421 1.489 . . . . 0.0 110.982 176.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -85.0 -8.95 58.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pm0 -130.92 159.62 36.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -167.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 65.02 -160.25 42.62 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.965 1.269 . . . . 0.0 114.98 164.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -18.64 60.52 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 40.9 mtp -99.71 11.65 38.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.054 1.341 . . . . 0.0 113.029 174.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -54.03 113.01 1.07 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.512 1.125 . . . . 0.0 110.306 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.81 31.39 23.97 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.282 0.944 . . . . 0.0 113.875 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -106.4 155.35 19.63 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.517 1.127 . . . . 0.0 110.412 157.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.2 154.48 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.962 -1.086 . . . . 0.0 113.604 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -116.23 144.41 44.23 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.653 1.981 . . . . 0.0 115.58 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.25 118.27 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.554 1.941 . . . . 0.0 110.026 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -81.95 142.02 22.12 Favored Glycine 0 CA--C 1.534 1.249 0 O-C-N 121.447 -0.783 . . . . 0.0 111.383 159.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.6 mt -120.87 160.8 43.25 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.059 1.344 . . . . 0.0 109.986 174.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.78 -6.19 17.84 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.527 2.152 . . . . 0.0 114.447 -175.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -155.59 143.56 19.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.563 0.745 . . . . 0.0 111.466 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.31 -43.31 32.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.407 1.483 . . . . 0.0 112.469 162.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -62.54 -34.96 77.96 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.466 -0.771 . . . . 0.0 113.017 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.03 -37.43 75.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.413 0.685 . . . . 0.0 111.816 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.74 80.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.394 0.997 . . . . 0.0 111.783 170.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.03 -34.07 67.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.583 0.753 . . . . 0.0 112.398 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -75.11 -49.39 19.76 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.849 1.26 . . . . 0.0 112.848 170.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.7 -29.73 68.3 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.575 -0.703 . . . . 0.0 112.602 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.471 HD23 HG12 ' A' ' 498' ' ' VAL . 65.9 mt -71.71 -28.84 63.97 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.299 1.04 . . . . 0.0 113.412 173.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -67.57 -37.72 83.04 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.575 0.75 . . . . 0.0 111.033 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -91.71 -56.49 3.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -169.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -74.35 -18.22 60.72 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -75.65 111.6 11.15 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.221 -0.924 . . . . 0.0 111.002 -174.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 107.12 8.49 31.36 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.022 -168.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -75.79 126.73 31.56 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.444 1.622 . . . . 0.0 110.082 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.316 1.2 t -97.76 45.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.473 1.509 . . . . 0.0 114.704 -162.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 36.0 tp -52.8 123.72 12.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.027 1.731 . . . . 0.0 111.218 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.37 65.7 m-85 57.84 11.58 1.42 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 118.345 2.72 . . . . 0.0 118.345 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 87.06 18.87 57.07 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 120.871 -1.143 . . . . 0.0 114.234 -171.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -121.69 118.95 29.34 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.536 1.535 . . . . 0.0 109.384 175.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -72.92 117.11 4.98 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.831 1.687 . . . . 0.0 111.893 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 32.2 mtp -71.65 130.97 42.49 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.974 1.71 . . . . 0.0 111.272 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.32 106.42 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.055 1.342 . . . . 0.0 108.088 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.471 HG12 HD23 ' A' ' 483' ' ' LEU . 11.6 t -98.95 123.72 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.302 1.441 . . . . 0.0 110.331 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -138.94 160.47 39.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.057 0.932 . . . . 0.0 112.972 -175.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -55.2 140.92 37.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.507 0.723 . . . . 0.0 111.611 167.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.609 0 O-C-N 121.721 -0.612 . . . . 0.0 112.245 -179.699 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 . . . . . 0 C--O 1.241 0.606 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 8.1 p -148.03 167.69 24.27 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -173.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.03 146.23 8.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 123.654 0.782 . . . . 0.0 111.133 -169.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 31.6 m -87.67 149.8 24.03 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -66.31 -27.81 68.2 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.976 -1.077 . . . . 0.0 112.704 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -67.34 -23.41 65.61 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 171.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -74.39 -52.43 12.16 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.307 0.958 . . . . 0.0 110.917 163.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.8 -45.12 78.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.914 1.286 . . . . 0.0 112.895 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -56.04 -17.98 8.32 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.597 1.959 . . . . 0.0 115.481 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -72.26 -30.63 65.04 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.936 -1.102 . . . . 0.0 112.811 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.62 90.63 0.5 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.612 1.101 . . . . 0.0 113.468 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 -164.71 147.73 8.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.504 1.122 . . . . 0.0 111.343 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.7 pt -126.76 158.7 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.671 1.188 . . . . 0.0 112.88 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.59 179.23 4.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.975 1.31 . . . . 0.0 111.074 163.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -61.84 -20.9 64.17 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 120.558 -1.339 . . . . 0.0 114.259 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -78.03 -29.09 49.24 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.063 0.945 . . . . 0.0 112.002 -173.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.87 -33.17 24.87 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.712 -1.243 . . . . 0.0 110.982 161.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 29.4 ttm -63.02 -38.45 91.22 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.438 -1.414 . . . . 0.0 113.371 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -83.22 12.83 4.74 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.285 -0.884 . . . . 0.0 112.196 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.62 -29.69 5.0 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.233 2.213 . . . . 0.0 115.119 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.82 128.1 34.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.908 1.283 . . . . 0.0 109.898 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 75.6 p -63.43 -27.01 69.0 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.299 -0.875 . . . . 0.0 111.38 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . 0.273 2.2 m -68.97 -16.02 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 171.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -119.6 -17.07 8.75 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 119.189 3.033 . . . . 0.0 119.189 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.24 -8.84 0.35 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 54.1 p -137.47 12.77 3.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.949 1.3 . . . . 0.0 113.456 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -131.55 137.91 48.67 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.39 1.876 . . . . 0.0 114.41 -173.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -142.66 129.02 10.68 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -157.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -86.47 -174.28 1.42 Allowed 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 124.736 3.624 . . . . 0.0 113.413 171.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.427 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 72.69 71.77 1.04 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 125.144 1.354 . . . . 0.0 116.13 164.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -145.59 151.96 48.02 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.377 1.471 . . . . 0.0 111.862 172.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.81 95.6 1.07 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.964 3.109 . . . . 0.0 113.0 -172.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.551 HD21 ' HB2' ' A' ' 500' ' ' PHE . 0.3 OUTLIER -163.06 147.83 11.44 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.7 2.0 . . . . 0.0 111.431 166.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.2 p -82.11 18.72 1.3 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -135.16 150.24 50.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.985 1.314 . . . . 0.0 109.99 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.77 157.84 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 126.375 1.87 . . . . 0.0 109.929 -177.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -131.79 162.1 31.33 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.08 140.18 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 125.582 1.553 . . . . 0.0 111.631 -174.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -122.03 170.65 9.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.116 1.367 . . . . 0.0 109.951 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 22.8 t30 66.62 38.73 3.93 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.839 1.256 . . . . 0.0 111.717 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -77.12 139.56 40.0 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.963 -1.086 . . . . 0.0 110.318 167.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.41 142.09 58.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.485 1.514 . . . . 0.0 112.83 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.27 -29.15 60.76 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.649 -1.282 . . . . 0.0 113.932 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -73.35 -31.09 63.76 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.412 HG21 HD21 ' A' ' 491' ' ' LEU . 1.0 OUTLIER -79.69 160.0 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -169.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -134.29 166.94 21.64 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.906 1.283 . . . . 0.0 111.326 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -59.89 -33.09 71.38 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.526 -1.359 . . . . 0.0 113.018 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -57.42 -22.04 40.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.871 1.668 . . . . 0.0 115.018 170.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.64 -33.08 18.95 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.749 1.619 . . . . 0.0 115.094 169.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.81 -25.27 67.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.89 0.876 . . . . 0.0 112.272 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -53.56 -30.97 44.66 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.341 1.056 . . . . 0.0 111.472 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.36 -41.59 97.32 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.945 1.298 . . . . 0.0 111.781 -173.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mt -91.81 -57.49 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 120.64 -1.287 . . . . 0.0 110.826 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -55.98 -36.04 67.42 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.69 -9.19 82.54 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.145 -0.808 . . . . 0.0 114.454 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -60.08 -29.03 68.29 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.36 1.58 . . . . 0.0 111.543 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -93.91 16.26 14.74 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.117 1.767 . . . . 0.0 114.341 -174.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 451' ' ' GLN . 96.7 t -128.47 119.23 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.228 1.811 . . . . 0.0 107.52 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.257 57.3 m-20 -68.89 73.6 0.27 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 173.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -49.78 -22.49 1.44 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 120.044 3.35 . . . . 0.0 120.044 -169.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 17.2 m -71.99 -13.55 61.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.742 1.61 . . . . 0.0 112.935 172.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 4.8 t -104.39 123.38 47.32 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.19 1.396 . . . . 0.0 110.887 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -56.79 -45.39 82.22 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.394 -0.816 . . . . 0.0 112.068 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.3 t -55.18 -15.1 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . 0.456 ' HB3' HG13 ' A' ' 444' ' ' VAL . 43.4 mm-40 -88.86 -61.75 1.64 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.905 0.882 . . . . 0.0 109.854 173.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -69.13 -24.52 64.11 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.854 1.262 . . . . 0.0 113.518 -172.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 11.3 tt -64.22 -33.45 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.505 1.522 . . . . 0.0 112.413 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 62.8 mmm -80.6 -13.71 58.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.104 1.362 . . . . 0.0 111.453 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -107.66 127.35 53.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.774 2.03 . . . . 0.0 113.804 -171.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -162.56 138.5 7.34 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.2 mt -119.85 136.79 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.69 1.196 . . . . 0.0 110.543 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -130.19 138.58 50.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.646 1.178 . . . . 0.0 111.071 164.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 2.1 tt -109.74 131.95 54.59 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.63 1.572 . . . . 0.0 109.127 172.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -90.57 134.81 34.12 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.667 1.587 . . . . 0.0 111.547 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -130.71 9.19 4.97 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -158.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -148.47 156.31 42.3 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.558 1.143 . . . . 0.0 111.975 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 61.34 -161.13 26.55 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.626 1.107 . . . . 0.0 114.911 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.71 -27.13 62.66 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.249 -1.148 . . . . 0.0 113.425 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 28.0 ttm -85.25 -2.8 58.45 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.423 1.089 . . . . 0.0 113.359 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -54.04 128.03 28.92 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.48 1.112 . . . . 0.0 111.868 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.3 27.22 66.36 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.403 1.001 . . . . 0.0 112.913 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -109.7 161.93 14.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.302 1.441 . . . . 0.0 110.71 160.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.12 157.19 42.86 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.94 1.296 . . . . 0.0 112.876 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -118.35 147.04 43.91 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 168.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.17 126.09 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.724 1.609 . . . . 0.0 110.339 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.62 150.09 19.72 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.482 -0.761 . . . . 0.0 112.001 161.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.7 mt -128.64 163.2 46.55 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.098 1.759 . . . . 0.0 110.758 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.53 -3.36 13.26 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.484 2.789 . . . . 0.0 115.552 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -155.72 150.82 26.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.881 1.272 . . . . 0.0 111.602 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -53.77 -43.52 69.28 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.513 -0.742 . . . . 0.0 112.859 163.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -60.38 -40.33 90.44 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.581 1.152 . . . . 0.0 113.003 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.59 99.1 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.588 0.555 . . . . 0.0 111.412 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.62 -42.64 77.81 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.212 0.915 . . . . 0.0 112.164 174.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.24 -43.69 83.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.48 0.712 . . . . 0.0 111.746 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -68.3 -51.96 39.03 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.084 0.954 . . . . 0.0 111.339 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.53 -29.8 66.59 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.545 HD23 HG12 ' A' ' 498' ' ' VAL . 29.4 mt -70.69 -47.67 58.64 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.56 1.073 . . . . 0.0 111.144 172.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -57.89 -34.55 69.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.945 0.898 . . . . 0.0 112.149 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.49 -49.13 7.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.208 1.003 . . . . 0.0 112.925 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -82.14 -20.06 38.72 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -66.37 105.14 1.37 Allowed 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.171 -0.956 . . . . 0.0 110.588 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 110.27 -0.92 29.63 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.004 -1.442 . . . . 0.0 116.148 -173.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -68.23 122.48 18.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.921 1.86 . . . . 0.0 113.836 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.299 1.7 t -86.43 57.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -166.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 431' ' ' VAL . 15.2 tp -55.11 114.16 1.65 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.832 2.053 . . . . 0.0 111.436 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.332 61.3 m-85 58.42 23.17 10.33 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 -178.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 85.31 15.31 66.84 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 121.393 -0.817 . . . . 0.0 114.53 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.32 115.59 18.54 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.397 1.479 . . . . 0.0 110.672 -176.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.35 114.92 4.1 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.889 2.392 . . . . 0.0 112.149 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 72.3 mtp -68.98 128.07 35.38 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.834 1.254 . . . . 0.0 112.393 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 34.9 t -90.92 79.44 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.66 1.584 . . . . 0.0 110.799 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.545 HG12 HD23 ' A' ' 483' ' ' LEU . 2.6 t -83.24 126.93 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.627 1.971 . . . . 0.0 112.534 -174.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -145.19 157.64 44.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.996 1.318 . . . . 0.0 113.652 -170.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . 0.551 ' HB2' HD21 ' A' ' 419' ' ' ASN . 44.1 p90 -63.05 146.39 53.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.679 0.792 . . . . 0.0 110.936 173.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.696 0 O-C-N 121.562 -0.711 . . . . 0.0 111.004 173.56 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 . . . . . 0 C--O 1.237 0.4 0 CA-C-O 122.264 1.031 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.4 p -147.97 160.41 42.86 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.008 1.323 . . . . 0.0 111.697 172.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.9 tt -70.95 145.89 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 125.707 1.603 . . . . 0.0 111.071 -166.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 10.6 m -78.54 146.3 34.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -56.57 -41.63 77.22 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.624 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -62.59 -32.48 73.48 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -73.5 -41.73 62.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.835 0.854 . . . . 0.0 113.179 170.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.22 -46.9 88.54 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.866 0.866 . . . . 0.0 110.661 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -58.49 -24.72 61.16 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.425 1.89 . . . . 0.0 115.16 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 48.0 mmtt -62.56 -49.9 73.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.995 0.816 . . . . 0.0 111.333 168.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.87 65.27 3.28 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.175 1.845 . . . . 0.0 112.351 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -153.41 137.57 16.48 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.916 1.286 . . . . 0.0 110.873 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.3 pt -121.57 157.43 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.597 1.159 . . . . 0.0 113.284 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.0 m -95.8 169.01 10.3 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.267 1.427 . . . . 0.0 112.199 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -54.3 -31.07 53.12 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.902 -1.124 . . . . 0.0 113.433 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -60.68 -25.64 66.53 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.561 1.145 . . . . 0.0 113.167 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.0 -41.5 10.51 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.671 1.188 . . . . 0.0 110.988 169.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 15.9 ttm -65.87 -30.93 71.61 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.817 -1.177 . . . . 0.0 113.098 -172.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -82.97 6.35 19.0 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.318 -0.864 . . . . 0.0 112.823 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.93 -30.53 4.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.989 2.116 . . . . 0.0 114.051 -176.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.403 ' HB3' HG22 ' A' ' 409' ' ' VAL . 40.3 mt -74.12 129.5 37.96 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.581 1.552 . . . . 0.0 111.343 174.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 88.3 p -59.29 -34.2 72.0 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.628 -0.67 . . . . 0.0 111.989 171.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 407' ' ' LEU . 33.7 m -60.38 -22.98 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 117.559 -1.21 . . . . 0.0 113.523 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.339 69.7 m-85 -94.55 2.0 55.66 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 119.113 3.005 . . . . 0.0 119.113 174.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -50.27 -23.58 2.37 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 -164.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 19.0 m -143.23 20.95 1.91 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.484 1.114 . . . . 0.0 112.926 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -135.71 133.87 38.51 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.343 1.457 . . . . 0.0 109.244 -161.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . 0.412 ' HA ' ' HD2' ' A' ' 415' ' ' PRO . 45.0 mt-10 -136.33 92.92 15.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -165.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 414' ' ' GLU . 54.3 Cg_endo -64.76 159.65 44.48 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.201 3.267 . . . . 0.0 113.608 165.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 84.32 0.67 89.49 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.021 1.296 . . . . 0.0 113.305 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -77.3 136.11 65.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.409 1.484 . . . . 0.0 112.447 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.51 126.6 9.11 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.33 2.687 . . . . 0.0 112.48 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -160.41 152.39 20.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.537 1.535 . . . . 0.0 109.156 158.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.9 p -77.87 3.15 15.15 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.101 -1.624 . . . . 0.0 114.59 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -135.91 145.58 46.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.669 2.387 . . . . 0.0 108.961 171.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 12.7 pt -124.46 165.82 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.496 1.918 . . . . 0.0 110.071 174.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.86 159.09 42.9 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 174.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.489 HG22 HG13 ' A' ' 498' ' ' VAL . 8.6 t -132.07 132.93 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.409 1.483 . . . . 0.0 110.897 -174.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -106.56 164.53 11.99 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.693 1.197 . . . . 0.0 109.936 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 16.5 t30 68.2 39.36 2.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.839 1.256 . . . . 0.0 113.394 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.67 150.02 41.55 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.421 -0.799 . . . . 0.0 111.459 171.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.51 160.56 8.74 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.168 1.387 . . . . 0.0 114.471 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -62.26 -43.36 99.01 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.99 -1.069 . . . . 0.0 112.491 169.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -70.61 -35.33 72.92 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.1 p -71.51 149.3 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -170.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -123.2 166.84 14.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.423 1.489 . . . . 0.0 112.556 170.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -55.39 -33.58 63.61 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.826 -1.171 . . . . 0.0 112.719 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 9.1 pttm -62.87 -28.99 70.41 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.77 -37.44 48.98 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.189 0.996 . . . . 0.0 113.469 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.01 -20.54 54.0 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.404 1.882 . . . . 0.0 113.39 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.99 -18.97 5.77 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 171.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -61.81 -38.97 90.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.829 0.852 . . . . 0.0 112.009 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.29 -51.86 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.297 -0.877 . . . . 0.0 110.032 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -63.37 -33.1 74.81 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.2 -12.8 83.27 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 123.478 0.561 . . . . 0.0 114.121 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -58.8 -34.61 71.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.926 1.291 . . . . 0.0 112.565 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -79.93 -6.41 57.43 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.897 1.679 . . . . 0.0 113.548 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.27 111.24 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.984 1.714 . . . . 0.0 111.085 -172.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -69.84 86.78 0.51 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -54.04 -23.94 15.39 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 118.482 2.771 . . . . 0.0 118.482 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 61.2 m -65.75 -21.72 66.54 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.1 m -109.87 121.99 46.51 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.327 1.851 . . . . 0.0 111.88 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.75 -45.91 88.63 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.275 -0.891 . . . . 0.0 113.037 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -17.15 5.48 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -89.87 -57.01 3.01 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.64 0.776 . . . . 0.0 108.984 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -72.58 -21.06 61.2 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.265 1.426 . . . . 0.0 113.539 -173.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 17.0 tt -62.89 -36.26 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.295 1.838 . . . . 0.0 112.265 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.4 mtm -87.36 -8.0 57.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.829 0.851 . . . . 0.0 112.208 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -102.91 124.67 48.86 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -173.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.42 158.98 21.74 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.978 1.311 . . . . 0.0 108.626 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.0 mt -123.24 147.99 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.002 1.321 . . . . 0.0 111.224 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -134.93 132.37 38.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.31 2.244 . . . . 0.0 109.457 169.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.4 tp -124.93 113.13 17.44 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.877 2.071 . . . . 0.0 110.776 172.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 57.3 mtm -70.68 108.34 4.36 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.649 1.18 . . . . 0.0 111.454 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -96.48 10.8 37.19 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -147.23 154.16 40.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.158 1.783 . . . . 0.0 110.821 -174.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 85.18 -166.8 40.82 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.286 1.422 . . . . 0.0 116.273 168.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -11.17 2.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.622 1.969 . . . . 0.0 116.007 -172.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 24.7 ptp -140.7 41.53 1.86 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.948 1.699 . . . . 0.0 112.468 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -52.81 133.39 37.3 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.465 1.106 . . . . 0.0 111.709 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.07 31.71 34.16 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 124.476 1.036 . . . . 0.0 113.34 -177.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -125.99 147.76 49.45 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.539 0.736 . . . . 0.0 111.389 172.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -139.48 155.42 47.57 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.93 1.292 . . . . 0.0 114.038 -165.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -119.87 142.48 48.62 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.757 2.023 . . . . 0.0 114.96 171.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.2 mp -141.44 120.4 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.812 1.645 . . . . 0.0 110.893 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -83.01 140.02 19.69 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.433 -0.792 . . . . 0.0 111.397 163.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 20.8 mt -120.33 158.0 52.1 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.428 1.091 . . . . 0.0 110.766 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.53 -11.75 28.56 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.01 2.473 . . . . 0.0 114.405 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -151.27 142.45 23.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.821 0.849 . . . . 0.0 110.804 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -53.7 -35.46 61.15 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.204 1.402 . . . . 0.0 112.391 167.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -65.91 -38.5 88.87 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.99 85.86 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.309 0.504 . . . . 0.0 110.695 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.38 78.76 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 170.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.64 -36.46 69.53 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.243 0.929 . . . . 0.0 112.553 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -73.52 -53.62 10.17 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.096 1.359 . . . . 0.0 112.694 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.17 -31.75 69.27 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.614 HD23 HG12 ' A' ' 498' ' ' VAL . 49.1 mt -69.22 -42.6 75.49 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.573 -0.705 . . . . 0.0 112.387 176.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.1 -34.47 78.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.446 0.698 . . . . 0.0 111.991 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -82.1 -51.28 8.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.116 1.366 . . . . 0.0 114.37 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.61 -16.31 61.73 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.19 106.08 0.48 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.003 1.721 . . . . 0.0 112.361 174.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 112.23 -6.73 26.89 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 118.49 -1.172 . . . . 0.0 114.949 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -71.7 128.39 35.65 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.154 1.477 . . . . 0.0 107.324 -174.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.253 5.8 p -122.72 63.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 124.185 1.945 . . . . 0.0 110.427 -162.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.16 131.22 50.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.485 1.914 . . . . 0.0 110.913 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.371 52.1 m-85 56.05 21.72 5.31 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -175.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 77.93 8.03 87.39 Favored Glycine 0 CA--C 1.537 1.466 0 O-C-N 121.027 -1.046 . . . . 0.0 114.351 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -112.78 112.59 50.61 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.861 1.664 . . . . 0.0 110.196 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.9 121.28 7.2 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.713 2.275 . . . . 0.0 110.965 -174.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 41.7 mtp -79.77 124.44 28.61 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.614 1.566 . . . . 0.0 110.747 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 36.0 t -93.83 84.16 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.99 1.316 . . . . 0.0 110.719 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.614 HG12 HD23 ' A' ' 483' ' ' LEU . 2.0 t -77.78 131.84 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.012 1.725 . . . . 0.0 112.605 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -145.01 158.44 43.81 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.021 1.328 . . . . 0.0 113.469 -172.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -61.88 147.32 47.05 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.18 -0.95 . . . . 0.0 108.441 164.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.481 0 O-C-N 121.452 -0.78 . . . . 0.0 112.975 -177.274 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 121.882 0.848 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 25.7 p -151.43 163.26 39.38 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.052 1.741 . . . . 0.0 113.3 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 3.1 tt -72.44 158.35 6.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.199 1.399 . . . . 0.0 111.196 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 66.2 m -96.41 150.87 20.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.052 0.941 . . . . 0.0 110.797 168.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -56.75 -39.45 74.03 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 111.281 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -68.58 -26.4 65.37 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -78.68 -38.62 38.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.973 1.26 . . . . 0.0 112.811 166.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.08 -45.83 91.62 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.857 0.863 . . . . 0.0 112.385 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -56.1 -25.55 46.2 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.938 1.295 . . . . 0.0 114.091 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -69.8 -25.36 63.75 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.053 0.941 . . . . 0.0 112.98 176.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -105.17 72.95 0.23 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.088 1.328 . . . . 0.0 110.969 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -156.11 141.52 17.63 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.568 1.147 . . . . 0.0 109.316 -174.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.7 pt -115.3 155.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 83.4 p -67.4 160.14 28.0 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.393 1.477 . . . . 0.0 111.749 161.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 52.2 mmt-85 -61.87 -30.64 70.99 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.606 -0.684 . . . . 0.0 111.139 168.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.49 -42.34 95.92 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.451 0.7 . . . . 0.0 112.103 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -36.01 77.51 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.671 0.669 . . . . 0.0 109.621 172.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 11.3 ttp -65.01 -39.88 94.09 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 120.556 -1.34 . . . . 0.0 112.078 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -81.03 15.86 1.7 Allowed 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.73 -35.95 2.98 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.798 2.039 . . . . 0.0 116.485 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.31 125.21 25.71 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.694 1.197 . . . . 0.0 108.994 172.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.2 m -65.12 -17.76 64.73 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.89 -25.49 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 170.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.31 75.8 m-85 -98.35 10.49 40.63 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 118.565 2.802 . . . . 0.0 118.565 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -60.31 -19.0 53.42 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 9.6 t -139.13 -35.58 0.55 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.816 1.646 . . . . 0.0 112.68 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -76.12 145.8 39.73 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -138.46 129.82 15.57 Favored Pre-proline 0 N--CA 1.478 0.951 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -168.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.6 172.33 13.54 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.586 2.857 . . . . 0.0 113.983 170.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.426 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 95.8 -21.33 45.43 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 116.954 1.541 . . . . 0.0 116.954 164.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.09 138.54 96.2 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 119.019 1.41 . . . . 0.0 112.588 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.27 116.85 4.77 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.283 2.655 . . . . 0.0 113.23 -174.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -153.66 146.93 24.75 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.201 1.4 . . . . 0.0 108.595 164.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.1 p -73.8 6.21 3.43 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -144.47 145.46 31.89 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.306 1.842 . . . . 0.0 108.921 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 27.7 pt -133.99 164.13 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.554 1.942 . . . . 0.0 109.865 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -136.01 162.23 33.45 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 172.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.4 p -140.03 146.95 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.934 1.294 . . . . 0.0 110.696 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . 0.514 ' HB2' ' HG2' ' A' ' 468' ' ' GLN . 17.1 ptpt -131.13 -175.38 3.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.283 0.633 . . . . 0.0 111.062 165.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.0 t30 66.44 38.33 4.33 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.072 1.349 . . . . 0.0 111.305 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.17 148.14 34.21 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.819 0.848 . . . . 0.0 110.447 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.68 173.83 9.94 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.636 1.975 . . . . 0.0 115.062 -173.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -60.88 -53.98 50.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.747 1.219 . . . . 0.0 113.507 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -78.39 -19.18 53.87 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.436 1.494 . . . . 0.0 114.731 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.55 148.72 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -173.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -129.32 162.88 26.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.186 1.794 . . . . 0.0 110.399 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -59.16 -28.67 66.81 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 119.47 -2.019 . . . . 0.0 112.403 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -58.13 -30.97 66.75 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -72.7 -36.28 67.81 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 173.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.25 -27.35 66.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.626 0.77 . . . . 0.0 111.692 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.34 -31.33 61.63 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.823 0.849 . . . . 0.0 112.748 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -61.35 -30.03 70.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.013 1.325 . . . . 0.0 111.697 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.7 mt -106.6 -57.66 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.682 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -58.85 -30.77 67.95 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -76.53 -8.74 86.1 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.87 -0.961 . . . . 0.0 114.661 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -64.82 -21.74 66.85 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.376 1.588 . . . . 0.0 112.63 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -92.64 4.46 53.63 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.874 1.67 . . . . 0.0 113.566 -177.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.7 108.73 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.289 1.836 . . . . 0.0 110.622 -171.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -64.53 99.86 0.33 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.311 17.8 m-85 -62.62 -16.18 55.4 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 64.7 m -64.83 -16.12 62.7 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 169.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 16.4 m -130.49 117.82 20.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.443 1.097 . . . . 0.0 112.713 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -60.44 -39.94 89.29 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.007 -1.058 . . . . 0.0 112.39 -174.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.6 t -56.44 -13.95 2.66 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -86.91 -63.84 1.25 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.983 0.913 . . . . 0.0 109.546 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.9 ptt85 -69.81 -22.78 63.28 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.517 1.527 . . . . 0.0 114.16 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.8 tt -57.87 -35.39 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.257 1.023 . . . . 0.0 111.899 171.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 21.6 mtm -90.37 -2.95 58.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.948 1.299 . . . . 0.0 112.228 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -105.89 129.56 54.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.77 2.028 . . . . 0.0 116.086 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -166.14 149.03 7.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.963 1.305 . . . . 0.0 109.399 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.9 mt -120.65 136.53 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.494 1.518 . . . . 0.0 111.807 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -114.74 141.33 47.99 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.974 1.31 . . . . 0.0 110.571 158.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 13.7 tp -120.61 114.54 21.87 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.562 1.545 . . . . 0.0 109.212 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -71.28 120.33 16.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.98 1.312 . . . . 0.0 109.274 169.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . 0.413 ' O ' ' HE2' ' A' ' 466' ' ' LYS . 10.1 mtpt -113.51 12.86 18.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.753 1.621 . . . . 0.0 113.035 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -142.23 152.65 43.29 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.306 1.843 . . . . 0.0 112.126 -167.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 59.58 -144.08 46.14 Favored Glycine 0 CA--C 1.534 1.269 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 161.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.75 -12.71 2.02 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.065 2.146 . . . . 0.0 116.335 -172.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 24.9 ptp -145.44 41.13 1.23 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.507 1.123 . . . . 0.0 112.539 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 461' ' ' LYS . 23.6 ttmt -60.38 122.44 14.56 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.409 1.084 . . . . 0.0 112.256 175.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.65 37.91 18.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.411 1.958 . . . . 0.0 112.858 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . 0.514 ' HG2' ' HB2' ' A' ' 425' ' ' LYS . 43.1 mt-30 -125.83 148.33 49.18 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.211 1.004 . . . . 0.0 110.892 173.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -138.94 151.59 47.02 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -109.08 137.98 46.14 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.829 2.051 . . . . 0.0 114.394 169.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.5 119.77 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.197 1.399 . . . . 0.0 109.968 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -85.2 142.04 19.5 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 162.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 19.3 mt -122.64 160.87 46.78 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.35 1.46 . . . . 0.0 110.343 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.01 -13.07 21.49 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.045 2.497 . . . . 0.0 114.55 -174.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -153.07 146.13 24.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.513 1.125 . . . . 0.0 110.254 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -52.31 -38.82 59.51 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.933 0.893 . . . . 0.0 111.95 165.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -61.42 -37.16 82.48 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.288 1.035 . . . . 0.0 113.122 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.36 90.84 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.262 -0.274 . . . . 0.0 110.947 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.3 -48.43 67.64 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.605 -0.684 . . . . 0.0 112.741 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.66 -28.05 68.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.306 1.042 . . . . 0.0 112.689 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -85.22 -44.27 13.06 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.048 0.939 . . . . 0.0 113.348 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.51 -33.21 71.08 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.881 1.219 . . . . 0.0 112.709 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.449 HD23 HG12 ' A' ' 498' ' ' VAL . 57.2 mt -65.47 -40.04 92.69 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.424 1.09 . . . . 0.0 112.989 174.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -63.34 -42.18 98.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.077 0.551 . . . . 0.0 111.454 174.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -78.87 -43.83 24.17 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -175.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.39 57.54 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -64.12 99.23 0.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.701 1.2 . . . . 0.0 112.245 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 115.45 1.6 21.65 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.469 -1.184 . . . . 0.0 115.044 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -74.44 110.4 8.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.944 1.372 . . . . 0.0 108.929 -169.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.275 6.4 p -93.71 65.77 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.054 1.742 . . . . 0.0 110.372 -170.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.79 129.42 39.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.199 1.8 . . . . 0.0 110.66 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.272 64.0 m-85 54.18 21.81 3.25 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -176.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 86.35 10.22 74.5 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 117.983 -1.454 . . . . 0.0 115.566 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -121.78 115.65 30.66 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 120.217 2.008 . . . . 0.0 111.751 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.44 112.41 3.54 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 123.868 3.045 . . . . 0.0 111.696 -174.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 80.1 mtp -73.64 131.44 41.67 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.855 1.262 . . . . 0.0 113.566 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 24.8 t -90.15 90.07 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.599 1.56 . . . . 0.0 111.502 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.449 HG12 HD23 ' A' ' 483' ' ' LEU . 1.4 t -90.17 129.47 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.889 1.276 . . . . 0.0 114.308 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -149.47 155.57 40.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.847 0.859 . . . . 0.0 112.953 -170.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -53.96 142.05 25.96 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 169.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.613 0 O-C-N 121.729 -0.607 . . . . 0.0 112.236 177.178 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 120.484 0.183 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 14.0 p -142.56 165.07 28.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.65 1.18 . . . . 0.0 113.474 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.3 tt -69.02 152.31 9.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 125.65 1.58 . . . . 0.0 111.678 -168.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 59.4 m -84.67 147.87 26.71 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.435 0.694 . . . . 0.0 110.429 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -58.06 -43.01 86.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.414 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -61.43 -29.87 70.21 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.324 1.45 . . . . 0.0 114.52 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -78.14 -49.69 13.4 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.39 1.076 . . . . 0.0 112.696 171.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 26.1 tp -57.89 -42.29 84.35 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.56 0.744 . . . . 0.0 112.096 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -58.67 -21.22 53.72 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.592 1.557 . . . . 0.0 114.977 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -75.76 -34.01 60.23 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.184 0.994 . . . . 0.0 112.753 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -93.66 75.26 1.13 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.026 1.298 . . . . 0.0 112.183 170.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -158.04 146.82 19.19 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.246 1.018 . . . . 0.0 111.008 -171.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 9.1 pt -128.66 157.84 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.45 1.5 . . . . 0.0 111.819 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 21.6 t -105.03 174.74 5.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.538 1.535 . . . . 0.0 111.047 166.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 21.6 mtp85 -57.93 -23.53 53.86 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.007 1.323 . . . . 0.0 113.402 175.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -54.61 -35.88 63.86 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.076 1.751 . . . . 0.0 111.856 171.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -99.18 -35.4 10.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.419 1.088 . . . . 0.0 112.526 169.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 26.3 ttp -65.18 -38.42 90.47 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.49 -1.381 . . . . 0.0 112.36 -172.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -80.23 17.26 1.06 Allowed 'General case' 0 CA--C 1.55 0.962 0 O-C-N 121.349 -0.845 . . . . 0.0 112.123 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.98 -30.37 2.72 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.405 2.282 . . . . 0.0 115.005 176.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 35.6 mt -74.22 137.92 43.36 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.59 1.956 . . . . 0.0 112.48 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 47.0 t -67.98 -36.61 80.34 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.036 0.934 . . . . 0.0 111.834 172.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.5 m -59.16 -14.41 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.403 ' CE1' HG13 ' A' ' 497' ' ' VAL 0.261 94.0 m-85 -116.58 16.74 15.48 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 170.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -8.47 12.53 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 16.7 p -148.52 -46.05 0.15 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.828 2.051 . . . . 0.0 112.527 -159.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -81.79 140.52 34.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.222 1.809 . . . . 0.0 113.783 -175.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -134.57 123.0 16.04 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.792 0.837 . . . . 0.0 112.921 -169.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.3 174.49 9.87 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.354 3.37 . . . . 0.0 113.357 170.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.485 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 82.1 -16.71 20.94 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.671 1.605 . . . . 0.0 116.798 170.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -57.53 139.21 81.22 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 118.801 1.3 . . . . 0.0 112.661 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.48 108.73 2.09 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.773 2.315 . . . . 0.0 112.083 -172.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.496 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 7.5 t30 -156.64 149.41 23.75 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.693 1.597 . . . . 0.0 109.269 167.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.4 p -86.1 -10.71 54.39 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 173.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.496 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 33.6 mtm180 -106.26 142.32 36.13 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.957 0.903 . . . . 0.0 110.022 172.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.16 162.59 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.373 1.469 . . . . 0.0 110.44 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -144.47 161.07 39.98 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.0 t -139.22 131.92 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.196 1.399 . . . . 0.0 113.422 -165.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -98.81 163.77 12.48 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.582 1.153 . . . . 0.0 111.904 167.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.287 98.0 m-20 75.78 34.9 0.54 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.925 2.09 . . . . 0.0 116.592 172.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.95 160.59 29.05 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.182 -0.949 . . . . 0.0 111.143 167.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.33 177.7 5.7 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.074 1.75 . . . . 0.0 114.172 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -82.41 -48.44 11.12 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.983 -1.073 . . . . 0.0 110.544 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -69.49 -18.98 63.74 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.2 p -77.08 139.84 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 121.008 -1.057 . . . . 0.0 113.08 171.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -120.65 167.22 12.67 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.189 1.396 . . . . 0.0 111.703 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.97 -34.1 58.81 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.94 -1.1 . . . . 0.0 112.657 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -59.97 -23.44 63.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.163 1.385 . . . . 0.0 114.675 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -87.57 -33.43 18.9 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.05 -19.69 64.63 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.699 1.6 . . . . 0.0 112.645 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -25.16 49.19 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.381 1.073 . . . . 0.0 112.869 174.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -60.01 -34.78 73.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.573 0.749 . . . . 0.0 112.4 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 4.4 mt -103.3 -57.0 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.635 -0.666 . . . . 0.0 110.739 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -59.55 -29.49 67.96 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.95 -11.41 84.73 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.806 -0.997 . . . . 0.0 114.847 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -62.49 -36.2 81.77 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.015 1.407 . . . . 0.0 111.435 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -77.47 3.37 13.59 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.926 1.69 . . . . 0.0 114.989 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 14.9 t -123.94 126.08 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.942 1.697 . . . . 0.0 110.593 -173.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -59.63 133.3 55.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -73.43 -23.14 60.09 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 99.0 p -92.14 -51.72 5.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.695 1.198 . . . . 0.0 113.262 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.2 m -76.45 118.78 19.48 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.412 0.685 . . . . 0.0 111.718 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -54.65 -49.59 70.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.115 1.366 . . . . 0.0 112.098 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.7 t -54.97 -15.2 1.85 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -88.75 -62.97 1.37 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.239 1.015 . . . . 0.0 110.228 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.17 -26.27 63.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.048 0.939 . . . . 0.0 113.253 -175.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.9 tt -58.18 -40.34 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.816 0.847 . . . . 0.0 111.857 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 9.2 mtm -86.93 -9.12 56.42 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.944 0.898 . . . . 0.0 112.334 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -87.6 125.83 34.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.853 1.661 . . . . 0.0 115.281 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -163.11 136.15 5.63 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.322 1.449 . . . . 0.0 110.195 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 10.7 mt -113.06 143.14 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.769 1.228 . . . . 0.0 111.55 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -129.57 143.21 50.73 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.822 1.649 . . . . 0.0 110.623 160.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 0.522 HD23 ' HE2' ' A' ' 461' ' ' LYS . 19.1 tp -123.59 119.65 30.52 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.871 2.069 . . . . 0.0 110.098 174.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -81.84 143.38 31.77 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.487 1.515 . . . . 0.0 112.25 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . 0.522 ' HE2' HD23 ' A' ' 459' ' ' LEU . 53.5 mmtt -130.9 8.99 4.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.107 1.763 . . . . 0.0 114.816 -167.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -145.49 143.38 29.96 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.615 1.166 . . . . 0.0 113.292 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 78.92 -160.58 46.8 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 126.514 2.007 . . . . 0.0 114.521 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.02 -18.05 59.28 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.833 -1.393 . . . . 0.0 113.269 172.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 98.2 mmm -83.86 -1.49 54.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.153 1.781 . . . . 0.0 114.546 171.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.6 127.0 29.34 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.701 -1.249 . . . . 0.0 111.834 176.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.71 17.93 80.04 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.779 -175.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -108.33 139.77 42.56 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.799 0.8 . . . . 0.0 112.188 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -123.06 147.42 46.73 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.876 1.27 . . . . 0.0 112.736 -174.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -107.14 140.59 39.75 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.323 1.449 . . . . 0.0 114.629 161.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.61 113.81 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.239 1.816 . . . . 0.0 109.032 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -76.38 125.24 7.58 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 160.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 37.4 mt -101.15 159.77 28.54 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.126 0.963 . . . . 0.0 109.484 165.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.3 -10.46 17.61 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.895 1.73 . . . . 0.0 114.222 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -151.16 138.67 19.55 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.467 1.107 . . . . 0.0 110.583 -171.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -56.18 -35.23 66.99 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 171.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -62.07 -42.29 99.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.844 0.747 . . . . 0.0 112.608 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.9 92.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.127 0.571 . . . . 0.0 111.24 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.56 -50.43 63.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.437 0.562 . . . . 0.0 112.418 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.24 72.63 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.75 1.159 . . . . 0.0 112.047 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -70.9 -46.58 62.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.085 1.354 . . . . 0.0 112.834 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.15 -37.4 77.2 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.771 0.714 . . . . 0.0 112.415 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.518 HD23 HG12 ' A' ' 498' ' ' VAL . 79.8 mt -70.41 -25.84 63.41 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.667 1.187 . . . . 0.0 112.548 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.61 -24.29 36.51 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.711 1.204 . . . . 0.0 112.647 175.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -104.87 -48.08 3.85 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.74 -15.88 58.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.621 1.168 . . . . 0.0 113.468 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -73.65 112.66 9.96 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.442 -0.787 . . . . 0.0 109.666 -174.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 110.32 -4.82 29.9 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 118.858 -0.968 . . . . 0.0 115.298 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -69.48 129.43 39.69 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.492 1.146 . . . . 0.0 108.54 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.252 3.5 p -120.81 68.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 124.394 2.045 . . . . 0.0 108.87 -162.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 39.2 tp -61.25 139.15 58.2 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 112.763 -2.017 . . . . 0.0 109.588 168.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.324 75.5 t80 61.05 13.97 5.04 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 173.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 80.1 11.02 84.87 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.476 1.512 . . . . 0.0 114.896 -171.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -121.86 120.57 28.48 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 126.472 1.909 . . . . 0.0 110.832 -173.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.71 121.84 7.71 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 C-N-CA 122.774 2.316 . . . . 0.0 110.79 -175.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 59.9 mtp -76.89 129.79 36.68 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.919 1.688 . . . . 0.0 112.293 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . 0.403 HG13 ' CE1' ' A' ' 410' ' ' PHE . 4.4 t -92.46 90.42 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.681 1.592 . . . . 0.0 112.306 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.518 HG12 HD23 ' A' ' 483' ' ' LEU . 2.6 t -85.67 120.52 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.989 1.315 . . . . 0.0 112.102 -172.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -135.99 157.38 46.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.22 1.008 . . . . 0.0 113.63 -168.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -59.74 145.41 45.23 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 163.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.822 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -152.41 29.67 0.55 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.874 1.27 . . . . 0.0 110.043 -174.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -134.09 142.53 47.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.9 1.68 . . . . 0.0 110.209 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 50.2 mtp 61.63 156.38 0.11 Allowed Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.478 1.511 . . . . 0.0 114.917 -161.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.63 147.72 28.4 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.591 2.194 . . . . 0.0 112.417 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 37.0 m -73.08 39.7 0.09 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.645 1.978 . . . . 0.0 115.0 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -149.72 127.05 11.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.51 1.524 . . . . 0.0 109.578 164.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 19.5 p -129.79 167.37 18.2 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.58 1.952 . . . . 0.0 109.951 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.3 tt -68.92 144.38 14.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 O-C-N 121.511 -0.743 . . . . 0.0 111.106 -160.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 62.0 m -84.11 150.63 25.42 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.159 -0.338 . . . . 0.0 111.471 172.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 42.5 ttp85 -59.37 -41.24 88.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.54 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -61.67 -29.83 70.33 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -80.29 -44.39 19.67 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.449 1.1 . . . . 0.0 113.121 171.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.416 HD12 ' CD2' ' A' ' 489' ' ' TYR . 22.3 tp -59.18 -46.07 89.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.725 0.81 . . . . 0.0 112.145 175.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -60.3 -21.9 62.53 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -63.26 -33.87 76.43 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.889 0.768 . . . . 0.0 112.328 171.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -107.41 84.19 0.37 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.999 1.285 . . . . 0.0 110.958 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -161.34 152.51 18.59 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.259 0.624 . . . . 0.0 110.555 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.6 pt -127.76 151.07 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.131 0.972 . . . . 0.0 112.868 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 92.1 p -76.75 166.13 23.79 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.203 1.401 . . . . 0.0 112.057 162.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -57.03 -24.51 54.26 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 168.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -71.89 -37.28 70.17 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.493 1.517 . . . . 0.0 111.815 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -80.08 -37.04 34.61 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.487 0.715 . . . . 0.0 110.548 167.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 27.6 ttm -59.74 -46.86 87.84 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.614 -1.304 . . . . 0.0 112.161 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -78.8 15.0 1.15 Allowed 'General case' 0 CA--C 1.552 1.032 0 O-C-N 120.627 -1.296 . . . . 0.0 112.74 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.69 -31.92 5.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.28 2.632 . . . . 0.0 114.474 171.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 34.1 mt -75.54 133.69 40.93 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.857 1.663 . . . . 0.0 111.755 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 91.5 p -63.31 -32.32 73.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.277 1.031 . . . . 0.0 112.17 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.71 -15.34 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.328 78.0 m-85 -106.66 8.38 31.07 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -54.06 -16.27 1.88 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 118.105 2.632 . . . . 0.0 118.105 -165.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.4 m -147.6 14.19 1.07 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.589 1.155 . . . . 0.0 113.98 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -130.49 130.72 44.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.221 1.008 . . . . 0.0 109.465 -162.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -143.87 133.01 11.41 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.153 1.381 . . . . 0.0 113.183 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.02 -178.77 4.0 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 125.207 3.938 . . . . 0.0 114.982 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 96.52 -9.7 66.8 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 164.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -68.92 150.74 97.53 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 119.031 1.416 . . . . 0.0 113.204 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.11 114.35 4.01 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.767 2.978 . . . . 0.0 111.923 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.51 142.65 12.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.25 1.42 . . . . 0.0 107.579 168.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.5 p -77.51 -14.02 59.78 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.406 1.082 . . . . 0.0 112.691 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -107.33 141.09 39.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.531 1.132 . . . . 0.0 109.029 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 4.8 pt -126.94 159.21 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 125.504 1.522 . . . . 0.0 109.429 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -140.63 160.17 40.59 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.9 t -134.25 137.19 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.191 1.396 . . . . 0.0 111.261 -172.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -112.11 165.83 11.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.136 0.974 . . . . 0.0 109.961 166.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.3 t30 65.81 36.07 6.36 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.721 1.209 . . . . 0.0 113.491 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.95 153.78 42.81 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.422 -0.798 . . . . 0.0 110.294 163.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.76 148.45 49.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.857 0.863 . . . . 0.0 113.029 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -62.06 -34.04 75.52 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.767 -1.208 . . . . 0.0 111.141 158.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -60.86 -10.2 5.27 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.545 1.938 . . . . 0.0 115.418 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.1 p -121.13 155.99 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -170.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -119.53 161.65 20.23 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.619 1.567 . . . . 0.0 111.122 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -55.08 -35.38 64.51 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.955 -1.091 . . . . 0.0 113.059 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -63.63 -16.68 61.6 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.108 1.363 . . . . 0.0 114.585 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -91.64 -31.68 15.76 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.15 -21.36 66.52 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.319 -0.863 . . . . 0.0 112.315 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -48.57 -35.14 12.8 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.068 1.347 . . . . 0.0 112.813 169.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -58.6 -35.34 72.29 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.0 mt -98.6 -57.88 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.284 0.634 . . . . 0.0 110.298 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.291 59.6 m-85 -60.7 -30.38 69.92 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.44 -6.91 86.96 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.104 0.859 . . . . 0.0 114.669 173.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -56.36 -34.02 66.24 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.341 1.57 . . . . 0.0 111.412 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.96 9.8 26.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.106 1.762 . . . . 0.0 113.855 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.36 113.49 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.554 1.541 . . . . 0.0 109.535 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.77 80.17 0.19 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -54.7 -18.2 4.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 119.013 2.968 . . . . 0.0 119.013 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.4 m -71.75 -12.64 61.41 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.563 1.074 . . . . 0.0 112.857 170.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.7 m -115.15 116.49 28.47 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.191 1.796 . . . . 0.0 111.867 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -59.06 -43.41 91.74 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.216 -0.928 . . . . 0.0 112.704 -173.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.3 t -55.96 -14.56 2.59 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -88.09 -60.99 1.82 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.697 0.761 . . . . 0.0 110.018 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -69.69 -25.82 64.06 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.127 1.371 . . . . 0.0 113.876 -173.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.8 tt -55.25 -35.91 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.057 1.343 . . . . 0.0 112.098 170.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 10.5 mtm -90.03 -3.93 57.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.343 1.057 . . . . 0.0 112.614 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -101.12 134.21 44.48 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.244 2.217 . . . . 0.0 115.994 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -166.16 156.71 12.73 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.212 1.405 . . . . 0.0 108.183 174.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.2 mt -130.82 134.94 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.741 1.216 . . . . 0.0 110.283 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -120.81 132.8 55.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.891 0.876 . . . . 0.0 109.873 159.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 4.1 tt -103.2 133.29 48.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.155 1.382 . . . . 0.0 110.006 168.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.61 91.68 3.43 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 125.767 1.627 . . . . 0.0 110.846 171.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -67.95 -23.82 65.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 -174.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.415 ' HA ' ' HE3' ' A' ' 466' ' ' LYS . 26.0 pt-20 -154.76 175.03 14.23 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -175.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 87.79 -169.05 38.34 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.669 1.604 . . . . 0.0 114.15 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 4.02 1.99 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 74.1 mtp -129.98 20.21 5.44 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.965 2.506 . . . . 0.0 112.437 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 462' ' ' GLU . 35.9 ttmt -52.08 138.85 24.47 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.994 1.318 . . . . 0.0 111.803 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.78 32.56 61.16 Favored Glycine 0 CA--C 1.524 0.619 0 O-C-N 121.809 -0.557 . . . . 0.0 111.81 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.71 155.49 20.13 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.683 1.193 . . . . 0.0 110.79 165.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -148.27 148.19 30.19 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.143 -0.973 . . . . 0.0 112.733 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -113.05 138.24 50.2 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.761 1.624 . . . . 0.0 114.768 167.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.7 112.72 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.164 1.786 . . . . 0.0 109.482 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -78.79 134.55 14.14 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 159.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 20.2 mt -109.39 161.96 21.99 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.226 1.41 . . . . 0.0 109.913 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.53 -12.3 29.17 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.031 2.487 . . . . 0.0 113.654 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -153.5 142.66 21.4 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.703 0.683 . . . . 0.0 112.013 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -60.12 -29.88 68.91 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -67.94 -36.42 80.1 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 170.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -66.48 -39.32 88.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.79 0.436 . . . . 0.0 110.663 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.39 -43.16 86.63 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.512 -0.743 . . . . 0.0 112.638 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -55.78 -43.52 76.85 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.35 0.977 . . . . 0.0 111.78 176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -65.69 -52.86 48.14 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.081 1.352 . . . . 0.0 111.773 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.27 71.44 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.54 HD23 HG12 ' A' ' 498' ' ' VAL . 51.3 mt -68.95 -39.05 79.76 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.929 -1.107 . . . . 0.0 110.712 173.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -68.07 -22.77 64.91 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.794 1.238 . . . . 0.0 112.44 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -110.14 -39.73 4.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -84.45 -17.75 38.17 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -75.45 117.33 17.12 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.097 -1.002 . . . . 0.0 112.308 -168.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 101.47 3.24 53.44 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.231 -1.316 . . . . 0.0 115.043 -169.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.416 ' CD2' HD12 ' A' ' 394' ' ' LEU . 72.7 t80 -69.08 125.49 26.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.482 1.641 . . . . 0.0 113.48 -169.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.266 1.9 t -86.01 46.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.632 1.573 . . . . 0.0 114.836 -162.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 57.3 tp -58.85 120.26 8.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.47 1.508 . . . . 0.0 111.71 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.334 72.1 m-85 55.22 21.25 3.89 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -173.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 98.31 -6.41 61.42 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.689 1.614 . . . . 0.0 115.015 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -106.15 122.11 43.33 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.182 1.491 . . . . 0.0 111.864 -170.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.75 105.92 2.17 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.416 2.744 . . . . 0.0 112.548 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 44.1 mtp -67.41 131.82 46.44 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.999 1.32 . . . . 0.0 113.403 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.52 84.7 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.901 2.081 . . . . 0.0 110.945 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.54 HG12 HD23 ' A' ' 483' ' ' LEU . 4.0 t -87.28 125.79 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 126.578 1.951 . . . . 0.0 112.321 -170.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -141.63 158.73 43.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.654 1.181 . . . . 0.0 113.046 -170.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -61.24 146.41 47.92 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 166.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -59.12 132.6 54.5 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 122.586 1.184 . . . . 0.0 112.233 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 8.1 tpp85 -74.03 -46.67 41.89 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.551 -166.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 43.9 t -160.95 143.92 12.88 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.616 1.166 . . . . 0.0 111.302 165.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -154.14 155.84 36.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.1 1.76 . . . . 0.0 109.022 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 51.4 mmm-85 -117.9 53.14 1.53 Allowed Pre-proline 0 N--CA 1.476 0.867 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -170.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -69.05 170.54 15.5 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.638 2.225 . . . . 0.0 111.535 166.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -84.47 -32.3 24.08 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.639 1.575 . . . . 0.0 112.972 173.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -152.08 142.82 22.88 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.723 1.209 . . . . 0.0 112.666 -169.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -60.04 152.05 62.83 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 164.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -81.3 -176.17 2.98 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.504 2.802 . . . . 0.0 112.941 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 175.96 9.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.68 1.992 . . . . 0.0 111.896 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -70.29 133.2 46.75 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.667 1.187 . . . . 0.0 112.005 172.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -72.98 -36.29 57.29 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.037 -0.868 . . . . 0.0 114.973 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -85.77 108.85 18.27 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.287 1.044 . . . . 0.0 111.514 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 47.05 62.68 2.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 128.44 2.696 . . . . 0.0 114.31 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.319 0 CA-C-O 116.841 -1.552 . . . . 0.0 110.174 171.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . 0.269 4.2 p30 -139.32 -0.47 1.8 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -134.46 27.19 3.75 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.373 1.469 . . . . 0.0 113.632 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 86.6 mmm -68.62 136.88 90.5 Favored Pre-proline 0 CA--C 1.547 0.838 0 O-C-N 121.063 -1.023 . . . . 0.0 112.845 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -64.05 170.89 8.32 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.433 3.422 . . . . 0.0 113.353 167.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 31.4 t -120.16 124.2 45.17 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.697 1.199 . . . . 0.0 112.703 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -159.32 85.43 0.79 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.123 1.369 . . . . 0.0 111.99 170.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -143.28 167.66 21.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.132 1.373 . . . . 0.0 112.151 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.8 tt -78.68 154.29 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.855 1.262 . . . . 0.0 111.989 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 30.6 t -91.01 154.07 19.69 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.235 0.614 . . . . 0.0 111.101 167.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -44.26 -43.09 7.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.034 1.333 . . . . 0.0 112.502 164.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -71.55 -18.19 62.27 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -89.44 -39.34 13.44 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.177 -0.952 . . . . 0.0 113.445 165.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.38 -48.65 69.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.201 1.0 . . . . 0.0 112.788 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -56.8 -25.89 56.72 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.76 1.624 . . . . 0.0 113.941 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.86 -44.87 84.12 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.91 1.284 . . . . 0.0 110.832 175.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.55 78.08 0.73 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.308 1.432 . . . . 0.0 113.196 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -157.48 149.47 22.39 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.642 1.577 . . . . 0.0 109.642 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.7 pt -127.83 149.97 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.9 0.88 . . . . 0.0 111.567 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 8.8 m -80.41 167.78 19.78 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.89 0.876 . . . . 0.0 112.228 169.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -55.92 -29.22 59.73 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.271 -0.893 . . . . 0.0 112.765 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.63 -31.79 69.83 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.56 1.944 . . . . 0.0 113.309 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.57 -34.29 14.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.502 1.121 . . . . 0.0 110.947 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 9.7 ttm -61.26 -39.29 89.81 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.952 -1.092 . . . . 0.0 111.279 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.15 26.41 0.88 Allowed 'General case' 0 CA--C 1.552 1.056 0 O-C-N 120.846 -1.159 . . . . 0.0 112.455 172.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.51 -34.81 1.17 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.109 2.563 . . . . 0.0 113.858 174.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.37 134.0 42.48 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.803 1.641 . . . . 0.0 112.613 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 27.1 t -59.43 -37.86 79.18 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.707 0.803 . . . . 0.0 113.092 172.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.421 HG23 ' CD2' ' A' ' 410' ' ' PHE 0.27 3.1 m -60.44 -11.05 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 171.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.421 ' CD2' HG23 ' A' ' 409' ' ' VAL . 79.0 m-85 -122.49 11.2 9.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 119.237 3.051 . . . . 0.0 119.237 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -14.28 16.27 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -173.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.53 -27.48 1.18 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.556 1.542 . . . . 0.0 114.423 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -69.83 136.56 50.92 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -144.86 124.98 7.25 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.53 171.97 16.66 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.128 3.219 . . . . 0.0 111.629 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.48 -4.79 33.02 Favored Glycine 0 N--CA 1.48 1.594 0 N-CA-C 117.33 1.692 . . . . 0.0 117.33 170.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -74.58 131.75 79.41 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 119.079 1.439 . . . . 0.0 111.817 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.12 112.92 2.43 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.105 2.537 . . . . 0.0 111.032 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.459 HD22 ' H ' ' A' ' 421' ' ' ARG . 4.6 t30 -159.9 145.7 15.61 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.605 1.162 . . . . 0.0 109.498 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 21.3 p -86.1 -8.35 57.94 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.459 ' H ' HD22 ' A' ' 419' ' ' ASN . 41.7 mtt180 -117.95 148.54 42.09 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.667 1.187 . . . . 0.0 110.07 176.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 17.8 pt -135.01 166.35 28.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.474 1.91 . . . . 0.0 110.046 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -137.93 163.64 31.0 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.88 143.85 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.652 1.581 . . . . 0.0 111.573 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -126.65 168.81 13.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.658 1.983 . . . . 0.0 109.905 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 12.9 t30 68.5 31.25 4.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.817 1.247 . . . . 0.0 112.808 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -74.54 144.51 44.01 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.018 -1.051 . . . . 0.0 111.856 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.34 156.98 17.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.928 1.691 . . . . 0.0 114.778 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -59.55 -45.74 90.93 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.238 -0.914 . . . . 0.0 112.964 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -70.87 -26.94 63.47 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -175.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.15 152.65 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -172.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -129.41 162.1 28.83 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.732 2.013 . . . . 0.0 111.038 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -53.22 -30.84 40.12 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.096 1.358 . . . . 0.0 113.401 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -58.06 -25.85 61.77 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.166 1.787 . . . . 0.0 115.282 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -90.02 -28.55 19.0 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.5 mp -66.47 -19.99 65.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.32 1.448 . . . . 0.0 112.206 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.44 -25.24 59.34 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 174.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -61.47 -36.33 80.12 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.941 0.791 . . . . 0.0 111.477 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.4 mp -96.78 -56.58 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.202 0.601 . . . . 0.0 110.679 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.258 70.1 m-85 -60.11 -32.99 71.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.82 -7.24 87.41 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.062 0.839 . . . . 0.0 114.522 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -61.2 -39.71 91.2 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.842 1.321 . . . . 0.0 111.46 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -81.06 -0.79 41.41 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.585 1.954 . . . . 0.0 113.815 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 36.0 t -115.09 116.53 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.718 1.207 . . . . 0.0 109.996 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.262 4.2 m-20 -68.72 90.97 0.42 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 176.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -61.74 -16.53 50.12 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 119.006 2.965 . . . . 0.0 119.006 -173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 71.0 m -79.09 1.5 24.0 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.01 0.924 . . . . 0.0 113.361 168.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 11.1 t -126.89 112.68 15.6 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.65 1.18 . . . . 0.0 110.947 -173.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -59.86 -47.14 86.95 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.243 -0.911 . . . . 0.0 112.274 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 3.9 t -55.92 -15.24 3.13 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -89.21 -58.39 2.55 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.221 1.008 . . . . 0.0 110.685 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -71.59 -25.58 62.24 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.716 1.206 . . . . 0.0 113.432 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.3 tt -56.65 -33.12 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.263 1.425 . . . . 0.0 112.151 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -87.51 -5.81 58.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.308 1.443 . . . . 0.0 112.964 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -115.81 120.11 38.19 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -162.41 155.34 19.87 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.327 1.451 . . . . 0.0 107.61 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.1 mt -125.05 137.6 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.767 1.627 . . . . 0.0 110.499 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 -127.51 128.78 46.24 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.395 1.478 . . . . 0.0 109.485 165.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 14.1 tp -111.18 134.91 52.41 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.439 1.896 . . . . 0.0 109.308 170.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 50.7 mtm -89.38 133.18 34.62 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 126.518 1.927 . . . . 0.0 111.151 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -129.45 11.53 5.83 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -167.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -136.98 153.16 50.76 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.555 1.142 . . . . 0.0 112.476 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 70.66 -160.75 53.8 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.659 1.123 . . . . 0.0 115.379 171.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -6.11 27.37 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.732 1.613 . . . . 0.0 115.269 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 95.8 mmm -102.39 1.23 35.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.563 1.545 . . . . 0.0 114.611 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -62.31 132.99 54.48 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.639 1.563 . . . . 0.0 110.651 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.56 29.36 36.21 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.98 0.8 . . . . 0.0 113.597 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -121.09 148.05 44.7 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.444 1.098 . . . . 0.0 112.265 165.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -140.35 155.24 46.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.427 1.491 . . . . 0.0 114.02 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -113.46 140.35 48.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.415 1.886 . . . . 0.0 115.711 167.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -138.06 128.28 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.764 1.626 . . . . 0.0 111.223 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.76 143.94 17.44 Favored Glycine 0 CA--C 1.534 1.246 0 O-C-N 121.434 -0.792 . . . . 0.0 111.955 164.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 31.7 mt -126.67 155.17 75.37 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.579 1.152 . . . . 0.0 110.799 172.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.47 -6.17 17.93 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.835 2.357 . . . . 0.0 114.94 -168.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -154.25 143.15 21.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.92 0.888 . . . . 0.0 110.606 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -56.29 -30.9 63.09 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.044 -1.035 . . . . 0.0 112.859 169.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -66.26 -41.17 90.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.274 0.943 . . . . 0.0 113.394 171.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.62 96.89 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 119.423 -0.322 . . . . 0.0 110.797 174.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.84 -46.62 77.84 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.763 0.711 . . . . 0.0 112.338 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.9 -41.97 83.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.277 0.944 . . . . 0.0 112.101 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -69.96 -45.8 66.63 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.527 1.131 . . . . 0.0 112.159 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -63.12 -31.56 72.73 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.609 HD23 HG12 ' A' ' 498' ' ' VAL . 26.6 mt -69.32 -45.98 68.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.634 1.106 . . . . 0.0 110.549 172.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -59.92 -34.38 73.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.97 1.308 . . . . 0.0 111.86 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -88.11 -49.52 6.97 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.22 -23.87 37.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -167.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -73.08 104.62 4.22 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.816 -0.553 . . . . 0.0 109.602 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 117.82 -6.8 15.59 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 117.829 -1.539 . . . . 0.0 116.134 -167.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -65.67 132.64 49.29 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.064 1.932 . . . . 0.0 113.874 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.281 0.2 OUTLIER -94.06 47.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -157.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 31.5 tp -54.9 122.02 9.91 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.016 1.326 . . . . 0.0 111.342 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.385 50.5 m-85 59.42 12.97 2.95 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 -173.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 89.15 1.42 79.15 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.046 -1.034 . . . . 0.0 114.306 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -107.06 125.13 33.28 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 126.235 1.814 . . . . 0.0 111.012 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.05 121.06 7.5 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.034 2.49 . . . . 0.0 112.644 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 71.5 mtp -73.01 127.58 32.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.163 1.385 . . . . 0.0 111.347 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 92.7 t -92.55 95.89 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.352 1.861 . . . . 0.0 109.041 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.609 HG12 HD23 ' A' ' 483' ' ' LEU . 15.2 t -100.07 114.54 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.399 2.28 . . . . 0.0 112.296 -172.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.09 162.5 32.75 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -56.91 144.98 31.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.418 1.087 . . . . 0.0 110.27 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -59.37 154.18 17.35 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -73.06 -1.47 17.41 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 1.7 t -149.19 171.93 15.65 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.859 1.208 . . . . 0.0 111.732 160.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -87.48 132.88 33.87 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -161.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -149.15 103.09 3.34 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.774 1.63 . . . . 0.0 111.341 167.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -67.52 143.52 63.28 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 124.129 3.219 . . . . 0.0 111.375 165.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 37.4 tptt -169.24 122.44 0.78 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.806 1.242 . . . . 0.0 109.717 171.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -158.9 138.82 11.99 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -79.63 158.78 72.98 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 167.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.29 148.47 61.67 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.816 2.344 . . . . 0.0 112.358 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 155.45 21.19 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.053 0.93 . . . . 0.0 112.46 173.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 15.4 pm0 -65.11 124.35 21.9 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.916 1.686 . . . . 0.0 113.65 -167.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -81.42 -16.17 74.45 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.49 1.043 . . . . 0.0 114.475 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -82.96 128.88 34.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.986 1.315 . . . . 0.0 111.659 173.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.48 154.62 42.43 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.898 1.679 . . . . 0.0 111.191 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 82.3 tttt . . . . . 0 C--O 1.253 1.244 0 C-N-CA 123.809 0.844 . . . . 0.0 113.046 -170.507 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -73.02 -48.9 32.17 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -153.17 157.93 41.04 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.237 2.215 . . . . 0.0 111.228 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 17.1 ptm -150.22 166.2 15.71 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.734 1.614 . . . . 0.0 110.33 173.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -53.79 149.67 32.26 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.386 2.724 . . . . 0.0 114.649 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 67.5 m -106.93 -2.62 21.07 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 -164.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -157.89 156.88 32.14 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.868 1.267 . . . . 0.0 111.323 -166.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.3 p -148.0 161.9 40.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.328 1.451 . . . . 0.0 114.761 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.3 tt -69.87 158.64 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 126.177 1.791 . . . . 0.0 111.8 -172.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 73.8 m -92.33 152.38 19.8 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.953 -0.467 . . . . 0.0 111.399 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -56.56 -41.31 76.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.2 0.6 . . . . 0.0 111.365 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.09 -35.86 79.96 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -77.71 -30.87 52.0 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.2 tt -65.17 -48.96 71.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.378 1.071 . . . . 0.0 111.274 171.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -54.42 -24.69 20.95 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.376 1.871 . . . . 0.0 115.711 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -67.53 -36.01 80.19 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.568 1.147 . . . . 0.0 111.959 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.61 76.37 0.73 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 125.992 1.758 . . . . 0.0 111.372 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -163.65 145.98 9.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.24 1.016 . . . . 0.0 110.155 -172.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.7 pt -124.8 148.97 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.116 0.966 . . . . 0.0 112.509 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 33.7 t -81.28 166.97 20.05 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.643 1.177 . . . . 0.0 110.695 165.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -53.29 -31.96 46.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.41 1.084 . . . . 0.0 112.905 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -59.15 -19.68 47.0 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.927 1.691 . . . . 0.0 113.075 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -111.83 -28.56 8.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.342 1.857 . . . . 0.0 111.934 171.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 15.7 ttm -67.01 -38.38 85.87 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.195 -1.566 . . . . 0.0 111.936 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -83.89 31.51 0.48 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.815 0.846 . . . . 0.0 111.062 169.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.98 -42.18 0.53 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.313 1.845 . . . . 0.0 115.404 171.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.39 128.43 35.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.648 0.779 . . . . 0.0 109.308 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 50.9 m -59.97 -33.53 72.07 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.329 0.651 . . . . 0.0 112.34 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 5.3 m -63.41 -25.58 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.288 82.6 m-85 -94.07 -9.71 35.77 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -21.5 0.85 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 -163.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 15.6 m -143.9 24.82 1.65 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.476 1.91 . . . . 0.0 112.081 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -122.0 132.3 54.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.428 2.291 . . . . 0.0 112.371 -173.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -142.28 131.98 12.3 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -164.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.1 176.73 8.57 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.566 2.844 . . . . 0.0 111.685 161.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.01 69.16 1.41 Allowed Glycine 0 CA--C 1.532 1.098 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 172.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -145.7 155.16 52.62 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 126.463 1.905 . . . . 0.0 110.833 165.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -82.24 84.74 1.78 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.978 3.119 . . . . 0.0 112.371 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -139.4 143.46 37.68 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.232 -0.917 . . . . 0.0 111.792 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 29.8 p -84.33 7.21 20.16 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -135.11 145.49 47.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.682 1.593 . . . . 0.0 110.082 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 24.1 pt -139.53 162.21 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.507 1.923 . . . . 0.0 109.706 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -133.4 161.77 33.64 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 123.193 1.473 . . . . 0.0 107.722 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.414 HG22 HG13 ' A' ' 498' ' ' VAL . 10.5 t -130.27 139.35 51.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.769 1.628 . . . . 0.0 110.834 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -119.68 168.23 11.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.184 1.794 . . . . 0.0 109.916 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 9.8 t30 68.31 32.38 4.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.657 1.183 . . . . 0.0 111.602 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.96 134.51 41.5 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.522 -0.736 . . . . 0.0 109.972 167.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.9 170.82 1.91 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -173.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -65.52 -50.04 66.74 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.772 1.229 . . . . 0.0 112.92 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -68.06 -42.17 80.88 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.46 152.45 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 127.258 2.223 . . . . 0.0 116.231 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -139.69 170.39 15.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.975 1.31 . . . . 0.0 112.488 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -54.51 -33.77 60.49 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.435 -1.415 . . . . 0.0 113.565 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 34.6 pttt -58.75 -39.46 80.99 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 171.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.28 -32.75 72.11 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.737 1.215 . . . . 0.0 113.538 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.6 mp -69.57 -27.61 65.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.677 1.191 . . . . 0.0 112.805 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -30.67 63.55 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.023 0.829 . . . . 0.0 112.293 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.08 -34.18 74.51 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.46 1.104 . . . . 0.0 111.845 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.12 -58.34 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.127 -0.983 . . . . 0.0 110.827 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -57.68 -29.57 64.75 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.51 -14.78 82.11 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.077 -0.846 . . . . 0.0 114.581 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -56.97 -37.05 71.05 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.263 1.531 . . . . 0.0 111.959 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.63 -7.48 53.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.353 1.461 . . . . 0.0 113.686 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 18.1 t -118.54 123.11 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.72 2.008 . . . . 0.0 110.929 -171.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -75.69 111.6 11.19 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -65.42 -15.13 62.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 70.5 m -89.23 -12.47 40.69 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.197 0.999 . . . . 0.0 113.402 172.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 24.1 t -111.72 109.44 19.3 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.252 1.021 . . . . 0.0 110.845 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -57.92 -45.33 86.68 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.563 -0.711 . . . . 0.0 111.739 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.74 -17.2 5.48 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -87.34 -61.21 1.77 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.31 1.044 . . . . 0.0 110.28 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -70.5 -19.31 62.93 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.084 1.353 . . . . 0.0 113.986 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.1 tt -63.66 -32.62 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.468 1.507 . . . . 0.0 112.531 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.1 mmm -86.88 -14.52 41.77 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.639 1.176 . . . . 0.0 112.42 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -96.13 124.59 40.19 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -171.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -160.51 146.3 15.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.31 143.94 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.305 1.042 . . . . 0.0 110.57 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 73.0 mtp85 -126.66 138.76 53.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.573 1.549 . . . . 0.0 109.858 164.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 2.1 tt -118.96 125.0 48.41 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.057 1.343 . . . . 0.0 110.153 167.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -82.01 125.93 31.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.053 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -115.48 4.92 14.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.065 1.346 . . . . 0.0 112.998 -165.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.6 157.16 34.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.105 2.162 . . . . 0.0 110.457 -170.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 72.22 -164.62 54.41 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.507 1.051 . . . . 0.0 115.445 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -21.57 55.67 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 82.8 mtp -101.32 12.0 38.24 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -55.27 122.57 11.4 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.552 1.523 . . . . 0.0 111.154 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.23 28.05 56.7 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.599 1.095 . . . . 0.0 112.835 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -112.84 155.75 24.11 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.704 1.202 . . . . 0.0 110.909 163.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -149.08 155.62 41.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.508 1.123 . . . . 0.0 112.764 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.46 137.78 54.41 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.58 124.96 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.814 1.645 . . . . 0.0 110.623 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.65 141.19 15.42 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 160.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.6 mt -119.45 157.42 51.62 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.878 1.271 . . . . 0.0 110.187 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.59 -5.99 17.64 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.515 2.143 . . . . 0.0 114.242 -173.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -148.93 138.82 22.06 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.979 1.312 . . . . 0.0 110.102 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.07 -37.39 71.79 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.7 -0.625 . . . . 0.0 111.753 168.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -60.61 -37.66 82.14 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -69.23 -38.02 78.31 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.674 0.79 . . . . 0.0 111.701 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.82 -45.77 81.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.55 1.068 . . . . 0.0 111.86 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.05 76.12 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.766 0.712 . . . . 0.0 112.284 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -69.2 -47.78 63.89 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.998 0.919 . . . . 0.0 112.336 173.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.52 -31.52 71.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.484 0.714 . . . . 0.0 112.65 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.646 HD23 HG12 ' A' ' 498' ' ' VAL . 66.7 mt -73.28 -31.94 64.36 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.514 1.126 . . . . 0.0 112.468 172.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -71.03 -34.29 71.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.304 0.642 . . . . 0.0 111.34 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -89.85 -54.86 3.87 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -73.52 -17.05 61.26 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -69.22 101.92 1.59 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.281 1.032 . . . . 0.0 110.225 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 114.66 -2.1 23.27 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 117.919 -1.49 . . . . 0.0 116.103 -172.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -68.71 120.53 14.84 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.316 2.058 . . . . 0.0 109.367 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.32 69.83 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 124.067 1.889 . . . . 0.0 110.225 -167.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 22.7 tp -76.03 130.22 38.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.181 175.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.341 55.6 m-85 58.01 31.93 21.3 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 76.81 0.21 68.0 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.097 1.332 . . . . 0.0 115.594 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 27.4 tptt -112.78 108.61 53.6 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.653 1.581 . . . . 0.0 110.628 -169.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.39 113.44 3.32 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.756 2.304 . . . . 0.0 110.705 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 48.6 mtp -72.7 128.55 35.87 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.059 1.743 . . . . 0.0 111.891 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.5 t -93.59 99.0 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.078 1.751 . . . . 0.0 109.314 -176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 483' ' ' LEU . 2.8 t -101.69 124.24 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.444 1.898 . . . . 0.0 112.266 -173.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -147.82 155.17 41.37 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.098 1.359 . . . . 0.0 111.707 -170.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -54.23 148.19 11.84 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -61.58 158.01 16.1 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 16.2 mmm-85 -121.01 -21.64 6.43 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -160.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 30.2 t -104.09 88.51 3.02 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.121 1.768 . . . . 0.0 107.431 162.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -155.5 160.19 40.37 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -165.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.38 86.76 34.27 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.545 1.538 . . . . 0.0 107.664 161.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -57.34 138.43 86.18 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 123.456 2.771 . . . . 0.0 112.694 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -157.23 133.37 9.61 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.489 1.916 . . . . 0.0 109.305 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -73.66 139.83 45.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.938 1.295 . . . . 0.0 112.933 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -79.13 147.68 69.94 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 170.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.87 159.64 53.0 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.742 2.961 . . . . 0.0 114.422 -171.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 166.67 11.83 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.343 1.457 . . . . 0.0 114.272 175.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -67.27 -28.98 68.48 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.773 1.629 . . . . 0.0 114.564 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 91.26 22.19 32.98 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.094 1.33 . . . . 0.0 113.647 -172.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -151.93 130.84 12.52 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.896 2.478 . . . . 0.0 109.889 -172.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.35 130.1 40.5 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.655 0.782 . . . . 0.0 111.98 -172.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt . . . . . 0 C--O 1.252 1.199 0 C-N-CA 127.675 2.39 . . . . 0.0 112.706 -177.482 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 N--CA 1.475 0.788 0 CA-C-O 119.534 -0.27 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -74.22 175.81 7.22 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -174.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -75.52 -54.04 7.65 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.181 1.392 . . . . 0.0 113.505 -165.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 68.8 mtp 59.64 157.76 0.1 Allowed Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 129.772 3.229 . . . . 0.0 118.188 171.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -93.16 165.64 2.48 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 124.089 3.193 . . . . 0.0 113.258 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 59.1 p -78.43 46.55 0.64 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.615 1.566 . . . . 0.0 114.028 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -88.81 71.39 8.67 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.038 -1.663 . . . . 0.0 111.57 -173.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.3 p -155.02 160.27 40.93 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.595 1.158 . . . . 0.0 111.715 169.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.8 tt -68.39 145.99 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.328 1.451 . . . . 0.0 110.492 -174.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 37.1 t -82.63 157.08 23.55 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 122.107 0.956 . . . . 0.0 109.021 163.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -56.73 -30.14 63.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.699 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -63.82 -37.17 86.39 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 175.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -81.33 -27.84 34.78 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.44 -46.94 62.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.096 1.358 . . . . 0.0 113.042 174.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -55.88 -22.04 23.43 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.594 1.958 . . . . 0.0 114.411 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -62.9 -30.78 71.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.064 1.346 . . . . 0.0 112.704 173.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.22 80.66 0.31 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.55 1.548 . . . . 0.0 111.108 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -162.01 145.52 12.08 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.958 1.703 . . . . 0.0 109.908 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.8 pt -120.61 152.13 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 63.6 m -74.67 159.56 31.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.35 1.46 . . . . 0.0 111.823 161.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 33.3 mtm105 -58.84 -27.11 64.81 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.879 -1.138 . . . . 0.0 112.728 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -61.87 -31.56 71.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.949 1.3 . . . . 0.0 112.019 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.78 -32.18 21.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.672 1.189 . . . . 0.0 111.254 170.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 37.4 ttm -62.23 -43.52 98.64 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.653 -1.279 . . . . 0.0 111.483 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -78.99 29.47 0.21 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.568 0.747 . . . . 0.0 112.162 171.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.05 -39.7 0.44 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.049 1.74 . . . . 0.0 115.388 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 5.3 mp -68.19 134.96 51.3 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.052 1.341 . . . . 0.0 110.586 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 82.4 p -62.94 -27.64 69.53 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.412 HG23 ' CD2' ' A' ' 410' ' ' PHE . 11.4 m -65.79 -22.77 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 172.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.412 ' CD2' HG23 ' A' ' 409' ' ' VAL 0.401 66.4 m-85 -101.25 14.23 32.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 118.482 2.771 . . . . 0.0 118.482 -177.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -23.01 62.5 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 4.3 m -140.06 -33.72 0.57 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.847 1.659 . . . . 0.0 113.735 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.58 144.99 56.09 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -147.96 143.24 17.44 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -83.18 -171.67 1.18 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.757 3.638 . . . . 0.0 111.226 157.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.46 -0.48 32.71 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 117.494 1.758 . . . . 0.0 117.494 163.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -102.77 143.51 26.74 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 119.236 1.518 . . . . 0.0 113.91 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.31 82.74 2.42 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.849 3.7 . . . . 0.0 112.435 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 18.1 t30 -128.29 146.59 50.71 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.552 -1.343 . . . . 0.0 111.026 174.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 32.0 p -77.34 -9.89 59.11 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.54 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 36.3 mtm180 -119.59 146.4 45.55 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.715 1.206 . . . . 0.0 111.586 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 10.3 pt -134.82 151.11 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.997 1.719 . . . . 0.0 110.125 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -114.24 154.67 27.52 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.309 1.052 . . . . 0.0 108.486 166.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.412 HG22 HG13 ' A' ' 498' ' ' VAL . 2.5 t -128.82 147.45 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.531 1.532 . . . . 0.0 112.693 176.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -134.99 165.99 24.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.092 1.757 . . . . 0.0 111.011 -174.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.291 12.6 m-20 71.55 24.4 3.59 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -174.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.29 131.55 42.83 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.289 -1.507 . . . . 0.0 112.12 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -56.17 152.6 10.51 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.57 1.948 . . . . 0.0 115.513 -172.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -58.36 -40.23 81.67 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -84.52 -21.77 30.43 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.08 150.26 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -117.35 167.26 11.4 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.547 1.139 . . . . 0.0 112.125 171.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 459' ' ' LEU . 5.2 pm0 -53.94 -34.36 59.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.606 1.162 . . . . 0.0 112.613 170.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -66.58 -32.85 74.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.799 1.24 . . . . 0.0 114.115 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -68.02 -29.66 68.72 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.24 -18.25 60.76 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.01 1.324 . . . . 0.0 113.681 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -58.19 -29.29 65.54 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.361 0.982 . . . . 0.0 112.873 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.66 -32.21 72.36 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.398 0.545 . . . . 0.0 110.733 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.2 mt -99.16 -60.13 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.526 0.73 . . . . 0.0 110.844 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.294 81.5 m-85 -62.92 -23.98 67.63 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 117.349 2.352 . . . . 0.0 117.349 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -82.51 -5.51 89.45 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.737 1.16 . . . . 0.0 114.22 171.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -58.0 -31.8 67.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.656 1.728 . . . . 0.0 111.378 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -93.81 6.77 47.29 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.908 1.683 . . . . 0.0 111.572 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 19.0 t -118.37 120.29 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 120.209 1.368 . . . . 0.0 110.828 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -75.59 103.36 5.67 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.45 1.1 . . . . 0.0 110.422 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -56.42 -29.28 61.4 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 4.2 m -77.81 -2.6 37.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.293 1.837 . . . . 0.0 113.898 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.8 m -130.44 98.0 4.56 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.358 1.463 . . . . 0.0 110.468 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -51.93 -41.05 61.73 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.2 t -48.63 -16.67 0.12 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 118.688 2.847 . . . . 0.0 118.688 173.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -93.07 -58.65 2.26 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.463 -0.773 . . . . 0.0 111.575 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -71.14 -17.07 62.57 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.077 1.351 . . . . 0.0 113.78 -175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.7 tt -63.3 -35.15 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.557 1.543 . . . . 0.0 111.803 168.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.5 mtm -85.04 -27.64 26.22 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.52 0.328 . . . . 0.0 110.891 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . 0.28 32.4 t80 -83.75 128.64 34.68 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 -173.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -162.28 155.85 20.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.778 1.631 . . . . 0.0 107.716 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 11.3 mt -130.78 135.88 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.617 1.167 . . . . 0.0 109.77 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -122.3 125.16 45.4 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.487 1.515 . . . . 0.0 108.044 163.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' A' ' 433' ' ' GLU . 7.1 tp -99.73 113.37 25.8 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.278 1.431 . . . . 0.0 108.203 165.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -77.7 107.04 9.9 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 126.355 1.862 . . . . 0.0 110.034 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -98.28 2.15 47.88 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.354 1.062 . . . . 0.0 113.763 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -118.68 157.16 27.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.4 1.88 . . . . 0.0 112.89 -171.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 74.07 174.55 30.91 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.997 1.284 . . . . 0.0 113.174 -171.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -28.77 68.46 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.445 -1.032 . . . . 0.0 113.068 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -91.89 34.64 0.99 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.55 1.14 . . . . 0.0 112.927 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -70.59 166.25 21.05 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.283 1.033 . . . . 0.0 113.139 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 68.7 38.16 85.41 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 124.891 1.234 . . . . 0.0 110.605 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -125.74 156.92 38.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.079 0.952 . . . . 0.0 110.525 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -143.77 136.99 27.75 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -93.85 127.06 39.4 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 165.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.17 135.83 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.327 1.451 . . . . 0.0 109.378 171.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.89 133.4 11.58 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 160.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 17.9 mt -106.58 160.27 26.87 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.349 1.46 . . . . 0.0 109.868 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.26 -10.46 20.8 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.579 2.186 . . . . 0.0 113.842 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -153.42 145.51 23.74 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.159 0.984 . . . . 0.0 110.249 -174.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -55.67 -36.37 67.02 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.977 -0.452 . . . . 0.0 111.756 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -62.68 -33.99 76.21 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -69.6 -39.87 77.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.203 0.601 . . . . 0.0 111.084 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -69.73 -42.87 73.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.05 0.841 . . . . 0.0 111.618 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.24 -31.11 67.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.984 0.914 . . . . 0.0 112.778 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -78.72 -49.08 13.69 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.328 -0.858 . . . . 0.0 112.617 168.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.87 -27.74 69.55 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.57 HD23 HG12 ' A' ' 498' ' ' VAL . 54.1 mt -76.49 -28.3 56.4 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.192 -0.943 . . . . 0.0 112.736 174.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -71.12 -40.36 71.5 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.108 0.563 . . . . 0.0 110.681 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.44 -55.01 5.18 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.36 -16.26 52.83 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -68.49 108.79 3.42 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.931 -1.106 . . . . 0.0 110.835 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 115.52 -6.09 20.87 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 117.987 -1.452 . . . . 0.0 115.42 -171.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.78 120.41 12.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.292 2.046 . . . . 0.0 114.99 -160.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.287 1.9 t -85.63 46.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.102 1.761 . . . . 0.0 115.507 -163.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 32.5 tp -52.9 130.06 32.18 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.353 1.061 . . . . 0.0 110.335 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . . 81.2 t80 60.31 16.04 5.89 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 86.77 10.3 72.95 Favored Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.464 -1.398 . . . . 0.0 114.656 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -127.66 125.55 23.77 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 126.031 1.732 . . . . 0.0 111.934 -172.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.54 127.51 12.56 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.09 1.86 . . . . 0.0 112.651 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 61.4 mtp -78.42 131.76 37.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.538 1.535 . . . . 0.0 112.524 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.28 97.05 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.356 1.862 . . . . 0.0 109.554 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.57 HG12 HD23 ' A' ' 483' ' ' LEU . 2.9 t -98.51 119.87 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 127.481 2.312 . . . . 0.0 112.774 -176.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -139.41 158.76 43.58 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.825 1.25 . . . . 0.0 113.525 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -58.5 145.89 37.38 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.615 -0.678 . . . . 0.0 112.817 166.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -52.69 142.72 17.83 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.829 0.851 . . . . 0.0 112.606 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -80.56 -12.73 59.48 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -166.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 21.7 m -72.23 142.92 48.97 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.585 1.954 . . . . 0.0 110.702 170.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -60.22 151.99 25.85 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -174.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 31.0 tpt85 -124.78 82.35 60.38 Favored Pre-proline 0 N--CA 1.48 1.053 0 C-N-CA 126.936 2.094 . . . . 0.0 110.915 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.44 -176.94 2.45 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.634 2.889 . . . . 0.0 112.617 177.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -53.1 126.15 19.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.329 1.051 . . . . 0.0 109.18 161.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -160.24 179.97 8.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.391 1.076 . . . . 0.0 110.169 -162.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -63.68 144.31 97.87 Favored Pre-proline 0 CA--C 1.545 0.782 0 O-C-N 120.474 -1.391 . . . . 0.0 112.006 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.83 166.54 28.61 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.988 2.458 . . . . 0.0 113.103 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 168.67 6.19 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.548 1.139 . . . . 0.0 112.599 168.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -125.09 173.15 8.91 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -172.86 -165.95 30.63 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.404 1.002 . . . . 0.0 112.843 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -160.41 167.44 27.33 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.958 1.303 . . . . 0.0 112.258 160.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.76 -44.7 8.83 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.84 1.656 . . . . 0.0 111.001 171.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 15.7 pttp . . . . . 0 C--O 1.252 1.197 0 C-N-CA 128.325 2.65 . . . . 0.0 112.841 170.131 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.568 ' N ' ' HG ' ' A' ' 386' ' ' SER . 26.4 p . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 117.958 -1.02 . . . . 0.0 111.625 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -129.81 -70.55 0.64 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.52 -22.76 54.0 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 69.3 mmm -136.63 162.68 54.71 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.872 1.669 . . . . 0.0 112.834 -172.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.71 164.36 11.69 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.801 3.001 . . . . 0.0 113.393 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . 0.568 ' HG ' ' N ' ' A' ' 381' ' ' SER . 5.6 m -117.36 149.36 40.62 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.199 1.4 . . . . 0.0 114.311 177.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -159.83 156.78 28.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.14 2.176 . . . . 0.0 109.804 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.1 p -141.9 175.69 9.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.657 1.183 . . . . 0.0 112.828 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.5 tt -82.62 150.42 4.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 126.063 1.745 . . . . 0.0 111.964 -172.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 6.5 m -81.77 161.02 23.44 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.511 0.725 . . . . 0.0 109.709 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -65.04 -39.63 93.61 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.113 -0.992 . . . . 0.0 110.769 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -54.89 -43.72 73.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.351 1.46 . . . . 0.0 112.785 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.87 -37.73 70.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.098 1.359 . . . . 0.0 114.551 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 19.8 tp -69.05 -39.6 79.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.251 1.021 . . . . 0.0 112.528 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -59.97 -18.03 42.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -65.66 -21.41 66.55 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.057 0.943 . . . . 0.0 112.253 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -134.96 86.49 0.25 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.656 1.598 . . . . 0.0 111.495 173.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -155.7 151.08 26.93 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.751 1.221 . . . . 0.0 109.658 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.3 pt -136.41 148.64 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 13.0 m -86.97 164.17 16.67 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.98 1.712 . . . . 0.0 110.178 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -50.24 -38.76 42.15 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.38 -27.35 66.16 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.54 -31.42 42.06 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.142 -0.974 . . . . 0.0 111.821 167.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 4.5 ttm -58.93 -38.7 79.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.784 0.834 . . . . 0.0 110.076 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -74.65 11.2 1.09 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.764 1.626 . . . . 0.0 114.059 171.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.47 -22.05 3.4 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.209 1.803 . . . . 0.0 115.227 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.0 mp -91.17 130.82 37.02 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.253 1.821 . . . . 0.0 111.202 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 14.5 p -62.41 -24.25 67.29 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.441 HG23 ' CD2' ' A' ' 410' ' ' PHE . 6.1 m -66.18 -23.22 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 119.501 1.046 . . . . 0.0 113.595 169.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.441 ' CD2' HG23 ' A' ' 409' ' ' VAL 0.27 42.2 m-85 -100.44 -10.35 21.22 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 121.276 3.806 . . . . 0.0 121.276 -171.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.79 -19.59 29.42 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 -169.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 4.4 m -142.54 28.28 1.64 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.451 1.9 . . . . 0.0 111.799 -176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -134.12 137.72 44.73 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.192 2.197 . . . . 0.0 115.924 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -142.11 121.01 7.76 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -171.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -74.84 176.79 9.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.178 3.252 . . . . 0.0 113.282 160.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.55 31.61 10.19 Favored Glycine 0 N--CA 1.468 0.787 0 C-N-CA 124.532 1.063 . . . . 0.0 114.853 167.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -125.82 149.87 67.06 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.693 1.197 . . . . 0.0 113.255 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.53 109.93 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.027 3.151 . . . . 0.0 114.056 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.564 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 42.1 t30 -158.17 159.96 36.71 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.807 1.643 . . . . 0.0 109.669 160.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 25.4 p -80.59 -7.52 59.28 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.564 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 20.3 mtp180 -130.92 152.39 50.3 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.086 1.754 . . . . 0.0 110.084 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 6.6 pt -137.88 165.13 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 126.725 2.01 . . . . 0.0 109.404 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -135.56 164.18 28.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.606 1.193 . . . . 0.0 107.818 167.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.4 143.34 34.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.608 1.163 . . . . 0.0 110.522 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -126.43 168.78 13.73 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.227 1.811 . . . . 0.0 110.868 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 38.8 t30 67.32 32.8 5.72 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.663 1.585 . . . . 0.0 113.085 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.56 139.79 53.77 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.449 1.1 . . . . 0.0 110.919 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -59.47 161.86 5.43 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.871 1.669 . . . . 0.0 115.098 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -63.09 -37.26 86.51 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -80.15 -32.7 38.88 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.713 1.605 . . . . 0.0 114.022 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.35 144.19 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -166.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -120.25 163.87 17.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.602 1.561 . . . . 0.0 112.308 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -56.15 -32.55 64.39 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.583 -1.323 . . . . 0.0 113.033 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -62.37 -33.37 74.61 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -66.98 -36.21 81.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.494 1.118 . . . . 0.0 113.028 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.56 -22.6 63.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.192 1.397 . . . . 0.0 112.969 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.88 -26.78 62.57 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.48 1.036 . . . . 0.0 112.471 176.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -62.5 -31.77 72.58 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.237 0.471 . . . . 0.0 110.494 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.11 -56.27 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 120.591 -1.318 . . . . 0.0 110.841 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -59.27 -30.32 68.21 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.28 -3.49 88.55 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.906 1.241 . . . . 0.0 114.641 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -59.25 -31.06 68.74 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.384 1.592 . . . . 0.0 112.23 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -97.94 13.85 29.3 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.205 2.202 . . . . 0.0 111.678 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 15.4 t -131.03 139.73 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.919 1.688 . . . . 0.0 110.389 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.61 117.05 14.91 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.717 -0.615 . . . . 0.0 109.872 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.31 -13.81 32.65 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 118.716 2.858 . . . . 0.0 118.716 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.2 t -123.04 -33.48 3.32 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.4 m -67.66 110.83 3.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.951 0.796 . . . . 0.0 110.814 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -57.07 -46.4 82.53 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -13.55 2.57 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -92.91 -60.34 1.83 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.819 1.248 . . . . 0.0 110.374 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -70.81 -12.55 61.62 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.986 1.714 . . . . 0.0 114.114 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.02 -39.91 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 126.869 2.068 . . . . 0.0 112.968 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 11.8 mtm -83.96 -29.96 26.64 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.573 0.749 . . . . 0.0 109.669 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -66.43 131.15 45.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.04 1.336 . . . . 0.0 113.825 164.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -165.43 149.04 8.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.358 1.463 . . . . 0.0 108.809 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.2 mt -125.95 137.03 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.48 1.112 . . . . 0.0 111.424 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -126.53 129.37 48.49 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.945 1.298 . . . . 0.0 108.892 162.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 5.7 tt -109.1 115.97 31.06 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.225 1.41 . . . . 0.0 109.533 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 59.7 mtm -72.8 134.26 44.84 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.065 1.346 . . . . 0.0 111.575 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -123.93 14.94 9.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.492 1.517 . . . . 0.0 113.168 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -139.89 153.31 46.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.898 1.679 . . . . 0.0 112.241 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 59.33 -146.88 43.04 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.046 1.308 . . . . 0.0 116.318 168.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -7.59 47.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.819 2.048 . . . . 0.0 115.465 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . 0.256 13.1 mtm -120.25 19.25 12.19 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 173.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -55.58 120.22 6.89 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.273 -1.517 . . . . 0.0 111.513 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.01 30.17 29.42 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.16 1.362 . . . . 0.0 113.77 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -123.85 149.33 45.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.472 1.109 . . . . 0.0 109.288 168.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -137.94 141.52 40.57 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.437 -0.79 . . . . 0.0 112.656 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -101.64 135.06 43.8 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 172.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.82 122.83 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.29 1.436 . . . . 0.0 110.533 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -85.73 149.99 23.86 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 162.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 21.9 mt -125.21 158.34 64.06 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.401 1.08 . . . . 0.0 110.233 170.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.3 -8.27 21.67 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.545 2.163 . . . . 0.0 113.991 -175.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -155.78 144.24 20.19 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.033 1.333 . . . . 0.0 110.487 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -58.36 -31.95 68.1 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.613 1.165 . . . . 0.0 113.154 168.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -56.3 -45.69 80.13 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.394 -0.816 . . . . 0.0 111.978 171.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.73 -35.87 81.98 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.993 0.808 . . . . 0.0 112.914 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.38 -44.37 75.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.439 1.472 . . . . 0.0 112.586 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.83 -38.22 75.23 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.42 -0.8 . . . . 0.0 112.022 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -67.2 -53.7 27.88 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.721 1.208 . . . . 0.0 112.192 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.79 -32.95 69.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.979 0.911 . . . . 0.0 112.608 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.561 HD23 HG12 ' A' ' 498' ' ' VAL . 50.8 mt -69.81 -43.58 71.77 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.068 0.947 . . . . 0.0 111.742 175.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -65.97 -26.1 67.41 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.81 0.844 . . . . 0.0 111.688 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -100.65 -44.69 5.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -175.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -76.1 -24.45 55.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.519 1.128 . . . . 0.0 113.865 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -72.5 120.5 18.2 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.645 -0.659 . . . . 0.0 112.343 -169.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 108.96 -8.19 33.51 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 117.984 -1.454 . . . . 0.0 115.032 -170.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . 0.262 61.7 t80 -64.82 133.12 51.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.524 1.662 . . . . 0.0 115.164 -164.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.252 2.5 t -99.8 46.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.181 1.392 . . . . 0.0 113.768 -158.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 19.4 tp -50.49 126.28 14.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.123 1.369 . . . . 0.0 110.572 172.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.361 32.9 m-85 58.64 12.58 2.22 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 89.84 3.03 74.36 Favored Glycine 0 CA--C 1.536 1.355 0 O-C-N 120.683 -1.26 . . . . 0.0 114.519 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -119.35 118.1 32.68 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 119.477 1.639 . . . . 0.0 112.829 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.18 126.76 14.1 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.886 2.39 . . . . 0.0 113.216 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 71.7 mtp -81.72 134.47 35.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.652 1.581 . . . . 0.0 112.137 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.76 93.47 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 126.655 1.982 . . . . 0.0 110.528 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.561 HG12 HD23 ' A' ' 483' ' ' LEU . 2.8 t -94.67 118.25 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 126.814 2.045 . . . . 0.0 113.086 -173.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -134.41 160.8 36.86 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.65 1.18 . . . . 0.0 114.119 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -60.01 144.58 48.96 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.165 -0.96 . . . . 0.0 113.174 167.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -60.91 168.72 2.23 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.96 15.3 1.19 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -143.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 8.8 t -64.06 -48.56 75.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.428 1.013 . . . . 0.0 109.373 173.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -79.58 135.58 36.63 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.155 0.582 . . . . 0.0 110.207 155.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -118.26 49.85 1.09 Allowed Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.351 1.46 . . . . 0.0 113.575 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -65.51 165.86 21.45 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.715 2.277 . . . . 0.0 111.964 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -54.66 113.34 1.27 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.673 1.189 . . . . 0.0 112.297 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -81.14 -41.61 22.18 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.634 0.774 . . . . 0.0 110.085 166.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -156.89 159.34 31.34 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.631 1.972 . . . . 0.0 114.191 -168.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -70.97 -165.65 0.19 Allowed 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.135 2.557 . . . . 0.0 111.38 162.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.35 160.16 0.26 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.236 1.015 . . . . 0.0 113.264 160.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -63.75 148.32 49.48 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.409 -0.807 . . . . 0.0 112.012 -173.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -175.74 112.85 0.41 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.653 0.644 . . . . 0.0 112.286 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -153.74 175.66 13.02 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -162.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -123.12 120.25 32.67 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.328 1.451 . . . . 0.0 112.464 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 18.9 pttp . . . . . 0 C--O 1.251 1.152 0 C-N-CA 127.375 2.27 . . . . 0.0 112.562 172.709 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 76.0 p . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 120.3 0.095 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -86.41 -39.35 16.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.781 0.832 . . . . 0.0 112.225 174.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -145.47 151.05 37.59 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.725 1.21 . . . . 0.0 111.223 172.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 23.0 ptm -151.66 158.03 34.33 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.15 1.38 . . . . 0.0 110.435 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -92.05 39.33 0.28 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.926 2.417 . . . . 0.0 112.298 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 33.7 t -162.32 156.44 21.45 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.882 1.273 . . . . 0.0 113.167 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -142.6 144.41 32.84 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 129.206 3.002 . . . . 0.0 106.81 167.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 30.1 p -144.82 164.78 30.01 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.3 tt -72.64 171.14 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.647 2.379 . . . . 0.0 111.701 -175.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 34.5 m -110.67 166.85 10.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.425 1.09 . . . . 0.0 111.834 167.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 14.1 ttm-85 -59.15 -48.33 81.99 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.037 -1.039 . . . . 0.0 112.48 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -61.78 -37.16 83.3 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.591 1.157 . . . . 0.0 113.398 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -70.31 -38.66 75.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.696 1.198 . . . . 0.0 113.226 173.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.06 -41.08 82.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.889 1.276 . . . . 0.0 112.982 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.33 -17.84 32.89 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.172 1.789 . . . . 0.0 115.101 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -70.29 -16.23 62.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.961 0.905 . . . . 0.0 113.357 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -127.29 87.6 0.33 Allowed Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.84 1.686 . . . . 0.0 113.166 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -167.7 147.25 4.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.629 1.172 . . . . 0.0 111.372 -170.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 10.8 pt -125.28 152.71 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 69.3 m -100.82 164.44 11.84 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.963 2.505 . . . . 0.0 111.111 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -55.46 -33.81 63.97 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -169.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -76.86 -10.56 59.45 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.588 1.086 . . . . 0.0 112.877 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -96.61 -33.19 11.87 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.001 -1.062 . . . . 0.0 111.208 163.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 17.5 ttp -63.29 -40.47 97.47 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.881 -1.137 . . . . 0.0 111.352 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -79.68 30.62 0.24 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.148 0.979 . . . . 0.0 112.723 171.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.12 -29.02 0.41 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 176.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.8 mp -72.27 134.31 45.51 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.17 0.988 . . . . 0.0 109.842 167.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 9.2 t -66.94 -29.48 69.36 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.444 -0.785 . . . . 0.0 111.923 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.7 m -66.63 -7.77 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 170.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.261 83.5 m-85 -119.74 3.68 11.1 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 118.553 2.797 . . . . 0.0 118.553 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -14.08 62.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -169.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.7 t -130.76 -25.9 2.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.218 1.007 . . . . 0.0 111.681 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -70.36 137.76 50.82 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.284 1.586 . . . . 0.0 115.284 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -142.81 125.79 9.14 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.22 179.71 5.68 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 125.045 3.83 . . . . 0.0 113.513 167.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 121.25 -19.68 8.62 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 156.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -82.03 150.2 64.5 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.13 96.98 1.09 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 124.109 3.206 . . . . 0.0 112.725 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.83 137.47 45.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.069 1.747 . . . . 0.0 106.903 161.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.9 p -72.99 -0.67 14.43 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -124.43 149.88 46.28 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.331 1.453 . . . . 0.0 110.849 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.6 pt -140.15 161.22 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.61 1.964 . . . . 0.0 109.654 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -131.35 156.97 44.6 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.5 t -127.2 143.76 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 125.349 1.46 . . . . 0.0 111.575 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -127.34 166.95 16.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.364 1.865 . . . . 0.0 109.569 173.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 34.6 t30 66.24 32.45 7.9 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.8 1.24 . . . . 0.0 113.109 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -71.33 157.23 38.46 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.318 -0.864 . . . . 0.0 111.49 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -71.46 166.52 21.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.255 1.422 . . . . 0.0 114.804 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -76.36 -42.1 45.87 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.204 -0.935 . . . . 0.0 113.034 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -70.98 -35.79 72.26 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.38 156.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -130.24 158.32 40.08 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.994 1.718 . . . . 0.0 110.55 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -56.15 -29.82 61.3 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.155 -1.59 . . . . 0.0 113.454 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -57.18 -37.71 72.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.066 1.747 . . . . 0.0 114.26 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -68.13 -33.98 75.5 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.65 -21.41 66.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.136 0.974 . . . . 0.0 112.547 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -24.12 62.27 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.841 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -59.39 -29.46 67.73 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.708 0.803 . . . . 0.0 110.96 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.41 -55.0 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 120.866 -1.147 . . . . 0.0 111.207 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -59.53 -29.64 68.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.73 -4.71 89.47 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.409 1.004 . . . . 0.0 114.43 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -65.36 -36.22 83.34 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 119.974 1.887 . . . . 0.0 111.527 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -79.26 6.29 10.24 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.623 1.969 . . . . 0.0 113.08 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 16.1 t -131.57 135.06 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.469 1.908 . . . . 0.0 110.862 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -91.13 113.32 25.55 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -63.77 -18.51 64.15 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 69.5 m -90.88 -0.58 57.77 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.3 t -118.5 107.22 13.52 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.29 1.036 . . . . 0.0 110.629 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -61.24 -43.16 99.33 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.186 -0.946 . . . . 0.0 111.998 -176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.91 -14.11 5.65 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 117.189 2.292 . . . . 0.0 117.189 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -88.27 -62.21 1.54 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.016 0.926 . . . . 0.0 110.095 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -69.92 -24.74 63.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.754 1.222 . . . . 0.0 114.227 -173.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 16.4 tt -54.19 -36.71 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.694 1.197 . . . . 0.0 112.28 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.2 mtm -84.71 -12.83 53.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.267 1.027 . . . . 0.0 112.483 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -94.36 134.13 37.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.859 1.664 . . . . 0.0 114.777 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -167.86 141.26 3.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.872 1.669 . . . . 0.0 107.303 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.8 mt -116.24 138.1 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.958 1.703 . . . . 0.0 110.149 174.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -132.13 133.98 44.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.023 1.329 . . . . 0.0 110.163 166.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 1.4 tt -112.2 124.8 53.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.098 1.359 . . . . 0.0 110.943 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 35.2 mtm -72.27 135.02 45.88 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.648 1.579 . . . . 0.0 111.172 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -134.51 -26.06 1.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.657 1.583 . . . . 0.0 115.136 -163.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -101.15 139.39 36.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.596 1.558 . . . . 0.0 111.512 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 72.5 -158.32 53.16 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.38 1.312 . . . . 0.0 116.38 163.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -13.97 62.32 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -169.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 75.9 mtm -110.63 12.42 22.68 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -61.17 148.82 39.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.844 -1.16 . . . . 0.0 111.949 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.77 24.61 76.45 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.737 0.684 . . . . 0.0 112.156 -175.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -104.23 160.04 15.21 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.758 1.223 . . . . 0.0 109.697 158.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -152.51 157.11 40.64 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.829 -1.17 . . . . 0.0 112.77 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -116.86 143.39 45.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.98 127.05 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.617 1.567 . . . . 0.0 109.071 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -97.18 145.6 17.92 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 162.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 27.1 mt -126.29 156.66 72.14 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.592 1.557 . . . . 0.0 110.412 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -73.06 -7.7 21.03 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.747 2.298 . . . . 0.0 114.579 -171.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -151.22 143.43 24.07 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.469 1.108 . . . . 0.0 111.397 -172.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.19 -41.93 69.15 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.559 -0.713 . . . . 0.0 111.394 166.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -67.16 -28.01 67.76 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.493 1.117 . . . . 0.0 113.381 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -71.24 -43.35 67.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.664 0.386 . . . . 0.0 110.777 174.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.81 -44.06 74.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.36 0.527 . . . . 0.0 112.056 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.79 -37.73 71.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.38 0.672 . . . . 0.0 111.923 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -73.15 -48.4 35.75 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.783 0.833 . . . . 0.0 112.744 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.96 -29.57 70.33 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.559 HD23 HG12 ' A' ' 498' ' ' VAL . 47.2 mt -71.15 -34.13 70.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.106 -0.996 . . . . 0.0 112.461 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -63.92 -39.45 94.18 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.312 0.505 . . . . 0.0 111.429 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.06 -47.49 8.87 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -171.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -79.02 -20.89 47.86 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -69.1 109.48 4.04 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.277 -0.89 . . . . 0.0 110.699 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 108.96 -3.31 31.74 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 117.684 -1.62 . . . . 0.0 116.435 -174.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -65.89 131.23 45.77 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.779 1.789 . . . . 0.0 112.356 -172.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.299 1.2 t -93.31 44.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 -161.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 16.8 tp -50.01 122.26 6.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.016 1.726 . . . . 0.0 111.489 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.309 76.1 m-85 49.57 30.34 3.48 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 117.361 2.356 . . . . 0.0 117.361 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 77.37 24.36 65.9 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.125 -0.984 . . . . 0.0 114.171 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -132.43 116.62 15.24 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 119.028 1.414 . . . . 0.0 110.33 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.96 114.88 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.313 2.009 . . . . 0.0 112.003 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 61.9 mtp -71.25 127.81 33.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.723 1.609 . . . . 0.0 112.347 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 30.8 t -93.52 94.16 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.992 2.117 . . . . 0.0 109.63 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.559 HG12 HD23 ' A' ' 483' ' ' LEU . 3.7 t -100.4 120.49 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 127.142 2.177 . . . . 0.0 113.08 -171.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -137.95 158.95 43.29 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.399 1.479 . . . . 0.0 113.644 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -57.71 142.19 46.06 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 167.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -62.63 163.82 8.51 Favored 'General case' 0 CA--C 1.556 1.178 0 CA-C-N 118.507 0.594 . . . . 0.0 112.462 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -103.42 13.14 34.28 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 -148.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 4.3 t -116.33 37.66 3.65 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.878 1.671 . . . . 0.0 111.902 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -163.95 99.67 0.87 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.113 1.765 . . . . 0.0 111.524 173.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 18.9 tpt85 -145.37 68.56 13.59 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 125.66 1.584 . . . . 0.0 111.384 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.99 158.19 53.0 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.768 2.979 . . . . 0.0 112.939 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -112.05 137.06 50.6 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.9 1.28 . . . . 0.0 111.402 -171.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -161.53 150.73 16.21 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.711 1.604 . . . . 0.0 110.889 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -79.83 147.08 65.69 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -80.44 172.66 13.29 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.318 3.345 . . . . 0.0 112.479 164.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 146.94 28.25 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.373 1.069 . . . . 0.0 113.433 175.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -72.66 132.13 43.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.124 0.969 . . . . 0.0 112.992 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -88.96 -31.28 12.41 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.572 1.082 . . . . 0.0 112.672 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -55.6 144.22 27.3 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.937 1.695 . . . . 0.0 111.627 169.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -61.86 147.21 47.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.212 1.405 . . . . 0.0 112.116 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 14.3 tttt . . . . . 0 C--O 1.251 1.163 0 CA-C-O 116.204 -1.855 . . . . 0.0 114.463 177.326 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.728 0.299 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -61.84 -36.37 80.98 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.985 0.914 . . . . 0.0 113.135 164.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -84.34 15.35 3.67 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.443 1.497 . . . . 0.0 113.558 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -58.23 148.06 64.21 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.907 0.883 . . . . 0.0 111.852 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.49 122.98 7.81 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.781 2.321 . . . . 0.0 112.246 -173.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 55.8 m -89.4 92.5 9.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.962 1.305 . . . . 0.0 109.573 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -152.37 127.73 9.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.274 1.03 . . . . 0.0 111.719 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.4 p -161.54 159.82 28.28 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.7 1.2 . . . . 0.0 113.403 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.8 tt -75.67 166.15 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.203 1.401 . . . . 0.0 112.441 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 19.9 m -115.39 161.49 18.46 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.199 1.4 . . . . 0.0 111.711 169.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -63.99 -39.36 93.95 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.616 -0.678 . . . . 0.0 112.132 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -58.8 -34.72 71.81 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -79.56 -38.77 33.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.759 1.624 . . . . 0.0 113.864 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.14 -41.62 97.11 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.768 1.227 . . . . 0.0 113.137 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -58.47 -23.32 57.47 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.637 1.575 . . . . 0.0 114.486 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.52 -18.43 64.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.611 1.164 . . . . 0.0 112.1 173.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -123.96 82.05 0.35 Allowed Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.986 2.232 . . . . 0.0 111.482 167.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -157.28 139.61 14.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.936 1.694 . . . . 0.0 109.346 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.8 pt -122.58 150.6 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 123.391 1.567 . . . . 0.0 115.002 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.6 m -78.58 160.86 27.38 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.796 2.039 . . . . 0.0 112.045 167.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -55.3 -30.05 59.41 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.371 -0.831 . . . . 0.0 112.092 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -65.1 -22.73 66.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.619 1.168 . . . . 0.0 113.826 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -93.06 -33.46 14.08 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.236 1.014 . . . . 0.0 111.24 168.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 37.8 ttm -59.59 -42.25 92.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 122.454 1.121 . . . . 0.0 111.574 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -85.96 33.79 0.6 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.587 1.555 . . . . 0.0 110.827 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.98 -41.24 0.35 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 128.099 2.56 . . . . 0.0 114.852 173.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.6 mp -66.88 136.83 55.98 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.354 1.062 . . . . 0.0 110.02 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 21.0 m -65.24 -34.33 78.1 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 169.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 17.5 m -59.0 -29.94 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 119.906 1.23 . . . . 0.0 112.704 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -101.68 11.16 39.31 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -19.17 49.48 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 47.3 t -142.57 -28.81 0.58 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.301 1.04 . . . . 0.0 113.015 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -71.72 146.52 48.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.2 1.4 . . . . 0.0 114.768 169.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 415' ' ' PRO . 0.8 OUTLIER -159.65 130.5 3.74 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 121.298 -0.876 . . . . 0.0 113.031 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 414' ' ' GLU . 6.8 Cg_exo -69.89 165.06 32.37 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 125.278 3.986 . . . . 0.0 114.66 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 143.86 -27.87 2.03 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.184 1.233 . . . . 0.0 116.184 152.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -72.42 139.67 81.54 Favored Pre-proline 0 CA--C 1.552 1.053 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -165.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.06 105.41 1.79 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.591 2.861 . . . . 0.0 112.988 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -134.17 150.52 51.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.689 1.995 . . . . 0.0 108.215 163.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 29.8 p -72.27 -2.18 18.05 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 38.7 mtm-85 -134.15 148.83 51.01 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.891 2.076 . . . . 0.0 110.082 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 4.4 pt -131.22 159.4 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.139 2.176 . . . . 0.0 110.456 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -128.86 158.48 38.62 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.32 139.58 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.512 1.525 . . . . 0.0 111.515 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -121.71 167.52 12.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.166 1.387 . . . . 0.0 110.116 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 31.4 t30 68.08 31.7 5.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.052 1.341 . . . . 0.0 112.859 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -66.64 145.95 55.02 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.41 -0.806 . . . . 0.0 110.617 173.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.24 163.61 12.51 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.49 1.516 . . . . 0.0 114.413 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -64.64 -47.98 76.5 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -71.42 -29.5 64.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.4 p -65.28 145.53 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -166.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -119.48 163.95 16.5 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.312 1.845 . . . . 0.0 111.906 170.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.36 -26.27 64.94 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.749 -1.219 . . . . 0.0 113.459 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -60.36 -37.03 79.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.656 1.182 . . . . 0.0 114.038 171.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -72.36 -26.93 62.1 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.87 1.268 . . . . 0.0 114.308 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -73.41 -21.47 60.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.229 1.812 . . . . 0.0 112.744 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -27.57 58.79 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.436 1.016 . . . . 0.0 112.585 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -60.99 -30.95 70.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.439 1.096 . . . . 0.0 111.56 -173.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.2 mp -104.48 -54.78 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.018 -1.051 . . . . 0.0 111.218 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -58.03 -27.68 63.78 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.24 -11.73 84.71 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 118.83 -0.983 . . . . 0.0 114.598 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -62.58 -30.99 71.73 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 120.792 2.296 . . . . 0.0 112.1 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -79.29 2.06 22.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.114 1.766 . . . . 0.0 112.858 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.58 136.22 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.35 1.86 . . . . 0.0 110.818 -172.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -79.73 119.64 22.92 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.898 -1.126 . . . . 0.0 108.056 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.329 49.5 m-85 -67.91 -16.91 64.29 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 167.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.0 t -94.03 -38.04 11.34 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.252 0.933 . . . . 0.0 113.469 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.1 m -83.27 118.62 23.77 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.394 -0.816 . . . . 0.0 111.588 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -57.89 -45.07 86.97 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.482 -0.761 . . . . 0.0 112.328 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.36 -16.02 1.98 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -89.75 -62.5 1.46 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.151 0.98 . . . . 0.0 110.562 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -68.39 -21.47 64.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.931 1.292 . . . . 0.0 113.295 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.74 -33.86 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.753 1.621 . . . . 0.0 112.261 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -93.85 3.13 55.86 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.938 1.295 . . . . 0.0 112.886 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -110.44 136.01 50.25 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.869 2.068 . . . . 0.0 115.81 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -166.53 152.31 8.4 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.411 1.885 . . . . 0.0 106.596 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 9.9 mt -126.11 137.32 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.238 1.015 . . . . 0.0 110.226 171.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 52.7 ttm-85 -125.3 133.8 52.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.115 0.966 . . . . 0.0 110.446 163.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.5 tp -118.15 124.1 47.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.582 1.553 . . . . 0.0 108.846 168.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 39.7 mtm -74.68 116.97 15.98 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.161 0.585 . . . . 0.0 110.083 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -103.0 5.28 38.15 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.014 1.726 . . . . 0.0 112.56 174.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -126.96 149.12 50.0 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.654 1.582 . . . . 0.0 112.952 -174.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.06 -156.51 52.01 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.241 1.4 . . . . 0.0 115.604 164.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -51.91 -34.47 41.64 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.305 1.442 . . . . 0.0 114.094 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 72.3 mtp -97.3 12.27 33.6 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -51.21 123.75 10.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.214 1.006 . . . . 0.0 111.448 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.03 31.47 31.82 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.586 1.565 . . . . 0.0 113.979 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -125.18 145.2 50.07 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.355 1.062 . . . . 0.0 112.224 169.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -135.15 156.05 49.66 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.938 1.295 . . . . 0.0 114.147 -169.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.8 132.8 52.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.585 1.954 . . . . 0.0 115.451 171.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.6 mp -132.34 122.07 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.891 1.676 . . . . 0.0 110.042 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.92 145.48 18.25 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 33.6 mt -126.3 158.96 65.09 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.012 1.325 . . . . 0.0 110.42 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -75.34 -9.08 20.17 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.418 2.745 . . . . 0.0 114.556 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -150.82 143.01 24.15 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.588 0.755 . . . . 0.0 111.388 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -59.01 -37.25 76.47 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.004 0.922 . . . . 0.0 111.803 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 18.6 mtmm -62.89 -35.88 81.48 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.85 92.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.411 0.55 . . . . 0.0 110.915 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -69.44 -44.44 71.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.247 0.93 . . . . 0.0 112.746 172.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.33 69.12 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.806 0.73 . . . . 0.0 112.122 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -75.48 -48.44 22.6 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.874 1.67 . . . . 0.0 113.069 170.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.78 70.33 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.845 0.748 . . . . 0.0 112.765 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.46 HD23 HG12 ' A' ' 498' ' ' VAL . 50.1 mt -68.67 -37.5 79.66 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.94 0.896 . . . . 0.0 112.178 174.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -65.3 -41.32 94.2 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.637 0.775 . . . . 0.0 111.463 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.9 -48.57 11.36 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -174.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.14 -16.74 59.03 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -63.75 107.4 1.18 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.025 0.93 . . . . 0.0 112.114 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 106.94 3.54 36.39 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.578 -1.123 . . . . 0.0 115.254 -174.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -71.57 112.99 8.13 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.184 1.492 . . . . 0.0 108.892 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.97 79.43 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.923 1.689 . . . . 0.0 108.029 -169.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 51.6 tp -79.05 132.83 36.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.058 1.743 . . . . 0.0 110.464 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.258 65.7 m-85 55.74 19.43 3.41 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -174.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 81.84 18.56 67.51 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.187 -1.341 . . . . 0.0 115.464 -171.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -128.42 120.64 21.03 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 119.833 1.816 . . . . 0.0 112.508 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.5 121.85 8.36 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 123.547 2.831 . . . . 0.0 112.305 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 38.6 mtp -79.14 132.0 36.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.828 1.251 . . . . 0.0 111.829 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.8 t -94.23 101.18 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.112 1.365 . . . . 0.0 109.816 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.46 HG12 HD23 ' A' ' 483' ' ' LEU . 2.4 t -97.15 127.3 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 126.716 2.006 . . . . 0.0 112.908 -173.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -146.3 161.35 40.5 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -64.26 143.56 57.8 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 121.038 -1.039 . . . . 0.0 108.962 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -55.39 142.23 33.25 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.084 0.953 . . . . 0.0 112.696 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -63.43 108.62 1.38 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.705 0.802 . . . . 0.0 111.603 -165.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 8.4 t -167.61 161.29 13.53 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.82 1.248 . . . . 0.0 111.143 -163.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -63.35 136.92 57.97 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.955 -1.091 . . . . 0.0 113.385 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -127.92 93.14 40.33 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 125.255 1.422 . . . . 0.0 110.139 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.33 164.67 28.64 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 124.213 3.275 . . . . 0.0 113.122 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -89.19 10.36 22.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.255 1.822 . . . . 0.0 114.747 175.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -59.62 149.36 30.55 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -59.7 148.61 74.8 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.99 145.67 22.42 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 122.757 2.304 . . . . 0.0 111.726 167.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.72 158.46 27.46 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.681 0.753 . . . . 0.0 112.85 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -87.41 151.17 23.29 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.492 1.117 . . . . 0.0 113.881 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 88.01 165.71 41.59 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.545 1.545 . . . . 0.0 115.781 170.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -158.25 153.29 25.36 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.388 1.875 . . . . 0.0 111.301 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 8.5 ptm85 -137.82 -14.78 1.39 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.251 1.162 0 C-N-CA 124.215 1.006 . . . . 0.0 112.93 -173.745 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 53.0 p . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 120.719 0.295 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -71.82 -3.44 22.21 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 168.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -126.03 14.93 7.92 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.367 1.867 . . . . 0.0 113.776 -165.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 75.9 mtp -65.93 131.71 94.61 Favored Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 121.176 -0.952 . . . . 0.0 111.561 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.3 142.58 41.61 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.105 2.536 . . . . 0.0 111.587 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 33.6 t -84.88 83.35 8.08 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 166.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -144.1 100.63 3.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.661 1.985 . . . . 0.0 108.55 -172.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 28.2 p -158.03 160.21 37.19 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -164.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.7 tt -76.6 161.05 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.268 1.427 . . . . 0.0 112.44 -170.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 18.5 m -114.33 162.33 16.76 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.821 1.649 . . . . 0.0 113.11 168.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -55.25 -43.26 74.45 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.809 0.844 . . . . 0.0 112.469 -172.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -61.76 -33.54 74.26 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -82.83 -37.21 24.73 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.779 0.832 . . . . 0.0 112.715 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.22 -42.16 96.71 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.404 1.082 . . . . 0.0 113.659 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.89 -24.0 48.79 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.635 1.574 . . . . 0.0 114.247 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -70.81 -13.0 61.88 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.979 1.712 . . . . 0.0 112.825 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -123.34 77.66 0.36 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 126.303 1.906 . . . . 0.0 112.63 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -161.39 142.69 11.44 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.386 1.075 . . . . 0.0 111.529 -174.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 20.7 pt -127.91 161.28 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.556 1.542 . . . . 0.0 112.2 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.9 m -110.7 179.36 4.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.144 1.378 . . . . 0.0 111.975 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 32.3 mtm105 -54.25 -27.3 33.92 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.267 -0.895 . . . . 0.0 113.292 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -58.67 -32.56 69.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.537 1.535 . . . . 0.0 112.672 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -98.93 -40.06 8.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.892 0.877 . . . . 0.0 111.209 168.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.88 -40.63 98.1 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.704 -1.248 . . . . 0.0 112.244 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -80.46 11.03 3.94 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 121.319 -0.863 . . . . 0.0 112.672 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.89 -27.08 5.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.584 2.353 . . . . 0.0 113.454 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 43.9 mt -77.51 135.87 38.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.305 1.442 . . . . 0.0 112.654 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 55.3 p -60.14 -34.26 73.28 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.048 0.939 . . . . 0.0 112.325 167.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.406 HG23 ' CD2' ' A' ' 410' ' ' PHE 0.255 1.8 m -67.32 -15.28 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 173.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.406 ' CD2' HG23 ' A' ' 409' ' ' VAL 0.356 83.2 m-85 -112.52 9.16 19.5 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 118.852 2.908 . . . . 0.0 118.852 178.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -57.78 0.11 0.06 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 118.51 2.781 . . . . 0.0 118.51 -172.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.4 m -157.25 8.98 0.18 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -132.59 132.13 42.2 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.36 -0.838 . . . . 0.0 109.353 -155.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -138.5 131.04 16.02 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -164.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -90.09 176.09 2.78 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 125.168 3.912 . . . . 0.0 115.006 175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.77 -10.02 72.81 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.657 1.599 . . . . 0.0 116.572 161.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.34 142.39 74.88 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 118.749 1.275 . . . . 0.0 113.45 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -85.71 60.86 5.19 Favored 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 124.86 3.707 . . . . 0.0 114.757 -166.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.504 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 34.0 t30 -96.5 151.29 19.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.08 0.952 . . . . 0.0 110.722 164.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.1 p -77.51 -4.05 43.62 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.504 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 77.5 mtt180 -130.64 149.31 52.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.454 1.502 . . . . 0.0 111.883 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 12.9 pt -134.92 161.73 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.755 2.022 . . . . 0.0 110.141 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -131.52 159.93 36.72 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.417 HG22 HG13 ' A' ' 498' ' ' VAL . 2.6 t -130.81 138.21 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.565 1.546 . . . . 0.0 112.425 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -122.25 168.94 11.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.37 1.468 . . . . 0.0 110.545 170.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 33.0 t30 68.05 40.37 2.25 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.914 1.685 . . . . 0.0 112.533 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.85 153.16 40.01 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.45 -0.782 . . . . 0.0 110.92 171.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.45 ' O ' HG12 ' A' ' 431' ' ' VAL . . . -67.7 154.36 41.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.928 1.291 . . . . 0.0 113.296 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -64.82 -36.31 83.93 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -77.3 -17.24 58.5 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 120.581 1.537 . . . . 0.0 115.097 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 428' ' ' ALA . 2.4 p -75.08 151.39 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -165.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -126.02 160.86 28.95 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.869 1.668 . . . . 0.0 111.216 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -53.98 -34.09 58.8 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.408 -1.433 . . . . 0.0 113.46 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -63.8 -20.38 65.74 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -77.51 -43.31 32.52 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.949 0.899 . . . . 0.0 111.72 166.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.1 mp -61.65 -31.29 71.39 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.389 1.075 . . . . 0.0 111.836 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . 0.521 ' HD2' HD12 ' A' ' 457' ' ' ILE . 1.5 mptm? -47.58 -36.89 11.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.267 1.427 . . . . 0.0 113.06 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -62.25 -35.02 77.67 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.027 0.931 . . . . 0.0 112.383 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 4.2 mt -96.26 -58.46 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 121.254 -0.904 . . . . 0.0 110.679 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -57.16 -29.93 64.05 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.16 -14.51 82.52 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 118.43 -1.206 . . . . 0.0 114.619 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -25.1 67.17 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.976 2.388 . . . . 0.0 112.022 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -81.21 5.38 17.17 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.238 1.815 . . . . 0.0 113.19 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 12.7 t -130.52 122.29 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.256 1.823 . . . . 0.0 110.668 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -76.32 103.66 6.44 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -58.44 -16.24 14.18 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 t -82.89 -15.95 49.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.151 0.98 . . . . 0.0 113.021 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 36.1 t -111.24 120.04 40.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.558 1.143 . . . . 0.0 111.617 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -58.02 -48.76 79.09 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.587 -0.696 . . . . 0.0 112.032 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.63 -14.87 2.4 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -92.82 -63.91 1.16 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.851 1.261 . . . . 0.0 110.075 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -25.49 67.92 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.561 1.544 . . . . 0.0 113.361 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.8 tt -57.89 -37.96 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.24 1.416 . . . . 0.0 111.995 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.4 mmm -89.2 0.29 56.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.991 1.716 . . . . 0.0 113.259 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -109.57 132.39 54.19 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -164.43 144.67 7.81 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.527 1.531 . . . . 0.0 111.074 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.521 HD12 ' HD2' ' A' ' 437' ' ' LYS . 5.1 mt -123.81 140.01 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 119.419 1.009 . . . . 0.0 111.373 169.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -121.03 134.54 55.29 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.596 1.558 . . . . 0.0 107.945 154.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 32.1 tp -107.65 91.13 3.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.719 1.247 . . . . 0.0 108.097 166.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -59.43 123.7 17.64 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.66 1.584 . . . . 0.0 110.782 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . 0.304 51.5 mtmt -129.71 35.47 4.18 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -174.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -133.07 148.18 52.19 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.092 0.957 . . . . 0.0 113.565 174.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 69.62 -177.41 30.3 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.58 1.562 . . . . 0.0 114.266 -173.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -15.92 49.26 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.811 -1.406 . . . . 0.0 113.597 177.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 73.4 mtm -87.07 11.2 14.36 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.785 1.634 . . . . 0.0 113.698 171.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -64.83 152.31 43.18 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 119.555 -1.966 . . . . 0.0 111.819 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.35 26.13 52.59 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.152 0.882 . . . . 0.0 112.726 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -121.48 147.37 45.85 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.301 1.041 . . . . 0.0 110.265 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -133.39 148.98 51.84 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -172.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -107.13 139.56 41.37 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 162.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.4 mp -136.88 124.11 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.721 1.208 . . . . 0.0 109.865 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -92.68 146.63 18.24 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 162.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 24.2 mt -126.16 159.61 61.45 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.211 1.404 . . . . 0.0 111.347 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.55 -7.89 19.01 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.991 2.46 . . . . 0.0 115.317 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -150.55 147.59 27.65 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.643 1.177 . . . . 0.0 110.322 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -56.98 -38.98 73.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.564 1.146 . . . . 0.0 111.626 170.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.48 -42.04 95.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.113 0.965 . . . . 0.0 112.878 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.39 -40.39 96.32 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.19 -0.433 . . . . 0.0 111.592 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.98 -44.6 72.57 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.172 0.896 . . . . 0.0 112.832 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.22 83.84 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.869 0.758 . . . . 0.0 111.141 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -64.45 -48.95 73.37 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.154 1.382 . . . . 0.0 112.23 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.11 -32.34 70.9 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.653 HD23 HG12 ' A' ' 498' ' ' VAL . 58.1 mt -68.7 -45.6 71.19 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.105 -0.997 . . . . 0.0 111.341 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -63.22 -33.78 76.23 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.556 0.617 . . . . 0.0 111.837 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.3 -48.0 11.71 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.73 -18.24 45.01 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.21 105.59 1.13 Allowed 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.843 -1.16 . . . . 0.0 110.194 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 111.44 6.05 25.73 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 117.541 -1.7 . . . . 0.0 116.061 -172.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -73.34 126.85 31.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.07 1.935 . . . . 0.0 110.749 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 1.7 t -101.19 48.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 127.002 2.121 . . . . 0.0 114.298 -163.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.8 tp -48.84 123.68 7.36 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.186 1.395 . . . . 0.0 110.308 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.352 62.4 t80 63.92 -2.7 0.52 Allowed 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 107.24 -5.31 35.81 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 125.773 1.654 . . . . 0.0 114.134 -166.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -104.41 119.4 54.0 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 127.686 2.394 . . . . 0.0 111.14 -174.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -79.77 114.88 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.235 2.623 . . . . 0.0 113.137 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 66.5 mtp -73.21 131.32 41.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.112 1.365 . . . . 0.0 112.572 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 56.5 t -91.08 91.0 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.004 1.722 . . . . 0.0 109.38 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.653 HG12 HD23 ' A' ' 483' ' ' LEU . 2.4 t -91.3 125.81 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.93 1.692 . . . . 0.0 111.9 -177.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -142.12 155.94 45.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.671 1.188 . . . . 0.0 113.816 -169.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -63.28 147.35 51.3 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.299 -0.876 . . . . 0.0 112.423 166.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -58.52 157.96 8.28 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -175.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -87.92 -33.68 18.4 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.289 1.436 . . . . 0.0 114.496 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 4.7 t -92.46 19.55 7.12 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.595 1.558 . . . . 0.0 112.576 173.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -61.32 140.82 57.92 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.542 1.137 . . . . 0.0 111.867 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 48.1 ttm-85 -149.14 61.3 5.27 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 124.548 1.139 . . . . 0.0 110.276 167.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.7 151.57 74.66 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.234 2.623 . . . . 0.0 112.954 -171.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -145.82 138.15 25.51 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.69 1.596 . . . . 0.0 110.42 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -82.84 154.54 24.61 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.264 0.626 . . . . 0.0 111.515 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -54.76 146.7 35.04 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 160.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -68.34 167.93 20.9 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.744 2.296 . . . . 0.0 112.138 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.71 178.72 4.59 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.119 0.962 . . . . 0.0 112.966 173.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -123.47 157.68 32.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.392 1.877 . . . . 0.0 110.391 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -70.88 144.5 38.28 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 121.288 -0.883 . . . . 0.0 113.462 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -63.35 141.64 58.69 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.944 1.298 . . . . 0.0 112.317 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -146.09 -19.06 0.45 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -174.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 85.2 tttt . . . . . 0 C--O 1.255 1.362 0 C-N-CA 128.136 2.574 . . . . 0.0 109.502 -174.259 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 88.8 p . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 120.908 0.385 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 23.0 p30 -151.02 -57.91 0.16 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -173.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -150.32 -39.11 0.14 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 128.256 2.622 . . . . 0.0 111.797 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . 0.251 3.4 ptm 67.45 142.41 0.08 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 130.778 3.631 . . . . 0.0 115.114 -175.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.96 144.82 93.64 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.421 2.747 . . . . 0.0 111.925 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 71.2 m -152.15 139.57 19.53 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -148.35 89.06 1.68 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.76 1.624 . . . . 0.0 107.838 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 7.8 p -152.52 155.29 37.16 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.669 1.588 . . . . 0.0 113.333 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.3 tt -75.85 153.16 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.923 0.889 . . . . 0.0 111.994 -163.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 60.4 m -89.05 153.25 21.15 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.405 0.682 . . . . 0.0 110.349 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -61.71 -35.05 76.92 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 118.175 -0.917 . . . . 0.0 112.629 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -41.5 79.63 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 170.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -74.13 -34.31 63.85 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.976 1.311 . . . . 0.0 112.714 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.5 tt -66.76 -50.97 60.99 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.164 1.386 . . . . 0.0 111.661 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -57.62 -26.57 61.74 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.854 1.662 . . . . 0.0 114.792 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -46.61 80.43 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.273 1.029 . . . . 0.0 109.908 171.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -92.63 59.59 2.52 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 127.636 2.541 . . . . 0.0 112.511 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -150.14 157.06 42.72 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.876 1.27 . . . . 0.0 109.837 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.7 pt -136.98 162.57 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.95 1.7 . . . . 0.0 110.791 176.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.7 m -110.09 170.41 8.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.481 1.912 . . . . 0.0 111.154 172.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -43.67 -45.77 7.09 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -170.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.45 -26.0 68.53 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.01 -30.78 20.97 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.306 -0.871 . . . . 0.0 111.55 169.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 13.9 ttm -66.18 -27.53 68.07 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.424 -1.422 . . . . 0.0 113.248 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -85.58 0.88 51.27 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.2 -35.27 6.88 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.25 2.22 . . . . 0.0 116.857 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 3.5 mp -72.83 133.96 44.68 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.261 1.025 . . . . 0.0 111.908 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 78.3 p -62.41 -18.61 62.05 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 173.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.2 m -88.17 -10.84 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -122.83 -10.49 8.25 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -34.73 56.58 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.754 -1.216 . . . . 0.0 113.875 173.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 23.7 p -113.42 -3.58 13.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.286 2.235 . . . . 0.0 114.641 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -134.87 114.44 12.57 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.02 1.728 . . . . 0.0 113.681 -167.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -130.52 120.12 18.68 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -159.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.13 164.76 30.8 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 124.313 3.342 . . . . 0.0 113.114 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 116.28 -1.53 20.72 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 117.075 1.59 . . . . 0.0 117.075 163.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -78.2 145.56 69.13 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.948 1.374 . . . . 0.0 113.992 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.94 103.92 1.78 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.092 3.195 . . . . 0.0 112.015 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -143.13 147.28 34.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.752 1.221 . . . . 0.0 108.515 166.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 19.7 p -81.02 5.76 15.5 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.889 -1.132 . . . . 0.0 113.389 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -137.26 148.71 46.62 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.482 1.913 . . . . 0.0 110.604 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.0 164.65 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 126.678 1.991 . . . . 0.0 109.524 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -136.98 164.44 28.35 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.3 p -143.66 142.33 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.06 1.344 . . . . 0.0 111.543 -176.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -118.77 171.03 8.49 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.745 2.018 . . . . 0.0 110.519 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 72.51 25.62 2.67 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.01 157.13 37.4 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.831 -1.168 . . . . 0.0 111.115 172.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -62.46 158.84 16.82 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.425 1.09 . . . . 0.0 113.548 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -68.28 -33.61 74.66 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.507 -0.746 . . . . 0.0 112.445 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -81.47 -40.56 23.09 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.14 155.78 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.884 1.673 . . . . 0.0 115.034 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -128.68 162.09 28.16 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.001 1.32 . . . . 0.0 112.837 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -33.8 57.69 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.81 -1.181 . . . . 0.0 113.237 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -58.05 -34.29 69.93 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.841 1.256 . . . . 0.0 114.213 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -77.46 -29.97 53.0 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -174.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.59 -20.73 66.43 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.923 1.689 . . . . 0.0 112.955 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.75 -17.23 21.29 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.351 0.978 . . . . 0.0 113.233 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -62.64 -36.72 83.73 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.557 1.143 . . . . 0.0 111.613 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 7.2 mt -105.97 -58.09 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.442 0.697 . . . . 0.0 110.089 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -54.67 -36.95 65.17 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.92 -10.58 85.06 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.939 0.781 . . . . 0.0 114.54 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -62.31 -29.11 70.2 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.584 1.692 . . . . 0.0 111.009 172.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -82.76 1.16 40.24 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.047 1.739 . . . . 0.0 115.533 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 32.1 t -132.12 132.14 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.03 1.732 . . . . 0.0 110.12 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -90.14 106.2 18.33 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.68 -0.637 . . . . 0.0 111.964 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -58.39 -18.17 25.96 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 92.3 p -77.52 -21.65 52.35 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 22.7 t -109.09 118.23 36.22 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.578 0.704 . . . . 0.0 110.974 -165.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -58.83 -51.07 71.56 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.307 0.643 . . . . 0.0 112.268 -170.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.37 -16.19 13.65 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.944 2.201 . . . . 0.0 116.944 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -85.65 -58.83 2.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.538 0.685 . . . . 0.0 109.966 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 15.0 ptt85 -75.62 -23.95 56.43 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.624 1.169 . . . . 0.0 113.662 -171.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.7 tt -54.01 -35.17 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.042 1.337 . . . . 0.0 112.442 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.3 mmm -86.07 -10.64 54.6 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.569 1.148 . . . . 0.0 112.83 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.86 109.04 20.85 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -169.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -154.08 149.49 27.21 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.161 1.384 . . . . 0.0 109.946 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 11.4 mt -128.98 134.64 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.372 1.469 . . . . 0.0 110.882 -173.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -116.6 145.33 43.45 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.764 1.226 . . . . 0.0 109.836 158.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.3 tp -125.21 120.22 30.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.943 2.097 . . . . 0.0 109.313 168.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 47.1 mtm -73.19 135.3 44.59 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 125.029 1.332 . . . . 0.0 110.851 166.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -134.12 -4.42 2.74 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -170.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.89 144.64 47.3 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.566 1.546 . . . . 0.0 111.36 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 60.47 -165.17 14.0 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.94 1.257 . . . . 0.0 114.412 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -19.29 48.53 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 96.0 mmm -85.87 1.68 48.89 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -58.98 149.66 26.71 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.651 1.114 . . . . 0.0 112.097 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 76.36 17.74 79.73 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.934 1.254 . . . . 0.0 112.952 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -114.33 134.21 55.12 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 123.803 0.841 . . . . 0.0 113.112 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -135.53 150.89 49.88 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -109.05 141.88 40.56 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.326 1.85 . . . . 0.0 114.013 167.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.4 mp -138.88 127.02 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.358 1.463 . . . . 0.0 109.872 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -91.93 146.87 18.47 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.522 -0.736 . . . . 0.0 112.167 165.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 39.7 mt -127.32 158.24 70.08 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.052 1.341 . . . . 0.0 110.927 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -74.22 -6.31 18.23 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.883 2.389 . . . . 0.0 114.737 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -153.28 146.01 24.31 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.249 -0.907 . . . . 0.0 111.153 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -65.39 -30.16 70.95 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.213 1.005 . . . . 0.0 111.523 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -63.94 -44.71 92.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.746 0.818 . . . . 0.0 113.014 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -60.74 -39.07 87.31 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.11 -0.472 . . . . 0.0 111.374 174.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.35 -47.51 76.18 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.089 0.859 . . . . 0.0 112.595 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.39 80.95 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.782 1.174 . . . . 0.0 112.174 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -67.71 -51.91 43.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.396 1.078 . . . . 0.0 112.164 175.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.48 70.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.953 0.501 . . . . 0.0 112.224 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.535 HD23 HG12 ' A' ' 498' ' ' VAL . 60.9 mt -69.0 -51.08 43.11 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.286 -0.884 . . . . 0.0 111.427 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -68.0 -14.91 63.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.865 0.866 . . . . 0.0 112.412 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -94.74 -50.79 5.0 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.705 1.602 . . . . 0.0 115.114 168.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.19 -19.72 42.71 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -173.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.32 100.82 0.86 Allowed 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.978 -1.076 . . . . 0.0 109.35 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 127.15 -5.97 7.26 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.313 -1.27 . . . . 0.0 114.912 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -72.31 129.63 38.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.257 1.529 . . . . 0.0 112.766 -170.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 3.3 t -96.03 110.25 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.444 1.097 . . . . 0.0 112.164 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 44.6 tp -121.22 141.82 50.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.536 1.934 . . . . 0.0 108.105 169.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.421 28.5 t80 61.77 17.83 9.13 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 73.54 15.59 79.16 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.332 1.444 . . . . 0.0 114.272 -168.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -127.4 133.39 25.03 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.165 1.386 . . . . 0.0 112.328 -170.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.36 120.27 6.85 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.182 2.588 . . . . 0.0 112.266 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 66.2 mtp -75.65 129.91 37.91 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.737 1.615 . . . . 0.0 112.089 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.09 73.5 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -171.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.535 HG12 HD23 ' A' ' 483' ' ' LEU . 1.4 t -76.56 120.51 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.294 1.038 . . . . 0.0 112.765 -175.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -142.3 161.39 38.15 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.433 1.493 . . . . 0.0 112.92 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -61.53 144.3 54.52 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -55.69 149.79 13.69 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -172.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -75.61 -7.24 53.76 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 12.5 m -58.42 163.11 3.26 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.994 2.117 . . . . 0.0 112.377 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -63.76 102.81 0.49 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.762 0.825 . . . . 0.0 112.141 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -151.27 96.85 3.2 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 126.464 1.906 . . . . 0.0 109.572 -174.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.15 136.26 59.42 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.173 2.582 . . . . 0.0 112.896 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -85.5 137.9 32.58 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.197 0.999 . . . . 0.0 111.74 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -163.23 155.05 17.64 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.88 2.072 . . . . 0.0 111.235 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -53.01 154.44 5.2 Favored Pre-proline 0 CA--C 1.559 1.289 0 C-N-CA 127.486 2.314 . . . . 0.0 116.7 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.35 172.65 15.66 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 124.274 3.316 . . . . 0.0 115.603 -166.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 150.69 21.52 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.599 1.559 . . . . 0.0 114.19 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -79.81 177.02 9.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.677 1.591 . . . . 0.0 113.635 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 78.82 -133.01 12.06 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.361 -0.837 . . . . 0.0 114.94 166.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -147.56 160.93 42.08 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.317 2.247 . . . . 0.0 112.546 -171.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 59.72 28.11 17.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.041 2.136 . . . . 0.0 115.592 170.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 24.5 tptp . . . . . 0 C--O 1.251 1.142 0 C-N-CA 126.671 1.988 . . . . 0.0 111.714 179.878 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -59.6 -20.48 56.14 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -70.1 -27.84 64.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.502 1.521 . . . . 0.0 113.867 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 94.6 mtp -81.77 149.91 64.82 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.783 1.233 . . . . 0.0 112.518 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.96 152.91 46.93 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.289 2.659 . . . . 0.0 112.979 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 94.7 p -93.93 131.31 39.49 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.261 1.424 . . . . 0.0 111.163 168.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -153.03 126.49 8.71 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.344 1.458 . . . . 0.0 109.11 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.3 p -146.56 159.04 43.95 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -170.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.5 tt -76.64 148.29 7.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.974 1.71 . . . . 0.0 110.122 -172.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 39.9 t -80.0 151.1 30.19 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.345 0.593 . . . . 0.0 110.197 164.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -47.23 -43.86 22.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.729 161.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -64.94 -30.05 71.02 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -75.27 -46.09 35.87 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.916 0.886 . . . . 0.0 112.865 167.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 27.5 tp -63.74 -38.19 90.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.749 1.62 . . . . 0.0 112.606 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -57.01 -24.26 52.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.084 1.354 . . . . 0.0 114.261 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -68.46 -20.66 64.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.374 1.07 . . . . 0.0 113.073 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.87 68.7 0.32 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.198 1.856 . . . . 0.0 111.814 174.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -159.23 136.56 9.84 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.048 1.339 . . . . 0.0 109.976 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.9 pt -112.6 150.75 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.682 0.793 . . . . 0.0 111.099 174.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 30.8 m -74.78 160.85 30.19 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.707 1.203 . . . . 0.0 111.666 163.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.38 -25.79 60.06 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.133 -0.979 . . . . 0.0 112.751 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.25 -28.79 69.0 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.113 1.365 . . . . 0.0 113.215 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.35 -30.64 23.51 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.692 -1.255 . . . . 0.0 110.72 167.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 27.3 ttp -62.8 -37.53 87.1 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 120.984 -1.072 . . . . 0.0 111.207 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -84.05 34.57 0.51 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.356 1.462 . . . . 0.0 111.889 170.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.78 -31.42 0.43 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.434 2.294 . . . . 0.0 114.142 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 11.3 mt -74.0 131.92 41.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.002 1.321 . . . . 0.0 111.596 174.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 98.2 p -65.96 -27.67 68.33 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.215 1.406 . . . . 0.0 112.383 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.16 -19.99 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.195 -0.94 . . . . 0.0 112.782 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.261 51.7 m-85 -113.91 12.29 18.07 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 119.133 3.012 . . . . 0.0 119.133 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -14.24 62.62 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 46.7 t -136.73 -39.46 0.63 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.172 1.389 . . . . 0.0 113.227 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -73.29 144.67 46.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -132.95 126.9 19.95 Favored Pre-proline 0 N--CA 1.478 0.948 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -163.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -84.79 -176.69 2.56 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.503 3.468 . . . . 0.0 113.132 164.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 83.41 -26.74 4.39 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.787 1.661 . . . . 0.0 116.712 164.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -60.41 140.83 91.81 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 117.828 0.814 . . . . 0.0 112.999 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.26 104.41 1.9 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.25 3.3 . . . . 0.0 112.826 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -150.25 144.52 25.64 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.373 1.069 . . . . 0.0 110.129 161.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 27.9 p -77.55 8.55 4.19 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.719 -1.238 . . . . 0.0 114.118 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -139.08 142.57 38.13 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.525 1.93 . . . . 0.0 109.463 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 10.7 pt -131.67 165.25 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 126.539 1.936 . . . . 0.0 109.125 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -132.08 162.05 31.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 123.285 1.517 . . . . 0.0 107.994 164.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 498' ' ' VAL . 9.7 t -124.18 136.9 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 126.035 1.734 . . . . 0.0 109.952 175.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -115.9 165.84 12.64 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.335 1.454 . . . . 0.0 109.06 169.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 5.6 t30 66.0 35.09 6.59 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.08 0.552 . . . . 0.0 111.731 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -69.62 154.18 42.37 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.286 -0.884 . . . . 0.0 109.938 162.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -56.12 154.7 7.4 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.047 0.939 . . . . 0.0 111.873 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -74.84 -37.75 62.17 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.385 -0.822 . . . . 0.0 111.638 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -70.33 -41.79 72.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.027 1.731 . . . . 0.0 114.124 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.8 p -55.39 148.05 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -112.16 161.65 16.32 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.643 1.177 . . . . 0.0 113.057 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -56.51 -29.62 62.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.475 1.11 . . . . 0.0 113.277 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -64.48 -36.18 83.35 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 174.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.27 -30.79 68.98 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.319 1.448 . . . . 0.0 113.762 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.83 -19.93 62.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.996 1.718 . . . . 0.0 112.633 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.4 -26.49 63.3 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.383 0.992 . . . . 0.0 112.579 176.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -57.98 -37.55 74.42 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.429 0.558 . . . . 0.0 110.917 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.4 mt -95.16 -59.43 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.184 -0.948 . . . . 0.0 111.711 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -58.62 -29.56 66.59 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.04 -16.05 81.09 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.271 0.939 . . . . 0.0 114.469 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -14.32 62.02 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 119.879 1.84 . . . . 0.0 112.817 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -86.66 -4.77 59.22 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.873 2.069 . . . . 0.0 115.633 172.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.18 125.24 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.908 1.683 . . . . 0.0 110.83 -166.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -78.6 105.12 9.67 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.753 -0.592 . . . . 0.0 110.439 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -60.18 -10.83 4.94 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 70.2 m -93.9 -6.67 45.1 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.294 1.038 . . . . 0.0 113.709 172.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 40.0 t -115.22 115.61 26.98 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.345 1.058 . . . . 0.0 110.536 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -58.92 -48.49 81.28 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.721 0.808 . . . . 0.0 112.385 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.1 t -56.79 -16.63 6.92 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -87.9 -60.7 1.9 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.576 0.75 . . . . 0.0 110.03 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.6 ptt85 -72.17 -22.96 61.22 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.139 0.976 . . . . 0.0 112.971 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 18.7 tt -54.83 -41.68 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.824 1.25 . . . . 0.0 112.093 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.8 mtm -83.43 -6.85 59.59 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.761 0.71 . . . . 0.0 112.33 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -100.79 126.4 47.36 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -164.16 151.5 12.02 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.941 2.096 . . . . 0.0 108.28 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 10.5 mt -125.41 134.7 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.757 1.223 . . . . 0.0 110.538 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -133.72 90.3 2.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.899 0.88 . . . . 0.0 112.842 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.02 125.57 31.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.178 1.791 . . . . 0.0 111.273 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 34.9 mtm -79.31 127.01 31.54 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.835 2.454 . . . . 0.0 111.39 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -118.36 -3.41 10.98 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.725 1.61 . . . . 0.0 115.225 -173.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -130.37 148.57 52.21 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.653 1.181 . . . . 0.0 112.768 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 70.34 -159.21 53.57 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.771 1.177 . . . . 0.0 115.046 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -33.13 73.01 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.588 1.155 . . . . 0.0 113.521 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 73.3 mtm -85.96 12.41 9.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -54.81 106.34 0.21 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.157 0.889 . . . . 0.0 110.53 168.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.47 27.23 7.73 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.362 1.458 . . . . 0.0 115.401 -172.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -113.62 154.64 26.86 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.608 1.204 . . . . 0.0 110.131 163.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.57 139.69 21.12 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.462 -1.399 . . . . 0.0 113.973 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -90.68 144.24 25.94 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 166.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.72 122.58 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.118 1.767 . . . . 0.0 110.136 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.0 145.51 17.63 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 164.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 26.1 mt -126.93 156.3 74.29 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.794 1.238 . . . . 0.0 110.867 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.16 -4.32 15.19 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.578 2.852 . . . . 0.0 114.838 -173.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -153.88 130.87 10.99 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.461 1.104 . . . . 0.0 110.564 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -52.9 -38.49 61.8 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.1 1.36 . . . . 0.0 112.507 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -32.64 74.18 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.33 -37.49 74.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.117 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.54 72.31 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.41 1.004 . . . . 0.0 112.151 171.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.7 71.14 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 118.738 0.699 . . . . 0.0 111.914 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -69.9 -48.51 58.34 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.509 1.124 . . . . 0.0 112.96 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.2 -31.34 71.1 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.7 -0.625 . . . . 0.0 112.359 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.68 HD23 HG12 ' A' ' 498' ' ' VAL . 76.8 mt -67.31 -36.96 82.57 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.35 -0.844 . . . . 0.0 112.33 173.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -67.21 -33.1 74.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.601 0.76 . . . . 0.0 111.686 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -93.85 -34.05 13.3 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -170.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -91.01 -13.85 32.52 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.091 1.356 . . . . 0.0 113.931 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -65.3 105.94 1.24 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.212 1.005 . . . . 0.0 110.36 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 111.64 0.7 27.58 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.495 -1.17 . . . . 0.0 115.876 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -73.04 129.33 37.85 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 4.9 p -128.38 67.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 124.171 1.938 . . . . 0.0 109.521 -163.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.32 127.67 33.16 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 113.235 -1.802 . . . . 0.0 110.594 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.43 11.2 m-85 58.8 24.44 12.35 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 74.82 3.92 69.51 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.691 1.139 . . . . 0.0 114.422 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -95.37 104.4 15.43 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.025 1.73 . . . . 0.0 108.816 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.75 110.99 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.376 2.051 . . . . 0.0 110.025 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 28.0 mtp -74.13 124.06 25.62 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.748 1.619 . . . . 0.0 111.841 -169.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 97.1 t -90.26 91.92 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.736 1.614 . . . . 0.0 109.492 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.68 HG12 HD23 ' A' ' 483' ' ' LEU . 2.2 t -87.75 123.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 126.12 1.768 . . . . 0.0 112.323 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -153.67 152.19 30.54 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -164.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -61.4 150.14 36.27 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.737 -1.227 . . . . 0.0 111.153 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -59.22 154.13 16.92 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -68.15 25.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 128.835 2.854 . . . . 0.0 118.518 -158.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 3.6 t -62.38 147.55 48.11 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.778 -1.201 . . . . 0.0 111.228 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -59.29 115.96 3.58 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.415 0.686 . . . . 0.0 112.698 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -160.04 106.62 1.41 Allowed Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 126.144 1.778 . . . . 0.0 110.512 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -65.05 -179.69 1.13 Allowed 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 123.731 2.954 . . . . 0.0 112.819 170.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -69.34 62.03 0.14 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.283 -0.886 . . . . 0.0 111.641 157.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -91.71 151.14 20.78 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.753 2.021 . . . . 0.0 109.621 165.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.55 142.23 83.68 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.9 -37.15 95.17 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.917 3.078 . . . . 0.0 114.223 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.17 169.53 21.09 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.921 1.289 . . . . 0.0 110.395 162.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -75.88 -50.5 14.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.365 1.066 . . . . 0.0 113.738 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -95.76 140.3 14.97 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.795 1.188 . . . . 0.0 115.294 -169.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -121.01 146.98 46.12 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.832 1.653 . . . . 0.0 111.796 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.8 -32.18 0.58 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.679 1.192 . . . . 0.0 113.373 174.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 38.3 pttt . . . . . 0 C--O 1.256 1.424 0 C-N-CA 124.544 1.137 . . . . 0.0 112.428 177.936 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -75.73 -16.76 60.1 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -159.47 174.3 14.89 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.2 1.4 . . . . 0.0 112.556 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 55.4 54.87 9.96 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.522 1.929 . . . . 0.0 116.129 175.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.04 156.94 63.68 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.814 3.009 . . . . 0.0 111.348 169.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 64.1 p -148.2 151.16 35.04 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -141.17 140.14 33.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.616 1.567 . . . . 0.0 108.761 164.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 11.1 p -149.15 163.14 38.45 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -171.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 4.5 tt -74.33 149.63 7.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 125.692 1.597 . . . . 0.0 111.313 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 17.7 m -86.55 152.11 22.91 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -63.36 -29.63 70.9 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.322 -0.861 . . . . 0.0 110.75 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -34.85 75.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.719 1.607 . . . . 0.0 114.64 174.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -78.58 -48.28 15.5 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.397 0.679 . . . . 0.0 111.636 170.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 16.5 tp -57.53 -37.66 73.4 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -57.41 -25.65 59.9 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.124 1.37 . . . . 0.0 113.941 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -73.99 -20.07 60.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.859 1.264 . . . . 0.0 112.506 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -120.36 63.94 0.47 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.532 2.015 . . . . 0.0 112.327 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -151.14 143.59 24.24 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.738 1.615 . . . . 0.0 110.006 -176.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 18.2 pt -125.04 163.08 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 44.6 t -110.54 172.43 6.87 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.691 1.596 . . . . 0.0 110.36 165.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 32.5 mtt-85 -49.96 -30.42 10.38 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.852 1.261 . . . . 0.0 113.899 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.25 -13.79 21.23 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 125.989 1.715 . . . . 0.0 113.187 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -123.1 -37.3 2.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.051 1.74 . . . . 0.0 112.289 167.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 53.7 ttp -61.18 -40.17 92.9 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.707 -1.246 . . . . 0.0 111.551 -176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.24 2.36 28.26 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.461 -0.774 . . . . 0.0 112.177 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.59 -34.28 10.29 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.415 2.286 . . . . 0.0 113.771 169.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 29.8 mt -77.88 129.07 34.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.363 1.865 . . . . 0.0 113.06 -174.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 88.4 p -58.17 -33.31 69.1 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.168 -0.958 . . . . 0.0 113.58 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.448 HG23 ' CD2' ' A' ' 410' ' ' PHE . 3.4 m -64.07 -12.64 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.448 ' CD2' HG23 ' A' ' 409' ' ' VAL . 83.9 m-85 -125.64 14.89 8.14 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -61.28 -23.42 65.67 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.9 t -135.85 -16.15 1.75 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.096 0.958 . . . . 0.0 113.292 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -71.88 144.31 49.07 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -141.45 124.59 9.75 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -169.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.32 -176.49 3.29 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.785 2.99 . . . . 0.0 112.841 171.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.512 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 76.15 -4.83 45.68 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.779 1.872 . . . . 0.0 117.779 165.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -72.38 148.13 90.58 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 118.98 1.39 . . . . 0.0 113.384 174.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.39 110.58 3.13 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.775 2.983 . . . . 0.0 113.872 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.482 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 40.6 t30 -157.01 154.77 30.13 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.254 1.822 . . . . 0.0 109.478 161.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 27.4 p -80.43 -3.52 50.15 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.482 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 69.9 mtt180 -130.64 150.85 51.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.931 1.692 . . . . 0.0 110.408 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.4 pt -131.06 160.99 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.387 1.875 . . . . 0.0 109.965 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -135.11 162.09 33.48 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 173.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.9 t -136.35 135.36 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 125.673 1.589 . . . . 0.0 112.056 -174.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -117.61 169.03 9.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.44 1.896 . . . . 0.0 108.395 168.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.26 13.1 m-20 68.13 29.73 6.1 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -171.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.66 143.43 40.11 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 119.868 -1.77 . . . . 0.0 110.535 166.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.52 25.82 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 118.418 2.747 . . . . 0.0 118.418 -165.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp 59.58 -65.6 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 128.703 2.801 . . . . 0.0 113.863 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -58.16 -41.38 83.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.325 1.85 . . . . 0.0 113.89 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 9.1 p -51.12 140.76 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.291 1.037 . . . . 0.0 113.526 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -104.12 157.76 16.9 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.061 0.945 . . . . 0.0 113.102 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -61.02 -26.78 67.85 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.797 -1.814 . . . . 0.0 112.77 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -70.7 -22.05 62.5 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -74.41 -33.82 63.1 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.524 1.129 . . . . 0.0 112.97 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.6 mp -73.64 -23.79 59.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.193 1.797 . . . . 0.0 113.733 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . 0.424 ' HD3' HD12 ' A' ' 457' ' ' ILE . 26.9 mmtp -56.59 -28.78 61.11 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 118.842 0.747 . . . . 0.0 110.876 -177.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -57.68 -33.22 68.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.758 1.623 . . . . 0.0 111.854 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.7 mt -98.33 -58.24 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.361 -0.837 . . . . 0.0 110.795 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -59.59 -25.91 64.99 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -80.74 -7.61 88.38 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.766 1.174 . . . . 0.0 114.379 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 36.7 ttp85 -61.03 -23.8 65.69 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.946 1.873 . . . . 0.0 112.049 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -95.72 2.16 53.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.026 2.131 . . . . 0.0 112.594 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.8 110.39 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.035 1.734 . . . . 0.0 110.701 -172.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -71.41 90.17 0.95 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.281 53.7 m-85 -58.32 -24.05 58.46 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 119.307 3.077 . . . . 0.0 119.307 -171.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.5 m -64.96 -22.48 67.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 17.4 m -101.08 122.66 43.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.122 1.369 . . . . 0.0 112.816 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -55.65 -48.46 74.97 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.453 -0.78 . . . . 0.0 112.181 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 2.8 t -54.05 -18.01 3.21 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -88.21 -63.64 1.27 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.592 0.757 . . . . 0.0 110.778 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -65.08 -29.57 70.46 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.696 1.198 . . . . 0.0 112.2 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.0 tt -58.02 -32.92 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.246 1.419 . . . . 0.0 112.679 173.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 9.1 mmm -84.93 -10.25 57.27 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.097 0.959 . . . . 0.0 112.499 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -105.85 135.03 48.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.136 1.774 . . . . 0.0 115.092 -172.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -168.0 145.16 4.2 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.984 1.314 . . . . 0.0 108.464 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.424 HD12 ' HD3' ' A' ' 437' ' ' LYS . 6.3 mt -117.13 132.52 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.738 1.215 . . . . 0.0 110.087 174.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -121.23 122.8 40.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.695 1.198 . . . . 0.0 109.976 166.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 3.3 tt -107.58 123.52 48.57 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.145 1.378 . . . . 0.0 110.352 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 45.7 mtm -79.88 130.51 35.36 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.117 1.367 . . . . 0.0 111.973 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -118.04 -7.03 10.9 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.851 1.66 . . . . 0.0 114.472 -168.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -117.25 154.67 30.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.533 1.133 . . . . 0.0 112.061 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 57.89 -142.12 44.28 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 161.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 29.0 tpt85 -57.67 -31.56 66.44 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.01 2.124 . . . . 0.0 115.11 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 20.8 mtm -111.44 18.79 18.83 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.065 1.346 . . . . 0.0 113.791 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -57.5 112.53 1.45 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.089 -1.007 . . . . 0.0 110.813 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 91.05 24.0 28.36 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 124.384 0.992 . . . . 0.0 114.805 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -112.32 155.65 23.75 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.668 1.187 . . . . 0.0 110.619 165.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -148.35 153.51 38.71 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -116.29 141.33 48.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.064 1.745 . . . . 0.0 115.346 170.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.3 124.02 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.275 1.43 . . . . 0.0 110.704 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -90.87 147.55 18.99 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.33 0.49 . . . . 0.0 112.028 163.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 19.3 mt -128.01 160.69 60.2 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.866 1.266 . . . . 0.0 111.105 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.58 -5.23 16.29 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.318 2.679 . . . . 0.0 115.05 -173.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -157.9 146.25 18.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.515 1.526 . . . . 0.0 109.993 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -56.38 -32.78 65.11 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.416 -0.802 . . . . 0.0 112.81 166.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -56.98 -44.69 82.92 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.417 -0.802 . . . . 0.0 113.163 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -64.16 -38.3 90.56 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.435 0.694 . . . . 0.0 111.097 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.83 -43.91 82.49 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.319 0.963 . . . . 0.0 112.25 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.67 85.32 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.197 0.908 . . . . 0.0 112.312 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -70.96 -46.73 61.86 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.316 1.047 . . . . 0.0 112.306 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.57 72.13 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.542 HD23 HG12 ' A' ' 498' ' ' VAL . 45.7 mt -66.25 -47.58 73.27 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.246 -0.909 . . . . 0.0 110.229 173.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -30.64 71.69 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.586 0.63 . . . . 0.0 112.242 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -84.77 -40.23 17.5 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -91.89 -22.47 20.05 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -67.12 106.58 2.03 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.871 -1.143 . . . . 0.0 109.498 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 120.88 -8.46 10.69 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.89 1.233 . . . . 0.0 115.579 -171.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -73.22 129.28 37.7 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.44 1.62 . . . . 0.0 109.169 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.305 7.3 p -115.44 55.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 124.183 1.944 . . . . 0.0 110.871 -163.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 26.2 tp -48.01 123.84 6.75 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.442 2.697 . . . . 0.0 111.475 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.307 68.7 m-85 55.08 8.39 0.24 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -174.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 101.67 0.52 52.75 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.994 1.283 . . . . 0.0 115.251 -173.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -107.35 113.6 61.81 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.202 1.501 . . . . 0.0 110.471 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.0 115.45 4.36 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 122.397 2.064 . . . . 0.0 110.23 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 32.4 mtp -75.19 129.15 37.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.812 1.645 . . . . 0.0 111.957 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.5 t -87.95 94.47 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.384 1.073 . . . . 0.0 109.035 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.542 HG12 HD23 ' A' ' 483' ' ' LEU . 2.5 t -91.57 123.35 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.05 1.74 . . . . 0.0 111.856 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -149.95 156.15 41.23 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.724 0.81 . . . . 0.0 112.291 -167.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -56.89 144.78 32.15 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.396 -0.815 . . . . 0.0 109.787 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -55.83 147.07 19.96 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -173.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -71.84 145.51 48.56 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.567 -168.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 50.2 m 66.98 9.27 6.75 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.465 2.306 . . . . 0.0 115.791 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -69.54 153.76 43.01 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.471 -0.768 . . . . 0.0 110.68 161.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 45.3 mtp180 -115.71 45.61 0.43 Allowed Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 125.165 1.386 . . . . 0.0 114.233 -176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.38 -31.5 34.63 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.629 2.219 . . . . 0.0 114.173 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -129.28 -33.92 1.89 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.277 1.431 . . . . 0.0 113.797 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -149.79 148.78 29.6 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.66 1.984 . . . . 0.0 112.089 -168.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -66.54 143.13 98.03 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 172.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -71.51 156.32 58.26 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.031 2.488 . . . . 0.0 113.146 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 153.42 43.07 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 171.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -58.7 -36.06 73.63 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.476 1.51 . . . . 0.0 114.665 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 83.47 -166.37 43.63 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.357 0.98 . . . . 0.0 113.67 -173.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -150.77 123.69 8.69 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.899 1.68 . . . . 0.0 109.225 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -67.36 143.66 56.23 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.253 1.268 0 C-N-CA 127.874 2.469 . . . . 0.0 110.937 167.885 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -72.41 -77.89 0.09 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.784 2.034 . . . . 0.0 115.049 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.61 -15.26 21.65 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.914 1.285 . . . . 0.0 113.937 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 62.7 mtp -96.27 160.37 29.93 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 126.073 1.749 . . . . 0.0 109.042 162.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.58 155.56 20.98 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.732 2.955 . . . . 0.0 114.125 -172.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 40.0 t -62.77 123.35 18.22 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 122.673 0.389 . . . . 0.0 110.689 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -137.72 95.92 3.14 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 123.128 1.442 . . . . 0.0 110.933 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 24.8 p -154.51 155.16 34.35 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.543 1.137 . . . . 0.0 112.527 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.4 tt -70.94 155.37 7.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 125.139 1.376 . . . . 0.0 110.53 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 30.2 t -86.66 150.67 24.03 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 121.442 -0.787 . . . . 0.0 110.756 161.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -43.96 -39.54 4.11 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.531 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -46.25 86.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -79.6 -33.7 41.36 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.031 0.933 . . . . 0.0 112.91 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.17 -48.61 80.99 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.252 1.421 . . . . 0.0 111.192 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -57.6 -23.29 50.09 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.866 1.266 . . . . 0.0 114.363 -176.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -65.42 -25.91 67.74 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.983 1.313 . . . . 0.0 113.042 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.51 89.28 0.46 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.66 1.6 . . . . 0.0 109.946 173.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -167.01 131.75 2.02 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.799 1.239 . . . . 0.0 109.334 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.2 pt -109.42 155.93 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.11 165.6 13.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.08 1.752 . . . . 0.0 110.575 161.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -57.3 -33.59 67.84 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.127 1.371 . . . . 0.0 111.442 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -59.92 -35.28 74.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.853 1.261 . . . . 0.0 113.272 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -79.74 -40.23 29.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.419 0.688 . . . . 0.0 110.602 167.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 31.3 ttm -55.28 -42.41 73.57 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.151 -0.968 . . . . 0.0 112.486 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -79.81 -14.24 58.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.034 0.934 . . . . 0.0 112.974 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.31 -37.27 45.09 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.95 1.7 . . . . 0.0 111.14 168.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 65.3 mt -77.31 121.16 23.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.658 1.583 . . . . 0.0 112.579 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 55.9 p -56.12 -29.64 60.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.233 1.013 . . . . 0.0 113.296 168.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.2 m -63.48 -31.92 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 175.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.311 58.6 m-85 -85.29 -5.66 59.3 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 -175.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -57.75 -16.01 9.84 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 -160.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 26.9 t -127.37 6.42 6.35 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.626 1.17 . . . . 0.0 113.096 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -129.16 133.73 47.73 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.831 -1.168 . . . . 0.0 107.85 -160.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -147.39 123.31 5.41 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -168.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.99 -173.45 1.88 Allowed 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.946 3.098 . . . . 0.0 112.934 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 99.37 -18.43 56.41 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 116.376 1.311 . . . . 0.0 116.376 170.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -76.59 155.8 83.32 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 118.682 1.241 . . . . 0.0 113.142 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -90.56 113.78 0.46 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.586 3.524 . . . . 0.0 113.768 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -154.29 147.54 24.84 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.636 1.175 . . . . 0.0 109.7 168.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 19.9 p -78.64 11.83 2.36 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.158 -1.589 . . . . 0.0 114.074 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -142.94 146.67 34.2 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.984 2.114 . . . . 0.0 109.063 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 19.0 pt -129.23 167.86 23.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 125.426 1.49 . . . . 0.0 109.606 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -145.57 162.61 37.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.94 139.83 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.782 1.233 . . . . 0.0 111.982 -170.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -119.11 165.81 13.71 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.934 1.693 . . . . 0.0 109.837 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 8.4 t30 64.18 45.78 3.88 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.71 1.204 . . . . 0.0 111.915 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.54 153.31 29.61 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.313 -0.867 . . . . 0.0 111.445 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.32 169.8 8.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.334 1.454 . . . . 0.0 114.502 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -70.23 -48.12 58.38 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.139 -0.976 . . . . 0.0 112.924 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -72.91 -25.23 60.98 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.4 1.48 . . . . 0.0 114.209 -176.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.7 p -69.4 146.49 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -123.36 162.08 23.43 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.419 1.888 . . . . 0.0 110.538 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.38 -29.89 59.32 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.61 -1.306 . . . . 0.0 112.72 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -60.19 -35.44 75.4 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.03 -33.39 70.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.111 0.964 . . . . 0.0 112.918 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.3 mp -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.481 1.512 . . . . 0.0 112.533 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -55.51 -31.34 61.96 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.075 0.852 . . . . 0.0 112.848 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -61.78 -29.98 70.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.741 0.816 . . . . 0.0 110.792 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.92 -55.27 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 121.227 -0.92 . . . . 0.0 110.783 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.253 50.2 m-85 -62.66 -23.84 67.31 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.25 -15.69 81.29 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.015 0.817 . . . . 0.0 114.069 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 38.0 ttp85 -59.52 -25.93 64.9 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.331 1.452 . . . . 0.0 112.849 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -90.2 -0.22 57.51 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.229 1.812 . . . . 0.0 111.676 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 15.2 t -120.92 116.14 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.326 1.85 . . . . 0.0 110.654 -173.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -79.85 97.43 6.67 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.845 0.858 . . . . 0.0 110.761 -175.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.286 58.5 m-85 -62.44 -11.68 17.37 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 119.064 2.987 . . . . 0.0 119.064 -173.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 72.6 m -75.95 -6.73 52.31 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 168.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 47.3 t -116.68 113.42 22.62 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.053 1.741 . . . . 0.0 110.715 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -59.77 -47.22 86.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.845 -0.535 . . . . 0.0 110.975 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -17.02 6.96 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -86.11 -64.9 1.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.801 0.81 . . . . 0.0 109.472 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -68.01 -23.22 64.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.909 1.284 . . . . 0.0 113.889 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.3 tt -56.2 -40.03 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.081 1.352 . . . . 0.0 111.911 172.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -8.85 59.62 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.287 1.035 . . . . 0.0 112.244 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -100.5 125.14 46.8 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -173.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -162.58 155.12 19.23 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.843 1.657 . . . . 0.0 107.767 172.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 4.5 mt -115.95 146.7 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.558 1.143 . . . . 0.0 109.85 174.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -128.05 137.5 52.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.569 1.148 . . . . 0.0 109.72 161.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.1 tp -120.4 136.6 54.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.457 1.503 . . . . 0.0 109.644 168.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 41.8 mtm -91.05 127.97 36.68 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.853 1.661 . . . . 0.0 110.664 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -113.57 -1.79 13.99 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.003 1.721 . . . . 0.0 114.229 -170.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -151.85 -169.86 3.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.787 1.635 . . . . 0.0 111.572 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.36 -163.22 46.21 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.143 0.878 . . . . 0.0 114.484 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -68.95 -11.93 61.16 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.569 1.948 . . . . 0.0 115.344 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 18.0 ptm -137.2 43.23 2.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.759 1.224 . . . . 0.0 112.841 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -52.7 127.69 23.95 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.68 1.192 . . . . 0.0 110.645 168.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 77.61 34.76 38.5 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.423 1.011 . . . . 0.0 112.286 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -120.91 150.69 40.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.132 0.973 . . . . 0.0 112.466 164.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -138.7 157.17 46.61 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.672 1.589 . . . . 0.0 113.49 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -120.33 144.09 48.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.549 1.939 . . . . 0.0 115.079 166.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.91 119.75 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.388 1.475 . . . . 0.0 110.93 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -82.23 137.98 17.84 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.365 -0.834 . . . . 0.0 111.285 162.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 24.2 mt -118.2 160.95 37.3 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.756 1.222 . . . . 0.0 110.112 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 -6.57 15.73 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.092 1.862 . . . . 0.0 114.983 -172.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -156.37 143.99 19.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.506 1.523 . . . . 0.0 110.351 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -51.64 -36.96 48.2 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.789 1.636 . . . . 0.0 112.341 165.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -61.42 -40.38 94.21 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.276 1.03 . . . . 0.0 112.853 174.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.56 -39.32 91.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.118 0.567 . . . . 0.0 110.723 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.68 87.38 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.922 -0.486 . . . . 0.0 112.107 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.26 -43.53 78.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.981 0.81 . . . . 0.0 112.16 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -75.76 -45.08 38.37 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.82 1.248 . . . . 0.0 112.855 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.39 -33.83 73.04 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.626 0.648 . . . . 0.0 112.729 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 498' ' ' VAL . 38.3 mt -67.8 -46.55 71.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.85 0.75 . . . . 0.0 110.915 172.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -64.49 -32.76 74.53 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 119.114 -0.47 . . . . 0.0 111.322 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -82.8 -54.67 4.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.17 -17.86 61.91 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.38 102.59 0.14 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.167 1.387 . . . . 0.0 111.965 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 105.18 -0.77 40.76 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 118.149 -1.361 . . . . 0.0 115.754 -175.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.63 128.75 37.15 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.556 1.678 . . . . 0.0 112.84 -173.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.314 1.4 t -93.55 49.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -163.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 58.9 tp -57.91 122.42 12.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.663 1.585 . . . . 0.0 111.677 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.403 56.4 m-85 59.16 20.3 8.3 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -175.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 83.16 13.47 76.95 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.335 0.969 . . . . 0.0 114.198 -172.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -119.78 119.86 30.92 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.042 1.337 . . . . 0.0 110.616 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.9 114.59 4.08 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.064 2.509 . . . . 0.0 111.003 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 63.1 mtp -74.72 134.78 41.85 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.529 1.132 . . . . 0.0 111.952 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.47 100.15 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.473 1.509 . . . . 0.0 108.458 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.501 HG12 HD23 ' A' ' 483' ' ' LEU . 2.4 t -101.93 132.38 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.019 1.728 . . . . 0.0 112.993 -170.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -150.43 156.77 42.1 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -170.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -56.16 144.71 28.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.793 0.837 . . . . 0.0 109.346 170.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -63.04 141.29 58.82 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.23 -0.919 . . . . 0.0 113.145 -176.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.1 119.31 23.87 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.652 1.181 . . . . 0.0 111.333 173.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 80.1 p -162.98 155.65 18.9 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 127.781 2.432 . . . . 0.0 109.681 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -77.58 37.42 0.22 Allowed 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -165.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -148.6 66.53 9.08 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 125.402 1.481 . . . . 0.0 112.661 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -67.67 150.55 79.5 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.435 2.757 . . . . 0.0 113.358 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -69.88 153.86 42.72 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.199 1.0 . . . . 0.0 111.687 172.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -49.22 155.67 0.66 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 122.097 0.951 . . . . 0.0 112.2 161.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -66.21 148.35 98.5 Favored Pre-proline 0 CA--C 1.555 1.149 0 O-C-N 121.203 -0.935 . . . . 0.0 112.755 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -81.98 -153.99 0.05 OUTLIER 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 125.169 3.913 . . . . 0.0 113.048 -174.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -84.55 167.76 16.03 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.107 1.363 . . . . 0.0 114.002 -174.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -65.18 154.88 36.74 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.995 1.318 . . . . 0.0 110.966 168.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -83.49 -133.99 2.34 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.378 0.99 . . . . 0.0 113.992 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.27 119.55 10.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.009 0.924 . . . . 0.0 112.03 -171.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 22.1 tpp85 -89.81 -15.47 32.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.202 1.401 . . . . 0.0 113.196 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 45.7 pttt . . . . . 0 C--O 1.251 1.162 0 CA-C-O 117.134 -1.412 . . . . 0.0 112.803 168.884 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . 0.303 74.8 m-20 71.43 -15.76 0.41 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 119.442 3.126 . . . . 0.0 119.442 169.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -93.05 -32.29 14.53 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.872 0.869 . . . . 0.0 112.538 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 90.8 mmm 60.39 146.69 0.07 OUTLIER Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 128.878 2.871 . . . . 0.0 116.836 170.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.99 -13.52 15.73 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.33 2.687 . . . . 0.0 114.678 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 97.9 p -68.94 162.91 25.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.644 1.178 . . . . 0.0 110.938 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -144.74 110.54 5.37 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.745 0.818 . . . . 0.0 111.706 -171.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 8.8 m -155.14 161.28 41.28 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.41 1.884 . . . . 0.0 112.568 171.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.5 tt -67.94 140.88 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 124.222 1.009 . . . . 0.0 110.892 -170.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 70.5 m -82.68 160.44 22.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.998 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -63.64 -33.2 75.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 118.889 -0.576 . . . . 0.0 111.809 -174.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -62.47 -55.72 24.91 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.67 0.788 . . . . 0.0 112.964 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -62.06 -38.37 88.51 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.25 -44.64 83.1 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -60.67 -21.16 62.52 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -61.29 -46.29 90.94 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.178 1.391 . . . . 0.0 111.892 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.9 75.55 0.39 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.477 1.037 . . . . 0.0 111.999 -170.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 6.1 ttp85 -155.5 152.97 29.54 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.212 1.005 . . . . 0.0 110.97 -173.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.6 pt -130.94 155.06 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.9 0.88 . . . . 0.0 112.031 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 74.5 p -86.65 172.12 10.47 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.321 1.048 . . . . 0.0 111.456 169.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -55.18 -32.92 62.55 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.567 -0.708 . . . . 0.0 111.43 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.12 -25.72 67.89 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.88 -32.05 14.74 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.767 0.712 . . . . 0.0 110.803 166.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 16.0 ttm -66.55 -42.26 87.41 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.444 -1.41 . . . . 0.0 112.598 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -78.43 12.48 1.96 Allowed 'General case' 0 CA--C 1.552 1.042 0 O-C-N 120.973 -1.079 . . . . 0.0 111.573 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -125.03 -30.31 3.24 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.116 2.166 . . . . 0.0 116.006 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 1.7 mp -75.7 130.67 39.08 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.916 -1.115 . . . . 0.0 109.753 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 38.1 m -66.07 -20.65 66.24 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 1.3 m -57.19 -25.91 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 167.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.15 21.22 17.02 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -63.87 -22.52 66.96 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.238 -1.539 . . . . 0.0 114.78 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 78.0 p -139.97 -19.49 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.741 1.616 . . . . 0.0 113.365 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.18 135.89 41.06 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -141.95 132.05 12.65 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -85.26 175.77 6.2 Favored 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.283 3.322 . . . . 0.0 113.683 168.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.26 -3.39 72.54 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 117.894 1.918 . . . . 0.0 117.894 165.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -81.7 144.37 52.26 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 119.096 1.448 . . . . 0.0 113.996 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.17 86.21 1.7 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.148 3.232 . . . . 0.0 112.686 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.536 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 30.9 t30 -133.55 151.44 51.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.28 1.432 . . . . 0.0 110.257 165.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 24.2 p -82.07 -9.2 59.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.536 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 82.7 mtt-85 -121.61 150.52 41.58 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.944 1.298 . . . . 0.0 110.629 177.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 19.7 pt -135.02 158.84 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.638 1.975 . . . . 0.0 110.37 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -133.79 158.11 44.18 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.24 131.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.246 1.418 . . . . 0.0 113.614 -171.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -108.63 172.66 6.71 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.262 1.425 . . . . 0.0 110.63 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.283 88.6 m-20 71.67 32.91 1.89 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.645 1.978 . . . . 0.0 116.029 -176.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.49 147.2 25.48 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.175 -0.953 . . . . 0.0 111.73 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.67 161.72 22.74 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.149 1.779 . . . . 0.0 115.109 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -67.14 -39.85 86.63 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.664 -1.272 . . . . 0.0 112.681 166.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -73.1 -27.83 61.93 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.752 1.621 . . . . 0.0 114.798 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.01 146.43 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -128.23 164.05 23.39 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.889 1.276 . . . . 0.0 112.584 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -33.99 68.21 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.63 -1.294 . . . . 0.0 113.021 -174.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -54.22 -30.82 51.43 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.191 1.797 . . . . 0.0 115.297 170.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -83.43 -34.18 25.52 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.877 1.671 . . . . 0.0 113.6 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.06 -22.32 66.88 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.323 1.049 . . . . 0.0 111.973 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -20.18 44.63 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -67.29 -30.52 70.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.83 0.741 . . . . 0.0 111.843 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.83 -55.47 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.27 -0.894 . . . . 0.0 110.46 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -57.61 -30.07 65.03 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.36 -12.07 82.14 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 123.997 0.808 . . . . 0.0 114.602 174.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 5.4 ttt85 -58.83 -27.89 65.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.334 1.567 . . . . 0.0 110.85 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -95.66 18.26 13.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.241 1.816 . . . . 0.0 113.558 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 27.3 t -140.54 124.56 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.099 1.76 . . . . 0.0 111.223 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -77.23 110.07 11.63 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -61.71 -12.42 16.51 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 118.178 2.658 . . . . 0.0 118.178 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 16.5 m -88.83 -18.95 26.6 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.455 0.702 . . . . 0.0 112.676 174.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 28.9 t -108.63 112.54 24.93 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.758 1.223 . . . . 0.0 111.754 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -54.11 -50.64 66.41 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.228 0.611 . . . . 0.0 111.016 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.45 -12.77 1.85 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -93.17 -61.76 1.51 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.978 1.311 . . . . 0.0 110.692 172.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -69.3 -20.41 63.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.796 1.239 . . . . 0.0 113.784 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.08 -28.97 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.773 1.629 . . . . 0.0 112.69 169.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 37.5 mtp -85.86 -13.1 48.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.958 1.303 . . . . 0.0 111.761 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -108.32 117.32 33.84 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -163.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -159.2 154.54 25.55 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.891 1.676 . . . . 0.0 110.065 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 8.4 mt -130.63 142.21 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.189 1.396 . . . . 0.0 110.797 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -123.37 142.64 50.76 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.028 1.331 . . . . 0.0 110.283 160.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 11.2 tp -133.47 115.68 15.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.842 2.057 . . . . 0.0 109.134 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 45.8 mtm -71.27 144.62 49.96 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 124.602 1.161 . . . . 0.0 111.751 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -128.64 -6.93 5.14 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -172.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.96 145.1 35.57 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.824 1.193 . . . . 0.0 114.122 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 75.37 -177.16 49.29 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.096 1.331 . . . . 0.0 113.216 -172.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -18.72 61.68 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -170.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 70.4 mtp -89.12 3.17 52.72 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -58.52 145.63 38.39 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.533 -1.354 . . . . 0.0 111.131 175.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.54 27.66 70.84 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.749 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -126.83 146.04 50.42 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.727 1.211 . . . . 0.0 111.339 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -137.07 155.26 49.87 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -167.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -125.71 134.0 51.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.678 1.991 . . . . 0.0 115.307 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.94 125.05 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.974 1.709 . . . . 0.0 109.952 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -89.07 137.62 14.27 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 162.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 25.2 mt -118.18 160.45 39.25 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.515 1.526 . . . . 0.0 109.26 173.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.03 -8.96 20.5 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.139 1.226 . . . . 0.0 114.642 -170.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.402 ' OD1' ' HE2' ' A' ' 477' ' ' LYS . 64.1 t-20 -153.47 142.38 21.16 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.72 1.208 . . . . 0.0 111.059 -172.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -60.24 -37.19 79.63 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.389 -0.819 . . . . 0.0 111.147 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.402 ' HE2' ' OD1' ' A' ' 475' ' ' ASN . 3.0 mppt? -65.25 -32.35 73.97 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.311 0.644 . . . . 0.0 112.591 176.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -73.58 -35.5 65.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.084 0.554 . . . . 0.0 111.777 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.97 -45.14 86.92 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.359 0.981 . . . . 0.0 111.696 168.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.56 77.83 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.767 1.167 . . . . 0.0 112.263 176.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.33 -50.97 61.78 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.207 1.403 . . . . 0.0 112.545 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.54 -33.53 72.8 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.862 0.865 . . . . 0.0 112.118 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.523 HD23 HG12 ' A' ' 498' ' ' VAL . 45.6 mt -71.19 -36.87 72.11 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.927 1.291 . . . . 0.0 111.521 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -67.28 -22.99 65.63 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.513 1.125 . . . . 0.0 112.698 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -112.15 -33.04 6.36 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -171.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -84.83 -17.54 37.73 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -66.56 109.29 2.73 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.263 1.025 . . . . 0.0 111.672 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 104.57 4.41 43.13 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 118.061 -1.41 . . . . 0.0 115.976 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -70.4 123.66 22.3 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.704 1.752 . . . . 0.0 110.956 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.27 2.0 t -92.31 52.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.196 1.398 . . . . 0.0 114.416 -163.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.08 126.01 25.82 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.739 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . . 4.9 t80 53.79 35.91 22.67 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.579 1.952 . . . . 0.0 110.14 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 76.89 11.53 85.4 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.664 -1.272 . . . . 0.0 115.068 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -127.11 123.35 23.43 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 119.253 1.526 . . . . 0.0 111.11 -176.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.2 118.15 5.41 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.566 2.177 . . . . 0.0 111.648 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 72.1 mtp -69.14 126.06 28.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.693 1.197 . . . . 0.0 112.304 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -86.23 83.11 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.674 1.589 . . . . 0.0 113.422 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.523 HG12 HD23 ' A' ' 483' ' ' LEU . 1.6 t -85.86 122.61 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.398 1.479 . . . . 0.0 112.895 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -145.95 155.6 42.95 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.954 1.301 . . . . 0.0 111.693 -174.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -60.35 144.28 51.08 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.937 -1.102 . . . . 0.0 110.796 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -57.73 160.47 4.44 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -71.72 68.11 0.6 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.615 1.966 . . . . 0.0 112.817 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 29.9 m -146.04 161.59 39.77 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.959 2.104 . . . . 0.0 111.149 -167.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -68.03 137.08 54.79 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.528 -0.733 . . . . 0.0 111.478 170.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.93 45.14 1.22 Allowed Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -170.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -58.89 156.06 35.2 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.003 2.469 . . . . 0.0 112.618 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -49.33 142.91 6.93 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.087 1.355 . . . . 0.0 113.564 -172.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -155.72 118.54 4.24 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.397 1.479 . . . . 0.0 109.231 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -67.88 147.1 98.54 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 170.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -73.88 179.75 5.38 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.652 2.901 . . . . 0.0 111.423 166.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . 0.452 ' H ' ' HE2' ' A' ' 511' ' ' LYS . 0.0 OUTLIER -57.29 162.7 2.59 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.896 1.331 . . . . 0.0 114.047 173.026 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.88 123.53 18.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.785 1.634 . . . . 0.0 113.461 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -83.05 -13.26 77.8 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.956 1.265 . . . . 0.0 115.216 -177.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -65.63 130.66 44.09 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.334 1.453 . . . . 0.0 111.219 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.42 136.45 53.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.913 0.885 . . . . 0.0 112.397 171.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 32.9 tttm . . . . . 0 C--O 1.254 1.325 0 C-N-CA 125.292 1.437 . . . . 0.0 110.184 163.952 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -79.72 -57.69 3.54 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 172.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -158.89 145.77 17.25 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.267 1.427 . . . . 0.0 110.17 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 92.2 mtp 63.23 167.99 0.1 Allowed Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 127.156 2.183 . . . . 0.0 115.3 -177.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -72.95 -10.94 25.24 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.077 2.518 . . . . 0.0 115.646 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.6 p -78.0 48.74 0.74 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.734 2.014 . . . . 0.0 114.046 -173.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -78.07 61.22 2.57 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.812 1.645 . . . . 0.0 111.361 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 14.7 p -150.22 149.61 30.43 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.92 1.288 . . . . 0.0 114.332 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.5 tt -76.08 153.04 6.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 125.795 1.638 . . . . 0.0 111.516 -167.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 33.9 t -83.54 156.6 22.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.386 0.612 . . . . 0.0 110.745 165.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -53.92 -36.01 62.3 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.491 0.717 . . . . 0.0 111.029 163.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -45.4 86.78 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -71.1 -35.17 71.72 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.546 0.738 . . . . 0.0 112.85 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.422 HD12 ' CD2' ' A' ' 489' ' ' TYR . 31.4 tp -67.76 -44.68 76.9 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -54.91 -24.19 22.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.816 1.246 . . . . 0.0 114.03 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.68 -29.29 69.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.126 1.371 . . . . 0.0 112.855 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.22 97.94 0.76 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.436 1.017 . . . . 0.0 111.521 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -159.8 152.22 21.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.448 1.099 . . . . 0.0 110.635 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.44 150.21 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.428 0.632 . . . . 0.0 112.68 168.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 39.9 m -98.22 169.45 9.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.66 1.584 . . . . 0.0 111.694 168.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -54.57 -23.71 17.93 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -171.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -72.16 -28.43 63.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.798 0.839 . . . . 0.0 112.81 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.79 -32.9 14.49 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.527 1.131 . . . . 0.0 111.094 171.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 35.8 ttm -58.08 -46.3 85.69 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.08 -1.013 . . . . 0.0 111.239 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -85.04 37.16 0.65 Allowed 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.385 -0.822 . . . . 0.0 111.363 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.44 -37.52 0.31 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.948 2.099 . . . . 0.0 114.332 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.48 131.37 42.46 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.993 1.317 . . . . 0.0 110.008 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 53.1 p -69.01 -22.48 64.07 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.012 -1.055 . . . . 0.0 112.065 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 2.3 m -71.38 -7.53 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 168.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.426 ' CE1' HG13 ' A' ' 497' ' ' VAL 0.286 89.4 m-85 -117.79 3.93 12.25 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 173.718 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -66.01 -15.07 62.71 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -174.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 79.9 p -141.1 -16.12 0.86 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.907 1.283 . . . . 0.0 114.187 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -80.75 141.27 34.96 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 170.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -140.59 129.8 13.09 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -169.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -84.91 -174.86 1.86 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 124.263 3.309 . . . . 0.0 114.242 171.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.83 -44.99 2.34 Favored Glycine 0 N--CA 1.466 0.659 0 C-N-CA 126.488 1.994 . . . . 0.0 115.774 164.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -65.85 142.37 98.08 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -164.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.2 106.5 2.29 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.53 2.82 . . . . 0.0 112.199 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 37.7 t30 -144.37 151.21 38.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.222 2.209 . . . . 0.0 107.752 159.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 28.9 p -75.06 2.55 10.35 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.476 -1.39 . . . . 0.0 114.361 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.405 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 61.3 mtt85 -137.53 147.69 45.36 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.124 1.77 . . . . 0.0 110.333 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 43.9 pt -134.43 159.97 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.203 2.201 . . . . 0.0 110.123 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -139.86 159.86 41.22 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.19 140.24 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.694 1.597 . . . . 0.0 113.412 -164.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -119.5 175.59 5.76 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.331 1.452 . . . . 0.0 111.168 167.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.279 13.6 m-20 69.07 25.42 5.85 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.322 1.849 . . . . 0.0 115.824 -172.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -74.68 146.53 42.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.262 -1.524 . . . . 0.0 111.043 173.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.18 173.65 3.69 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -173.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -77.98 -50.58 11.87 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.518 1.127 . . . . 0.0 111.78 -176.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -81.97 -23.68 35.94 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.24 1.816 . . . . 0.0 113.251 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.58 152.07 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -122.53 168.27 12.34 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.697 1.599 . . . . 0.0 113.346 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -57.2 -35.21 69.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.542 1.137 . . . . 0.0 112.616 174.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -62.35 -36.42 82.19 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -71.92 -25.18 61.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.641 1.176 . . . . 0.0 113.636 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.23 -15.4 59.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.099 2.16 . . . . 0.0 114.024 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.67 -22.75 57.75 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.324 0.966 . . . . 0.0 112.857 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -55.31 -37.23 67.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.076 1.351 . . . . 0.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.79 -57.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 121.253 -0.904 . . . . 0.0 111.659 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.274 58.9 m-85 -59.68 -31.83 69.92 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -175.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.76 -19.84 79.74 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 123.668 0.652 . . . . 0.0 114.072 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -55.0 -35.82 64.77 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.713 1.605 . . . . 0.0 112.506 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -77.71 0.79 22.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.431 1.892 . . . . 0.0 114.873 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 11.7 t -124.59 121.99 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.742 2.017 . . . . 0.0 109.946 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.254 3.2 m-20 -66.78 90.56 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 175.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -52.64 -21.42 3.93 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 173.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 15.8 m -65.2 -22.29 66.88 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.346 1.058 . . . . 0.0 113.176 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 31.2 m -124.45 117.84 25.31 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.697 1.599 . . . . 0.0 112.733 -170.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -63.09 -40.67 98.33 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.234 -0.916 . . . . 0.0 113.278 -174.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 2.9 t -54.48 -15.23 1.58 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -88.75 -62.65 1.44 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.213 1.405 . . . . 0.0 110.714 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -67.02 -24.55 66.03 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.14 1.376 . . . . 0.0 113.169 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.3 tt -58.53 -36.58 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.3 1.04 . . . . 0.0 112.366 171.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 16.6 mtm -87.52 -2.59 58.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.089 1.355 . . . . 0.0 112.439 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.56 143.81 31.77 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.938 2.495 . . . . 0.0 115.212 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -168.7 154.85 6.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.08 1.752 . . . . 0.0 107.006 168.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.08 126.75 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.599 1.16 . . . . 0.0 109.544 172.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -104.3 137.65 41.89 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.845 1.258 . . . . 0.0 108.899 165.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.2 tp -128.1 127.75 43.63 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.886 1.274 . . . . 0.0 109.191 164.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 48.0 mtm -93.17 125.04 37.57 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.808 1.643 . . . . 0.0 109.948 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -122.14 -0.46 9.43 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.963 2.105 . . . . 0.0 112.925 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.9 148.79 23.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.832 1.653 . . . . 0.0 112.512 173.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 90.57 -168.77 33.56 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 163.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -20.55 64.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.344 1.858 . . . . 0.0 113.772 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 62.7 mtp -115.92 24.28 11.59 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.282 2.233 . . . . 0.0 112.202 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -65.46 151.95 45.11 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.792 -1.193 . . . . 0.0 113.204 -172.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.66 36.83 18.5 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 126.194 1.854 . . . . 0.0 112.798 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -120.19 142.01 49.37 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.189 0.996 . . . . 0.0 112.128 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -129.93 153.37 48.41 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -168.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -126.83 129.63 48.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.0 2.12 . . . . 0.0 114.733 171.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.5 mp -126.42 120.56 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.674 1.59 . . . . 0.0 109.856 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -83.14 141.03 20.45 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 162.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 21.4 mt -124.51 158.82 60.41 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.726 1.61 . . . . 0.0 109.686 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.88 -15.62 26.39 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.948 2.432 . . . . 0.0 114.085 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -150.07 143.74 25.31 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.035 0.934 . . . . 0.0 110.623 -175.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -57.6 -37.67 73.61 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.41 1.084 . . . . 0.0 111.61 170.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -69.78 -23.23 63.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.346 1.058 . . . . 0.0 113.575 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -77.56 -38.22 48.98 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.774 171.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.06 79.27 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.254 0.933 . . . . 0.0 112.259 170.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -54.64 -43.19 72.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.4 1.0 . . . . 0.0 111.614 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -64.77 -50.05 68.35 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.962 1.305 . . . . 0.0 113.009 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -62.38 -31.54 72.22 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.359 0.664 . . . . 0.0 111.816 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.511 HD23 HG12 ' A' ' 498' ' ' VAL . 89.7 mt -77.87 -31.58 51.45 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.099 -1.001 . . . . 0.0 112.346 173.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -60.62 -33.29 72.55 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.617 1.167 . . . . 0.0 110.606 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -101.9 -54.45 2.72 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -174.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -75.52 -14.45 60.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -168.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -65.46 104.43 0.98 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.207 1.003 . . . . 0.0 110.323 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 107.31 1.5 35.46 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 117.583 -1.676 . . . . 0.0 116.18 -172.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.422 ' CD2' HD12 ' A' ' 394' ' ' LEU 0.314 92.2 t80 -64.65 128.86 37.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.672 2.236 . . . . 0.0 115.925 -168.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.325 2.0 t -91.68 45.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -160.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 23.2 tp -52.8 138.87 28.35 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.156 1.382 . . . . 0.0 110.183 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.356 7.0 t80 62.91 -4.08 0.28 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 94.7 9.57 58.57 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 124.958 1.266 . . . . 0.0 114.358 -166.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -127.21 128.48 24.09 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 126.686 1.995 . . . . 0.0 111.581 -173.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.86 119.04 5.51 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.544 2.162 . . . . 0.0 112.511 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 56.9 mtp -75.58 130.81 39.4 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.729 1.612 . . . . 0.0 112.419 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . 0.426 HG13 ' CE1' ' A' ' 410' ' ' PHE . 2.5 t -87.95 76.79 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.857 1.663 . . . . 0.0 115.131 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.511 HG12 HD23 ' A' ' 483' ' ' LEU . 1.7 t -79.83 122.72 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.355 1.062 . . . . 0.0 113.789 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -141.63 155.7 45.7 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.175 1.79 . . . . 0.0 112.514 -173.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -59.7 143.28 51.18 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.346 -1.471 . . . . 0.0 113.193 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -60.91 146.06 48.02 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -169.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -74.95 115.2 14.29 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.85 157.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 38.5 m -169.88 157.39 6.72 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.867 1.667 . . . . 0.0 111.909 -170.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -59.71 135.3 57.64 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.85 0.46 . . . . 0.0 110.807 161.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 55.5 ttp85 -149.01 83.06 6.85 Favored Pre-proline 0 N--CA 1.47 0.555 0 C-N-CA 125.218 1.407 . . . . 0.0 109.744 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -60.39 -35.2 91.95 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.126 1.884 . . . . 0.0 113.142 174.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -64.54 127.13 30.21 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.419 1.088 . . . . 0.0 112.317 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -147.23 151.55 36.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.681 1.592 . . . . 0.0 110.66 170.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -49.77 140.96 14.4 Favored Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.93 173.11 9.74 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.381 2.721 . . . . 0.0 112.117 173.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 135.58 39.8 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 174.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -149.85 62.61 0.99 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.3 1.44 . . . . 0.0 109.833 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -63.25 133.59 42.51 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 121.278 -0.889 . . . . 0.0 111.094 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -155.77 167.64 29.76 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.731 1.212 . . . . 0.0 113.147 -167.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -61.95 135.68 57.65 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.432 1.493 . . . . 0.0 113.921 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.924 2.09 . . . . 0.0 112.276 159.567 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 28.5 p . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 121.571 0.7 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . 0.271 49.9 m-20 -114.21 -135.63 0.36 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.954 2.102 . . . . 0.0 111.879 168.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -132.15 159.06 40.04 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.757 1.617 . . . . 0.0 113.316 -174.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.12 170.75 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 126.173 1.789 . . . . 0.0 114.156 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.93 155.74 37.07 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.677 2.251 . . . . 0.0 113.55 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.1 t 55.23 54.9 8.12 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.093 1.757 . . . . 0.0 112.695 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -79.67 73.27 6.38 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.817 -1.177 . . . . 0.0 111.991 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 28.0 p -139.05 159.81 41.26 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 2.9 tt -70.06 152.37 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.863 1.665 . . . . 0.0 110.94 -174.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 1.6 m -86.65 152.6 22.44 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 7.2 ttm-85 -59.06 -35.79 73.95 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.1 -1.0 . . . . 0.0 111.124 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -41.51 98.26 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.838 1.655 . . . . 0.0 113.733 174.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.85 -38.91 92.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.095 0.958 . . . . 0.0 112.692 174.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.4 tt -70.2 -39.99 74.86 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.412 1.485 . . . . 0.0 111.943 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.36 -17.17 18.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.488 1.915 . . . . 0.0 115.153 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -63.95 -64.61 0.84 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.74 -0.6 . . . . 0.0 110.88 164.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -78.99 72.09 2.51 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.497 1.999 . . . . 0.0 114.072 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -159.66 143.33 14.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.763 1.225 . . . . 0.0 110.973 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.4 pt -123.3 153.74 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.356 1.063 . . . . 0.0 113.866 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 77.3 p -85.02 169.87 13.55 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.54 1.536 . . . . 0.0 111.828 168.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 -58.37 -28.92 65.6 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.326 -0.859 . . . . 0.0 113.288 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.83 -30.94 71.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.543 0.737 . . . . 0.0 112.265 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.44 -36.59 26.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.641 1.176 . . . . 0.0 111.775 168.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 20.3 ttp -63.06 -40.6 98.18 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.919 -1.113 . . . . 0.0 111.829 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -83.29 25.12 0.75 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.441 0.696 . . . . 0.0 112.609 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.69 -38.23 1.51 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.892 2.077 . . . . 0.0 115.933 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.58 127.58 33.44 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.509 1.524 . . . . 0.0 110.131 172.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 27.9 t -59.48 -32.12 69.96 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.543 -0.723 . . . . 0.0 112.314 168.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 18.5 m -60.21 -21.64 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 120.753 -1.217 . . . . 0.0 114.08 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.263 79.7 m-85 -109.52 6.8 24.39 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -69.67 -22.33 63.45 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 46.6 t -123.43 -42.16 2.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.426 1.09 . . . . 0.0 112.381 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -72.56 150.79 42.84 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.898 1.279 . . . . 0.0 114.319 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -140.24 125.49 11.36 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -163.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -92.74 177.01 1.55 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 124.958 3.772 . . . . 0.0 114.887 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.438 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 98.58 -8.86 62.2 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.302 1.906 . . . . 0.0 116.843 163.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -85.69 139.79 35.52 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 119.294 1.547 . . . . 0.0 114.556 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -83.55 65.43 7.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 1 C-N-CA 125.392 4.061 . . . . 0.0 113.038 -174.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 46.6 t30 -89.79 153.98 20.26 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.551 -0.718 . . . . 0.0 110.485 162.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 28.4 p -76.05 -3.63 36.94 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.088 -1.633 . . . . 0.0 115.068 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.48 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 87.7 mtt-85 -136.44 152.52 50.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.352 1.861 . . . . 0.0 111.833 176.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 8.6 pt -135.4 164.14 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.671 1.989 . . . . 0.0 109.588 176.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -138.47 161.21 37.59 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.447 HG22 HG13 ' A' ' 498' ' ' VAL . 2.7 t -135.62 150.52 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.241 1.816 . . . . 0.0 112.018 -171.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -138.01 -178.25 5.18 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.292 0.496 . . . . 0.0 112.158 162.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 69.61 21.73 6.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.215 1.806 . . . . 0.0 114.516 -165.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.87 154.64 41.65 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.991 -1.068 . . . . 0.0 110.912 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -68.26 173.7 4.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.172 0.989 . . . . 0.0 113.03 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.02 -30.43 13.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.225 1.41 . . . . 0.0 112.285 170.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -73.69 -14.81 61.21 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.107 1.363 . . . . 0.0 113.92 172.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.8 p -86.16 147.16 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.807 1.643 . . . . 0.0 113.898 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -117.49 164.81 14.34 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.333 1.053 . . . . 0.0 111.953 173.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -58.67 -30.51 67.41 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.6 -1.313 . . . . 0.0 111.966 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -20.93 63.8 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.842 1.657 . . . . 0.0 114.84 174.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -76.78 -37.86 55.09 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.269 1.028 . . . . 0.0 113.533 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.18 -18.31 63.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.595 1.558 . . . . 0.0 112.541 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -49.14 -33.13 11.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.176 1.391 . . . . 0.0 112.869 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -66.14 -31.2 71.91 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -169.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.9 mt -98.75 -56.15 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.821 -1.174 . . . . 0.0 111.151 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.265 75.6 m-85 -60.79 -22.52 64.2 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -79.73 -6.88 88.89 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.399 0.999 . . . . 0.0 114.519 170.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -63.05 -26.39 68.82 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 120.794 2.297 . . . . 0.0 112.09 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -94.51 3.83 54.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.081 2.152 . . . . 0.0 111.424 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.8 107.8 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.355 1.462 . . . . 0.0 109.432 -174.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -72.15 104.96 3.79 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -170.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -50.3 -40.31 48.19 Favored 'General case' 0 C--N 1.338 0.109 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 -170.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.0 p -68.16 -4.08 12.66 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 14.9 t -118.02 116.05 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.747 1.158 . . . . 0.0 111.782 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -60.3 -43.78 96.0 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.209 -0.932 . . . . 0.0 112.25 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.2 t -54.83 -16.08 2.38 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -90.09 -60.28 1.97 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.186 0.994 . . . . 0.0 110.032 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -68.13 -23.86 64.94 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.785 1.234 . . . . 0.0 113.286 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.0 tt -61.36 -31.84 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.938 1.695 . . . . 0.0 112.96 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.7 mtm -97.85 2.39 49.25 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.23 1.412 . . . . 0.0 112.698 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -111.6 112.23 23.79 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.372 1.869 . . . . 0.0 115.85 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -154.62 131.85 11.07 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.573 -0.704 . . . . 0.0 109.419 -168.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 5.1 mt -113.47 142.96 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.654 1.182 . . . . 0.0 110.407 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -134.37 129.64 35.71 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.992 1.717 . . . . 0.0 109.322 165.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 4.2 tt -115.53 139.73 49.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.345 1.858 . . . . 0.0 111.005 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -101.67 131.78 47.73 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 125.234 1.414 . . . . 0.0 112.463 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -113.9 1.76 14.84 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -171.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -145.9 154.82 42.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.211 1.004 . . . . 0.0 113.042 -174.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 77.23 -162.08 51.03 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.207 1.384 . . . . 0.0 113.809 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -22.27 66.07 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 121.483 -1.01 . . . . 0.0 112.743 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 23.2 ptp -87.18 8.84 22.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.112 1.365 . . . . 0.0 114.395 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -56.77 115.85 2.81 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.825 1.193 . . . . 0.0 110.838 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.16 22.79 58.48 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.732 1.634 . . . . 0.0 113.859 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -93.79 155.98 16.92 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.353 0.661 . . . . 0.0 110.697 158.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -149.74 152.8 35.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.224 1.009 . . . . 0.0 113.179 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -105.63 144.53 32.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.145 1.778 . . . . 0.0 114.123 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.9 mp -139.62 115.01 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.198 1.399 . . . . 0.0 109.244 169.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -81.69 144.15 23.97 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 158.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.1 mt -123.5 159.83 53.44 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.712 1.205 . . . . 0.0 110.332 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.01 -8.78 24.44 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.658 2.906 . . . . 0.0 114.321 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -156.71 144.11 19.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.582 0.706 . . . . 0.0 112.125 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -49.77 -44.79 49.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.406 1.882 . . . . 0.0 112.579 166.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -68.01 -28.75 67.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.706 1.202 . . . . 0.0 113.779 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.52 73.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.563 174.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.0 88.03 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.939 0.79 . . . . 0.0 112.776 174.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.68 71.11 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.722 0.692 . . . . 0.0 112.371 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.16 -52.0 15.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.134 1.374 . . . . 0.0 112.885 172.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.08 -30.54 69.3 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.094 0.958 . . . . 0.0 113.293 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.597 HD23 HG12 ' A' ' 498' ' ' VAL . 28.8 mt -64.17 -49.32 72.56 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.379 0.671 . . . . 0.0 111.028 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -21.6 48.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.614 0.766 . . . . 0.0 112.729 -176.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -72.01 -54.57 9.48 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.397 0.999 . . . . 0.0 112.62 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.67 -14.67 59.56 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -172.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -61.8 99.07 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.013 1.325 . . . . 0.0 111.657 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 119.34 -1.5 14.29 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 117.778 -1.568 . . . . 0.0 115.405 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -71.23 131.0 42.85 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.354 1.577 . . . . 0.0 111.254 -172.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.18 67.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.971 1.708 . . . . 0.0 113.437 -168.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 23.6 tp -66.28 142.8 57.54 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.363 162.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.4 27.3 t80 63.8 7.81 3.44 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 118.228 2.677 . . . . 0.0 118.228 167.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 78.93 14.97 81.42 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.1 1.333 . . . . 0.0 114.277 -169.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -133.87 125.65 18.37 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.66 1.584 . . . . 0.0 110.689 -171.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.4 125.18 11.54 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.121 1.881 . . . . 0.0 112.167 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 63.7 mtp -73.15 127.3 32.2 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.817 1.247 . . . . 0.0 111.696 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.24 98.86 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.901 0.88 . . . . 0.0 109.712 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.597 HG12 HD23 ' A' ' 483' ' ' LEU . 2.0 t -94.18 124.27 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.641 1.577 . . . . 0.0 112.337 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -148.28 152.81 37.77 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.61 0.764 . . . . 0.0 112.765 -168.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . 0.31 17.6 p90 -57.85 144.66 37.98 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 173.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -60.35 163.3 5.25 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -171.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -77.69 -34.3 52.91 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.462 1.505 . . . . 0.0 112.136 172.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 92.3 p -74.88 162.8 28.3 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.412 1.085 . . . . 0.0 111.138 159.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -151.53 132.45 14.21 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -175.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -152.3 73.49 7.58 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 127.692 2.397 . . . . 0.0 110.549 160.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -65.53 168.25 15.14 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.002 2.468 . . . . 0.0 114.113 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -73.58 136.93 44.01 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 121.478 -0.764 . . . . 0.0 111.509 173.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -70.35 -16.09 62.94 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 -165.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -148.89 170.66 7.3 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 126.322 1.849 . . . . 0.0 115.909 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -60.12 -22.08 68.4 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.59 2.86 . . . . 0.0 114.475 174.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.39 161.46 22.1 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.154 1.782 . . . . 0.0 114.088 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -137.78 -32.31 0.75 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.261 1.824 . . . . 0.0 111.965 170.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 75.69 -35.57 1.2 Allowed Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.358 1.932 . . . . 0.0 115.592 168.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.16 129.91 42.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.868 1.267 . . . . 0.0 109.309 168.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 21.2 mmt-85 -82.93 175.96 9.65 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -168.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 22.9 pttm . . . . . 0 C--O 1.252 1.235 0 C-N-CA 126.39 1.876 . . . . 0.0 114.333 -172.396 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 384' ' ' MET . 21.1 t . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.641 0.734 . . . . 0.0 109.914 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -112.18 -19.62 12.19 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.928 1.691 . . . . 0.0 112.837 170.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -152.47 30.14 0.54 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.877 1.271 . . . . 0.0 113.28 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . 0.453 ' HG3' ' HA ' ' A' ' 381' ' ' SER . 82.6 mtp -71.31 160.17 83.33 Favored Pre-proline 0 CA--C 1.548 0.883 0 O-C-N 121.168 -0.958 . . . . 0.0 111.925 173.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.3 144.59 81.58 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.281 2.654 . . . . 0.0 113.844 172.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 17.2 t -80.42 161.93 24.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.492 1.117 . . . . 0.0 112.332 174.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -156.4 154.06 29.89 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.489 2.716 . . . . 0.0 107.429 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 23.2 p -135.85 162.5 32.64 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 12.5 tt -76.66 144.03 12.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 125.694 1.597 . . . . 0.0 111.971 -162.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 69.3 m -90.05 155.96 18.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.506 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -53.48 -38.77 63.97 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.929 0.892 . . . . 0.0 111.655 -174.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -62.53 -47.97 81.58 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -69.67 -34.11 73.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -42.52 94.41 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.8 0.84 . . . . 0.0 112.408 169.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -57.91 -27.14 63.06 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.659 -1.276 . . . . 0.0 114.443 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -68.93 -21.84 64.18 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 118.996 0.816 . . . . 0.0 112.412 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -116.52 62.95 0.37 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.088 1.804 . . . . 0.0 112.888 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -148.21 166.25 28.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.832 1.653 . . . . 0.0 109.371 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 4.2 pt -144.83 148.88 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.125 0.97 . . . . 0.0 112.143 167.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.6 m -74.17 160.38 31.27 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.4 1.88 . . . . 0.0 112.815 165.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -53.76 -35.62 61.47 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.804 1.242 . . . . 0.0 112.323 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -60.3 -30.08 69.25 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.299 1.04 . . . . 0.0 113.258 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.33 -26.24 18.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.568 1.147 . . . . 0.0 112.123 172.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 8.2 ttm -61.77 -38.98 90.05 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 120.785 -1.197 . . . . 0.0 111.366 174.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -80.15 22.18 0.54 Allowed 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 171.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.38 -31.46 1.09 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 5.5 mp -74.5 137.85 42.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.64 1.176 . . . . 0.0 111.402 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 81.1 p -63.64 -31.89 73.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.429 HG23 ' CD2' ' A' ' 410' ' ' PHE . 1.5 m -63.54 -19.54 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.38 1.472 . . . . 0.0 114.677 173.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.429 ' CD2' HG23 ' A' ' 409' ' ' VAL 0.308 65.7 m-85 -109.41 3.08 21.06 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 119.152 3.019 . . . . 0.0 119.152 -176.41 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -29.12 67.05 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 37.5 t -126.43 -34.94 2.42 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.064 1.346 . . . . 0.0 112.829 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -72.02 139.61 48.63 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -142.41 130.32 11.47 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.709 1.204 . . . . 0.0 112.15 -170.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -76.48 -166.28 0.36 Allowed 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 124.3 3.334 . . . . 0.0 113.156 164.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.411 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 91.16 13.8 58.35 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 117.688 1.835 . . . . 0.0 117.688 156.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -102.38 149.87 37.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 119.613 1.706 . . . . 0.0 113.088 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.54 109.53 2.92 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.583 2.856 . . . . 0.0 112.355 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.488 HD22 ' H ' ' A' ' 421' ' ' ARG . 7.0 t30 -148.38 145.0 27.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.347 1.059 . . . . 0.0 109.098 164.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 24.2 p -76.0 -2.66 31.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.488 ' H ' HD22 ' A' ' 419' ' ' ASN . 33.8 mtp85 -130.09 147.08 51.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.888 2.075 . . . . 0.0 108.901 177.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 3.3 pt -131.81 161.18 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 126.386 1.875 . . . . 0.0 109.431 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -136.8 161.44 35.98 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.7 t -131.65 140.68 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.453 1.501 . . . . 0.0 111.655 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -120.56 166.23 13.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.544 1.537 . . . . 0.0 109.36 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 69.49 36.88 2.1 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -171.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.8 160.2 26.23 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 120.148 -1.595 . . . . 0.0 112.221 168.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -79.02 176.15 9.92 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.002 1.721 . . . . 0.0 115.282 -171.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -77.93 -48.04 17.24 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 171.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -72.8 -36.04 67.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.656 1.182 . . . . 0.0 113.179 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.64 153.95 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -130.93 163.55 27.24 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.467 1.507 . . . . 0.0 111.566 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -52.62 -31.06 34.71 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.548 1.139 . . . . 0.0 113.408 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -60.08 -33.04 71.53 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 171.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -76.88 -26.82 54.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.427 1.491 . . . . 0.0 114.494 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.44 -19.98 60.83 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.044 1.738 . . . . 0.0 113.549 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.76 -25.88 61.08 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.587 1.085 . . . . 0.0 112.358 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -59.29 -38.87 81.25 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.552 0.741 . . . . 0.0 111.5 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mt -94.47 -56.97 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 121.26 -0.9 . . . . 0.0 110.632 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -60.25 -28.33 67.95 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -77.57 -12.75 84.21 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.437 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -55.12 -40.4 70.46 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.135 1.467 . . . . 0.0 112.064 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -80.89 -5.96 58.04 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.403 1.881 . . . . 0.0 112.022 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.61 117.54 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.154 1.782 . . . . 0.0 110.726 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -69.07 90.87 0.47 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.299 30.7 m-85 -59.14 -16.05 17.73 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 118.198 2.666 . . . . 0.0 118.198 177.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.9 t -66.73 -26.26 66.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.854 1.207 . . . . 0.0 112.295 171.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.1 m -110.23 120.76 43.46 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.636 1.574 . . . . 0.0 112.303 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -58.23 -44.11 88.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.005 -1.059 . . . . 0.0 112.826 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.11 -7.14 0.46 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -100.0 -55.6 2.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.842 1.257 . . . . 0.0 109.768 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -70.58 -24.13 62.71 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.485 1.114 . . . . 0.0 112.691 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.5 tt -59.24 -31.91 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.8 1.64 . . . . 0.0 112.694 171.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 36.1 mtp -86.71 -9.24 56.37 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.23 1.412 . . . . 0.0 112.485 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.22 122.23 46.51 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -170.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -159.62 119.33 2.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.215 1.006 . . . . 0.0 110.981 -170.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 8.1 mt -102.59 133.03 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.986 0.914 . . . . 0.0 111.323 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -133.19 120.46 21.2 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.004 0.921 . . . . 0.0 110.388 170.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 7.8 tt -108.76 129.63 55.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.132 1.773 . . . . 0.0 110.101 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -77.96 109.53 12.09 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.421 1.489 . . . . 0.0 110.982 176.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -85.0 -8.95 58.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pm0 -130.92 159.62 36.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -167.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 65.02 -160.25 42.62 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.965 1.269 . . . . 0.0 114.98 164.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -18.64 60.52 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 40.9 mtp -99.71 11.65 38.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.054 1.341 . . . . 0.0 113.029 174.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -54.03 113.01 1.07 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.512 1.125 . . . . 0.0 110.306 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.81 31.39 23.97 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.282 0.944 . . . . 0.0 113.875 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -106.4 155.35 19.63 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.517 1.127 . . . . 0.0 110.412 157.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.2 154.48 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.962 -1.086 . . . . 0.0 113.604 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -116.23 144.41 44.23 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.653 1.981 . . . . 0.0 115.58 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.25 118.27 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.554 1.941 . . . . 0.0 110.026 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -81.95 142.02 22.12 Favored Glycine 0 CA--C 1.534 1.249 0 O-C-N 121.447 -0.783 . . . . 0.0 111.383 159.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.6 mt -120.87 160.8 43.25 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.059 1.344 . . . . 0.0 109.986 174.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.78 -6.19 17.84 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.527 2.152 . . . . 0.0 114.447 -175.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -155.59 143.56 19.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.563 0.745 . . . . 0.0 111.466 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.31 -43.31 32.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.407 1.483 . . . . 0.0 112.469 162.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -62.54 -34.96 77.96 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.466 -0.771 . . . . 0.0 113.017 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -70.03 -37.43 75.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.413 0.685 . . . . 0.0 111.816 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.74 80.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.394 0.997 . . . . 0.0 111.783 170.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.03 -34.07 67.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.583 0.753 . . . . 0.0 112.398 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -75.11 -49.39 19.76 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.849 1.26 . . . . 0.0 112.848 170.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.7 -29.73 68.3 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.575 -0.703 . . . . 0.0 112.602 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.471 HD23 HG12 ' A' ' 498' ' ' VAL . 65.9 mt -71.71 -28.84 63.97 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.299 1.04 . . . . 0.0 113.412 173.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -67.57 -37.72 83.04 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.575 0.75 . . . . 0.0 111.033 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -91.71 -56.49 3.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -169.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -74.35 -18.22 60.72 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -75.65 111.6 11.15 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.221 -0.924 . . . . 0.0 111.002 -174.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 107.12 8.49 31.36 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.022 -168.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -75.79 126.73 31.56 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.444 1.622 . . . . 0.0 110.082 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.316 1.2 t -97.76 45.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.473 1.509 . . . . 0.0 114.704 -162.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 36.0 tp -52.8 123.72 12.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.027 1.731 . . . . 0.0 111.218 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.37 65.7 m-85 57.84 11.58 1.42 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 118.345 2.72 . . . . 0.0 118.345 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 87.06 18.87 57.07 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 120.871 -1.143 . . . . 0.0 114.234 -171.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -121.69 118.95 29.34 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.536 1.535 . . . . 0.0 109.384 175.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -72.92 117.11 4.98 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.831 1.687 . . . . 0.0 111.893 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 32.2 mtp -71.65 130.97 42.49 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.974 1.71 . . . . 0.0 111.272 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.32 106.42 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.055 1.342 . . . . 0.0 108.088 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.471 HG12 HD23 ' A' ' 483' ' ' LEU . 11.6 t -98.95 123.72 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.302 1.441 . . . . 0.0 110.331 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -138.94 160.47 39.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.057 0.932 . . . . 0.0 112.972 -175.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -55.2 140.92 37.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.507 0.723 . . . . 0.0 111.611 167.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -62.84 149.7 43.59 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.721 -0.612 . . . . 0.0 112.245 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -73.33 -19.06 61.11 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.834 1.791 . . . . 0.0 115.834 -168.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 48.0 t -158.52 -36.03 0.07 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -85.97 139.47 31.17 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -164.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -152.98 42.67 0.22 Allowed Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 126.364 1.865 . . . . 0.0 114.823 170.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.51 179.3 5.69 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 124.626 3.551 . . . . 0.0 114.97 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -142.43 101.6 3.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.946 2.099 . . . . 0.0 110.714 169.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -72.53 135.2 45.57 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.381 -0.824 . . . . 0.0 112.666 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -70.47 148.72 95.49 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.09 149.43 36.32 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.288 2.659 . . . . 0.0 113.82 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 153.04 28.0 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.101 1.761 . . . . 0.0 113.889 173.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -78.29 65.44 3.63 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.418 1.487 . . . . 0.0 112.907 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -99.79 -171.3 30.2 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.67 1.605 . . . . 0.0 113.614 173.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -142.01 150.77 41.75 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.879 1.271 . . . . 0.0 112.612 173.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.35 -35.74 15.05 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.895 1.278 . . . . 0.0 113.235 177.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt . . . . . 0 C--O 1.251 1.136 0 C-N-CA 126.075 1.75 . . . . 0.0 113.34 173.387 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.46 166.84 19.58 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 16.2 pm0 -66.83 -19.31 65.72 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 98.5 mtp -66.06 138.3 96.16 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.553 1.141 . . . . 0.0 111.616 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.68 134.95 36.92 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 122.643 2.229 . . . . 0.0 112.477 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 43.1 t -153.76 129.76 10.28 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.911 1.285 . . . . 0.0 110.918 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -149.77 129.0 12.81 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.916 0.886 . . . . 0.0 110.141 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 8.1 p -148.03 167.69 24.27 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -173.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.03 146.23 8.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 123.654 0.782 . . . . 0.0 111.133 -169.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 31.6 m -87.67 149.8 24.03 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -66.31 -27.81 68.2 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.976 -1.077 . . . . 0.0 112.704 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -67.34 -23.41 65.61 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 171.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -74.39 -52.43 12.16 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.307 0.958 . . . . 0.0 110.917 163.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.8 -45.12 78.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.914 1.286 . . . . 0.0 112.895 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -56.04 -17.98 8.32 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.597 1.959 . . . . 0.0 115.481 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -72.26 -30.63 65.04 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.936 -1.102 . . . . 0.0 112.811 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -118.62 90.63 0.5 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.612 1.101 . . . . 0.0 113.468 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 -164.71 147.73 8.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.504 1.122 . . . . 0.0 111.343 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.7 pt -126.76 158.7 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.671 1.188 . . . . 0.0 112.88 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.59 179.23 4.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.975 1.31 . . . . 0.0 111.074 163.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -61.84 -20.9 64.17 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 120.558 -1.339 . . . . 0.0 114.259 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -78.03 -29.09 49.24 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.063 0.945 . . . . 0.0 112.002 -173.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.87 -33.17 24.87 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.712 -1.243 . . . . 0.0 110.982 161.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 29.4 ttm -63.02 -38.45 91.22 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.438 -1.414 . . . . 0.0 113.371 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -83.22 12.83 4.74 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.285 -0.884 . . . . 0.0 112.196 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.62 -29.69 5.0 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.233 2.213 . . . . 0.0 115.119 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.82 128.1 34.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.908 1.283 . . . . 0.0 109.898 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 75.6 p -63.43 -27.01 69.0 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.299 -0.875 . . . . 0.0 111.38 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . 0.273 2.2 m -68.97 -16.02 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 171.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -119.6 -17.07 8.75 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 119.189 3.033 . . . . 0.0 119.189 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.24 -8.84 0.35 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 54.1 p -137.47 12.77 3.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.949 1.3 . . . . 0.0 113.456 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -131.55 137.91 48.67 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.39 1.876 . . . . 0.0 114.41 -173.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -142.66 129.02 10.68 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -157.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -86.47 -174.28 1.42 Allowed 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 124.736 3.624 . . . . 0.0 113.413 171.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.427 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 72.69 71.77 1.04 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 125.144 1.354 . . . . 0.0 116.13 164.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -145.59 151.96 48.02 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.377 1.471 . . . . 0.0 111.862 172.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.81 95.6 1.07 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.964 3.109 . . . . 0.0 113.0 -172.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.551 HD21 ' HB2' ' A' ' 500' ' ' PHE . 0.3 OUTLIER -163.06 147.83 11.44 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.7 2.0 . . . . 0.0 111.431 166.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.2 p -82.11 18.72 1.3 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -135.16 150.24 50.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.985 1.314 . . . . 0.0 109.99 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.77 157.84 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 126.375 1.87 . . . . 0.0 109.929 -177.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -131.79 162.1 31.33 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.08 140.18 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 125.582 1.553 . . . . 0.0 111.631 -174.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -122.03 170.65 9.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.116 1.367 . . . . 0.0 109.951 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 22.8 t30 66.62 38.73 3.93 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.839 1.256 . . . . 0.0 111.717 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -77.12 139.56 40.0 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.963 -1.086 . . . . 0.0 110.318 167.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.41 142.09 58.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.485 1.514 . . . . 0.0 112.83 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.27 -29.15 60.76 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.649 -1.282 . . . . 0.0 113.932 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -73.35 -31.09 63.76 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.412 HG21 HD21 ' A' ' 491' ' ' LEU . 1.0 OUTLIER -79.69 160.0 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -169.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -134.29 166.94 21.64 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.906 1.283 . . . . 0.0 111.326 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -59.89 -33.09 71.38 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.526 -1.359 . . . . 0.0 113.018 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -57.42 -22.04 40.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.871 1.668 . . . . 0.0 115.018 170.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.64 -33.08 18.95 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.749 1.619 . . . . 0.0 115.094 169.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.81 -25.27 67.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.89 0.876 . . . . 0.0 112.272 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -53.56 -30.97 44.66 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.341 1.056 . . . . 0.0 111.472 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.36 -41.59 97.32 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.945 1.298 . . . . 0.0 111.781 -173.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mt -91.81 -57.49 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 120.64 -1.287 . . . . 0.0 110.826 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -55.98 -36.04 67.42 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -74.69 -9.19 82.54 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.145 -0.808 . . . . 0.0 114.454 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -60.08 -29.03 68.29 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.36 1.58 . . . . 0.0 111.543 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -93.91 16.26 14.74 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.117 1.767 . . . . 0.0 114.341 -174.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 451' ' ' GLN . 96.7 t -128.47 119.23 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.228 1.811 . . . . 0.0 107.52 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . 0.257 57.3 m-20 -68.89 73.6 0.27 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 173.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -49.78 -22.49 1.44 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 120.044 3.35 . . . . 0.0 120.044 -169.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 17.2 m -71.99 -13.55 61.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.742 1.61 . . . . 0.0 112.935 172.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 4.8 t -104.39 123.38 47.32 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.19 1.396 . . . . 0.0 110.887 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -56.79 -45.39 82.22 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.394 -0.816 . . . . 0.0 112.068 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.3 t -55.18 -15.1 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . 0.456 ' HB3' HG13 ' A' ' 444' ' ' VAL . 43.4 mm-40 -88.86 -61.75 1.64 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.905 0.882 . . . . 0.0 109.854 173.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -69.13 -24.52 64.11 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.854 1.262 . . . . 0.0 113.518 -172.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 11.3 tt -64.22 -33.45 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.505 1.522 . . . . 0.0 112.413 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 62.8 mmm -80.6 -13.71 58.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.104 1.362 . . . . 0.0 111.453 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -107.66 127.35 53.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.774 2.03 . . . . 0.0 113.804 -171.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -162.56 138.5 7.34 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.2 mt -119.85 136.79 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.69 1.196 . . . . 0.0 110.543 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -130.19 138.58 50.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.646 1.178 . . . . 0.0 111.071 164.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 2.1 tt -109.74 131.95 54.59 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.63 1.572 . . . . 0.0 109.127 172.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -90.57 134.81 34.12 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.667 1.587 . . . . 0.0 111.547 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -130.71 9.19 4.97 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -158.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -148.47 156.31 42.3 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.558 1.143 . . . . 0.0 111.975 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 61.34 -161.13 26.55 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.626 1.107 . . . . 0.0 114.911 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.71 -27.13 62.66 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.249 -1.148 . . . . 0.0 113.425 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 28.0 ttm -85.25 -2.8 58.45 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.423 1.089 . . . . 0.0 113.359 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -54.04 128.03 28.92 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.48 1.112 . . . . 0.0 111.868 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.3 27.22 66.36 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.403 1.001 . . . . 0.0 112.913 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -109.7 161.93 14.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.302 1.441 . . . . 0.0 110.71 160.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -150.12 157.19 42.86 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.94 1.296 . . . . 0.0 112.876 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -118.35 147.04 43.91 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 168.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.17 126.09 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.724 1.609 . . . . 0.0 110.339 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -93.62 150.09 19.72 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.482 -0.761 . . . . 0.0 112.001 161.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 18.7 mt -128.64 163.2 46.55 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.098 1.759 . . . . 0.0 110.758 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.53 -3.36 13.26 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.484 2.789 . . . . 0.0 115.552 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -155.72 150.82 26.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.881 1.272 . . . . 0.0 111.602 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -53.77 -43.52 69.28 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.513 -0.742 . . . . 0.0 112.859 163.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -60.38 -40.33 90.44 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.581 1.152 . . . . 0.0 113.003 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.59 99.1 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.588 0.555 . . . . 0.0 111.412 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.62 -42.64 77.81 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.212 0.915 . . . . 0.0 112.164 174.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -57.24 -43.69 83.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.48 0.712 . . . . 0.0 111.746 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -68.3 -51.96 39.03 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.084 0.954 . . . . 0.0 111.339 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.53 -29.8 66.59 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.545 HD23 HG12 ' A' ' 498' ' ' VAL . 29.4 mt -70.69 -47.67 58.64 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.56 1.073 . . . . 0.0 111.144 172.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -57.89 -34.55 69.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.945 0.898 . . . . 0.0 112.149 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.49 -49.13 7.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.208 1.003 . . . . 0.0 112.925 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -82.14 -20.06 38.72 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -66.37 105.14 1.37 Allowed 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.171 -0.956 . . . . 0.0 110.588 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 110.27 -0.92 29.63 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.004 -1.442 . . . . 0.0 116.148 -173.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -68.23 122.48 18.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.921 1.86 . . . . 0.0 113.836 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.299 1.7 t -86.43 57.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -166.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 431' ' ' VAL . 15.2 tp -55.11 114.16 1.65 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.832 2.053 . . . . 0.0 111.436 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.332 61.3 m-85 58.42 23.17 10.33 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 -178.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 85.31 15.31 66.84 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 121.393 -0.817 . . . . 0.0 114.53 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.32 115.59 18.54 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.397 1.479 . . . . 0.0 110.672 -176.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.35 114.92 4.1 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.889 2.392 . . . . 0.0 112.149 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 72.3 mtp -68.98 128.07 35.38 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.834 1.254 . . . . 0.0 112.393 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 34.9 t -90.92 79.44 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.66 1.584 . . . . 0.0 110.799 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.545 HG12 HD23 ' A' ' 483' ' ' LEU . 2.6 t -83.24 126.93 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.627 1.971 . . . . 0.0 112.534 -174.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -145.19 157.64 44.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.996 1.318 . . . . 0.0 113.652 -170.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . 0.551 ' HB2' HD21 ' A' ' 419' ' ' ASN . 44.1 p90 -63.05 146.39 53.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.679 0.792 . . . . 0.0 110.936 173.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.1 131.77 48.48 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.562 -0.711 . . . . 0.0 111.004 173.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -99.24 -40.37 7.98 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -123.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 1.2 t 46.81 26.86 0.61 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.82 2.048 . . . . 0.0 115.983 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . 53.44 31.17 11.66 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.32 1.848 . . . . 0.0 115.837 -170.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -119.99 50.22 1.61 Allowed Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -163.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.51 142.4 53.79 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.511 2.14 . . . . 0.0 112.318 173.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.76 157.49 40.24 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.485 1.514 . . . . 0.0 111.615 169.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.3 tp60 -71.05 151.2 44.8 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.5 0.72 . . . . 0.0 111.44 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -56.9 140.24 76.96 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 -164.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -73.75 -35.06 4.82 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.021 2.48 . . . . 0.0 114.559 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.61 159.39 27.55 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.357 1.463 . . . . 0.0 112.107 174.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 21.8 pm0 -63.59 -22.87 67.13 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -176.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 76.8 -56.83 3.48 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.593 -1.317 . . . . 0.0 112.455 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt 60.09 -45.97 0.09 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 130.205 3.402 . . . . 0.0 117.029 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -56.46 135.5 54.24 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.174 2.19 . . . . 0.0 110.279 172.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.409 1.484 . . . . 0.0 110.381 175.966 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 9.2 m . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.62 -41.12 79.96 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 117.117 2.266 . . . . 0.0 117.117 -175.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -150.56 16.35 0.8 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -171.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 97.7 mtp -69.15 148.01 97.56 Favored Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 120.528 -1.357 . . . . 0.0 112.169 170.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.5 9.41 2.21 Favored 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 124.125 3.216 . . . . 0.0 115.042 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 87.8 p -146.82 167.3 24.24 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.886 2.474 . . . . 0.0 109.709 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -123.28 126.38 46.79 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 120.824 -1.172 . . . . 0.0 111.395 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.4 p -147.97 160.41 42.86 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.008 1.323 . . . . 0.0 111.697 172.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.9 tt -70.95 145.89 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 125.707 1.603 . . . . 0.0 111.071 -166.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 10.6 m -78.54 146.3 34.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -56.57 -41.63 77.22 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.624 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -62.59 -32.48 73.48 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -73.5 -41.73 62.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.835 0.854 . . . . 0.0 113.179 170.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.22 -46.9 88.54 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.866 0.866 . . . . 0.0 110.661 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -58.49 -24.72 61.16 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.425 1.89 . . . . 0.0 115.16 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 48.0 mmtt -62.56 -49.9 73.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.995 0.816 . . . . 0.0 111.333 168.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.87 65.27 3.28 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.175 1.845 . . . . 0.0 112.351 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -153.41 137.57 16.48 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.916 1.286 . . . . 0.0 110.873 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.3 pt -121.57 157.43 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.597 1.159 . . . . 0.0 113.284 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.0 m -95.8 169.01 10.3 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.267 1.427 . . . . 0.0 112.199 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -54.3 -31.07 53.12 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.902 -1.124 . . . . 0.0 113.433 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -60.68 -25.64 66.53 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.561 1.145 . . . . 0.0 113.167 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.0 -41.5 10.51 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.671 1.188 . . . . 0.0 110.988 169.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 15.9 ttm -65.87 -30.93 71.61 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.817 -1.177 . . . . 0.0 113.098 -172.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -82.97 6.35 19.0 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.318 -0.864 . . . . 0.0 112.823 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.93 -30.53 4.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.989 2.116 . . . . 0.0 114.051 -176.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.403 ' HB3' HG22 ' A' ' 409' ' ' VAL . 40.3 mt -74.12 129.5 37.96 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.581 1.552 . . . . 0.0 111.343 174.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 88.3 p -59.29 -34.2 72.0 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.628 -0.67 . . . . 0.0 111.989 171.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 407' ' ' LEU . 33.7 m -60.38 -22.98 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 117.559 -1.21 . . . . 0.0 113.523 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.339 69.7 m-85 -94.55 2.0 55.66 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 119.113 3.005 . . . . 0.0 119.113 174.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -50.27 -23.58 2.37 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 -164.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 19.0 m -143.23 20.95 1.91 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.484 1.114 . . . . 0.0 112.926 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -135.71 133.87 38.51 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.343 1.457 . . . . 0.0 109.244 -161.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.412 ' HA ' ' HD2' ' A' ' 415' ' ' PRO . 45.0 mt-10 -136.33 92.92 15.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -165.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 414' ' ' GLU . 54.3 Cg_endo -64.76 159.65 44.48 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.201 3.267 . . . . 0.0 113.608 165.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 84.32 0.67 89.49 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.021 1.296 . . . . 0.0 113.305 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -77.3 136.11 65.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.409 1.484 . . . . 0.0 112.447 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.51 126.6 9.11 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.33 2.687 . . . . 0.0 112.48 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -160.41 152.39 20.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.537 1.535 . . . . 0.0 109.156 158.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.9 p -77.87 3.15 15.15 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.101 -1.624 . . . . 0.0 114.59 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -135.91 145.58 46.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.669 2.387 . . . . 0.0 108.961 171.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 12.7 pt -124.46 165.82 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.496 1.918 . . . . 0.0 110.071 174.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.86 159.09 42.9 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 174.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.489 HG22 HG13 ' A' ' 498' ' ' VAL . 8.6 t -132.07 132.93 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.409 1.483 . . . . 0.0 110.897 -174.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -106.56 164.53 11.99 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.693 1.197 . . . . 0.0 109.936 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 16.5 t30 68.2 39.36 2.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.839 1.256 . . . . 0.0 113.394 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.67 150.02 41.55 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.421 -0.799 . . . . 0.0 111.459 171.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.51 160.56 8.74 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.168 1.387 . . . . 0.0 114.471 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -62.26 -43.36 99.01 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.99 -1.069 . . . . 0.0 112.491 169.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -70.61 -35.33 72.92 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.1 p -71.51 149.3 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -170.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -123.2 166.84 14.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.423 1.489 . . . . 0.0 112.556 170.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -55.39 -33.58 63.61 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.826 -1.171 . . . . 0.0 112.719 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 9.1 pttm -62.87 -28.99 70.41 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.77 -37.44 48.98 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.189 0.996 . . . . 0.0 113.469 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.01 -20.54 54.0 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.404 1.882 . . . . 0.0 113.39 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.99 -18.97 5.77 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 171.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -61.81 -38.97 90.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.829 0.852 . . . . 0.0 112.009 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.29 -51.86 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.297 -0.877 . . . . 0.0 110.032 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -63.37 -33.1 74.81 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.2 -12.8 83.27 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 123.478 0.561 . . . . 0.0 114.121 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -58.8 -34.61 71.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.926 1.291 . . . . 0.0 112.565 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -79.93 -6.41 57.43 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.897 1.679 . . . . 0.0 113.548 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.27 111.24 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.984 1.714 . . . . 0.0 111.085 -172.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -69.84 86.78 0.51 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -54.04 -23.94 15.39 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 118.482 2.771 . . . . 0.0 118.482 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 61.2 m -65.75 -21.72 66.54 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.1 m -109.87 121.99 46.51 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.327 1.851 . . . . 0.0 111.88 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.75 -45.91 88.63 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.275 -0.891 . . . . 0.0 113.037 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -17.15 5.48 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -89.87 -57.01 3.01 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.64 0.776 . . . . 0.0 108.984 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -72.58 -21.06 61.2 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.265 1.426 . . . . 0.0 113.539 -173.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 17.0 tt -62.89 -36.26 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.295 1.838 . . . . 0.0 112.265 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.4 mtm -87.36 -8.0 57.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.829 0.851 . . . . 0.0 112.208 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -102.91 124.67 48.86 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -173.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.42 158.98 21.74 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.978 1.311 . . . . 0.0 108.626 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 6.0 mt -123.24 147.99 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.002 1.321 . . . . 0.0 111.224 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -134.93 132.37 38.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.31 2.244 . . . . 0.0 109.457 169.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 15.4 tp -124.93 113.13 17.44 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.877 2.071 . . . . 0.0 110.776 172.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 57.3 mtm -70.68 108.34 4.36 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.649 1.18 . . . . 0.0 111.454 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -96.48 10.8 37.19 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -147.23 154.16 40.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.158 1.783 . . . . 0.0 110.821 -174.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 85.18 -166.8 40.82 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.286 1.422 . . . . 0.0 116.273 168.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -11.17 2.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.622 1.969 . . . . 0.0 116.007 -172.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 24.7 ptp -140.7 41.53 1.86 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.948 1.699 . . . . 0.0 112.468 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -52.81 133.39 37.3 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.465 1.106 . . . . 0.0 111.709 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.07 31.71 34.16 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 124.476 1.036 . . . . 0.0 113.34 -177.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -125.99 147.76 49.45 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.539 0.736 . . . . 0.0 111.389 172.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -139.48 155.42 47.57 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.93 1.292 . . . . 0.0 114.038 -165.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -119.87 142.48 48.62 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.757 2.023 . . . . 0.0 114.96 171.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.2 mp -141.44 120.4 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.812 1.645 . . . . 0.0 110.893 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -83.01 140.02 19.69 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.433 -0.792 . . . . 0.0 111.397 163.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 20.8 mt -120.33 158.0 52.1 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.428 1.091 . . . . 0.0 110.766 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.53 -11.75 28.56 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.01 2.473 . . . . 0.0 114.405 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -151.27 142.45 23.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.821 0.849 . . . . 0.0 110.804 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -53.7 -35.46 61.15 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.204 1.402 . . . . 0.0 112.391 167.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -65.91 -38.5 88.87 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.99 85.86 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.309 0.504 . . . . 0.0 110.695 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.38 78.76 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 170.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.64 -36.46 69.53 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.243 0.929 . . . . 0.0 112.553 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -73.52 -53.62 10.17 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.096 1.359 . . . . 0.0 112.694 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.17 -31.75 69.27 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.614 HD23 HG12 ' A' ' 498' ' ' VAL . 49.1 mt -69.22 -42.6 75.49 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.573 -0.705 . . . . 0.0 112.387 176.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.1 -34.47 78.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.446 0.698 . . . . 0.0 111.991 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -82.1 -51.28 8.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.116 1.366 . . . . 0.0 114.37 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.61 -16.31 61.73 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.19 106.08 0.48 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.003 1.721 . . . . 0.0 112.361 174.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 112.23 -6.73 26.89 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 118.49 -1.172 . . . . 0.0 114.949 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -71.7 128.39 35.65 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.154 1.477 . . . . 0.0 107.324 -174.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.253 5.8 p -122.72 63.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 124.185 1.945 . . . . 0.0 110.427 -162.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.16 131.22 50.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.485 1.914 . . . . 0.0 110.913 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.371 52.1 m-85 56.05 21.72 5.31 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -175.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 77.93 8.03 87.39 Favored Glycine 0 CA--C 1.537 1.466 0 O-C-N 121.027 -1.046 . . . . 0.0 114.351 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -112.78 112.59 50.61 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.861 1.664 . . . . 0.0 110.196 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.9 121.28 7.2 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.713 2.275 . . . . 0.0 110.965 -174.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 41.7 mtp -79.77 124.44 28.61 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.614 1.566 . . . . 0.0 110.747 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 36.0 t -93.83 84.16 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.99 1.316 . . . . 0.0 110.719 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.614 HG12 HD23 ' A' ' 483' ' ' LEU . 2.0 t -77.78 131.84 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.012 1.725 . . . . 0.0 112.605 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -145.01 158.44 43.81 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.021 1.328 . . . . 0.0 113.469 -172.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -61.88 147.32 47.05 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.18 -0.95 . . . . 0.0 108.441 164.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -62.38 138.97 58.55 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.452 -0.78 . . . . 0.0 112.975 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 13.3 tpp85 -54.92 111.14 0.77 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.617 1.567 . . . . 0.0 113.811 -158.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 35.7 t -158.84 169.82 23.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.438 2.695 . . . . 0.0 109.898 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -141.0 49.39 1.67 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.131 1.373 . . . . 0.0 113.134 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -135.23 78.04 53.27 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.535 1.534 . . . . 0.0 112.439 -173.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -59.18 148.33 86.38 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.136 2.557 . . . . 0.0 115.574 -170.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -137.2 22.95 3.01 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.351 2.66 . . . . 0.0 110.998 172.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -152.47 145.22 24.31 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.324 2.65 . . . . 0.0 110.448 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.23 147.12 76.38 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.92 -17.84 24.96 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.831 2.354 . . . . 0.0 115.936 -167.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -120.28 154.74 34.52 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.027 1.331 . . . . 0.0 112.556 168.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -85.45 24.21 1.21 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.335 1.854 . . . . 0.0 114.346 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 77.34 173.65 39.74 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.635 1.588 . . . . 0.0 114.565 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.88 145.98 25.31 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.818 1.247 . . . . 0.0 112.459 176.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -108.48 -12.09 15.06 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 174.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 92.5 mttt . . . . . 0 C--O 1.251 1.153 0 CA-C-O 117.546 -1.216 . . . . 0.0 113.208 176.907 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 95.8 p . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . 0.33 53.2 m-20 60.73 7.0 1.27 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 120.404 3.483 . . . . 0.0 120.404 169.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -139.46 137.3 35.45 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.357 1.063 . . . . 0.0 112.09 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 5.8 mtp -155.8 157.97 31.59 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.464 1.506 . . . . 0.0 111.637 175.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -61.3 140.67 89.68 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.269 2.646 . . . . 0.0 114.508 -173.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 9.9 m -83.5 60.55 5.72 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.057 1.743 . . . . 0.0 110.99 -178.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -134.75 136.55 42.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.037 1.335 . . . . 0.0 111.101 -175.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 25.7 p -151.43 163.26 39.38 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.052 1.741 . . . . 0.0 113.3 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 3.1 tt -72.44 158.35 6.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.199 1.399 . . . . 0.0 111.196 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 66.2 m -96.41 150.87 20.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.052 0.941 . . . . 0.0 110.797 168.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -56.75 -39.45 74.03 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 111.281 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -68.58 -26.4 65.37 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -78.68 -38.62 38.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.973 1.26 . . . . 0.0 112.811 166.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.08 -45.83 91.62 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.857 0.863 . . . . 0.0 112.385 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -56.1 -25.55 46.2 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.938 1.295 . . . . 0.0 114.091 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -69.8 -25.36 63.75 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.053 0.941 . . . . 0.0 112.98 176.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -105.17 72.95 0.23 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.088 1.328 . . . . 0.0 110.969 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -156.11 141.52 17.63 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.568 1.147 . . . . 0.0 109.316 -174.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.7 pt -115.3 155.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 83.4 p -67.4 160.14 28.0 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.393 1.477 . . . . 0.0 111.749 161.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 52.2 mmt-85 -61.87 -30.64 70.99 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.606 -0.684 . . . . 0.0 111.139 168.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.49 -42.34 95.92 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.451 0.7 . . . . 0.0 112.103 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -36.01 77.51 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.671 0.669 . . . . 0.0 109.621 172.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 11.3 ttp -65.01 -39.88 94.09 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 120.556 -1.34 . . . . 0.0 112.078 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -81.03 15.86 1.7 Allowed 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.73 -35.95 2.98 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.798 2.039 . . . . 0.0 116.485 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.31 125.21 25.71 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.694 1.197 . . . . 0.0 108.994 172.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.2 m -65.12 -17.76 64.73 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.89 -25.49 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 170.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . 0.31 75.8 m-85 -98.35 10.49 40.63 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 118.565 2.802 . . . . 0.0 118.565 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -60.31 -19.0 53.42 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 9.6 t -139.13 -35.58 0.55 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.816 1.646 . . . . 0.0 112.68 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -76.12 145.8 39.73 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -138.46 129.82 15.57 Favored Pre-proline 0 N--CA 1.478 0.951 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -168.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.6 172.33 13.54 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.586 2.857 . . . . 0.0 113.983 170.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.426 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 95.8 -21.33 45.43 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 116.954 1.541 . . . . 0.0 116.954 164.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.09 138.54 96.2 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 119.019 1.41 . . . . 0.0 112.588 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.27 116.85 4.77 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.283 2.655 . . . . 0.0 113.23 -174.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -153.66 146.93 24.75 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.201 1.4 . . . . 0.0 108.595 164.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 30.1 p -73.8 6.21 3.43 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -144.47 145.46 31.89 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.306 1.842 . . . . 0.0 108.921 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 27.7 pt -133.99 164.13 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.554 1.942 . . . . 0.0 109.865 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -136.01 162.23 33.45 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 172.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.4 p -140.03 146.95 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.934 1.294 . . . . 0.0 110.696 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . 0.514 ' HB2' ' HG2' ' A' ' 468' ' ' GLN . 17.1 ptpt -131.13 -175.38 3.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.283 0.633 . . . . 0.0 111.062 165.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.0 t30 66.44 38.33 4.33 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.072 1.349 . . . . 0.0 111.305 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.17 148.14 34.21 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.819 0.848 . . . . 0.0 110.447 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.68 173.83 9.94 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.636 1.975 . . . . 0.0 115.062 -173.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -60.88 -53.98 50.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.747 1.219 . . . . 0.0 113.507 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -78.39 -19.18 53.87 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.436 1.494 . . . . 0.0 114.731 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.55 148.72 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -173.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -129.32 162.88 26.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.186 1.794 . . . . 0.0 110.399 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -59.16 -28.67 66.81 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 119.47 -2.019 . . . . 0.0 112.403 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -58.13 -30.97 66.75 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -72.7 -36.28 67.81 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 173.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.25 -27.35 66.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.626 0.77 . . . . 0.0 111.692 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.34 -31.33 61.63 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.823 0.849 . . . . 0.0 112.748 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -61.35 -30.03 70.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.013 1.325 . . . . 0.0 111.697 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 5.7 mt -106.6 -57.66 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.682 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -58.85 -30.77 67.95 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -76.53 -8.74 86.1 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.87 -0.961 . . . . 0.0 114.661 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -64.82 -21.74 66.85 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.376 1.588 . . . . 0.0 112.63 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -92.64 4.46 53.63 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.874 1.67 . . . . 0.0 113.566 -177.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.7 108.73 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.289 1.836 . . . . 0.0 110.622 -171.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -64.53 99.86 0.33 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . 0.311 17.8 m-85 -62.62 -16.18 55.4 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 64.7 m -64.83 -16.12 62.7 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 169.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 16.4 m -130.49 117.82 20.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.443 1.097 . . . . 0.0 112.713 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -60.44 -39.94 89.29 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.007 -1.058 . . . . 0.0 112.39 -174.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.6 t -56.44 -13.95 2.66 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -86.91 -63.84 1.25 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.983 0.913 . . . . 0.0 109.546 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 5.9 ptt85 -69.81 -22.78 63.28 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.517 1.527 . . . . 0.0 114.16 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.8 tt -57.87 -35.39 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.257 1.023 . . . . 0.0 111.899 171.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 21.6 mtm -90.37 -2.95 58.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.948 1.299 . . . . 0.0 112.228 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -105.89 129.56 54.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.77 2.028 . . . . 0.0 116.086 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -166.14 149.03 7.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.963 1.305 . . . . 0.0 109.399 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 7.9 mt -120.65 136.53 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.494 1.518 . . . . 0.0 111.807 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -114.74 141.33 47.99 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.974 1.31 . . . . 0.0 110.571 158.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 13.7 tp -120.61 114.54 21.87 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.562 1.545 . . . . 0.0 109.212 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -71.28 120.33 16.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.98 1.312 . . . . 0.0 109.274 169.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . 0.413 ' O ' ' HE2' ' A' ' 466' ' ' LYS . 10.1 mtpt -113.51 12.86 18.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.753 1.621 . . . . 0.0 113.035 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -142.23 152.65 43.29 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.306 1.843 . . . . 0.0 112.126 -167.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 59.58 -144.08 46.14 Favored Glycine 0 CA--C 1.534 1.269 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 161.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.75 -12.71 2.02 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.065 2.146 . . . . 0.0 116.335 -172.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 24.9 ptp -145.44 41.13 1.23 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.507 1.123 . . . . 0.0 112.539 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 461' ' ' LYS . 23.6 ttmt -60.38 122.44 14.56 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.409 1.084 . . . . 0.0 112.256 175.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.65 37.91 18.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.411 1.958 . . . . 0.0 112.858 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . 0.514 ' HG2' ' HB2' ' A' ' 425' ' ' LYS . 43.1 mt-30 -125.83 148.33 49.18 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.211 1.004 . . . . 0.0 110.892 173.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -138.94 151.59 47.02 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -109.08 137.98 46.14 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.829 2.051 . . . . 0.0 114.394 169.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.5 119.77 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.197 1.399 . . . . 0.0 109.968 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -85.2 142.04 19.5 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 162.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 19.3 mt -122.64 160.87 46.78 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.35 1.46 . . . . 0.0 110.343 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.01 -13.07 21.49 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.045 2.497 . . . . 0.0 114.55 -174.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -153.07 146.13 24.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.513 1.125 . . . . 0.0 110.254 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -52.31 -38.82 59.51 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.933 0.893 . . . . 0.0 111.95 165.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -61.42 -37.16 82.48 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.288 1.035 . . . . 0.0 113.122 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.36 90.84 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.262 -0.274 . . . . 0.0 110.947 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.3 -48.43 67.64 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.605 -0.684 . . . . 0.0 112.741 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.66 -28.05 68.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.306 1.042 . . . . 0.0 112.689 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -85.22 -44.27 13.06 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.048 0.939 . . . . 0.0 113.348 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.51 -33.21 71.08 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.881 1.219 . . . . 0.0 112.709 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.449 HD23 HG12 ' A' ' 498' ' ' VAL . 57.2 mt -65.47 -40.04 92.69 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.424 1.09 . . . . 0.0 112.989 174.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -63.34 -42.18 98.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.077 0.551 . . . . 0.0 111.454 174.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -78.87 -43.83 24.17 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -175.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.39 57.54 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -64.12 99.23 0.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.701 1.2 . . . . 0.0 112.245 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 115.45 1.6 21.65 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.469 -1.184 . . . . 0.0 115.044 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -74.44 110.4 8.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.944 1.372 . . . . 0.0 108.929 -169.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.275 6.4 p -93.71 65.77 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.054 1.742 . . . . 0.0 110.372 -170.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.79 129.42 39.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.199 1.8 . . . . 0.0 110.66 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.272 64.0 m-85 54.18 21.81 3.25 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -176.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 86.35 10.22 74.5 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 117.983 -1.454 . . . . 0.0 115.566 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -121.78 115.65 30.66 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 120.217 2.008 . . . . 0.0 111.751 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.44 112.41 3.54 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 123.868 3.045 . . . . 0.0 111.696 -174.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 80.1 mtp -73.64 131.44 41.67 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.855 1.262 . . . . 0.0 113.566 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 24.8 t -90.15 90.07 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.599 1.56 . . . . 0.0 111.502 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.449 HG12 HD23 ' A' ' 483' ' ' LEU . 1.4 t -90.17 129.47 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.889 1.276 . . . . 0.0 114.308 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -149.47 155.57 40.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.847 0.859 . . . . 0.0 112.953 -170.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -53.96 142.05 25.96 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 169.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -58.74 159.4 6.8 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.729 -0.607 . . . . 0.0 112.236 177.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -72.14 10.97 0.63 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -166.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 49.2 m -76.12 150.0 37.28 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.625 2.37 . . . . 0.0 112.98 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -64.47 159.38 21.6 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.775 1.23 . . . . 0.0 113.434 172.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -147.07 84.15 7.54 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 123.619 0.767 . . . . 0.0 112.719 173.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.39 162.9 16.2 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.529 2.82 . . . . 0.0 113.477 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 41.7 tptt 51.85 41.59 29.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.799 1.64 . . . . 0.0 114.084 168.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -104.59 -176.73 3.16 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.92 -1.113 . . . . 0.0 112.79 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.79 141.24 92.96 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 173.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.8 158.22 53.55 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.051 2.5 . . . . 0.0 112.664 177.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 153.39 10.66 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.37 1.068 . . . . 0.0 113.471 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -155.62 137.7 14.62 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.039 1.336 . . . . 0.0 111.19 -176.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . 166.29 -177.04 41.42 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.509 0.576 . . . . 0.0 114.422 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -73.55 154.2 39.93 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.334 1.054 . . . . 0.0 110.945 168.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -138.51 120.92 16.02 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.83 1.252 . . . . 0.0 112.099 -171.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 25.4 pttm . . . . . 0 C--O 1.253 1.242 0 C-N-CA 125.25 1.42 . . . . 0.0 113.699 -178.909 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 111.41 0.152 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -124.43 -28.25 3.65 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 117.484 2.402 . . . . 0.0 117.484 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -134.27 -177.69 4.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.46 1.504 . . . . 0.0 111.715 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' MET . . . . . . . . . . . . . 88.5 mmm 58.51 88.16 0.13 Allowed Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 115.567 1.692 . . . . 0.0 115.567 169.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.71 164.21 34.16 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.683 2.922 . . . . 0.0 113.004 173.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 48.8 m -138.65 51.76 1.82 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.341 1.856 . . . . 0.0 110.611 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -156.25 124.13 5.61 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.759 1.224 . . . . 0.0 111.198 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 14.0 p -142.56 165.07 28.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.65 1.18 . . . . 0.0 113.474 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 7.3 tt -69.02 152.31 9.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 125.65 1.58 . . . . 0.0 111.678 -168.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 59.4 m -84.67 147.87 26.71 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.435 0.694 . . . . 0.0 110.429 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -58.06 -43.01 86.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.414 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -61.43 -29.87 70.21 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.324 1.45 . . . . 0.0 114.52 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -78.14 -49.69 13.4 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.39 1.076 . . . . 0.0 112.696 171.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 26.1 tp -57.89 -42.29 84.35 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.56 0.744 . . . . 0.0 112.096 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -58.67 -21.22 53.72 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.592 1.557 . . . . 0.0 114.977 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -75.76 -34.01 60.23 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.184 0.994 . . . . 0.0 112.753 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -93.66 75.26 1.13 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.026 1.298 . . . . 0.0 112.183 170.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -158.04 146.82 19.19 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.246 1.018 . . . . 0.0 111.008 -171.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 9.1 pt -128.66 157.84 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.45 1.5 . . . . 0.0 111.819 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 21.6 t -105.03 174.74 5.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.538 1.535 . . . . 0.0 111.047 166.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 21.6 mtp85 -57.93 -23.53 53.86 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.007 1.323 . . . . 0.0 113.402 175.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -54.61 -35.88 63.86 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.076 1.751 . . . . 0.0 111.856 171.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -99.18 -35.4 10.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.419 1.088 . . . . 0.0 112.526 169.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 26.3 ttp -65.18 -38.42 90.47 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.49 -1.381 . . . . 0.0 112.36 -172.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -80.23 17.26 1.06 Allowed 'General case' 0 CA--C 1.55 0.962 0 O-C-N 121.349 -0.845 . . . . 0.0 112.123 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.98 -30.37 2.72 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.405 2.282 . . . . 0.0 115.005 176.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 35.6 mt -74.22 137.92 43.36 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.59 1.956 . . . . 0.0 112.48 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 47.0 t -67.98 -36.61 80.34 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.036 0.934 . . . . 0.0 111.834 172.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 3.5 m -59.16 -14.41 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.403 ' CE1' HG13 ' A' ' 497' ' ' VAL 0.261 94.0 m-85 -116.58 16.74 15.48 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 170.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -8.47 12.53 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 16.7 p -148.52 -46.05 0.15 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.828 2.051 . . . . 0.0 112.527 -159.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -81.79 140.52 34.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.222 1.809 . . . . 0.0 113.783 -175.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -134.57 123.0 16.04 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.792 0.837 . . . . 0.0 112.921 -169.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.3 174.49 9.87 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.354 3.37 . . . . 0.0 113.357 170.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.485 ' H ' HD13 ' A' ' 483' ' ' LEU . . . 82.1 -16.71 20.94 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.671 1.605 . . . . 0.0 116.798 170.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -57.53 139.21 81.22 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 118.801 1.3 . . . . 0.0 112.661 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.48 108.73 2.09 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.773 2.315 . . . . 0.0 112.083 -172.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.496 ' ND2' ' H ' ' A' ' 421' ' ' ARG . 7.5 t30 -156.64 149.41 23.75 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.693 1.597 . . . . 0.0 109.269 167.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' CYS . . . . . . . . . . . . . 31.4 p -86.1 -10.71 54.39 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 173.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.496 ' H ' ' ND2' ' A' ' 419' ' ' ASN . 33.6 mtm180 -106.26 142.32 36.13 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.957 0.903 . . . . 0.0 110.022 172.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.16 162.59 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.373 1.469 . . . . 0.0 110.44 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -144.47 161.07 39.98 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.0 t -139.22 131.92 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.196 1.399 . . . . 0.0 113.422 -165.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -98.81 163.77 12.48 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.582 1.153 . . . . 0.0 111.904 167.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . 0.287 98.0 m-20 75.78 34.9 0.54 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.925 2.09 . . . . 0.0 116.592 172.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.95 160.59 29.05 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.182 -0.949 . . . . 0.0 111.143 167.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.33 177.7 5.7 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.074 1.75 . . . . 0.0 114.172 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -82.41 -48.44 11.12 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.983 -1.073 . . . . 0.0 110.544 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -69.49 -18.98 63.74 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 1.2 p -77.08 139.84 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 121.008 -1.057 . . . . 0.0 113.08 171.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -120.65 167.22 12.67 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.189 1.396 . . . . 0.0 111.703 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.97 -34.1 58.81 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.94 -1.1 . . . . 0.0 112.657 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -59.97 -23.44 63.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.163 1.385 . . . . 0.0 114.675 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -87.57 -33.43 18.9 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.05 -19.69 64.63 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.699 1.6 . . . . 0.0 112.645 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -25.16 49.19 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.381 1.073 . . . . 0.0 112.869 174.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -60.01 -34.78 73.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.573 0.749 . . . . 0.0 112.4 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' ILE . . . . . . . . . . . . . 4.4 mt -103.3 -57.0 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.635 -0.666 . . . . 0.0 110.739 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -59.55 -29.49 67.96 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.95 -11.41 84.73 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.806 -0.997 . . . . 0.0 114.847 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -62.49 -36.2 81.77 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.015 1.407 . . . . 0.0 111.435 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -77.47 3.37 13.59 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.926 1.69 . . . . 0.0 114.989 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 14.9 t -123.94 126.08 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.942 1.697 . . . . 0.0 110.593 -173.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -59.63 133.3 55.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -73.43 -23.14 60.09 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 99.0 p -92.14 -51.72 5.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.695 1.198 . . . . 0.0 113.262 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.2 m -76.45 118.78 19.48 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.412 0.685 . . . . 0.0 111.718 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -54.65 -49.59 70.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.115 1.366 . . . . 0.0 112.098 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' THR . . . . . . . . . . . . . 1.7 t -54.97 -15.2 1.85 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -88.75 -62.97 1.37 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.239 1.015 . . . . 0.0 110.228 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.17 -26.27 63.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.048 0.939 . . . . 0.0 113.253 -175.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.9 tt -58.18 -40.34 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.816 0.847 . . . . 0.0 111.857 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 9.2 mtm -86.93 -9.12 56.42 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.944 0.898 . . . . 0.0 112.334 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -87.6 125.83 34.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.853 1.661 . . . . 0.0 115.281 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -163.11 136.15 5.63 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.322 1.449 . . . . 0.0 110.195 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 10.7 mt -113.06 143.14 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.769 1.228 . . . . 0.0 111.55 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -129.57 143.21 50.73 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.822 1.649 . . . . 0.0 110.623 160.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 0.522 HD23 ' HE2' ' A' ' 461' ' ' LYS . 19.1 tp -123.59 119.65 30.52 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.871 2.069 . . . . 0.0 110.098 174.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -81.84 143.38 31.77 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.487 1.515 . . . . 0.0 112.25 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . 0.522 ' HE2' HD23 ' A' ' 459' ' ' LEU . 53.5 mmtt -130.9 8.99 4.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.107 1.763 . . . . 0.0 114.816 -167.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -145.49 143.38 29.96 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.615 1.166 . . . . 0.0 113.292 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 78.92 -160.58 46.8 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 126.514 2.007 . . . . 0.0 114.521 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.02 -18.05 59.28 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.833 -1.393 . . . . 0.0 113.269 172.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' MET . . . . . . . . . . . . . 98.2 mmm -83.86 -1.49 54.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.153 1.781 . . . . 0.0 114.546 171.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.6 127.0 29.34 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.701 -1.249 . . . . 0.0 111.834 176.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.71 17.93 80.04 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.779 -175.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -108.33 139.77 42.56 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.799 0.8 . . . . 0.0 112.188 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -123.06 147.42 46.73 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.876 1.27 . . . . 0.0 112.736 -174.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -107.14 140.59 39.75 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.323 1.449 . . . . 0.0 114.629 161.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.61 113.81 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.239 1.816 . . . . 0.0 109.032 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -76.38 125.24 7.58 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 160.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 37.4 mt -101.15 159.77 28.54 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.126 0.963 . . . . 0.0 109.484 165.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.3 -10.46 17.61 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.895 1.73 . . . . 0.0 114.222 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -151.16 138.67 19.55 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.467 1.107 . . . . 0.0 110.583 -171.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -56.18 -35.23 66.99 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 171.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -62.07 -42.29 99.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.844 0.747 . . . . 0.0 112.608 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.9 92.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.127 0.571 . . . . 0.0 111.24 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -66.56 -50.43 63.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.437 0.562 . . . . 0.0 112.418 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.24 72.63 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.75 1.159 . . . . 0.0 112.047 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -70.9 -46.58 62.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.085 1.354 . . . . 0.0 112.834 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.15 -37.4 77.2 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.771 0.714 . . . . 0.0 112.415 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.518 HD23 HG12 ' A' ' 498' ' ' VAL . 79.8 mt -70.41 -25.84 63.41 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.667 1.187 . . . . 0.0 112.548 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.61 -24.29 36.51 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.711 1.204 . . . . 0.0 112.647 175.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -104.87 -48.08 3.85 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -77.74 -15.88 58.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.621 1.168 . . . . 0.0 113.468 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -73.65 112.66 9.96 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.442 -0.787 . . . . 0.0 109.666 -174.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . 110.32 -4.82 29.9 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 118.858 -0.968 . . . . 0.0 115.298 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -69.48 129.43 39.69 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.492 1.146 . . . . 0.0 108.54 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . 0.252 3.5 p -120.81 68.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 124.394 2.045 . . . . 0.0 108.87 -162.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 39.2 tp -61.25 139.15 58.2 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 112.763 -2.017 . . . . 0.0 109.588 168.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' PHE . . . . . . . . . . . . 0.324 75.5 t80 61.05 13.97 5.04 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 173.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 80.1 11.02 84.87 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.476 1.512 . . . . 0.0 114.896 -171.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -121.86 120.57 28.48 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 126.472 1.909 . . . . 0.0 110.832 -173.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.71 121.84 7.71 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 C-N-CA 122.774 2.316 . . . . 0.0 110.79 -175.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' MET . . . . . . . . . . . . . 59.9 mtp -76.89 129.79 36.68 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.919 1.688 . . . . 0.0 112.293 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . 0.403 HG13 ' CE1' ' A' ' 410' ' ' PHE . 4.4 t -92.46 90.42 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.681 1.592 . . . . 0.0 112.306 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.518 HG12 HD23 ' A' ' 483' ' ' LEU . 2.6 t -85.67 120.52 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.989 1.315 . . . . 0.0 112.102 -172.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -135.99 157.38 46.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.22 1.008 . . . . 0.0 113.63 -168.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -59.74 145.41 45.23 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 163.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -56.03 140.76 42.44 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -82.21 49.29 1.39 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.614 1.166 . . . . 0.0 112.693 -173.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 16.4 m -68.07 -30.31 69.48 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.903 1.281 . . . . 0.0 114.146 -165.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' ALA . . . . . . . . . . . . . . . -79.76 -14.96 58.35 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.188 0.995 . . . . 0.0 113.682 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 43.58 54.66 11.21 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 126.637 1.975 . . . . 0.0 114.03 169.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.11 144.36 81.48 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.1 2.533 . . . . 0.0 113.348 -172.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -54.3 121.77 8.94 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.719 1.608 . . . . 0.0 113.976 -168.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -63.18 133.28 54.07 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.228 1.411 . . . . 0.0 112.039 175.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -61.46 145.14 91.44 Favored Pre-proline 0 N--CA 1.475 0.81 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 170.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.0 158.02 38.39 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.868 2.379 . . . . 0.0 113.566 -173.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.01 160.04 0.79 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.895 -1.502 . . . . 0.0 114.053 161.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -83.8 169.31 15.31 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.872 1.269 . . . . 0.0 111.188 162.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . . . . . . . . . . . -70.96 19.01 0.77 Allowed Glycine 0 CA--C 1.539 1.553 0 N-CA-C 116.553 1.381 . . . . 0.0 116.553 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -64.09 110.33 2.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.729 1.611 . . . . 0.0 109.938 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -152.95 135.99 15.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.567 1.947 . . . . 0.0 110.855 -167.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 53.8 mttp . . . . . 0 C--O 1.253 1.242 0 C-N-CA 124.864 1.266 . . . . 0.0 113.645 176.196 . . . . . . . . 0 0 . 1 stop_ save_